data_1ss2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ss2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.637 0.256 . . . . 0.0 111.455 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.657 HD12 ' H ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -51.39 140.33 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.379 . . . . 0.0 111.28 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.606 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 87.2 m -55.28 157.79 3.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.061 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.7 p -47.69 128.54 13.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.328 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.678 ' HB2' ' HZ2' ' A' ' 101' ' ' LYS . 10.1 mtmp? -80.44 -21.51 42.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.206 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.4 p -53.13 -40.97 64.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.573 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.663 ' HA ' ' HE3' ' A' ' 153' ' ' LYS . 2.6 m-85 -52.91 -31.29 39.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.551 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.445 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 96.6 mt -50.66 -42.89 57.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.816 0.341 . . . . 0.0 110.916 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.439 HG21 ' N ' ' A' ' 106' ' ' LEU . 73.7 m -95.03 142.22 27.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.054 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.439 ' N ' HG21 ' A' ' 105' ' ' THR . 47.3 tp -145.31 127.7 15.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.833 0.349 . . . . 0.0 110.893 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -73.01 144.24 47.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.158 0.504 . . . . 0.0 111.276 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 57.91 32.85 22.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.241 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' A' ' 130' ' ' CYS . . . -176.98 -166.9 34.67 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.771 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -142.0 145.17 34.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.724 0.297 . . . . 0.0 110.786 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 104' ' ' LEU . 72.7 t -106.29 135.45 44.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.016 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.465 ' O ' HG23 ' A' ' 126' ' ' VAL . 2.7 m-85 -110.24 120.52 42.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.286 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.539 ' N ' HD21 ' A' ' 113' ' ' LEU . 2.9 mm? -103.27 147.11 27.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.489 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.9 m -157.02 132.93 9.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.431 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 64.03 49.89 64.22 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.096 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.51 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . 178.08 136.47 2.53 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.996 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -174.93 124.38 0.26 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.592 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 7.2 tt -51.41 137.48 30.57 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.891 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.543 ' HA ' ' HG ' ' A' ' 118' ' ' LEU . 71.2 Cg_endo -89.19 60.42 0.31 Allowed 'Cis proline' 0 C--N 1.345 0.393 0 C-N-CA 123.558 -1.434 . . . . 0.0 113.02 0.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.592 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -155.61 162.1 40.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.597 0.237 . . . . 0.0 110.822 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.654 HD11 ' N ' ' A' ' 122' ' ' ASP . 1.7 pp -168.35 -34.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.744 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.654 ' N ' HD11 ' A' ' 121' ' ' LEU . 63.2 t0 36.38 51.13 0.82 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.925 0.393 . . . . 0.0 110.959 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.532 ' H ' HD11 ' A' ' 121' ' ' LEU . . . 68.8 47.84 52.88 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.837 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.51 ' HB2' ' HA3' ' A' ' 116' ' ' GLY . . . -54.74 139.19 40.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.989 0.423 . . . . 0.0 111.697 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -107.27 151.51 25.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.379 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.535 HG12 ' HZ3' ' A' ' 149' ' ' TRP . 5.1 p -143.66 133.46 20.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.407 0.623 . . . . 0.0 112.232 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -105.04 131.58 52.37 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.543 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.408 ' HE1' HG13 ' A' ' 126' ' ' VAL . 3.5 m-85 -102.8 143.52 32.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.004 0.43 . . . . 0.0 111.732 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -162.94 125.15 2.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.383 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.417 ' HA ' ' CA ' ' A' ' 109' ' ' GLY . 63.9 m -89.27 170.11 10.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.207 0.527 . . . . 0.0 112.222 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.7 157.01 2.85 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.636 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.87 69.37 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.025 2.483 . . . . 0.0 112.413 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -173.25 -31.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.861 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.771 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 3.7 m-85 -108.14 132.93 53.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.833 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.464 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 18.9 p-80 -102.13 125.98 48.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.012 0.434 . . . . 0.0 110.726 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.594 HD21 ' HG ' ' A' ' 140' ' ' SER . 20.5 tp -72.65 126.9 31.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.042 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.418 HG21 ' C ' ' A' ' 136' ' ' LEU . 22.0 t -135.39 60.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.584 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -170.59 -131.38 1.33 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 119.801 -1.19 . . . . 0.0 113.419 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.59 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 56.6 p -73.53 55.32 0.49 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 111.431 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.594 ' HG ' HD21 ' A' ' 136' ' ' LEU . 42.3 t -57.88 -42.11 83.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.136 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -99.37 132.24 44.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.068 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.0 p -149.84 145.02 26.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.302 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 124' ' ' ALA . 7.2 p -138.62 134.41 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.998 0.428 . . . . 0.0 111.698 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.435 ' SG ' HD21 ' A' ' 121' ' ' LEU . 37.9 t -67.46 134.87 52.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.023 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.1 m -165.63 130.03 2.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.072 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 50.9 tt0 53.62 45.25 28.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.966 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 56.91 43.51 92.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.603 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -173.12 140.56 0.89 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.352 . . . . 0.0 110.652 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.606 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 28.5 m95 -84.24 140.99 31.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.732 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 67.1 m -52.82 -56.51 15.24 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.015 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 60.6 p -117.65 133.59 23.28 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.05 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.534 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 43.9 Cg_endo -67.8 -155.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.548 2.166 . . . . 0.0 112.758 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.663 ' HE3' ' HA ' ' A' ' 103' ' ' TYR . 27.8 mmtp -81.05 129.3 67.85 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.288 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.59 ' HB3' ' N ' ' A' ' 139' ' ' SER . 83.0 Cg_endo -81.61 -146.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.837 2.358 . . . . 0.0 112.242 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.453 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 24.3 p-80 -153.66 126.29 8.17 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.93 0.395 . . . . 0.0 111.328 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . 0.771 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 76.2 m -99.13 130.34 45.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.156 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.464 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 4.3 tp-100 -103.92 140.14 38.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.005 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.448 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 9.7 p -75.35 136.09 25.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.388 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.49 ' N ' HD21 ' A' ' 159' ' ' ASN . 2.1 m120 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.18 -0.914 . . . . 0.0 110.94 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.744 0.307 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.476 ' HA ' HD23 ' A' ' 121' ' ' LEU . 20.9 pt -157.83 43.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.032 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.479 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 90.1 m 62.18 139.18 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.748 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.5 m -47.88 131.51 15.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.399 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -83.75 -28.64 28.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.079 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.2 p -53.18 -35.49 59.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.509 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.843 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.8 m-85 -50.86 -36.39 37.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.41 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.742 HD21 HG21 ' A' ' 114' ' ' THR . 88.4 mt -53.44 -44.45 68.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.955 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.1 m -92.55 133.99 35.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.25 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.2 tp -145.39 132.77 20.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.692 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.31 131.53 50.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.672 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m120 54.66 44.93 27.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.662 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.03 165.36 34.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.509 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -141.88 151.41 42.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.005 0.431 . . . . 0.0 110.942 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.48 HG12 ' HB ' ' A' ' 126' ' ' VAL . 95.1 t -111.18 141.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.253 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -106.57 134.46 49.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.406 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.653 HD23 ' N ' ' A' ' 114' ' ' THR . 6.3 tt 69.79 129.96 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.374 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.742 HG21 HD21 ' A' ' 104' ' ' LEU . 92.0 m -109.37 -45.99 3.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.929 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.595 ' HA3' ' HA ' ' A' ' 124' ' ' ALA . . . 79.92 53.44 4.24 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.26 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -142.19 150.67 22.29 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.462 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -159.67 65.81 0.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.967 0.413 . . . . 0.0 110.034 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.551 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 90.2 mt -38.39 137.77 0.78 Allowed Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.171 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -89.03 59.9 0.32 Allowed 'Cis proline' 0 CA--C 1.531 0.366 0 C-N-CA 123.762 -1.349 . . . . 0.0 113.265 0.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.551 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -164.13 126.3 2.38 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.927 0.394 . . . . 0.0 111.471 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 115' ' ' GLY . 26.6 tp -78.87 -55.84 4.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.481 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.7 t70 38.37 109.13 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 55.46 54.6 33.42 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.728 -0.669 . . . . 0.0 114.224 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.595 ' HA ' ' HA3' ' A' ' 115' ' ' GLY . . . -73.66 132.5 42.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.948 0.374 . . . . 0.0 110.894 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.516 ' HB2' HD21 ' A' ' 113' ' ' LEU . 62.2 mtt85 -137.97 153.63 49.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.617 HG21 ' HE1' ' A' ' 128' ' ' PHE . 12.5 m -154.6 131.04 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.946 0.403 . . . . 0.0 111.322 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -107.59 117.78 34.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.32 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.617 ' HE1' HG21 ' A' ' 126' ' ' VAL . 4.6 m-85 -86.56 141.38 29.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.121 0.486 . . . . 0.0 111.516 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.46 ' HG2' HH11 ' A' ' 129' ' ' ARG . 3.5 ptp85 -161.01 128.95 4.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.761 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 136' ' ' LEU . 20.7 t -89.2 147.41 24.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.744 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.664 ' OD1' ' HD2' ' A' ' 132' ' ' PRO . 36.4 t70 -52.72 145.75 20.56 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.906 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.664 ' HD2' ' OD1' ' A' ' 131' ' ' ASP . 3.2 Cg_exo -40.45 157.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.596 2.864 . . . . 0.0 112.545 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 55.6 m-20 80.93 -40.31 0.15 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.408 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -106.32 128.99 54.41 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.453 ' HE1' ' HA ' ' A' ' 159' ' ' ASN . 16.9 p-80 -102.76 128.32 49.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.973 0.416 . . . . 0.0 110.981 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.551 HD11 ' HG2' ' A' ' 154' ' ' PRO . 20.5 tp -74.55 127.33 32.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.497 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.6 t -131.13 72.2 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.79 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' A' ' 154' ' ' PRO . . . -167.55 56.72 0.22 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.799 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 141' ' ' ARG . 41.1 t 51.46 65.05 1.61 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.46 ' CA ' ' HB2' ' A' ' 128' ' ' PHE . 96.0 p -70.43 38.81 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.53 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.441 ' H ' ' C ' ' A' ' 139' ' ' SER . 40.1 ttm180 -141.21 133.99 28.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.209 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.488 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 64.7 m -146.21 140.33 26.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.941 0.401 . . . . 0.0 111.319 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.496 ' HA ' ' HZ3' ' A' ' 149' ' ' TRP . 7.2 p -144.47 129.48 14.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.873 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 71.9 m -71.49 156.28 39.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.582 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.9 t -158.72 -29.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.471 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -149.29 48.08 0.97 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.719 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.82 35.49 89.72 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.493 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -159.19 146.81 17.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.706 0.288 . . . . 0.0 110.462 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.496 ' HZ3' ' HA ' ' A' ' 143' ' ' VAL . 68.3 m95 -84.19 142.22 30.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.864 0.364 . . . . 0.0 110.777 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' A' ' 142' ' ' SER . 46.9 t -47.91 -45.52 30.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.141 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.6 p -136.61 143.94 45.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.838 0.352 . . . . 0.0 111.797 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.518 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 24.0 Cg_exo -64.01 -159.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.856 2.371 . . . . 0.0 112.818 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.843 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 14.4 mmmm -86.12 127.14 62.94 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.263 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.551 ' HG2' HD11 ' A' ' 136' ' ' LEU . 92.4 Cg_endo -79.89 -149.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.741 2.294 . . . . 0.0 112.637 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.464 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 17.9 p-80 -153.7 150.04 28.14 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.073 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 77.8 m -97.43 138.1 35.38 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.381 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -108.55 136.05 48.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.554 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.4 p -82.47 52.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.498 0.666 . . . . 0.0 110.301 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.453 ' HA ' ' HE1' ' A' ' 135' ' ' HIS . 76.1 m-20 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.374 -0.822 . . . . 0.0 111.069 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.962 0.411 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.453 ' H ' HD13 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -60.15 138.36 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.166 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.579 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 75.6 m -60.58 140.99 57.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.677 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.2 m -47.87 128.71 13.7 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.53 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 101' ' ' LYS . 26.3 ttpp -82.76 11.01 6.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.6 t -68.31 -40.46 81.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.332 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.616 ' HH ' ' HA ' ' A' ' 152' ' ' PRO . 1.3 m-85 -59.59 -40.73 88.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.413 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.672 HD21 HD13 ' A' ' 113' ' ' LEU . 6.8 mp -49.28 -43.62 43.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.6 0.238 . . . . 0.0 111.295 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.4 t -92.56 126.06 37.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.861 0.362 . . . . 0.0 110.765 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.598 HD22 ' HZ3' ' A' ' 153' ' ' LYS . 14.0 tp -145.7 133.16 20.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.465 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -71.55 134.32 46.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.345 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 57.74 40.7 26.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.632 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -179.56 156.98 19.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.937 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -123.47 141.78 51.65 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 112' ' ' PHE . 90.5 t -109.94 142.36 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.253 0.549 . . . . 0.0 112.003 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.535 ' N ' HG12 ' A' ' 111' ' ' VAL . 4.6 m-85 -103.42 139.87 38.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.738 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.672 HD13 HD21 ' A' ' 104' ' ' LEU . 1.5 pt? -139.21 57.69 1.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.029 0.442 . . . . 0.0 111.793 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.9 p -54.48 142.81 26.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.698 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.67 137.95 5.08 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.235 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 178.03 149.58 8.09 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.358 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -151.02 58.1 0.91 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.696 ' N ' HD21 ' A' ' 118' ' ' LEU . 2.0 pt? -40.6 136.17 1.48 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.159 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -89.05 61.18 0.27 Allowed 'Cis proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.663 -1.39 . . . . 0.0 113.254 0.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.566 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -165.56 130.81 2.49 Favored 'General case' 0 C--O 1.23 0.064 0 CA-C-O 120.895 0.379 . . . . 0.0 111.335 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.546 ' O ' ' HB2' ' A' ' 124' ' ' ALA . 1.1 pt? -112.56 48.65 0.98 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.991 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -62.77 133.37 54.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.64 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.86 33.34 82.89 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.489 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 121' ' ' LEU . . . -78.11 135.07 37.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.691 0.281 . . . . 0.0 110.966 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -105.08 136.42 44.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.018 0.437 . . . . 0.0 110.422 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.536 HG21 ' CZ3' ' A' ' 149' ' ' TRP . 2.6 t -132.08 137.1 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.957 -178.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.519 ' HG3' ' HB2' ' A' ' 112' ' ' PHE . 9.3 pt-20 -132.66 117.48 17.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.921 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.536 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 2.9 m-85 -77.4 147.53 35.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.211 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -145.8 117.75 8.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.663 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 16.9 t -89.22 147.67 24.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 111.254 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -52.71 152.1 7.26 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.312 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.481 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 1.1 Cg_endo -44.44 158.38 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.366 2.711 . . . . 0.0 112.738 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 38.5 t70 77.98 -31.89 0.16 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.959 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.421 ' H ' ' C ' ' A' ' 132' ' ' PRO . 2.3 m-85 -108.89 127.18 53.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.679 0.276 . . . . 0.0 110.511 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -104.95 135.36 46.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 110.903 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.402 HD23 ' CB ' ' A' ' 140' ' ' SER . 25.7 tp -71.58 133.35 45.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.466 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.69 61.37 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.538 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -168.41 -135.58 1.91 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.914 -1.136 . . . . 0.0 113.091 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.577 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 93.4 p -74.26 61.82 0.9 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.808 0.337 . . . . 0.0 111.039 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.402 ' CB ' HD23 ' A' ' 136' ' ' LEU . 91.3 p -63.14 4.41 0.2 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.413 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.529 ' H ' ' C ' ' A' ' 139' ' ' SER . 16.8 ptm180 -140.53 133.9 29.84 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.955 0.407 . . . . 0.0 110.944 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 54.9 m -150.73 140.76 22.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.868 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 124' ' ' ALA . 14.2 p -126.93 131.86 70.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.996 0.427 . . . . 0.0 111.63 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 52.6 t -80.49 148.29 30.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.271 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 89.2 p -150.67 -137.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.936 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.43 ' H ' ' CD ' ' A' ' 146' ' ' GLN . 14.7 mp0 -55.88 -38.62 70.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.94 0.4 . . . . 0.0 110.55 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 148' ' ' GLN . . . 179.93 145.46 6.44 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.708 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 147' ' ' GLY . 69.0 tp60 69.67 147.74 0.07 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.915 0.388 . . . . 0.0 110.633 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.579 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 26.9 m95 -84.16 147.52 27.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.234 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.6 t -51.85 -55.02 22.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.106 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.54 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 74.8 p -123.39 134.58 25.3 Favored Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.66 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.616 ' HA ' ' HH ' ' A' ' 103' ' ' TYR . 27.0 Cg_exo -61.82 143.19 95.67 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.825 2.35 . . . . 0.0 111.879 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.598 ' HZ3' HD22 ' A' ' 106' ' ' LEU . 21.9 ttmm -42.45 133.33 2.74 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 111.601 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.577 ' HB3' ' N ' ' A' ' 139' ' ' SER . 73.5 Cg_endo -75.26 -143.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.88 2.386 . . . . 0.0 112.678 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.487 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 22.9 p-80 -153.68 154.43 34.11 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.292 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 89.6 m -95.7 140.37 30.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.065 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -132.96 144.41 50.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.262 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.432 ' O ' HG12 ' A' ' 158' ' ' VAL . 6.2 p -75.11 133.52 31.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.457 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.9 p30 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.966 -179.617 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.974 0.416 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.442 ' HA ' HD12 ' A' ' 121' ' ' LEU . 38.6 pt -55.49 147.12 4.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 39.4 m -47.28 148.42 1.28 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.027 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.428 ' HB2' ' CD1' ' A' ' 149' ' ' TRP . 54.1 m -47.85 127.17 11.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.057 0.456 . . . . 0.0 111.252 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -85.25 -25.21 27.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.27 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.2 m -53.08 -41.15 64.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.552 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.505 ' HH ' ' HA ' ' A' ' 152' ' ' PRO . 1.4 m-85 -56.46 -41.57 76.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.887 0.375 . . . . 0.0 110.713 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.5 mt -59.9 -35.3 74.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.0 p -91.87 77.92 5.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.162 0.506 . . . . 0.0 110.569 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.593 ' C ' HD22 ' A' ' 106' ' ' LEU . 7.2 tt -93.88 125.47 38.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.577 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -68.1 127.61 33.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 62.94 48.47 3.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 0.0 110.583 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.453 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . -158.56 -163.47 12.96 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.62 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.705 ' HB3' ' HZ1' ' A' ' 110' ' ' LYS . 8.2 mtpm? -144.02 -41.6 0.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.554 HG21 ' HA ' ' A' ' 128' ' ' PHE . 13.7 p 52.02 136.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 123.594 0.758 . . . . 0.0 112.581 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -108.11 142.74 37.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.586 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.465 HD12 ' CG1' ' A' ' 126' ' ' VAL . 24.9 tp -120.31 136.15 54.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.608 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.5 p -145.0 139.1 27.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.211 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 66.36 44.1 91.25 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.457 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -179.49 130.6 1.53 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.974 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.765 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 54.3 m-20 -160.25 121.35 3.06 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.585 ' CD1' ' HA ' ' A' ' 119' ' ' PRO . 40.6 tp -38.58 133.51 1.01 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.279 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.585 ' HA ' ' CD1' ' A' ' 118' ' ' LEU . 77.1 Cg_endo -92.43 44.69 2.24 Favored 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.56 -1.433 . . . . 0.0 113.399 0.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.765 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -81.12 148.26 29.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.803 0.335 . . . . 0.0 111.209 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 121' ' ' LEU . 3.6 tt -162.45 79.27 0.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.309 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -167.07 122.07 1.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.595 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.7 31.16 29.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.718 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.9 127.66 33.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.631 0.253 . . . . 0.0 110.804 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -125.46 143.4 51.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 111.021 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.465 ' CG1' HD12 ' A' ' 113' ' ' LEU . 30.0 m -133.24 135.7 56.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.133 0.492 . . . . 0.0 111.598 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -109.36 88.83 2.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.312 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.554 ' HA ' HG21 ' A' ' 111' ' ' VAL . 67.0 m-85 -55.44 141.64 35.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 111.178 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.46 ' HG2' HH11 ' A' ' 129' ' ' ARG . 13.8 tpp85 -143.4 129.13 19.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.897 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 35.9 t -89.17 153.13 21.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.087 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -52.75 154.09 5.17 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.313 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.493 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 8.1 Cg_endo -49.64 155.47 3.71 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.802 2.334 . . . . 0.0 111.356 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 11.4 m-20 79.37 -29.74 0.14 Allowed 'General case' 0 N--CA 1.463 0.221 0 O-C-N 123.377 0.423 . . . . 0.0 110.098 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.746 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 1.6 m-85 -105.7 152.22 23.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.806 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -133.03 131.44 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.991 0.424 . . . . 0.0 111.442 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.767 HD23 ' HA ' ' A' ' 140' ' ' SER . 42.8 tp -69.37 133.81 48.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.428 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.0 t -131.33 70.93 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.905 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.27 -132.54 1.96 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.349 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.701 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 49.4 m -73.15 58.82 0.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 122.712 0.405 . . . . 0.0 111.177 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.767 ' HA ' HD23 ' A' ' 136' ' ' LEU . 87.6 p -56.91 -28.13 61.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.688 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.437 HH11 ' HG3' ' A' ' 141' ' ' ARG . 20.1 mmt85 -109.95 139.21 45.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.991 0.424 . . . . 0.0 111.914 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.776 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 68.0 m -150.7 142.04 23.33 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.438 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.648 ' H ' ' H ' ' A' ' 150' ' ' SER . 7.7 p -145.49 137.34 20.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 111.648 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 41.3 m -60.36 159.03 10.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.73 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.8 t -162.8 -29.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.158 0.504 . . . . 0.0 110.67 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -166.68 57.07 0.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.975 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.6 37.84 89.76 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.541 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -155.33 -149.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.045 0.45 . . . . 0.0 110.395 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.776 ' HB3' ' HB3' ' A' ' 142' ' ' SER . 86.6 m95 -146.54 155.6 42.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.329 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.648 ' H ' ' H ' ' A' ' 143' ' ' VAL . 47.5 t -41.93 -50.23 4.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.414 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.488 ' CG2' ' HB3' ' A' ' 139' ' ' SER . 1.5 t -147.44 145.89 23.15 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.505 ' HA ' ' HH ' ' A' ' 103' ' ' TYR . 76.1 Cg_exo -47.15 156.99 0.7 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.431 2.754 . . . . 0.0 113.302 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.459 ' HZ3' ' HG ' ' A' ' 106' ' ' LEU . 60.1 tttm -56.6 129.04 75.97 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.984 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.701 ' HB3' ' N ' ' A' ' 139' ' ' SER . 74.3 Cg_endo -75.02 -147.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.647 2.231 . . . . 0.0 112.568 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.449 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 23.2 p-80 -153.7 144.91 22.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.346 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . 0.746 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 47.6 t -95.21 132.18 40.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.949 0.404 . . . . 0.0 110.575 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.408 ' NE2' ' HA ' ' A' ' 157' ' ' GLN . 3.0 tp-100 -116.69 138.54 51.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.952 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 158' ' ' VAL . 7.5 p -82.32 131.71 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.167 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 25.0 p30 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.958 -179.565 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.574 ' NH1' ' HA3' ' A' ' 147' ' ' GLY . 33.2 ptt85 . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 121.066 0.46 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.5 pt -53.77 154.46 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.345 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.471 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 84.1 m -46.38 141.57 3.48 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.971 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.7 m -47.9 124.76 7.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.822 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -81.88 -13.18 57.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.28 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.2 p -53.12 -38.06 62.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.253 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.903 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 5.4 m-85 -48.48 -31.83 6.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.43 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.465 ' O ' HG21 ' A' ' 105' ' ' THR . 90.6 mt -77.23 39.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.583 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.465 HG21 ' O ' ' A' ' 104' ' ' LEU . 70.6 p -147.36 58.58 1.15 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.886 0.374 . . . . 0.0 110.373 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.563 HD11 ' HZ2' ' A' ' 153' ' ' LYS . 35.6 tp -93.83 130.52 39.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.584 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.544 ' HG2' ' ND2' ' A' ' 108' ' ' ASN . 89.3 tt0 -72.0 137.03 46.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.735 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.544 ' ND2' ' HG2' ' A' ' 107' ' ' GLU . 74.8 m-20 59.31 40.82 20.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.075 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.24 -166.44 13.14 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.375 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 111' ' ' VAL . 54.5 mtpt -142.14 -41.06 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.441 0.12 . . . . 0.0 111.102 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 128' ' ' PHE . 9.0 p 51.0 133.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.735 0.814 . . . . 0.0 112.903 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.407 ' N ' HG22 ' A' ' 111' ' ' VAL . 2.7 m-85 -112.15 -167.05 1.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.448 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.598 HD22 ' N ' ' A' ' 114' ' ' THR . 8.1 tt -173.33 141.48 0.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.285 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.598 ' N ' HD22 ' A' ' 113' ' ' LEU . 89.8 m -154.07 145.97 23.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.159 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.496 ' N ' HG21 ' A' ' 114' ' ' THR . . . 76.29 43.94 19.02 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.147 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.494 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . 174.28 140.57 3.31 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.067 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -166.47 129.83 1.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.739 0.304 . . . . 0.0 110.241 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.558 HD13 ' H ' ' A' ' 118' ' ' LEU . 5.7 mp -52.07 135.2 39.27 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.812 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -94.35 63.27 0.36 Allowed 'Cis proline' 0 N--CA 1.46 -0.453 0 C-N-CA 124.098 -1.209 . . . . 0.0 113.059 0.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -149.53 134.03 17.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.882 0.373 . . . . 0.0 111.689 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.499 HD11 ' SG ' ' A' ' 144' ' ' CYS . 88.1 mt -102.35 -45.07 5.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.801 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.412 ' OD1' ' HA2' ' A' ' 116' ' ' GLY . 10.2 p-10 36.4 47.97 0.55 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.512 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.94 45.86 94.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.302 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.494 ' HB2' ' HA3' ' A' ' 116' ' ' GLY . . . -58.25 136.9 57.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.776 0.322 . . . . 0.0 111.112 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.773 ' HD3' ' HD3' ' A' ' 141' ' ' ARG . 38.6 ttm180 -118.43 119.22 33.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.513 ' HB ' ' HZ3' ' A' ' 149' ' ' TRP . 12.1 p -84.86 148.84 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.045 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.498 ' N ' HG23 ' A' ' 126' ' ' VAL . 56.4 mt-10 -133.7 76.79 1.68 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.233 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.63 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 79.9 m-85 -53.85 151.9 6.05 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.886 0.374 . . . . 0.0 111.058 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -157.11 135.83 11.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.637 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 134' ' ' PHE . 59.6 m -89.23 146.9 24.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.785 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' ASP . 63.4 m-20 -52.69 154.7 4.53 Favored Pre-proline 0 N--CA 1.463 0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.491 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.12 73.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.483 2.789 . . . . 0.0 113.033 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 131' ' ' ASP . 39.0 t70 178.75 -38.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.449 ' O ' ' HB2' ' A' ' 130' ' ' CYS . 3.2 m-85 -108.14 139.22 43.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.529 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -102.52 132.24 48.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.041 0.448 . . . . 0.0 110.794 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.581 HD13 ' HA ' ' A' ' 140' ' ' SER . 6.0 tt -75.14 128.15 34.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.183 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.96 65.05 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.488 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.86 -129.49 1.31 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.304 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.822 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.5 t -71.4 57.19 0.25 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.597 0.359 . . . . 0.0 111.874 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.581 ' HA ' HD13 ' A' ' 136' ' ' LEU . 32.6 t -60.9 -16.6 43.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.122 0.487 . . . . 0.0 110.037 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.773 ' HD3' ' HD3' ' A' ' 125' ' ' ARG . 39.1 ttm180 -140.09 140.29 36.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.901 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.478 ' HB2' ' CG1' ' A' ' 126' ' ' VAL . 33.5 m -149.16 122.62 9.09 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.209 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' A' ' 150' ' ' SER . 11.8 p -83.78 132.55 31.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 111.749 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.499 ' SG ' HD11 ' A' ' 121' ' ' LEU . 16.3 t -83.97 130.35 34.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.592 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.535 ' HG ' ' H ' ' A' ' 146' ' ' GLN . 25.4 t -114.34 -139.48 0.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.543 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.535 ' H ' ' HG ' ' A' ' 145' ' ' SER . 4.3 tp-100 -64.96 -40.82 95.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.807 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.574 ' HA3' ' NH1' ' A' ' 97' ' ' ARG . . . -175.88 46.58 0.12 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.169 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -170.07 134.76 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.734 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.513 ' HZ3' ' HB ' ' A' ' 126' ' ' VAL . 32.4 m95 -84.21 141.43 31.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.582 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.472 ' HB3' HG13 ' A' ' 143' ' ' VAL . 79.2 p -52.66 -60.35 3.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.577 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 27.4 p -114.38 134.18 22.33 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 0.0 111.897 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 16.5 Cg_exo -67.37 150.56 80.98 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.104 2.536 . . . . 0.0 112.179 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.903 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 8.7 mtpm? -42.8 132.27 3.02 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.556 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.822 ' HB3' ' H ' ' A' ' 139' ' ' SER . 98.9 Cg_endo -79.43 -140.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.819 2.346 . . . . 0.0 112.998 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.512 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.0 p-80 -153.64 144.44 22.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.43 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 81.9 m -97.89 133.11 42.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.833 0.349 . . . . 0.0 111.068 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -123.62 140.54 52.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.541 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 158' ' ' VAL . 9.4 p -82.82 132.37 31.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.488 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.7 p30 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.008 -179.531 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 97' ' ' ARG . 68.1 mtt-85 . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.776 0.322 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.9 pt -54.22 140.79 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.36 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 72.8 m -56.3 127.0 28.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.7 t -48.01 128.36 13.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.37 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.825 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -90.23 25.83 2.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.807 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.0 p -68.82 -41.63 78.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.238 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.727 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 3.9 m-85 -56.95 -31.35 64.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.864 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.44 ' O ' ' CG2' ' A' ' 105' ' ' THR . 83.4 mt -53.99 146.72 13.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.761 -0.199 . . . . 0.0 111.098 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.44 ' CG2' ' O ' ' A' ' 104' ' ' LEU . 6.9 t 56.36 138.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.72 0.808 . . . . 0.0 112.367 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.7 tp -145.45 138.96 26.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.971 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.08 44.2 0.56 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.517 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -157.29 -30.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.858 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.633 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . -158.69 -141.36 3.12 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.947 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -139.47 152.26 46.86 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.912 0.386 . . . . 0.0 110.792 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.1 t -109.34 139.47 32.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.208 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.449 ' CE1' ' HD3' ' A' ' 129' ' ' ARG . 2.8 m-85 -108.34 137.56 46.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.05 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.575 HD13 ' O ' ' A' ' 125' ' ' ARG . 0.4 OUTLIER 71.85 133.97 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.697 -179.487 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.501 ' N ' HD13 ' A' ' 113' ' ' LEU . 66.1 p -126.69 -130.59 0.24 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.722 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.39 133.87 45.13 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.033 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.3 -48.87 75.35 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.835 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 118' ' ' LEU . 37.5 t70 -174.47 61.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.448 ' H ' ' CD1' ' A' ' 118' ' ' LEU . 7.2 mp -33.2 132.87 0.33 Allowed Pre-proline 0 N--CA 1.462 0.133 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.3 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -85.89 46.11 0.85 Allowed 'Cis proline' 0 C--N 1.346 0.413 0 C-N-CA 123.661 -1.391 . . . . 0.0 113.49 0.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.441 ' H ' ' CA ' ' A' ' 118' ' ' LEU . . . -85.53 127.64 34.5 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.616 0.246 . . . . 0.0 111.185 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.534 HD21 ' N ' ' A' ' 147' ' ' GLY . 5.7 mp -101.89 -42.63 6.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.034 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.33 61.18 0.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.954 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -177.39 -32.89 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.323 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.417 ' HB1' ' CH2' ' A' ' 149' ' ' TRP . . . -51.59 129.29 25.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.915 0.388 . . . . 0.0 111.162 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.575 ' O ' HD13 ' A' ' 113' ' ' LEU . 55.2 ttp85 -135.24 156.11 49.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.745 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.518 HG12 ' CH2' ' A' ' 149' ' ' TRP . 16.1 m -152.25 135.93 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.871 0.367 . . . . 0.0 111.085 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -121.1 104.26 9.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.132 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.647 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 4.5 m-85 -78.57 143.78 36.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.205 0.526 . . . . 0.0 111.977 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.449 ' HD3' ' CE1' ' A' ' 112' ' ' PHE . 8.0 ptm180 -166.53 124.28 1.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.659 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.633 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 96.3 m -89.22 149.43 23.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.323 0.582 . . . . 0.0 112.453 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.483 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 59.8 m-20 -52.71 159.68 1.67 Allowed Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.939 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 18.2 Cg_endo -59.22 76.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.111 2.54 . . . . 0.0 112.454 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.3 t70 -175.63 -42.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.663 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 5.3 m-85 -108.83 131.86 54.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.416 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.604 ' HE2' ' HB2' ' A' ' 157' ' ' GLN . 0.3 OUTLIER -101.23 121.6 42.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.245 0.545 . . . . 0.0 110.897 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.559 HD21 ' HB3' ' A' ' 140' ' ' SER . 5.5 tt -69.94 125.4 26.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.974 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.474 ' N ' HD23 ' A' ' 136' ' ' LEU . 15.0 t -134.32 63.13 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.578 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -169.98 -135.78 1.97 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.357 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.673 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 63.8 m -75.03 57.18 0.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.914 0.388 . . . . 0.0 111.037 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.559 ' HB3' HD21 ' A' ' 136' ' ' LEU . 99.1 p -51.65 -43.55 62.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.339 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -99.36 138.86 35.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.544 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 44.2 t -150.16 139.7 21.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.863 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.0 p -137.56 127.26 36.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.941 0.4 . . . . 0.0 111.222 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.412 ' HB2' ' CD2' ' A' ' 149' ' ' TRP . 45.8 t -87.71 149.31 24.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.591 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 38.4 t -167.13 30.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.207 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 52.8 tt0 175.7 43.32 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.85 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.534 ' N ' HD21 ' A' ' 121' ' ' LEU . . . 77.9 -51.07 3.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.975 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -88.42 149.37 23.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.544 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 81.7 m95 -84.15 146.27 27.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.911 0.386 . . . . 0.0 110.946 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.3 t -45.0 -55.7 5.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.904 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 72.4 p -126.0 133.12 24.62 Favored Pre-proline 0 C--N 1.329 -0.308 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.775 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.452 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 23.7 Cg_exo -63.65 155.66 61.85 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.993 2.462 . . . . 0.0 112.326 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.727 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 55.1 mtpt -49.19 128.18 16.03 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.874 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.673 ' HB3' ' N ' ' A' ' 139' ' ' SER . 58.2 Cg_endo -71.4 -146.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.631 2.221 . . . . 0.0 112.582 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -153.68 130.51 10.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.894 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . 0.663 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 90.5 m -102.56 136.85 41.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.243 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.604 ' HB2' ' HE2' ' A' ' 135' ' ' HIS . 10.6 mm100 -104.21 147.85 26.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.106 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.3 p -72.73 129.02 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.363 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.522 ' N ' HD21 ' A' ' 159' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.101 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.995 0.426 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.463 HD13 ' O ' ' A' ' 98' ' ' ILE . 2.4 pp -61.27 145.92 12.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.679 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.933 ' HB2' HD23 ' A' ' 121' ' ' LEU . 43.8 m -56.93 135.61 56.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.05 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.0 t -47.9 126.97 11.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.129 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.501 ' HB2' HD13 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -83.06 16.77 2.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.98 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -68.92 -45.72 70.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.301 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.647 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 10.7 m-85 -58.37 -32.15 68.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.796 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 101' ' ' LYS . 86.8 mt -49.77 140.33 11.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.553 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.9 m 67.13 139.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.965 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.528 HD21 ' O ' ' A' ' 107' ' ' GLU . 7.3 tt -145.07 127.7 16.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.308 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.528 ' O ' HD21 ' A' ' 106' ' ' LEU . 23.5 pt-20 -64.98 128.43 35.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 111.213 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 63.68 40.3 7.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.725 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.414 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -170.83 -163.88 25.61 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.548 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -142.37 141.93 32.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.795 0.331 . . . . 0.0 110.891 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.5 t -110.25 129.84 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.99 0.424 . . . . 0.0 110.969 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.2 m-85 -110.7 152.92 25.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.184 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.764 HD13 ' HB2' ' A' ' 124' ' ' ALA . 47.9 tp -154.48 134.03 12.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.008 0.432 . . . . 0.0 111.706 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.5 p -154.05 132.81 12.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.606 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.521 ' HA3' ' HB1' ' A' ' 124' ' ' ALA . . . 164.38 -44.69 0.31 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.688 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -169.67 -127.84 0.96 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.403 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -149.17 -138.57 0.09 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.61 0.243 . . . . 0.0 110.609 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.889 HD11 ' HA ' ' A' ' 119' ' ' PRO . 35.0 tp -125.17 127.44 25.02 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.78 0.324 . . . . 0.0 111.099 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.889 ' HA ' HD11 ' A' ' 118' ' ' LEU . 78.2 Cg_endo -90.99 37.98 4.81 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.266 -1.556 . . . . 0.0 112.713 -0.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.15 37.59 0.82 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.852 0.358 . . . . 0.0 111.481 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.933 HD23 ' HB2' ' A' ' 99' ' ' CYS . 28.1 tp -77.67 0.38 23.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.811 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.59 141.81 58.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.18 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.61 -38.27 1.89 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.151 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.764 ' HB2' HD13 ' A' ' 113' ' ' LEU . . . -51.04 142.82 11.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 0.0 111.615 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.448 ' HG2' HH11 ' A' ' 125' ' ' ARG . 20.3 ptt-85 -127.44 134.63 49.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.924 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.551 HG21 ' CZ3' ' A' ' 149' ' ' TRP . 29.1 m -97.37 139.45 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.218 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -110.39 128.2 55.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.247 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.427 ' CE1' HG22 ' A' ' 126' ' ' VAL . 6.4 m-85 -99.94 141.85 32.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.43 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -150.99 132.15 14.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.297 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 69.1 m -89.16 154.17 20.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.959 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.56 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 1.1 m-20 -52.62 163.45 0.78 Allowed Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.334 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 55.7 Cg_endo -70.0 50.2 0.85 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.075 2.517 . . . . 0.0 113.212 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -149.49 -43.01 0.14 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.416 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 0.8 OUTLIER -108.92 140.72 42.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.833 179.21 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -100.99 128.57 46.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.984 0.421 . . . . 0.0 110.954 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.732 HD22 ' HB2' ' A' ' 140' ' ' SER . 6.1 tt -68.87 130.12 41.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.625 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.552 ' N ' HD21 ' A' ' 136' ' ' LEU . 24.1 t -135.18 63.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.657 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -166.82 -134.04 1.63 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.205 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.668 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 67.2 m -74.95 53.59 0.61 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.74 0.305 . . . . 0.0 111.159 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.732 ' HB2' HD22 ' A' ' 136' ' ' LEU . 35.0 t -52.06 -43.71 63.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 58.9 mtm-85 -99.41 132.42 44.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.803 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.494 ' HB2' HG23 ' A' ' 126' ' ' VAL . 38.3 m -145.63 137.6 25.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.762 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.08 129.34 37.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.966 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 48.8 t -93.71 134.07 36.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 90.4 p -115.44 -35.12 4.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -144.99 -140.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.093 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.74 41.25 2.33 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.491 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -174.94 136.64 0.4 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.809 0.337 . . . . 0.0 110.922 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.551 ' CZ3' HG21 ' A' ' 126' ' ' VAL . 30.4 m95 -84.19 149.39 26.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.839 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -55.9 -65.27 0.63 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.558 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 42.9 p -106.8 139.07 20.01 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.34 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 21.9 Cg_exo -65.17 -155.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.706 2.271 . . . . 0.0 112.558 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.647 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 12.9 mmmm -92.67 131.94 32.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.335 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.668 ' HB3' ' N ' ' A' ' 139' ' ' SER . 89.6 Cg_endo -84.55 -155.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.798 2.332 . . . . 0.0 112.786 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -153.7 148.86 26.88 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.764 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 84.0 m -97.41 131.38 44.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.817 0.342 . . . . 0.0 110.865 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -110.36 141.1 43.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.016 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.14 128.47 38.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.425 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.018 -179.714 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.819 ' H ' ' HD2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.724 0.297 . . . . 0.0 111.371 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 30.2 pt -56.4 139.38 15.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.918 0.389 . . . . 0.0 111.13 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 36.8 m -57.22 137.43 55.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.874 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.1 t -47.93 124.31 7.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.039 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -82.26 21.63 0.9 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.387 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.0 t -68.85 -45.13 71.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.918 0.39 . . . . 0.0 111.057 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.543 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.2 m-85 -60.15 -31.33 69.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.304 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.469 ' O ' HG22 ' A' ' 111' ' ' VAL . 71.6 mt -52.29 -40.9 62.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.369 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t -92.48 129.1 38.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.917 0.389 . . . . 0.0 110.816 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.536 HD11 ' HE2' ' A' ' 153' ' ' LYS . 20.4 tp -145.39 124.65 12.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.304 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.66 129.97 41.47 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 59.1 37.13 24.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.979 0.419 . . . . 0.0 110.439 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -163.81 147.52 13.1 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.78 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.422 ' HZ3' ' HE ' ' A' ' 129' ' ' ARG . 22.4 pttp -112.8 139.57 48.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.375 -0.413 . . . . 0.0 110.517 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 104' ' ' LEU . 47.7 t -111.21 134.65 52.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.291 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -108.59 130.21 55.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.883 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.587 ' N ' HD21 ' A' ' 113' ' ' LEU . 3.6 mm? -104.69 140.96 37.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.664 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.499 HG21 ' O ' ' A' ' 125' ' ' ARG . 8.6 t -155.06 138.58 15.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.034 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.472 ' O ' ' HB1' ' A' ' 124' ' ' ALA . . . 80.92 127.91 0.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.308 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 164.81 -139.68 5.97 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.183 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -177.63 -62.42 0.01 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.224 0.535 . . . . 0.0 111.008 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.831 ' N ' ' HA ' ' A' ' 119' ' ' PRO . 3.4 tm? -74.15 -42.69 5.75 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.918 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.831 ' HA ' ' N ' ' A' ' 118' ' ' LEU . 96.5 Cg_endo -90.11 126.25 6.61 Favored 'Cis proline' 0 N--CA 1.454 -0.799 0 C-N-CA 124.03 -1.238 . . . . 0.0 112.944 0.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.566 ' N ' ' HB3' ' A' ' 118' ' ' LEU . . . -74.41 -23.6 58.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.783 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.463 ' C ' ' H ' ' A' ' 123' ' ' GLY . 88.2 mt 70.24 29.48 3.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.311 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.9 35.87 0.13 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.96 0.41 . . . . 0.0 111.094 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.474 ' HA2' ' HG ' ' A' ' 145' ' ' SER . . . 140.36 29.29 0.19 Allowed Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 115' ' ' GLY . . . -79.05 146.77 33.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.921 0.391 . . . . 0.0 111.514 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.499 ' O ' HG21 ' A' ' 114' ' ' THR . 98.9 mtt180 -108.31 138.74 44.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.662 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.568 HG23 HD13 ' A' ' 113' ' ' LEU . 12.7 p -127.57 136.74 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.115 0.484 . . . . 0.0 112.0 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -105.04 128.08 53.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.076 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.543 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 15.2 m-85 -98.45 139.29 34.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.0 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.422 ' HE ' ' HZ3' ' A' ' 110' ' ' LYS . 46.7 mtp85 -150.0 129.59 13.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.75 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 40.0 t -89.2 144.87 25.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.29 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.8 154.76 17.03 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.321 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.477 ' C ' ' H ' ' A' ' 134' ' ' PHE . 6.0 Cg_endo -47.93 159.98 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.077 2.518 . . . . 0.0 112.17 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 61.5 t0 76.86 -26.96 0.18 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.374 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.735 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 2.7 m-85 -122.04 132.77 54.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.932 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.454 ' CG ' ' HB2' ' A' ' 159' ' ' ASN . 0.4 OUTLIER -109.38 137.98 46.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.09 0.471 . . . . 0.0 112.01 -179.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 137' ' ' VAL . 6.4 tt -74.02 128.96 36.9 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.538 ' N ' HD22 ' A' ' 136' ' ' LEU . 42.9 t -128.05 74.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 171.33 -127.6 1.46 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.687 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.8 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.4 t -70.84 61.25 0.25 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.13 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.4 t -58.12 -20.76 42.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.922 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.674 ' HD3' ' H ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -129.31 143.87 51.01 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.801 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.7 m -150.25 144.59 25.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.282 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.488 ' O ' HG11 ' A' ' 143' ' ' VAL . 11.7 p -140.31 134.38 35.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.057 0.456 . . . . 0.0 111.594 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 54.0 t -116.63 147.57 41.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.204 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.474 ' HG ' ' HA2' ' A' ' 123' ' ' GLY . 49.1 m -154.66 41.5 0.47 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 145' ' ' SER . 41.8 tt0 176.17 -57.4 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.897 0.379 . . . . 0.0 111.21 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.06 37.31 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -173.37 137.9 0.68 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -84.23 133.91 34.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.228 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -50.23 -64.03 0.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.934 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 33.4 p -92.55 138.25 24.0 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.539 ' HA ' ' HH ' ' A' ' 103' ' ' TYR . 55.7 Cg_endo -69.2 146.32 63.25 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.784 2.323 . . . . 0.0 111.795 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.536 ' HE2' HD11 ' A' ' 106' ' ' LEU . 83.9 tttt -48.06 129.3 12.18 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.629 0.252 . . . . 0.0 110.796 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.8 ' HB3' ' H ' ' A' ' 139' ' ' SER . 89.8 Cg_endo -81.41 -152.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.647 2.231 . . . . 0.0 113.334 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.69 148.31 26.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.024 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . 0.735 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 13.0 t -98.49 139.2 34.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.056 0.455 . . . . 0.0 111.246 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -103.05 146.13 28.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.696 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.5 p -66.71 81.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.348 0.594 . . . . 0.0 111.271 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 35.7 t30 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.942 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.524 ' N ' ' HD2' ' A' ' 97' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.005 0.431 . . . . 0.0 110.917 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.517 ' H ' ' CD1' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -96.27 142.78 13.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.364 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.564 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 80.8 m -51.79 141.74 16.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.12 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.1 m -47.94 130.71 15.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.393 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -78.72 -6.89 57.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.086 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.9 p -55.88 -42.4 75.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.106 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.554 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 2.1 m-85 -59.17 -35.4 73.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.437 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.496 ' O ' HG23 ' A' ' 111' ' ' VAL . 89.8 mt -54.97 -47.3 74.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.682 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.1 m -92.56 130.81 38.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.839 0.352 . . . . 0.0 111.405 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.535 HD11 ' HE2' ' A' ' 153' ' ' LYS . 28.7 tp -145.44 127.86 15.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.834 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -66.71 130.65 43.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.301 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 57.13 41.16 27.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.026 0.441 . . . . 0.0 110.401 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.28 153.68 22.45 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.596 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -121.25 143.67 49.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.816 0.341 . . . . 0.0 110.76 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 104' ' ' LEU . 61.9 t -110.63 140.23 30.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.221 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -105.86 153.58 21.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.332 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.417 HD22 ' C ' ' A' ' 113' ' ' LEU . 6.7 tt -153.33 135.06 14.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.884 0.373 . . . . 0.0 110.521 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.2 m -156.21 125.64 6.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.784 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.89 -125.67 1.38 Allowed Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.833 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.32 -125.44 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.047 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.619 ' H ' ' HB2' ' A' ' 120' ' ' ALA . 12.2 p-10 -173.36 128.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.424 HD11 ' C ' ' A' ' 118' ' ' LEU . 4.4 pp -38.66 138.04 0.8 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.317 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -85.88 35.64 3.63 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.424 -1.49 . . . . 0.0 113.097 0.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.619 ' HB2' ' H ' ' A' ' 117' ' ' ASP . . . -90.73 46.42 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.981 0.42 . . . . 0.0 110.623 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.78 ' H ' HD21 ' A' ' 121' ' ' LEU . 3.7 mm? -54.75 -39.94 68.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.342 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.28 139.96 58.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 0.0 111.011 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.43 -36.38 3.65 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.314 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.3 142.09 52.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.95 0.405 . . . . 0.0 111.51 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.591 ' HD3' ' N ' ' A' ' 125' ' ' ARG . 1.0 OUTLIER -108.51 139.87 42.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.23 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.8 m -124.67 142.75 40.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 111.961 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.487 ' OE1' ' HG2' ' A' ' 141' ' ' ARG . 5.2 mm-40 -121.44 119.62 32.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.83 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.554 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 3.1 m-85 -85.1 152.57 23.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.422 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.3 ttt-85 -163.34 125.77 2.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.903 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.579 ' SG ' HD21 ' A' ' 136' ' ' LEU . 100.0 m -89.19 142.18 27.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.375 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -55.34 158.18 5.8 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.573 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.543 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 1.1 Cg_endo -43.14 155.03 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.095 2.53 . . . . 0.0 112.186 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.6 m-20 79.43 -35.81 0.16 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.656 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 157' ' ' GLN . 5.9 m-85 -108.8 129.28 55.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.574 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.436 ' CD2' ' HB3' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -102.87 145.34 29.95 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 111.85 -179.587 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.579 HD21 ' SG ' ' A' ' 130' ' ' CYS . 2.4 tm? -75.56 132.88 40.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.969 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.415 HG13 ' NE2' ' A' ' 155' ' ' HIS . 7.4 p -135.65 70.38 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.535 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . 171.23 -123.6 1.05 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.756 -1.211 . . . . 0.0 113.363 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.869 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 27.5 t -71.68 55.07 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.705 0.288 . . . . 0.0 111.775 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 128' ' ' PHE . 94.3 p -56.16 -21.93 25.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.436 0.636 . . . . 0.0 109.322 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.487 ' HG2' ' OE1' ' A' ' 127' ' ' GLU . 62.4 mtm-85 -140.59 126.43 19.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.489 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.549 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 47.2 t -142.98 134.48 26.32 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.94 0.4 . . . . 0.0 111.418 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.8 t -98.24 134.18 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.637 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 144' ' ' CYS . 41.9 t -79.17 48.02 0.83 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 111.29 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 83.4 p -65.14 126.96 29.73 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 55.21 -140.0 0.95 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.487 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -106.5 37.47 3.81 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.098 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -155.41 143.87 20.34 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 122.261 0.224 . . . . 0.0 110.513 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.564 ' CE2' ' HB3' ' A' ' 99' ' ' CYS . 45.1 m95 -84.14 137.91 33.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.704 0.288 . . . . 0.0 110.418 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.9 t -57.19 -61.26 2.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.302 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.1 p -94.13 133.87 26.76 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.746 0.307 . . . . 0.0 111.759 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 139' ' ' SER . 36.7 Cg_endo -65.21 140.08 63.21 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.758 2.305 . . . . 0.0 112.152 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.535 ' HE2' HD11 ' A' ' 106' ' ' LEU . 86.9 tttt -42.56 131.62 2.89 Favored Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.526 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.869 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 84.6 Cg_endo -81.58 -158.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.881 2.387 . . . . 0.0 112.872 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.415 ' NE2' HG13 ' A' ' 137' ' ' VAL . 12.5 p-80 -153.64 150.64 28.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.642 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 72.3 m -96.18 139.36 32.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.97 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 134' ' ' PHE . 40.4 tt0 -130.59 133.68 46.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.711 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.6 124.72 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.959 0.409 . . . . 0.0 110.407 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.999 -179.418 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.521 ' NE ' ' HA ' ' A' ' 97' ' ' ARG . 4.0 mmp_? . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.778 0.323 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.516 ' HB ' HD22 ' A' ' 121' ' ' LEU . 26.2 pt -151.02 46.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 75.6 m 63.01 131.75 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.966 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 87.4 p -47.97 126.42 10.58 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.897 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -78.34 -11.39 59.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.142 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.0 t -54.54 -36.58 64.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.043 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.446 ' CE2' ' HA ' ' A' ' 152' ' ' PRO . 2.0 m-85 -77.35 47.27 0.56 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.487 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.8 mt -133.86 20.13 3.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.942 0.401 . . . . 0.0 110.436 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.44 ' O ' ' HE3' ' A' ' 153' ' ' LYS . 86.0 m -147.43 132.65 18.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.509 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.404 HD21 ' HD2' ' A' ' 128' ' ' PHE . 25.4 tp -145.4 133.76 21.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.967 0.413 . . . . 0.0 111.443 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.661 ' HG2' ' OD1' ' A' ' 108' ' ' ASN . 33.2 tt0 -78.0 141.75 38.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.879 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.661 ' OD1' ' HG2' ' A' ' 107' ' ' GLU . 5.6 m120 63.17 30.15 16.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.81 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 176.12 -160.81 28.93 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.915 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.516 ' HG3' ' HE1' ' A' ' 112' ' ' PHE . 14.9 ptmm? -142.04 153.62 44.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.656 0.265 . . . . 0.0 110.412 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.65 137.92 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.075 0.464 . . . . 0.0 111.763 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.598 ' HB2' ' HG3' ' A' ' 127' ' ' GLU . 6.1 m-85 -107.74 146.15 32.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.308 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.564 ' N ' HD22 ' A' ' 113' ' ' LEU . 1.9 pt? -146.17 139.44 25.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.004 0.43 . . . . 0.0 111.041 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.8 t -168.83 133.98 1.62 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.969 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 140.6 -40.51 1.36 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.35 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 121' ' ' LEU . . . -66.32 150.15 51.74 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.058 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -136.74 56.32 1.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.717 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 1.6 pt? -39.36 127.72 1.36 Allowed Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.345 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.73 74.09 0.07 OUTLIER 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 123.683 -1.382 . . . . 0.0 113.059 -0.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.717 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -168.69 58.44 0.06 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.837 0.351 . . . . 0.0 111.167 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.668 HD13 ' H ' ' A' ' 121' ' ' LEU . 5.3 mp -74.92 37.98 0.12 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.334 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.428 ' H ' ' C ' ' A' ' 120' ' ' ALA . 1.5 m-20 -72.26 132.2 43.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.914 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.5 37.36 94.56 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.926 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.39 137.0 52.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.538 0.208 . . . . 0.0 110.587 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.441 ' HG2' HH11 ' A' ' 125' ' ' ARG . 49.3 ttp85 -130.52 139.22 50.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.41 . . . . 0.0 111.374 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.475 HG12 ' CB ' ' A' ' 113' ' ' LEU . 30.7 m -130.11 138.22 54.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.125 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.598 ' HG3' ' HB2' ' A' ' 112' ' ' PHE . 13.9 pt-20 -114.98 124.47 51.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.499 ' HE2' ' HG2' ' A' ' 153' ' ' LYS . 2.0 m-85 -90.36 146.85 23.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.213 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.432 ' HD3' ' CE1' ' A' ' 112' ' ' PHE . 7.5 ptm180 -168.62 126.95 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.127 0.489 . . . . 0.0 111.12 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.492 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 69.5 m -89.76 157.39 17.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.382 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 133' ' ' ASP . 34.9 m-20 -52.7 149.66 10.83 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.536 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -52.25 81.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.178 2.585 . . . . 0.0 112.789 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 36.5 t70 178.67 -20.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.186 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 31.7 m-85 -129.38 132.93 47.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.723 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -102.81 127.22 50.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.038 0.447 . . . . 0.0 111.078 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.5 HD12 ' HG2' ' A' ' 154' ' ' PRO . 16.5 tp -71.92 131.06 42.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.034 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 36.0 t -136.01 66.73 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.739 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.53 -134.73 1.88 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.247 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.741 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 67.9 m -75.03 51.77 0.53 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.795 0.331 . . . . 0.0 111.099 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.7 t -51.08 -39.05 55.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.746 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -99.45 133.15 44.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.572 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.4 t -145.33 119.41 9.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 0.0 110.697 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.8 p -108.78 125.34 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.088 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 149' ' ' TRP . 47.4 t -71.9 145.29 48.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.389 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.6 p -161.37 122.85 2.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.953 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' A' ' 146' ' ' GLN . 8.3 tt0 57.06 43.05 24.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.188 0.518 . . . . 0.0 109.839 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.55 -49.87 3.71 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.754 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -77.34 137.83 38.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.704 0.287 . . . . 0.0 111.362 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 144' ' ' CYS . 68.2 m95 -84.23 143.89 29.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.513 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 65.3 m -53.91 -61.42 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.745 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 60.5 p -111.98 134.56 21.37 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.677 0.275 . . . . 0.0 111.503 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.446 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 44.4 Cg_endo -68.23 -163.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.382 2.055 . . . . 0.0 112.166 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.59 ' HB3' ' NZ ' ' A' ' 153' ' ' LYS . 9.3 mtpm? -83.35 125.43 74.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.219 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.741 ' HB3' ' H ' ' A' ' 139' ' ' SER . 62.4 Cg_endo -73.73 -144.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.705 2.27 . . . . 0.0 112.376 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.425 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 19.8 p-80 -153.66 139.9 18.51 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.801 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 86.2 m -98.67 133.97 42.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.027 0.442 . . . . 0.0 111.217 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -103.07 142.69 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.198 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 82.7 t -53.57 102.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.945 0.402 . . . . 0.0 110.496 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 38.9 t30 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.115 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 . . . . . 0 N--CA 1.465 0.281 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.592 ' HA ' HD12 ' A' ' 121' ' ' LEU . 16.1 pt -65.03 133.42 30.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.749 0.309 . . . . 0.0 110.821 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.721 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 69.7 m -56.29 138.78 50.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.455 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.5 m -47.97 132.0 15.31 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.603 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.514 ' HB2' HD12 ' A' ' 104' ' ' LEU . 8.9 ptpp? -89.76 11.41 20.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.13 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.1 t -66.35 -35.78 81.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 110.945 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.522 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 0.9 OUTLIER -55.98 -33.24 64.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.909 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.514 HD12 ' HB2' ' A' ' 101' ' ' LYS . 70.4 mt -57.03 146.43 27.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.985 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.8 m 65.18 132.4 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.352 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.691 HD12 ' HE2' ' A' ' 153' ' ' LYS . 28.1 tp -145.41 135.41 23.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.124 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.407 ' H ' HD13 ' A' ' 106' ' ' LEU . 59.7 mp0 -69.85 131.29 44.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.269 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.465 ' N ' HD21 ' A' ' 108' ' ' ASN . 2.3 m120 57.81 39.6 26.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.456 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.518 ' HA2' ' H ' ' A' ' 131' ' ' ASP . . . -174.78 155.41 20.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.7 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -113.12 146.29 39.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.863 0.363 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.452 HG11 ' N ' ' A' ' 112' ' ' PHE . 60.0 t -108.17 139.01 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.061 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.528 ' C ' HD13 ' A' ' 113' ' ' LEU . 3.4 m-85 -106.52 140.49 39.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.807 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.528 HD13 ' C ' ' A' ' 112' ' ' PHE . 5.2 mp -133.51 137.32 45.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 110.484 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.469 HG21 ' N ' ' A' ' 115' ' ' GLY . 96.1 m -159.98 143.56 14.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.157 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.469 ' N ' HG21 ' A' ' 114' ' ' THR . . . 96.7 132.24 7.23 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.61 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 52.28 -149.58 9.59 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.83 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.495 ' H ' ' HB2' ' A' ' 120' ' ' ALA . 7.8 t70 178.41 117.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.658 HD13 ' HA ' ' A' ' 119' ' ' PRO . 29.9 tp -40.19 134.3 1.48 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.502 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.658 ' HA ' HD13 ' A' ' 118' ' ' LEU . 66.8 Cg_endo -94.02 44.58 2.52 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.713 -1.37 . . . . 0.0 113.109 0.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.495 ' HB2' ' H ' ' A' ' 117' ' ' ASP . . . -71.95 -49.73 34.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.139 0.495 . . . . 0.0 110.845 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.592 HD12 ' HA ' ' A' ' 98' ' ' ILE . 65.7 mt 54.76 40.89 32.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.533 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.404 ' OD1' ' HB1' ' A' ' 120' ' ' ALA . 1.2 m-20 -75.89 48.04 0.46 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.033 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.86 39.95 95.28 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.294 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 115' ' ' GLY . . . -62.38 138.26 58.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.772 0.32 . . . . 0.0 110.849 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -107.84 140.92 40.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.735 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.511 HG22 ' CZ3' ' A' ' 149' ' ' TRP . 32.8 m -129.06 141.02 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.994 0.426 . . . . 0.0 111.671 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 95.4 mt-10 -113.24 123.79 51.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.629 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.47 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 8.0 m-85 -90.23 52.06 2.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.55 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -61.72 129.17 39.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.783 0.325 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.637 ' SG ' HD22 ' A' ' 136' ' ' LEU . 79.9 m -89.25 142.29 27.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.399 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.518 ' H ' ' HA2' ' A' ' 109' ' ' GLY . 54.9 m-20 -57.75 158.37 12.32 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.306 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.476 ' C ' ' H ' ' A' ' 134' ' ' PHE . 2.2 Cg_endo -44.71 156.04 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.305 2.67 . . . . 0.0 112.382 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.7 m-20 73.58 -12.32 0.84 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.422 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.476 ' H ' ' C ' ' A' ' 132' ' ' PRO . 7.5 m-85 -130.64 137.3 49.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.77 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.723 ' HD1' ' HB2' ' A' ' 159' ' ' ASN . 14.1 p-80 -121.1 137.05 54.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.064 0.459 . . . . 0.0 111.608 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.637 HD22 ' SG ' ' A' ' 130' ' ' CYS . 2.2 tm? -68.29 130.38 42.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.029 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.412 ' N ' HD11 ' A' ' 136' ' ' LEU . 21.3 t -134.35 62.52 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.524 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.439 ' H ' ' CD1' ' A' ' 136' ' ' LEU . . . -176.01 -133.43 1.77 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.018 -1.087 . . . . 0.0 113.227 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.64 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 66.8 m -74.44 56.31 0.66 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.565 0.346 . . . . 0.0 111.397 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.564 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 34.4 t -54.56 -39.57 67.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.106 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -99.36 130.2 45.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.093 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.1 m -147.04 146.77 30.13 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.57 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.36 132.03 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.032 0.444 . . . . 0.0 111.377 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.474 ' SG ' HD23 ' A' ' 121' ' ' LEU . 39.0 t -72.13 132.46 44.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.088 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.9 m -166.41 130.82 2.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.82 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 55.82 44.38 26.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.37 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 57.45 45.28 93.17 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.967 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -177.12 142.01 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.635 0.255 . . . . 0.0 110.643 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.721 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 45.7 m95 -84.15 145.14 28.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.882 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.8 t -51.93 -49.63 62.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.022 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.607 ' HG1' ' HB3' ' A' ' 139' ' ' SER . 60.4 p -127.85 140.42 38.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.058 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 35.3 Cg_exo -60.33 -165.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.564 2.176 . . . . 0.0 112.476 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.691 ' HE2' HD12 ' A' ' 106' ' ' LEU . 84.5 tttt -86.56 125.29 67.81 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.64 ' HB3' ' N ' ' A' ' 139' ' ' SER . 73.6 Cg_endo -75.35 -151.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.562 2.175 . . . . 0.0 112.677 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.46 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.3 p-80 -153.8 146.22 23.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.06 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 75.3 m -97.95 132.4 43.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.598 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -103.05 142.9 33.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.168 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 53.0 t -67.25 80.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.868 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.723 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 34.1 t30 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.048 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.48 ' NH1' ' HB2' ' A' ' 97' ' ' ARG . 23.4 mtm105 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.795 0.331 . . . . 0.0 111.571 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.705 ' HB ' HD23 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -53.16 145.84 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.7 m -53.36 135.43 39.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.241 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.8 t -47.93 123.33 6.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.521 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -81.24 113.1 19.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.606 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.0 m -171.15 -41.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.171 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.846 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 1.6 m-85 -62.51 -28.7 70.02 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.074 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.605 HD22 HD13 ' A' ' 113' ' ' LEU . 61.4 mt -72.14 28.21 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.332 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.453 ' H ' ' C ' ' A' ' 103' ' ' TYR . 64.5 p -147.48 127.61 13.76 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.914 0.388 . . . . 0.0 111.666 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 tp -145.44 121.98 11.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.297 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -92.28 40.22 1.04 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -163.65 36.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.719 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.34 -146.45 11.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.837 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -141.56 139.37 33.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.528 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.6 t -105.97 136.6 39.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.981 0.419 . . . . 0.0 111.007 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 1.6 m-85 -107.83 145.78 33.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.408 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.605 HD13 HD22 ' A' ' 104' ' ' LEU . 6.7 tt -152.55 138.97 18.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.928 0.394 . . . . 0.0 110.846 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.502 ' N ' HD22 ' A' ' 113' ' ' LEU . 84.9 m -153.53 123.16 6.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.683 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.27 -38.51 0.28 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.104 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -168.2 -130.08 1.14 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.138 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.639 ' H ' ' HB2' ' A' ' 120' ' ' ALA . 8.2 t70 -172.3 125.47 0.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.497 HD13 ' H ' ' A' ' 118' ' ' LEU . 6.8 mp -41.84 138.48 1.78 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.208 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -86.73 41.37 1.88 Allowed 'Cis proline' 0 C--N 1.347 0.465 0 C-N-CA 123.574 -1.428 . . . . 0.0 113.478 0.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.639 ' HB2' ' H ' ' A' ' 117' ' ' ASP . . . -92.49 129.87 38.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.831 0.348 . . . . 0.0 111.065 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.705 HD23 ' HB ' ' A' ' 98' ' ' ILE . 3.8 mm? -131.47 51.13 2.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.585 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.88 59.66 1.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.931 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.91 42.27 99.61 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.578 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.52 141.22 57.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.724 0.297 . . . . 0.0 111.18 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -106.95 130.43 54.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.194 0.521 . . . . 0.0 110.733 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.44 134.3 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.59 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -118.31 123.89 46.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.306 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.543 ' CE2' ' HG2' ' A' ' 153' ' ' LYS . 19.0 m-85 -82.78 151.08 26.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.2 0.524 . . . . 0.0 111.942 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.407 HH11 ' HG2' ' A' ' 129' ' ' ARG . 15.4 tpp85 -153.46 121.97 6.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.644 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 9.2 t -102.38 144.63 30.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.035 0.445 . . . . 0.0 111.748 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -56.28 157.76 8.64 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.338 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 71.4 Cg_exo -48.82 163.14 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.765 2.31 . . . . 0.0 112.275 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.517 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 55.7 m-20 76.56 -32.53 0.2 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.847 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.863 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 1.4 m-85 -108.5 133.78 52.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.391 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.466 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 20.4 p-80 -112.95 137.34 51.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.972 0.415 . . . . 0.0 111.284 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.754 HD21 ' HA ' ' A' ' 140' ' ' SER . 18.7 tp -68.35 135.91 52.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.308 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 137' ' ' VAL . 14.8 p -136.74 60.01 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.788 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . 171.97 -123.42 1.02 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 119.172 -1.489 . . . . 0.0 113.692 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.798 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 39.9 t -65.11 66.06 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.866 0.365 . . . . 0.0 111.553 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.754 ' HA ' HD21 ' A' ' 136' ' ' LEU . 98.9 p -66.39 -14.81 62.68 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.266 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.556 ' HD3' ' H ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -140.62 138.16 34.18 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.973 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.451 ' HA ' ' HB3' ' A' ' 150' ' ' SER . 86.1 p -141.62 140.51 33.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.771 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.856 HG11 ' HB2' ' A' ' 150' ' ' SER . 7.3 p -134.75 132.84 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.063 0.459 . . . . 0.0 111.981 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 121' ' ' LEU . 41.5 t -79.34 149.98 31.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.828 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.1 t -147.79 -130.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.715 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -58.44 -42.72 87.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.643 0.259 . . . . 0.0 111.202 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 176.15 47.5 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.657 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -173.71 142.24 0.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.735 0.302 . . . . 0.0 110.696 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -84.2 153.36 23.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.074 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.856 ' HB2' HG11 ' A' ' 143' ' ' VAL . 43.2 t -48.08 -57.65 5.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.87 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.673 ' HG1' ' HB2' ' A' ' 139' ' ' SER . 0.5 OUTLIER -147.42 143.73 18.46 Favored Pre-proline 0 C--N 1.332 -0.163 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.543 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.477 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 31.4 Cg_exo -57.82 140.81 94.97 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.483 2.789 . . . . 0.0 112.716 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.846 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 9.0 mtpm? -49.81 137.35 18.87 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.024 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.798 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 85.2 Cg_endo -83.05 -140.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.989 2.459 . . . . 0.0 112.142 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.425 ' O ' HG11 ' A' ' 137' ' ' VAL . 18.9 p-80 -153.72 152.16 30.46 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.763 0.316 . . . . 0.0 110.999 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . 0.863 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 71.1 m -94.95 127.37 40.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.555 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.466 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 69.8 tp60 -105.56 136.76 44.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.818 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.4 t -76.3 122.95 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.164 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 133' ' ' ASP . 24.4 p30 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.953 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.731 0.3 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.9 pt -137.43 145.71 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.923 0.392 . . . . 0.0 111.473 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 38.7 m -51.49 140.17 18.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.058 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.4 t -47.91 130.26 14.95 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.308 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.578 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -83.14 -28.44 29.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.235 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.1 m -68.89 38.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.771 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 6.8 m-85 -127.28 -46.92 1.47 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.573 0.225 . . . . 0.0 111.305 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.784 HD13 ' H ' ' A' ' 105' ' ' THR . 0.4 OUTLIER -52.92 -32.08 43.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.462 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.784 ' H ' HD13 ' A' ' 104' ' ' LEU . 41.9 p -96.29 135.37 38.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.663 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 34.5 tp -145.43 131.19 19.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 111.135 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.01 131.73 45.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.66 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 54.1 41.8 31.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.401 . . . . 0.0 110.6 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.53 148.56 9.51 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.522 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -104.09 151.75 22.9 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.953 0.406 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 104' ' ' LEU . 96.4 t -128.2 141.39 46.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.987 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.478 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.8 m-85 -105.83 134.3 49.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.84 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.433 HD23 HG13 ' A' ' 126' ' ' VAL . 2.7 tm? -109.18 131.76 54.76 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.3 m -157.51 125.09 5.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.91 0.386 . . . . 0.0 111.107 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 157.93 -133.52 3.53 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.293 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.85 -135.24 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.394 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -160.17 123.4 3.49 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.64 ' H ' HD12 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -53.27 136.41 50.18 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.003 -179.293 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -90.21 63.16 0.26 Allowed 'Cis proline' 0 C--N 1.346 0.445 0 C-N-CA 123.834 -1.319 . . . . 0.0 113.032 0.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.573 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -155.43 57.21 0.63 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.779 0.323 . . . . 0.0 111.549 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.671 ' N ' HD13 ' A' ' 121' ' ' LEU . 5.2 mp -77.28 45.87 0.48 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.855 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.65 131.27 49.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 111.215 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.83 35.52 39.53 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.749 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.57 136.94 32.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.673 0.273 . . . . 0.0 111.35 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.437 ' NH2' HH21 ' A' ' 141' ' ' ARG . 15.9 ptm180 -130.55 130.29 43.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 110.789 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.539 HG21 ' CE1' ' A' ' 128' ' ' PHE . 23.2 m -100.27 139.81 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.027 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 46.6 mp0 -102.93 123.88 47.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.245 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.539 ' CE1' HG21 ' A' ' 126' ' ' VAL . 7.0 m-85 -91.31 143.04 27.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.144 0.497 . . . . 0.0 112.036 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.439 ' HD3' ' CE1' ' A' ' 112' ' ' PHE . 47.9 mtp85 -152.59 125.1 8.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.723 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 26.2 t -89.29 163.8 15.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.943 0.402 . . . . 0.0 111.462 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -52.79 156.71 3.13 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.306 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.08 52.44 1.84 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.286 2.658 . . . . 0.0 112.868 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -155.88 -37.72 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.121 0.486 . . . . 0.0 109.989 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.445 ' CE2' ' HB ' ' A' ' 158' ' ' VAL . 0.9 OUTLIER -108.32 146.53 32.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.724 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.421 ' H ' ' HD1' ' A' ' 135' ' ' HIS . 15.0 p-80 -100.08 132.99 45.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.137 0.494 . . . . 0.0 111.152 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.504 HD22 ' HA ' ' A' ' 140' ' ' SER . 27.9 tp -73.46 128.47 35.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.279 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.6 t -134.98 64.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.225 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.53 -123.52 0.72 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.005 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.906 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.4 t -71.17 52.28 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.678 0.391 . . . . 0.0 111.686 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.504 ' HA ' HD22 ' A' ' 136' ' ' LEU . 44.9 t -56.02 -26.35 48.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.066 0.46 . . . . 0.0 110.15 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.437 HH21 ' NH2' ' A' ' 125' ' ' ARG . 24.0 mmm180 -132.87 129.14 38.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.853 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.442 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 47.1 t -141.77 148.56 39.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.237 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 125' ' ' ARG . 7.3 p -144.04 131.35 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.818 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 45.4 t -68.47 144.11 54.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.595 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.6 t -172.72 129.51 0.52 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.546 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 56.6 43.93 24.79 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.05 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 57.31 42.75 93.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.315 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -174.33 140.18 0.64 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 0.0 110.498 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.433 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 56.0 m95 -84.24 140.81 31.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.937 0.399 . . . . 0.0 110.965 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.8 m -54.2 -60.64 3.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.478 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -94.32 129.08 38.13 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.739 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 139' ' ' SER . 73.7 Cg_endo -75.91 148.86 32.39 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.848 2.366 . . . . 0.0 112.273 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.771 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 14.1 mmmm -40.86 127.27 1.96 Allowed Pre-proline 0 N--CA 1.464 0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 111.267 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.906 ' HB3' ' H ' ' A' ' 139' ' ' SER . 91.5 Cg_endo -83.77 -149.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.972 2.448 . . . . 0.0 113.571 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.483 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 17.8 p-80 -153.75 150.09 28.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.337 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 82.7 m -94.95 127.63 41.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.799 0.333 . . . . 0.0 110.933 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -103.48 137.09 42.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.52 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.445 ' HB ' ' CE2' ' A' ' 134' ' ' PHE . 11.7 p -86.62 131.29 35.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.432 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.829 -179.598 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 97' ' ' ARG . 29.4 tpt180 . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.925 0.393 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.639 ' HB ' ' HG ' ' A' ' 121' ' ' LEU . 35.7 pt -55.56 142.48 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.088 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.475 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 95.1 m -51.09 135.77 24.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.362 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.8 t -47.97 127.48 12.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.301 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.732 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -81.07 12.61 3.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 179.727 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.1 t -68.82 -41.55 78.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.793 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.549 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.9 m-85 -56.09 -34.94 66.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.21 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 87.1 mt -47.77 -46.02 29.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.961 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 60.1 p -92.61 137.95 31.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.441 HD12 ' HZ2' ' A' ' 153' ' ' LYS . 30.4 tp -145.41 133.4 21.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 110.972 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.97 132.23 46.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.772 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.417 ' N ' HD21 ' A' ' 108' ' ' ASN . 2.5 m120 58.65 33.03 22.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.152 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.507 ' CA ' ' HA ' ' A' ' 130' ' ' CYS . . . -175.51 153.14 14.44 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.423 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -109.27 144.5 37.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.513 -0.344 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 103' ' ' TYR . 93.1 t -109.66 136.94 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.95 0.405 . . . . 0.0 111.058 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.446 ' CE1' ' HD3' ' A' ' 129' ' ' ARG . 2.8 m-85 -108.57 146.51 33.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.755 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.614 HD21 ' N ' ' A' ' 114' ' ' THR . 6.3 tt -144.26 131.45 20.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.546 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.614 ' N ' HD21 ' A' ' 113' ' ' LEU . 68.7 p -150.08 123.36 8.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.567 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.02 -36.01 0.27 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.242 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.4 -135.12 1.8 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.419 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.584 ' H ' ' HB1' ' A' ' 120' ' ' ALA . 12.2 p-10 -175.67 129.5 0.25 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.72 ' N ' HD13 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -41.28 138.82 1.44 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.279 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -86.69 40.32 2.2 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.503 -1.457 . . . . 0.0 113.117 0.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.584 ' HB1' ' H ' ' A' ' 117' ' ' ASP . . . -96.62 47.11 1.06 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.783 0.325 . . . . 0.0 111.242 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.639 ' HG ' ' HB ' ' A' ' 98' ' ' ILE . 3.9 mm? -54.42 -40.59 68.44 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.789 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -61.21 136.93 58.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.505 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.87 54.4 7.24 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.458 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -143.62 136.12 27.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.0 111.189 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.46 ' HD3' HG23 ' A' ' 143' ' ' VAL . 48.6 mmt-85 -105.66 143.56 33.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.733 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 142' ' ' SER . 32.7 m -133.74 135.53 55.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.088 0.47 . . . . 0.0 111.489 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -112.9 118.34 34.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.514 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.447 ' HE1' ' HB3' ' A' ' 142' ' ' SER . 5.4 m-85 -82.42 140.53 33.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.024 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.446 ' HD3' ' CE1' ' A' ' 112' ' ' PHE . 16.6 ptm180 -166.66 127.46 1.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.77 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.507 ' HA ' ' CA ' ' A' ' 109' ' ' GLY . 61.5 m -92.89 160.6 14.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.149 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.443 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 31.9 m-20 -52.68 157.58 2.55 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.556 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 17.9 Cg_endo -58.78 76.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.142 2.561 . . . . 0.0 112.64 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.3 t70 -177.07 -38.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.675 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.735 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 2.9 m-85 -108.91 132.58 53.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.872 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 157' ' ' GLN . 17.6 p-80 -102.8 127.79 49.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.993 0.425 . . . . 0.0 111.145 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.736 HD23 ' HA ' ' A' ' 140' ' ' SER . 26.7 tp -72.11 129.51 38.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.648 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.1 t -135.33 67.89 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.749 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.12 -136.09 2.28 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.623 -1.275 . . . . 0.0 113.398 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.593 ' HB2' ' HG1' ' A' ' 151' ' ' THR . 71.1 p -74.82 58.26 0.82 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.022 0.439 . . . . 0.0 110.854 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.736 ' HA ' HD23 ' A' ' 136' ' ' LEU . 36.5 t -52.16 -31.39 31.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.743 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -99.44 136.26 39.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.779 0.323 . . . . 0.0 111.237 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.471 ' O ' HG21 ' A' ' 126' ' ' VAL . 42.8 t -150.05 149.56 30.49 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.34 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.518 HG12 ' HB2' ' A' ' 150' ' ' SER . 7.3 p -144.36 135.69 21.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.993 0.425 . . . . 0.0 111.75 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 121' ' ' LEU . 43.1 t -66.72 151.2 47.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.005 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.1 t -151.54 -136.91 0.07 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.054 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -74.63 66.56 1.45 Allowed 'General case' 0 C--O 1.232 0.153 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.36 43.45 92.67 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.649 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -176.41 139.9 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.757 0.313 . . . . 0.0 110.505 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.475 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 33.8 m95 -84.26 141.65 30.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.653 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.518 ' HB2' HG12 ' A' ' 143' ' ' VAL . 48.5 t -49.54 -52.72 27.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.645 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.593 ' HG1' ' HB2' ' A' ' 139' ' ' SER . 48.8 p -124.95 133.88 25.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 0.0 111.803 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.87 147.5 85.21 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.773 2.316 . . . . 0.0 111.841 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 50.2 mtpt -46.66 131.37 8.33 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.325 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.567 ' HG2' HD12 ' A' ' 136' ' ' LEU . 3.9 Cg_exo -78.93 -141.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.073 2.515 . . . . 0.0 112.086 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -153.75 134.75 13.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.772 0.32 . . . . 0.0 110.948 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . 0.735 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 77.5 m -98.73 132.41 44.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.487 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.448 ' HB2' ' CE1' ' A' ' 135' ' ' HIS . 23.2 mt-30 -103.4 142.46 34.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.821 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -76.21 135.99 25.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.21 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.7 m120 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.917 -179.523 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.436 ' HG2' HH11 ' A' ' 97' ' ' ARG . 22.4 ptt-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.749 0.309 . . . . 0.0 110.706 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.429 HG23 ' O ' ' A' ' 97' ' ' ARG . 31.4 pt -142.31 144.79 24.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.315 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.551 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 73.7 m -51.51 139.46 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.54 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 102' ' ' SER . 47.3 t -47.99 127.52 12.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.021 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.539 ' NZ ' ' HB3' ' A' ' 101' ' ' LYS . 8.4 mtpm? -74.16 14.36 0.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.343 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 100' ' ' SER . 61.1 m -68.87 -46.19 69.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.936 0.398 . . . . 0.0 110.895 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.407 ' HH ' ' HA ' ' A' ' 152' ' ' PRO . 1.2 m-85 -61.7 -41.12 97.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.116 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.9 mt -54.94 -41.79 71.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.501 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.6 p -92.54 136.89 32.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.865 0.364 . . . . 0.0 111.564 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.502 HD21 ' SG ' ' A' ' 130' ' ' CYS . 40.4 tp -145.44 130.81 18.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.572 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.409 ' HG2' ' OD1' ' A' ' 108' ' ' ASN . 10.3 pm0 -90.48 38.94 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.335 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.409 ' OD1' ' HG2' ' A' ' 107' ' ' GLU . 8.2 m120 -155.85 25.44 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 154.57 -144.36 11.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.88 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.403 ' HE2' ' CZ ' ' A' ' 112' ' ' PHE . 25.0 pttm -141.97 140.19 32.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.251 -0.474 . . . . 0.0 110.302 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.33 143.91 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.013 0.435 . . . . 0.0 111.354 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.403 ' CZ ' ' HE2' ' A' ' 110' ' ' LYS . 1.4 m-85 -105.36 151.76 23.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.146 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.5 tp -145.29 132.97 20.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.605 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.2 p -150.95 147.32 27.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.429 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.2 39.7 26.31 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.918 -0.583 . . . . 0.0 113.017 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.456 ' HA2' ' HB2' ' A' ' 124' ' ' ALA . . . -79.61 -140.88 2.24 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.158 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -176.1 49.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.619 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 1.7 pt? -42.47 135.07 2.62 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.986 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -87.71 63.04 0.19 OUTLIER 'Cis proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.638 -1.401 . . . . 0.0 113.345 0.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.619 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -166.32 132.56 2.47 Favored 'General case' 0 C--O 1.228 -0.074 0 CA-C-O 120.929 0.395 . . . . 0.0 111.486 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.476 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 83.3 mt -80.9 43.09 0.67 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.84 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -65.01 126.24 27.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.236 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 50.12 31.42 18.76 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.007 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.456 ' HB2' ' HA2' ' A' ' 116' ' ' GLY . . . -84.25 140.25 31.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.579 0.228 . . . . 0.0 110.959 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -108.54 124.23 50.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.785 0.326 . . . . 0.0 110.438 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 142' ' ' SER . 7.5 p -103.59 140.26 22.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.537 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -125.25 111.97 15.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.166 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -75.23 146.59 41.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.57 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.402 ' NH1' ' O ' ' A' ' 130' ' ' CYS . 26.7 tpt85 -156.27 117.06 3.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.097 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.502 ' SG ' HD21 ' A' ' 106' ' ' LEU . 98.6 m -96.41 165.25 12.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.691 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.55 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 56.2 m-20 -52.66 162.32 0.97 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.017 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 56.7 Cg_endo -70.92 51.76 1.29 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.851 2.368 . . . . 0.0 112.727 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -146.53 -35.85 0.26 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.773 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.59 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 0.7 OUTLIER -108.82 135.93 49.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.034 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.402 ' CE1' ' HB2' ' A' ' 157' ' ' GLN . 17.0 p-80 -102.74 129.86 49.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.948 0.404 . . . . 0.0 110.826 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.799 HD21 ' HA ' ' A' ' 140' ' ' SER . 50.7 tp -72.72 128.18 34.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.019 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.6 t -135.99 68.69 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.665 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.18 -131.36 1.74 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.442 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.75 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.2 t -69.84 63.8 0.2 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.958 0.408 . . . . 0.0 111.364 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.799 ' HA ' HD21 ' A' ' 136' ' ' LEU . 95.5 p -61.22 -15.12 31.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.729 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -139.04 137.96 36.74 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.721 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.639 ' HG ' ' HB3' ' A' ' 149' ' ' TRP . 36.4 t -150.69 124.17 9.01 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.735 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 143' ' ' VAL . 8.2 p -88.01 130.51 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.978 0.418 . . . . 0.0 111.084 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 26.4 t -75.84 78.13 2.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.56 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 51.5 m -65.59 -124.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.444 ' C ' ' H ' ' A' ' 148' ' ' GLN . 26.1 mt-30 -67.27 -140.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -77.29 29.32 1.67 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.445 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.444 ' H ' ' C ' ' A' ' 146' ' ' GLN . 87.9 mt-30 -157.76 150.24 22.63 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.725 0.297 . . . . 0.0 110.652 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.639 ' HB3' ' HG ' ' A' ' 142' ' ' SER . 33.1 m95 -84.22 139.21 32.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.222 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 80.7 p -53.91 -63.07 1.27 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.517 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 40.2 p -92.6 132.31 31.9 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.706 0.288 . . . . 0.0 111.533 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.407 ' HA ' ' HH ' ' A' ' 103' ' ' TYR . 30.4 Cg_endo -63.34 142.5 85.95 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.826 2.35 . . . . 0.0 112.356 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -51.81 127.93 35.43 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.128 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.75 ' HB3' ' H ' ' A' ' 139' ' ' SER . 81.9 Cg_endo -78.15 -152.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.765 2.31 . . . . 0.0 112.805 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.443 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 19.4 p-80 -153.83 138.96 17.39 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.073 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . 0.59 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 99.7 m -98.72 131.55 44.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.891 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.402 ' HB2' ' CE1' ' A' ' 135' ' ' HIS . 25.9 mt-30 -103.0 140.16 37.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.793 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.465 ' HB ' ' CE2' ' A' ' 134' ' ' PHE . 14.7 p -79.9 44.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.39 0.614 . . . . 0.0 110.583 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.174 179.989 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.872 0.368 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.5 pp -83.66 159.21 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.543 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 51.5 m -55.01 137.26 46.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.38 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.58 ' HB2' ' HE1' ' A' ' 149' ' ' TRP . 56.4 m -47.95 123.8 6.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.844 0.354 . . . . 0.0 111.226 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.648 ' HA ' HD13 ' A' ' 104' ' ' LEU . 58.9 tptt -75.47 -26.67 58.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.328 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.5 p -53.22 -41.8 65.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.488 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.68 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 3.7 m-85 -59.0 -42.63 90.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.651 0.262 . . . . 0.0 111.179 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.648 HD13 ' HA ' ' A' ' 101' ' ' LYS . 5.7 mp -55.74 -41.13 73.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.064 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.7 p -92.56 127.06 37.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.976 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.5 tp -145.36 128.36 16.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.092 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -69.15 138.06 53.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.971 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 m120 58.24 39.74 25.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.298 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.85 168.36 41.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.703 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -138.88 140.25 38.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.732 0.301 . . . . 0.0 110.743 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 112' ' ' PHE . 74.9 t -109.18 141.45 24.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.206 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.483 ' N ' HG13 ' A' ' 111' ' ' VAL . 7.6 m-85 -105.53 136.1 45.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.644 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.401 ' HA ' HD11 ' A' ' 113' ' ' LEU . 2.6 mm? -101.05 144.2 30.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.575 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.9 m -151.76 126.62 9.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.713 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 124' ' ' ALA . . . 65.01 149.98 0.06 OUTLIER Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.424 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.65 143.13 0.49 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.603 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -173.44 138.31 0.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.761 ' N ' HD13 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -43.16 134.93 3.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.829 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -87.9 54.01 0.52 Allowed 'Cis proline' 0 C--N 1.347 0.486 0 C-N-CA 123.721 -1.366 . . . . 0.0 113.401 0.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.51 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -135.11 135.55 41.27 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.7 0.286 . . . . 0.0 110.861 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.59 ' HB2' ' SG ' ' A' ' 99' ' ' CYS . 2.1 pt? -124.42 -39.92 2.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.104 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -61.32 136.78 58.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.561 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.17 54.59 4.03 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.14 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 115' ' ' GLY . . . -147.7 132.17 17.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 0.0 111.068 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.547 ' HG3' HG21 ' A' ' 143' ' ' VAL . 8.6 mpt_? -124.93 138.86 54.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.113 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.553 HG22 ' CZ3' ' A' ' 149' ' ' TRP . 28.4 m -116.97 137.06 52.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.104 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -106.67 113.72 27.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.95 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.451 ' CE1' HG23 ' A' ' 126' ' ' VAL . 3.8 m-85 -74.83 155.95 37.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.603 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.481 HH22 ' H ' ' A' ' 136' ' ' LEU . 2.4 tpm_? -161.11 128.45 4.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.525 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.456 ' H ' ' CZ ' ' A' ' 129' ' ' ARG . 87.6 m -89.22 140.77 29.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.067 0.46 . . . . 0.0 111.456 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.416 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 63.9 m-20 -54.29 158.88 3.49 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.16 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.513 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 3.5 Cg_endo -45.92 153.14 0.95 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.002 2.468 . . . . 0.0 112.07 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 22.2 m-20 77.92 -32.07 0.17 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.664 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.44 ' H ' ' C ' ' A' ' 132' ' ' PRO . 3.2 m-85 -107.65 128.12 54.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.331 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -107.52 136.44 47.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.425 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.639 HD11 ' HA ' ' A' ' 140' ' ' SER . 6.2 tt -74.94 130.46 39.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.469 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.04 67.43 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.461 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.5 -134.94 1.91 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.092 -1.052 . . . . 0.0 113.058 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.652 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 50.0 m -75.53 55.26 0.81 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.851 0.358 . . . . 0.0 110.964 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.639 ' HA ' HD11 ' A' ' 136' ' ' LEU . 33.6 t -49.77 -40.51 41.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.171 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.424 ' HG2' HH11 ' A' ' 141' ' ' ARG . 22.2 ptt-85 -99.31 134.53 42.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.98 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.2 m -146.29 133.87 20.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.77 0.319 . . . . 0.0 110.736 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.547 HG21 ' HG3' ' A' ' 125' ' ' ARG . 7.3 p -120.05 129.76 75.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.05 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 51.4 t -71.39 141.95 50.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.454 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.3 t -171.3 125.65 0.64 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.216 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.441 ' OE1' ' N ' ' A' ' 146' ' ' GLN . 0.6 OUTLIER 57.15 39.61 28.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 0.0 110.448 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.17 -51.65 3.26 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.774 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -76.92 143.7 39.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.678 0.275 . . . . 0.0 111.057 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.58 ' HE1' ' HB2' ' A' ' 100' ' ' SER . 70.0 m95 -84.2 146.82 27.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.828 0.347 . . . . 0.0 110.659 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.3 t -53.37 -61.17 2.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.524 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 139' ' ' SER . 82.4 p -107.79 135.78 19.77 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.774 0.321 . . . . 0.0 111.776 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 139' ' ' SER . 57.6 Cg_endo -70.78 145.67 51.9 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.785 2.323 . . . . 0.0 112.161 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.68 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 7.6 mtpm? -45.32 130.17 5.98 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.433 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.652 ' HB3' ' H ' ' A' ' 139' ' ' SER . 76.1 Cg_endo -77.51 -141.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.69 2.26 . . . . 0.0 112.547 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.518 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.4 p-80 -153.74 147.6 25.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.036 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 71.0 m -96.89 140.26 31.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.279 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -131.26 146.69 52.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.875 0.369 . . . . 0.0 111.48 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 79.6 t -76.61 125.18 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.174 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.067 -179.634 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.417 ' NH1' ' HA3' ' A' ' 147' ' ' GLY . 31.2 ptt85 . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.92 0.39 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.541 ' HA ' HD11 ' A' ' 121' ' ' LEU . 2.3 pp -51.13 148.21 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.991 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.586 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 97.7 m -59.76 143.83 49.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.04 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.2 m -48.03 124.81 8.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.226 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.68 ' HB2' HD13 ' A' ' 104' ' ' LEU . 7.6 ptpp? -84.46 14.98 3.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.933 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.2 m -67.34 -35.63 79.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.678 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.744 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 3.4 m-85 -58.74 -25.69 63.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.417 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.68 HD13 ' HB2' ' A' ' 101' ' ' LYS . 84.4 mt -50.0 -38.41 37.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.737 0.303 . . . . 0.0 111.118 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.3 p -92.55 127.81 38.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.111 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.664 ' HG ' ' HZ1' ' A' ' 153' ' ' LYS . 6.4 tt -145.37 124.02 12.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.182 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -74.25 130.69 40.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.37 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.497 ' N ' HD21 ' A' ' 108' ' ' ASN . 2.0 m120 60.11 47.22 9.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.221 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.95 -171.83 39.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.075 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -142.09 146.29 35.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.659 0.266 . . . . 0.0 110.647 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 103' ' ' TYR . 60.3 t -108.05 127.4 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.631 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.5 m-85 -112.01 70.88 0.72 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.149 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.69 ' HA ' ' HB ' ' A' ' 126' ' ' VAL . 2.3 tt -74.67 62.39 1.05 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.618 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.8 p -75.0 120.89 21.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.712 0.291 . . . . 0.0 111.118 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.14 -43.89 0.31 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.654 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -173.16 -128.26 1.05 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.531 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.515 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 11.6 p-10 -165.24 -136.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.565 ' N ' HD21 ' A' ' 118' ' ' LEU . 2.7 mm? -116.31 132.98 23.02 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.526 0.203 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -93.09 42.06 3.15 Favored 'Cis proline' 0 C--N 1.348 0.537 0 C-N-CA 123.837 -1.318 . . . . 0.0 112.497 -0.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.515 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -74.07 140.89 45.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 0.0 111.742 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.664 HD23 ' N ' ' A' ' 121' ' ' LEU . 2.1 pt? -167.39 36.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.803 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.93 60.57 1.39 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.917 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.22 40.84 32.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.225 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.589 ' O ' HG21 ' A' ' 143' ' ' VAL . . . -62.9 135.29 57.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 110.981 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.582 ' HD2' ' NH2' ' A' ' 141' ' ' ARG . 85.7 mtm180 -103.83 141.47 36.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.498 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.69 ' HB ' ' HA ' ' A' ' 113' ' ' LEU . 6.5 p -143.23 135.66 24.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.257 0.551 . . . . 0.0 112.315 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.454 ' N ' HG23 ' A' ' 126' ' ' VAL . 5.0 tp10 -109.17 121.11 44.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.737 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.519 ' HE1' ' HB3' ' A' ' 142' ' ' SER . 3.2 m-85 -87.3 56.19 3.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.801 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.43 ' HG2' HH11 ' A' ' 129' ' ' ARG . 63.5 mtt-85 -59.05 132.97 55.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.591 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 53.7 t -89.2 149.13 23.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.34 . . . . 0.0 111.13 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.483 ' OD1' ' HB2' ' A' ' 134' ' ' PHE . 52.5 p-10 -52.81 149.8 10.88 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.404 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.509 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 10.1 Cg_endo -51.59 152.74 12.0 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.751 2.301 . . . . 0.0 111.527 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.57 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 37.4 t70 76.44 -2.41 2.72 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.399 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.684 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 19.1 m-85 -134.28 130.61 37.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.951 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.56 ' HD1' ' HB2' ' A' ' 159' ' ' ASN . 17.8 p-80 -104.16 128.19 51.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.923 0.392 . . . . 0.0 111.197 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.574 HD12 ' HB3' ' A' ' 140' ' ' SER . 2.8 tm? -71.44 132.15 44.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.795 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.46 ' N ' HD11 ' A' ' 136' ' ' LEU . 24.8 t -132.23 67.88 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.9 -135.13 2.11 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 119.901 -1.142 . . . . 0.0 113.276 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.639 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 39.2 p -74.99 56.05 0.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.929 0.395 . . . . 0.0 111.072 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.574 ' HB3' HD12 ' A' ' 136' ' ' LEU . 92.6 p -57.0 -38.95 73.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.801 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.582 ' NH2' ' HD2' ' A' ' 125' ' ' ARG . 29.4 tpt180 -99.32 133.97 42.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.703 0.287 . . . . 0.0 111.508 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.519 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 46.7 t -150.34 148.67 29.1 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.258 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.589 HG21 ' O ' ' A' ' 124' ' ' ALA . 7.4 p -146.23 130.27 10.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.146 0.498 . . . . 0.0 112.046 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.527 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 13.7 t -92.54 140.96 29.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.901 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.4 t -169.52 -60.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.042 0.449 . . . . 0.0 111.218 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -87.98 43.63 1.13 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.417 ' HA3' ' NH1' ' A' ' 97' ' ' ARG . . . 56.54 39.9 85.91 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.89 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -174.73 146.98 1.0 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.728 0.299 . . . . 0.0 110.402 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.586 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 29.5 m95 -84.22 138.78 32.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.778 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.559 ' HB2' HG11 ' A' ' 143' ' ' VAL . 45.2 t -50.15 -46.31 53.95 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.965 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 70.9 p -135.65 138.84 29.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.891 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.516 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 28.0 Cg_exo -62.02 -162.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.561 2.174 . . . . 0.0 112.627 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.744 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 3.9 mmmp? -80.75 127.3 75.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.783 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.639 ' HB3' ' N ' ' A' ' 139' ' ' SER . 84.0 Cg_endo -81.37 -151.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.635 2.223 . . . . 0.0 112.891 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.452 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 22.4 p-80 -153.65 136.52 15.38 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.936 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . 0.684 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 7.8 t -98.72 136.83 38.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.979 0.418 . . . . 0.0 111.664 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -103.04 142.4 34.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.02 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 98.2 t -61.24 111.03 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.78 0.324 . . . . 0.0 110.327 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.57 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 38.6 t30 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.05 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.744 0.307 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.499 HD11 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -54.33 142.36 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 0.0 111.49 -179.547 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 82.1 m -56.42 154.47 8.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.757 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.7 m -45.67 127.51 7.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.492 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -76.19 -3.38 35.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.262 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.5 m -56.12 -41.15 74.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.87 0.367 . . . . 0.0 110.994 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.468 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 1.7 m-85 -59.98 -34.17 72.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.196 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.6 mt -52.11 -40.01 60.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.967 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.1 m -92.6 136.29 33.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 106' ' ' LEU . 23.5 tp -145.42 131.35 19.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.86 0.362 . . . . 0.0 111.31 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -75.02 133.56 41.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.853 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 52.47 36.07 19.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 110.664 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.36 145.81 9.91 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.538 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.64 ' HB3' ' HZ3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -101.93 140.87 35.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.972 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.03 135.93 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.79 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.412 ' HE1' ' HG3' ' A' ' 110' ' ' LYS . 3.5 m-85 -110.35 136.16 49.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.779 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.673 HD23 HG21 ' A' ' 126' ' ' VAL . 94.8 mt -112.4 144.86 41.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.163 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.8 t -159.83 143.1 14.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.005 0.431 . . . . 0.0 111.81 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.09 126.07 0.13 Allowed Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.911 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 152.06 -140.36 7.7 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.312 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 120' ' ' ALA . 65.6 t0 -173.86 119.14 0.27 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.494 ' HA ' ' C ' ' A' ' 119' ' ' PRO . 3.1 mm? -29.49 126.16 0.26 Allowed Pre-proline 0 N--CA 1.465 0.301 0 O-C-N 123.591 0.557 . . . . 0.0 111.555 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 118' ' ' LEU . 25.5 Cg_exo -63.18 -22.1 4.86 Favored 'Cis proline' 0 C--N 1.351 0.682 0 C-N-CA 124.097 -1.209 . . . . 0.0 112.992 0.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 117' ' ' ASP . . . 69.26 129.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.413 0.625 . . . . 0.0 111.752 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 120' ' ' ALA . 2.2 tm? 175.33 -35.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.236 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -62.14 132.32 52.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.677 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.5 31.72 36.88 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.331 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.581 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -77.19 139.65 39.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.758 0.313 . . . . 0.0 111.193 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' A' ' 125' ' ' ARG . 41.1 ttt85 -103.98 63.25 0.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.126 0.489 . . . . 0.0 109.725 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.673 HG21 HD23 ' A' ' 113' ' ' LEU . 11.0 p -57.96 141.7 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.776 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.411 ' N ' HG22 ' A' ' 126' ' ' VAL . 97.1 mt-10 -123.92 113.3 18.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.863 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.516 ' HE1' HG12 ' A' ' 126' ' ' VAL . 3.8 m-85 -80.06 151.3 29.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.9 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.452 HH11 ' HG3' ' A' ' 129' ' ' ARG . 38.3 ttt85 -161.11 133.12 5.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.785 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 84.1 m -89.25 142.45 27.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.204 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.446 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 60.8 m-20 -56.27 160.81 4.54 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.022 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.516 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 78.2 Cg_exo -41.15 154.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.982 2.455 . . . . 0.0 112.652 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.516 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 8.1 t70 78.89 -33.77 0.16 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.717 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 132' ' ' PRO . 1.7 m-85 -107.6 129.5 54.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.237 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -110.75 134.75 52.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.99 0.424 . . . . 0.0 111.08 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 tt -75.21 132.42 41.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.597 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.7 t -133.39 67.3 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.452 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.25 -126.33 1.07 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.15 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.596 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 42.7 t -70.2 64.46 0.25 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.986 0.422 . . . . 0.0 111.258 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.3 t -64.36 -18.0 64.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.172 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 56.5 mtt85 -140.7 140.86 34.97 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.056 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.514 ' O ' HG13 ' A' ' 126' ' ' VAL . 35.9 m -145.03 136.27 25.02 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 7.2 p -113.32 130.55 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.924 0.393 . . . . 0.0 111.357 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 45.6 t -75.05 139.46 42.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.96 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 m -163.12 134.58 4.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.844 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 67.36 -66.68 0.19 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.462 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.0 37.44 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.526 -0.629 . . . . 0.0 111.526 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -176.32 152.36 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.105 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.411 ' CZ3' HG11 ' A' ' 126' ' ' VAL . 27.9 m95 -84.19 140.93 31.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.741 0.305 . . . . 0.0 110.724 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.6 m -52.3 -59.89 3.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.013 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.2 p -100.91 134.26 20.56 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.05 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.59 -157.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.398 2.066 . . . . 0.0 112.366 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.554 ' HB3' ' NZ ' ' A' ' 153' ' ' LYS . 9.5 mtpm? -92.98 129.93 37.98 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.037 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.596 ' HB3' ' N ' ' A' ' 139' ' ' SER . 66.5 Cg_endo -73.09 -144.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.673 2.249 . . . . 0.0 112.722 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.481 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.7 p-80 -153.67 149.26 27.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.415 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 73.9 m -97.86 129.33 44.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 0.0 111.189 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -111.87 133.24 54.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.682 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -84.79 127.15 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.912 -179.767 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.448 HH11 ' HG3' ' A' ' 97' ' ' ARG . 38.5 ttm-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.972 0.415 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.413 HG22 HD22 ' A' ' 121' ' ' LEU . 31.7 pt -72.88 141.83 15.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.717 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 59.7 m -61.22 143.23 55.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.945 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.4 ' HB3' ' HE1' ' A' ' 149' ' ' TRP . 41.1 t -47.91 130.78 15.27 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.354 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -76.69 -19.93 57.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.429 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.3 p -53.06 -46.63 68.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.787 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.423 ' O ' HG22 ' A' ' 111' ' ' VAL . 3.5 m-85 -61.72 -36.72 81.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.587 0.232 . . . . 0.0 111.204 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.6 mt -54.43 -48.64 71.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.109 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.6 m -92.55 137.85 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.45 HD13 ' HZ3' ' A' ' 153' ' ' LYS . 24.8 tp -145.4 130.77 18.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.037 0.446 . . . . 0.0 111.348 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.468 ' HG2' ' ND2' ' A' ' 108' ' ' ASN . 44.4 tt0 -72.43 137.35 46.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.404 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.468 ' ND2' ' HG2' ' A' ' 107' ' ' GLU . 76.0 m-20 61.06 37.21 18.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.147 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 178.98 -179.33 48.92 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.704 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -142.03 147.12 36.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.79 0.328 . . . . 0.0 110.791 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 112' ' ' PHE . 86.3 t -107.23 141.61 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.969 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.531 ' N ' HG12 ' A' ' 111' ' ' VAL . 2.4 m-85 -105.15 135.32 46.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.802 HD11 HG11 ' A' ' 126' ' ' VAL . 2.0 mm? -102.77 147.07 27.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.237 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.0 m -151.59 129.81 11.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.815 0.341 . . . . 0.0 111.256 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 56.19 43.56 89.0 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.62 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.604 ' HA3' ' HB3' ' A' ' 124' ' ' ALA . . . -179.92 141.15 4.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.653 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -174.86 134.21 0.35 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.76 HD11 ' HA ' ' A' ' 119' ' ' PRO . 37.3 tp -43.82 131.62 4.07 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.939 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.76 ' HA ' HD11 ' A' ' 118' ' ' LEU . 84.6 Cg_endo -90.7 63.02 0.27 Allowed 'Cis proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.585 -1.423 . . . . 0.0 113.143 0.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.478 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -141.83 48.79 1.6 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.816 0.341 . . . . 0.0 111.26 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.513 HD21 HD13 ' A' ' 118' ' ' LEU . 3.1 mm? -62.61 -45.08 94.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.636 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 145' ' ' SER . 64.3 t0 -62.59 138.89 58.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.615 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.93 57.73 5.14 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.375 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.604 ' HB3' ' HA3' ' A' ' 116' ' ' GLY . . . -154.03 141.23 19.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 111.271 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.607 HH21 ' HD2' ' A' ' 141' ' ' ARG . 41.9 ttt85 -108.62 141.66 40.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.504 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.802 HG11 HD11 ' A' ' 113' ' ' LEU . 19.1 m -130.88 140.16 49.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.963 0.411 . . . . 0.0 111.679 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -103.5 125.26 49.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.094 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.471 ' CE1' HG21 ' A' ' 126' ' ' VAL . 9.7 m-85 -92.38 143.04 26.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.084 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 41.3 ttt85 -172.34 124.07 0.49 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.991 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.509 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 56.9 m -89.31 146.03 24.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.883 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.69 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 59.5 m-20 -55.88 167.14 0.89 Allowed Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.37 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.69 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 2.1 Cg_endo -45.01 159.81 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.268 2.645 . . . . 0.0 112.399 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.5 m-20 77.95 -37.67 0.24 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.258 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' A' ' 132' ' ' PRO . 6.6 m-85 -108.52 126.25 52.71 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -117.94 126.28 52.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.243 0.544 . . . . 0.0 111.335 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.5 tt -72.58 130.16 39.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.029 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.6 t -129.06 67.09 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.531 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.95 -131.99 1.48 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.496 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.535 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 80.1 p -73.86 64.51 0.98 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.979 0.418 . . . . 0.0 110.272 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.7 t -58.33 -2.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.436 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.607 ' HD2' HH21 ' A' ' 125' ' ' ARG . 53.8 mtm-85 -140.69 137.08 33.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.523 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.46 ' O ' HG22 ' A' ' 126' ' ' VAL . 47.0 m -149.12 133.34 17.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.389 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.408 ' O ' HG11 ' A' ' 143' ' ' VAL . 6.2 p -123.25 126.22 73.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.106 0.479 . . . . 0.0 111.289 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 52.6 t -98.99 140.04 33.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.755 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.441 ' HA ' ' OD1' ' A' ' 122' ' ' ASP . 43.7 t -170.05 38.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.128 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 52.0 tt0 177.68 47.18 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.502 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 54.36 35.27 55.51 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.949 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -177.39 144.86 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.4 ' HE1' ' HB3' ' A' ' 100' ' ' SER . 29.7 m95 -84.22 140.82 31.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.82 0.343 . . . . 0.0 110.689 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.4 t -52.72 -65.87 0.48 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.933 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 81.1 p -98.42 135.68 21.11 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.73 0.3 . . . . 0.0 111.8 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 27.1 Cg_exo -62.1 143.85 95.25 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.758 2.305 . . . . 0.0 111.616 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.45 ' HZ3' HD13 ' A' ' 106' ' ' LEU . 83.3 tttt -47.92 130.71 11.81 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.839 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.535 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.3 Cg_endo -75.84 -148.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.814 2.343 . . . . 0.0 113.206 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.458 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 16.9 p-80 -153.75 130.99 11.17 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.181 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 93.5 m -99.07 135.38 40.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.064 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -103.02 141.51 35.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.224 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 49.3 t -69.52 79.53 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.055 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.472 -179.961 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.442 ' O ' ' HA2' ' A' ' 147' ' ' GLY . 70.0 mtt-85 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.588 0.233 . . . . 0.0 110.534 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.52 ' HB ' ' HG ' ' A' ' 121' ' ' LEU . 29.4 pt -78.51 38.81 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.448 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.49 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 68.0 m 59.21 141.06 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.013 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.6 t -48.03 126.3 10.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.312 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.469 ' O ' HD23 ' A' ' 104' ' ' LEU . 63.9 pttt -80.01 -12.97 59.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.881 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.6 m -57.07 -42.26 80.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.563 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -52.94 -37.6 61.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.234 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.499 HD23 ' H ' ' A' ' 104' ' ' LEU . 2.0 mm? -54.1 -41.59 68.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.336 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.5 m -92.54 136.07 33.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.043 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.841 HD12 ' HE2' ' A' ' 153' ' ' LYS . 15.5 tp -145.39 130.62 18.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.25 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.494 ' N ' HD13 ' A' ' 106' ' ' LEU . 42.6 tt0 -70.66 131.15 43.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.416 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.423 ' ND2' ' HG2' ' A' ' 107' ' ' GLU . 76.5 m-20 54.81 42.42 31.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.993 0.425 . . . . 0.0 110.609 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.08 153.57 14.01 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.588 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -115.29 142.79 46.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.691 0.281 . . . . 0.0 110.758 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.1 t -107.89 131.34 58.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.053 0.454 . . . . 0.0 110.977 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.561 ' O ' HG22 ' A' ' 126' ' ' VAL . 3.0 m-85 -109.82 150.78 27.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.784 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 pp -158.13 149.78 21.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.916 0.388 . . . . 0.0 111.52 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.0 p -151.33 132.26 14.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.72 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 167.68 -129.78 1.97 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.433 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.75 -122.82 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.507 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 118' ' ' LEU . 54.4 t0 -161.68 -127.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.478 0.18 . . . . 0.0 110.64 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.899 HD11 ' HA ' ' A' ' 119' ' ' PRO . 31.9 tp -128.88 130.05 23.46 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.761 0.315 . . . . 0.0 111.172 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.899 ' HA ' HD11 ' A' ' 118' ' ' LEU . 89.7 Cg_endo -91.86 42.47 2.84 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.442 -1.483 . . . . 0.0 112.581 -0.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -80.96 46.96 0.94 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.523 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.715 ' H ' HD21 ' A' ' 121' ' ' LEU . 3.5 mm? -61.89 -38.05 86.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.147 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -61.27 146.03 49.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.1 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.1 -34.54 3.02 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.61 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.08 141.88 38.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.904 0.383 . . . . 0.0 111.649 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.619 ' HD2' HG21 ' A' ' 143' ' ' VAL . 43.9 mmm-85 -104.26 136.96 42.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.087 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 112' ' ' PHE . 15.0 p -123.83 133.14 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.189 0.519 . . . . 0.0 111.986 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -112.81 120.58 41.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.697 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.461 ' HE1' HG11 ' A' ' 126' ' ' VAL . 8.5 m-85 -88.75 149.81 23.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.256 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -164.64 134.81 3.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.051 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 70.5 m -89.23 155.44 19.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.772 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 133' ' ' ASP . 11.5 p-10 -52.69 149.11 11.7 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.987 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -58.14 74.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.08 2.52 . . . . 0.0 112.576 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.1 t70 -177.74 -40.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.736 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.466 ' CE2' ' HB ' ' A' ' 158' ' ' VAL . 1.4 m-85 -107.86 142.65 37.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.829 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -101.24 129.1 47.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 0.0 111.066 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.423 HD23 ' H ' ' A' ' 138' ' ' GLY . 6.9 tt -77.91 130.54 36.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.451 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.5 t -131.87 66.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.415 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.423 ' H ' HD23 ' A' ' 136' ' ' LEU . . . -172.04 -126.61 0.9 Allowed Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.079 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.736 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 34.9 t -72.3 58.52 0.39 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 111.201 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.5 t -56.58 -26.58 55.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.853 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.406 ' HG3' HH11 ' A' ' 141' ' ' ARG . 45.2 ttm-85 -129.84 137.76 50.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 39.4 t -149.25 175.83 11.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.023 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.619 HG21 ' HD2' ' A' ' 125' ' ' ARG . 8.6 p -160.6 137.34 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.08 0.467 . . . . 0.0 112.003 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 37.1 t -78.79 135.07 36.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.886 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.8 t -175.26 133.48 0.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.953 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 56.87 40.94 28.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 97' ' ' ARG . . . 56.15 43.2 88.8 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.522 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -175.13 138.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.69 0.281 . . . . 0.0 110.702 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.49 ' CE2' ' HB3' ' A' ' 99' ' ' CYS . 14.5 m95 -84.2 140.25 31.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.371 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.4 p -52.92 -60.83 2.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.741 0.305 . . . . 0.0 110.865 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 40.3 p -101.23 140.54 21.36 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.127 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 24.4 Cg_exo -63.62 -153.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.628 2.218 . . . . 0.0 112.365 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.841 ' HE2' HD12 ' A' ' 106' ' ' LEU . 83.7 tttt -102.39 127.9 29.47 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.486 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.736 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 60.3 Cg_endo -72.66 -153.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.538 2.159 . . . . 0.0 112.717 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.402 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.7 p-80 -153.67 144.64 22.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.484 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 66.2 m -97.3 134.05 41.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.895 0.379 . . . . 0.0 110.775 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -117.9 138.75 51.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.136 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 134' ' ' PHE . 8.6 p -85.95 129.45 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.436 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.2 p30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.968 -179.7 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.414 ' O ' HG21 ' A' ' 98' ' ' ILE . 79.2 mtm180 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.04 0.448 . . . . 0.0 111.4 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.414 HG21 ' O ' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -148.49 134.66 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.411 179.296 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 7.4 p -53.27 139.33 29.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.614 -179.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.4 m -47.91 128.1 12.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.482 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -84.56 3.75 35.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.019 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.4 t -63.29 -39.02 93.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.009 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.404 ' H ' ' HD1' ' A' ' 103' ' ' TYR . 1.5 m-85 -54.94 -38.23 67.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.971 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.43 HD11 ' H ' ' A' ' 104' ' ' LEU . 6.2 mp -54.56 -34.26 61.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.304 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.2 p -92.33 129.45 38.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 111.029 -179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.808 HD12 ' HE2' ' A' ' 153' ' ' LYS . 22.3 tp -145.48 133.8 21.77 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.335 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.427 ' H ' HD13 ' A' ' 106' ' ' LEU . 8.2 pm0 -74.73 132.19 41.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.331 179.124 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 55.89 39.22 30.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.609 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.31 151.2 14.02 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.821 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -112.48 142.1 45.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.351 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 43.0 t -106.98 137.5 37.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.994 0.426 . . . . 0.0 111.287 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.527 ' O ' HG23 ' A' ' 126' ' ' VAL . 3.6 m-85 -104.72 142.09 35.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.293 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.56 ' HB3' HG23 ' A' ' 126' ' ' VAL . 4.1 pp -166.81 150.65 6.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.983 0.42 . . . . 0.0 111.697 -179.53 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.6 m -160.33 135.04 7.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.784 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 132.15 136.26 3.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.73 141.75 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.044 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 32.7 m-20 -130.53 -42.51 1.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.246 0.546 . . . . 0.0 109.64 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.726 ' H ' HD12 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -130.27 123.01 20.36 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.407 179.559 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.7 33.59 2.16 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 123.28 -1.55 . . . . 0.0 112.338 0.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.456 ' H ' ' CA ' ' A' ' 118' ' ' LEU . . . 66.65 146.82 0.04 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.874 0.369 . . . . 0.0 111.245 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.495 ' HB3' ' SG ' ' A' ' 99' ' ' CYS . 6.6 mp 62.43 35.1 15.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.01 -178.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.96 51.02 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.099 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.441 ' HA2' ' C ' ' A' ' 144' ' ' CYS . . . 71.44 42.32 56.41 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.567 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.35 -163.59 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 111.318 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -112.3 146.29 38.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.435 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.56 HG23 ' HB3' ' A' ' 113' ' ' LEU . 8.1 p -141.86 138.56 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.114 0.483 . . . . 0.0 111.4 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -132.59 111.68 11.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.375 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -69.18 153.75 43.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.206 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.1 tpp85 -160.6 129.47 4.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.833 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 55.8 m -89.18 143.83 26.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.735 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 133' ' ' ASP . 61.4 m-20 -53.2 150.85 10.38 Favored Pre-proline 0 N--CA 1.462 0.155 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.123 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.55 77.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.23 2.62 . . . . 0.0 113.105 -179.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 131' ' ' ASP . 39.0 t70 177.73 -38.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.761 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -108.33 142.37 38.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.797 179.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.474 ' CD2' ' HB3' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -100.8 132.71 46.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.126 0.489 . . . . 0.0 111.07 179.91 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 137' ' ' VAL . 4.9 tt -76.93 124.71 28.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.07 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.491 ' N ' HD22 ' A' ' 136' ' ' LEU . 21.2 t -134.78 61.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.598 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -166.11 -133.65 1.55 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 119.869 -1.158 . . . . 0.0 113.148 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.626 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 64.2 m -74.56 55.06 0.63 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.832 0.349 . . . . 0.0 110.991 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.455 ' HB2' HD23 ' A' ' 136' ' ' LEU . 36.6 t -51.39 -43.05 61.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.968 -179.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.429 HH11 ' HG3' ' A' ' 141' ' ' ARG . 40.1 ttt85 -99.47 131.16 45.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.829 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.9 m -150.72 153.49 35.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.965 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.636 HG12 ' HB2' ' A' ' 150' ' ' SER . 15.0 p -138.27 134.24 43.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.172 0.51 . . . . 0.0 112.004 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.441 ' C ' ' HA2' ' A' ' 123' ' ' GLY . 27.5 t -74.14 152.51 39.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.481 179.202 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.9 p -155.9 -135.97 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.016 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -53.51 -38.88 64.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.882 0.373 . . . . 0.0 110.952 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . -174.11 -49.09 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.123 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -85.0 142.22 29.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.744 0.307 . . . . 0.0 110.355 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.403 ' NE1' ' HB2' ' A' ' 99' ' ' CYS . 35.9 m95 -84.11 151.18 25.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.484 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.636 ' HB2' HG12 ' A' ' 143' ' ' VAL . 48.3 t -44.97 -57.15 4.0 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.179 -179.31 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.495 ' HB ' ' HG ' ' A' ' 139' ' ' SER . 72.4 p -121.23 145.13 41.4 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.947 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -57.61 -161.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.616 2.211 . . . . 0.0 112.765 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.808 ' HE2' HD12 ' A' ' 106' ' ' LEU . 83.0 tttt -94.12 126.13 49.93 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.833 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.626 ' HB3' ' N ' ' A' ' 139' ' ' SER . 57.1 Cg_endo -70.77 -155.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.481 2.12 . . . . 0.0 112.384 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.416 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 24.9 p-80 -153.69 142.27 20.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 75.5 m -98.72 132.67 43.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.912 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.474 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 53.0 tt0 -116.33 141.05 48.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.808 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.03 132.42 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.287 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.7 p30 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.986 -179.422 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.701 0.286 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.437 HG23 ' O ' ' A' ' 119' ' ' PRO . 33.1 pt -54.65 139.32 13.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.995 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.496 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 96.4 m -53.15 135.62 37.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.18 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.433 ' HG ' ' H ' ' A' ' 102' ' ' SER . 42.6 t -47.92 127.96 12.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.457 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.814 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -87.25 -6.53 58.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.935 179.666 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.433 ' H ' ' HG ' ' A' ' 100' ' ' SER . 87.1 p -54.09 -34.73 60.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.219 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.586 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.9 m-85 -57.04 -35.55 69.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.56 -179.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.658 HD13 ' N ' ' A' ' 104' ' ' LEU . 4.1 mp -77.8 37.49 0.24 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.107 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.4 p -147.5 63.55 1.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.802 0.334 . . . . 0.0 110.803 179.125 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.785 HD13 ' HE2' ' A' ' 153' ' ' LYS . 29.6 tp -94.12 128.91 40.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.634 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -73.4 137.03 44.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.996 178.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.454 ' HB3' ' OD2' ' A' ' 131' ' ' ASP . 2.9 m120 58.64 42.03 21.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.108 0.48 . . . . 0.0 110.126 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -171.27 164.58 37.57 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.647 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -125.14 141.84 51.86 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.7 t -109.38 137.04 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.885 0.374 . . . . 0.0 111.021 -179.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.451 ' O ' HG21 ' A' ' 126' ' ' VAL . 2.3 m-85 -107.69 141.77 38.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.684 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 114' ' ' THR . 7.1 tt -147.84 138.02 22.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.006 0.432 . . . . 0.0 111.015 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.463 ' N ' HD22 ' A' ' 113' ' ' LEU . 76.2 p -145.07 121.27 10.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.645 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.38 -43.37 0.77 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.163 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -179.7 -138.67 3.41 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.071 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -178.04 -60.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.004 0.43 . . . . 0.0 110.824 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.752 ' N ' HD13 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -149.41 132.83 8.45 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.302 -179.468 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.437 ' O ' HG23 ' A' ' 98' ' ' ILE . 5.9 Cg_exo -78.07 19.72 6.56 Favored 'Cis proline' 0 C--N 1.347 0.464 0 C-N-CA 123.531 -1.446 . . . . 0.0 112.148 -0.018 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.411 ' HB2' ' H ' ' A' ' 121' ' ' LEU . . . 50.73 -138.26 1.05 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.994 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.411 ' H ' ' HB2' ' A' ' 120' ' ' ALA . 28.5 mt 58.72 63.2 1.72 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.831 0.348 . . . . 0.0 111.306 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -164.02 50.92 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.029 0.442 . . . . 0.0 110.702 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.93 41.39 97.4 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.971 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.32 134.3 39.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 111.058 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -112.72 144.61 41.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 142' ' ' SER . 8.5 p -141.39 142.03 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.081 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -133.81 123.0 24.06 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.111 -179.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.586 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 2.8 m-85 -79.99 147.13 31.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.871 179.695 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -141.24 130.99 24.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.515 ' SG ' HD13 ' A' ' 136' ' ' LEU . 76.1 m -93.88 140.81 29.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.181 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.557 ' HB2' ' HD2' ' A' ' 132' ' ' PRO . 1.9 p30 -62.25 161.16 26.61 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.514 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.557 ' HD2' ' HB2' ' A' ' 131' ' ' ASP . 1.5 Cg_endo -43.07 148.07 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.967 2.445 . . . . 0.0 112.067 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 21.8 m-20 78.96 -24.41 0.22 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.798 -179.039 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.531 ' HA ' ' O ' ' A' ' 157' ' ' GLN . 22.2 m-85 -108.61 134.86 50.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.7 0.286 . . . . 0.0 110.619 179.353 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -123.02 133.97 54.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.589 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 154' ' ' PRO . 17.1 tp -75.35 130.14 38.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.722 -179.509 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.85 67.42 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.827 -179.199 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.87 -134.24 1.95 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.05 -1.072 . . . . 0.0 112.975 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.522 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 30.5 p -73.85 59.42 0.68 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.102 0.477 . . . . 0.0 110.712 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.421 ' HA ' HD22 ' A' ' 136' ' ' LEU . 94.2 p -54.97 -50.9 67.8 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.444 -178.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.674 ' HD2' ' O ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -99.38 141.79 31.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.144 0.497 . . . . 0.0 112.006 -179.259 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.629 ' O ' HG12 ' A' ' 126' ' ' VAL . 55.3 p -150.69 146.0 26.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.148 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.453 ' H ' ' HG ' ' A' ' 150' ' ' SER . 10.0 p -126.92 134.76 65.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.053 0.454 . . . . 0.0 111.863 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.71 143.98 51.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.714 179.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.2 m -149.9 -134.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.41 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -52.85 -34.72 55.57 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.929 0.395 . . . . 0.0 110.476 179.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.5 -48.8 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.767 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -80.41 144.12 32.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.676 0.274 . . . . 0.0 110.724 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.609 ' CZ3' HG13 ' A' ' 126' ' ' VAL . 44.0 m95 -84.2 151.07 25.07 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.421 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.626 ' OG ' ' HA ' ' A' ' 142' ' ' SER . 98.5 p -43.34 -42.85 4.75 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.78 0.324 . . . . 0.0 110.703 -179.477 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.8 p -141.39 145.8 39.59 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.469 179.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.8 -156.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.697 2.265 . . . . 0.0 112.769 -179.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.785 ' HE2' HD13 ' A' ' 106' ' ' LEU . 87.3 tttt -101.5 125.39 37.68 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.821 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.522 ' HB3' ' N ' ' A' ' 139' ' ' SER . 60.0 Cg_endo -74.87 -149.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.407 2.071 . . . . 0.0 112.565 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.438 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 17.3 p-80 -153.7 147.75 25.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.251 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 73.0 m -98.54 129.2 45.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.687 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.531 ' O ' ' HA ' ' A' ' 134' ' ' PHE . 84.5 mt-30 -107.59 136.58 47.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.994 0.426 . . . . 0.0 111.764 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.419 ' HB ' ' CE2' ' A' ' 134' ' ' PHE . 11.9 p -83.11 47.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.499 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.954 -179.416 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.908 0.385 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.564 HD11 ' H ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -65.03 146.47 13.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.359 -179.644 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 35.1 m -52.21 143.23 14.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.464 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.606 ' HB2' ' HE1' ' A' ' 149' ' ' TRP . 53.3 m -47.98 125.7 9.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.998 0.427 . . . . 0.0 111.38 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HD3' HD22 ' A' ' 104' ' ' LEU . 16.8 tppt? -82.18 84.82 6.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.081 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.0 t -171.07 -44.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.748 0.309 . . . . 0.0 111.582 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.572 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.5 m-85 -60.71 -42.61 97.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.736 -179.454 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 105' ' ' THR . 0.2 OUTLIER -49.95 -29.52 8.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.622 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.679 ' N ' HD13 ' A' ' 104' ' ' LEU . 74.6 p -98.45 127.4 44.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.713 0.292 . . . . 0.0 110.766 179.345 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.684 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 69.0 tp -145.42 121.55 10.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.013 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 107' ' ' GLU . 0.1 OUTLIER -72.44 136.01 45.9 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.224 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 m120 58.71 39.3 24.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.136 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.75 155.87 23.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.313 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -111.67 140.05 46.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.975 0.417 . . . . 0.0 111.361 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.626 HG12 ' HA ' ' A' ' 104' ' ' LEU . 96.1 t -111.08 128.59 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.648 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.61 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.8 m-85 -112.38 65.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.482 -179.099 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.633 ' HA ' ' HB ' ' A' ' 126' ' ' VAL . 2.2 pt? -75.84 45.06 0.32 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.686 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.8 p -73.89 134.78 43.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.787 0.327 . . . . 0.0 111.414 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 124' ' ' ALA . . . 160.33 -54.92 0.33 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.426 -0.893 . . . . 0.0 113.111 179.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.693 ' HA3' ' HA ' ' A' ' 121' ' ' LEU . . . -82.78 -147.36 6.81 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.333 -179.389 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.8 t0 179.3 67.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.77 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 88.2 mt -33.74 123.69 0.48 Allowed Pre-proline 0 N--CA 1.462 0.154 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.745 -178.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.64 92.61 0.12 OUTLIER 'Cis proline' 0 C--N 1.348 0.525 0 C-N-CA 123.471 -1.47 . . . . 0.0 112.559 -0.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.77 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -177.52 150.15 0.67 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.637 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.693 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 0.4 OUTLIER -170.15 39.18 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.657 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.94 124.52 26.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.745 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 53.45 40.07 61.03 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.595 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.572 ' O ' HG22 ' A' ' 143' ' ' VAL . . . -72.1 124.7 25.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.756 0.312 . . . . 0.0 111.236 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -113.08 144.48 42.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.186 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.633 ' HB ' ' HA ' ' A' ' 113' ' ' LEU . 5.8 p -133.05 130.44 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.365 0.603 . . . . 0.0 112.22 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -98.48 136.12 39.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.29 179.404 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.561 ' HB2' ' HB2' ' A' ' 140' ' ' SER . 20.4 m-85 -112.85 142.73 45.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 0.0 111.569 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.452 ' HA ' HD13 ' A' ' 136' ' ' LEU . 37.3 ptt180 -163.14 126.85 2.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.271 179.067 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 18.1 t -89.19 140.42 29.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.189 -179.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.519 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 59.2 m-20 -54.82 161.39 2.31 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.267 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 8.2 Cg_endo -49.54 165.09 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.011 2.474 . . . . 0.0 112.031 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 28.3 m-20 75.43 -17.99 0.48 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.396 -179.233 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.886 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 11.4 m-85 -131.16 131.43 44.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.896 179.383 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.638 ' HE1' ' HA ' ' A' ' 159' ' ' ASN . 5.8 m80 -102.86 124.04 47.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.639 0.256 . . . . 0.0 111.156 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.497 HD21 ' HB3' ' A' ' 140' ' ' SER . 5.1 tt -79.54 118.91 21.83 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.0 t -136.87 76.98 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.548 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.627 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . -171.6 60.1 0.17 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.027 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.464 ' C ' ' H ' ' A' ' 141' ' ' ARG . 37.7 t 53.1 67.23 1.03 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.088 0.471 . . . . 0.0 109.744 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' A' ' 128' ' ' PHE . 84.9 p -71.09 37.7 0.05 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.917 -178.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.464 ' H ' ' C ' ' A' ' 139' ' ' SER . 38.5 ttt85 -140.62 132.6 27.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.314 179.328 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 52.7 m -150.7 147.69 27.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.821 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 124' ' ' ALA . 7.1 p -147.58 132.05 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.897 0.38 . . . . 0.0 111.236 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 55.6 m -64.6 148.48 50.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.147 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 42.8 m -149.54 -30.49 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.761 0.315 . . . . 0.0 111.353 -179.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -170.81 54.1 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.897 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.09 42.7 83.8 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.923 -179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -172.5 136.88 0.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.606 ' HE1' ' HB2' ' A' ' 100' ' ' SER . 36.0 m95 -84.17 144.41 29.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.745 -179.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 61.3 m -50.51 -49.77 54.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.697 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 72.9 p -131.15 136.96 29.63 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.444 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 27.3 Cg_exo -62.61 159.38 37.01 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.089 2.526 . . . . 0.0 112.506 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.684 ' NZ ' HD13 ' A' ' 106' ' ' LEU . 3.9 mmmp? -53.61 134.76 54.46 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.331 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.627 ' HB3' ' HA3' ' A' ' 138' ' ' GLY . 5.7 Cg_exo -78.85 -146.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.328 2.686 . . . . 0.0 112.432 -179.765 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -153.71 149.43 27.49 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.602 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . 0.886 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 74.4 m -95.24 133.88 38.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 110.848 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.701 HE21 HG11 ' A' ' 158' ' ' VAL . 71.0 tp60 -103.09 138.07 40.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.871 -179.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.701 HG11 HE21 ' A' ' 157' ' ' GLN . 9.1 p -60.18 133.15 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.638 ' HA ' ' HE1' ' A' ' 135' ' ' HIS . 26.5 t-20 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.911 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.455 HH11 ' HG3' ' A' ' 97' ' ' ARG . 19.4 mmt85 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.812 0.339 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.9 pt -84.03 145.15 8.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.148 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.4 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 75.0 m -53.97 140.46 31.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.699 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.9 m -48.02 129.27 14.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.42 -179.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.751 ' HB2' HD11 ' A' ' 104' ' ' LEU . 17.6 ptpt -81.31 11.48 4.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.375 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.8 t -68.51 -39.75 81.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.036 0.446 . . . . 0.0 110.72 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.431 ' OH ' ' HA ' ' A' ' 152' ' ' PRO . 1.3 m-85 -61.73 -33.22 73.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.43 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.751 HD11 ' HB2' ' A' ' 101' ' ' LYS . 80.8 mt -45.63 -45.43 13.9 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.276 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t -92.52 138.53 31.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.501 179.339 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.663 ' HG ' ' HZ3' ' A' ' 153' ' ' LYS . 6.6 tt -145.41 124.39 12.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.507 -179.268 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -61.45 125.67 24.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.677 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 56.55 39.84 29.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.135 0.493 . . . . 0.0 110.09 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.426 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . -161.72 174.94 38.29 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.121 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -142.01 137.55 31.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.792 0.33 . . . . 0.0 110.914 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.0 t -109.73 132.43 57.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.009 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -111.76 133.13 54.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.624 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.524 ' N ' HD13 ' A' ' 113' ' ' LEU . 6.1 mp -108.39 132.6 53.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.151 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.1 t -162.03 129.44 3.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.078 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 157.51 -39.43 0.54 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.373 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.31 -127.86 0.91 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.208 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 64.5 t0 -174.82 133.66 0.35 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.484 HD11 ' C ' ' A' ' 118' ' ' LEU . 4.3 pp -43.27 140.57 2.11 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -87.97 45.19 1.28 Allowed 'Cis proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.578 -1.426 . . . . 0.0 113.54 0.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 117' ' ' ASP . . . -65.21 146.79 54.5 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.789 0.328 . . . . 0.0 110.778 179.544 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -140.35 -52.0 0.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.154 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.98 44.99 0.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.759 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 169.42 61.1 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.134 -1.032 . . . . 0.0 113.022 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.66 125.62 4.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.955 0.407 . . . . 0.0 111.45 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.417 HH11 ' HG3' ' A' ' 125' ' ' ARG . 61.2 mtt85 -133.6 129.79 37.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.753 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.534 HG23 ' CE1' ' A' ' 128' ' ' PHE . 31.0 m -97.72 132.64 42.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 120.946 0.403 . . . . 0.0 111.501 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -98.16 124.98 42.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.764 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.534 ' CE1' HG23 ' A' ' 126' ' ' VAL . 5.2 m-85 -93.18 143.93 25.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.965 0.412 . . . . 0.0 110.986 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -158.96 127.46 5.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.197 179.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 136' ' ' LEU . 49.8 t -89.27 144.93 25.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.263 -179.042 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.78 152.1 7.39 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.937 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.483 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 3.7 Cg_endo -46.66 156.66 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.961 2.441 . . . . 0.0 111.928 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 62.7 t0 78.64 -35.54 0.18 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.584 -179.217 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.684 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 0.6 OUTLIER -108.33 135.5 49.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.058 179.287 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -112.96 134.02 54.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.551 -179.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 130' ' ' CYS . 7.4 tt -79.02 132.89 36.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.203 179.508 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.3 t -128.6 77.91 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.584 -179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 173.88 -124.42 1.04 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.838 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.855 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 26.8 t -71.25 60.37 0.29 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.958 0.409 . . . . 0.0 111.263 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 128' ' ' PHE . 35.4 t -58.05 -23.74 55.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -140.64 139.78 34.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.705 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.564 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 63.3 m -144.53 130.3 19.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.9 0.381 . . . . 0.0 111.322 -179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.546 HG13 ' OG ' ' A' ' 145' ' ' SER . 32.1 t -97.6 133.02 41.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.074 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 50.4 t -80.5 50.87 1.36 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.986 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.546 ' OG ' HG13 ' A' ' 143' ' ' VAL . 62.8 m -80.24 134.85 36.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.902 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 37.4 tt0 50.67 46.96 25.14 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.487 179.179 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 51.94 44.51 56.04 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.317 179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -165.48 142.79 5.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.738 0.304 . . . . 0.0 110.282 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 142' ' ' SER . 55.3 m95 -84.2 139.88 32.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.917 0.389 . . . . 0.0 111.046 -179.34 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -56.5 -51.66 67.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.375 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 29.0 p -118.85 134.28 23.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.804 0.335 . . . . 0.0 111.898 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.431 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 39.6 Cg_endo -66.52 145.36 76.34 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.985 2.456 . . . . 0.0 112.461 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.663 ' HZ3' ' HG ' ' A' ' 106' ' ' LEU . 60.8 tttm -46.76 127.35 8.44 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.949 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.855 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 68.4 Cg_endo -89.24 -141.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.096 2.531 . . . . 0.0 113.343 -179.311 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.494 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.2 p-80 -153.71 146.67 24.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.101 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . 0.684 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 22.3 t -97.39 133.07 42.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 111.179 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -103.04 137.03 41.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.948 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 158' ' ' VAL . 9.9 p -88.9 133.12 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.935 -179.837 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.742 0.306 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -174.17 43.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.12 136.21 57.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.408 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 1.6 m-85 -62.39 134.65 56.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.802 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.404 ' O ' HD12 ' A' ' 98' ' ' ILE . 20.4 m -58.73 134.41 23.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.241 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -78.9 57.53 2.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.455 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.657 HD12 ' H ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -51.39 140.33 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.379 . . . . 0.0 111.28 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.606 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 87.2 m -55.28 157.79 3.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.061 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.7 p -47.69 128.54 13.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.328 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.678 ' HB2' ' HZ2' ' A' ' 101' ' ' LYS . 10.1 mtmp? -80.44 -21.51 42.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.206 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.4 p -53.13 -40.97 64.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.573 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.663 ' HA ' ' HE3' ' A' ' 153' ' ' LYS . 2.6 m-85 -52.91 -31.29 39.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.551 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.445 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 96.6 mt -50.66 -42.89 57.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.816 0.341 . . . . 0.0 110.916 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.439 HG21 ' N ' ' A' ' 106' ' ' LEU . 73.7 m -95.03 142.22 27.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.054 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.439 ' N ' HG21 ' A' ' 105' ' ' THR . 47.3 tp -145.31 127.7 15.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.833 0.349 . . . . 0.0 110.893 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -73.01 144.24 47.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.158 0.504 . . . . 0.0 111.276 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 57.91 32.85 22.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.241 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' A' ' 130' ' ' CYS . . . -176.98 -166.9 34.67 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.771 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -142.0 145.17 34.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.724 0.297 . . . . 0.0 110.786 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 104' ' ' LEU . 72.7 t -106.29 135.45 44.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.016 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.465 ' O ' HG23 ' A' ' 126' ' ' VAL . 2.7 m-85 -110.24 120.52 42.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.286 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.539 ' N ' HD21 ' A' ' 113' ' ' LEU . 2.9 mm? -103.27 147.11 27.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.489 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.9 m -157.02 132.93 9.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.431 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 64.03 49.89 64.22 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.096 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.51 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . 178.08 136.47 2.53 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.996 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -174.93 124.38 0.26 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.592 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 7.2 tt -51.41 137.48 30.57 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.891 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.543 ' HA ' ' HG ' ' A' ' 118' ' ' LEU . 71.2 Cg_endo -89.19 60.42 0.31 Allowed 'Cis proline' 0 C--N 1.345 0.393 0 C-N-CA 123.558 -1.434 . . . . 0.0 113.02 0.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.592 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -155.61 162.1 40.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.597 0.237 . . . . 0.0 110.822 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.654 HD11 ' N ' ' A' ' 122' ' ' ASP . 1.7 pp -168.35 -34.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.744 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.654 ' N ' HD11 ' A' ' 121' ' ' LEU . 63.2 t0 36.38 51.13 0.82 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.925 0.393 . . . . 0.0 110.959 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.532 ' H ' HD11 ' A' ' 121' ' ' LEU . . . 68.8 47.84 52.88 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.837 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.51 ' HB2' ' HA3' ' A' ' 116' ' ' GLY . . . -54.74 139.19 40.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.989 0.423 . . . . 0.0 111.697 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -107.27 151.51 25.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.379 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.535 HG12 ' HZ3' ' A' ' 149' ' ' TRP . 5.1 p -143.66 133.46 20.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.407 0.623 . . . . 0.0 112.232 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -105.04 131.58 52.37 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.543 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.408 ' HE1' HG13 ' A' ' 126' ' ' VAL . 3.5 m-85 -102.8 143.52 32.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.004 0.43 . . . . 0.0 111.732 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -162.94 125.15 2.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.383 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.417 ' HA ' ' CA ' ' A' ' 109' ' ' GLY . 63.9 m -89.27 170.11 10.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.207 0.527 . . . . 0.0 112.222 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.7 157.01 2.85 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.636 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.87 69.37 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.025 2.483 . . . . 0.0 112.413 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -173.25 -31.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.861 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.771 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 3.7 m-85 -108.14 132.93 53.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.833 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.464 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 18.9 p-80 -102.13 125.98 48.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.012 0.434 . . . . 0.0 110.726 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.594 HD21 ' HG ' ' A' ' 140' ' ' SER . 20.5 tp -72.65 126.9 31.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.042 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.418 HG21 ' C ' ' A' ' 136' ' ' LEU . 22.0 t -135.39 60.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.584 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -170.59 -131.38 1.33 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 119.801 -1.19 . . . . 0.0 113.419 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.59 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 56.6 p -73.53 55.32 0.49 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 111.431 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.594 ' HG ' HD21 ' A' ' 136' ' ' LEU . 42.3 t -57.88 -42.11 83.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.136 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -99.37 132.24 44.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.068 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.0 p -149.84 145.02 26.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.302 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 124' ' ' ALA . 7.2 p -138.62 134.41 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.998 0.428 . . . . 0.0 111.698 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.435 ' SG ' HD21 ' A' ' 121' ' ' LEU . 37.9 t -67.46 134.87 52.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.023 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.1 m -165.63 130.03 2.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.072 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 50.9 tt0 53.62 45.25 28.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.966 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 56.91 43.51 92.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.603 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -173.12 140.56 0.89 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.352 . . . . 0.0 110.652 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.606 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 28.5 m95 -84.24 140.99 31.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.732 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 67.1 m -52.82 -56.51 15.24 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.015 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 60.6 p -117.65 133.59 23.28 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.05 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.534 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 43.9 Cg_endo -67.8 -155.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.548 2.166 . . . . 0.0 112.758 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.663 ' HE3' ' HA ' ' A' ' 103' ' ' TYR . 27.8 mmtp -81.05 129.3 67.85 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.288 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.59 ' HB3' ' N ' ' A' ' 139' ' ' SER . 83.0 Cg_endo -81.61 -146.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.837 2.358 . . . . 0.0 112.242 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.453 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 24.3 p-80 -153.66 126.29 8.17 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.93 0.395 . . . . 0.0 111.328 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . 0.771 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 76.2 m -99.13 130.34 45.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.156 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.464 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 4.3 tp-100 -103.92 140.14 38.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.005 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.448 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 9.7 p -75.35 136.09 25.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.388 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.49 ' N ' HD21 ' A' ' 159' ' ' ASN . 2.1 m120 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.18 -0.914 . . . . 0.0 110.94 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.782 0.325 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.86 134.76 55.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.177 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.574 ' HG2' ' CD1' ' A' ' 95' ' ' PHE . 7.5 pm0 -72.23 -129.28 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.002 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.574 ' CD1' ' HG2' ' A' ' 94' ' ' GLU . 4.8 m-85 68.27 133.88 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.85 0.357 . . . . 0.0 111.091 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.6 m -149.24 135.81 12.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.861 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -66.56 130.96 44.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.228 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.476 ' HA ' HD23 ' A' ' 121' ' ' LEU . 20.9 pt -157.83 43.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.032 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.479 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 90.1 m 62.18 139.18 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.748 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.5 m -47.88 131.51 15.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.399 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -83.75 -28.64 28.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.079 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.2 p -53.18 -35.49 59.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.509 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.843 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.8 m-85 -50.86 -36.39 37.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.41 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.742 HD21 HG21 ' A' ' 114' ' ' THR . 88.4 mt -53.44 -44.45 68.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.955 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.1 m -92.55 133.99 35.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.25 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.2 tp -145.39 132.77 20.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.692 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.31 131.53 50.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.672 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m120 54.66 44.93 27.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.662 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.03 165.36 34.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.509 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -141.88 151.41 42.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.005 0.431 . . . . 0.0 110.942 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.48 HG12 ' HB ' ' A' ' 126' ' ' VAL . 95.1 t -111.18 141.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.253 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -106.57 134.46 49.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.406 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.653 HD23 ' N ' ' A' ' 114' ' ' THR . 6.3 tt 69.79 129.96 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.374 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.742 HG21 HD21 ' A' ' 104' ' ' LEU . 92.0 m -109.37 -45.99 3.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.929 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.595 ' HA3' ' HA ' ' A' ' 124' ' ' ALA . . . 79.92 53.44 4.24 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.26 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -142.19 150.67 22.29 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.462 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -159.67 65.81 0.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.967 0.413 . . . . 0.0 110.034 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.551 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 90.2 mt -38.39 137.77 0.78 Allowed Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.171 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -89.03 59.9 0.32 Allowed 'Cis proline' 0 CA--C 1.531 0.366 0 C-N-CA 123.762 -1.349 . . . . 0.0 113.265 0.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.551 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -164.13 126.3 2.38 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.927 0.394 . . . . 0.0 111.471 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 115' ' ' GLY . 26.6 tp -78.87 -55.84 4.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.481 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.7 t70 38.37 109.13 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 55.46 54.6 33.42 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.728 -0.669 . . . . 0.0 114.224 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.595 ' HA ' ' HA3' ' A' ' 115' ' ' GLY . . . -73.66 132.5 42.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.948 0.374 . . . . 0.0 110.894 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.516 ' HB2' HD21 ' A' ' 113' ' ' LEU . 62.2 mtt85 -137.97 153.63 49.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.617 HG21 ' HE1' ' A' ' 128' ' ' PHE . 12.5 m -154.6 131.04 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.946 0.403 . . . . 0.0 111.322 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -107.59 117.78 34.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.32 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.617 ' HE1' HG21 ' A' ' 126' ' ' VAL . 4.6 m-85 -86.56 141.38 29.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.121 0.486 . . . . 0.0 111.516 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.46 ' HG2' HH11 ' A' ' 129' ' ' ARG . 3.5 ptp85 -161.01 128.95 4.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.761 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 136' ' ' LEU . 20.7 t -89.2 147.41 24.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.744 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.664 ' OD1' ' HD2' ' A' ' 132' ' ' PRO . 36.4 t70 -52.72 145.75 20.56 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.906 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.664 ' HD2' ' OD1' ' A' ' 131' ' ' ASP . 3.2 Cg_exo -40.45 157.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.596 2.864 . . . . 0.0 112.545 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 55.6 m-20 80.93 -40.31 0.15 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.408 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -106.32 128.99 54.41 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.453 ' HE1' ' HA ' ' A' ' 159' ' ' ASN . 16.9 p-80 -102.76 128.32 49.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.973 0.416 . . . . 0.0 110.981 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.551 HD11 ' HG2' ' A' ' 154' ' ' PRO . 20.5 tp -74.55 127.33 32.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.497 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.6 t -131.13 72.2 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.79 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' A' ' 154' ' ' PRO . . . -167.55 56.72 0.22 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.799 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.441 ' C ' ' H ' ' A' ' 141' ' ' ARG . 41.1 t 51.46 65.05 1.61 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.46 ' CA ' ' HB2' ' A' ' 128' ' ' PHE . 96.0 p -70.43 38.81 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.53 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.441 ' H ' ' C ' ' A' ' 139' ' ' SER . 40.1 ttm180 -141.21 133.99 28.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.209 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.488 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 64.7 m -146.21 140.33 26.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.941 0.401 . . . . 0.0 111.319 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.496 ' HA ' ' HZ3' ' A' ' 149' ' ' TRP . 7.2 p -144.47 129.48 14.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.873 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 71.9 m -71.49 156.28 39.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.582 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.9 t -158.72 -29.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.471 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -149.29 48.08 0.97 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.719 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.82 35.49 89.72 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.493 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -159.19 146.81 17.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.706 0.288 . . . . 0.0 110.462 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.496 ' HZ3' ' HA ' ' A' ' 143' ' ' VAL . 68.3 m95 -84.19 142.22 30.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.864 0.364 . . . . 0.0 110.777 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' A' ' 142' ' ' SER . 46.9 t -47.91 -45.52 30.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.141 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.6 p -136.61 143.94 45.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.838 0.352 . . . . 0.0 111.797 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.518 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 24.0 Cg_exo -64.01 -159.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.856 2.371 . . . . 0.0 112.818 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.843 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 14.4 mmmm -86.12 127.14 62.94 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.263 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.551 ' HG2' HD11 ' A' ' 136' ' ' LEU . 92.4 Cg_endo -79.89 -149.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.741 2.294 . . . . 0.0 112.637 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.464 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 17.9 p-80 -153.7 150.04 28.14 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.073 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 77.8 m -97.43 138.1 35.38 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.381 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -108.55 136.05 48.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.554 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.4 p -82.47 52.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.498 0.666 . . . . 0.0 110.301 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.453 ' HA ' ' HE1' ' A' ' 135' ' ' HIS . 76.1 m-20 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.374 -0.822 . . . . 0.0 111.069 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.671 0.272 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.21 136.89 0.21 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.066 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 64.9 135.56 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.428 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.8 t80 60.48 109.76 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.298 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.472 HG22 HD13 ' A' ' 98' ' ' ILE . 27.7 m -82.57 130.63 35.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.008 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -89.62 44.47 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.962 0.411 . . . . 0.0 111.039 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.472 HD13 HG22 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.15 138.36 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.166 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.579 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 75.6 m -60.58 140.99 57.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.677 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.2 m -47.87 128.71 13.7 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.53 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 101' ' ' LYS . 26.3 ttpp -82.76 11.01 6.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.6 t -68.31 -40.46 81.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.332 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.616 ' HH ' ' HA ' ' A' ' 152' ' ' PRO . 1.3 m-85 -59.59 -40.73 88.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.413 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.672 HD21 HD13 ' A' ' 113' ' ' LEU . 6.8 mp -49.28 -43.62 43.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.6 0.238 . . . . 0.0 111.295 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.4 t -92.56 126.06 37.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.861 0.362 . . . . 0.0 110.765 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.598 HD22 ' HZ3' ' A' ' 153' ' ' LYS . 14.0 tp -145.7 133.16 20.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.465 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -71.55 134.32 46.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.345 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 57.74 40.7 26.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.632 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -179.56 156.98 19.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.937 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -123.47 141.78 51.65 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 112' ' ' PHE . 90.5 t -109.94 142.36 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.253 0.549 . . . . 0.0 112.003 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.535 ' N ' HG12 ' A' ' 111' ' ' VAL . 4.6 m-85 -103.42 139.87 38.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.738 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.672 HD13 HD21 ' A' ' 104' ' ' LEU . 1.5 pt? -139.21 57.69 1.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.029 0.442 . . . . 0.0 111.793 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.9 p -54.48 142.81 26.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.698 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.67 137.95 5.08 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.235 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 178.03 149.58 8.09 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.358 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -151.02 58.1 0.91 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.696 ' N ' HD21 ' A' ' 118' ' ' LEU . 2.0 pt? -40.6 136.17 1.48 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.159 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -89.05 61.18 0.27 Allowed 'Cis proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.663 -1.39 . . . . 0.0 113.254 0.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.566 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -165.56 130.81 2.49 Favored 'General case' 0 C--O 1.23 0.064 0 CA-C-O 120.895 0.379 . . . . 0.0 111.335 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.546 ' O ' ' HB2' ' A' ' 124' ' ' ALA . 1.1 pt? -112.56 48.65 0.98 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.991 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -62.77 133.37 54.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.64 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.86 33.34 82.89 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.489 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 121' ' ' LEU . . . -78.11 135.07 37.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.691 0.281 . . . . 0.0 110.966 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -105.08 136.42 44.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.018 0.437 . . . . 0.0 110.422 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.536 HG21 ' CZ3' ' A' ' 149' ' ' TRP . 2.6 t -132.08 137.1 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.957 -178.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.519 ' HG3' ' HB2' ' A' ' 112' ' ' PHE . 9.3 pt-20 -132.66 117.48 17.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.921 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.536 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 2.9 m-85 -77.4 147.53 35.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.211 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -145.8 117.75 8.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.663 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 16.9 t -89.22 147.67 24.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 111.254 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -52.71 152.1 7.26 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.312 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.481 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 1.1 Cg_endo -44.44 158.38 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.366 2.711 . . . . 0.0 112.738 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 38.5 t70 77.98 -31.89 0.16 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.959 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.421 ' H ' ' C ' ' A' ' 132' ' ' PRO . 2.3 m-85 -108.89 127.18 53.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.679 0.276 . . . . 0.0 110.511 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -104.95 135.36 46.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 110.903 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.402 HD23 ' CB ' ' A' ' 140' ' ' SER . 25.7 tp -71.58 133.35 45.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.466 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.69 61.37 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.538 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -168.41 -135.58 1.91 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.914 -1.136 . . . . 0.0 113.091 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.577 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 93.4 p -74.26 61.82 0.9 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.808 0.337 . . . . 0.0 111.039 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.402 ' CB ' HD23 ' A' ' 136' ' ' LEU . 91.3 p -63.14 4.41 0.2 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.413 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.529 ' H ' ' C ' ' A' ' 139' ' ' SER . 16.8 ptm180 -140.53 133.9 29.84 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.955 0.407 . . . . 0.0 110.944 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 54.9 m -150.73 140.76 22.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.868 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 124' ' ' ALA . 14.2 p -126.93 131.86 70.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.996 0.427 . . . . 0.0 111.63 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 52.6 t -80.49 148.29 30.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.271 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 89.2 p -150.67 -137.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.936 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.43 ' H ' ' CD ' ' A' ' 146' ' ' GLN . 14.7 mp0 -55.88 -38.62 70.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.94 0.4 . . . . 0.0 110.55 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 148' ' ' GLN . . . 179.93 145.46 6.44 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.708 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 147' ' ' GLY . 69.0 tp60 69.67 147.74 0.07 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.915 0.388 . . . . 0.0 110.633 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.579 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 26.9 m95 -84.16 147.52 27.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.234 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.6 t -51.85 -55.02 22.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.106 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.54 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 74.8 p -123.39 134.58 25.3 Favored Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.66 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.616 ' HA ' ' HH ' ' A' ' 103' ' ' TYR . 27.0 Cg_exo -61.82 143.19 95.67 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.825 2.35 . . . . 0.0 111.879 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.598 ' HZ3' HD22 ' A' ' 106' ' ' LEU . 21.9 ttmm -42.45 133.33 2.74 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 111.601 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.577 ' HB3' ' N ' ' A' ' 139' ' ' SER . 73.5 Cg_endo -75.26 -143.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.88 2.386 . . . . 0.0 112.678 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.487 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 22.9 p-80 -153.68 154.43 34.11 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.292 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 89.6 m -95.7 140.37 30.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.065 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -132.96 144.41 50.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.262 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.432 ' O ' HG12 ' A' ' 158' ' ' VAL . 6.2 p -75.11 133.52 31.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.457 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.9 p30 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.966 -179.617 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.589 0.233 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 57.96 46.38 16.65 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.809 0.337 . . . . 0.0 111.131 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -63.34 138.14 58.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.968 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.504 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -58.36 -41.03 83.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.445 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.8 t 66.01 140.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.712 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 62.27 55.82 2.3 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.124 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.442 ' HA ' HD12 ' A' ' 121' ' ' LEU . 38.6 pt -55.49 147.12 4.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 39.4 m -47.28 148.42 1.28 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.027 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.428 ' HB2' ' CD1' ' A' ' 149' ' ' TRP . 54.1 m -47.85 127.17 11.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.057 0.456 . . . . 0.0 111.252 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -85.25 -25.21 27.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.27 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.2 m -53.08 -41.15 64.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.552 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.505 ' HH ' ' HA ' ' A' ' 152' ' ' PRO . 1.4 m-85 -56.46 -41.57 76.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.887 0.375 . . . . 0.0 110.713 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.5 mt -59.9 -35.3 74.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.0 p -91.87 77.92 5.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.162 0.506 . . . . 0.0 110.569 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.593 ' C ' HD22 ' A' ' 106' ' ' LEU . 7.2 tt -93.88 125.47 38.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.577 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -68.1 127.61 33.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 62.94 48.47 3.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 0.0 110.583 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.453 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . -158.56 -163.47 12.96 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.62 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.705 ' HB3' ' HZ1' ' A' ' 110' ' ' LYS . 8.2 mtpm? -144.02 -41.6 0.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.554 HG21 ' HA ' ' A' ' 128' ' ' PHE . 13.7 p 52.02 136.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 123.594 0.758 . . . . 0.0 112.581 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -108.11 142.74 37.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.586 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.465 HD12 ' CG1' ' A' ' 126' ' ' VAL . 24.9 tp -120.31 136.15 54.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.608 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.5 p -145.0 139.1 27.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.211 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 66.36 44.1 91.25 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.457 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -179.49 130.6 1.53 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.974 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.765 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 54.3 m-20 -160.25 121.35 3.06 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.585 ' CD1' ' HA ' ' A' ' 119' ' ' PRO . 40.6 tp -38.58 133.51 1.01 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.279 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.585 ' HA ' ' CD1' ' A' ' 118' ' ' LEU . 77.1 Cg_endo -92.43 44.69 2.24 Favored 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.56 -1.433 . . . . 0.0 113.399 0.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.765 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -81.12 148.26 29.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.803 0.335 . . . . 0.0 111.209 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.613 HD23 ' O ' ' A' ' 121' ' ' LEU . 3.6 tt -162.45 79.27 0.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.309 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -167.07 122.07 1.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.595 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.7 31.16 29.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.718 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.9 127.66 33.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.631 0.253 . . . . 0.0 110.804 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -125.46 143.4 51.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 111.021 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.465 ' CG1' HD12 ' A' ' 113' ' ' LEU . 30.0 m -133.24 135.7 56.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.133 0.492 . . . . 0.0 111.598 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -109.36 88.83 2.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.312 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.554 ' HA ' HG21 ' A' ' 111' ' ' VAL . 67.0 m-85 -55.44 141.64 35.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 111.178 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.46 ' HG2' HH11 ' A' ' 129' ' ' ARG . 13.8 tpp85 -143.4 129.13 19.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.897 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 35.9 t -89.17 153.13 21.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.087 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -52.75 154.09 5.17 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.313 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.493 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 8.1 Cg_endo -49.64 155.47 3.71 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.802 2.334 . . . . 0.0 111.356 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 11.4 m-20 79.37 -29.74 0.14 Allowed 'General case' 0 N--CA 1.463 0.221 0 O-C-N 123.377 0.423 . . . . 0.0 110.098 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.746 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 1.6 m-85 -105.7 152.22 23.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.806 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -133.03 131.44 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.991 0.424 . . . . 0.0 111.442 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.767 HD23 ' HA ' ' A' ' 140' ' ' SER . 42.8 tp -69.37 133.81 48.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.428 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.0 t -131.33 70.93 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.905 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.27 -132.54 1.96 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.349 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.701 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 49.4 m -73.15 58.82 0.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 122.712 0.405 . . . . 0.0 111.177 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.767 ' HA ' HD23 ' A' ' 136' ' ' LEU . 87.6 p -56.91 -28.13 61.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.688 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.437 HH11 ' HG3' ' A' ' 141' ' ' ARG . 20.1 mmt85 -109.95 139.21 45.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.991 0.424 . . . . 0.0 111.914 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.776 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 68.0 m -150.7 142.04 23.33 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.438 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.648 ' H ' ' H ' ' A' ' 150' ' ' SER . 7.7 p -145.49 137.34 20.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 111.648 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 41.3 m -60.36 159.03 10.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.73 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.8 t -162.8 -29.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.158 0.504 . . . . 0.0 110.67 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -166.68 57.07 0.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.975 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.6 37.84 89.76 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.541 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -155.33 -149.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.045 0.45 . . . . 0.0 110.395 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.776 ' HB3' ' HB3' ' A' ' 142' ' ' SER . 86.6 m95 -146.54 155.6 42.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.329 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.648 ' H ' ' H ' ' A' ' 143' ' ' VAL . 47.5 t -41.93 -50.23 4.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.414 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.488 ' CG2' ' HB3' ' A' ' 139' ' ' SER . 1.5 t -147.44 145.89 23.15 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.505 ' HA ' ' HH ' ' A' ' 103' ' ' TYR . 76.1 Cg_exo -47.15 156.99 0.7 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.431 2.754 . . . . 0.0 113.302 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.459 ' HZ3' ' HG ' ' A' ' 106' ' ' LEU . 60.1 tttm -56.6 129.04 75.97 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.984 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.701 ' HB3' ' N ' ' A' ' 139' ' ' SER . 74.3 Cg_endo -75.02 -147.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.647 2.231 . . . . 0.0 112.568 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.449 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 23.2 p-80 -153.7 144.91 22.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.346 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . 0.746 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 47.6 t -95.21 132.18 40.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.949 0.404 . . . . 0.0 110.575 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.408 ' NE2' ' HA ' ' A' ' 157' ' ' GLN . 3.0 tp-100 -116.69 138.54 51.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.952 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 158' ' ' VAL . 7.5 p -82.32 131.71 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.167 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 25.0 p30 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.958 -179.565 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.843 0.354 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.406 ' HB3' ' H ' ' A' ' 94' ' ' GLU . . . -66.31 -140.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.188 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.501 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -174.29 135.07 0.43 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.919 0.39 . . . . 0.0 111.047 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -70.86 -130.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.018 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.2 m -51.55 145.83 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.481 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.574 ' NH1' ' HA3' ' A' ' 147' ' ' GLY . 33.2 ptt85 -69.88 70.55 0.34 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.409 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.5 pt -53.77 154.46 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.345 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.471 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 84.1 m -46.38 141.57 3.48 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.971 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.7 m -47.9 124.76 7.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.822 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -81.88 -13.18 57.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.28 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.2 p -53.12 -38.06 62.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.253 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.903 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 5.4 m-85 -48.48 -31.83 6.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.43 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.465 ' O ' HG21 ' A' ' 105' ' ' THR . 90.6 mt -77.23 39.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.583 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.465 HG21 ' O ' ' A' ' 104' ' ' LEU . 70.6 p -147.36 58.58 1.15 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.886 0.374 . . . . 0.0 110.373 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.563 HD11 ' HZ2' ' A' ' 153' ' ' LYS . 35.6 tp -93.83 130.52 39.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.584 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.544 ' HG2' ' ND2' ' A' ' 108' ' ' ASN . 89.3 tt0 -72.0 137.03 46.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.735 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.544 ' ND2' ' HG2' ' A' ' 107' ' ' GLU . 74.8 m-20 59.31 40.82 20.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.075 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.24 -166.44 13.14 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.375 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 111' ' ' VAL . 54.5 mtpt -142.14 -41.06 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.441 0.12 . . . . 0.0 111.102 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 128' ' ' PHE . 9.0 p 51.0 133.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.735 0.814 . . . . 0.0 112.903 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.407 ' N ' HG22 ' A' ' 111' ' ' VAL . 2.7 m-85 -112.15 -167.05 1.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.448 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.598 HD22 ' N ' ' A' ' 114' ' ' THR . 8.1 tt -173.33 141.48 0.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.285 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.598 ' N ' HD22 ' A' ' 113' ' ' LEU . 89.8 m -154.07 145.97 23.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.159 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.496 ' N ' HG21 ' A' ' 114' ' ' THR . . . 76.29 43.94 19.02 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.147 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.494 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . 174.28 140.57 3.31 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.067 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -166.47 129.83 1.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.739 0.304 . . . . 0.0 110.241 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.558 HD13 ' H ' ' A' ' 118' ' ' LEU . 5.7 mp -52.07 135.2 39.27 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.812 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -94.35 63.27 0.36 Allowed 'Cis proline' 0 N--CA 1.46 -0.453 0 C-N-CA 124.098 -1.209 . . . . 0.0 113.059 0.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -149.53 134.03 17.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.882 0.373 . . . . 0.0 111.689 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.499 HD11 ' SG ' ' A' ' 144' ' ' CYS . 88.1 mt -102.35 -45.07 5.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.801 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.412 ' OD1' ' HA2' ' A' ' 116' ' ' GLY . 10.2 p-10 36.4 47.97 0.55 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.512 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.94 45.86 94.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.302 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.494 ' HB2' ' HA3' ' A' ' 116' ' ' GLY . . . -58.25 136.9 57.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.776 0.322 . . . . 0.0 111.112 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.773 ' HD3' ' HD3' ' A' ' 141' ' ' ARG . 38.6 ttm180 -118.43 119.22 33.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.513 ' HB ' ' HZ3' ' A' ' 149' ' ' TRP . 12.1 p -84.86 148.84 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.045 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.498 ' N ' HG23 ' A' ' 126' ' ' VAL . 56.4 mt-10 -133.7 76.79 1.68 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.233 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.63 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 79.9 m-85 -53.85 151.9 6.05 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.886 0.374 . . . . 0.0 111.058 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -157.11 135.83 11.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.637 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 134' ' ' PHE . 59.6 m -89.23 146.9 24.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.785 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' ASP . 63.4 m-20 -52.69 154.7 4.53 Favored Pre-proline 0 N--CA 1.463 0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.491 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.12 73.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.483 2.789 . . . . 0.0 113.033 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 131' ' ' ASP . 39.0 t70 178.75 -38.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.449 ' O ' ' HB2' ' A' ' 130' ' ' CYS . 3.2 m-85 -108.14 139.22 43.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.529 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -102.52 132.24 48.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.041 0.448 . . . . 0.0 110.794 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.581 HD13 ' HA ' ' A' ' 140' ' ' SER . 6.0 tt -75.14 128.15 34.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.183 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.96 65.05 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.488 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.86 -129.49 1.31 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.304 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.822 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.5 t -71.4 57.19 0.25 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.597 0.359 . . . . 0.0 111.874 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.581 ' HA ' HD13 ' A' ' 136' ' ' LEU . 32.6 t -60.9 -16.6 43.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.122 0.487 . . . . 0.0 110.037 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.773 ' HD3' ' HD3' ' A' ' 125' ' ' ARG . 39.1 ttm180 -140.09 140.29 36.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.901 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.478 ' HB2' ' CG1' ' A' ' 126' ' ' VAL . 33.5 m -149.16 122.62 9.09 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.209 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' A' ' 150' ' ' SER . 11.8 p -83.78 132.55 31.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 111.749 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.499 ' SG ' HD11 ' A' ' 121' ' ' LEU . 16.3 t -83.97 130.35 34.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.592 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.535 ' HG ' ' H ' ' A' ' 146' ' ' GLN . 25.4 t -114.34 -139.48 0.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.543 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.535 ' H ' ' HG ' ' A' ' 145' ' ' SER . 4.3 tp-100 -64.96 -40.82 95.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.807 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.574 ' HA3' ' NH1' ' A' ' 97' ' ' ARG . . . -175.88 46.58 0.12 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.169 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -170.07 134.76 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.734 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.513 ' HZ3' ' HB ' ' A' ' 126' ' ' VAL . 32.4 m95 -84.21 141.43 31.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.582 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.472 ' HB3' HG13 ' A' ' 143' ' ' VAL . 79.2 p -52.66 -60.35 3.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.577 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 27.4 p -114.38 134.18 22.33 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 0.0 111.897 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 16.5 Cg_exo -67.37 150.56 80.98 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.104 2.536 . . . . 0.0 112.179 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.903 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 8.7 mtpm? -42.8 132.27 3.02 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.556 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.822 ' HB3' ' H ' ' A' ' 139' ' ' SER . 98.9 Cg_endo -79.43 -140.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.819 2.346 . . . . 0.0 112.998 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.512 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.0 p-80 -153.64 144.44 22.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.43 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 81.9 m -97.89 133.11 42.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.833 0.349 . . . . 0.0 111.068 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -123.62 140.54 52.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.541 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 158' ' ' VAL . 9.4 p -82.82 132.37 31.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.488 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.7 p30 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.008 -179.531 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.573 0.225 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.1 -49.87 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.773 0.32 . . . . 0.0 111.13 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 41.4 tp10 55.49 49.19 17.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.113 0.483 . . . . 0.0 110.838 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -72.22 -133.73 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.393 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 119' ' ' PRO . 13.3 t -83.15 44.07 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 121.08 0.467 . . . . 0.0 110.917 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 97' ' ' ARG . 68.1 mtt-85 54.44 46.95 23.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.286 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.9 pt -54.22 140.79 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.36 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 72.8 m -56.3 127.0 28.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.7 t -48.01 128.36 13.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.37 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.825 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -90.23 25.83 2.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.807 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.0 p -68.82 -41.63 78.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.238 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.727 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 3.9 m-85 -56.95 -31.35 64.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.864 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.44 ' O ' ' CG2' ' A' ' 105' ' ' THR . 83.4 mt -53.99 146.72 13.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.761 -0.199 . . . . 0.0 111.098 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.44 ' CG2' ' O ' ' A' ' 104' ' ' LEU . 6.9 t 56.36 138.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.72 0.808 . . . . 0.0 112.367 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.7 tp -145.45 138.96 26.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.971 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.08 44.2 0.56 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.517 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -157.29 -30.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.858 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.633 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . -158.69 -141.36 3.12 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.947 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -139.47 152.26 46.86 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.912 0.386 . . . . 0.0 110.792 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.1 t -109.34 139.47 32.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.208 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.449 ' CE1' ' HD3' ' A' ' 129' ' ' ARG . 2.8 m-85 -108.34 137.56 46.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.05 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.575 HD13 ' O ' ' A' ' 125' ' ' ARG . 0.4 OUTLIER 71.85 133.97 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.697 -179.487 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.501 ' N ' HD13 ' A' ' 113' ' ' LEU . 66.1 p -126.69 -130.59 0.24 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.722 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -62.39 133.87 45.13 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.033 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.3 -48.87 75.35 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.835 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 118' ' ' LEU . 37.5 t70 -174.47 61.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.448 ' H ' ' CD1' ' A' ' 118' ' ' LEU . 7.2 mp -33.2 132.87 0.33 Allowed Pre-proline 0 N--CA 1.462 0.133 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.3 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.536 ' HB2' ' HB ' ' A' ' 96' ' ' VAL . 75.6 Cg_endo -85.89 46.11 0.85 Allowed 'Cis proline' 0 C--N 1.346 0.413 0 C-N-CA 123.661 -1.391 . . . . 0.0 113.49 0.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.441 ' H ' ' CA ' ' A' ' 118' ' ' LEU . . . -85.53 127.64 34.5 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.616 0.246 . . . . 0.0 111.185 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.534 HD21 ' N ' ' A' ' 147' ' ' GLY . 5.7 mp -101.89 -42.63 6.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.034 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.33 61.18 0.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.954 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -177.39 -32.89 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.323 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.417 ' HB1' ' CH2' ' A' ' 149' ' ' TRP . . . -51.59 129.29 25.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.915 0.388 . . . . 0.0 111.162 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.575 ' O ' HD13 ' A' ' 113' ' ' LEU . 55.2 ttp85 -135.24 156.11 49.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.745 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.518 HG12 ' CH2' ' A' ' 149' ' ' TRP . 16.1 m -152.25 135.93 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.871 0.367 . . . . 0.0 111.085 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -121.1 104.26 9.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.132 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.647 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 4.5 m-85 -78.57 143.78 36.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.205 0.526 . . . . 0.0 111.977 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.449 ' HD3' ' CE1' ' A' ' 112' ' ' PHE . 8.0 ptm180 -166.53 124.28 1.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.659 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.633 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 96.3 m -89.22 149.43 23.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.323 0.582 . . . . 0.0 112.453 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.483 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 59.8 m-20 -52.71 159.68 1.67 Allowed Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.939 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 18.2 Cg_endo -59.22 76.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.111 2.54 . . . . 0.0 112.454 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.3 t70 -175.63 -42.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.663 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 5.3 m-85 -108.83 131.86 54.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.416 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.604 ' HE2' ' HB2' ' A' ' 157' ' ' GLN . 0.3 OUTLIER -101.23 121.6 42.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.245 0.545 . . . . 0.0 110.897 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.559 HD21 ' HB3' ' A' ' 140' ' ' SER . 5.5 tt -69.94 125.4 26.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.974 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.474 ' N ' HD23 ' A' ' 136' ' ' LEU . 15.0 t -134.32 63.13 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.578 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -169.98 -135.78 1.97 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.357 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.673 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 63.8 m -75.03 57.18 0.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.914 0.388 . . . . 0.0 111.037 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.559 ' HB3' HD21 ' A' ' 136' ' ' LEU . 99.1 p -51.65 -43.55 62.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.339 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -99.36 138.86 35.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.544 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 44.2 t -150.16 139.7 21.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.863 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.0 p -137.56 127.26 36.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.941 0.4 . . . . 0.0 111.222 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.412 ' HB2' ' CD2' ' A' ' 149' ' ' TRP . 45.8 t -87.71 149.31 24.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.591 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 38.4 t -167.13 30.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.207 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 52.8 tt0 175.7 43.32 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.85 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.534 ' N ' HD21 ' A' ' 121' ' ' LEU . . . 77.9 -51.07 3.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.975 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -88.42 149.37 23.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.544 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 81.7 m95 -84.15 146.27 27.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.911 0.386 . . . . 0.0 110.946 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.3 t -45.0 -55.7 5.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.904 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 72.4 p -126.0 133.12 24.62 Favored Pre-proline 0 C--N 1.329 -0.308 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.775 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.452 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 23.7 Cg_exo -63.65 155.66 61.85 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.993 2.462 . . . . 0.0 112.326 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.727 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 55.1 mtpt -49.19 128.18 16.03 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.874 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.673 ' HB3' ' N ' ' A' ' 139' ' ' SER . 58.2 Cg_endo -71.4 -146.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.631 2.221 . . . . 0.0 112.582 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -153.68 130.51 10.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.894 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . 0.663 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 90.5 m -102.56 136.85 41.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.243 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.604 ' HB2' ' HE2' ' A' ' 135' ' ' HIS . 10.6 mm100 -104.21 147.85 26.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.106 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.3 p -72.73 129.02 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.363 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.522 ' N ' HD21 ' A' ' 159' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.101 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.913 0.387 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -164.41 133.38 3.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.141 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.28 132.38 51.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.115 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -80.32 44.99 0.72 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.222 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.523 HG12 HG22 ' A' ' 98' ' ' ILE . 21.8 t -80.05 49.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.032 0.444 . . . . 0.0 111.087 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -78.03 45.27 0.52 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.34 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.523 HG22 HG12 ' A' ' 96' ' ' VAL . 2.4 pp -61.27 145.92 12.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.679 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.933 ' HB2' HD23 ' A' ' 121' ' ' LEU . 43.8 m -56.93 135.61 56.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.05 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.0 t -47.9 126.97 11.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.129 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.501 ' HB2' HD13 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -83.06 16.77 2.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.98 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -68.92 -45.72 70.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.301 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.647 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 10.7 m-85 -58.37 -32.15 68.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.796 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 101' ' ' LYS . 86.8 mt -49.77 140.33 11.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.553 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.9 m 67.13 139.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.965 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.528 HD21 ' O ' ' A' ' 107' ' ' GLU . 7.3 tt -145.07 127.7 16.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.308 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.528 ' O ' HD21 ' A' ' 106' ' ' LEU . 23.5 pt-20 -64.98 128.43 35.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 111.213 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 63.68 40.3 7.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.725 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.414 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -170.83 -163.88 25.61 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.548 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -142.37 141.93 32.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.795 0.331 . . . . 0.0 110.891 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.5 t -110.25 129.84 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.99 0.424 . . . . 0.0 110.969 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.2 m-85 -110.7 152.92 25.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.184 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.764 HD13 ' HB2' ' A' ' 124' ' ' ALA . 47.9 tp -154.48 134.03 12.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.008 0.432 . . . . 0.0 111.706 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.5 p -154.05 132.81 12.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.606 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.521 ' HA3' ' HB1' ' A' ' 124' ' ' ALA . . . 164.38 -44.69 0.31 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.688 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -169.67 -127.84 0.96 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.403 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -149.17 -138.57 0.09 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.61 0.243 . . . . 0.0 110.609 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.889 HD11 ' HA ' ' A' ' 119' ' ' PRO . 35.0 tp -125.17 127.44 25.02 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.78 0.324 . . . . 0.0 111.099 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.889 ' HA ' HD11 ' A' ' 118' ' ' LEU . 78.2 Cg_endo -90.99 37.98 4.81 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.266 -1.556 . . . . 0.0 112.713 -0.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -88.15 37.59 0.82 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.852 0.358 . . . . 0.0 111.481 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.933 HD23 ' HB2' ' A' ' 99' ' ' CYS . 28.1 tp -77.67 0.38 23.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.811 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.59 141.81 58.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.18 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.61 -38.27 1.89 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.151 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.764 ' HB2' HD13 ' A' ' 113' ' ' LEU . . . -51.04 142.82 11.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 0.0 111.615 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.448 ' HG2' HH11 ' A' ' 125' ' ' ARG . 20.3 ptt-85 -127.44 134.63 49.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.924 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.551 HG21 ' CZ3' ' A' ' 149' ' ' TRP . 29.1 m -97.37 139.45 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.218 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -110.39 128.2 55.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.247 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.427 ' CE1' HG22 ' A' ' 126' ' ' VAL . 6.4 m-85 -99.94 141.85 32.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.43 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -150.99 132.15 14.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.297 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 69.1 m -89.16 154.17 20.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.959 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.56 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 1.1 m-20 -52.62 163.45 0.78 Allowed Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.334 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 55.7 Cg_endo -70.0 50.2 0.85 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.075 2.517 . . . . 0.0 113.212 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -149.49 -43.01 0.14 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.416 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 0.8 OUTLIER -108.92 140.72 42.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.833 179.21 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -100.99 128.57 46.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.984 0.421 . . . . 0.0 110.954 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.732 HD22 ' HB2' ' A' ' 140' ' ' SER . 6.1 tt -68.87 130.12 41.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.625 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.552 ' N ' HD21 ' A' ' 136' ' ' LEU . 24.1 t -135.18 63.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.657 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -166.82 -134.04 1.63 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.205 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.668 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 67.2 m -74.95 53.59 0.61 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.74 0.305 . . . . 0.0 111.159 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.732 ' HB2' HD22 ' A' ' 136' ' ' LEU . 35.0 t -52.06 -43.71 63.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 58.9 mtm-85 -99.41 132.42 44.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.803 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.494 ' HB2' HG23 ' A' ' 126' ' ' VAL . 38.3 m -145.63 137.6 25.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.762 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.08 129.34 37.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.966 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 48.8 t -93.71 134.07 36.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 90.4 p -115.44 -35.12 4.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -144.99 -140.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.093 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.74 41.25 2.33 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.491 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -174.94 136.64 0.4 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.809 0.337 . . . . 0.0 110.922 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.551 ' CZ3' HG21 ' A' ' 126' ' ' VAL . 30.4 m95 -84.19 149.39 26.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.839 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -55.9 -65.27 0.63 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.558 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 42.9 p -106.8 139.07 20.01 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.34 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 21.9 Cg_exo -65.17 -155.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.706 2.271 . . . . 0.0 112.558 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.647 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 12.9 mmmm -92.67 131.94 32.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.335 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.668 ' HB3' ' N ' ' A' ' 139' ' ' SER . 89.6 Cg_endo -84.55 -155.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.798 2.332 . . . . 0.0 112.786 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -153.7 148.86 26.88 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.764 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 84.0 m -97.41 131.38 44.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.817 0.342 . . . . 0.0 110.865 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -110.36 141.1 43.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.016 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.14 128.47 38.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.425 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.018 -179.714 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.775 0.321 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.461 ' HB2' ' H ' ' A' ' 94' ' ' GLU . . . -66.41 -135.92 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.197 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.461 ' H ' ' HB2' ' A' ' 93' ' ' ALA . 4.9 mm-40 57.83 42.31 23.47 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.964 0.411 . . . . 0.0 110.733 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.464 ' O ' HG21 ' A' ' 96' ' ' VAL . 24.9 t80 -62.82 -41.74 99.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.972 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.603 HG21 HG23 ' A' ' 98' ' ' ILE . 23.1 m 42.67 -156.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.814 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.819 ' H ' ' HD2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -101.21 46.77 0.93 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.371 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.603 HG23 HG21 ' A' ' 96' ' ' VAL . 30.2 pt -56.4 139.38 15.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.918 0.389 . . . . 0.0 111.13 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 36.8 m -57.22 137.43 55.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.874 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.1 t -47.93 124.31 7.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.039 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -82.26 21.63 0.9 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.387 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.0 t -68.85 -45.13 71.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.918 0.39 . . . . 0.0 111.057 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.543 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.2 m-85 -60.15 -31.33 69.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.304 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.469 ' O ' HG22 ' A' ' 111' ' ' VAL . 71.6 mt -52.29 -40.9 62.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.369 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t -92.48 129.1 38.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.917 0.389 . . . . 0.0 110.816 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.536 HD11 ' HE2' ' A' ' 153' ' ' LYS . 20.4 tp -145.39 124.65 12.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.304 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.66 129.97 41.47 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 59.1 37.13 24.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.979 0.419 . . . . 0.0 110.439 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -163.81 147.52 13.1 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.78 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.422 ' HZ3' ' HE ' ' A' ' 129' ' ' ARG . 22.4 pttp -112.8 139.57 48.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.375 -0.413 . . . . 0.0 110.517 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 104' ' ' LEU . 47.7 t -111.21 134.65 52.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.291 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -108.59 130.21 55.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.883 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.587 ' N ' HD21 ' A' ' 113' ' ' LEU . 3.6 mm? -104.69 140.96 37.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.664 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.499 HG21 ' O ' ' A' ' 125' ' ' ARG . 8.6 t -155.06 138.58 15.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.034 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.472 ' O ' ' HB1' ' A' ' 124' ' ' ALA . . . 80.92 127.91 0.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.308 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 164.81 -139.68 5.97 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.183 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -177.63 -62.42 0.01 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.224 0.535 . . . . 0.0 111.008 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.831 ' N ' ' HA ' ' A' ' 119' ' ' PRO . 3.4 tm? -74.15 -42.69 5.75 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.918 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.831 ' HA ' ' N ' ' A' ' 118' ' ' LEU . 96.5 Cg_endo -90.11 126.25 6.61 Favored 'Cis proline' 0 N--CA 1.454 -0.799 0 C-N-CA 124.03 -1.238 . . . . 0.0 112.944 0.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.566 ' N ' ' HB3' ' A' ' 118' ' ' LEU . . . -74.41 -23.6 58.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.783 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.463 ' C ' ' H ' ' A' ' 123' ' ' GLY . 88.2 mt 70.24 29.48 3.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.311 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.9 35.87 0.13 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.96 0.41 . . . . 0.0 111.094 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.474 ' HA2' ' HG ' ' A' ' 145' ' ' SER . . . 140.36 29.29 0.19 Allowed Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 115' ' ' GLY . . . -79.05 146.77 33.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.921 0.391 . . . . 0.0 111.514 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.499 ' O ' HG21 ' A' ' 114' ' ' THR . 98.9 mtt180 -108.31 138.74 44.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.662 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.568 HG23 HD13 ' A' ' 113' ' ' LEU . 12.7 p -127.57 136.74 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.115 0.484 . . . . 0.0 112.0 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -105.04 128.08 53.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.076 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.543 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 15.2 m-85 -98.45 139.29 34.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.0 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.422 ' HE ' ' HZ3' ' A' ' 110' ' ' LYS . 46.7 mtp85 -150.0 129.59 13.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.75 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 40.0 t -89.2 144.87 25.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.29 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.8 154.76 17.03 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.321 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.477 ' C ' ' H ' ' A' ' 134' ' ' PHE . 6.0 Cg_endo -47.93 159.98 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.077 2.518 . . . . 0.0 112.17 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 61.5 t0 76.86 -26.96 0.18 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.374 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.735 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 2.7 m-85 -122.04 132.77 54.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.932 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.454 ' CG ' ' HB2' ' A' ' 159' ' ' ASN . 0.4 OUTLIER -109.38 137.98 46.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.09 0.471 . . . . 0.0 112.01 -179.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 137' ' ' VAL . 6.4 tt -74.02 128.96 36.9 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.538 ' N ' HD22 ' A' ' 136' ' ' LEU . 42.9 t -128.05 74.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 171.33 -127.6 1.46 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.687 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.8 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.4 t -70.84 61.25 0.25 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.13 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.4 t -58.12 -20.76 42.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.922 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.674 ' HD3' ' H ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -129.31 143.87 51.01 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.801 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.7 m -150.25 144.59 25.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.282 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.488 ' O ' HG11 ' A' ' 143' ' ' VAL . 11.7 p -140.31 134.38 35.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.057 0.456 . . . . 0.0 111.594 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 54.0 t -116.63 147.57 41.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.204 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.474 ' HG ' ' HA2' ' A' ' 123' ' ' GLY . 49.1 m -154.66 41.5 0.47 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 145' ' ' SER . 41.8 tt0 176.17 -57.4 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.897 0.379 . . . . 0.0 111.21 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.06 37.31 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -173.37 137.9 0.68 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -84.23 133.91 34.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.228 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -50.23 -64.03 0.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.934 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 33.4 p -92.55 138.25 24.0 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.539 ' HA ' ' HH ' ' A' ' 103' ' ' TYR . 55.7 Cg_endo -69.2 146.32 63.25 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.784 2.323 . . . . 0.0 111.795 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.536 ' HE2' HD11 ' A' ' 106' ' ' LEU . 83.9 tttt -48.06 129.3 12.18 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.629 0.252 . . . . 0.0 110.796 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.8 ' HB3' ' H ' ' A' ' 139' ' ' SER . 89.8 Cg_endo -81.41 -152.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.647 2.231 . . . . 0.0 113.334 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.69 148.31 26.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.024 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . 0.735 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 13.0 t -98.49 139.2 34.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.056 0.455 . . . . 0.0 111.246 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -103.05 146.13 28.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.696 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.5 p -66.71 81.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.348 0.594 . . . . 0.0 111.271 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 35.7 t30 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.942 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 92' ' ' GLU . 5.3 tp10 . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.113 0.482 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -174.14 42.52 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.878 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -152.05 -43.45 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.67 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 64.08 135.57 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.048 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.714 HG21 ' HD2' ' A' ' 97' ' ' ARG . 10.8 p -169.86 135.88 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.714 ' HD2' HG21 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -56.98 126.64 28.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.917 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.517 ' H ' ' CD1' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -96.27 142.78 13.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.364 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.564 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 80.8 m -51.79 141.74 16.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.12 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.1 m -47.94 130.71 15.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.393 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -78.72 -6.89 57.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.086 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.9 p -55.88 -42.4 75.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.106 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.554 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 2.1 m-85 -59.17 -35.4 73.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.437 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.496 ' O ' HG23 ' A' ' 111' ' ' VAL . 89.8 mt -54.97 -47.3 74.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.682 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.1 m -92.56 130.81 38.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.839 0.352 . . . . 0.0 111.405 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.535 HD11 ' HE2' ' A' ' 153' ' ' LYS . 28.7 tp -145.44 127.86 15.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.834 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -66.71 130.65 43.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.301 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 57.13 41.16 27.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.026 0.441 . . . . 0.0 110.401 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.28 153.68 22.45 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.596 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -121.25 143.67 49.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.816 0.341 . . . . 0.0 110.76 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 104' ' ' LEU . 61.9 t -110.63 140.23 30.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.221 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -105.86 153.58 21.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.332 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.417 HD22 ' C ' ' A' ' 113' ' ' LEU . 6.7 tt -153.33 135.06 14.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.884 0.373 . . . . 0.0 110.521 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.2 m -156.21 125.64 6.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.784 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.89 -125.67 1.38 Allowed Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.833 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.32 -125.44 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.047 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.619 ' H ' ' HB2' ' A' ' 120' ' ' ALA . 12.2 p-10 -173.36 128.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.424 HD11 ' C ' ' A' ' 118' ' ' LEU . 4.4 pp -38.66 138.04 0.8 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.317 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -85.88 35.64 3.63 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.424 -1.49 . . . . 0.0 113.097 0.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.619 ' HB2' ' H ' ' A' ' 117' ' ' ASP . . . -90.73 46.42 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.981 0.42 . . . . 0.0 110.623 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.78 ' H ' HD21 ' A' ' 121' ' ' LEU . 3.7 mm? -54.75 -39.94 68.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.342 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.28 139.96 58.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 0.0 111.011 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.43 -36.38 3.65 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.314 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.3 142.09 52.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.95 0.405 . . . . 0.0 111.51 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.591 ' HD3' ' N ' ' A' ' 125' ' ' ARG . 1.0 OUTLIER -108.51 139.87 42.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.23 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.8 m -124.67 142.75 40.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 111.961 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.487 ' OE1' ' HG2' ' A' ' 141' ' ' ARG . 5.2 mm-40 -121.44 119.62 32.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.83 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.554 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 3.1 m-85 -85.1 152.57 23.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.422 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.3 ttt-85 -163.34 125.77 2.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.903 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.579 ' SG ' HD21 ' A' ' 136' ' ' LEU . 100.0 m -89.19 142.18 27.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.375 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -55.34 158.18 5.8 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.573 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.543 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 1.1 Cg_endo -43.14 155.03 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.095 2.53 . . . . 0.0 112.186 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.6 m-20 79.43 -35.81 0.16 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.656 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 157' ' ' GLN . 5.9 m-85 -108.8 129.28 55.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.574 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.436 ' CD2' ' HB3' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -102.87 145.34 29.95 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 111.85 -179.587 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.579 HD21 ' SG ' ' A' ' 130' ' ' CYS . 2.4 tm? -75.56 132.88 40.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.969 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.415 HG13 ' NE2' ' A' ' 155' ' ' HIS . 7.4 p -135.65 70.38 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.535 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . 171.23 -123.6 1.05 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.756 -1.211 . . . . 0.0 113.363 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.869 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 27.5 t -71.68 55.07 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.705 0.288 . . . . 0.0 111.775 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 128' ' ' PHE . 94.3 p -56.16 -21.93 25.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.436 0.636 . . . . 0.0 109.322 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.487 ' HG2' ' OE1' ' A' ' 127' ' ' GLU . 62.4 mtm-85 -140.59 126.43 19.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.489 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.549 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 47.2 t -142.98 134.48 26.32 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.94 0.4 . . . . 0.0 111.418 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.8 t -98.24 134.18 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.637 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 144' ' ' CYS . 41.9 t -79.17 48.02 0.83 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 111.29 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 83.4 p -65.14 126.96 29.73 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 55.21 -140.0 0.95 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.487 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -106.5 37.47 3.81 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.098 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -155.41 143.87 20.34 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 122.261 0.224 . . . . 0.0 110.513 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.564 ' CE2' ' HB3' ' A' ' 99' ' ' CYS . 45.1 m95 -84.14 137.91 33.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.704 0.288 . . . . 0.0 110.418 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.9 t -57.19 -61.26 2.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.302 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.1 p -94.13 133.87 26.76 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.746 0.307 . . . . 0.0 111.759 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 139' ' ' SER . 36.7 Cg_endo -65.21 140.08 63.21 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.758 2.305 . . . . 0.0 112.152 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.535 ' HE2' HD11 ' A' ' 106' ' ' LEU . 86.9 tttt -42.56 131.62 2.89 Favored Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.526 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.869 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 84.6 Cg_endo -81.58 -158.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.881 2.387 . . . . 0.0 112.872 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.415 ' NE2' HG13 ' A' ' 137' ' ' VAL . 12.5 p-80 -153.64 150.64 28.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.642 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 72.3 m -96.18 139.36 32.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.97 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 134' ' ' PHE . 40.4 tt0 -130.59 133.68 46.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.711 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.6 124.72 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.959 0.409 . . . . 0.0 110.407 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.999 -179.418 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.813 0.339 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.415 ' HB3' ' H ' ' A' ' 94' ' ' GLU . . . -173.14 -140.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.812 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.415 ' H ' ' HB3' ' A' ' 93' ' ' ALA . 66.9 mm-40 56.24 -146.51 0.56 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.073 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 63.45 137.37 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.065 0.46 . . . . 0.0 111.321 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.7 m -58.5 142.38 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.996 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.521 ' NE ' ' HA ' ' A' ' 97' ' ' ARG . 4.0 mmp_? -54.58 136.2 45.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.851 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.516 ' HB ' HD22 ' A' ' 121' ' ' LEU . 26.2 pt -151.02 46.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 75.6 m 63.01 131.75 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.966 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 87.4 p -47.97 126.42 10.58 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.897 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -78.34 -11.39 59.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.142 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.0 t -54.54 -36.58 64.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.043 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.446 ' CE2' ' HA ' ' A' ' 152' ' ' PRO . 2.0 m-85 -77.35 47.27 0.56 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.487 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.8 mt -133.86 20.13 3.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.942 0.401 . . . . 0.0 110.436 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.44 ' O ' ' HE3' ' A' ' 153' ' ' LYS . 86.0 m -147.43 132.65 18.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.509 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.404 HD21 ' HD2' ' A' ' 128' ' ' PHE . 25.4 tp -145.4 133.76 21.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.967 0.413 . . . . 0.0 111.443 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.661 ' HG2' ' OD1' ' A' ' 108' ' ' ASN . 33.2 tt0 -78.0 141.75 38.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.879 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.661 ' OD1' ' HG2' ' A' ' 107' ' ' GLU . 5.6 m120 63.17 30.15 16.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.81 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 176.12 -160.81 28.93 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.915 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.516 ' HG3' ' HE1' ' A' ' 112' ' ' PHE . 14.9 ptmm? -142.04 153.62 44.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.656 0.265 . . . . 0.0 110.412 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.65 137.92 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.075 0.464 . . . . 0.0 111.763 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.598 ' HB2' ' HG3' ' A' ' 127' ' ' GLU . 6.1 m-85 -107.74 146.15 32.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.308 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.564 ' N ' HD22 ' A' ' 113' ' ' LEU . 1.9 pt? -146.17 139.44 25.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.004 0.43 . . . . 0.0 111.041 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.8 t -168.83 133.98 1.62 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.969 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 140.6 -40.51 1.36 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.35 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 121' ' ' LEU . . . -66.32 150.15 51.74 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.058 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -136.74 56.32 1.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.717 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 1.6 pt? -39.36 127.72 1.36 Allowed Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.345 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.73 74.09 0.07 OUTLIER 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 123.683 -1.382 . . . . 0.0 113.059 -0.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.717 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -168.69 58.44 0.06 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.837 0.351 . . . . 0.0 111.167 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.668 HD13 ' H ' ' A' ' 121' ' ' LEU . 5.3 mp -74.92 37.98 0.12 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.334 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.428 ' H ' ' C ' ' A' ' 120' ' ' ALA . 1.5 m-20 -72.26 132.2 43.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.914 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.5 37.36 94.56 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.926 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.39 137.0 52.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.538 0.208 . . . . 0.0 110.587 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.441 ' HG2' HH11 ' A' ' 125' ' ' ARG . 49.3 ttp85 -130.52 139.22 50.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.41 . . . . 0.0 111.374 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.475 HG12 ' CB ' ' A' ' 113' ' ' LEU . 30.7 m -130.11 138.22 54.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.125 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.598 ' HG3' ' HB2' ' A' ' 112' ' ' PHE . 13.9 pt-20 -114.98 124.47 51.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.499 ' HE2' ' HG2' ' A' ' 153' ' ' LYS . 2.0 m-85 -90.36 146.85 23.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.213 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.432 ' HD3' ' CE1' ' A' ' 112' ' ' PHE . 7.5 ptm180 -168.62 126.95 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.127 0.489 . . . . 0.0 111.12 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.492 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 69.5 m -89.76 157.39 17.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.382 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 133' ' ' ASP . 34.9 m-20 -52.7 149.66 10.83 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.536 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -52.25 81.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.178 2.585 . . . . 0.0 112.789 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 36.5 t70 178.67 -20.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.186 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 31.7 m-85 -129.38 132.93 47.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.723 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -102.81 127.22 50.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.038 0.447 . . . . 0.0 111.078 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.5 HD12 ' HG2' ' A' ' 154' ' ' PRO . 16.5 tp -71.92 131.06 42.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.034 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 36.0 t -136.01 66.73 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.739 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.53 -134.73 1.88 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.247 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.741 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 67.9 m -75.03 51.77 0.53 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.795 0.331 . . . . 0.0 111.099 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.7 t -51.08 -39.05 55.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.746 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -99.45 133.15 44.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.572 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.4 t -145.33 119.41 9.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 0.0 110.697 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.8 p -108.78 125.34 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.088 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 149' ' ' TRP . 47.4 t -71.9 145.29 48.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.389 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.6 p -161.37 122.85 2.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.953 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' A' ' 146' ' ' GLN . 8.3 tt0 57.06 43.05 24.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.188 0.518 . . . . 0.0 109.839 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.55 -49.87 3.71 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.754 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -77.34 137.83 38.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.704 0.287 . . . . 0.0 111.362 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 144' ' ' CYS . 68.2 m95 -84.23 143.89 29.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.513 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 65.3 m -53.91 -61.42 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.745 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 60.5 p -111.98 134.56 21.37 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.677 0.275 . . . . 0.0 111.503 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.446 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 44.4 Cg_endo -68.23 -163.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.382 2.055 . . . . 0.0 112.166 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.59 ' HB3' ' NZ ' ' A' ' 153' ' ' LYS . 9.3 mtpm? -83.35 125.43 74.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.219 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.741 ' HB3' ' H ' ' A' ' 139' ' ' SER . 62.4 Cg_endo -73.73 -144.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.705 2.27 . . . . 0.0 112.376 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.425 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 19.8 p-80 -153.66 139.9 18.51 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.801 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 86.2 m -98.67 133.97 42.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.027 0.442 . . . . 0.0 111.217 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -103.07 142.69 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.198 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 82.7 t -53.57 102.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.945 0.402 . . . . 0.0 110.496 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 38.9 t30 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.115 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.883 0.373 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.1 -48.02 59.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.187 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.77 -20.21 65.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.964 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.588 ' HB3' HG23 ' A' ' 98' ' ' ILE . 1.8 m-85 -76.65 44.79 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.812 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.1 m -65.67 131.38 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.979 0.419 . . . . 0.0 111.923 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 37.4 45.86 0.59 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.483 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.592 ' HA ' HD12 ' A' ' 121' ' ' LEU . 16.1 pt -65.03 133.42 30.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.749 0.309 . . . . 0.0 110.821 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.721 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 69.7 m -56.29 138.78 50.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.455 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.5 m -47.97 132.0 15.31 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.603 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.514 ' HB2' HD12 ' A' ' 104' ' ' LEU . 8.9 ptpp? -89.76 11.41 20.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.13 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.1 t -66.35 -35.78 81.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 110.945 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.522 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 0.9 OUTLIER -55.98 -33.24 64.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.909 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.514 HD12 ' HB2' ' A' ' 101' ' ' LYS . 70.4 mt -57.03 146.43 27.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.985 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.8 m 65.18 132.4 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.352 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.691 HD12 ' HE2' ' A' ' 153' ' ' LYS . 28.1 tp -145.41 135.41 23.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.124 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.407 ' H ' HD13 ' A' ' 106' ' ' LEU . 59.7 mp0 -69.85 131.29 44.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.269 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.465 ' N ' HD21 ' A' ' 108' ' ' ASN . 2.3 m120 57.81 39.6 26.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.456 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.518 ' HA2' ' H ' ' A' ' 131' ' ' ASP . . . -174.78 155.41 20.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.7 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -113.12 146.29 39.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.863 0.363 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.452 HG11 ' N ' ' A' ' 112' ' ' PHE . 60.0 t -108.17 139.01 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.061 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.528 ' C ' HD13 ' A' ' 113' ' ' LEU . 3.4 m-85 -106.52 140.49 39.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.807 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.528 HD13 ' C ' ' A' ' 112' ' ' PHE . 5.2 mp -133.51 137.32 45.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 110.484 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.469 HG21 ' N ' ' A' ' 115' ' ' GLY . 96.1 m -159.98 143.56 14.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.157 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.469 ' N ' HG21 ' A' ' 114' ' ' THR . . . 96.7 132.24 7.23 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.61 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 52.28 -149.58 9.59 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.83 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.495 ' H ' ' HB2' ' A' ' 120' ' ' ALA . 7.8 t70 178.41 117.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.658 HD13 ' HA ' ' A' ' 119' ' ' PRO . 29.9 tp -40.19 134.3 1.48 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.502 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.658 ' HA ' HD13 ' A' ' 118' ' ' LEU . 66.8 Cg_endo -94.02 44.58 2.52 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.713 -1.37 . . . . 0.0 113.109 0.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.495 ' HB2' ' H ' ' A' ' 117' ' ' ASP . . . -71.95 -49.73 34.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.139 0.495 . . . . 0.0 110.845 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.592 HD12 ' HA ' ' A' ' 98' ' ' ILE . 65.7 mt 54.76 40.89 32.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.533 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.404 ' OD1' ' HB1' ' A' ' 120' ' ' ALA . 1.2 m-20 -75.89 48.04 0.46 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.033 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.86 39.95 95.28 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.294 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 115' ' ' GLY . . . -62.38 138.26 58.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.772 0.32 . . . . 0.0 110.849 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -107.84 140.92 40.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.735 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.511 HG22 ' CZ3' ' A' ' 149' ' ' TRP . 32.8 m -129.06 141.02 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.994 0.426 . . . . 0.0 111.671 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 95.4 mt-10 -113.24 123.79 51.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.629 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.47 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 8.0 m-85 -90.23 52.06 2.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.55 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -61.72 129.17 39.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.783 0.325 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.637 ' SG ' HD22 ' A' ' 136' ' ' LEU . 79.9 m -89.25 142.29 27.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.399 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.518 ' H ' ' HA2' ' A' ' 109' ' ' GLY . 54.9 m-20 -57.75 158.37 12.32 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.306 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.476 ' C ' ' H ' ' A' ' 134' ' ' PHE . 2.2 Cg_endo -44.71 156.04 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.305 2.67 . . . . 0.0 112.382 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.7 m-20 73.58 -12.32 0.84 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.422 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.476 ' H ' ' C ' ' A' ' 132' ' ' PRO . 7.5 m-85 -130.64 137.3 49.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.77 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.723 ' HD1' ' HB2' ' A' ' 159' ' ' ASN . 14.1 p-80 -121.1 137.05 54.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.064 0.459 . . . . 0.0 111.608 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.637 HD22 ' SG ' ' A' ' 130' ' ' CYS . 2.2 tm? -68.29 130.38 42.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.029 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.412 ' N ' HD11 ' A' ' 136' ' ' LEU . 21.3 t -134.35 62.52 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.524 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.439 ' H ' ' CD1' ' A' ' 136' ' ' LEU . . . -176.01 -133.43 1.77 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.018 -1.087 . . . . 0.0 113.227 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.64 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 66.8 m -74.44 56.31 0.66 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.565 0.346 . . . . 0.0 111.397 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.564 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 34.4 t -54.56 -39.57 67.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.106 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -99.36 130.2 45.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.093 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.1 m -147.04 146.77 30.13 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.57 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.36 132.03 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.032 0.444 . . . . 0.0 111.377 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.474 ' SG ' HD23 ' A' ' 121' ' ' LEU . 39.0 t -72.13 132.46 44.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.088 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.9 m -166.41 130.82 2.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.82 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 55.82 44.38 26.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.37 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 57.45 45.28 93.17 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.967 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -177.12 142.01 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.635 0.255 . . . . 0.0 110.643 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.721 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 45.7 m95 -84.15 145.14 28.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.882 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.8 t -51.93 -49.63 62.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.022 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.607 ' HG1' ' HB3' ' A' ' 139' ' ' SER . 60.4 p -127.85 140.42 38.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.058 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 35.3 Cg_exo -60.33 -165.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.564 2.176 . . . . 0.0 112.476 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.691 ' HE2' HD12 ' A' ' 106' ' ' LEU . 84.5 tttt -86.56 125.29 67.81 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.64 ' HB3' ' N ' ' A' ' 139' ' ' SER . 73.6 Cg_endo -75.35 -151.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.562 2.175 . . . . 0.0 112.677 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.46 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.3 p-80 -153.8 146.22 23.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.06 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 75.3 m -97.95 132.4 43.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.598 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -103.05 142.9 33.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.168 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 53.0 t -67.25 80.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.868 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.723 ' HB2' ' HD1' ' A' ' 135' ' ' HIS . 34.1 t30 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.048 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.774 0.321 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -169.09 -136.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.974 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.433 ' HG3' ' CD1' ' A' ' 95' ' ' PHE . 40.1 tp10 65.92 128.59 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.887 0.375 . . . . 0.0 110.978 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.433 ' CD1' ' HG3' ' A' ' 94' ' ' GLU . 2.5 m-85 54.51 36.1 24.93 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.023 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.7 HG11 ' HG3' ' A' ' 97' ' ' ARG . 91.8 t -99.61 137.28 27.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.312 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.7 ' HG3' HG11 ' A' ' 96' ' ' VAL . 23.4 mtm105 60.45 56.53 3.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.571 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.705 ' HB ' HD23 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -53.16 145.84 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.7 m -53.36 135.43 39.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.241 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.8 t -47.93 123.33 6.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.521 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -81.24 113.1 19.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.606 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.0 m -171.15 -41.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.171 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.846 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 1.6 m-85 -62.51 -28.7 70.02 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.074 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.605 HD22 HD13 ' A' ' 113' ' ' LEU . 61.4 mt -72.14 28.21 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.332 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.453 ' H ' ' C ' ' A' ' 103' ' ' TYR . 64.5 p -147.48 127.61 13.76 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.914 0.388 . . . . 0.0 111.666 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 tp -145.44 121.98 11.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.297 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -92.28 40.22 1.04 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -163.65 36.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.719 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.34 -146.45 11.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.837 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -141.56 139.37 33.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.528 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.6 t -105.97 136.6 39.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.981 0.419 . . . . 0.0 111.007 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 1.6 m-85 -107.83 145.78 33.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.408 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.605 HD13 HD22 ' A' ' 104' ' ' LEU . 6.7 tt -152.55 138.97 18.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.928 0.394 . . . . 0.0 110.846 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.502 ' N ' HD22 ' A' ' 113' ' ' LEU . 84.9 m -153.53 123.16 6.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.683 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.27 -38.51 0.28 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.104 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -168.2 -130.08 1.14 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.138 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.639 ' H ' ' HB2' ' A' ' 120' ' ' ALA . 8.2 t70 -172.3 125.47 0.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.497 HD13 ' H ' ' A' ' 118' ' ' LEU . 6.8 mp -41.84 138.48 1.78 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.208 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -86.73 41.37 1.88 Allowed 'Cis proline' 0 C--N 1.347 0.465 0 C-N-CA 123.574 -1.428 . . . . 0.0 113.478 0.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.639 ' HB2' ' H ' ' A' ' 117' ' ' ASP . . . -92.49 129.87 38.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.831 0.348 . . . . 0.0 111.065 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.705 HD23 ' HB ' ' A' ' 98' ' ' ILE . 3.8 mm? -131.47 51.13 2.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.585 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.88 59.66 1.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.931 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.91 42.27 99.61 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.578 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.52 141.22 57.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.724 0.297 . . . . 0.0 111.18 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -106.95 130.43 54.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.194 0.521 . . . . 0.0 110.733 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.44 134.3 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.59 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -118.31 123.89 46.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.306 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.543 ' CE2' ' HG2' ' A' ' 153' ' ' LYS . 19.0 m-85 -82.78 151.08 26.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.2 0.524 . . . . 0.0 111.942 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.407 HH11 ' HG2' ' A' ' 129' ' ' ARG . 15.4 tpp85 -153.46 121.97 6.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.644 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 9.2 t -102.38 144.63 30.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.035 0.445 . . . . 0.0 111.748 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -56.28 157.76 8.64 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.338 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 71.4 Cg_exo -48.82 163.14 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.765 2.31 . . . . 0.0 112.275 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.517 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 55.7 m-20 76.56 -32.53 0.2 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.847 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.863 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 1.4 m-85 -108.5 133.78 52.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.391 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.466 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 20.4 p-80 -112.95 137.34 51.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.972 0.415 . . . . 0.0 111.284 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.754 HD21 ' HA ' ' A' ' 140' ' ' SER . 18.7 tp -68.35 135.91 52.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.308 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 137' ' ' VAL . 14.8 p -136.74 60.01 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.788 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . 171.97 -123.42 1.02 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 119.172 -1.489 . . . . 0.0 113.692 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.798 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 39.9 t -65.11 66.06 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.866 0.365 . . . . 0.0 111.553 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.754 ' HA ' HD21 ' A' ' 136' ' ' LEU . 98.9 p -66.39 -14.81 62.68 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.266 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.556 ' HD3' ' H ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -140.62 138.16 34.18 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.973 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.451 ' HA ' ' HB3' ' A' ' 150' ' ' SER . 86.1 p -141.62 140.51 33.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.771 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.856 HG11 ' HB2' ' A' ' 150' ' ' SER . 7.3 p -134.75 132.84 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.063 0.459 . . . . 0.0 111.981 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 121' ' ' LEU . 41.5 t -79.34 149.98 31.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.828 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.1 t -147.79 -130.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.715 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -58.44 -42.72 87.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.643 0.259 . . . . 0.0 111.202 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 176.15 47.5 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.657 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -173.71 142.24 0.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.735 0.302 . . . . 0.0 110.696 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -84.2 153.36 23.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.074 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.856 ' HB2' HG11 ' A' ' 143' ' ' VAL . 43.2 t -48.08 -57.65 5.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.87 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.673 ' HG1' ' HB2' ' A' ' 139' ' ' SER . 0.5 OUTLIER -147.42 143.73 18.46 Favored Pre-proline 0 C--N 1.332 -0.163 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.543 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.477 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 31.4 Cg_exo -57.82 140.81 94.97 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.483 2.789 . . . . 0.0 112.716 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.846 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 9.0 mtpm? -49.81 137.35 18.87 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.024 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.798 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 85.2 Cg_endo -83.05 -140.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.989 2.459 . . . . 0.0 112.142 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.425 ' O ' HG11 ' A' ' 137' ' ' VAL . 18.9 p-80 -153.72 152.16 30.46 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.763 0.316 . . . . 0.0 110.999 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . 0.863 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 71.1 m -94.95 127.37 40.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.555 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.466 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 69.8 tp60 -105.56 136.76 44.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.818 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.4 t -76.3 122.95 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.164 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 133' ' ' ASP . 24.4 p30 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.953 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.795 0.331 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.23 -42.78 95.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.255 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.485 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -62.69 131.49 49.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.631 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -65.97 -43.2 88.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.94 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.3 t 66.77 139.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.011 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -49.69 136.16 17.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.369 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.9 pt -137.43 145.71 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.923 0.392 . . . . 0.0 111.473 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 38.7 m -51.49 140.17 18.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.058 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.4 t -47.91 130.26 14.95 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.308 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.578 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -83.14 -28.44 29.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.235 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.1 m -68.89 38.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.771 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 6.8 m-85 -127.28 -46.92 1.47 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.573 0.225 . . . . 0.0 111.305 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.784 HD13 ' H ' ' A' ' 105' ' ' THR . 0.4 OUTLIER -52.92 -32.08 43.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.462 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.784 ' H ' HD13 ' A' ' 104' ' ' LEU . 41.9 p -96.29 135.37 38.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.663 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 34.5 tp -145.43 131.19 19.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 111.135 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.01 131.73 45.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.66 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 54.1 41.8 31.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.401 . . . . 0.0 110.6 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.53 148.56 9.51 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.522 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -104.09 151.75 22.9 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.953 0.406 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 104' ' ' LEU . 96.4 t -128.2 141.39 46.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.987 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.478 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.8 m-85 -105.83 134.3 49.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.84 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.433 HD23 HG13 ' A' ' 126' ' ' VAL . 2.7 tm? -109.18 131.76 54.76 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.3 m -157.51 125.09 5.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.91 0.386 . . . . 0.0 111.107 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 157.93 -133.52 3.53 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.293 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.85 -135.24 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.394 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -160.17 123.4 3.49 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.64 ' H ' HD12 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -53.27 136.41 50.18 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.003 -179.293 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -90.21 63.16 0.26 Allowed 'Cis proline' 0 C--N 1.346 0.445 0 C-N-CA 123.834 -1.319 . . . . 0.0 113.032 0.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.573 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -155.43 57.21 0.63 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.779 0.323 . . . . 0.0 111.549 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.671 ' N ' HD13 ' A' ' 121' ' ' LEU . 5.2 mp -77.28 45.87 0.48 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.855 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.65 131.27 49.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 111.215 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.83 35.52 39.53 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.749 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.57 136.94 32.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.673 0.273 . . . . 0.0 111.35 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.437 ' NH2' HH21 ' A' ' 141' ' ' ARG . 15.9 ptm180 -130.55 130.29 43.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 110.789 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.539 HG21 ' CE1' ' A' ' 128' ' ' PHE . 23.2 m -100.27 139.81 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.027 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 46.6 mp0 -102.93 123.88 47.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.245 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.539 ' CE1' HG21 ' A' ' 126' ' ' VAL . 7.0 m-85 -91.31 143.04 27.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.144 0.497 . . . . 0.0 112.036 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.439 ' HD3' ' CE1' ' A' ' 112' ' ' PHE . 47.9 mtp85 -152.59 125.1 8.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.723 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 26.2 t -89.29 163.8 15.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.943 0.402 . . . . 0.0 111.462 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -52.79 156.71 3.13 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.306 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.08 52.44 1.84 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.286 2.658 . . . . 0.0 112.868 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -155.88 -37.72 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.121 0.486 . . . . 0.0 109.989 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.445 ' CE2' ' HB ' ' A' ' 158' ' ' VAL . 0.9 OUTLIER -108.32 146.53 32.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.724 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.421 ' H ' ' HD1' ' A' ' 135' ' ' HIS . 15.0 p-80 -100.08 132.99 45.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.137 0.494 . . . . 0.0 111.152 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.504 HD22 ' HA ' ' A' ' 140' ' ' SER . 27.9 tp -73.46 128.47 35.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.279 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.6 t -134.98 64.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.225 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.53 -123.52 0.72 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.005 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.906 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.4 t -71.17 52.28 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.678 0.391 . . . . 0.0 111.686 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.504 ' HA ' HD22 ' A' ' 136' ' ' LEU . 44.9 t -56.02 -26.35 48.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.066 0.46 . . . . 0.0 110.15 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.437 HH21 ' NH2' ' A' ' 125' ' ' ARG . 24.0 mmm180 -132.87 129.14 38.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.853 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.442 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 47.1 t -141.77 148.56 39.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.237 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 125' ' ' ARG . 7.3 p -144.04 131.35 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.818 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 45.4 t -68.47 144.11 54.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.595 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.6 t -172.72 129.51 0.52 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.546 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 56.6 43.93 24.79 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.05 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 57.31 42.75 93.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.315 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -174.33 140.18 0.64 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 0.0 110.498 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.433 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 56.0 m95 -84.24 140.81 31.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.937 0.399 . . . . 0.0 110.965 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.8 m -54.2 -60.64 3.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.478 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -94.32 129.08 38.13 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.739 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 139' ' ' SER . 73.7 Cg_endo -75.91 148.86 32.39 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.848 2.366 . . . . 0.0 112.273 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.771 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 14.1 mmmm -40.86 127.27 1.96 Allowed Pre-proline 0 N--CA 1.464 0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 111.267 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.906 ' HB3' ' H ' ' A' ' 139' ' ' SER . 91.5 Cg_endo -83.77 -149.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.972 2.448 . . . . 0.0 113.571 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.483 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 17.8 p-80 -153.75 150.09 28.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.337 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 82.7 m -94.95 127.63 41.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.799 0.333 . . . . 0.0 110.933 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -103.48 137.09 42.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.52 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.445 ' HB ' ' CE2' ' A' ' 134' ' ' PHE . 11.7 p -86.62 131.29 35.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.432 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.829 -179.598 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.798 0.332 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 59.54 48.05 10.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.482 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -174.08 47.41 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.188 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -172.36 146.08 1.76 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.178 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.4 HG23 ' N ' ' A' ' 97' ' ' ARG . 7.1 p -176.39 136.07 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.258 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 97' ' ' ARG . 29.4 tpt180 52.21 54.74 10.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.074 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.639 ' HB ' ' HG ' ' A' ' 121' ' ' LEU . 35.7 pt -55.56 142.48 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.088 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.475 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 95.1 m -51.09 135.77 24.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.362 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.8 t -47.97 127.48 12.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.301 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.732 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -81.07 12.61 3.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 179.727 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.1 t -68.82 -41.55 78.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.793 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.549 ' O ' HG23 ' A' ' 111' ' ' VAL . 1.9 m-85 -56.09 -34.94 66.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.21 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 87.1 mt -47.77 -46.02 29.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.961 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 60.1 p -92.61 137.95 31.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.441 HD12 ' HZ2' ' A' ' 153' ' ' LYS . 30.4 tp -145.41 133.4 21.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 110.972 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.97 132.23 46.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.772 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.417 ' N ' HD21 ' A' ' 108' ' ' ASN . 2.5 m120 58.65 33.03 22.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.152 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.507 ' CA ' ' HA ' ' A' ' 130' ' ' CYS . . . -175.51 153.14 14.44 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.423 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -109.27 144.5 37.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.513 -0.344 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 103' ' ' TYR . 93.1 t -109.66 136.94 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.95 0.405 . . . . 0.0 111.058 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.446 ' CE1' ' HD3' ' A' ' 129' ' ' ARG . 2.8 m-85 -108.57 146.51 33.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.755 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.614 HD21 ' N ' ' A' ' 114' ' ' THR . 6.3 tt -144.26 131.45 20.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.546 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.614 ' N ' HD21 ' A' ' 113' ' ' LEU . 68.7 p -150.08 123.36 8.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.567 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.02 -36.01 0.27 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.242 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.4 -135.12 1.8 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.419 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.584 ' H ' ' HB1' ' A' ' 120' ' ' ALA . 12.2 p-10 -175.67 129.5 0.25 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.72 ' N ' HD13 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -41.28 138.82 1.44 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.279 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -86.69 40.32 2.2 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.503 -1.457 . . . . 0.0 113.117 0.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.584 ' HB1' ' H ' ' A' ' 117' ' ' ASP . . . -96.62 47.11 1.06 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.783 0.325 . . . . 0.0 111.242 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.639 ' HG ' ' HB ' ' A' ' 98' ' ' ILE . 3.9 mm? -54.42 -40.59 68.44 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.789 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -61.21 136.93 58.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.505 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.87 54.4 7.24 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.458 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -143.62 136.12 27.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.0 111.189 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.46 ' HD3' HG23 ' A' ' 143' ' ' VAL . 48.6 mmt-85 -105.66 143.56 33.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.733 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 142' ' ' SER . 32.7 m -133.74 135.53 55.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.088 0.47 . . . . 0.0 111.489 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -112.9 118.34 34.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.514 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.447 ' HE1' ' HB3' ' A' ' 142' ' ' SER . 5.4 m-85 -82.42 140.53 33.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.024 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.446 ' HD3' ' CE1' ' A' ' 112' ' ' PHE . 16.6 ptm180 -166.66 127.46 1.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.77 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.507 ' HA ' ' CA ' ' A' ' 109' ' ' GLY . 61.5 m -92.89 160.6 14.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.149 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.443 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 31.9 m-20 -52.68 157.58 2.55 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.556 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 17.9 Cg_endo -58.78 76.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.142 2.561 . . . . 0.0 112.64 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.3 t70 -177.07 -38.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.675 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.735 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 2.9 m-85 -108.91 132.58 53.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.872 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 157' ' ' GLN . 17.6 p-80 -102.8 127.79 49.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.993 0.425 . . . . 0.0 111.145 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.736 HD23 ' HA ' ' A' ' 140' ' ' SER . 26.7 tp -72.11 129.51 38.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.648 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.1 t -135.33 67.89 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.749 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.12 -136.09 2.28 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.623 -1.275 . . . . 0.0 113.398 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.593 ' HB2' ' HG1' ' A' ' 151' ' ' THR . 71.1 p -74.82 58.26 0.82 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.022 0.439 . . . . 0.0 110.854 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.736 ' HA ' HD23 ' A' ' 136' ' ' LEU . 36.5 t -52.16 -31.39 31.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.743 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -99.44 136.26 39.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.779 0.323 . . . . 0.0 111.237 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.471 ' O ' HG21 ' A' ' 126' ' ' VAL . 42.8 t -150.05 149.56 30.49 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.34 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.518 HG12 ' HB2' ' A' ' 150' ' ' SER . 7.3 p -144.36 135.69 21.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.993 0.425 . . . . 0.0 111.75 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 121' ' ' LEU . 43.1 t -66.72 151.2 47.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.005 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.1 t -151.54 -136.91 0.07 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.054 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -74.63 66.56 1.45 Allowed 'General case' 0 C--O 1.232 0.153 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.36 43.45 92.67 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.649 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -176.41 139.9 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.757 0.313 . . . . 0.0 110.505 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.475 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 33.8 m95 -84.26 141.65 30.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.653 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.518 ' HB2' HG12 ' A' ' 143' ' ' VAL . 48.5 t -49.54 -52.72 27.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.645 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.593 ' HG1' ' HB2' ' A' ' 139' ' ' SER . 48.8 p -124.95 133.88 25.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 0.0 111.803 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.87 147.5 85.21 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.773 2.316 . . . . 0.0 111.841 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 50.2 mtpt -46.66 131.37 8.33 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.325 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.567 ' HG2' HD12 ' A' ' 136' ' ' LEU . 3.9 Cg_exo -78.93 -141.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.073 2.515 . . . . 0.0 112.086 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -153.75 134.75 13.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.772 0.32 . . . . 0.0 110.948 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . 0.735 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 77.5 m -98.73 132.41 44.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.487 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.448 ' HB2' ' CE1' ' A' ' 135' ' ' HIS . 23.2 mt-30 -103.4 142.46 34.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.821 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -76.21 135.99 25.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.21 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.7 m120 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.917 -179.523 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.804 0.335 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.43 42.98 0.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.427 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.7 mp0 48.86 -137.47 0.95 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.626 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -173.92 47.31 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.973 0.416 . . . . 0.0 110.969 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.404 HG11 ' N ' ' A' ' 97' ' ' ARG . 90.4 t -65.09 138.82 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.054 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.436 ' HG2' HH11 ' A' ' 97' ' ' ARG . 22.4 ptt-85 -55.64 141.75 36.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.706 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.429 HG23 ' O ' ' A' ' 97' ' ' ARG . 31.4 pt -142.31 144.79 24.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.315 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.551 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 73.7 m -51.51 139.46 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.54 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 102' ' ' SER . 47.3 t -47.99 127.52 12.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.021 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.539 ' NZ ' ' HB3' ' A' ' 101' ' ' LYS . 8.4 mtpm? -74.16 14.36 0.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.343 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 100' ' ' SER . 61.1 m -68.87 -46.19 69.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.936 0.398 . . . . 0.0 110.895 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.407 ' HH ' ' HA ' ' A' ' 152' ' ' PRO . 1.2 m-85 -61.7 -41.12 97.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.116 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.9 mt -54.94 -41.79 71.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.501 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.6 p -92.54 136.89 32.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.865 0.364 . . . . 0.0 111.564 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.502 HD21 ' SG ' ' A' ' 130' ' ' CYS . 40.4 tp -145.44 130.81 18.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.572 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.409 ' HG2' ' OD1' ' A' ' 108' ' ' ASN . 10.3 pm0 -90.48 38.94 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.335 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.409 ' OD1' ' HG2' ' A' ' 107' ' ' GLU . 8.2 m120 -155.85 25.44 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 154.57 -144.36 11.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.88 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.403 ' HE2' ' CZ ' ' A' ' 112' ' ' PHE . 25.0 pttm -141.97 140.19 32.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.251 -0.474 . . . . 0.0 110.302 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.33 143.91 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.013 0.435 . . . . 0.0 111.354 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.403 ' CZ ' ' HE2' ' A' ' 110' ' ' LYS . 1.4 m-85 -105.36 151.76 23.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.146 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.5 tp -145.29 132.97 20.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.605 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.2 p -150.95 147.32 27.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.429 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.2 39.7 26.31 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.918 -0.583 . . . . 0.0 113.017 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.456 ' HA2' ' HB2' ' A' ' 124' ' ' ALA . . . -79.61 -140.88 2.24 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.158 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -176.1 49.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.619 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 1.7 pt? -42.47 135.07 2.62 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.986 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -87.71 63.04 0.19 OUTLIER 'Cis proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.638 -1.401 . . . . 0.0 113.345 0.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.619 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -166.32 132.56 2.47 Favored 'General case' 0 C--O 1.228 -0.074 0 CA-C-O 120.929 0.395 . . . . 0.0 111.486 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.476 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 83.3 mt -80.9 43.09 0.67 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.84 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -65.01 126.24 27.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.236 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 50.12 31.42 18.76 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.007 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.456 ' HB2' ' HA2' ' A' ' 116' ' ' GLY . . . -84.25 140.25 31.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.579 0.228 . . . . 0.0 110.959 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -108.54 124.23 50.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.785 0.326 . . . . 0.0 110.438 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 142' ' ' SER . 7.5 p -103.59 140.26 22.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.537 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -125.25 111.97 15.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.166 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -75.23 146.59 41.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.57 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.402 ' NH1' ' O ' ' A' ' 130' ' ' CYS . 26.7 tpt85 -156.27 117.06 3.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.097 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.502 ' SG ' HD21 ' A' ' 106' ' ' LEU . 98.6 m -96.41 165.25 12.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.691 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.55 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 56.2 m-20 -52.66 162.32 0.97 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.017 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 56.7 Cg_endo -70.92 51.76 1.29 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.851 2.368 . . . . 0.0 112.727 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -146.53 -35.85 0.26 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.773 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.59 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 0.7 OUTLIER -108.82 135.93 49.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.034 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.402 ' CE1' ' HB2' ' A' ' 157' ' ' GLN . 17.0 p-80 -102.74 129.86 49.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.948 0.404 . . . . 0.0 110.826 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.799 HD21 ' HA ' ' A' ' 140' ' ' SER . 50.7 tp -72.72 128.18 34.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.019 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.6 t -135.99 68.69 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.665 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.18 -131.36 1.74 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.442 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.75 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.2 t -69.84 63.8 0.2 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.958 0.408 . . . . 0.0 111.364 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.799 ' HA ' HD21 ' A' ' 136' ' ' LEU . 95.5 p -61.22 -15.12 31.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.729 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -139.04 137.96 36.74 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.721 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.639 ' HG ' ' HB3' ' A' ' 149' ' ' TRP . 36.4 t -150.69 124.17 9.01 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.735 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 143' ' ' VAL . 8.2 p -88.01 130.51 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.978 0.418 . . . . 0.0 111.084 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 26.4 t -75.84 78.13 2.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.56 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 51.5 m -65.59 -124.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.444 ' C ' ' H ' ' A' ' 148' ' ' GLN . 26.1 mt-30 -67.27 -140.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -77.29 29.32 1.67 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.445 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.444 ' H ' ' C ' ' A' ' 146' ' ' GLN . 87.9 mt-30 -157.76 150.24 22.63 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.725 0.297 . . . . 0.0 110.652 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.639 ' HB3' ' HG ' ' A' ' 142' ' ' SER . 33.1 m95 -84.22 139.21 32.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.222 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 80.7 p -53.91 -63.07 1.27 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.517 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 40.2 p -92.6 132.31 31.9 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.706 0.288 . . . . 0.0 111.533 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.407 ' HA ' ' HH ' ' A' ' 103' ' ' TYR . 30.4 Cg_endo -63.34 142.5 85.95 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.826 2.35 . . . . 0.0 112.356 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -51.81 127.93 35.43 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.128 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.75 ' HB3' ' H ' ' A' ' 139' ' ' SER . 81.9 Cg_endo -78.15 -152.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.765 2.31 . . . . 0.0 112.805 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.443 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 19.4 p-80 -153.83 138.96 17.39 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.073 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . 0.59 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 99.7 m -98.72 131.55 44.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.891 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.402 ' HB2' ' CE1' ' A' ' 135' ' ' HIS . 25.9 mt-30 -103.0 140.16 37.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.793 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.465 ' HB ' ' CE2' ' A' ' 134' ' ' PHE . 14.7 p -79.9 44.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.39 0.614 . . . . 0.0 110.583 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.174 179.989 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.816 0.341 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.72 127.84 0.4 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.076 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.461 ' OE1' HG23 ' A' ' 98' ' ' ILE . 23.1 pt-20 -74.84 133.74 41.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.003 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.42 40.39 0.65 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.37 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.6 p -175.07 129.19 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.907 0.384 . . . . 0.0 111.09 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -70.24 120.03 15.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.976 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.461 HG23 ' OE1' ' A' ' 94' ' ' GLU . 2.5 pp -83.66 159.21 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.543 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 51.5 m -55.01 137.26 46.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.38 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.58 ' HB2' ' HE1' ' A' ' 149' ' ' TRP . 56.4 m -47.95 123.8 6.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.844 0.354 . . . . 0.0 111.226 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.648 ' HA ' HD13 ' A' ' 104' ' ' LEU . 58.9 tptt -75.47 -26.67 58.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.328 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.5 p -53.22 -41.8 65.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.488 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.68 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 3.7 m-85 -59.0 -42.63 90.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.651 0.262 . . . . 0.0 111.179 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.648 HD13 ' HA ' ' A' ' 101' ' ' LYS . 5.7 mp -55.74 -41.13 73.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.064 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.7 p -92.56 127.06 37.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.976 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.5 tp -145.36 128.36 16.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.092 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -69.15 138.06 53.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.971 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 m120 58.24 39.74 25.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.298 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.85 168.36 41.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.703 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -138.88 140.25 38.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.732 0.301 . . . . 0.0 110.743 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 112' ' ' PHE . 74.9 t -109.18 141.45 24.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.206 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.483 ' N ' HG13 ' A' ' 111' ' ' VAL . 7.6 m-85 -105.53 136.1 45.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.644 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.401 ' HA ' HD11 ' A' ' 113' ' ' LEU . 2.6 mm? -101.05 144.2 30.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.575 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.9 m -151.76 126.62 9.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.713 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 124' ' ' ALA . . . 65.01 149.98 0.06 OUTLIER Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.424 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.65 143.13 0.49 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.603 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -173.44 138.31 0.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.761 ' N ' HD13 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -43.16 134.93 3.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.829 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -87.9 54.01 0.52 Allowed 'Cis proline' 0 C--N 1.347 0.486 0 C-N-CA 123.721 -1.366 . . . . 0.0 113.401 0.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.51 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -135.11 135.55 41.27 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.7 0.286 . . . . 0.0 110.861 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.59 ' HB2' ' SG ' ' A' ' 99' ' ' CYS . 2.1 pt? -124.42 -39.92 2.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.104 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -61.32 136.78 58.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.561 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.17 54.59 4.03 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.14 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 115' ' ' GLY . . . -147.7 132.17 17.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 0.0 111.068 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.547 ' HG3' HG21 ' A' ' 143' ' ' VAL . 8.6 mpt_? -124.93 138.86 54.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.113 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.553 HG22 ' CZ3' ' A' ' 149' ' ' TRP . 28.4 m -116.97 137.06 52.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.104 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -106.67 113.72 27.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.95 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.451 ' CE1' HG23 ' A' ' 126' ' ' VAL . 3.8 m-85 -74.83 155.95 37.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.603 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.481 HH22 ' H ' ' A' ' 136' ' ' LEU . 2.4 tpm_? -161.11 128.45 4.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.525 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.456 ' H ' ' CZ ' ' A' ' 129' ' ' ARG . 87.6 m -89.22 140.77 29.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.067 0.46 . . . . 0.0 111.456 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.416 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 63.9 m-20 -54.29 158.88 3.49 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.16 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.513 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 3.5 Cg_endo -45.92 153.14 0.95 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.002 2.468 . . . . 0.0 112.07 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 22.2 m-20 77.92 -32.07 0.17 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.664 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.44 ' H ' ' C ' ' A' ' 132' ' ' PRO . 3.2 m-85 -107.65 128.12 54.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.331 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -107.52 136.44 47.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.425 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.639 HD11 ' HA ' ' A' ' 140' ' ' SER . 6.2 tt -74.94 130.46 39.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.469 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.04 67.43 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.461 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.5 -134.94 1.91 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.092 -1.052 . . . . 0.0 113.058 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.652 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 50.0 m -75.53 55.26 0.81 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.851 0.358 . . . . 0.0 110.964 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.639 ' HA ' HD11 ' A' ' 136' ' ' LEU . 33.6 t -49.77 -40.51 41.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.171 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.424 ' HG2' HH11 ' A' ' 141' ' ' ARG . 22.2 ptt-85 -99.31 134.53 42.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.98 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.2 m -146.29 133.87 20.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.77 0.319 . . . . 0.0 110.736 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.547 HG21 ' HG3' ' A' ' 125' ' ' ARG . 7.3 p -120.05 129.76 75.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.05 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 51.4 t -71.39 141.95 50.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.454 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.3 t -171.3 125.65 0.64 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.216 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.441 ' OE1' ' N ' ' A' ' 146' ' ' GLN . 0.6 OUTLIER 57.15 39.61 28.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 0.0 110.448 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.17 -51.65 3.26 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.774 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -76.92 143.7 39.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.678 0.275 . . . . 0.0 111.057 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.58 ' HE1' ' HB2' ' A' ' 100' ' ' SER . 70.0 m95 -84.2 146.82 27.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.828 0.347 . . . . 0.0 110.659 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.3 t -53.37 -61.17 2.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.524 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 139' ' ' SER . 82.4 p -107.79 135.78 19.77 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.774 0.321 . . . . 0.0 111.776 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 139' ' ' SER . 57.6 Cg_endo -70.78 145.67 51.9 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.785 2.323 . . . . 0.0 112.161 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.68 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 7.6 mtpm? -45.32 130.17 5.98 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.433 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.652 ' HB3' ' H ' ' A' ' 139' ' ' SER . 76.1 Cg_endo -77.51 -141.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.69 2.26 . . . . 0.0 112.547 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.518 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.4 p-80 -153.74 147.6 25.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.036 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 71.0 m -96.89 140.26 31.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.279 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -131.26 146.69 52.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.875 0.369 . . . . 0.0 111.48 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 79.6 t -76.61 125.18 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.174 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.067 -179.634 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.634 0.254 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 64.75 135.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.412 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -175.1 -43.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.237 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -61.95 -43.99 97.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.344 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 92.6 t -62.2 128.73 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.89 0.376 . . . . 0.0 111.272 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.417 ' NH1' ' HA3' ' A' ' 147' ' ' GLY . 31.2 ptt85 -84.71 55.52 3.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.119 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.541 ' HA ' HD11 ' A' ' 121' ' ' LEU . 2.3 pp -51.13 148.21 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.991 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.586 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 97.7 m -59.76 143.83 49.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.04 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.2 m -48.03 124.81 8.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.226 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.68 ' HB2' HD13 ' A' ' 104' ' ' LEU . 7.6 ptpp? -84.46 14.98 3.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.933 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.2 m -67.34 -35.63 79.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.678 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.744 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 3.4 m-85 -58.74 -25.69 63.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.417 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.68 HD13 ' HB2' ' A' ' 101' ' ' LYS . 84.4 mt -50.0 -38.41 37.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.737 0.303 . . . . 0.0 111.118 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.3 p -92.55 127.81 38.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.111 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.664 ' HG ' ' HZ1' ' A' ' 153' ' ' LYS . 6.4 tt -145.37 124.02 12.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.182 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -74.25 130.69 40.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.37 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.497 ' N ' HD21 ' A' ' 108' ' ' ASN . 2.0 m120 60.11 47.22 9.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.221 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.95 -171.83 39.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.075 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -142.09 146.29 35.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.659 0.266 . . . . 0.0 110.647 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 103' ' ' TYR . 60.3 t -108.05 127.4 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.631 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.5 m-85 -112.01 70.88 0.72 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.149 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.69 ' HA ' ' HB ' ' A' ' 126' ' ' VAL . 2.3 tt -74.67 62.39 1.05 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.618 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.8 p -75.0 120.89 21.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.712 0.291 . . . . 0.0 111.118 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.14 -43.89 0.31 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.654 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -173.16 -128.26 1.05 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.531 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.515 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 11.6 p-10 -165.24 -136.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.565 ' N ' HD21 ' A' ' 118' ' ' LEU . 2.7 mm? -116.31 132.98 23.02 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.526 0.203 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -93.09 42.06 3.15 Favored 'Cis proline' 0 C--N 1.348 0.537 0 C-N-CA 123.837 -1.318 . . . . 0.0 112.497 -0.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.515 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -74.07 140.89 45.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 0.0 111.742 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.664 HD23 ' N ' ' A' ' 121' ' ' LEU . 2.1 pt? -167.39 36.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.803 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.93 60.57 1.39 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.917 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.22 40.84 32.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.225 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.589 ' O ' HG21 ' A' ' 143' ' ' VAL . . . -62.9 135.29 57.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 110.981 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.582 ' HD2' ' NH2' ' A' ' 141' ' ' ARG . 85.7 mtm180 -103.83 141.47 36.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.498 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.69 ' HB ' ' HA ' ' A' ' 113' ' ' LEU . 6.5 p -143.23 135.66 24.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.257 0.551 . . . . 0.0 112.315 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.454 ' N ' HG23 ' A' ' 126' ' ' VAL . 5.0 tp10 -109.17 121.11 44.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.737 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.519 ' HE1' ' HB3' ' A' ' 142' ' ' SER . 3.2 m-85 -87.3 56.19 3.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.801 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.43 ' HG2' HH11 ' A' ' 129' ' ' ARG . 63.5 mtt-85 -59.05 132.97 55.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.591 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 53.7 t -89.2 149.13 23.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.34 . . . . 0.0 111.13 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.483 ' OD1' ' HB2' ' A' ' 134' ' ' PHE . 52.5 p-10 -52.81 149.8 10.88 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.404 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.509 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 10.1 Cg_endo -51.59 152.74 12.0 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.751 2.301 . . . . 0.0 111.527 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.57 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 37.4 t70 76.44 -2.41 2.72 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.399 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.684 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 19.1 m-85 -134.28 130.61 37.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.951 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.56 ' HD1' ' HB2' ' A' ' 159' ' ' ASN . 17.8 p-80 -104.16 128.19 51.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.923 0.392 . . . . 0.0 111.197 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.574 HD12 ' HB3' ' A' ' 140' ' ' SER . 2.8 tm? -71.44 132.15 44.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.795 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.46 ' N ' HD11 ' A' ' 136' ' ' LEU . 24.8 t -132.23 67.88 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.9 -135.13 2.11 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 119.901 -1.142 . . . . 0.0 113.276 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.639 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 39.2 p -74.99 56.05 0.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.929 0.395 . . . . 0.0 111.072 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.574 ' HB3' HD12 ' A' ' 136' ' ' LEU . 92.6 p -57.0 -38.95 73.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.801 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.582 ' NH2' ' HD2' ' A' ' 125' ' ' ARG . 29.4 tpt180 -99.32 133.97 42.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.703 0.287 . . . . 0.0 111.508 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.519 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 46.7 t -150.34 148.67 29.1 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.258 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.589 HG21 ' O ' ' A' ' 124' ' ' ALA . 7.4 p -146.23 130.27 10.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.146 0.498 . . . . 0.0 112.046 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.527 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 13.7 t -92.54 140.96 29.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.901 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.4 t -169.52 -60.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.042 0.449 . . . . 0.0 111.218 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -87.98 43.63 1.13 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.417 ' HA3' ' NH1' ' A' ' 97' ' ' ARG . . . 56.54 39.9 85.91 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.89 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -174.73 146.98 1.0 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.728 0.299 . . . . 0.0 110.402 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.586 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 29.5 m95 -84.22 138.78 32.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.778 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.559 ' HB2' HG11 ' A' ' 143' ' ' VAL . 45.2 t -50.15 -46.31 53.95 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.965 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 70.9 p -135.65 138.84 29.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.891 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.516 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 28.0 Cg_exo -62.02 -162.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.561 2.174 . . . . 0.0 112.627 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.744 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 3.9 mmmp? -80.75 127.3 75.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.783 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.639 ' HB3' ' N ' ' A' ' 139' ' ' SER . 84.0 Cg_endo -81.37 -151.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.635 2.223 . . . . 0.0 112.891 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.452 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 22.4 p-80 -153.65 136.52 15.38 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.936 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . 0.684 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 7.8 t -98.72 136.83 38.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.979 0.418 . . . . 0.0 111.664 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -103.04 142.4 34.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.02 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 98.2 t -61.24 111.03 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.78 0.324 . . . . 0.0 110.327 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.57 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 38.6 t30 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.05 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.7 0.286 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 55.23 43.35 29.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.169 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -60.38 -44.71 95.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.792 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.463 ' HB2' ' H ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -175.34 -148.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.165 179.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.609 HG13 HG23 ' A' ' 98' ' ' ILE . 61.0 t -73.47 134.45 29.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.868 0.366 . . . . 0.0 111.326 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -79.95 49.93 1.14 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.005 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.609 HG23 HG13 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -54.33 142.36 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 0.0 111.49 -179.547 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 82.1 m -56.42 154.47 8.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.757 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.7 m -45.67 127.51 7.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.492 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -76.19 -3.38 35.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.262 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.5 m -56.12 -41.15 74.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.87 0.367 . . . . 0.0 110.994 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.468 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 1.7 m-85 -59.98 -34.17 72.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.196 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.6 mt -52.11 -40.01 60.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.967 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.1 m -92.6 136.29 33.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 106' ' ' LEU . 23.5 tp -145.42 131.35 19.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.86 0.362 . . . . 0.0 111.31 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -75.02 133.56 41.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.853 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 52.47 36.07 19.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 110.664 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.36 145.81 9.91 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.538 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.64 ' HB3' ' HZ3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -101.93 140.87 35.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.972 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.03 135.93 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.79 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.412 ' HE1' ' HG3' ' A' ' 110' ' ' LYS . 3.5 m-85 -110.35 136.16 49.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.779 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.673 HD23 HG21 ' A' ' 126' ' ' VAL . 94.8 mt -112.4 144.86 41.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.163 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.8 t -159.83 143.1 14.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.005 0.431 . . . . 0.0 111.81 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.09 126.07 0.13 Allowed Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.911 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 152.06 -140.36 7.7 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.312 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 120' ' ' ALA . 65.6 t0 -173.86 119.14 0.27 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.494 ' HA ' ' C ' ' A' ' 119' ' ' PRO . 3.1 mm? -29.49 126.16 0.26 Allowed Pre-proline 0 N--CA 1.465 0.301 0 O-C-N 123.591 0.557 . . . . 0.0 111.555 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 118' ' ' LEU . 25.5 Cg_exo -63.18 -22.1 4.86 Favored 'Cis proline' 0 C--N 1.351 0.682 0 C-N-CA 124.097 -1.209 . . . . 0.0 112.992 0.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 117' ' ' ASP . . . 69.26 129.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.413 0.625 . . . . 0.0 111.752 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 120' ' ' ALA . 2.2 tm? 175.33 -35.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.236 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -62.14 132.32 52.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.677 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.5 31.72 36.88 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.331 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.581 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -77.19 139.65 39.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.758 0.313 . . . . 0.0 111.193 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' A' ' 125' ' ' ARG . 41.1 ttt85 -103.98 63.25 0.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.126 0.489 . . . . 0.0 109.725 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.673 HG21 HD23 ' A' ' 113' ' ' LEU . 11.0 p -57.96 141.7 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.776 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.411 ' N ' HG22 ' A' ' 126' ' ' VAL . 97.1 mt-10 -123.92 113.3 18.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.863 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.516 ' HE1' HG12 ' A' ' 126' ' ' VAL . 3.8 m-85 -80.06 151.3 29.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.9 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.452 HH11 ' HG3' ' A' ' 129' ' ' ARG . 38.3 ttt85 -161.11 133.12 5.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.785 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 84.1 m -89.25 142.45 27.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.204 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.446 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 60.8 m-20 -56.27 160.81 4.54 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.022 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.516 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 78.2 Cg_exo -41.15 154.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.982 2.455 . . . . 0.0 112.652 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.516 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 8.1 t70 78.89 -33.77 0.16 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.717 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 132' ' ' PRO . 1.7 m-85 -107.6 129.5 54.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.237 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -110.75 134.75 52.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.99 0.424 . . . . 0.0 111.08 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 tt -75.21 132.42 41.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.597 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.7 t -133.39 67.3 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.452 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.25 -126.33 1.07 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.15 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.596 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 42.7 t -70.2 64.46 0.25 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.986 0.422 . . . . 0.0 111.258 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.3 t -64.36 -18.0 64.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.172 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 56.5 mtt85 -140.7 140.86 34.97 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.056 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.514 ' O ' HG13 ' A' ' 126' ' ' VAL . 35.9 m -145.03 136.27 25.02 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 7.2 p -113.32 130.55 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.924 0.393 . . . . 0.0 111.357 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 45.6 t -75.05 139.46 42.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.96 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 m -163.12 134.58 4.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.844 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 67.36 -66.68 0.19 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.462 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.0 37.44 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.526 -0.629 . . . . 0.0 111.526 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -176.32 152.36 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.105 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.411 ' CZ3' HG11 ' A' ' 126' ' ' VAL . 27.9 m95 -84.19 140.93 31.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.741 0.305 . . . . 0.0 110.724 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.6 m -52.3 -59.89 3.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.013 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.2 p -100.91 134.26 20.56 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.05 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.59 -157.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.398 2.066 . . . . 0.0 112.366 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.554 ' HB3' ' NZ ' ' A' ' 153' ' ' LYS . 9.5 mtpm? -92.98 129.93 37.98 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.037 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.596 ' HB3' ' N ' ' A' ' 139' ' ' SER . 66.5 Cg_endo -73.09 -144.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.673 2.249 . . . . 0.0 112.722 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.481 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.7 p-80 -153.67 149.26 27.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.415 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 73.9 m -97.86 129.33 44.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 0.0 111.189 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -111.87 133.24 54.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.682 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -84.79 127.15 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.522 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.912 -179.767 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.894 0.378 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -170.07 -44.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.171 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -60.87 135.3 57.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -65.85 -45.65 81.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.036 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.9 p -172.61 141.25 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.98 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.448 HH11 ' HG3' ' A' ' 97' ' ' ARG . 38.5 ttm-85 -56.4 127.14 29.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.166 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.413 HG22 HD22 ' A' ' 121' ' ' LEU . 31.7 pt -72.88 141.83 15.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.717 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 59.7 m -61.22 143.23 55.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.945 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.4 ' HB3' ' HE1' ' A' ' 149' ' ' TRP . 41.1 t -47.91 130.78 15.27 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.354 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -76.69 -19.93 57.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.429 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.3 p -53.06 -46.63 68.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.787 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.423 ' O ' HG22 ' A' ' 111' ' ' VAL . 3.5 m-85 -61.72 -36.72 81.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.587 0.232 . . . . 0.0 111.204 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.6 mt -54.43 -48.64 71.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.109 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.6 m -92.55 137.85 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.45 HD13 ' HZ3' ' A' ' 153' ' ' LYS . 24.8 tp -145.4 130.77 18.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.037 0.446 . . . . 0.0 111.348 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.468 ' HG2' ' ND2' ' A' ' 108' ' ' ASN . 44.4 tt0 -72.43 137.35 46.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.404 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.468 ' ND2' ' HG2' ' A' ' 107' ' ' GLU . 76.0 m-20 61.06 37.21 18.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.147 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 178.98 -179.33 48.92 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.704 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -142.03 147.12 36.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.79 0.328 . . . . 0.0 110.791 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 112' ' ' PHE . 86.3 t -107.23 141.61 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.969 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.531 ' N ' HG12 ' A' ' 111' ' ' VAL . 2.4 m-85 -105.15 135.32 46.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.802 HD11 HG11 ' A' ' 126' ' ' VAL . 2.0 mm? -102.77 147.07 27.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.237 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.0 m -151.59 129.81 11.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.815 0.341 . . . . 0.0 111.256 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 56.19 43.56 89.0 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.62 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.604 ' HA3' ' HB3' ' A' ' 124' ' ' ALA . . . -179.92 141.15 4.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.653 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -174.86 134.21 0.35 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.76 HD11 ' HA ' ' A' ' 119' ' ' PRO . 37.3 tp -43.82 131.62 4.07 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.939 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.76 ' HA ' HD11 ' A' ' 118' ' ' LEU . 84.6 Cg_endo -90.7 63.02 0.27 Allowed 'Cis proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.585 -1.423 . . . . 0.0 113.143 0.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.478 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -141.83 48.79 1.6 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.816 0.341 . . . . 0.0 111.26 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.513 HD21 HD13 ' A' ' 118' ' ' LEU . 3.1 mm? -62.61 -45.08 94.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.636 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 145' ' ' SER . 64.3 t0 -62.59 138.89 58.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.615 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.93 57.73 5.14 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.375 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.604 ' HB3' ' HA3' ' A' ' 116' ' ' GLY . . . -154.03 141.23 19.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 111.271 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.607 HH21 ' HD2' ' A' ' 141' ' ' ARG . 41.9 ttt85 -108.62 141.66 40.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.504 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.802 HG11 HD11 ' A' ' 113' ' ' LEU . 19.1 m -130.88 140.16 49.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.963 0.411 . . . . 0.0 111.679 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -103.5 125.26 49.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.094 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.471 ' CE1' HG21 ' A' ' 126' ' ' VAL . 9.7 m-85 -92.38 143.04 26.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.084 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 41.3 ttt85 -172.34 124.07 0.49 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.991 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.509 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 56.9 m -89.31 146.03 24.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.883 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.69 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 59.5 m-20 -55.88 167.14 0.89 Allowed Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.37 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.69 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 2.1 Cg_endo -45.01 159.81 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.268 2.645 . . . . 0.0 112.399 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.5 m-20 77.95 -37.67 0.24 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.258 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' A' ' 132' ' ' PRO . 6.6 m-85 -108.52 126.25 52.71 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -117.94 126.28 52.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.243 0.544 . . . . 0.0 111.335 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.5 tt -72.58 130.16 39.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.029 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.6 t -129.06 67.09 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.531 -179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.95 -131.99 1.48 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.496 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.535 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 80.1 p -73.86 64.51 0.98 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.979 0.418 . . . . 0.0 110.272 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.7 t -58.33 -2.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.436 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.607 ' HD2' HH21 ' A' ' 125' ' ' ARG . 53.8 mtm-85 -140.69 137.08 33.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.523 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.46 ' O ' HG22 ' A' ' 126' ' ' VAL . 47.0 m -149.12 133.34 17.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.389 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.408 ' O ' HG11 ' A' ' 143' ' ' VAL . 6.2 p -123.25 126.22 73.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.106 0.479 . . . . 0.0 111.289 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 52.6 t -98.99 140.04 33.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.755 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.441 ' HA ' ' OD1' ' A' ' 122' ' ' ASP . 43.7 t -170.05 38.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.128 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 52.0 tt0 177.68 47.18 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.502 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 54.36 35.27 55.51 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.949 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -177.39 144.86 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.4 ' HE1' ' HB3' ' A' ' 100' ' ' SER . 29.7 m95 -84.22 140.82 31.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.82 0.343 . . . . 0.0 110.689 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.4 t -52.72 -65.87 0.48 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.933 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 81.1 p -98.42 135.68 21.11 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.73 0.3 . . . . 0.0 111.8 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 27.1 Cg_exo -62.1 143.85 95.25 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.758 2.305 . . . . 0.0 111.616 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.45 ' HZ3' HD13 ' A' ' 106' ' ' LEU . 83.3 tttt -47.92 130.71 11.81 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.839 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.535 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.3 Cg_endo -75.84 -148.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.814 2.343 . . . . 0.0 113.206 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.458 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 16.9 p-80 -153.75 130.99 11.17 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.181 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 93.5 m -99.07 135.38 40.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.064 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -103.02 141.51 35.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.224 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 49.3 t -69.52 79.53 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.055 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.472 -179.961 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.546 ' HG3' ' H ' ' A' ' 93' ' ' ALA . 5.1 tp10 . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 110.763 -0.088 . . . . 0.0 110.763 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.546 ' H ' ' HG3' ' A' ' 92' ' ' GLU . . . 58.61 -136.63 0.88 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.623 0.249 . . . . 0.0 111.061 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -148.77 -134.68 0.07 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.336 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -61.29 -48.62 80.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.712 0.291 . . . . 0.0 110.639 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.8 p -179.89 138.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.916 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.442 ' O ' ' HA2' ' A' ' 147' ' ' GLY . 70.0 mtt-85 -56.93 136.99 55.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.534 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.52 ' HB ' ' HG ' ' A' ' 121' ' ' LEU . 29.4 pt -78.51 38.81 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.448 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.49 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 68.0 m 59.21 141.06 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.013 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.6 t -48.03 126.3 10.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.312 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.469 ' O ' HD23 ' A' ' 104' ' ' LEU . 63.9 pttt -80.01 -12.97 59.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.881 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.6 m -57.07 -42.26 80.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.563 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -52.94 -37.6 61.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.234 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.499 HD23 ' H ' ' A' ' 104' ' ' LEU . 2.0 mm? -54.1 -41.59 68.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.336 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.5 m -92.54 136.07 33.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.043 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.841 HD12 ' HE2' ' A' ' 153' ' ' LYS . 15.5 tp -145.39 130.62 18.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.25 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.494 ' N ' HD13 ' A' ' 106' ' ' LEU . 42.6 tt0 -70.66 131.15 43.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.416 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.423 ' ND2' ' HG2' ' A' ' 107' ' ' GLU . 76.5 m-20 54.81 42.42 31.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.993 0.425 . . . . 0.0 110.609 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.08 153.57 14.01 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.588 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -115.29 142.79 46.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.691 0.281 . . . . 0.0 110.758 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.1 t -107.89 131.34 58.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.053 0.454 . . . . 0.0 110.977 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.561 ' O ' HG22 ' A' ' 126' ' ' VAL . 3.0 m-85 -109.82 150.78 27.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.784 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 pp -158.13 149.78 21.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.916 0.388 . . . . 0.0 111.52 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.0 p -151.33 132.26 14.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.72 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 167.68 -129.78 1.97 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.433 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.75 -122.82 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.507 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 118' ' ' LEU . 54.4 t0 -161.68 -127.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.478 0.18 . . . . 0.0 110.64 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.899 HD11 ' HA ' ' A' ' 119' ' ' PRO . 31.9 tp -128.88 130.05 23.46 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.761 0.315 . . . . 0.0 111.172 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.899 ' HA ' HD11 ' A' ' 118' ' ' LEU . 89.7 Cg_endo -91.86 42.47 2.84 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.442 -1.483 . . . . 0.0 112.581 -0.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -80.96 46.96 0.94 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.523 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.715 ' H ' HD21 ' A' ' 121' ' ' LEU . 3.5 mm? -61.89 -38.05 86.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.147 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -61.27 146.03 49.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.1 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.1 -34.54 3.02 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.61 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.08 141.88 38.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.904 0.383 . . . . 0.0 111.649 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.619 ' HD2' HG21 ' A' ' 143' ' ' VAL . 43.9 mmm-85 -104.26 136.96 42.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.087 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 112' ' ' PHE . 15.0 p -123.83 133.14 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.189 0.519 . . . . 0.0 111.986 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -112.81 120.58 41.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.697 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.461 ' HE1' HG11 ' A' ' 126' ' ' VAL . 8.5 m-85 -88.75 149.81 23.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.256 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -164.64 134.81 3.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.051 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 70.5 m -89.23 155.44 19.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.772 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 133' ' ' ASP . 11.5 p-10 -52.69 149.11 11.7 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.987 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -58.14 74.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.08 2.52 . . . . 0.0 112.576 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.1 t70 -177.74 -40.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.736 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.466 ' CE2' ' HB ' ' A' ' 158' ' ' VAL . 1.4 m-85 -107.86 142.65 37.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.829 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -101.24 129.1 47.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 0.0 111.066 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.423 HD23 ' H ' ' A' ' 138' ' ' GLY . 6.9 tt -77.91 130.54 36.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.451 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.5 t -131.87 66.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.415 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.423 ' H ' HD23 ' A' ' 136' ' ' LEU . . . -172.04 -126.61 0.9 Allowed Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.079 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.736 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 34.9 t -72.3 58.52 0.39 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 111.201 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.5 t -56.58 -26.58 55.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.853 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.406 ' HG3' HH11 ' A' ' 141' ' ' ARG . 45.2 ttm-85 -129.84 137.76 50.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 39.4 t -149.25 175.83 11.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.023 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.619 HG21 ' HD2' ' A' ' 125' ' ' ARG . 8.6 p -160.6 137.34 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.08 0.467 . . . . 0.0 112.003 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 37.1 t -78.79 135.07 36.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.886 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.8 t -175.26 133.48 0.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.953 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 56.87 40.94 28.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 97' ' ' ARG . . . 56.15 43.2 88.8 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.522 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -175.13 138.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.69 0.281 . . . . 0.0 110.702 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.49 ' CE2' ' HB3' ' A' ' 99' ' ' CYS . 14.5 m95 -84.2 140.25 31.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.371 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.4 p -52.92 -60.83 2.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.741 0.305 . . . . 0.0 110.865 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 40.3 p -101.23 140.54 21.36 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.127 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 24.4 Cg_exo -63.62 -153.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.628 2.218 . . . . 0.0 112.365 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.841 ' HE2' HD12 ' A' ' 106' ' ' LEU . 83.7 tttt -102.39 127.9 29.47 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.486 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.736 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 60.3 Cg_endo -72.66 -153.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.538 2.159 . . . . 0.0 112.717 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.402 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.7 p-80 -153.67 144.64 22.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.484 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 66.2 m -97.3 134.05 41.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.895 0.379 . . . . 0.0 110.775 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -117.9 138.75 51.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.136 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.466 ' HB ' ' CE2' ' A' ' 134' ' ' PHE . 8.6 p -85.95 129.45 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.436 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.2 p30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.968 -179.7 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.726 0.298 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -174.85 -133.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 60.32 49.73 6.79 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.72 0.295 . . . . 0.0 110.832 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 65.92 136.51 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.035 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 p -167.52 46.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.365 0.603 . . . . 0.0 110.543 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.414 ' O ' HG21 ' A' ' 98' ' ' ILE . 79.2 mtm180 66.51 134.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.4 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.414 HG21 ' O ' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -148.49 134.66 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.411 179.296 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 7.4 p -53.27 139.33 29.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.614 -179.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.4 m -47.91 128.1 12.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.482 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -84.56 3.75 35.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.019 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.4 t -63.29 -39.02 93.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.009 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.404 ' H ' ' HD1' ' A' ' 103' ' ' TYR . 1.5 m-85 -54.94 -38.23 67.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.971 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.43 HD11 ' H ' ' A' ' 104' ' ' LEU . 6.2 mp -54.56 -34.26 61.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.304 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.2 p -92.33 129.45 38.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 111.029 -179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.808 HD12 ' HE2' ' A' ' 153' ' ' LYS . 22.3 tp -145.48 133.8 21.77 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.335 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.427 ' H ' HD13 ' A' ' 106' ' ' LEU . 8.2 pm0 -74.73 132.19 41.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.331 179.124 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 55.89 39.22 30.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.609 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.31 151.2 14.02 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.821 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -112.48 142.1 45.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.351 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 43.0 t -106.98 137.5 37.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.994 0.426 . . . . 0.0 111.287 -179.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.527 ' O ' HG23 ' A' ' 126' ' ' VAL . 3.6 m-85 -104.72 142.09 35.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.293 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.56 ' HB3' HG23 ' A' ' 126' ' ' VAL . 4.1 pp -166.81 150.65 6.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.983 0.42 . . . . 0.0 111.697 -179.53 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.6 m -160.33 135.04 7.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.784 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 132.15 136.26 3.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.73 141.75 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.044 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 32.7 m-20 -130.53 -42.51 1.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.246 0.546 . . . . 0.0 109.64 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.726 ' H ' HD12 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -130.27 123.01 20.36 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.407 179.559 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.7 33.59 2.16 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 123.28 -1.55 . . . . 0.0 112.338 0.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.456 ' H ' ' CA ' ' A' ' 118' ' ' LEU . . . 66.65 146.82 0.04 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.874 0.369 . . . . 0.0 111.245 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.495 ' HB3' ' SG ' ' A' ' 99' ' ' CYS . 6.6 mp 62.43 35.1 15.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.01 -178.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.96 51.02 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.099 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.441 ' HA2' ' C ' ' A' ' 144' ' ' CYS . . . 71.44 42.32 56.41 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.567 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.35 -163.59 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 111.318 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -112.3 146.29 38.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.435 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.56 HG23 ' HB3' ' A' ' 113' ' ' LEU . 8.1 p -141.86 138.56 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.114 0.483 . . . . 0.0 111.4 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -132.59 111.68 11.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.375 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -69.18 153.75 43.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.206 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.1 tpp85 -160.6 129.47 4.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.833 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 55.8 m -89.18 143.83 26.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.735 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 133' ' ' ASP . 61.4 m-20 -53.2 150.85 10.38 Favored Pre-proline 0 N--CA 1.462 0.155 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.123 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.55 77.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.23 2.62 . . . . 0.0 113.105 -179.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 131' ' ' ASP . 39.0 t70 177.73 -38.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.761 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -108.33 142.37 38.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.797 179.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.474 ' CD2' ' HB3' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -100.8 132.71 46.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.126 0.489 . . . . 0.0 111.07 179.91 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 137' ' ' VAL . 4.9 tt -76.93 124.71 28.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.07 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.491 ' N ' HD22 ' A' ' 136' ' ' LEU . 21.2 t -134.78 61.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.598 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -166.11 -133.65 1.55 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 119.869 -1.158 . . . . 0.0 113.148 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.626 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 64.2 m -74.56 55.06 0.63 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.832 0.349 . . . . 0.0 110.991 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.455 ' HB2' HD23 ' A' ' 136' ' ' LEU . 36.6 t -51.39 -43.05 61.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.968 -179.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.429 HH11 ' HG3' ' A' ' 141' ' ' ARG . 40.1 ttt85 -99.47 131.16 45.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.829 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.9 m -150.72 153.49 35.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.965 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.636 HG12 ' HB2' ' A' ' 150' ' ' SER . 15.0 p -138.27 134.24 43.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.172 0.51 . . . . 0.0 112.004 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.441 ' C ' ' HA2' ' A' ' 123' ' ' GLY . 27.5 t -74.14 152.51 39.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.481 179.202 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.9 p -155.9 -135.97 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.016 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -53.51 -38.88 64.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.882 0.373 . . . . 0.0 110.952 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . -174.11 -49.09 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.123 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -85.0 142.22 29.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.744 0.307 . . . . 0.0 110.355 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.403 ' NE1' ' HB2' ' A' ' 99' ' ' CYS . 35.9 m95 -84.11 151.18 25.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.484 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.636 ' HB2' HG12 ' A' ' 143' ' ' VAL . 48.3 t -44.97 -57.15 4.0 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.179 -179.31 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.495 ' HB ' ' HG ' ' A' ' 139' ' ' SER . 72.4 p -121.23 145.13 41.4 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.947 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -57.61 -161.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.616 2.211 . . . . 0.0 112.765 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.808 ' HE2' HD12 ' A' ' 106' ' ' LEU . 83.0 tttt -94.12 126.13 49.93 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.833 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.626 ' HB3' ' N ' ' A' ' 139' ' ' SER . 57.1 Cg_endo -70.77 -155.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.481 2.12 . . . . 0.0 112.384 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.416 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 24.9 p-80 -153.69 142.27 20.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.603 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 75.5 m -98.72 132.67 43.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.912 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.474 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 53.0 tt0 -116.33 141.05 48.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.808 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.03 132.42 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.287 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.7 p30 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.986 -179.422 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.811 0.339 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.44 -50.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.806 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -73.6 140.46 46.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.78 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -161.96 142.28 10.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.178 0.513 . . . . 0.0 111.152 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.405 HG11 ' N ' ' A' ' 97' ' ' ARG . 60.8 t -61.67 138.8 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.214 -179.5 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.405 ' N ' HG11 ' A' ' 96' ' ' VAL . 79.1 mtp180 -77.5 49.78 0.75 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.357 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.437 HG23 ' O ' ' A' ' 119' ' ' PRO . 33.1 pt -54.65 139.32 13.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.995 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.496 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 96.4 m -53.15 135.62 37.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.18 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.433 ' HG ' ' H ' ' A' ' 102' ' ' SER . 42.6 t -47.92 127.96 12.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.457 -179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.814 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -87.25 -6.53 58.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.935 179.666 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.433 ' H ' ' HG ' ' A' ' 100' ' ' SER . 87.1 p -54.09 -34.73 60.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.219 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.586 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.9 m-85 -57.04 -35.55 69.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.56 -179.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.658 HD13 ' N ' ' A' ' 104' ' ' LEU . 4.1 mp -77.8 37.49 0.24 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.107 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.4 p -147.5 63.55 1.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.802 0.334 . . . . 0.0 110.803 179.125 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.785 HD13 ' HE2' ' A' ' 153' ' ' LYS . 29.6 tp -94.12 128.91 40.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.634 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -73.4 137.03 44.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.996 178.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.454 ' HB3' ' OD2' ' A' ' 131' ' ' ASP . 2.9 m120 58.64 42.03 21.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.108 0.48 . . . . 0.0 110.126 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -171.27 164.58 37.57 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.647 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -125.14 141.84 51.86 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.7 t -109.38 137.04 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.885 0.374 . . . . 0.0 111.021 -179.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.451 ' O ' HG21 ' A' ' 126' ' ' VAL . 2.3 m-85 -107.69 141.77 38.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.684 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 114' ' ' THR . 7.1 tt -147.84 138.02 22.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.006 0.432 . . . . 0.0 111.015 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.463 ' N ' HD22 ' A' ' 113' ' ' LEU . 76.2 p -145.07 121.27 10.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.645 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.38 -43.37 0.77 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.163 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -179.7 -138.67 3.41 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.071 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -178.04 -60.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.004 0.43 . . . . 0.0 110.824 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.752 ' N ' HD13 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -149.41 132.83 8.45 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.302 -179.468 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.437 ' O ' HG23 ' A' ' 98' ' ' ILE . 5.9 Cg_exo -78.07 19.72 6.56 Favored 'Cis proline' 0 C--N 1.347 0.464 0 C-N-CA 123.531 -1.446 . . . . 0.0 112.148 -0.018 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.411 ' HB2' ' H ' ' A' ' 121' ' ' LEU . . . 50.73 -138.26 1.05 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.994 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.411 ' H ' ' HB2' ' A' ' 120' ' ' ALA . 28.5 mt 58.72 63.2 1.72 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.831 0.348 . . . . 0.0 111.306 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -164.02 50.92 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.029 0.442 . . . . 0.0 110.702 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.93 41.39 97.4 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.971 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.32 134.3 39.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 111.058 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -112.72 144.61 41.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.629 HG12 ' O ' ' A' ' 142' ' ' SER . 8.5 p -141.39 142.03 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.081 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -133.81 123.0 24.06 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.111 -179.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.586 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 2.8 m-85 -79.99 147.13 31.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.871 179.695 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -141.24 130.99 24.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.515 ' SG ' HD13 ' A' ' 136' ' ' LEU . 76.1 m -93.88 140.81 29.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.181 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.557 ' HB2' ' HD2' ' A' ' 132' ' ' PRO . 1.9 p30 -62.25 161.16 26.61 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.514 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.557 ' HD2' ' HB2' ' A' ' 131' ' ' ASP . 1.5 Cg_endo -43.07 148.07 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.967 2.445 . . . . 0.0 112.067 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 21.8 m-20 78.96 -24.41 0.22 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.798 -179.039 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.531 ' HA ' ' O ' ' A' ' 157' ' ' GLN . 22.2 m-85 -108.61 134.86 50.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.7 0.286 . . . . 0.0 110.619 179.353 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -123.02 133.97 54.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.589 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 154' ' ' PRO . 17.1 tp -75.35 130.14 38.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.722 -179.509 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.85 67.42 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.827 -179.199 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.87 -134.24 1.95 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.05 -1.072 . . . . 0.0 112.975 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.522 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 30.5 p -73.85 59.42 0.68 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.102 0.477 . . . . 0.0 110.712 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.421 ' HA ' HD22 ' A' ' 136' ' ' LEU . 94.2 p -54.97 -50.9 67.8 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.444 -178.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.674 ' HD2' ' O ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -99.38 141.79 31.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.144 0.497 . . . . 0.0 112.006 -179.259 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.629 ' O ' HG12 ' A' ' 126' ' ' VAL . 55.3 p -150.69 146.0 26.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.148 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.453 ' H ' ' HG ' ' A' ' 150' ' ' SER . 10.0 p -126.92 134.76 65.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.053 0.454 . . . . 0.0 111.863 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.71 143.98 51.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.714 179.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.2 m -149.9 -134.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.41 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -52.85 -34.72 55.57 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.929 0.395 . . . . 0.0 110.476 179.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.5 -48.8 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.767 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -80.41 144.12 32.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.676 0.274 . . . . 0.0 110.724 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.609 ' CZ3' HG13 ' A' ' 126' ' ' VAL . 44.0 m95 -84.2 151.07 25.07 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.421 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.626 ' OG ' ' HA ' ' A' ' 142' ' ' SER . 98.5 p -43.34 -42.85 4.75 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.78 0.324 . . . . 0.0 110.703 -179.477 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.8 p -141.39 145.8 39.59 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.469 179.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.8 -156.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.697 2.265 . . . . 0.0 112.769 -179.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.785 ' HE2' HD13 ' A' ' 106' ' ' LEU . 87.3 tttt -101.5 125.39 37.68 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.821 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.522 ' HB3' ' N ' ' A' ' 139' ' ' SER . 60.0 Cg_endo -74.87 -149.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.407 2.071 . . . . 0.0 112.565 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.438 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 17.3 p-80 -153.7 147.75 25.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.251 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 73.0 m -98.54 129.2 45.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.687 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.531 ' O ' ' HA ' ' A' ' 134' ' ' PHE . 84.5 mt-30 -107.59 136.58 47.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.994 0.426 . . . . 0.0 111.764 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.419 ' HB ' ' CE2' ' A' ' 134' ' ' PHE . 11.9 p -83.11 47.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.499 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.954 -179.416 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.658 0.266 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.58 135.29 56.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.834 0.35 . . . . 0.0 111.421 -179.766 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -175.46 133.62 0.3 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.625 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -172.95 142.58 1.1 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.443 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.423 HG21 ' N ' ' A' ' 97' ' ' ARG . 7.3 p -68.82 140.71 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.833 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.423 ' N ' HG21 ' A' ' 96' ' ' VAL . 80.3 ttt180 -57.02 112.13 1.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.908 0.385 . . . . 0.0 110.756 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.564 HD11 ' H ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -65.03 146.47 13.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.359 -179.644 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 35.1 m -52.21 143.23 14.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.464 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.606 ' HB2' ' HE1' ' A' ' 149' ' ' TRP . 53.3 m -47.98 125.7 9.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.998 0.427 . . . . 0.0 111.38 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.414 ' HD3' HD22 ' A' ' 104' ' ' LEU . 16.8 tppt? -82.18 84.82 6.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.081 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.0 t -171.07 -44.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.748 0.309 . . . . 0.0 111.582 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.572 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.5 m-85 -60.71 -42.61 97.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.736 -179.454 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 105' ' ' THR . 0.2 OUTLIER -49.95 -29.52 8.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.622 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.679 ' N ' HD13 ' A' ' 104' ' ' LEU . 74.6 p -98.45 127.4 44.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.713 0.292 . . . . 0.0 110.766 179.345 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.684 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 69.0 tp -145.42 121.55 10.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.013 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 107' ' ' GLU . 0.1 OUTLIER -72.44 136.01 45.9 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.224 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 m120 58.71 39.3 24.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.136 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.75 155.87 23.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.313 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -111.67 140.05 46.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.975 0.417 . . . . 0.0 111.361 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.626 HG12 ' HA ' ' A' ' 104' ' ' LEU . 96.1 t -111.08 128.59 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.648 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.61 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.8 m-85 -112.38 65.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.482 -179.099 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.633 ' HA ' ' HB ' ' A' ' 126' ' ' VAL . 2.2 pt? -75.84 45.06 0.32 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.686 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.8 p -73.89 134.78 43.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.787 0.327 . . . . 0.0 111.414 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 124' ' ' ALA . . . 160.33 -54.92 0.33 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.426 -0.893 . . . . 0.0 113.111 179.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.693 ' HA3' ' HA ' ' A' ' 121' ' ' LEU . . . -82.78 -147.36 6.81 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.333 -179.389 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.8 t0 179.3 67.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.77 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 88.2 mt -33.74 123.69 0.48 Allowed Pre-proline 0 N--CA 1.462 0.154 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.745 -178.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.64 92.61 0.12 OUTLIER 'Cis proline' 0 C--N 1.348 0.525 0 C-N-CA 123.471 -1.47 . . . . 0.0 112.559 -0.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.77 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -177.52 150.15 0.67 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.637 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.693 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 0.4 OUTLIER -170.15 39.18 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.657 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.94 124.52 26.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.745 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 53.45 40.07 61.03 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.595 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.572 ' O ' HG22 ' A' ' 143' ' ' VAL . . . -72.1 124.7 25.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.756 0.312 . . . . 0.0 111.236 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -113.08 144.48 42.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.186 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.633 ' HB ' ' HA ' ' A' ' 113' ' ' LEU . 5.8 p -133.05 130.44 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.365 0.603 . . . . 0.0 112.22 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -98.48 136.12 39.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.29 179.404 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.561 ' HB2' ' HB2' ' A' ' 140' ' ' SER . 20.4 m-85 -112.85 142.73 45.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 0.0 111.569 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.452 ' HA ' HD13 ' A' ' 136' ' ' LEU . 37.3 ptt180 -163.14 126.85 2.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.271 179.067 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 18.1 t -89.19 140.42 29.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.189 -179.369 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.519 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 59.2 m-20 -54.82 161.39 2.31 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.267 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 8.2 Cg_endo -49.54 165.09 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.011 2.474 . . . . 0.0 112.031 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 28.3 m-20 75.43 -17.99 0.48 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.396 -179.233 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.886 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 11.4 m-85 -131.16 131.43 44.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.896 179.383 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.638 ' HE1' ' HA ' ' A' ' 159' ' ' ASN . 5.8 m80 -102.86 124.04 47.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.639 0.256 . . . . 0.0 111.156 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.497 HD21 ' HB3' ' A' ' 140' ' ' SER . 5.1 tt -79.54 118.91 21.83 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.0 t -136.87 76.98 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.548 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.627 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . -171.6 60.1 0.17 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.027 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.464 ' C ' ' H ' ' A' ' 141' ' ' ARG . 37.7 t 53.1 67.23 1.03 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.088 0.471 . . . . 0.0 109.744 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' A' ' 128' ' ' PHE . 84.9 p -71.09 37.7 0.05 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.917 -178.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.464 ' H ' ' C ' ' A' ' 139' ' ' SER . 38.5 ttt85 -140.62 132.6 27.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.314 179.328 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 52.7 m -150.7 147.69 27.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.821 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 124' ' ' ALA . 7.1 p -147.58 132.05 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.897 0.38 . . . . 0.0 111.236 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 55.6 m -64.6 148.48 50.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.147 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 42.8 m -149.54 -30.49 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.761 0.315 . . . . 0.0 111.353 -179.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -170.81 54.1 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.897 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.09 42.7 83.8 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.923 -179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -172.5 136.88 0.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.606 ' HE1' ' HB2' ' A' ' 100' ' ' SER . 36.0 m95 -84.17 144.41 29.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.745 -179.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 61.3 m -50.51 -49.77 54.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.697 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 72.9 p -131.15 136.96 29.63 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.444 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 27.3 Cg_exo -62.61 159.38 37.01 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.089 2.526 . . . . 0.0 112.506 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.684 ' NZ ' HD13 ' A' ' 106' ' ' LEU . 3.9 mmmp? -53.61 134.76 54.46 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.331 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.627 ' HB3' ' HA3' ' A' ' 138' ' ' GLY . 5.7 Cg_exo -78.85 -146.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.328 2.686 . . . . 0.0 112.432 -179.765 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -153.71 149.43 27.49 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.602 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . 0.886 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 74.4 m -95.24 133.88 38.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 110.848 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.701 HE21 HG11 ' A' ' 158' ' ' VAL . 71.0 tp60 -103.09 138.07 40.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.871 -179.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.701 HG11 HE21 ' A' ' 157' ' ' GLN . 9.1 p -60.18 133.15 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.638 ' HA ' ' HE1' ' A' ' 135' ' ' HIS . 26.5 t-20 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.911 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.723 0.297 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.43 130.46 42.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.983 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -66.17 130.14 42.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.438 ' HB2' ' H ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -71.88 -146.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.475 -179.955 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.438 ' H ' ' HB2' ' A' ' 95' ' ' PHE . 7.6 p -175.37 134.7 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.687 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.455 HH11 ' HG3' ' A' ' 97' ' ' ARG . 19.4 mmt85 -67.17 118.97 11.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.068 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.9 pt -84.03 145.15 8.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.148 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.4 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 75.0 m -53.97 140.46 31.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.699 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.9 m -48.02 129.27 14.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.42 -179.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.751 ' HB2' HD11 ' A' ' 104' ' ' LEU . 17.6 ptpt -81.31 11.48 4.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.375 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.8 t -68.51 -39.75 81.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.036 0.446 . . . . 0.0 110.72 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.431 ' OH ' ' HA ' ' A' ' 152' ' ' PRO . 1.3 m-85 -61.73 -33.22 73.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.43 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.751 HD11 ' HB2' ' A' ' 101' ' ' LYS . 80.8 mt -45.63 -45.43 13.9 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.276 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t -92.52 138.53 31.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.501 179.339 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.663 ' HG ' ' HZ3' ' A' ' 153' ' ' LYS . 6.6 tt -145.41 124.39 12.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.507 -179.268 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -61.45 125.67 24.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.677 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 56.55 39.84 29.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.135 0.493 . . . . 0.0 110.09 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.426 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . -161.72 174.94 38.29 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.121 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -142.01 137.55 31.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.792 0.33 . . . . 0.0 110.914 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.0 t -109.73 132.43 57.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.009 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -111.76 133.13 54.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.624 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.524 ' N ' HD13 ' A' ' 113' ' ' LEU . 6.1 mp -108.39 132.6 53.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.151 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.1 t -162.03 129.44 3.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.078 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 157.51 -39.43 0.54 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.373 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.31 -127.86 0.91 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.208 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 64.5 t0 -174.82 133.66 0.35 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.484 HD11 ' C ' ' A' ' 118' ' ' LEU . 4.3 pp -43.27 140.57 2.11 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -87.97 45.19 1.28 Allowed 'Cis proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.578 -1.426 . . . . 0.0 113.54 0.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 117' ' ' ASP . . . -65.21 146.79 54.5 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.789 0.328 . . . . 0.0 110.778 179.544 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -140.35 -52.0 0.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.154 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.98 44.99 0.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.759 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 169.42 61.1 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.134 -1.032 . . . . 0.0 113.022 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.66 125.62 4.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.955 0.407 . . . . 0.0 111.45 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.417 HH11 ' HG3' ' A' ' 125' ' ' ARG . 61.2 mtt85 -133.6 129.79 37.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.753 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.534 HG23 ' CE1' ' A' ' 128' ' ' PHE . 31.0 m -97.72 132.64 42.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 120.946 0.403 . . . . 0.0 111.501 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -98.16 124.98 42.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.764 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.534 ' CE1' HG23 ' A' ' 126' ' ' VAL . 5.2 m-85 -93.18 143.93 25.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.965 0.412 . . . . 0.0 110.986 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -158.96 127.46 5.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.197 179.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 136' ' ' LEU . 49.8 t -89.27 144.93 25.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.263 -179.042 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.78 152.1 7.39 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.937 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.483 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 3.7 Cg_endo -46.66 156.66 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.961 2.441 . . . . 0.0 111.928 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 62.7 t0 78.64 -35.54 0.18 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.584 -179.217 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.684 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 0.6 OUTLIER -108.33 135.5 49.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.058 179.287 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -112.96 134.02 54.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.551 -179.575 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 130' ' ' CYS . 7.4 tt -79.02 132.89 36.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.203 179.508 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.3 t -128.6 77.91 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.584 -179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 173.88 -124.42 1.04 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.838 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.855 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 26.8 t -71.25 60.37 0.29 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.958 0.409 . . . . 0.0 111.263 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 128' ' ' PHE . 35.4 t -58.05 -23.74 55.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -140.64 139.78 34.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.705 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.564 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 63.3 m -144.53 130.3 19.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.9 0.381 . . . . 0.0 111.322 -179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.546 HG13 ' OG ' ' A' ' 145' ' ' SER . 32.1 t -97.6 133.02 41.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.074 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 50.4 t -80.5 50.87 1.36 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.986 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.546 ' OG ' HG13 ' A' ' 143' ' ' VAL . 62.8 m -80.24 134.85 36.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.902 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 37.4 tt0 50.67 46.96 25.14 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.487 179.179 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 51.94 44.51 56.04 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.317 179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -165.48 142.79 5.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.738 0.304 . . . . 0.0 110.282 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 142' ' ' SER . 55.3 m95 -84.2 139.88 32.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.917 0.389 . . . . 0.0 111.046 -179.34 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -56.5 -51.66 67.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.375 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 29.0 p -118.85 134.28 23.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.804 0.335 . . . . 0.0 111.898 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.431 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 39.6 Cg_endo -66.52 145.36 76.34 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.985 2.456 . . . . 0.0 112.461 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.663 ' HZ3' ' HG ' ' A' ' 106' ' ' LEU . 60.8 tttm -46.76 127.35 8.44 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.949 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.855 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 68.4 Cg_endo -89.24 -141.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.096 2.531 . . . . 0.0 113.343 -179.311 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.494 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.2 p-80 -153.71 146.67 24.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.101 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . 0.684 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 22.3 t -97.39 133.07 42.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 111.179 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -103.04 137.03 41.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.948 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 158' ' ' VAL . 9.9 p -88.9 133.12 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.935 -179.837 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.637 0.256 . . . . 0.0 111.455 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.559 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -51.39 140.33 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.379 . . . . 0.0 111.28 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.627 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 87.2 m -55.28 157.79 3.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.061 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.7 p -47.69 128.54 13.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.328 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.577 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 10.1 mtmp? -80.44 -21.51 42.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.206 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.4 p -53.13 -40.97 64.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.573 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.68 ' HA ' ' HE3' ' A' ' 153' ' ' LYS . 2.6 m-85 -52.91 -31.29 39.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.551 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.449 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 96.6 mt -50.66 -42.89 57.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.816 0.341 . . . . 0.0 110.916 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.7 m -95.03 142.22 27.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.054 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.449 HD13 ' HD2' ' A' ' 153' ' ' LYS . 47.3 tp -145.31 127.7 15.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.833 0.349 . . . . 0.0 110.893 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -73.01 144.24 47.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.158 0.504 . . . . 0.0 111.276 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 57.91 32.85 22.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.241 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.426 ' CA ' ' HA ' ' A' ' 130' ' ' CYS . . . -176.98 -166.9 34.67 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.771 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -142.0 145.17 34.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.724 0.297 . . . . 0.0 110.786 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 103' ' ' TYR . 72.7 t -106.29 135.45 44.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.016 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.711 ' O ' HG23 ' A' ' 126' ' ' VAL . 2.7 m-85 -110.24 120.52 42.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.286 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.522 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.9 mm? -103.27 147.11 27.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.489 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.9 m -157.02 132.93 9.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.431 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 64.03 49.89 64.22 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.096 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.624 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . 178.08 136.47 2.53 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.996 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -174.93 124.38 0.26 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.568 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 7.2 tt -51.41 137.48 30.57 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.891 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.53 ' HA ' ' HG ' ' A' ' 118' ' ' LEU . 71.2 Cg_endo -89.19 60.42 0.31 Allowed 'Cis proline' 0 C--N 1.345 0.393 0 C-N-CA 123.558 -1.434 . . . . 0.0 113.02 0.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.568 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -155.61 162.1 40.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.597 0.237 . . . . 0.0 110.822 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.895 HD12 ' N ' ' A' ' 122' ' ' ASP . 1.7 pp -168.35 -34.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.744 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.895 ' N ' HD12 ' A' ' 121' ' ' LEU . 63.2 t0 36.38 51.13 0.82 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.925 0.393 . . . . 0.0 110.959 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.8 47.84 52.88 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.837 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.624 ' HB2' ' HA3' ' A' ' 116' ' ' GLY . . . -54.74 139.19 40.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.989 0.423 . . . . 0.0 111.697 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -107.27 151.51 25.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.379 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 112' ' ' PHE . 5.1 p -143.66 133.46 20.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.407 0.623 . . . . 0.0 112.232 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -105.04 131.58 52.37 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.543 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -102.8 143.52 32.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.004 0.43 . . . . 0.0 111.732 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -162.94 125.15 2.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.383 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.426 ' HA ' ' CA ' ' A' ' 109' ' ' GLY . 63.9 m -89.27 170.11 10.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.207 0.527 . . . . 0.0 112.222 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.7 157.01 2.85 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.636 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.87 69.37 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.025 2.483 . . . . 0.0 112.413 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -173.25 -31.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.861 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.804 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 3.7 m-85 -108.14 132.93 53.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.833 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.461 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 18.9 p-80 -102.13 125.98 48.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.012 0.434 . . . . 0.0 110.726 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.648 HD21 ' HA ' ' A' ' 140' ' ' SER . 20.5 tp -72.65 126.9 31.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.042 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 137' ' ' VAL . 22.0 t -135.39 60.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.584 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -170.59 -131.38 1.33 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 119.801 -1.19 . . . . 0.0 113.419 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.601 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 56.6 p -73.53 55.32 0.49 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 111.431 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.648 ' HA ' HD21 ' A' ' 136' ' ' LEU . 42.3 t -57.88 -42.11 83.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.136 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -99.37 132.24 44.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.068 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.0 p -149.84 145.02 26.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.302 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 124' ' ' ALA . 7.2 p -138.62 134.41 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.998 0.428 . . . . 0.0 111.698 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.652 ' SG ' HD22 ' A' ' 121' ' ' LEU . 37.9 t -67.46 134.87 52.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.023 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.1 m -165.63 130.03 2.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.072 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 50.9 tt0 53.62 45.25 28.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.966 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 56.91 43.51 92.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.603 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -173.12 140.56 0.89 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.352 . . . . 0.0 110.652 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.627 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 28.5 m95 -84.24 140.99 31.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.732 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 67.1 m -52.82 -56.51 15.24 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.015 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.42 ' HB ' ' HB2' ' A' ' 139' ' ' SER . 60.6 p -117.65 133.59 23.28 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.05 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.492 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 43.9 Cg_endo -67.8 -155.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.548 2.166 . . . . 0.0 112.758 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.68 ' HE3' ' HA ' ' A' ' 103' ' ' TYR . 27.8 mmtp -81.05 129.3 67.85 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.288 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.601 ' HB3' ' N ' ' A' ' 139' ' ' SER . 83.0 Cg_endo -81.61 -146.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.837 2.358 . . . . 0.0 112.242 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.442 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 24.3 p-80 -153.66 126.29 8.17 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.93 0.395 . . . . 0.0 111.328 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.804 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 76.2 m -99.13 130.34 45.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.156 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.461 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 4.3 tp-100 -103.92 140.14 38.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.005 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.456 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 9.7 p -75.35 136.09 25.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.388 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.18 -0.914 . . . . 0.0 110.94 -179.548 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.431 ' O ' HG23 ' A' ' 98' ' ' ILE . 39.5 ptt180 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.744 0.307 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.456 ' HB ' HD13 ' A' ' 121' ' ' LEU . 20.9 pt -157.83 43.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.032 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.493 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 90.1 m 62.18 139.18 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.748 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.5 m -47.88 131.51 15.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.399 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -83.75 -28.64 28.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.079 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.2 p -53.18 -35.49 59.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.509 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.848 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.8 m-85 -50.86 -36.39 37.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.41 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.532 HD21 HG23 ' A' ' 114' ' ' THR . 88.4 mt -53.44 -44.45 68.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.955 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.1 m -92.55 133.99 35.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.25 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.2 tp -145.39 132.77 20.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.692 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.31 131.53 50.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.672 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 54.66 44.93 27.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.662 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.03 165.36 34.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.509 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -141.88 151.41 42.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.005 0.431 . . . . 0.0 110.942 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.504 HG11 ' HB ' ' A' ' 126' ' ' VAL . 95.1 t -111.18 141.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.253 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.402 ' CE1' ' HD2' ' A' ' 129' ' ' ARG . 3.7 m-85 -106.57 134.46 49.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.406 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.664 HD23 ' N ' ' A' ' 114' ' ' THR . 6.3 tt 69.79 129.96 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.374 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.664 ' N ' HD23 ' A' ' 113' ' ' LEU . 92.0 m -109.37 -45.99 3.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.929 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.61 ' HA3' ' HA ' ' A' ' 124' ' ' ALA . . . 79.92 53.44 4.24 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.26 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -142.19 150.67 22.29 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.462 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -159.67 65.81 0.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.967 0.413 . . . . 0.0 110.034 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.529 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 90.2 mt -38.39 137.77 0.78 Allowed Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.171 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -89.03 59.9 0.32 Allowed 'Cis proline' 0 CA--C 1.531 0.366 0 C-N-CA 123.762 -1.349 . . . . 0.0 113.265 0.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.529 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -164.13 126.3 2.38 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.927 0.394 . . . . 0.0 111.471 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.778 ' HG ' ' HB2' ' A' ' 124' ' ' ALA . 26.6 tp -78.87 -55.84 4.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.481 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.7 t70 38.37 109.13 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 55.46 54.6 33.42 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.728 -0.669 . . . . 0.0 114.224 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.778 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . . . -73.66 132.5 42.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.948 0.374 . . . . 0.0 110.894 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.548 ' HB2' HD22 ' A' ' 113' ' ' LEU . 62.2 mtt85 -137.97 153.63 49.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.583 HG22 ' CZ3' ' A' ' 149' ' ' TRP . 12.5 m -154.6 131.04 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.946 0.403 . . . . 0.0 111.322 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -107.59 117.78 34.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.32 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.472 ' HB2' ' CA ' ' A' ' 140' ' ' SER . 4.6 m-85 -86.56 141.38 29.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.121 0.486 . . . . 0.0 111.516 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.471 ' HG2' HH11 ' A' ' 129' ' ' ARG . 3.5 ptp85 -161.01 128.95 4.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.761 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 136' ' ' LEU . 20.7 t -89.2 147.41 24.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.744 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.655 ' OD1' ' HD2' ' A' ' 132' ' ' PRO . 36.4 t70 -52.72 145.75 20.56 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.906 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.655 ' HD2' ' OD1' ' A' ' 131' ' ' ASP . 3.2 Cg_exo -40.45 157.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.596 2.864 . . . . 0.0 112.545 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 55.6 m-20 80.93 -40.31 0.15 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.408 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -106.32 128.99 54.41 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.454 ' HE1' ' HA ' ' A' ' 159' ' ' ASN . 16.9 p-80 -102.76 128.32 49.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.973 0.416 . . . . 0.0 110.981 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.787 HD11 ' HG2' ' A' ' 154' ' ' PRO . 20.5 tp -74.55 127.33 32.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.497 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.6 t -131.13 72.2 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.79 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 154' ' ' PRO . . . -167.55 56.72 0.22 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.799 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.673 ' OG ' HG21 ' A' ' 151' ' ' THR . 41.1 t 51.46 65.05 1.61 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.472 ' CA ' ' HB2' ' A' ' 128' ' ' PHE . 96.0 p -70.43 38.81 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.53 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.409 ' H ' ' C ' ' A' ' 139' ' ' SER . 40.1 ttm180 -141.21 133.99 28.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.209 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.512 ' HB2' HG23 ' A' ' 126' ' ' VAL . 64.7 m -146.21 140.33 26.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.941 0.401 . . . . 0.0 111.319 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.513 ' HA ' ' HZ3' ' A' ' 149' ' ' TRP . 7.2 p -144.47 129.48 14.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.873 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 71.9 m -71.49 156.28 39.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.582 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.9 t -158.72 -29.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.471 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -149.29 48.08 0.97 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.719 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.82 35.49 89.72 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.493 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -159.19 146.81 17.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.706 0.288 . . . . 0.0 110.462 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.583 ' CZ3' HG22 ' A' ' 126' ' ' VAL . 68.3 m95 -84.19 142.22 30.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.864 0.364 . . . . 0.0 110.777 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 142' ' ' SER . 46.9 t -47.91 -45.52 30.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.141 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.673 HG21 ' OG ' ' A' ' 139' ' ' SER . 61.6 p -136.61 143.94 45.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.838 0.352 . . . . 0.0 111.797 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.496 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 24.0 Cg_exo -64.01 -159.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.856 2.371 . . . . 0.0 112.818 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.848 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 14.4 mmmm -86.12 127.14 62.94 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.263 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.787 ' HG2' HD11 ' A' ' 136' ' ' LEU . 92.4 Cg_endo -79.89 -149.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.741 2.294 . . . . 0.0 112.637 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.506 ' O ' HD12 ' A' ' 136' ' ' LEU . 17.9 p-80 -153.7 150.04 28.14 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.073 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 77.8 m -97.43 138.1 35.38 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.381 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -108.55 136.05 48.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.554 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.462 ' O ' HG22 ' A' ' 158' ' ' VAL . 11.4 p -82.47 52.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.498 0.666 . . . . 0.0 110.301 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.454 ' HA ' ' HE1' ' A' ' 135' ' ' HIS . 76.1 m-20 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.374 -0.822 . . . . 0.0 111.069 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.962 0.411 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.536 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -60.15 138.36 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.166 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.596 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 75.6 m -60.58 140.99 57.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.677 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.2 m -47.87 128.71 13.7 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.53 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.743 ' HA ' HD13 ' A' ' 104' ' ' LEU . 26.3 ttpp -82.76 11.01 6.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.6 t -68.31 -40.46 81.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.332 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.653 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.3 m-85 -59.59 -40.73 88.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.413 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.743 HD13 ' HA ' ' A' ' 101' ' ' LYS . 6.8 mp -49.28 -43.62 43.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.6 0.238 . . . . 0.0 111.295 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.4 t -92.56 126.06 37.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.861 0.362 . . . . 0.0 110.765 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.716 HD22 ' HZ2' ' A' ' 153' ' ' LYS . 14.0 tp -145.7 133.16 20.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.465 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.42 ' H ' HD12 ' A' ' 106' ' ' LEU . 44.7 tt0 -71.55 134.32 46.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.345 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 57.74 40.7 26.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.632 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -179.56 156.98 19.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.937 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -123.47 141.78 51.65 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.653 HG21 ' O ' ' A' ' 103' ' ' TYR . 90.5 t -109.94 142.36 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.253 0.549 . . . . 0.0 112.003 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.551 ' HB2' ' HG3' ' A' ' 127' ' ' GLU . 4.6 m-85 -103.42 139.87 38.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.738 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.629 ' HA ' HG22 ' A' ' 126' ' ' VAL . 1.5 pt? -139.21 57.69 1.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.029 0.442 . . . . 0.0 111.793 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.9 p -54.48 142.81 26.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.698 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.67 137.95 5.08 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.235 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 178.03 149.58 8.09 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.358 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -151.02 58.1 0.91 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.544 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 2.0 pt? -40.6 136.17 1.48 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.159 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -89.05 61.18 0.27 Allowed 'Cis proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.663 -1.39 . . . . 0.0 113.254 0.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.544 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -165.56 130.81 2.49 Favored 'General case' 0 C--O 1.23 0.064 0 CA-C-O 120.895 0.379 . . . . 0.0 111.335 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.879 HD23 ' H ' ' A' ' 121' ' ' LEU . 1.1 pt? -112.56 48.65 0.98 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.991 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -62.77 133.37 54.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.64 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.86 33.34 82.89 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.489 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 143' ' ' VAL . . . -78.11 135.07 37.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.691 0.281 . . . . 0.0 110.966 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -105.08 136.42 44.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.018 0.437 . . . . 0.0 110.422 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.629 HG22 ' HA ' ' A' ' 113' ' ' LEU . 2.6 t -132.08 137.1 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.957 -178.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.551 ' HG3' ' HB2' ' A' ' 112' ' ' PHE . 9.3 pt-20 -132.66 117.48 17.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.921 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.537 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 2.9 m-85 -77.4 147.53 35.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.211 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -145.8 117.75 8.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.663 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 16.9 t -89.22 147.67 24.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 111.254 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -52.71 152.1 7.26 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.312 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.495 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 1.1 Cg_endo -44.44 158.38 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.366 2.711 . . . . 0.0 112.738 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.495 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 38.5 t70 77.98 -31.89 0.16 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.959 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -108.89 127.18 53.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.679 0.276 . . . . 0.0 110.511 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -104.95 135.36 46.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 110.903 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.778 HD11 ' HG2' ' A' ' 154' ' ' PRO . 25.7 tp -71.58 133.35 45.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.466 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 137' ' ' VAL . 24.6 t -132.69 61.37 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.538 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -168.41 -135.58 1.91 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.914 -1.136 . . . . 0.0 113.091 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.588 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 93.4 p -74.26 61.82 0.9 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.808 0.337 . . . . 0.0 111.039 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 91.3 p -63.14 4.41 0.2 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.413 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.488 ' H ' ' C ' ' A' ' 139' ' ' SER . 16.8 ptm180 -140.53 133.9 29.84 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.955 0.407 . . . . 0.0 110.944 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 54.9 m -150.73 140.76 22.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.868 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 124' ' ' ALA . 14.2 p -126.93 131.86 70.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.996 0.427 . . . . 0.0 111.63 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 52.6 t -80.49 148.29 30.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.271 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 89.2 p -150.67 -137.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.936 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.504 ' H ' ' CD ' ' A' ' 146' ' ' GLN . 14.7 mp0 -55.88 -38.62 70.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.94 0.4 . . . . 0.0 110.55 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 148' ' ' GLN . . . 179.93 145.46 6.44 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.708 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.458 ' HB3' ' O ' ' A' ' 147' ' ' GLY . 12.1 tp-100 69.67 147.74 0.07 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.915 0.388 . . . . 0.0 110.633 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.596 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 26.9 m95 -84.16 147.52 27.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.234 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.6 t -51.85 -55.02 22.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.106 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.559 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 74.8 p -123.39 134.58 25.3 Favored Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.66 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.82 143.19 95.67 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.825 2.35 . . . . 0.0 111.879 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.716 ' HZ2' HD22 ' A' ' 106' ' ' LEU . 21.9 ttmm -42.45 133.33 2.74 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 111.601 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.778 ' HG2' HD11 ' A' ' 136' ' ' LEU . 73.5 Cg_endo -75.26 -143.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.88 2.386 . . . . 0.0 112.678 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.476 ' O ' HD12 ' A' ' 136' ' ' LEU . 5.8 p80 -153.68 154.43 34.11 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.292 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 89.6 m -95.7 140.37 30.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.065 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -132.96 144.41 50.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.262 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.2 p -75.11 133.52 31.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.457 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.9 p30 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.966 -179.617 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.974 0.416 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.789 ' HA ' HD12 ' A' ' 121' ' ' LEU . 38.6 pt -55.49 147.12 4.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 39.4 m -47.28 148.42 1.28 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.027 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.43 ' HB2' ' CD1' ' A' ' 149' ' ' TRP . 54.1 m -47.85 127.17 11.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.057 0.456 . . . . 0.0 111.252 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -85.25 -25.21 27.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.27 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.2 m -53.08 -41.15 64.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.552 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.479 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 1.4 m-85 -56.46 -41.57 76.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.887 0.375 . . . . 0.0 110.713 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.5 mt -59.9 -35.3 74.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.0 p -91.87 77.92 5.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.162 0.506 . . . . 0.0 110.569 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.721 HD22 ' HA3' ' A' ' 109' ' ' GLY . 7.2 tt -93.88 125.47 38.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.577 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.506 ' O ' HD23 ' A' ' 106' ' ' LEU . 24.6 pt-20 -68.1 127.61 33.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 62.94 48.47 3.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 0.0 110.583 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.721 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -158.56 -163.47 12.96 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.62 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.569 ' HB3' ' NZ ' ' A' ' 110' ' ' LYS . 8.2 mtpm? -144.02 -41.6 0.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.57 HG23 ' HA ' ' A' ' 128' ' ' PHE . 13.7 p 52.02 136.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 123.594 0.758 . . . . 0.0 112.581 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -108.11 142.74 37.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.586 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.442 HD12 ' H ' ' A' ' 114' ' ' THR . 24.9 tp -120.31 136.15 54.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.608 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.442 ' H ' HD12 ' A' ' 113' ' ' LEU . 68.5 p -145.0 139.1 27.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.211 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 66.36 44.1 91.25 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.457 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -179.49 130.6 1.53 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.974 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.831 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 54.3 m-20 -160.25 121.35 3.06 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.953 HD12 ' HA ' ' A' ' 119' ' ' PRO . 40.6 tp -38.58 133.51 1.01 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.279 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.953 ' HA ' HD12 ' A' ' 118' ' ' LEU . 77.1 Cg_endo -92.43 44.69 2.24 Favored 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.56 -1.433 . . . . 0.0 113.399 0.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.831 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -81.12 148.26 29.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.803 0.335 . . . . 0.0 111.209 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 98' ' ' ILE . 3.6 tt -162.45 79.27 0.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.309 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -167.07 122.07 1.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.595 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.7 31.16 29.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.718 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.594 ' O ' HG23 ' A' ' 143' ' ' VAL . . . -75.9 127.66 33.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.631 0.253 . . . . 0.0 110.804 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -125.46 143.4 51.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 111.021 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.24 135.7 56.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.133 0.492 . . . . 0.0 111.598 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.43 ' HG3' ' HE ' ' A' ' 141' ' ' ARG . 88.3 tt0 -109.36 88.83 2.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.312 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.57 ' HA ' HG23 ' A' ' 111' ' ' VAL . 67.0 m-85 -55.44 141.64 35.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 111.178 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.467 ' HG2' HH11 ' A' ' 129' ' ' ARG . 13.8 tpp85 -143.4 129.13 19.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.897 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 35.9 t -89.17 153.13 21.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.087 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -52.75 154.09 5.17 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.313 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 8.1 Cg_endo -49.64 155.47 3.71 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.802 2.334 . . . . 0.0 111.356 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 11.4 m-20 79.37 -29.74 0.14 Allowed 'General case' 0 N--CA 1.463 0.221 0 O-C-N 123.377 0.423 . . . . 0.0 110.098 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.775 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 1.6 m-85 -105.7 152.22 23.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.806 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -133.03 131.44 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.991 0.424 . . . . 0.0 111.442 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.505 HD21 ' HA ' ' A' ' 140' ' ' SER . 42.8 tp -69.37 133.81 48.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.428 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.0 t -131.33 70.93 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.905 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.27 -132.54 1.96 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.349 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.748 ' HB3' HG23 ' A' ' 151' ' ' THR . 49.4 m -73.15 58.82 0.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 122.712 0.405 . . . . 0.0 111.177 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.505 ' HA ' HD21 ' A' ' 136' ' ' LEU . 87.6 p -56.91 -28.13 61.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.688 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.435 HH11 ' HG3' ' A' ' 141' ' ' ARG . 20.1 mmt85 -109.95 139.21 45.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.991 0.424 . . . . 0.0 111.914 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.777 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 68.0 m -150.7 142.04 23.33 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.438 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.824 HG12 ' HB2' ' A' ' 150' ' ' SER . 7.7 p -145.49 137.34 20.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 111.648 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.494 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 41.3 m -60.36 159.03 10.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.73 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.8 t -162.8 -29.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.158 0.504 . . . . 0.0 110.67 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -166.68 57.07 0.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.975 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.6 37.84 89.76 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.541 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.423 ' HB3' ' H ' ' A' ' 149' ' ' TRP . 14.5 mm-40 -155.33 -149.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.045 0.45 . . . . 0.0 110.395 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.777 ' HB3' ' HB3' ' A' ' 142' ' ' SER . 86.6 m95 -146.54 155.6 42.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.329 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.824 ' HB2' HG12 ' A' ' 143' ' ' VAL . 47.5 t -41.93 -50.23 4.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.414 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.748 HG23 ' HB3' ' A' ' 139' ' ' SER . 1.5 t -147.44 145.89 23.15 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -47.15 156.99 0.7 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.431 2.754 . . . . 0.0 113.302 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.476 ' HE2' ' HG ' ' A' ' 106' ' ' LEU . 60.1 tttm -56.6 129.04 75.97 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.984 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.721 ' HB3' ' N ' ' A' ' 139' ' ' SER . 74.3 Cg_endo -75.02 -147.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.647 2.231 . . . . 0.0 112.568 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.423 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 23.2 p-80 -153.7 144.91 22.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.346 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.775 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 47.6 t -95.21 132.18 40.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.949 0.404 . . . . 0.0 110.575 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -116.69 138.54 51.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.952 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.32 131.71 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.167 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 25.0 p30 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.958 -179.565 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.578 ' NH1' ' HA3' ' A' ' 147' ' ' GLY . 33.2 ptt85 . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 121.066 0.46 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.5 pt -53.77 154.46 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.345 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.486 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 84.1 m -46.38 141.57 3.48 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.971 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.7 m -47.9 124.76 7.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.822 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -81.88 -13.18 57.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.28 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.2 p -53.12 -38.06 62.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.253 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.916 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 5.4 m-85 -48.48 -31.83 6.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.43 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.6 mt -77.23 39.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.583 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.6 p -147.36 58.58 1.15 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.886 0.374 . . . . 0.0 110.373 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.662 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 35.6 tp -93.83 130.52 39.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.584 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -72.0 137.03 46.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.735 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.8 m120 59.31 40.82 20.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.075 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.24 -166.44 13.14 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.375 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 111' ' ' VAL . 54.5 mtpt -142.14 -41.06 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.441 0.12 . . . . 0.0 111.102 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.598 HG23 ' HA ' ' A' ' 128' ' ' PHE . 9.0 p 51.0 133.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.735 0.814 . . . . 0.0 112.903 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -112.15 -167.05 1.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.448 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.611 HD23 ' N ' ' A' ' 114' ' ' THR . 8.1 tt -173.33 141.48 0.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.285 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.611 ' N ' HD23 ' A' ' 113' ' ' LEU . 89.8 m -154.07 145.97 23.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.159 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.29 43.94 19.02 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.147 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . 174.28 140.57 3.31 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.067 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -166.47 129.83 1.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.739 0.304 . . . . 0.0 110.241 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.568 ' H ' HD12 ' A' ' 118' ' ' LEU . 5.7 mp -52.07 135.2 39.27 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.812 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 59.2 Cg_endo -94.35 63.27 0.36 Allowed 'Cis proline' 0 N--CA 1.46 -0.453 0 C-N-CA 124.098 -1.209 . . . . 0.0 113.059 0.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -149.53 134.03 17.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.882 0.373 . . . . 0.0 111.689 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.476 HD13 ' SG ' ' A' ' 144' ' ' CYS . 88.1 mt -102.35 -45.07 5.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.801 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.428 ' OD1' ' HA2' ' A' ' 116' ' ' GLY . 10.2 p-10 36.4 47.97 0.55 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.512 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.94 45.86 94.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.302 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.436 ' HB2' ' HA3' ' A' ' 116' ' ' GLY . . . -58.25 136.9 57.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.776 0.322 . . . . 0.0 111.112 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.757 ' HD3' ' HD3' ' A' ' 141' ' ' ARG . 38.6 ttm180 -118.43 119.22 33.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 142' ' ' SER . 12.1 p -84.86 148.84 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.045 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -133.7 76.79 1.68 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.233 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.625 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 79.9 m-85 -53.85 151.9 6.05 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.886 0.374 . . . . 0.0 111.058 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -157.11 135.83 11.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.637 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 134' ' ' PHE . 59.6 m -89.23 146.9 24.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.785 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' ASP . 63.4 m-20 -52.69 154.7 4.53 Favored Pre-proline 0 N--CA 1.463 0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.491 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.12 73.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.483 2.789 . . . . 0.0 113.033 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 131' ' ' ASP . 39.0 t70 178.75 -38.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 130' ' ' CYS . 3.2 m-85 -108.14 139.22 43.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.529 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -102.52 132.24 48.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.041 0.448 . . . . 0.0 110.794 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.742 HD22 ' HB2' ' A' ' 140' ' ' SER . 6.0 tt -75.14 128.15 34.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.183 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.584 ' N ' HD23 ' A' ' 136' ' ' LEU . 21.8 t -131.96 65.05 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.488 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.86 -129.49 1.31 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.304 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.818 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.5 t -71.4 57.19 0.25 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.597 0.359 . . . . 0.0 111.874 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.742 ' HB2' HD22 ' A' ' 136' ' ' LEU . 32.6 t -60.9 -16.6 43.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.122 0.487 . . . . 0.0 110.037 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.757 ' HD3' ' HD3' ' A' ' 125' ' ' ARG . 39.1 ttm180 -140.09 140.29 36.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.901 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.656 ' O ' HG12 ' A' ' 126' ' ' VAL . 33.5 m -149.16 122.62 9.09 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.209 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.591 HG12 ' HB3' ' A' ' 150' ' ' SER . 11.8 p -83.78 132.55 31.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 111.749 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.476 ' SG ' HD13 ' A' ' 121' ' ' LEU . 16.3 t -83.97 130.35 34.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.592 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 25.4 t -114.34 -139.48 0.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.543 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -64.96 -40.82 95.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.807 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.578 ' HA3' ' NH1' ' A' ' 97' ' ' ARG . . . -175.88 46.58 0.12 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.169 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -170.07 134.76 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.734 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.521 ' HZ3' ' HB ' ' A' ' 126' ' ' VAL . 32.4 m95 -84.21 141.43 31.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.582 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.591 ' HB3' HG12 ' A' ' 143' ' ' VAL . 79.2 p -52.66 -60.35 3.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.577 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 27.4 p -114.38 134.18 22.33 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 0.0 111.897 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 16.5 Cg_exo -67.37 150.56 80.98 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.104 2.536 . . . . 0.0 112.179 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.916 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 8.7 mtpm? -42.8 132.27 3.02 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.556 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.818 ' HB3' ' H ' ' A' ' 139' ' ' SER . 98.9 Cg_endo -79.43 -140.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.819 2.346 . . . . 0.0 112.998 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.487 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.0 p-80 -153.64 144.44 22.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.43 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 81.9 m -97.89 133.11 42.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.833 0.349 . . . . 0.0 111.068 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -123.62 140.54 52.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.541 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.82 132.37 31.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.488 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.7 p30 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.008 -179.531 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.54 ' O ' HD21 ' A' ' 121' ' ' LEU . 68.1 mtt-85 . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.776 0.322 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.9 pt -54.22 140.79 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.36 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 72.8 m -56.3 127.0 28.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.7 t -48.01 128.36 13.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.37 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.894 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -90.23 25.83 2.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.807 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.0 p -68.82 -41.63 78.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.238 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.734 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 3.9 m-85 -56.95 -31.35 64.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.864 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.704 ' O ' HG22 ' A' ' 105' ' ' THR . 83.4 mt -53.99 146.72 13.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.761 -0.199 . . . . 0.0 111.098 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.704 HG22 ' O ' ' A' ' 104' ' ' LEU . 6.9 t 56.36 138.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.72 0.808 . . . . 0.0 112.367 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.7 tp -145.45 138.96 26.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.971 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.08 44.2 0.56 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.517 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -157.29 -30.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.858 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.661 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . -158.69 -141.36 3.12 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.947 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -139.47 152.26 46.86 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.912 0.386 . . . . 0.0 110.792 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.1 t -109.34 139.47 32.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.208 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.458 ' CE1' ' HD3' ' A' ' 129' ' ' ARG . 2.8 m-85 -108.34 137.56 46.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.05 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 125' ' ' ARG . 0.4 OUTLIER 71.85 133.97 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.697 -179.487 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.64 ' N ' HD13 ' A' ' 113' ' ' LEU . 66.1 p -126.69 -130.59 0.24 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.722 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.511 ' HA3' HD11 ' A' ' 118' ' ' LEU . . . -62.39 133.87 45.13 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.033 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.3 -48.87 75.35 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.835 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 118' ' ' LEU . 37.5 t70 -174.47 61.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.692 ' H ' HD12 ' A' ' 118' ' ' LEU . 7.2 mp -33.2 132.87 0.33 Allowed Pre-proline 0 N--CA 1.462 0.133 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.3 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -85.89 46.11 0.85 Allowed 'Cis proline' 0 C--N 1.346 0.413 0 C-N-CA 123.661 -1.391 . . . . 0.0 113.49 0.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.417 ' H ' ' CA ' ' A' ' 118' ' ' LEU . . . -85.53 127.64 34.5 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.616 0.246 . . . . 0.0 111.185 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.676 HD23 ' H ' ' A' ' 147' ' ' GLY . 5.7 mp -101.89 -42.63 6.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.034 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.33 61.18 0.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.954 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -177.39 -32.89 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.323 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.59 129.29 25.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.915 0.388 . . . . 0.0 111.162 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.731 ' O ' HD12 ' A' ' 113' ' ' LEU . 55.2 ttp85 -135.24 156.11 49.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.745 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.573 HG13 ' CH2' ' A' ' 149' ' ' TRP . 16.1 m -152.25 135.93 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.871 0.367 . . . . 0.0 111.085 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 54.5 mt-10 -121.1 104.26 9.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.132 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.65 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 4.5 m-85 -78.57 143.78 36.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.205 0.526 . . . . 0.0 111.977 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.458 ' HD3' ' CE1' ' A' ' 112' ' ' PHE . 8.0 ptm180 -166.53 124.28 1.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.659 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.661 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 96.3 m -89.22 149.43 23.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.323 0.582 . . . . 0.0 112.453 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.467 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 59.8 m-20 -52.71 159.68 1.67 Allowed Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.939 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 18.2 Cg_endo -59.22 76.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.111 2.54 . . . . 0.0 112.454 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.3 t70 -175.63 -42.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.706 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 5.3 m-85 -108.83 131.86 54.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.416 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.798 ' CE1' ' HB2' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -101.23 121.6 42.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.245 0.545 . . . . 0.0 110.897 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.639 HD22 ' HB3' ' A' ' 140' ' ' SER . 5.5 tt -69.94 125.4 26.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.974 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.501 ' N ' HD23 ' A' ' 136' ' ' LEU . 15.0 t -134.32 63.13 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.578 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -169.98 -135.78 1.97 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.357 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.685 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 63.8 m -75.03 57.18 0.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.914 0.388 . . . . 0.0 111.037 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.639 ' HB3' HD22 ' A' ' 136' ' ' LEU . 99.1 p -51.65 -43.55 62.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.339 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -99.36 138.86 35.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.558 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 44.2 t -150.16 139.7 21.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.863 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.418 ' H ' ' HB3' ' A' ' 150' ' ' SER . 7.0 p -137.56 127.26 36.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.941 0.4 . . . . 0.0 111.222 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.427 ' HB2' ' CD2' ' A' ' 149' ' ' TRP . 45.8 t -87.71 149.31 24.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.591 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 38.4 t -167.13 30.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.207 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 52.8 tt0 175.7 43.32 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.85 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.676 ' H ' HD23 ' A' ' 121' ' ' LEU . . . 77.9 -51.07 3.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.975 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -88.42 149.37 23.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.573 ' CH2' HG13 ' A' ' 126' ' ' VAL . 81.7 m95 -84.15 146.27 27.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.911 0.386 . . . . 0.0 110.946 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 143' ' ' VAL . 48.3 t -45.0 -55.7 5.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.904 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 72.4 p -126.0 133.12 24.62 Favored Pre-proline 0 C--N 1.329 -0.308 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.775 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.438 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 23.7 Cg_exo -63.65 155.66 61.85 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.993 2.462 . . . . 0.0 112.326 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.734 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 55.1 mtpt -49.19 128.18 16.03 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.874 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.685 ' HB3' ' N ' ' A' ' 139' ' ' SER . 58.2 Cg_endo -71.4 -146.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.631 2.221 . . . . 0.0 112.582 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.423 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 22.5 p-80 -153.68 130.51 10.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.894 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.706 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 90.5 m -102.56 136.85 41.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.243 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.798 ' HB2' ' CE1' ' A' ' 135' ' ' HIS . 10.6 mm100 -104.21 147.85 26.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.106 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.3 p -72.73 129.02 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.363 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.101 -179.709 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.995 0.426 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.54 ' O ' HD12 ' A' ' 98' ' ' ILE . 2.4 pp -61.27 145.92 12.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.679 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.576 ' HB2' HD23 ' A' ' 121' ' ' LEU . 43.8 m -56.93 135.61 56.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.05 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.0 t -47.9 126.97 11.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.129 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.497 ' HB2' HD12 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -83.06 16.77 2.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.98 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -68.92 -45.72 70.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.301 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.647 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 10.7 m-85 -58.37 -32.15 68.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.796 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' A' ' 101' ' ' LYS . 86.8 mt -49.77 140.33 11.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.553 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.9 m 67.13 139.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.965 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.618 HD12 ' HD2' ' A' ' 128' ' ' PHE . 7.3 tt -145.07 127.7 16.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.308 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.53 ' O ' HD23 ' A' ' 106' ' ' LEU . 23.5 pt-20 -64.98 128.43 35.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 111.213 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 63.68 40.3 7.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.725 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.416 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -170.83 -163.88 25.61 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.548 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -142.37 141.93 32.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.795 0.331 . . . . 0.0 110.891 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.5 t -110.25 129.84 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.99 0.424 . . . . 0.0 110.969 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.407 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 1.2 m-85 -110.7 152.92 25.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.184 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.477 HD13 ' CG1' ' A' ' 126' ' ' VAL . 47.9 tp -154.48 134.03 12.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.008 0.432 . . . . 0.0 111.706 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.5 p -154.05 132.81 12.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.606 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . 164.38 -44.69 0.31 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.688 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -169.67 -127.84 0.96 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.403 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.463 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 56.4 m-20 -149.17 -138.57 0.09 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.61 0.243 . . . . 0.0 110.609 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.846 HD12 ' HA ' ' A' ' 119' ' ' PRO . 35.0 tp -125.17 127.44 25.02 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.78 0.324 . . . . 0.0 111.099 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.846 ' HA ' HD12 ' A' ' 118' ' ' LEU . 78.2 Cg_endo -90.99 37.98 4.81 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.266 -1.556 . . . . 0.0 112.713 -0.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.463 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -88.15 37.59 0.82 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.852 0.358 . . . . 0.0 111.481 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.576 HD23 ' HB2' ' A' ' 99' ' ' CYS . 28.1 tp -77.67 0.38 23.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.811 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.59 141.81 58.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.18 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.61 -38.27 1.89 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.151 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.408 ' HB2' ' HA3' ' A' ' 115' ' ' GLY . . . -51.04 142.82 11.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 0.0 111.615 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' A' ' 125' ' ' ARG . 20.3 ptt-85 -127.44 134.63 49.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.924 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.503 HG23 ' CE1' ' A' ' 128' ' ' PHE . 29.1 m -97.37 139.45 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.218 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -110.39 128.2 55.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.247 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.618 ' HD2' HD12 ' A' ' 106' ' ' LEU . 6.4 m-85 -99.94 141.85 32.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.43 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -150.99 132.15 14.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.297 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 69.1 m -89.16 154.17 20.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.959 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.548 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 1.1 m-20 -52.62 163.45 0.78 Allowed Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.334 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 55.7 Cg_endo -70.0 50.2 0.85 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.075 2.517 . . . . 0.0 113.212 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -149.49 -43.01 0.14 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.416 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 0.8 OUTLIER -108.92 140.72 42.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.833 179.21 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -100.99 128.57 46.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.984 0.421 . . . . 0.0 110.954 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.687 HD22 ' HB2' ' A' ' 140' ' ' SER . 6.1 tt -68.87 130.12 41.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.625 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.558 ' N ' HD23 ' A' ' 136' ' ' LEU . 24.1 t -135.18 63.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.657 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -166.82 -134.04 1.63 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.205 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.678 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 67.2 m -74.95 53.59 0.61 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.74 0.305 . . . . 0.0 111.159 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.687 ' HB2' HD22 ' A' ' 136' ' ' LEU . 35.0 t -52.06 -43.71 63.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 58.9 mtm-85 -99.41 132.42 44.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.803 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.3 m -145.63 137.6 25.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.762 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.406 HG23 ' HB3' ' A' ' 125' ' ' ARG . 7.3 p -138.08 129.34 37.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.966 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 48.8 t -93.71 134.07 36.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 90.4 p -115.44 -35.12 4.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -144.99 -140.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.093 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.74 41.25 2.33 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.491 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -174.94 136.64 0.4 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.809 0.337 . . . . 0.0 110.922 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -84.19 149.39 26.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.839 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -55.9 -65.27 0.63 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.558 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 42.9 p -106.8 139.07 20.01 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.34 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.434 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 21.9 Cg_exo -65.17 -155.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.706 2.271 . . . . 0.0 112.558 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.647 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 12.9 mmmm -92.67 131.94 32.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.335 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.678 ' HB3' ' N ' ' A' ' 139' ' ' SER . 89.6 Cg_endo -84.55 -155.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.798 2.332 . . . . 0.0 112.786 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -153.7 148.86 26.88 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.764 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 84.0 m -97.41 131.38 44.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.817 0.342 . . . . 0.0 110.865 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -110.36 141.1 43.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.016 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.14 128.47 38.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.425 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.018 -179.714 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.508 ' N ' ' HD2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.724 0.297 . . . . 0.0 111.371 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 30.2 pt -56.4 139.38 15.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.918 0.389 . . . . 0.0 111.13 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 36.8 m -57.22 137.43 55.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.874 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.1 t -47.93 124.31 7.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.039 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.747 ' HB2' HD12 ' A' ' 104' ' ' LEU . 14.4 ptmm? -82.26 21.63 0.9 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.387 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.0 t -68.85 -45.13 71.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.918 0.39 . . . . 0.0 111.057 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.546 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.2 m-85 -60.15 -31.33 69.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.304 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.747 HD12 ' HB2' ' A' ' 101' ' ' LYS . 71.6 mt -52.29 -40.9 62.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.369 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t -92.48 129.1 38.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.917 0.389 . . . . 0.0 110.816 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.779 HD13 ' HE2' ' A' ' 153' ' ' LYS . 20.4 tp -145.39 124.65 12.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.304 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.66 129.97 41.47 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 59.1 37.13 24.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.979 0.419 . . . . 0.0 110.439 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -163.81 147.52 13.1 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.78 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -112.8 139.57 48.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.375 -0.413 . . . . 0.0 110.517 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.7 t -111.21 134.65 52.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.291 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.544 ' O ' HG23 ' A' ' 126' ' ' VAL . 3.1 m-85 -108.59 130.21 55.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.883 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.442 ' N ' HD22 ' A' ' 113' ' ' LEU . 3.6 mm? -104.69 140.96 37.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.664 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.6 t -155.06 138.58 15.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.034 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.92 127.91 0.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.308 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 164.81 -139.68 5.97 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.183 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -177.63 -62.42 0.01 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.224 0.535 . . . . 0.0 111.008 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.863 ' N ' ' HA ' ' A' ' 119' ' ' PRO . 3.4 tm? -74.15 -42.69 5.75 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.918 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.863 ' HA ' ' N ' ' A' ' 118' ' ' LEU . 96.5 Cg_endo -90.11 126.25 6.61 Favored 'Cis proline' 0 N--CA 1.454 -0.799 0 C-N-CA 124.03 -1.238 . . . . 0.0 112.944 0.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.577 ' N ' ' HB3' ' A' ' 118' ' ' LEU . . . -74.41 -23.6 58.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.783 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.431 ' C ' ' H ' ' A' ' 123' ' ' GLY . 88.2 mt 70.24 29.48 3.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.311 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.9 35.87 0.13 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.96 0.41 . . . . 0.0 111.094 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 121' ' ' LEU . . . 140.36 29.29 0.19 Allowed Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.05 146.77 33.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.921 0.391 . . . . 0.0 111.514 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -108.31 138.74 44.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.662 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 112' ' ' PHE . 12.7 p -127.57 136.74 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.115 0.484 . . . . 0.0 112.0 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -105.04 128.08 53.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.076 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.546 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 15.2 m-85 -98.45 139.29 34.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.0 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' A' ' 129' ' ' ARG . 46.7 mtp85 -150.0 129.59 13.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.75 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 40.0 t -89.2 144.87 25.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.29 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.8 154.76 17.03 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.321 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.479 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 6.0 Cg_endo -47.93 159.98 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.077 2.518 . . . . 0.0 112.17 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.51 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 61.5 t0 76.86 -26.96 0.18 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.374 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.763 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 2.7 m-85 -122.04 132.77 54.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.932 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.473 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -109.38 137.98 46.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.09 0.471 . . . . 0.0 112.01 -179.352 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 137' ' ' VAL . 6.4 tt -74.02 128.96 36.9 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.56 ' N ' HD23 ' A' ' 136' ' ' LEU . 42.9 t -128.05 74.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 171.33 -127.6 1.46 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.687 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.827 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.4 t -70.84 61.25 0.25 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.13 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.4 t -58.12 -20.76 42.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.922 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.738 ' HD3' ' H ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -129.31 143.87 51.01 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.801 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.7 m -150.25 144.59 25.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.282 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.7 p -140.31 134.38 35.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.057 0.456 . . . . 0.0 111.594 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 54.0 t -116.63 147.57 41.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.204 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 49.1 m -154.66 41.5 0.47 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 145' ' ' SER . 41.8 tt0 176.17 -57.4 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.897 0.379 . . . . 0.0 111.21 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.06 37.31 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -173.37 137.9 0.68 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -84.23 133.91 34.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.228 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -50.23 -64.03 0.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.934 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 33.4 p -92.55 138.25 24.0 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.2 146.32 63.25 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.784 2.323 . . . . 0.0 111.795 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.779 ' HE2' HD13 ' A' ' 106' ' ' LEU . 83.9 tttt -48.06 129.3 12.18 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.629 0.252 . . . . 0.0 110.796 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.827 ' HB3' ' H ' ' A' ' 139' ' ' SER . 89.8 Cg_endo -81.41 -152.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.647 2.231 . . . . 0.0 113.334 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.69 148.31 26.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.024 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.763 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 13.0 t -98.49 139.2 34.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.056 0.455 . . . . 0.0 111.246 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.473 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 34.3 tp60 -103.05 146.13 28.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.696 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 158' ' ' VAL . 6.5 p -66.71 81.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.348 0.594 . . . . 0.0 111.271 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.51 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 35.7 t30 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.942 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.523 ' HG2' ' HA3' ' A' ' 147' ' ' GLY . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.005 0.431 . . . . 0.0 110.917 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.907 ' H ' HD13 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -96.27 142.78 13.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.364 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 80.8 m -51.79 141.74 16.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.12 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.1 m -47.94 130.71 15.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.393 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -78.72 -6.89 57.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.086 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.9 p -55.88 -42.4 75.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.106 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.641 ' O ' HG21 ' A' ' 111' ' ' VAL . 2.1 m-85 -59.17 -35.4 73.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.437 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.8 mt -54.97 -47.3 74.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.682 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.1 m -92.56 130.81 38.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.839 0.352 . . . . 0.0 111.405 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.715 HD13 ' HE2' ' A' ' 153' ' ' LYS . 28.7 tp -145.44 127.86 15.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.834 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -66.71 130.65 43.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.301 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 57.13 41.16 27.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.026 0.441 . . . . 0.0 110.401 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.28 153.68 22.45 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.596 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -121.25 143.67 49.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.816 0.341 . . . . 0.0 110.76 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 103' ' ' TYR . 61.9 t -110.63 140.23 30.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.221 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -105.86 153.58 21.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.332 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.66 HD23 ' N ' ' A' ' 114' ' ' THR . 6.7 tt -153.33 135.06 14.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.884 0.373 . . . . 0.0 110.521 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.66 ' N ' HD23 ' A' ' 113' ' ' LEU . 89.2 m -156.21 125.64 6.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.784 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.89 -125.67 1.38 Allowed Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.833 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.32 -125.44 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.047 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.732 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 12.2 p-10 -173.36 128.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.726 ' O ' HD12 ' A' ' 118' ' ' LEU . 4.4 pp -38.66 138.04 0.8 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.317 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -85.88 35.64 3.63 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.424 -1.49 . . . . 0.0 113.097 0.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.732 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -90.73 46.42 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.981 0.42 . . . . 0.0 110.623 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.455 ' HG ' ' HB ' ' A' ' 98' ' ' ILE . 3.7 mm? -54.75 -39.94 68.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.342 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.28 139.96 58.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 0.0 111.011 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.43 -36.38 3.65 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.314 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.3 142.09 52.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.95 0.405 . . . . 0.0 111.51 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.581 ' HD3' ' N ' ' A' ' 125' ' ' ARG . 1.0 OUTLIER -108.51 139.87 42.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.23 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 142' ' ' SER . 21.8 m -124.67 142.75 40.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 111.961 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.485 ' OE1' ' HG2' ' A' ' 141' ' ' ARG . 5.2 mm-40 -121.44 119.62 32.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.83 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.547 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 3.1 m-85 -85.1 152.57 23.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.422 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.3 ttt-85 -163.34 125.77 2.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.903 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 100.0 m -89.19 142.18 27.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.375 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -55.34 158.18 5.8 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.573 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.538 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 1.1 Cg_endo -43.14 155.03 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.095 2.53 . . . . 0.0 112.186 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.6 m-20 79.43 -35.81 0.16 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.656 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 157' ' ' GLN . 5.9 m-85 -108.8 129.28 55.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.574 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.522 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -102.87 145.34 29.95 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 111.85 -179.587 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 137' ' ' VAL . 2.4 tm? -75.56 132.88 40.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.969 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.682 ' N ' HD13 ' A' ' 136' ' ' LEU . 7.4 p -135.65 70.38 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.518 ' CA ' ' HB3' ' A' ' 154' ' ' PRO . . . 171.23 -123.6 1.05 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.756 -1.211 . . . . 0.0 113.363 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.877 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 27.5 t -71.68 55.07 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.705 0.288 . . . . 0.0 111.775 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.553 ' HB3' HD12 ' A' ' 136' ' ' LEU . 94.3 p -56.16 -21.93 25.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.436 0.636 . . . . 0.0 109.322 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.485 ' HG2' ' OE1' ' A' ' 127' ' ' GLU . 62.4 mtm-85 -140.59 126.43 19.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.489 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.558 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 47.2 t -142.98 134.48 26.32 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.94 0.4 . . . . 0.0 111.418 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.8 t -98.24 134.18 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.637 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 144' ' ' CYS . 41.9 t -79.17 48.02 0.83 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 111.29 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 83.4 p -65.14 126.96 29.73 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 55.21 -140.0 0.95 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.523 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -106.5 37.47 3.81 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.098 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -155.41 143.87 20.34 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 122.261 0.224 . . . . 0.0 110.513 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.584 ' CE2' ' HB3' ' A' ' 99' ' ' CYS . 45.1 m95 -84.14 137.91 33.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.704 0.288 . . . . 0.0 110.418 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.9 t -57.19 -61.26 2.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.302 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.1 p -94.13 133.87 26.76 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.746 0.307 . . . . 0.0 111.759 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 139' ' ' SER . 36.7 Cg_endo -65.21 140.08 63.21 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.758 2.305 . . . . 0.0 112.152 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.715 ' HE2' HD13 ' A' ' 106' ' ' LEU . 86.9 tttt -42.56 131.62 2.89 Favored Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.526 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.877 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 84.6 Cg_endo -81.58 -158.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.881 2.387 . . . . 0.0 112.872 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.572 ' O ' HG12 ' A' ' 137' ' ' VAL . 12.5 p-80 -153.64 150.64 28.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.642 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 72.3 m -96.18 139.36 32.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.97 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.522 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 17.5 tt0 -130.59 133.68 46.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.711 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.6 124.72 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.959 0.409 . . . . 0.0 110.407 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.999 -179.418 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.522 ' NE ' ' HA ' ' A' ' 97' ' ' ARG . 4.0 mmp_? . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.778 0.323 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.447 ' HB ' HD22 ' A' ' 121' ' ' LEU . 26.2 pt -151.02 46.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 75.6 m 63.01 131.75 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.966 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 87.4 p -47.97 126.42 10.58 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.897 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -78.34 -11.39 59.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.142 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.0 t -54.54 -36.58 64.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.043 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.501 ' CE2' ' HA ' ' A' ' 152' ' ' PRO . 2.0 m-85 -77.35 47.27 0.56 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.487 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.8 mt -133.86 20.13 3.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.942 0.401 . . . . 0.0 110.436 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.459 ' O ' ' HE3' ' A' ' 153' ' ' LYS . 86.0 m -147.43 132.65 18.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.509 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.402 HD22 ' HD2' ' A' ' 128' ' ' PHE . 25.4 tp -145.4 133.76 21.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.967 0.413 . . . . 0.0 111.443 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.664 ' HG2' ' OD1' ' A' ' 108' ' ' ASN . 33.2 tt0 -78.0 141.75 38.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.879 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.664 ' OD1' ' HG2' ' A' ' 107' ' ' GLU . 5.6 m120 63.17 30.15 16.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.81 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 176.12 -160.81 28.93 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.915 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.528 ' HG3' ' HE1' ' A' ' 112' ' ' PHE . 14.9 ptmm? -142.04 153.62 44.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.656 0.265 . . . . 0.0 110.412 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.65 137.92 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.075 0.464 . . . . 0.0 111.763 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.64 ' HB2' ' HG3' ' A' ' 127' ' ' GLU . 6.1 m-85 -107.74 146.15 32.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.308 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.579 HD23 ' H ' ' A' ' 113' ' ' LEU . 1.9 pt? -146.17 139.44 25.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.004 0.43 . . . . 0.0 111.041 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.8 t -168.83 133.98 1.62 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.969 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 140.6 -40.51 1.36 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.35 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 121' ' ' LEU . . . -66.32 150.15 51.74 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.058 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -136.74 56.32 1.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.69 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 1.6 pt? -39.36 127.72 1.36 Allowed Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.345 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 94.2 Cg_endo -84.73 74.09 0.07 OUTLIER 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 123.683 -1.382 . . . . 0.0 113.059 -0.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.69 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -168.69 58.44 0.06 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.837 0.351 . . . . 0.0 111.167 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.575 ' HA ' ' HA2' ' A' ' 116' ' ' GLY . 5.3 mp -74.92 37.98 0.12 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.334 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 120' ' ' ALA . 1.5 m-20 -72.26 132.2 43.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.914 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.5 37.36 94.56 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.926 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.39 137.0 52.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.538 0.208 . . . . 0.0 110.587 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' A' ' 125' ' ' ARG . 49.3 ttp85 -130.52 139.22 50.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.41 . . . . 0.0 111.374 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' A' ' 113' ' ' LEU . 30.7 m -130.11 138.22 54.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.125 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.64 ' HG3' ' HB2' ' A' ' 112' ' ' PHE . 13.9 pt-20 -114.98 124.47 51.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.497 ' HE2' ' HG2' ' A' ' 153' ' ' LYS . 2.0 m-85 -90.36 146.85 23.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.213 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.434 HH11 ' HG3' ' A' ' 129' ' ' ARG . 7.5 ptm180 -168.62 126.95 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.127 0.489 . . . . 0.0 111.12 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.524 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 69.5 m -89.76 157.39 17.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.382 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 133' ' ' ASP . 34.9 m-20 -52.7 149.66 10.83 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.536 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -52.25 81.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.178 2.585 . . . . 0.0 112.789 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 36.5 t70 178.67 -20.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.186 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 31.7 m-85 -129.38 132.93 47.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.723 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -102.81 127.22 50.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.038 0.447 . . . . 0.0 111.078 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.631 HD21 ' HA ' ' A' ' 140' ' ' SER . 16.5 tp -71.92 131.06 42.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.034 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 36.0 t -136.01 66.73 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.739 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.53 -134.73 1.88 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.247 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.753 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 67.9 m -75.03 51.77 0.53 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.795 0.331 . . . . 0.0 111.099 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.631 ' HA ' HD21 ' A' ' 136' ' ' LEU . 46.7 t -51.08 -39.05 55.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.746 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -99.45 133.15 44.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.572 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.4 t -145.33 119.41 9.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 0.0 110.697 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.8 p -108.78 125.34 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.088 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 149' ' ' TRP . 47.4 t -71.9 145.29 48.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.389 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.6 p -161.37 122.85 2.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.953 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 64.3 tt0 57.06 43.05 24.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.188 0.518 . . . . 0.0 109.839 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.55 -49.87 3.71 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.754 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -77.34 137.83 38.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.704 0.287 . . . . 0.0 111.362 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 144' ' ' CYS . 68.2 m95 -84.23 143.89 29.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.513 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 65.3 m -53.91 -61.42 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.745 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 60.5 p -111.98 134.56 21.37 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.677 0.275 . . . . 0.0 111.503 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.501 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 44.4 Cg_endo -68.23 -163.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.382 2.055 . . . . 0.0 112.166 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.596 ' HB3' ' NZ ' ' A' ' 153' ' ' LYS . 9.3 mtpm? -83.35 125.43 74.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.219 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.753 ' HB3' ' H ' ' A' ' 139' ' ' SER . 62.4 Cg_endo -73.73 -144.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.705 2.27 . . . . 0.0 112.376 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.413 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 19.8 p-80 -153.66 139.9 18.51 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.801 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 86.2 m -98.67 133.97 42.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.027 0.442 . . . . 0.0 111.217 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.3 tp-100 -103.07 142.69 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.198 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 82.7 t -53.57 102.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.945 0.402 . . . . 0.0 110.496 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 38.9 t30 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.115 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 . . . . . 0 N--CA 1.465 0.281 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.795 ' HA ' HD11 ' A' ' 121' ' ' LEU . 16.1 pt -65.03 133.42 30.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.749 0.309 . . . . 0.0 110.821 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.738 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 69.7 m -56.29 138.78 50.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.455 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.5 m -47.97 132.0 15.31 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.603 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -89.76 11.41 20.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.13 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.1 t -66.35 -35.78 81.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 110.945 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.568 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 0.9 OUTLIER -55.98 -33.24 64.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.909 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.4 mt -57.03 146.43 27.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.985 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.8 m 65.18 132.4 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.352 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.757 HD13 ' HE2' ' A' ' 153' ' ' LYS . 28.1 tp -145.41 135.41 23.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.124 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 59.7 mp0 -69.85 131.29 44.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.269 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.0 m-20 57.81 39.6 26.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.456 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.556 ' HA2' ' H ' ' A' ' 131' ' ' ASP . . . -174.78 155.41 20.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.7 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -113.12 146.29 39.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.863 0.363 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.0 t -108.17 139.01 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.061 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.534 ' C ' HD12 ' A' ' 113' ' ' LEU . 3.4 m-85 -106.52 140.49 39.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.807 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 112' ' ' PHE . 5.2 mp -133.51 137.32 45.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 110.484 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.1 m -159.98 143.56 14.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.157 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.7 132.24 7.23 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.61 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 52.28 -149.58 9.59 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.83 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.698 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 7.8 t70 178.41 117.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.926 HD12 ' HA ' ' A' ' 119' ' ' PRO . 29.9 tp -40.19 134.3 1.48 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.502 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.926 ' HA ' HD12 ' A' ' 118' ' ' LEU . 66.8 Cg_endo -94.02 44.58 2.52 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.713 -1.37 . . . . 0.0 113.109 0.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.698 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -71.95 -49.73 34.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.139 0.495 . . . . 0.0 110.845 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.795 HD11 ' HA ' ' A' ' 98' ' ' ILE . 65.7 mt 54.76 40.89 32.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.533 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.664 ' OD1' ' HB1' ' A' ' 120' ' ' ALA . 1.2 m-20 -75.89 48.04 0.46 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.033 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.86 39.95 95.28 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.294 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.38 138.26 58.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.772 0.32 . . . . 0.0 110.849 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -107.84 140.92 40.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.735 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 32.8 m -129.06 141.02 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.994 0.426 . . . . 0.0 111.671 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 95.4 mt-10 -113.24 123.79 51.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.629 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.466 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 8.0 m-85 -90.23 52.06 2.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.55 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -61.72 129.17 39.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.783 0.325 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 79.9 m -89.25 142.29 27.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.399 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.556 ' H ' ' HA2' ' A' ' 109' ' ' GLY . 54.9 m-20 -57.75 158.37 12.32 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.306 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 2.2 Cg_endo -44.71 156.04 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.305 2.67 . . . . 0.0 112.382 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 1.7 m-20 73.58 -12.32 0.84 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.422 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.452 ' CE2' HG22 ' A' ' 158' ' ' VAL . 7.5 m-85 -130.64 137.3 49.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.77 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.666 ' ND1' ' HB2' ' A' ' 159' ' ' ASN . 14.1 p-80 -121.1 137.05 54.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.064 0.459 . . . . 0.0 111.608 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.743 HD12 ' HB2' ' A' ' 140' ' ' SER . 2.2 tm? -68.29 130.38 42.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.029 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.697 ' N ' HD13 ' A' ' 136' ' ' LEU . 21.3 t -134.35 62.52 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.524 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.452 ' H ' ' CD1' ' A' ' 136' ' ' LEU . . . -176.01 -133.43 1.77 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.018 -1.087 . . . . 0.0 113.227 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.653 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 66.8 m -74.44 56.31 0.66 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.565 0.346 . . . . 0.0 111.397 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.743 ' HB2' HD12 ' A' ' 136' ' ' LEU . 34.4 t -54.56 -39.57 67.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.106 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -99.36 130.2 45.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.093 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.1 m -147.04 146.77 30.13 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.57 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.36 132.03 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.032 0.444 . . . . 0.0 111.377 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.685 ' SG ' HD22 ' A' ' 121' ' ' LEU . 39.0 t -72.13 132.46 44.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.088 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.9 m -166.41 130.82 2.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.82 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 55.82 44.38 26.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.37 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 57.45 45.28 93.17 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.967 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -177.12 142.01 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.635 0.255 . . . . 0.0 110.643 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.738 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 45.7 m95 -84.15 145.14 28.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.882 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.8 t -51.93 -49.63 62.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.022 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 60.4 p -127.85 140.42 38.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.058 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 35.3 Cg_exo -60.33 -165.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.564 2.176 . . . . 0.0 112.476 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.757 ' HE2' HD13 ' A' ' 106' ' ' LEU . 84.5 tttt -86.56 125.29 67.81 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.653 ' HB3' ' N ' ' A' ' 139' ' ' SER . 73.6 Cg_endo -75.35 -151.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.562 2.175 . . . . 0.0 112.677 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -153.8 146.22 23.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.06 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 75.3 m -97.95 132.4 43.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.598 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -103.05 142.9 33.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.168 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.452 HG22 ' CE2' ' A' ' 134' ' ' PHE . 53.0 t -67.25 80.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.868 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.666 ' HB2' ' ND1' ' A' ' 135' ' ' HIS . 34.1 t30 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.048 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.49 ' NH1' ' HB2' ' A' ' 97' ' ' ARG . 23.4 mtm105 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.795 0.331 . . . . 0.0 111.571 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.537 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -53.16 145.84 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.7 m -53.36 135.43 39.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.241 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.8 t -47.93 123.33 6.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.521 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -81.24 113.1 19.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.606 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.0 m -171.15 -41.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.171 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.873 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 1.6 m-85 -62.51 -28.7 70.02 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.074 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.428 HD21 ' HH2' ' A' ' 149' ' ' TRP . 61.4 mt -72.14 28.21 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.332 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.444 ' O ' ' HE3' ' A' ' 153' ' ' LYS . 64.5 p -147.48 127.61 13.76 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.914 0.388 . . . . 0.0 111.666 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.416 HD13 ' HZ1' ' A' ' 153' ' ' LYS . 27.9 tp -145.44 121.98 11.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.297 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -92.28 40.22 1.04 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -163.65 36.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.719 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.34 -146.45 11.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.837 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -141.56 139.37 33.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.528 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.6 t -105.97 136.6 39.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.981 0.419 . . . . 0.0 111.007 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 1.6 m-85 -107.83 145.78 33.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.408 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.715 HD23 ' N ' ' A' ' 114' ' ' THR . 6.7 tt -152.55 138.97 18.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.928 0.394 . . . . 0.0 110.846 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.715 ' N ' HD23 ' A' ' 113' ' ' LEU . 84.9 m -153.53 123.16 6.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.683 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.27 -38.51 0.28 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.104 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -168.2 -130.08 1.14 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.138 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.694 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 8.2 t70 -172.3 125.47 0.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.643 ' H ' HD12 ' A' ' 118' ' ' LEU . 6.8 mp -41.84 138.48 1.78 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.208 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -86.73 41.37 1.88 Allowed 'Cis proline' 0 C--N 1.347 0.465 0 C-N-CA 123.574 -1.428 . . . . 0.0 113.478 0.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.728 ' C ' HD22 ' A' ' 121' ' ' LEU . . . -92.49 129.87 38.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.831 0.348 . . . . 0.0 111.065 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.728 HD22 ' C ' ' A' ' 120' ' ' ALA . 3.8 mm? -131.47 51.13 2.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.585 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.88 59.66 1.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.931 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.91 42.27 99.61 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.578 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.52 141.22 57.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.724 0.297 . . . . 0.0 111.18 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -106.95 130.43 54.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.194 0.521 . . . . 0.0 110.733 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.44 134.3 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.59 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -118.31 123.89 46.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.306 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.547 ' CE2' ' HG2' ' A' ' 153' ' ' LYS . 19.0 m-85 -82.78 151.08 26.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.2 0.524 . . . . 0.0 111.942 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.413 ' HG2' HH11 ' A' ' 129' ' ' ARG . 15.4 tpp85 -153.46 121.97 6.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.644 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 9.2 t -102.38 144.63 30.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.035 0.445 . . . . 0.0 111.748 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -56.28 157.76 8.64 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.338 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.493 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 71.4 Cg_exo -48.82 163.14 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.765 2.31 . . . . 0.0 112.275 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.523 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 55.7 m-20 76.56 -32.53 0.2 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.847 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.869 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 1.4 m-85 -108.5 133.78 52.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.391 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.462 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 20.4 p-80 -112.95 137.34 51.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.972 0.415 . . . . 0.0 111.284 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.671 HD21 ' HA ' ' A' ' 140' ' ' SER . 18.7 tp -68.35 135.91 52.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.308 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 155' ' ' HIS . 14.8 p -136.74 60.01 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.822 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . 171.97 -123.42 1.02 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 119.172 -1.489 . . . . 0.0 113.692 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.811 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 39.9 t -65.11 66.06 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.866 0.365 . . . . 0.0 111.553 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.671 ' HA ' HD21 ' A' ' 136' ' ' LEU . 98.9 p -66.39 -14.81 62.68 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.266 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.616 ' HD3' ' H ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -140.62 138.16 34.18 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.973 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.475 ' HA ' ' HB3' ' A' ' 150' ' ' SER . 86.1 p -141.62 140.51 33.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.771 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.776 HG12 ' HB2' ' A' ' 150' ' ' SER . 7.3 p -134.75 132.84 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.063 0.459 . . . . 0.0 111.981 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 121' ' ' LEU . 41.5 t -79.34 149.98 31.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.828 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.1 t -147.79 -130.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.715 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -58.44 -42.72 87.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.643 0.259 . . . . 0.0 111.202 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 176.15 47.5 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.657 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -173.71 142.24 0.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.735 0.302 . . . . 0.0 110.696 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.428 ' HH2' HD21 ' A' ' 104' ' ' LEU . 59.0 m95 -84.2 153.36 23.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.074 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.776 ' HB2' HG12 ' A' ' 143' ' ' VAL . 43.2 t -48.08 -57.65 5.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.87 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.669 HG23 ' OG ' ' A' ' 139' ' ' SER . 0.5 OUTLIER -147.42 143.73 18.46 Favored Pre-proline 0 C--N 1.332 -0.163 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.543 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.52 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 31.4 Cg_exo -57.82 140.81 94.97 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.483 2.789 . . . . 0.0 112.716 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.873 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 9.0 mtpm? -49.81 137.35 18.87 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.024 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.822 ' HB3' ' HA3' ' A' ' 138' ' ' GLY . 85.2 Cg_endo -83.05 -140.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.989 2.459 . . . . 0.0 112.142 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.598 ' O ' HG12 ' A' ' 137' ' ' VAL . 18.9 p-80 -153.72 152.16 30.46 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.763 0.316 . . . . 0.0 110.999 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.869 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 71.1 m -94.95 127.37 40.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.555 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.462 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 69.8 tp60 -105.56 136.76 44.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.818 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.4 t -76.3 122.95 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.164 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 133' ' ' ASP . 24.4 p30 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.953 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.731 0.3 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.9 pt -137.43 145.71 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.923 0.392 . . . . 0.0 111.473 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 38.7 m -51.49 140.17 18.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.058 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.4 t -47.91 130.26 14.95 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.308 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.586 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -83.14 -28.44 29.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.235 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.1 m -68.89 38.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.779 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 6.8 m-85 -127.28 -46.92 1.47 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.573 0.225 . . . . 0.0 111.305 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.784 HD12 ' H ' ' A' ' 105' ' ' THR . 0.4 OUTLIER -52.92 -32.08 43.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.462 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.784 ' H ' HD12 ' A' ' 104' ' ' LEU . 41.9 p -96.29 135.37 38.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.663 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 34.5 tp -145.43 131.19 19.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 111.135 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.01 131.73 45.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.66 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 54.1 41.8 31.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.401 . . . . 0.0 110.6 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.53 148.56 9.51 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.522 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -104.09 151.75 22.9 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.953 0.406 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 104' ' ' LEU . 96.4 t -128.2 141.39 46.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.987 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.8 m-85 -105.83 134.3 49.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.84 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.656 HD13 ' N ' ' A' ' 114' ' ' THR . 2.7 tm? -109.18 131.76 54.76 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.656 ' N ' HD13 ' A' ' 113' ' ' LEU . 72.3 m -157.51 125.09 5.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.91 0.386 . . . . 0.0 111.107 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 157.93 -133.52 3.53 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.293 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.85 -135.24 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.394 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -160.17 123.4 3.49 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.585 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -53.27 136.41 50.18 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.003 -179.293 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 65.1 Cg_endo -90.21 63.16 0.26 Allowed 'Cis proline' 0 C--N 1.346 0.445 0 C-N-CA 123.834 -1.319 . . . . 0.0 113.032 0.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.531 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -155.43 57.21 0.63 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.779 0.323 . . . . 0.0 111.549 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 121' ' ' LEU . 5.2 mp -77.28 45.87 0.48 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.855 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.65 131.27 49.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 111.215 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.83 35.52 39.53 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.749 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.57 136.94 32.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.673 0.273 . . . . 0.0 111.35 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.454 ' NH2' HH21 ' A' ' 141' ' ' ARG . 15.9 ptm180 -130.55 130.29 43.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 110.789 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.48 HG23 ' HE1' ' A' ' 128' ' ' PHE . 23.2 m -100.27 139.81 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.027 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 46.6 mp0 -102.93 123.88 47.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.245 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.48 ' HE1' HG23 ' A' ' 126' ' ' VAL . 7.0 m-85 -91.31 143.04 27.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.144 0.497 . . . . 0.0 112.036 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.453 ' HD3' ' CE1' ' A' ' 112' ' ' PHE . 47.9 mtp85 -152.59 125.1 8.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.723 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 26.2 t -89.29 163.8 15.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.943 0.402 . . . . 0.0 111.462 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -52.79 156.71 3.13 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.306 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.08 52.44 1.84 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.286 2.658 . . . . 0.0 112.868 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -155.88 -37.72 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.121 0.486 . . . . 0.0 109.989 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.452 ' CE2' ' HB ' ' A' ' 158' ' ' VAL . 0.9 OUTLIER -108.32 146.53 32.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.724 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -100.08 132.99 45.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.137 0.494 . . . . 0.0 111.152 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.786 HD21 ' HA ' ' A' ' 140' ' ' SER . 27.9 tp -73.46 128.47 35.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.279 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.6 t -134.98 64.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.225 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.53 -123.52 0.72 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.005 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.931 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.4 t -71.17 52.28 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.678 0.391 . . . . 0.0 111.686 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.786 ' HA ' HD21 ' A' ' 136' ' ' LEU . 44.9 t -56.02 -26.35 48.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.066 0.46 . . . . 0.0 110.15 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.454 HH21 ' NH2' ' A' ' 125' ' ' ARG . 24.0 mmm180 -132.87 129.14 38.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.853 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.465 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 47.1 t -141.77 148.56 39.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.237 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 125' ' ' ARG . 7.3 p -144.04 131.35 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.818 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 45.4 t -68.47 144.11 54.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.595 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.6 t -172.72 129.51 0.52 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.546 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 56.6 43.93 24.79 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.05 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 57.31 42.75 93.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.315 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -174.33 140.18 0.64 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 0.0 110.498 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.444 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 56.0 m95 -84.24 140.81 31.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.937 0.399 . . . . 0.0 110.965 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.8 m -54.2 -60.64 3.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.478 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -94.32 129.08 38.13 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.739 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 139' ' ' SER . 73.7 Cg_endo -75.91 148.86 32.39 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.848 2.366 . . . . 0.0 112.273 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.779 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 14.1 mmmm -40.86 127.27 1.96 Allowed Pre-proline 0 N--CA 1.464 0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 111.267 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.931 ' HB3' ' H ' ' A' ' 139' ' ' SER . 91.5 Cg_endo -83.77 -149.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.972 2.448 . . . . 0.0 113.571 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.405 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 17.8 p-80 -153.75 150.09 28.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.337 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 82.7 m -94.95 127.63 41.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.799 0.333 . . . . 0.0 110.933 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -103.48 137.09 42.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.52 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 134' ' ' PHE . 11.7 p -86.62 131.29 35.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.432 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.829 -179.598 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 97' ' ' ARG . 29.4 tpt180 . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.925 0.393 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.663 ' HB ' ' HG ' ' A' ' 121' ' ' LEU . 35.7 pt -55.56 142.48 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.088 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.488 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 95.1 m -51.09 135.77 24.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.362 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.8 t -47.97 127.48 12.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.301 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.772 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -81.07 12.61 3.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 179.727 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.1 t -68.82 -41.55 78.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.793 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.634 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.9 m-85 -56.09 -34.94 66.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.21 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.601 HD12 ' HB2' ' A' ' 101' ' ' LYS . 87.1 mt -47.77 -46.02 29.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.961 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 60.1 p -92.61 137.95 31.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.516 HD13 ' HE2' ' A' ' 153' ' ' LYS . 30.4 tp -145.41 133.4 21.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 110.972 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.97 132.23 46.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.772 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 58.65 33.03 22.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.152 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.519 ' CA ' ' HA ' ' A' ' 130' ' ' CYS . . . -175.51 153.14 14.44 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.423 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -109.27 144.5 37.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.513 -0.344 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.634 HG21 ' O ' ' A' ' 103' ' ' TYR . 93.1 t -109.66 136.94 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.95 0.405 . . . . 0.0 111.058 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.448 ' CE1' ' HD3' ' A' ' 129' ' ' ARG . 2.8 m-85 -108.57 146.51 33.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.755 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.644 HD23 ' N ' ' A' ' 114' ' ' THR . 6.3 tt -144.26 131.45 20.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.546 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.644 ' N ' HD23 ' A' ' 113' ' ' LEU . 68.7 p -150.08 123.36 8.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.567 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.02 -36.01 0.27 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.242 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.4 -135.12 1.8 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.419 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.598 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 12.2 p-10 -175.67 129.5 0.25 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.722 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -41.28 138.82 1.44 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.279 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -86.69 40.32 2.2 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.503 -1.457 . . . . 0.0 113.117 0.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.598 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -96.62 47.11 1.06 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.783 0.325 . . . . 0.0 111.242 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.663 ' HG ' ' HB ' ' A' ' 98' ' ' ILE . 3.9 mm? -54.42 -40.59 68.44 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.789 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -61.21 136.93 58.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.505 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.87 54.4 7.24 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.458 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.485 ' O ' HG23 ' A' ' 143' ' ' VAL . . . -143.62 136.12 27.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.0 111.189 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 125' ' ' ARG . 48.6 mmt-85 -105.66 143.56 33.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.733 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 142' ' ' SER . 32.7 m -133.74 135.53 55.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.088 0.47 . . . . 0.0 111.489 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -112.9 118.34 34.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.514 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.468 ' HE1' ' HB3' ' A' ' 142' ' ' SER . 5.4 m-85 -82.42 140.53 33.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.024 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.448 ' HD3' ' CE1' ' A' ' 112' ' ' PHE . 16.6 ptm180 -166.66 127.46 1.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.77 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.519 ' HA ' ' CA ' ' A' ' 109' ' ' GLY . 61.5 m -92.89 160.6 14.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.149 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.435 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 31.9 m-20 -52.68 157.58 2.55 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.556 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 17.9 Cg_endo -58.78 76.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.142 2.561 . . . . 0.0 112.64 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.3 t70 -177.07 -38.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.675 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.77 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 2.9 m-85 -108.91 132.58 53.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.872 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.467 ' CE1' ' HB2' ' A' ' 157' ' ' GLN . 17.6 p-80 -102.8 127.79 49.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.993 0.425 . . . . 0.0 111.145 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' A' ' 154' ' ' PRO . 26.7 tp -72.11 129.51 38.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.648 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.1 t -135.33 67.89 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.749 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.12 -136.09 2.28 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.623 -1.275 . . . . 0.0 113.398 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.483 ' HB2' ' CB ' ' A' ' 151' ' ' THR . 71.1 p -74.82 58.26 0.82 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.022 0.439 . . . . 0.0 110.854 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.693 ' HA ' HD21 ' A' ' 136' ' ' LEU . 36.5 t -52.16 -31.39 31.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.743 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -99.44 136.26 39.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.779 0.323 . . . . 0.0 111.237 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.468 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 42.8 t -150.05 149.56 30.49 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.34 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 124' ' ' ALA . 7.3 p -144.36 135.69 21.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.993 0.425 . . . . 0.0 111.75 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 121' ' ' LEU . 43.1 t -66.72 151.2 47.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.005 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.1 t -151.54 -136.91 0.07 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.054 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -74.63 66.56 1.45 Allowed 'General case' 0 C--O 1.232 0.153 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.36 43.45 92.67 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.649 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -176.41 139.9 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.757 0.313 . . . . 0.0 110.505 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.488 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 33.8 m95 -84.26 141.65 30.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.653 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.5 t -49.54 -52.72 27.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.645 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.483 ' CB ' ' HB2' ' A' ' 139' ' ' SER . 48.8 p -124.95 133.88 25.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 0.0 111.803 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.87 147.5 85.21 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.773 2.316 . . . . 0.0 111.841 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.516 ' HE2' HD13 ' A' ' 106' ' ' LEU . 50.2 mtpt -46.66 131.37 8.33 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.325 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.698 ' HG2' HD11 ' A' ' 136' ' ' LEU . 3.9 Cg_exo -78.93 -141.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.073 2.515 . . . . 0.0 112.086 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.422 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.1 p-80 -153.75 134.75 13.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.772 0.32 . . . . 0.0 110.948 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.77 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 77.5 m -98.73 132.41 44.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.487 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.467 ' HB2' ' CE1' ' A' ' 135' ' ' HIS . 78.3 mt-30 -103.4 142.46 34.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.821 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -76.21 135.99 25.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.21 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.917 -179.523 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.436 ' HG2' HH11 ' A' ' 97' ' ' ARG . 22.4 ptt-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.749 0.309 . . . . 0.0 110.706 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.4 pt -142.31 144.79 24.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.315 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.571 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 73.7 m -51.51 139.46 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.54 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.3 t -47.99 127.52 12.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.021 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.547 ' NZ ' ' HB3' ' A' ' 101' ' ' LYS . 8.4 mtpm? -74.16 14.36 0.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.343 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.1 m -68.87 -46.19 69.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.936 0.398 . . . . 0.0 110.895 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -61.7 -41.12 97.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.116 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.9 mt -54.94 -41.79 71.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.501 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.6 p -92.54 136.89 32.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.865 0.364 . . . . 0.0 111.564 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.44 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 40.4 tp -145.44 130.81 18.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.572 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 10.3 pm0 -90.48 38.94 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.335 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.412 ' OD1' ' HG2' ' A' ' 107' ' ' GLU . 8.2 m120 -155.85 25.44 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 154.57 -144.36 11.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.88 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.413 ' HE2' ' CZ ' ' A' ' 112' ' ' PHE . 25.0 pttm -141.97 140.19 32.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.251 -0.474 . . . . 0.0 110.302 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.33 143.91 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.013 0.435 . . . . 0.0 111.354 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.413 ' CZ ' ' HE2' ' A' ' 110' ' ' LYS . 1.4 m-85 -105.36 151.76 23.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.146 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.573 HD21 HD22 ' A' ' 121' ' ' LEU . 56.5 tp -145.29 132.97 20.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.605 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.2 p -150.95 147.32 27.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.429 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.2 39.7 26.31 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.918 -0.583 . . . . 0.0 113.017 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.596 ' HA2' ' HB2' ' A' ' 124' ' ' ALA . . . -79.61 -140.88 2.24 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.158 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -176.1 49.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 118' ' ' LEU . 1.7 pt? -42.47 135.07 2.62 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.986 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -87.71 63.04 0.19 OUTLIER 'Cis proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.638 -1.401 . . . . 0.0 113.345 0.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.579 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -166.32 132.56 2.47 Favored 'General case' 0 C--O 1.228 -0.074 0 CA-C-O 120.929 0.395 . . . . 0.0 111.486 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.573 HD22 HD21 ' A' ' 113' ' ' LEU . 83.3 mt -80.9 43.09 0.67 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.84 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -65.01 126.24 27.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.236 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 50.12 31.42 18.76 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.007 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.596 ' HB2' ' HA2' ' A' ' 116' ' ' GLY . . . -84.25 140.25 31.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.579 0.228 . . . . 0.0 110.959 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -108.54 124.23 50.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.785 0.326 . . . . 0.0 110.438 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 142' ' ' SER . 7.5 p -103.59 140.26 22.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.537 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -125.25 111.97 15.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.166 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -75.23 146.59 41.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.57 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.402 ' NH1' ' O ' ' A' ' 130' ' ' CYS . 26.7 tpt85 -156.27 117.06 3.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.097 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.514 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 98.6 m -96.41 165.25 12.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.691 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.544 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 56.2 m-20 -52.66 162.32 0.97 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.017 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 56.7 Cg_endo -70.92 51.76 1.29 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.851 2.368 . . . . 0.0 112.727 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -146.53 -35.85 0.26 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.773 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.634 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 0.7 OUTLIER -108.82 135.93 49.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.034 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 157' ' ' GLN . 17.0 p-80 -102.74 129.86 49.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.948 0.404 . . . . 0.0 110.826 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.732 HD21 ' HA ' ' A' ' 140' ' ' SER . 50.7 tp -72.72 128.18 34.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.019 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.6 t -135.99 68.69 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.665 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.18 -131.36 1.74 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.442 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.764 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.2 t -69.84 63.8 0.2 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.958 0.408 . . . . 0.0 111.364 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.732 ' HA ' HD21 ' A' ' 136' ' ' LEU . 95.5 p -61.22 -15.12 31.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.729 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -139.04 137.96 36.74 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.721 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.7 ' O ' HG12 ' A' ' 126' ' ' VAL . 36.4 t -150.69 124.17 9.01 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.735 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.2 p -88.01 130.51 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.978 0.418 . . . . 0.0 111.084 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 26.4 t -75.84 78.13 2.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.56 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 51.5 m -65.59 -124.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.412 ' C ' ' H ' ' A' ' 148' ' ' GLN . 85.9 mt-30 -67.27 -140.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -77.29 29.32 1.67 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.445 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.412 ' H ' ' C ' ' A' ' 146' ' ' GLN . 87.9 mt-30 -157.76 150.24 22.63 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.725 0.297 . . . . 0.0 110.652 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.571 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 33.1 m95 -84.22 139.21 32.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.222 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 80.7 p -53.91 -63.07 1.27 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.517 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 40.2 p -92.6 132.31 31.9 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.706 0.288 . . . . 0.0 111.533 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.34 142.5 85.95 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.826 2.35 . . . . 0.0 112.356 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.44 ' NZ ' HD13 ' A' ' 106' ' ' LEU . 63.2 tttm -51.81 127.93 35.43 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.128 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.764 ' HB3' ' H ' ' A' ' 139' ' ' SER . 81.9 Cg_endo -78.15 -152.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.765 2.31 . . . . 0.0 112.805 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -153.83 138.96 17.39 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.073 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 99.7 m -98.72 131.55 44.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.891 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.42 ' HB2' ' CE1' ' A' ' 135' ' ' HIS . 85.2 mt-30 -103.0 140.16 37.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.793 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.505 ' O ' HG22 ' A' ' 158' ' ' VAL . 14.7 p -79.9 44.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.39 0.614 . . . . 0.0 110.583 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.174 179.989 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.872 0.368 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.619 ' O ' HD12 ' A' ' 98' ' ' ILE . 2.5 pp -83.66 159.21 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.543 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.6 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 51.5 m -55.01 137.26 46.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.38 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.592 ' HB2' ' HE1' ' A' ' 149' ' ' TRP . 56.4 m -47.95 123.8 6.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.844 0.354 . . . . 0.0 111.226 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.737 ' HA ' HD13 ' A' ' 104' ' ' LEU . 58.9 tptt -75.47 -26.67 58.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.328 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.5 p -53.22 -41.8 65.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.488 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.678 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 3.7 m-85 -59.0 -42.63 90.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.651 0.262 . . . . 0.0 111.179 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.737 HD13 ' HA ' ' A' ' 101' ' ' LYS . 5.7 mp -55.74 -41.13 73.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.064 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.7 p -92.56 127.06 37.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.976 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.633 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 57.5 tp -145.36 128.36 16.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.092 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -69.15 138.06 53.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.971 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 m120 58.24 39.74 25.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.298 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.85 168.36 41.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.703 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -138.88 140.25 38.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.732 0.301 . . . . 0.0 110.743 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 74.9 t -109.18 141.45 24.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.206 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -105.53 136.1 45.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.644 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.551 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.6 mm? -101.05 144.2 30.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.575 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.9 m -151.76 126.62 9.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.713 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 65.01 149.98 0.06 OUTLIER Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.424 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.65 143.13 0.49 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.603 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -173.44 138.31 0.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.643 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -43.16 134.93 3.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.829 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 83.6 Cg_endo -87.9 54.01 0.52 Allowed 'Cis proline' 0 C--N 1.347 0.486 0 C-N-CA 123.721 -1.366 . . . . 0.0 113.401 0.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.454 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -135.11 135.55 41.27 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.7 0.286 . . . . 0.0 110.861 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.777 HD23 ' H ' ' A' ' 121' ' ' LEU . 2.1 pt? -124.42 -39.92 2.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.104 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -61.32 136.78 58.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.561 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.17 54.59 4.03 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.14 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.51 ' C ' ' HD2' ' A' ' 125' ' ' ARG . . . -147.7 132.17 17.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 0.0 111.068 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.51 ' HD2' ' C ' ' A' ' 124' ' ' ALA . 8.6 mpt_? -124.93 138.86 54.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.113 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.415 HG12 HD13 ' A' ' 113' ' ' LEU . 28.4 m -116.97 137.06 52.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.104 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -106.67 113.72 27.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.95 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -74.83 155.95 37.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.603 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.522 HH22 ' H ' ' A' ' 136' ' ' LEU . 2.4 tpm_? -161.11 128.45 4.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.525 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.47 ' H ' ' CZ ' ' A' ' 129' ' ' ARG . 87.6 m -89.22 140.77 29.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.067 0.46 . . . . 0.0 111.456 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -54.29 158.88 3.49 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.16 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.504 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 3.5 Cg_endo -45.92 153.14 0.95 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.002 2.468 . . . . 0.0 112.07 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 22.2 m-20 77.92 -32.07 0.17 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.664 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' A' ' 132' ' ' PRO . 3.2 m-85 -107.65 128.12 54.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.331 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -107.52 136.44 47.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.425 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.69 HD22 ' HB2' ' A' ' 140' ' ' SER . 6.2 tt -74.94 130.46 39.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.469 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.623 ' N ' HD23 ' A' ' 136' ' ' LEU . 40.8 t -135.04 67.43 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.461 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.5 -134.94 1.91 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.092 -1.052 . . . . 0.0 113.058 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.651 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 50.0 m -75.53 55.26 0.81 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.851 0.358 . . . . 0.0 110.964 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.69 ' HB2' HD22 ' A' ' 136' ' ' LEU . 33.6 t -49.77 -40.51 41.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.171 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.427 ' HG2' HH11 ' A' ' 141' ' ' ARG . 22.2 ptt-85 -99.31 134.53 42.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.98 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.2 m -146.29 133.87 20.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.77 0.319 . . . . 0.0 110.736 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.455 HG23 ' HG3' ' A' ' 125' ' ' ARG . 7.3 p -120.05 129.76 75.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.05 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 51.4 t -71.39 141.95 50.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.454 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.3 t -171.3 125.65 0.64 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.216 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.441 ' OE1' ' N ' ' A' ' 146' ' ' GLN . 0.6 OUTLIER 57.15 39.61 28.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 0.0 110.448 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.17 -51.65 3.26 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.774 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -76.92 143.7 39.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.678 0.275 . . . . 0.0 111.057 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.592 ' HE1' ' HB2' ' A' ' 100' ' ' SER . 70.0 m95 -84.2 146.82 27.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.828 0.347 . . . . 0.0 110.659 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.3 t -53.37 -61.17 2.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.524 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 139' ' ' SER . 82.4 p -107.79 135.78 19.77 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.774 0.321 . . . . 0.0 111.776 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 139' ' ' SER . 57.6 Cg_endo -70.78 145.67 51.9 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.785 2.323 . . . . 0.0 112.161 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.678 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 7.6 mtpm? -45.32 130.17 5.98 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.433 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.651 ' HB3' ' N ' ' A' ' 139' ' ' SER . 76.1 Cg_endo -77.51 -141.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.69 2.26 . . . . 0.0 112.547 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.482 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.4 p-80 -153.74 147.6 25.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.036 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 71.0 m -96.89 140.26 31.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.279 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -131.26 146.69 52.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.875 0.369 . . . . 0.0 111.48 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 79.6 t -76.61 125.18 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.174 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.067 -179.634 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.423 ' NH1' ' HA3' ' A' ' 147' ' ' GLY . 31.2 ptt85 . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.92 0.39 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.685 ' O ' HD12 ' A' ' 98' ' ' ILE . 2.3 pp -51.13 148.21 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.991 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.603 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 97.7 m -59.76 143.83 49.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.04 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.2 m -48.03 124.81 8.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.226 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -84.46 14.98 3.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.933 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.2 m -67.34 -35.63 79.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.678 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.739 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 3.4 m-85 -58.74 -25.69 63.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.417 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.4 mt -50.0 -38.41 37.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.737 0.303 . . . . 0.0 111.118 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.3 p -92.55 127.81 38.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.111 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.484 HD22 ' HA3' ' A' ' 109' ' ' GLY . 6.4 tt -145.37 124.02 12.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.182 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.457 ' N ' HD23 ' A' ' 106' ' ' LEU . 96.6 mt-10 -74.25 130.69 40.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.37 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 60.11 47.22 9.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.221 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.484 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -174.95 -171.83 39.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.075 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -142.09 146.29 35.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.659 0.266 . . . . 0.0 110.647 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 103' ' ' TYR . 60.3 t -108.05 127.4 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.631 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.627 ' C ' HG23 ' A' ' 126' ' ' VAL . 2.5 m-85 -112.01 70.88 0.72 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.149 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.702 ' HA ' ' HB ' ' A' ' 126' ' ' VAL . 2.3 tt -74.67 62.39 1.05 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.618 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.8 p -75.0 120.89 21.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.712 0.291 . . . . 0.0 111.118 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.14 -43.89 0.31 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.654 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -173.16 -128.26 1.05 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.531 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.86 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 11.6 p-10 -165.24 -136.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 118' ' ' LEU . 2.7 mm? -116.31 132.98 23.02 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.526 0.203 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 60.0 Cg_endo -93.09 42.06 3.15 Favored 'Cis proline' 0 C--N 1.348 0.537 0 C-N-CA 123.837 -1.318 . . . . 0.0 112.497 -0.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.86 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -74.07 140.89 45.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 0.0 111.742 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.541 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 2.1 pt? -167.39 36.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.803 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.93 60.57 1.39 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.917 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.22 40.84 32.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.225 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.526 ' O ' HG23 ' A' ' 143' ' ' VAL . . . -62.9 135.29 57.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 110.981 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.58 ' HD2' ' NH2' ' A' ' 141' ' ' ARG . 85.7 mtm180 -103.83 141.47 36.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.498 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.703 HG11 ' HZ3' ' A' ' 149' ' ' TRP . 6.5 p -143.23 135.66 24.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.257 0.551 . . . . 0.0 112.315 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -109.17 121.11 44.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.737 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.534 ' HE1' ' HB3' ' A' ' 142' ' ' SER . 3.2 m-85 -87.3 56.19 3.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.801 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 129' ' ' ARG . 63.5 mtt-85 -59.05 132.97 55.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.591 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 53.7 t -89.2 149.13 23.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.34 . . . . 0.0 111.13 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.482 ' OD1' ' HB2' ' A' ' 134' ' ' PHE . 52.5 p-10 -52.81 149.8 10.88 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.404 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 10.1 Cg_endo -51.59 152.74 12.0 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.751 2.301 . . . . 0.0 111.527 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.585 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 37.4 t70 76.44 -2.41 2.72 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.399 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.71 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 19.1 m-85 -134.28 130.61 37.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.951 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -104.16 128.19 51.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.923 0.392 . . . . 0.0 111.197 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.837 HD12 ' HB3' ' A' ' 140' ' ' SER . 2.8 tm? -71.44 132.15 44.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.795 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.625 ' N ' HD13 ' A' ' 136' ' ' LEU . 24.8 t -132.23 67.88 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.9 -135.13 2.11 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 119.901 -1.142 . . . . 0.0 113.276 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.652 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 39.2 p -74.99 56.05 0.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.929 0.395 . . . . 0.0 111.072 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.837 ' HB3' HD12 ' A' ' 136' ' ' LEU . 92.6 p -57.0 -38.95 73.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.801 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.58 ' NH2' ' HD2' ' A' ' 125' ' ' ARG . 29.4 tpt180 -99.32 133.97 42.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.703 0.287 . . . . 0.0 111.508 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.534 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 46.7 t -150.34 148.67 29.1 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.258 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 124' ' ' ALA . 7.4 p -146.23 130.27 10.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.146 0.498 . . . . 0.0 112.046 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 13.7 t -92.54 140.96 29.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.901 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.4 t -169.52 -60.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.042 0.449 . . . . 0.0 111.218 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -87.98 43.63 1.13 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.423 ' HA3' ' NH1' ' A' ' 97' ' ' ARG . . . 56.54 39.9 85.91 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.89 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -174.73 146.98 1.0 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.728 0.299 . . . . 0.0 110.402 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.703 ' HZ3' HG11 ' A' ' 126' ' ' VAL . 29.5 m95 -84.22 138.78 32.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.778 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.2 t -50.15 -46.31 53.95 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.965 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 70.9 p -135.65 138.84 29.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.891 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.499 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 28.0 Cg_exo -62.02 -162.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.561 2.174 . . . . 0.0 112.627 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.801 ' HZ2' ' HB3' ' A' ' 153' ' ' LYS . 3.9 mmmp? -80.75 127.3 75.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.783 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.652 ' HB3' ' N ' ' A' ' 139' ' ' SER . 84.0 Cg_endo -81.37 -151.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.635 2.223 . . . . 0.0 112.891 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.425 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 22.4 p-80 -153.65 136.52 15.38 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.936 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 7.8 t -98.72 136.83 38.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.979 0.418 . . . . 0.0 111.664 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -103.04 142.4 34.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.02 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 98.2 t -61.24 111.03 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.78 0.324 . . . . 0.0 110.327 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.585 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 38.6 t30 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.05 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.744 0.307 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.506 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -54.33 142.36 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 0.0 111.49 -179.547 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 82.1 m -56.42 154.47 8.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.757 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.7 m -45.67 127.51 7.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.492 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.572 ' HB2' HD12 ' A' ' 104' ' ' LEU . 7.8 ptpp? -76.19 -3.38 35.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.262 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.5 m -56.12 -41.15 74.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.87 0.367 . . . . 0.0 110.994 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.469 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 1.7 m-85 -59.98 -34.17 72.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.196 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.572 HD12 ' HB2' ' A' ' 101' ' ' LYS . 75.6 mt -52.11 -40.01 60.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.967 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.1 m -92.6 136.29 33.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.5 tp -145.42 131.35 19.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.86 0.362 . . . . 0.0 111.31 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -75.02 133.56 41.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.853 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 52.47 36.07 19.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 110.664 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.36 145.81 9.91 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.538 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.634 ' HB3' ' NZ ' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -101.93 140.87 35.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.972 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.03 135.93 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.79 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 126' ' ' VAL . 3.5 m-85 -110.35 136.16 49.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.779 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.48 HD11 HD22 ' A' ' 104' ' ' LEU . 94.8 mt -112.4 144.86 41.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.163 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.8 t -159.83 143.1 14.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.005 0.431 . . . . 0.0 111.81 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.09 126.07 0.13 Allowed Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.911 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 152.06 -140.36 7.7 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.312 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 120' ' ' ALA . 65.6 t0 -173.86 119.14 0.27 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.823 HD22 ' H ' ' A' ' 118' ' ' LEU . 3.1 mm? -29.49 126.16 0.26 Allowed Pre-proline 0 N--CA 1.465 0.301 0 O-C-N 123.591 0.557 . . . . 0.0 111.555 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 118' ' ' LEU . 25.5 Cg_exo -63.18 -22.1 4.86 Favored 'Cis proline' 0 C--N 1.351 0.682 0 C-N-CA 124.097 -1.209 . . . . 0.0 112.992 0.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 117' ' ' ASP . . . 69.26 129.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.413 0.625 . . . . 0.0 111.752 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.628 ' O ' HD13 ' A' ' 121' ' ' LEU . 2.2 tm? 175.33 -35.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.236 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -62.14 132.32 52.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.677 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.5 31.72 36.88 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.331 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -77.19 139.65 39.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.758 0.313 . . . . 0.0 111.193 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.403 HH11 ' HG3' ' A' ' 125' ' ' ARG . 41.1 ttt85 -103.98 63.25 0.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.126 0.489 . . . . 0.0 109.725 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 142' ' ' SER . 11.0 p -57.96 141.7 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.776 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -123.92 113.3 18.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.863 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -80.06 151.3 29.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.9 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.453 HH11 ' HG3' ' A' ' 129' ' ' ARG . 38.3 ttt85 -161.11 133.12 5.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.785 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 84.1 m -89.25 142.45 27.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.204 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 60.8 m-20 -56.27 160.81 4.54 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.022 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.53 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 78.2 Cg_exo -41.15 154.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.982 2.455 . . . . 0.0 112.652 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 8.1 t70 78.89 -33.77 0.16 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.717 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.411 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 1.7 m-85 -107.6 129.5 54.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.237 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -110.75 134.75 52.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.99 0.424 . . . . 0.0 111.08 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 137' ' ' VAL . 6.6 tt -75.21 132.42 41.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.597 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.602 ' N ' HD23 ' A' ' 136' ' ' LEU . 38.7 t -133.39 67.3 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.452 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.25 -126.33 1.07 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.15 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.604 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 42.7 t -70.2 64.46 0.25 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.986 0.422 . . . . 0.0 111.258 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.445 ' HB2' HD22 ' A' ' 136' ' ' LEU . 35.3 t -64.36 -18.0 64.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.172 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 56.5 mtt85 -140.7 140.86 34.97 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.056 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.608 ' O ' HG12 ' A' ' 126' ' ' VAL . 35.9 m -145.03 136.27 25.02 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 7.2 p -113.32 130.55 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.924 0.393 . . . . 0.0 111.357 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 45.6 t -75.05 139.46 42.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.96 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 m -163.12 134.58 4.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.844 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 12.8 tp-100 67.36 -66.68 0.19 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.462 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.0 37.44 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.526 -0.629 . . . . 0.0 111.526 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -176.32 152.36 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.105 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 27.9 m95 -84.19 140.93 31.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.741 0.305 . . . . 0.0 110.724 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.6 m -52.3 -59.89 3.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.013 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.2 p -100.91 134.26 20.56 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.05 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.461 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 38.3 Cg_endo -66.59 -157.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.398 2.066 . . . . 0.0 112.366 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.561 ' HB3' ' NZ ' ' A' ' 153' ' ' LYS . 9.5 mtpm? -92.98 129.93 37.98 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.037 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.604 ' HB3' ' N ' ' A' ' 139' ' ' SER . 66.5 Cg_endo -73.09 -144.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.673 2.249 . . . . 0.0 112.722 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.474 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.7 p-80 -153.67 149.26 27.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.415 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 73.9 m -97.86 129.33 44.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 0.0 111.189 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -111.87 133.24 54.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.682 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.438 HG23 ' OD1' ' A' ' 133' ' ' ASP . 7.2 p -84.79 127.15 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.522 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.912 -179.767 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.459 HH11 ' HG3' ' A' ' 97' ' ' ARG . 38.5 ttm-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.972 0.415 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.476 HG22 HD23 ' A' ' 121' ' ' LEU . 31.7 pt -72.88 141.83 15.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.717 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 59.7 m -61.22 143.23 55.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.945 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.422 ' HB3' ' HE1' ' A' ' 149' ' ' TRP . 41.1 t -47.91 130.78 15.27 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.354 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -76.69 -19.93 57.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.429 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.3 p -53.06 -46.63 68.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.787 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.527 ' O ' HG21 ' A' ' 111' ' ' VAL . 3.5 m-85 -61.72 -36.72 81.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.587 0.232 . . . . 0.0 111.204 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.6 mt -54.43 -48.64 71.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.109 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.6 m -92.55 137.85 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.625 HD13 ' HE2' ' A' ' 153' ' ' LYS . 24.8 tp -145.4 130.77 18.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.037 0.446 . . . . 0.0 111.348 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -72.43 137.35 46.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.404 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.4 m120 61.06 37.21 18.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.147 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 178.98 -179.33 48.92 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.704 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -142.03 147.12 36.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.79 0.328 . . . . 0.0 110.791 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.527 HG21 ' O ' ' A' ' 103' ' ' TYR . 86.3 t -107.23 141.61 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.969 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.15 135.32 46.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.598 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.0 mm? -102.77 147.07 27.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.237 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.0 m -151.59 129.81 11.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.815 0.341 . . . . 0.0 111.256 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 56.19 43.56 89.0 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.62 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . -179.92 141.15 4.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.653 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -174.86 134.21 0.35 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.959 HD12 ' HA ' ' A' ' 119' ' ' PRO . 37.3 tp -43.82 131.62 4.07 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.939 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.959 ' HA ' HD12 ' A' ' 118' ' ' LEU . 84.6 Cg_endo -90.7 63.02 0.27 Allowed 'Cis proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.585 -1.423 . . . . 0.0 113.143 0.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.442 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -141.83 48.79 1.6 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.816 0.341 . . . . 0.0 111.26 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 121' ' ' LEU . 3.1 mm? -62.61 -45.08 94.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.636 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.455 ' OD1' ' HA ' ' A' ' 145' ' ' SER . 64.3 t0 -62.59 138.89 58.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.615 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.93 57.73 5.14 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.375 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.639 ' HB2' ' HA3' ' A' ' 116' ' ' GLY . . . -154.03 141.23 19.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 111.271 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.62 HH21 ' HD2' ' A' ' 141' ' ' ARG . 41.9 ttt85 -108.62 141.66 40.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.504 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.408 HG23 ' CE1' ' A' ' 128' ' ' PHE . 19.1 m -130.88 140.16 49.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.963 0.411 . . . . 0.0 111.679 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -103.5 125.26 49.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.094 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.408 ' CE1' HG23 ' A' ' 126' ' ' VAL . 9.7 m-85 -92.38 143.04 26.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.084 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.404 HH11 ' HG3' ' A' ' 129' ' ' ARG . 41.3 ttt85 -172.34 124.07 0.49 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.991 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.533 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 56.9 m -89.31 146.03 24.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.883 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.663 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 59.5 m-20 -55.88 167.14 0.89 Allowed Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.37 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 2.1 Cg_endo -45.01 159.81 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.268 2.645 . . . . 0.0 112.399 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.5 m-20 77.95 -37.67 0.24 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.258 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.488 ' CE2' HG22 ' A' ' 158' ' ' VAL . 6.6 m-85 -108.52 126.25 52.71 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -117.94 126.28 52.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.243 0.544 . . . . 0.0 111.335 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 137' ' ' VAL . 6.5 tt -72.58 130.16 39.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.029 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.539 ' N ' HD23 ' A' ' 136' ' ' LEU . 31.6 t -129.06 67.09 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.531 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.95 -131.99 1.48 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.496 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.534 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 80.1 p -73.86 64.51 0.98 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.979 0.418 . . . . 0.0 110.272 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.7 t -58.33 -2.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.436 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.62 ' HD2' HH21 ' A' ' 125' ' ' ARG . 53.8 mtm-85 -140.69 137.08 33.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.523 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.0 m -149.12 133.34 17.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.389 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 6.2 p -123.25 126.22 73.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.106 0.479 . . . . 0.0 111.289 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 52.6 t -98.99 140.04 33.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.755 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.455 ' HA ' ' OD1' ' A' ' 122' ' ' ASP . 43.7 t -170.05 38.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.128 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 52.0 tt0 177.68 47.18 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.502 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 54.36 35.27 55.51 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.949 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -177.39 144.86 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.422 ' HE1' ' HB3' ' A' ' 100' ' ' SER . 29.7 m95 -84.22 140.82 31.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.82 0.343 . . . . 0.0 110.689 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.4 t -52.72 -65.87 0.48 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.933 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 81.1 p -98.42 135.68 21.11 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.73 0.3 . . . . 0.0 111.8 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 27.1 Cg_exo -62.1 143.85 95.25 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.758 2.305 . . . . 0.0 111.616 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.625 ' HE2' HD13 ' A' ' 106' ' ' LEU . 83.3 tttt -47.92 130.71 11.81 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.839 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.534 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.3 Cg_endo -75.84 -148.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.814 2.343 . . . . 0.0 113.206 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.46 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 16.9 p-80 -153.75 130.99 11.17 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.181 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 93.5 m -99.07 135.38 40.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.064 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -103.02 141.51 35.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.224 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.488 HG22 ' CE2' ' A' ' 134' ' ' PHE . 49.3 t -69.52 79.53 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.055 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.472 -179.961 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.459 ' O ' ' HA2' ' A' ' 147' ' ' GLY . 70.0 mtt-85 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.588 0.233 . . . . 0.0 110.534 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.536 ' HB ' ' HG ' ' A' ' 121' ' ' LEU . 29.4 pt -78.51 38.81 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.448 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.502 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 68.0 m 59.21 141.06 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.013 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.6 t -48.03 126.3 10.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.312 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.677 ' HA ' HD23 ' A' ' 104' ' ' LEU . 63.9 pttt -80.01 -12.97 59.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.881 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.6 m -57.07 -42.26 80.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.563 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.509 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.7 m-85 -52.94 -37.6 61.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.234 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.677 HD23 ' HA ' ' A' ' 101' ' ' LYS . 2.0 mm? -54.1 -41.59 68.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.336 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.5 m -92.54 136.07 33.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.043 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.848 HD13 ' HE2' ' A' ' 153' ' ' LYS . 15.5 tp -145.39 130.62 18.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.25 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.502 ' N ' HD12 ' A' ' 106' ' ' LEU . 42.6 tt0 -70.66 131.15 43.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.416 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.7 m120 54.81 42.42 31.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.993 0.425 . . . . 0.0 110.609 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.08 153.57 14.01 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.588 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -115.29 142.79 46.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.691 0.281 . . . . 0.0 110.758 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 103' ' ' TYR . 46.1 t -107.89 131.34 58.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.053 0.454 . . . . 0.0 110.977 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.428 ' O ' HG23 ' A' ' 126' ' ' VAL . 3.0 m-85 -109.82 150.78 27.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.784 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.663 ' O ' HD12 ' A' ' 113' ' ' LEU . 3.9 pp -158.13 149.78 21.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.916 0.388 . . . . 0.0 111.52 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.0 p -151.33 132.26 14.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.72 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 167.68 -129.78 1.97 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.433 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.75 -122.82 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.507 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.809 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 54.4 t0 -161.68 -127.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.478 0.18 . . . . 0.0 110.64 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 119' ' ' PRO . 31.9 tp -128.88 130.05 23.46 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.761 0.315 . . . . 0.0 111.172 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.868 ' HA ' HD12 ' A' ' 118' ' ' LEU . 89.7 Cg_endo -91.86 42.47 2.84 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.442 -1.483 . . . . 0.0 112.581 -0.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.809 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -80.96 46.96 0.94 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.523 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.536 ' HG ' ' HB ' ' A' ' 98' ' ' ILE . 3.5 mm? -61.89 -38.05 86.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.147 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -61.27 146.03 49.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.1 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.1 -34.54 3.02 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.61 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.08 141.88 38.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.904 0.383 . . . . 0.0 111.649 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.44 ' HD2' HG23 ' A' ' 143' ' ' VAL . 43.9 mmm-85 -104.26 136.96 42.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.087 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 112' ' ' PHE . 15.0 p -123.83 133.14 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.189 0.519 . . . . 0.0 111.986 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -112.81 120.58 41.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.697 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.407 ' HE1' ' HB3' ' A' ' 142' ' ' SER . 8.5 m-85 -88.75 149.81 23.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.256 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -164.64 134.81 3.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.051 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 70.5 m -89.23 155.44 19.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.772 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 133' ' ' ASP . 11.5 p-10 -52.69 149.11 11.7 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.987 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -58.14 74.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.08 2.52 . . . . 0.0 112.576 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.1 t70 -177.74 -40.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.736 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.474 ' CE2' ' HB ' ' A' ' 158' ' ' VAL . 1.4 m-85 -107.86 142.65 37.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.829 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -101.24 129.1 47.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 0.0 111.066 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 137' ' ' VAL . 6.9 tt -77.91 130.54 36.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.451 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.514 ' N ' HD23 ' A' ' 136' ' ' LEU . 38.5 t -131.87 66.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.415 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.04 -126.61 0.9 Allowed Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.079 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.713 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 34.9 t -72.3 58.52 0.39 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 111.201 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.5 t -56.58 -26.58 55.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.853 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.413 ' HG3' HH11 ' A' ' 141' ' ' ARG . 45.2 ttm-85 -129.84 137.76 50.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.407 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 39.4 t -149.25 175.83 11.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.023 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.44 HG23 ' HD2' ' A' ' 125' ' ' ARG . 8.6 p -160.6 137.34 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.08 0.467 . . . . 0.0 112.003 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 37.1 t -78.79 135.07 36.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.886 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.8 t -175.26 133.48 0.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.953 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 56.87 40.94 28.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 97' ' ' ARG . . . 56.15 43.2 88.8 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.522 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -175.13 138.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.69 0.281 . . . . 0.0 110.702 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.502 ' CE2' ' HB3' ' A' ' 99' ' ' CYS . 14.5 m95 -84.2 140.25 31.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.371 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.4 p -52.92 -60.83 2.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.741 0.305 . . . . 0.0 110.865 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 40.3 p -101.23 140.54 21.36 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.127 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 24.4 Cg_exo -63.62 -153.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.628 2.218 . . . . 0.0 112.365 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.848 ' HE2' HD13 ' A' ' 106' ' ' LEU . 83.7 tttt -102.39 127.9 29.47 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.486 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.713 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 60.3 Cg_endo -72.66 -153.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.538 2.159 . . . . 0.0 112.717 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -153.67 144.64 22.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.484 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 66.2 m -97.3 134.05 41.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.895 0.379 . . . . 0.0 110.775 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -117.9 138.75 51.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.136 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.474 ' HB ' ' CE2' ' A' ' 134' ' ' PHE . 8.6 p -85.95 129.45 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.436 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.2 p30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.968 -179.7 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.04 0.448 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.627 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -148.49 134.66 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.411 179.296 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 7.4 p -53.27 139.33 29.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.614 -179.332 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.4 m -47.91 128.1 12.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.482 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.687 ' HA ' HD13 ' A' ' 104' ' ' LEU . 9.0 ptpp? -84.56 3.75 35.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.019 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.4 t -63.29 -39.02 93.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.009 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.465 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.5 m-85 -54.94 -38.23 67.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.971 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.687 HD13 ' HA ' ' A' ' 101' ' ' LYS . 6.2 mp -54.56 -34.26 61.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.304 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.2 p -92.33 129.45 38.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 111.029 -179.794 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.844 HD13 ' HE2' ' A' ' 153' ' ' LYS . 22.3 tp -145.48 133.8 21.77 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.335 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 8.2 pm0 -74.73 132.19 41.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.331 179.124 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 55.89 39.22 30.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.609 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.31 151.2 14.02 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.821 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -112.48 142.1 45.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.351 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 103' ' ' TYR . 43.0 t -106.98 137.5 37.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.994 0.426 . . . . 0.0 111.287 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -104.72 142.09 35.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.293 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.651 ' HB3' HG23 ' A' ' 126' ' ' VAL . 4.1 pp -166.81 150.65 6.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.983 0.42 . . . . 0.0 111.697 -179.53 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.6 m -160.33 135.04 7.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.784 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 132.15 136.26 3.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.73 141.75 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.044 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 32.7 m-20 -130.53 -42.51 1.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.246 0.546 . . . . 0.0 109.64 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.715 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -130.27 123.01 20.36 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.407 179.559 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 87.4 Cg_endo -81.7 33.59 2.16 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 123.28 -1.55 . . . . 0.0 112.338 0.073 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 117' ' ' ASP . . . 66.65 146.82 0.04 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.874 0.369 . . . . 0.0 111.245 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.503 ' HB3' ' SG ' ' A' ' 99' ' ' CYS . 6.6 mp 62.43 35.1 15.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.01 -178.886 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.96 51.02 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.099 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.456 ' HA2' ' C ' ' A' ' 144' ' ' CYS . . . 71.44 42.32 56.41 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.567 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.35 -163.59 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 111.318 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -112.3 146.29 38.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.435 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.651 HG23 ' HB3' ' A' ' 113' ' ' LEU . 8.1 p -141.86 138.56 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.114 0.483 . . . . 0.0 111.4 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -132.59 111.68 11.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.375 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.471 ' HB2' HD11 ' A' ' 136' ' ' LEU . 3.1 m-85 -69.18 153.75 43.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.206 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.1 tpp85 -160.6 129.47 4.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.833 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 55.8 m -89.18 143.83 26.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.735 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 133' ' ' ASP . 61.4 m-20 -53.2 150.85 10.38 Favored Pre-proline 0 N--CA 1.462 0.155 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.123 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 52.7 Cg_exo -53.55 77.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.23 2.62 . . . . 0.0 113.105 -179.462 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 131' ' ' ASP . 39.0 t70 177.73 -38.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.761 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -108.33 142.37 38.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.797 179.201 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.479 ' CD2' ' HB3' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -100.8 132.71 46.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.126 0.489 . . . . 0.0 111.07 179.91 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 137' ' ' VAL . 4.9 tt -76.93 124.71 28.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.07 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.548 ' N ' HD23 ' A' ' 136' ' ' LEU . 21.2 t -134.78 61.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.598 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -166.11 -133.65 1.55 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 119.869 -1.158 . . . . 0.0 113.148 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.632 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 64.2 m -74.56 55.06 0.63 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.832 0.349 . . . . 0.0 110.991 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.528 ' HB2' HD22 ' A' ' 136' ' ' LEU . 36.6 t -51.39 -43.05 61.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.968 -179.746 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.434 HH11 ' HG3' ' A' ' 141' ' ' ARG . 40.1 ttt85 -99.47 131.16 45.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.829 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.437 ' O ' HG12 ' A' ' 126' ' ' VAL . 49.9 m -150.72 153.49 35.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.965 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.702 HG12 ' HB2' ' A' ' 150' ' ' SER . 15.0 p -138.27 134.24 43.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.172 0.51 . . . . 0.0 112.004 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.456 ' C ' ' HA2' ' A' ' 123' ' ' GLY . 27.5 t -74.14 152.51 39.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.481 179.202 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.9 p -155.9 -135.97 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.016 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -53.51 -38.88 64.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.882 0.373 . . . . 0.0 110.952 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . -174.11 -49.09 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.123 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -85.0 142.22 29.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.744 0.307 . . . . 0.0 110.355 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.411 ' NE1' ' HB2' ' A' ' 99' ' ' CYS . 35.9 m95 -84.11 151.18 25.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.484 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.702 ' HB2' HG12 ' A' ' 143' ' ' VAL . 48.3 t -44.97 -57.15 4.0 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.179 -179.31 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 72.4 p -121.23 145.13 41.4 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.947 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -57.61 -161.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.616 2.211 . . . . 0.0 112.765 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.844 ' HE2' HD13 ' A' ' 106' ' ' LEU . 83.0 tttt -94.12 126.13 49.93 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.833 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.632 ' HB3' ' N ' ' A' ' 139' ' ' SER . 57.1 Cg_endo -70.77 -155.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.481 2.12 . . . . 0.0 112.384 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -153.69 142.27 20.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 75.5 m -98.72 132.67 43.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.912 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.479 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 19.1 tt0 -116.33 141.05 48.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.808 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.03 132.42 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.287 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.7 p30 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.986 -179.422 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.701 0.286 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.1 pt -54.65 139.32 13.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.995 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.51 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 96.4 m -53.15 135.62 37.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.18 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.6 t -47.92 127.96 12.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.457 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.846 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -87.25 -6.53 58.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.935 179.666 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.1 p -54.09 -34.73 60.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.219 -179.596 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.581 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.9 m-85 -57.04 -35.55 69.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.56 -179.702 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 104' ' ' LEU . 4.1 mp -77.8 37.49 0.24 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.107 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.4 p -147.5 63.55 1.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.802 0.334 . . . . 0.0 110.803 179.125 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.744 HD13 ' HE2' ' A' ' 153' ' ' LYS . 29.6 tp -94.12 128.91 40.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.634 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -73.4 137.03 44.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.996 178.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.459 ' HB3' ' OD2' ' A' ' 131' ' ' ASP . 34.3 m-20 58.64 42.03 21.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.108 0.48 . . . . 0.0 110.126 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -171.27 164.58 37.57 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.647 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -125.14 141.84 51.86 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.411 HG21 ' HA ' ' A' ' 104' ' ' LEU . 4.7 t -109.38 137.04 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.885 0.374 . . . . 0.0 111.021 -179.501 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.636 ' O ' HG23 ' A' ' 126' ' ' VAL . 2.3 m-85 -107.69 141.77 38.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.684 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 114' ' ' THR . 7.1 tt -147.84 138.02 22.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.006 0.432 . . . . 0.0 111.015 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.589 ' N ' HD23 ' A' ' 113' ' ' LEU . 76.2 p -145.07 121.27 10.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.645 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.38 -43.37 0.77 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.163 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -179.7 -138.67 3.41 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.071 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -178.04 -60.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.004 0.43 . . . . 0.0 110.824 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.635 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -149.41 132.83 8.45 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.302 -179.468 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.07 19.72 6.56 Favored 'Cis proline' 0 C--N 1.347 0.464 0 C-N-CA 123.531 -1.446 . . . . 0.0 112.148 -0.018 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 50.73 -138.26 1.05 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.994 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 28.5 mt 58.72 63.2 1.72 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.831 0.348 . . . . 0.0 111.306 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -164.02 50.92 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.029 0.442 . . . . 0.0 110.702 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.93 41.39 97.4 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.971 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.32 134.3 39.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 111.058 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -112.72 144.61 41.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 112' ' ' PHE . 8.5 p -141.39 142.03 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.081 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -133.81 123.0 24.06 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.111 -179.443 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.581 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 2.8 m-85 -79.99 147.13 31.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.871 179.695 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -141.24 130.99 24.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 76.1 m -93.88 140.81 29.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.181 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.554 ' HB2' ' HD2' ' A' ' 132' ' ' PRO . 1.9 p30 -62.25 161.16 26.61 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.514 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 131' ' ' ASP . 1.5 Cg_endo -43.07 148.07 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.967 2.445 . . . . 0.0 112.067 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 21.8 m-20 78.96 -24.41 0.22 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.798 -179.039 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 157' ' ' GLN . 22.2 m-85 -108.61 134.86 50.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.7 0.286 . . . . 0.0 110.619 179.353 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -123.02 133.97 54.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.589 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.814 HD11 ' HG2' ' A' ' 154' ' ' PRO . 17.1 tp -75.35 130.14 38.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.722 -179.509 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.85 67.42 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.827 -179.199 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.87 -134.24 1.95 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.05 -1.072 . . . . 0.0 112.975 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.521 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 30.5 p -73.85 59.42 0.68 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.102 0.477 . . . . 0.0 110.712 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.443 ' HA ' HD21 ' A' ' 136' ' ' LEU . 94.2 p -54.97 -50.9 67.8 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.444 -178.881 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.68 ' HD2' ' O ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -99.38 141.79 31.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.144 0.497 . . . . 0.0 112.006 -179.259 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.636 ' HA ' ' OG ' ' A' ' 150' ' ' SER . 55.3 p -150.69 146.0 26.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.148 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.798 HG12 ' HB3' ' A' ' 150' ' ' SER . 10.0 p -126.92 134.76 65.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.053 0.454 . . . . 0.0 111.863 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.71 143.98 51.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.714 179.573 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.2 m -149.9 -134.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.41 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -52.85 -34.72 55.57 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.929 0.395 . . . . 0.0 110.476 179.735 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.5 -48.8 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.767 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -80.41 144.12 32.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.676 0.274 . . . . 0.0 110.724 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.569 ' HB3' ' HB2' ' A' ' 142' ' ' SER . 44.0 m95 -84.2 151.07 25.07 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.421 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.798 ' HB3' HG12 ' A' ' 143' ' ' VAL . 98.5 p -43.34 -42.85 4.75 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.78 0.324 . . . . 0.0 110.703 -179.477 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.8 p -141.39 145.8 39.59 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.469 179.387 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.8 -156.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.697 2.265 . . . . 0.0 112.769 -179.426 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.744 ' HE2' HD13 ' A' ' 106' ' ' LEU . 87.3 tttt -101.5 125.39 37.68 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.821 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.814 ' HG2' HD11 ' A' ' 136' ' ' LEU . 60.0 Cg_endo -74.87 -149.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.407 2.071 . . . . 0.0 112.565 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -153.7 147.75 25.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.251 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 73.0 m -98.54 129.2 45.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.687 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 134' ' ' PHE . 84.5 mt-30 -107.59 136.58 47.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.994 0.426 . . . . 0.0 111.764 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.51 ' O ' HG22 ' A' ' 158' ' ' VAL . 11.9 p -83.11 47.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.499 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 18.5 m120 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.954 -179.416 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.908 0.385 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.648 ' H ' HD13 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -65.03 146.47 13.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.359 -179.644 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 35.1 m -52.21 143.23 14.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.464 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.631 ' HB2' ' HE1' ' A' ' 149' ' ' TRP . 53.3 m -47.98 125.7 9.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.998 0.427 . . . . 0.0 111.38 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.843 ' HD3' HD21 ' A' ' 104' ' ' LEU . 16.8 tppt? -82.18 84.82 6.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.081 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.0 t -171.07 -44.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.748 0.309 . . . . 0.0 111.582 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.567 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.5 m-85 -60.71 -42.61 97.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.736 -179.454 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.91 ' HA ' HG11 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -49.95 -29.52 8.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.622 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.796 HG23 HD13 ' A' ' 104' ' ' LEU . 74.6 p -98.45 127.4 44.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.713 0.292 . . . . 0.0 110.766 179.345 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.646 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 69.0 tp -145.42 121.55 10.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.013 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.51 ' OE1' HD12 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -72.44 136.01 45.9 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.224 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 58.71 39.3 24.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.136 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.75 155.87 23.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.313 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -111.67 140.05 46.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.975 0.417 . . . . 0.0 111.361 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.91 HG11 ' HA ' ' A' ' 104' ' ' LEU . 96.1 t -111.08 128.59 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.648 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.614 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.8 m-85 -112.38 65.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.482 -179.099 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.762 HD23 ' H ' ' A' ' 113' ' ' LEU . 2.2 pt? -75.84 45.06 0.32 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.686 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.8 p -73.89 134.78 43.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.787 0.327 . . . . 0.0 111.414 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 124' ' ' ALA . . . 160.33 -54.92 0.33 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.426 -0.893 . . . . 0.0 113.111 179.513 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.72 ' HA3' ' HA ' ' A' ' 121' ' ' LEU . . . -82.78 -147.36 6.81 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.333 -179.389 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.8 t0 179.3 67.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.749 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 88.2 mt -33.74 123.69 0.48 Allowed Pre-proline 0 N--CA 1.462 0.154 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.745 -178.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.64 92.61 0.12 OUTLIER 'Cis proline' 0 C--N 1.348 0.525 0 C-N-CA 123.471 -1.47 . . . . 0.0 112.559 -0.329 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.749 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -177.52 150.15 0.67 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.637 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.72 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 0.4 OUTLIER -170.15 39.18 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.657 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.94 124.52 26.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.745 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 53.45 40.07 61.03 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.595 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.574 ' O ' HG23 ' A' ' 143' ' ' VAL . . . -72.1 124.7 25.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.756 0.312 . . . . 0.0 111.236 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -113.08 144.48 42.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.186 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.636 ' HB ' ' HA ' ' A' ' 113' ' ' LEU . 5.8 p -133.05 130.44 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.365 0.603 . . . . 0.0 112.22 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -98.48 136.12 39.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.29 179.404 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.589 ' HB2' ' HB2' ' A' ' 140' ' ' SER . 20.4 m-85 -112.85 142.73 45.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 0.0 111.569 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -163.14 126.85 2.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.271 179.067 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 18.1 t -89.19 140.42 29.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.189 -179.369 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.504 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 59.2 m-20 -54.82 161.39 2.31 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.267 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 8.2 Cg_endo -49.54 165.09 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.011 2.474 . . . . 0.0 112.031 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 159' ' ' ASN . 28.3 m-20 75.43 -17.99 0.48 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.396 -179.233 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.888 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 11.4 m-85 -131.16 131.43 44.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.896 179.383 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.461 ' N ' ' CD2' ' A' ' 135' ' ' HIS . 7.1 m-70 -102.86 124.04 47.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.639 0.256 . . . . 0.0 111.156 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.812 HD22 ' HB3' ' A' ' 140' ' ' SER . 5.1 tt -79.54 118.91 21.83 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.489 ' N ' HD23 ' A' ' 136' ' ' LEU . 46.0 t -136.87 76.98 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.548 -179.28 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.627 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . -171.6 60.1 0.17 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.027 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.527 ' OG ' HG21 ' A' ' 151' ' ' THR . 37.7 t 53.1 67.23 1.03 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.088 0.471 . . . . 0.0 109.744 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.812 ' HB3' HD22 ' A' ' 136' ' ' LEU . 84.9 p -71.09 37.7 0.05 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.917 -178.666 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.459 HH11 ' HG3' ' A' ' 141' ' ' ARG . 38.5 ttt85 -140.62 132.6 27.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.314 179.328 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.462 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 52.7 m -150.7 147.69 27.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.821 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 124' ' ' ALA . 7.1 p -147.58 132.05 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.897 0.38 . . . . 0.0 111.236 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 55.6 m -64.6 148.48 50.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.147 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 42.8 m -149.54 -30.49 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.761 0.315 . . . . 0.0 111.353 -179.371 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -170.81 54.1 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.897 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.09 42.7 83.8 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.923 -179.607 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -172.5 136.88 0.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.631 ' HE1' ' HB2' ' A' ' 100' ' ' SER . 36.0 m95 -84.17 144.41 29.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.745 -179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 61.3 m -50.51 -49.77 54.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.697 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.527 HG21 ' OG ' ' A' ' 139' ' ' SER . 72.9 p -131.15 136.96 29.63 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.417 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 27.3 Cg_exo -62.61 159.38 37.01 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.089 2.526 . . . . 0.0 112.506 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.646 ' NZ ' HD13 ' A' ' 106' ' ' LEU . 3.9 mmmp? -53.61 134.76 54.46 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.331 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.627 ' HB3' ' HA3' ' A' ' 138' ' ' GLY . 5.7 Cg_exo -78.85 -146.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.328 2.686 . . . . 0.0 112.432 -179.765 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -153.71 149.43 27.49 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.602 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.888 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 74.4 m -95.24 133.88 38.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 110.848 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 134' ' ' PHE . 11.8 tp-100 -103.09 138.07 40.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.871 -179.713 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.412 HG12 ' OE1' ' A' ' 157' ' ' GLN . 9.1 p -60.18 133.15 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.497 ' HB2' ' O ' ' A' ' 133' ' ' ASP . 26.5 t-20 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.911 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.456 HH11 ' HG3' ' A' ' 97' ' ' ARG . 19.4 mmt85 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.812 0.339 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.9 pt -84.03 145.15 8.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.148 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.421 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 75.0 m -53.97 140.46 31.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.699 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.9 m -48.02 129.27 14.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.42 -179.53 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.57 ' HB2' HD12 ' A' ' 104' ' ' LEU . 17.6 ptpt -81.31 11.48 4.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.375 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.8 t -68.51 -39.75 81.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.036 0.446 . . . . 0.0 110.72 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.63 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.3 m-85 -61.73 -33.22 73.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.43 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.57 HD12 ' HB2' ' A' ' 101' ' ' LYS . 80.8 mt -45.63 -45.43 13.9 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.276 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t -92.52 138.53 31.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.501 179.339 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.811 HD22 ' HA3' ' A' ' 109' ' ' GLY . 6.6 tt -145.41 124.39 12.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.507 -179.268 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.473 ' O ' HD23 ' A' ' 106' ' ' LEU . 22.9 pt-20 -61.45 125.67 24.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.677 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 56.55 39.84 29.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.135 0.493 . . . . 0.0 110.09 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.811 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -161.72 174.94 38.29 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.121 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -142.01 137.55 31.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.792 0.33 . . . . 0.0 110.914 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.63 HG21 ' O ' ' A' ' 103' ' ' TYR . 94.0 t -109.73 132.43 57.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.009 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -111.76 133.13 54.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.624 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.71 ' HG ' HG12 ' A' ' 126' ' ' VAL . 6.1 mp -108.39 132.6 53.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.151 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.1 t -162.03 129.44 3.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.078 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 157.51 -39.43 0.54 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.373 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.31 -127.86 0.91 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.208 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -174.82 133.66 0.35 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.716 ' O ' HD12 ' A' ' 118' ' ' LEU . 4.3 pp -43.27 140.57 2.11 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -87.97 45.19 1.28 Allowed 'Cis proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.578 -1.426 . . . . 0.0 113.54 0.758 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.21 146.79 54.5 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.789 0.328 . . . . 0.0 110.778 179.544 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.446 HD13 ' C ' ' A' ' 121' ' ' LEU . 2.2 tm? -140.35 -52.0 0.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.154 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.98 44.99 0.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.759 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 169.42 61.1 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.134 -1.032 . . . . 0.0 113.022 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.66 125.62 4.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.955 0.407 . . . . 0.0 111.45 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.472 ' HG2' HG13 ' A' ' 143' ' ' VAL . 61.2 mtt85 -133.6 129.79 37.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.753 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.71 HG12 ' HG ' ' A' ' 113' ' ' LEU . 31.0 m -97.72 132.64 42.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 120.946 0.403 . . . . 0.0 111.501 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -98.16 124.98 42.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.764 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 126' ' ' VAL . 5.2 m-85 -93.18 143.93 25.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.965 0.412 . . . . 0.0 110.986 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -158.96 127.46 5.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.197 179.153 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 136' ' ' LEU . 49.8 t -89.27 144.93 25.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.263 -179.042 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.78 152.1 7.39 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.937 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.497 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 3.7 Cg_endo -46.66 156.66 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.961 2.441 . . . . 0.0 111.928 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 62.7 t0 78.64 -35.54 0.18 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.584 -179.217 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.712 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 0.6 OUTLIER -108.33 135.5 49.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.058 179.287 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -112.96 134.02 54.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.551 -179.575 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 137' ' ' VAL . 7.4 tt -79.02 132.89 36.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.203 179.508 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.521 ' N ' HD23 ' A' ' 136' ' ' LEU . 46.3 t -128.6 77.91 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.584 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . 173.88 -124.42 1.04 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.838 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.829 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 26.8 t -71.25 60.37 0.29 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.958 0.409 . . . . 0.0 111.263 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 128' ' ' PHE . 35.4 t -58.05 -23.74 55.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -140.64 139.78 34.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.705 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.577 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 63.3 m -144.53 130.3 19.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.9 0.381 . . . . 0.0 111.322 -179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.472 HG13 ' HG2' ' A' ' 125' ' ' ARG . 32.1 t -97.6 133.02 41.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.074 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 50.4 t -80.5 50.87 1.36 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.986 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 62.8 m -80.24 134.85 36.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.902 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 37.4 tt0 50.67 46.96 25.14 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.487 179.179 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 51.94 44.51 56.04 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.317 179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -165.48 142.79 5.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.738 0.304 . . . . 0.0 110.282 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 142' ' ' SER . 55.3 m95 -84.2 139.88 32.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.917 0.389 . . . . 0.0 111.046 -179.34 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -56.5 -51.66 67.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.375 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 29.0 p -118.85 134.28 23.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.804 0.335 . . . . 0.0 111.898 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.419 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 39.6 Cg_endo -66.52 145.36 76.34 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.985 2.456 . . . . 0.0 112.461 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.434 ' NZ ' ' HG ' ' A' ' 106' ' ' LEU . 60.8 tttm -46.76 127.35 8.44 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.949 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.829 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 68.4 Cg_endo -89.24 -141.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.096 2.531 . . . . 0.0 113.343 -179.311 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.486 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.2 p-80 -153.71 146.67 24.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.101 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.712 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 22.3 t -97.39 133.07 42.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 111.179 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -103.04 137.03 41.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.948 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.9 p -88.9 133.12 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 179.722 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.935 -179.837 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.742 0.306 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -174.17 43.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.12 136.21 57.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.448 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 1.6 m-85 -62.39 134.65 56.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.802 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.748 HG23 HG23 ' A' ' 98' ' ' ILE . 20.4 m -58.73 134.41 23.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.241 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -78.9 57.53 2.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.455 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.748 HG23 HG23 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -51.39 140.33 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.379 . . . . 0.0 111.28 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.627 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 87.2 m -55.28 157.79 3.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.061 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.7 p -47.69 128.54 13.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.328 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.577 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 10.1 mtmp? -80.44 -21.51 42.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.206 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.4 p -53.13 -40.97 64.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.573 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.68 ' HA ' ' HE3' ' A' ' 153' ' ' LYS . 2.6 m-85 -52.91 -31.29 39.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.551 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.449 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 96.6 mt -50.66 -42.89 57.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.816 0.341 . . . . 0.0 110.916 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.7 m -95.03 142.22 27.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.054 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.449 HD13 ' HD2' ' A' ' 153' ' ' LYS . 47.3 tp -145.31 127.7 15.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.833 0.349 . . . . 0.0 110.893 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -73.01 144.24 47.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.158 0.504 . . . . 0.0 111.276 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 57.91 32.85 22.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.241 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.426 ' CA ' ' HA ' ' A' ' 130' ' ' CYS . . . -176.98 -166.9 34.67 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.771 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -142.0 145.17 34.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.724 0.297 . . . . 0.0 110.786 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 103' ' ' TYR . 72.7 t -106.29 135.45 44.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.016 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.711 ' O ' HG23 ' A' ' 126' ' ' VAL . 2.7 m-85 -110.24 120.52 42.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.286 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.522 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.9 mm? -103.27 147.11 27.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.489 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.9 m -157.02 132.93 9.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.431 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 64.03 49.89 64.22 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.096 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.624 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . 178.08 136.47 2.53 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.996 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -174.93 124.38 0.26 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.568 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 7.2 tt -51.41 137.48 30.57 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.891 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.53 ' HA ' ' HG ' ' A' ' 118' ' ' LEU . 71.2 Cg_endo -89.19 60.42 0.31 Allowed 'Cis proline' 0 C--N 1.345 0.393 0 C-N-CA 123.558 -1.434 . . . . 0.0 113.02 0.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.568 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -155.61 162.1 40.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.597 0.237 . . . . 0.0 110.822 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.895 HD12 ' N ' ' A' ' 122' ' ' ASP . 1.7 pp -168.35 -34.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.744 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.895 ' N ' HD12 ' A' ' 121' ' ' LEU . 63.2 t0 36.38 51.13 0.82 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.925 0.393 . . . . 0.0 110.959 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.8 47.84 52.88 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.837 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.624 ' HB2' ' HA3' ' A' ' 116' ' ' GLY . . . -54.74 139.19 40.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.989 0.423 . . . . 0.0 111.697 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -107.27 151.51 25.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.379 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 112' ' ' PHE . 5.1 p -143.66 133.46 20.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.407 0.623 . . . . 0.0 112.232 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -105.04 131.58 52.37 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.543 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -102.8 143.52 32.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.004 0.43 . . . . 0.0 111.732 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -162.94 125.15 2.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.383 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.426 ' HA ' ' CA ' ' A' ' 109' ' ' GLY . 63.9 m -89.27 170.11 10.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.207 0.527 . . . . 0.0 112.222 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.7 157.01 2.85 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.636 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.87 69.37 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.025 2.483 . . . . 0.0 112.413 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -173.25 -31.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.861 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.804 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 3.7 m-85 -108.14 132.93 53.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.833 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.461 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 18.9 p-80 -102.13 125.98 48.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.012 0.434 . . . . 0.0 110.726 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.648 HD21 ' HA ' ' A' ' 140' ' ' SER . 20.5 tp -72.65 126.9 31.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.042 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 137' ' ' VAL . 22.0 t -135.39 60.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.584 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -170.59 -131.38 1.33 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 119.801 -1.19 . . . . 0.0 113.419 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.601 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 56.6 p -73.53 55.32 0.49 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 111.431 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.648 ' HA ' HD21 ' A' ' 136' ' ' LEU . 42.3 t -57.88 -42.11 83.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.136 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -99.37 132.24 44.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.068 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.0 p -149.84 145.02 26.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.302 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 124' ' ' ALA . 7.2 p -138.62 134.41 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.998 0.428 . . . . 0.0 111.698 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.652 ' SG ' HD22 ' A' ' 121' ' ' LEU . 37.9 t -67.46 134.87 52.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.023 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.1 m -165.63 130.03 2.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.072 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 50.9 tt0 53.62 45.25 28.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.966 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 56.91 43.51 92.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.603 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -173.12 140.56 0.89 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.352 . . . . 0.0 110.652 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.627 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 28.5 m95 -84.24 140.99 31.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.732 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 67.1 m -52.82 -56.51 15.24 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.015 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.42 ' HB ' ' HB2' ' A' ' 139' ' ' SER . 60.6 p -117.65 133.59 23.28 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.05 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.492 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 43.9 Cg_endo -67.8 -155.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.548 2.166 . . . . 0.0 112.758 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.68 ' HE3' ' HA ' ' A' ' 103' ' ' TYR . 27.8 mmtp -81.05 129.3 67.85 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.288 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.601 ' HB3' ' N ' ' A' ' 139' ' ' SER . 83.0 Cg_endo -81.61 -146.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.837 2.358 . . . . 0.0 112.242 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.442 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 24.3 p-80 -153.66 126.29 8.17 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.93 0.395 . . . . 0.0 111.328 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.804 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 76.2 m -99.13 130.34 45.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.156 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.461 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 4.3 tp-100 -103.92 140.14 38.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.005 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.456 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 9.7 p -75.35 136.09 25.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.388 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.18 -0.914 . . . . 0.0 110.94 -179.548 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.782 0.325 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.86 134.76 55.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.177 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.581 ' HG2' ' CD1' ' A' ' 95' ' ' PHE . 7.5 pm0 -72.23 -129.28 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.002 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.581 ' CD1' ' HG2' ' A' ' 94' ' ' GLU . 4.8 m-85 68.27 133.88 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.85 0.357 . . . . 0.0 111.091 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.6 m -149.24 135.81 12.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.861 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.431 ' O ' HG23 ' A' ' 98' ' ' ILE . 39.5 ptt180 -66.56 130.96 44.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.228 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.456 ' HB ' HD13 ' A' ' 121' ' ' LEU . 20.9 pt -157.83 43.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.032 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.493 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 90.1 m 62.18 139.18 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.748 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.5 m -47.88 131.51 15.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.399 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -83.75 -28.64 28.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.079 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.2 p -53.18 -35.49 59.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.509 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.848 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.8 m-85 -50.86 -36.39 37.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.41 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.532 HD21 HG23 ' A' ' 114' ' ' THR . 88.4 mt -53.44 -44.45 68.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.955 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.1 m -92.55 133.99 35.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.25 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.2 tp -145.39 132.77 20.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.692 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.31 131.53 50.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.672 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 54.66 44.93 27.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.662 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.03 165.36 34.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.509 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -141.88 151.41 42.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.005 0.431 . . . . 0.0 110.942 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.504 HG11 ' HB ' ' A' ' 126' ' ' VAL . 95.1 t -111.18 141.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.253 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.402 ' CE1' ' HD2' ' A' ' 129' ' ' ARG . 3.7 m-85 -106.57 134.46 49.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.406 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.664 HD23 ' N ' ' A' ' 114' ' ' THR . 6.3 tt 69.79 129.96 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.374 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.664 ' N ' HD23 ' A' ' 113' ' ' LEU . 92.0 m -109.37 -45.99 3.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.929 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.61 ' HA3' ' HA ' ' A' ' 124' ' ' ALA . . . 79.92 53.44 4.24 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.26 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -142.19 150.67 22.29 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.462 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -159.67 65.81 0.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.967 0.413 . . . . 0.0 110.034 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.529 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 90.2 mt -38.39 137.77 0.78 Allowed Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.171 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -89.03 59.9 0.32 Allowed 'Cis proline' 0 CA--C 1.531 0.366 0 C-N-CA 123.762 -1.349 . . . . 0.0 113.265 0.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.529 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -164.13 126.3 2.38 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.927 0.394 . . . . 0.0 111.471 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.778 ' HG ' ' HB2' ' A' ' 124' ' ' ALA . 26.6 tp -78.87 -55.84 4.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.481 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.7 t70 38.37 109.13 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 55.46 54.6 33.42 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.728 -0.669 . . . . 0.0 114.224 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.778 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . . . -73.66 132.5 42.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.948 0.374 . . . . 0.0 110.894 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.548 ' HB2' HD22 ' A' ' 113' ' ' LEU . 62.2 mtt85 -137.97 153.63 49.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.583 HG22 ' CZ3' ' A' ' 149' ' ' TRP . 12.5 m -154.6 131.04 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.946 0.403 . . . . 0.0 111.322 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -107.59 117.78 34.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.32 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.472 ' HB2' ' CA ' ' A' ' 140' ' ' SER . 4.6 m-85 -86.56 141.38 29.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.121 0.486 . . . . 0.0 111.516 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.471 ' HG2' HH11 ' A' ' 129' ' ' ARG . 3.5 ptp85 -161.01 128.95 4.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.761 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 136' ' ' LEU . 20.7 t -89.2 147.41 24.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.744 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.655 ' OD1' ' HD2' ' A' ' 132' ' ' PRO . 36.4 t70 -52.72 145.75 20.56 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.906 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.655 ' HD2' ' OD1' ' A' ' 131' ' ' ASP . 3.2 Cg_exo -40.45 157.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.596 2.864 . . . . 0.0 112.545 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 55.6 m-20 80.93 -40.31 0.15 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.408 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -106.32 128.99 54.41 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.454 ' HE1' ' HA ' ' A' ' 159' ' ' ASN . 16.9 p-80 -102.76 128.32 49.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.973 0.416 . . . . 0.0 110.981 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.787 HD11 ' HG2' ' A' ' 154' ' ' PRO . 20.5 tp -74.55 127.33 32.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.497 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.6 t -131.13 72.2 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.79 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 154' ' ' PRO . . . -167.55 56.72 0.22 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.799 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.673 ' OG ' HG21 ' A' ' 151' ' ' THR . 41.1 t 51.46 65.05 1.61 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.472 ' CA ' ' HB2' ' A' ' 128' ' ' PHE . 96.0 p -70.43 38.81 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.53 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.409 ' H ' ' C ' ' A' ' 139' ' ' SER . 40.1 ttm180 -141.21 133.99 28.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.209 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.512 ' HB2' HG23 ' A' ' 126' ' ' VAL . 64.7 m -146.21 140.33 26.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.941 0.401 . . . . 0.0 111.319 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.513 ' HA ' ' HZ3' ' A' ' 149' ' ' TRP . 7.2 p -144.47 129.48 14.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.873 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 71.9 m -71.49 156.28 39.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.582 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.9 t -158.72 -29.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.471 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -149.29 48.08 0.97 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.719 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.82 35.49 89.72 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.493 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -159.19 146.81 17.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.706 0.288 . . . . 0.0 110.462 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.583 ' CZ3' HG22 ' A' ' 126' ' ' VAL . 68.3 m95 -84.19 142.22 30.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.864 0.364 . . . . 0.0 110.777 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 142' ' ' SER . 46.9 t -47.91 -45.52 30.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.141 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.673 HG21 ' OG ' ' A' ' 139' ' ' SER . 61.6 p -136.61 143.94 45.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.838 0.352 . . . . 0.0 111.797 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.496 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 24.0 Cg_exo -64.01 -159.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.856 2.371 . . . . 0.0 112.818 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.848 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 14.4 mmmm -86.12 127.14 62.94 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.263 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.787 ' HG2' HD11 ' A' ' 136' ' ' LEU . 92.4 Cg_endo -79.89 -149.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.741 2.294 . . . . 0.0 112.637 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.506 ' O ' HD12 ' A' ' 136' ' ' LEU . 17.9 p-80 -153.7 150.04 28.14 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.073 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 77.8 m -97.43 138.1 35.38 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.381 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -108.55 136.05 48.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.554 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.462 ' O ' HG22 ' A' ' 158' ' ' VAL . 11.4 p -82.47 52.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.498 0.666 . . . . 0.0 110.301 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.454 ' HA ' ' HE1' ' A' ' 135' ' ' HIS . 76.1 m-20 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.374 -0.822 . . . . 0.0 111.069 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.4 ' HG3' ' N ' ' A' ' 93' ' ' ALA . 22.7 pt-20 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.671 0.272 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' A' ' 92' ' ' GLU . . . -177.21 136.89 0.21 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.066 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 64.9 135.56 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.428 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.8 t80 60.48 109.76 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.298 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.914 HG23 HD12 ' A' ' 98' ' ' ILE . 27.7 m -82.57 130.63 35.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.008 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -89.62 44.47 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.962 0.411 . . . . 0.0 111.039 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.914 HD12 HG23 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.15 138.36 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.166 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.596 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 75.6 m -60.58 140.99 57.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.677 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.2 m -47.87 128.71 13.7 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.53 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.743 ' HA ' HD13 ' A' ' 104' ' ' LEU . 26.3 ttpp -82.76 11.01 6.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.6 t -68.31 -40.46 81.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.332 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.653 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.3 m-85 -59.59 -40.73 88.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.413 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.743 HD13 ' HA ' ' A' ' 101' ' ' LYS . 6.8 mp -49.28 -43.62 43.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.6 0.238 . . . . 0.0 111.295 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.4 t -92.56 126.06 37.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.861 0.362 . . . . 0.0 110.765 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.716 HD22 ' HZ2' ' A' ' 153' ' ' LYS . 14.0 tp -145.7 133.16 20.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.465 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.42 ' H ' HD12 ' A' ' 106' ' ' LEU . 44.7 tt0 -71.55 134.32 46.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.345 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 57.74 40.7 26.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.632 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -179.56 156.98 19.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.937 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -123.47 141.78 51.65 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.653 HG21 ' O ' ' A' ' 103' ' ' TYR . 90.5 t -109.94 142.36 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.253 0.549 . . . . 0.0 112.003 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.551 ' HB2' ' HG3' ' A' ' 127' ' ' GLU . 4.6 m-85 -103.42 139.87 38.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.738 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.629 ' HA ' HG22 ' A' ' 126' ' ' VAL . 1.5 pt? -139.21 57.69 1.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.029 0.442 . . . . 0.0 111.793 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.9 p -54.48 142.81 26.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.698 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.67 137.95 5.08 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.235 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 178.03 149.58 8.09 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.358 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -151.02 58.1 0.91 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.544 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 2.0 pt? -40.6 136.17 1.48 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.159 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -89.05 61.18 0.27 Allowed 'Cis proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.663 -1.39 . . . . 0.0 113.254 0.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.544 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -165.56 130.81 2.49 Favored 'General case' 0 C--O 1.23 0.064 0 CA-C-O 120.895 0.379 . . . . 0.0 111.335 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.879 HD23 ' H ' ' A' ' 121' ' ' LEU . 1.1 pt? -112.56 48.65 0.98 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.991 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -62.77 133.37 54.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.64 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.86 33.34 82.89 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.489 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 143' ' ' VAL . . . -78.11 135.07 37.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.691 0.281 . . . . 0.0 110.966 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -105.08 136.42 44.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.018 0.437 . . . . 0.0 110.422 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.629 HG22 ' HA ' ' A' ' 113' ' ' LEU . 2.6 t -132.08 137.1 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.957 -178.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.551 ' HG3' ' HB2' ' A' ' 112' ' ' PHE . 9.3 pt-20 -132.66 117.48 17.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.921 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.537 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 2.9 m-85 -77.4 147.53 35.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.211 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -145.8 117.75 8.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.663 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 16.9 t -89.22 147.67 24.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 111.254 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -52.71 152.1 7.26 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.312 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.495 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 1.1 Cg_endo -44.44 158.38 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.366 2.711 . . . . 0.0 112.738 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.495 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 38.5 t70 77.98 -31.89 0.16 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.959 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -108.89 127.18 53.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.679 0.276 . . . . 0.0 110.511 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -104.95 135.36 46.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 110.903 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.778 HD11 ' HG2' ' A' ' 154' ' ' PRO . 25.7 tp -71.58 133.35 45.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.466 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 137' ' ' VAL . 24.6 t -132.69 61.37 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.538 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -168.41 -135.58 1.91 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.914 -1.136 . . . . 0.0 113.091 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.588 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 93.4 p -74.26 61.82 0.9 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.808 0.337 . . . . 0.0 111.039 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 91.3 p -63.14 4.41 0.2 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.413 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.488 ' H ' ' C ' ' A' ' 139' ' ' SER . 16.8 ptm180 -140.53 133.9 29.84 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.955 0.407 . . . . 0.0 110.944 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 54.9 m -150.73 140.76 22.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.868 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 124' ' ' ALA . 14.2 p -126.93 131.86 70.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.996 0.427 . . . . 0.0 111.63 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 52.6 t -80.49 148.29 30.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.271 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 89.2 p -150.67 -137.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.936 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.504 ' H ' ' CD ' ' A' ' 146' ' ' GLN . 14.7 mp0 -55.88 -38.62 70.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.94 0.4 . . . . 0.0 110.55 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 148' ' ' GLN . . . 179.93 145.46 6.44 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.708 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.458 ' HB3' ' O ' ' A' ' 147' ' ' GLY . 12.1 tp-100 69.67 147.74 0.07 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.915 0.388 . . . . 0.0 110.633 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.596 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 26.9 m95 -84.16 147.52 27.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.234 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.6 t -51.85 -55.02 22.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.106 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.559 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 74.8 p -123.39 134.58 25.3 Favored Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.66 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.82 143.19 95.67 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.825 2.35 . . . . 0.0 111.879 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.716 ' HZ2' HD22 ' A' ' 106' ' ' LEU . 21.9 ttmm -42.45 133.33 2.74 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 111.601 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.778 ' HG2' HD11 ' A' ' 136' ' ' LEU . 73.5 Cg_endo -75.26 -143.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.88 2.386 . . . . 0.0 112.678 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.476 ' O ' HD12 ' A' ' 136' ' ' LEU . 5.8 p80 -153.68 154.43 34.11 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.292 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 89.6 m -95.7 140.37 30.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.065 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -132.96 144.41 50.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.262 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.2 p -75.11 133.52 31.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.457 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.9 p30 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.966 -179.617 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.589 0.233 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 57.96 46.38 16.65 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.809 0.337 . . . . 0.0 111.131 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 96' ' ' VAL . 57.6 mp0 -63.34 138.14 58.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.968 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.56 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -58.36 -41.03 83.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.445 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 94' ' ' GLU . 59.8 t 66.01 140.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.712 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 62.27 55.82 2.3 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.124 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.789 ' HA ' HD12 ' A' ' 121' ' ' LEU . 38.6 pt -55.49 147.12 4.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 39.4 m -47.28 148.42 1.28 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.027 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.43 ' HB2' ' CD1' ' A' ' 149' ' ' TRP . 54.1 m -47.85 127.17 11.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.057 0.456 . . . . 0.0 111.252 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -85.25 -25.21 27.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.27 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.2 m -53.08 -41.15 64.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.552 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.479 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 1.4 m-85 -56.46 -41.57 76.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.887 0.375 . . . . 0.0 110.713 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.5 mt -59.9 -35.3 74.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.0 p -91.87 77.92 5.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.162 0.506 . . . . 0.0 110.569 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.721 HD22 ' HA3' ' A' ' 109' ' ' GLY . 7.2 tt -93.88 125.47 38.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.577 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.506 ' O ' HD23 ' A' ' 106' ' ' LEU . 24.6 pt-20 -68.1 127.61 33.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 62.94 48.47 3.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 0.0 110.583 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.721 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -158.56 -163.47 12.96 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.62 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.569 ' HB3' ' NZ ' ' A' ' 110' ' ' LYS . 8.2 mtpm? -144.02 -41.6 0.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.57 HG23 ' HA ' ' A' ' 128' ' ' PHE . 13.7 p 52.02 136.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 123.594 0.758 . . . . 0.0 112.581 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -108.11 142.74 37.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.586 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.442 HD12 ' H ' ' A' ' 114' ' ' THR . 24.9 tp -120.31 136.15 54.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.608 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.442 ' H ' HD12 ' A' ' 113' ' ' LEU . 68.5 p -145.0 139.1 27.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.211 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 66.36 44.1 91.25 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.457 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -179.49 130.6 1.53 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.974 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.831 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 54.3 m-20 -160.25 121.35 3.06 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.953 HD12 ' HA ' ' A' ' 119' ' ' PRO . 40.6 tp -38.58 133.51 1.01 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.279 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.953 ' HA ' HD12 ' A' ' 118' ' ' LEU . 77.1 Cg_endo -92.43 44.69 2.24 Favored 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.56 -1.433 . . . . 0.0 113.399 0.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.831 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -81.12 148.26 29.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.803 0.335 . . . . 0.0 111.209 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 98' ' ' ILE . 3.6 tt -162.45 79.27 0.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.309 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -167.07 122.07 1.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.595 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.7 31.16 29.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.718 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.594 ' O ' HG23 ' A' ' 143' ' ' VAL . . . -75.9 127.66 33.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.631 0.253 . . . . 0.0 110.804 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -125.46 143.4 51.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 111.021 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.24 135.7 56.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.133 0.492 . . . . 0.0 111.598 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.43 ' HG3' ' HE ' ' A' ' 141' ' ' ARG . 88.3 tt0 -109.36 88.83 2.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.312 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.57 ' HA ' HG23 ' A' ' 111' ' ' VAL . 67.0 m-85 -55.44 141.64 35.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 111.178 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.467 ' HG2' HH11 ' A' ' 129' ' ' ARG . 13.8 tpp85 -143.4 129.13 19.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.897 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 35.9 t -89.17 153.13 21.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.087 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -52.75 154.09 5.17 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.313 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 8.1 Cg_endo -49.64 155.47 3.71 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.802 2.334 . . . . 0.0 111.356 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 11.4 m-20 79.37 -29.74 0.14 Allowed 'General case' 0 N--CA 1.463 0.221 0 O-C-N 123.377 0.423 . . . . 0.0 110.098 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.775 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 1.6 m-85 -105.7 152.22 23.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.806 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -133.03 131.44 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.991 0.424 . . . . 0.0 111.442 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.505 HD21 ' HA ' ' A' ' 140' ' ' SER . 42.8 tp -69.37 133.81 48.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.428 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.0 t -131.33 70.93 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.905 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.27 -132.54 1.96 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.349 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.748 ' HB3' HG23 ' A' ' 151' ' ' THR . 49.4 m -73.15 58.82 0.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 122.712 0.405 . . . . 0.0 111.177 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.505 ' HA ' HD21 ' A' ' 136' ' ' LEU . 87.6 p -56.91 -28.13 61.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.688 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.435 HH11 ' HG3' ' A' ' 141' ' ' ARG . 20.1 mmt85 -109.95 139.21 45.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.991 0.424 . . . . 0.0 111.914 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.777 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 68.0 m -150.7 142.04 23.33 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.438 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.824 HG12 ' HB2' ' A' ' 150' ' ' SER . 7.7 p -145.49 137.34 20.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 111.648 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.494 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 41.3 m -60.36 159.03 10.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.73 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.8 t -162.8 -29.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.158 0.504 . . . . 0.0 110.67 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -166.68 57.07 0.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.975 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.6 37.84 89.76 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.541 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.423 ' HB3' ' H ' ' A' ' 149' ' ' TRP . 14.5 mm-40 -155.33 -149.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.045 0.45 . . . . 0.0 110.395 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.777 ' HB3' ' HB3' ' A' ' 142' ' ' SER . 86.6 m95 -146.54 155.6 42.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.329 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.824 ' HB2' HG12 ' A' ' 143' ' ' VAL . 47.5 t -41.93 -50.23 4.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.414 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.748 HG23 ' HB3' ' A' ' 139' ' ' SER . 1.5 t -147.44 145.89 23.15 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -47.15 156.99 0.7 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.431 2.754 . . . . 0.0 113.302 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.476 ' HE2' ' HG ' ' A' ' 106' ' ' LEU . 60.1 tttm -56.6 129.04 75.97 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.984 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.721 ' HB3' ' N ' ' A' ' 139' ' ' SER . 74.3 Cg_endo -75.02 -147.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.647 2.231 . . . . 0.0 112.568 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.423 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 23.2 p-80 -153.7 144.91 22.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.346 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.775 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 47.6 t -95.21 132.18 40.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.949 0.404 . . . . 0.0 110.575 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -116.69 138.54 51.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.952 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.32 131.71 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.167 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 25.0 p30 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.958 -179.565 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.843 0.354 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.31 -140.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.188 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.501 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -174.29 135.07 0.43 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.919 0.39 . . . . 0.0 111.047 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -70.86 -130.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.018 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.2 m -51.55 145.83 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.481 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.578 ' NH1' ' HA3' ' A' ' 147' ' ' GLY . 33.2 ptt85 -69.88 70.55 0.34 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.409 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.5 pt -53.77 154.46 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.345 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.486 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 84.1 m -46.38 141.57 3.48 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.971 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.7 m -47.9 124.76 7.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.822 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -81.88 -13.18 57.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.28 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.2 p -53.12 -38.06 62.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.253 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.916 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 5.4 m-85 -48.48 -31.83 6.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.43 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.6 mt -77.23 39.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.583 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.6 p -147.36 58.58 1.15 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.886 0.374 . . . . 0.0 110.373 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.662 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 35.6 tp -93.83 130.52 39.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.584 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -72.0 137.03 46.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.735 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.8 m120 59.31 40.82 20.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.075 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.24 -166.44 13.14 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.375 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 111' ' ' VAL . 54.5 mtpt -142.14 -41.06 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.441 0.12 . . . . 0.0 111.102 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.598 HG23 ' HA ' ' A' ' 128' ' ' PHE . 9.0 p 51.0 133.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.735 0.814 . . . . 0.0 112.903 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -112.15 -167.05 1.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.448 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.611 HD23 ' N ' ' A' ' 114' ' ' THR . 8.1 tt -173.33 141.48 0.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.285 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.611 ' N ' HD23 ' A' ' 113' ' ' LEU . 89.8 m -154.07 145.97 23.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.159 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.29 43.94 19.02 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.147 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . 174.28 140.57 3.31 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.067 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -166.47 129.83 1.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.739 0.304 . . . . 0.0 110.241 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.568 ' H ' HD12 ' A' ' 118' ' ' LEU . 5.7 mp -52.07 135.2 39.27 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.812 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 59.2 Cg_endo -94.35 63.27 0.36 Allowed 'Cis proline' 0 N--CA 1.46 -0.453 0 C-N-CA 124.098 -1.209 . . . . 0.0 113.059 0.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -149.53 134.03 17.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.882 0.373 . . . . 0.0 111.689 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.476 HD13 ' SG ' ' A' ' 144' ' ' CYS . 88.1 mt -102.35 -45.07 5.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.801 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.428 ' OD1' ' HA2' ' A' ' 116' ' ' GLY . 10.2 p-10 36.4 47.97 0.55 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.512 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.94 45.86 94.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.302 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.436 ' HB2' ' HA3' ' A' ' 116' ' ' GLY . . . -58.25 136.9 57.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.776 0.322 . . . . 0.0 111.112 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.757 ' HD3' ' HD3' ' A' ' 141' ' ' ARG . 38.6 ttm180 -118.43 119.22 33.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 142' ' ' SER . 12.1 p -84.86 148.84 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.045 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -133.7 76.79 1.68 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.233 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.625 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 79.9 m-85 -53.85 151.9 6.05 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.886 0.374 . . . . 0.0 111.058 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -157.11 135.83 11.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.637 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 134' ' ' PHE . 59.6 m -89.23 146.9 24.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.785 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' ASP . 63.4 m-20 -52.69 154.7 4.53 Favored Pre-proline 0 N--CA 1.463 0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.491 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.12 73.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.483 2.789 . . . . 0.0 113.033 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 131' ' ' ASP . 39.0 t70 178.75 -38.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 130' ' ' CYS . 3.2 m-85 -108.14 139.22 43.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.529 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -102.52 132.24 48.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.041 0.448 . . . . 0.0 110.794 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.742 HD22 ' HB2' ' A' ' 140' ' ' SER . 6.0 tt -75.14 128.15 34.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.183 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.584 ' N ' HD23 ' A' ' 136' ' ' LEU . 21.8 t -131.96 65.05 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.488 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.86 -129.49 1.31 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.304 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.818 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.5 t -71.4 57.19 0.25 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.597 0.359 . . . . 0.0 111.874 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.742 ' HB2' HD22 ' A' ' 136' ' ' LEU . 32.6 t -60.9 -16.6 43.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.122 0.487 . . . . 0.0 110.037 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.757 ' HD3' ' HD3' ' A' ' 125' ' ' ARG . 39.1 ttm180 -140.09 140.29 36.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.901 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.656 ' O ' HG12 ' A' ' 126' ' ' VAL . 33.5 m -149.16 122.62 9.09 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.209 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.591 HG12 ' HB3' ' A' ' 150' ' ' SER . 11.8 p -83.78 132.55 31.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 111.749 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.476 ' SG ' HD13 ' A' ' 121' ' ' LEU . 16.3 t -83.97 130.35 34.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.592 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 25.4 t -114.34 -139.48 0.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.543 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -64.96 -40.82 95.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.807 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.578 ' HA3' ' NH1' ' A' ' 97' ' ' ARG . . . -175.88 46.58 0.12 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.169 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -170.07 134.76 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.734 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.521 ' HZ3' ' HB ' ' A' ' 126' ' ' VAL . 32.4 m95 -84.21 141.43 31.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.582 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.591 ' HB3' HG12 ' A' ' 143' ' ' VAL . 79.2 p -52.66 -60.35 3.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.577 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 27.4 p -114.38 134.18 22.33 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 0.0 111.897 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 16.5 Cg_exo -67.37 150.56 80.98 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.104 2.536 . . . . 0.0 112.179 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.916 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 8.7 mtpm? -42.8 132.27 3.02 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.556 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.818 ' HB3' ' H ' ' A' ' 139' ' ' SER . 98.9 Cg_endo -79.43 -140.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.819 2.346 . . . . 0.0 112.998 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.487 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.0 p-80 -153.64 144.44 22.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.43 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 81.9 m -97.89 133.11 42.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.833 0.349 . . . . 0.0 111.068 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -123.62 140.54 52.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.541 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.82 132.37 31.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.488 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.7 p30 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.008 -179.531 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.573 0.225 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.1 -49.87 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.773 0.32 . . . . 0.0 111.13 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 41.4 tp10 55.49 49.19 17.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.113 0.483 . . . . 0.0 110.838 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -72.22 -133.73 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.393 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 119' ' ' PRO . 13.3 t -83.15 44.07 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 121.08 0.467 . . . . 0.0 110.917 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.54 ' O ' HD21 ' A' ' 121' ' ' LEU . 68.1 mtt-85 54.44 46.95 23.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.286 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.9 pt -54.22 140.79 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.36 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 72.8 m -56.3 127.0 28.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.7 t -48.01 128.36 13.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.37 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.894 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -90.23 25.83 2.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.807 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.0 p -68.82 -41.63 78.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.238 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.734 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 3.9 m-85 -56.95 -31.35 64.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.864 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.704 ' O ' HG22 ' A' ' 105' ' ' THR . 83.4 mt -53.99 146.72 13.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.761 -0.199 . . . . 0.0 111.098 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.704 HG22 ' O ' ' A' ' 104' ' ' LEU . 6.9 t 56.36 138.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.72 0.808 . . . . 0.0 112.367 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.7 tp -145.45 138.96 26.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.971 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.08 44.2 0.56 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.517 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -157.29 -30.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.858 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.661 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . -158.69 -141.36 3.12 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.947 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -139.47 152.26 46.86 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.912 0.386 . . . . 0.0 110.792 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.1 t -109.34 139.47 32.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.208 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.458 ' CE1' ' HD3' ' A' ' 129' ' ' ARG . 2.8 m-85 -108.34 137.56 46.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.05 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 125' ' ' ARG . 0.4 OUTLIER 71.85 133.97 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.697 -179.487 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.64 ' N ' HD13 ' A' ' 113' ' ' LEU . 66.1 p -126.69 -130.59 0.24 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.722 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.511 ' HA3' HD11 ' A' ' 118' ' ' LEU . . . -62.39 133.87 45.13 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.033 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.3 -48.87 75.35 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.835 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 118' ' ' LEU . 37.5 t70 -174.47 61.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.692 ' H ' HD12 ' A' ' 118' ' ' LEU . 7.2 mp -33.2 132.87 0.33 Allowed Pre-proline 0 N--CA 1.462 0.133 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.3 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.573 ' HB2' ' HB ' ' A' ' 96' ' ' VAL . 75.6 Cg_endo -85.89 46.11 0.85 Allowed 'Cis proline' 0 C--N 1.346 0.413 0 C-N-CA 123.661 -1.391 . . . . 0.0 113.49 0.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.417 ' H ' ' CA ' ' A' ' 118' ' ' LEU . . . -85.53 127.64 34.5 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.616 0.246 . . . . 0.0 111.185 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.676 HD23 ' H ' ' A' ' 147' ' ' GLY . 5.7 mp -101.89 -42.63 6.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.034 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.33 61.18 0.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.954 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -177.39 -32.89 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.323 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.59 129.29 25.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.915 0.388 . . . . 0.0 111.162 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.731 ' O ' HD12 ' A' ' 113' ' ' LEU . 55.2 ttp85 -135.24 156.11 49.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.745 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.573 HG13 ' CH2' ' A' ' 149' ' ' TRP . 16.1 m -152.25 135.93 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.871 0.367 . . . . 0.0 111.085 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 54.5 mt-10 -121.1 104.26 9.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.132 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.65 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 4.5 m-85 -78.57 143.78 36.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.205 0.526 . . . . 0.0 111.977 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.458 ' HD3' ' CE1' ' A' ' 112' ' ' PHE . 8.0 ptm180 -166.53 124.28 1.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.659 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.661 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 96.3 m -89.22 149.43 23.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.323 0.582 . . . . 0.0 112.453 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.467 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 59.8 m-20 -52.71 159.68 1.67 Allowed Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.939 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 18.2 Cg_endo -59.22 76.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.111 2.54 . . . . 0.0 112.454 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.3 t70 -175.63 -42.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.706 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 5.3 m-85 -108.83 131.86 54.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.416 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.798 ' CE1' ' HB2' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -101.23 121.6 42.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.245 0.545 . . . . 0.0 110.897 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.639 HD22 ' HB3' ' A' ' 140' ' ' SER . 5.5 tt -69.94 125.4 26.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.974 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.501 ' N ' HD23 ' A' ' 136' ' ' LEU . 15.0 t -134.32 63.13 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.578 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -169.98 -135.78 1.97 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.357 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.685 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 63.8 m -75.03 57.18 0.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.914 0.388 . . . . 0.0 111.037 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.639 ' HB3' HD22 ' A' ' 136' ' ' LEU . 99.1 p -51.65 -43.55 62.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.339 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -99.36 138.86 35.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.558 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 44.2 t -150.16 139.7 21.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.863 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.418 ' H ' ' HB3' ' A' ' 150' ' ' SER . 7.0 p -137.56 127.26 36.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.941 0.4 . . . . 0.0 111.222 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.427 ' HB2' ' CD2' ' A' ' 149' ' ' TRP . 45.8 t -87.71 149.31 24.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.591 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 38.4 t -167.13 30.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.207 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 52.8 tt0 175.7 43.32 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.85 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.676 ' H ' HD23 ' A' ' 121' ' ' LEU . . . 77.9 -51.07 3.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.975 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -88.42 149.37 23.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.573 ' CH2' HG13 ' A' ' 126' ' ' VAL . 81.7 m95 -84.15 146.27 27.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.911 0.386 . . . . 0.0 110.946 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 143' ' ' VAL . 48.3 t -45.0 -55.7 5.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.904 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 72.4 p -126.0 133.12 24.62 Favored Pre-proline 0 C--N 1.329 -0.308 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.775 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.438 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 23.7 Cg_exo -63.65 155.66 61.85 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.993 2.462 . . . . 0.0 112.326 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.734 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 55.1 mtpt -49.19 128.18 16.03 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.874 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.685 ' HB3' ' N ' ' A' ' 139' ' ' SER . 58.2 Cg_endo -71.4 -146.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.631 2.221 . . . . 0.0 112.582 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.423 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 22.5 p-80 -153.68 130.51 10.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.894 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.706 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 90.5 m -102.56 136.85 41.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.243 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.798 ' HB2' ' CE1' ' A' ' 135' ' ' HIS . 10.6 mm100 -104.21 147.85 26.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.106 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.3 p -72.73 129.02 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.363 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 45.6 p-10 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.101 -179.709 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.913 0.387 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -164.41 133.38 3.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.141 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.437 ' HB3' HG23 ' A' ' 96' ' ' VAL . 5.0 mm-40 -63.28 132.38 51.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.115 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -80.32 44.99 0.72 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.222 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 96' ' ' VAL . 21.8 t -80.05 49.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.032 0.444 . . . . 0.0 111.087 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -78.03 45.27 0.52 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.34 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.54 ' O ' HD12 ' A' ' 98' ' ' ILE . 2.4 pp -61.27 145.92 12.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.679 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.576 ' HB2' HD23 ' A' ' 121' ' ' LEU . 43.8 m -56.93 135.61 56.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.05 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.0 t -47.9 126.97 11.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.129 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.497 ' HB2' HD12 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -83.06 16.77 2.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.98 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -68.92 -45.72 70.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.301 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.647 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 10.7 m-85 -58.37 -32.15 68.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.796 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' A' ' 101' ' ' LYS . 86.8 mt -49.77 140.33 11.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.553 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.9 m 67.13 139.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.965 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.618 HD12 ' HD2' ' A' ' 128' ' ' PHE . 7.3 tt -145.07 127.7 16.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.308 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.53 ' O ' HD23 ' A' ' 106' ' ' LEU . 23.5 pt-20 -64.98 128.43 35.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 111.213 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 63.68 40.3 7.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.725 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.416 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -170.83 -163.88 25.61 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.548 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -142.37 141.93 32.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.795 0.331 . . . . 0.0 110.891 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.5 t -110.25 129.84 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.99 0.424 . . . . 0.0 110.969 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.407 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 1.2 m-85 -110.7 152.92 25.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.184 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.477 HD13 ' CG1' ' A' ' 126' ' ' VAL . 47.9 tp -154.48 134.03 12.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.008 0.432 . . . . 0.0 111.706 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.5 p -154.05 132.81 12.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.606 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . 164.38 -44.69 0.31 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.688 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -169.67 -127.84 0.96 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.403 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.463 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 56.4 m-20 -149.17 -138.57 0.09 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.61 0.243 . . . . 0.0 110.609 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.846 HD12 ' HA ' ' A' ' 119' ' ' PRO . 35.0 tp -125.17 127.44 25.02 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.78 0.324 . . . . 0.0 111.099 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.846 ' HA ' HD12 ' A' ' 118' ' ' LEU . 78.2 Cg_endo -90.99 37.98 4.81 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.266 -1.556 . . . . 0.0 112.713 -0.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.463 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -88.15 37.59 0.82 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.852 0.358 . . . . 0.0 111.481 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.576 HD23 ' HB2' ' A' ' 99' ' ' CYS . 28.1 tp -77.67 0.38 23.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.811 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.59 141.81 58.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.18 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.61 -38.27 1.89 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.151 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.408 ' HB2' ' HA3' ' A' ' 115' ' ' GLY . . . -51.04 142.82 11.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 0.0 111.615 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' A' ' 125' ' ' ARG . 20.3 ptt-85 -127.44 134.63 49.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.924 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.503 HG23 ' CE1' ' A' ' 128' ' ' PHE . 29.1 m -97.37 139.45 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.218 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -110.39 128.2 55.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.247 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.618 ' HD2' HD12 ' A' ' 106' ' ' LEU . 6.4 m-85 -99.94 141.85 32.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.43 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -150.99 132.15 14.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.297 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 69.1 m -89.16 154.17 20.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.959 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.548 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 1.1 m-20 -52.62 163.45 0.78 Allowed Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.334 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 55.7 Cg_endo -70.0 50.2 0.85 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.075 2.517 . . . . 0.0 113.212 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -149.49 -43.01 0.14 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.416 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 0.8 OUTLIER -108.92 140.72 42.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.833 179.21 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -100.99 128.57 46.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.984 0.421 . . . . 0.0 110.954 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.687 HD22 ' HB2' ' A' ' 140' ' ' SER . 6.1 tt -68.87 130.12 41.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.625 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.558 ' N ' HD23 ' A' ' 136' ' ' LEU . 24.1 t -135.18 63.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.657 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -166.82 -134.04 1.63 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.205 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.678 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 67.2 m -74.95 53.59 0.61 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.74 0.305 . . . . 0.0 111.159 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.687 ' HB2' HD22 ' A' ' 136' ' ' LEU . 35.0 t -52.06 -43.71 63.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 58.9 mtm-85 -99.41 132.42 44.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.803 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.3 m -145.63 137.6 25.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.762 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.406 HG23 ' HB3' ' A' ' 125' ' ' ARG . 7.3 p -138.08 129.34 37.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.966 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 48.8 t -93.71 134.07 36.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 90.4 p -115.44 -35.12 4.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -144.99 -140.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.093 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.74 41.25 2.33 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.491 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -174.94 136.64 0.4 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.809 0.337 . . . . 0.0 110.922 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -84.19 149.39 26.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.839 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -55.9 -65.27 0.63 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.558 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 42.9 p -106.8 139.07 20.01 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.34 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.434 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 21.9 Cg_exo -65.17 -155.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.706 2.271 . . . . 0.0 112.558 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.647 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 12.9 mmmm -92.67 131.94 32.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.335 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.678 ' HB3' ' N ' ' A' ' 139' ' ' SER . 89.6 Cg_endo -84.55 -155.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.798 2.332 . . . . 0.0 112.786 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -153.7 148.86 26.88 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.764 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 84.0 m -97.41 131.38 44.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.817 0.342 . . . . 0.0 110.865 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -110.36 141.1 43.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.016 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.14 128.47 38.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.425 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.018 -179.714 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.775 0.321 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.41 -135.92 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.197 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 57.83 42.31 23.47 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.964 0.411 . . . . 0.0 110.733 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -62.82 -41.74 99.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.972 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.408 ' CG2' HG23 ' A' ' 98' ' ' ILE . 23.1 m 42.67 -156.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.814 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.906 ' H ' ' HD2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -101.21 46.77 0.93 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.371 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.408 HG23 ' CG2' ' A' ' 96' ' ' VAL . 30.2 pt -56.4 139.38 15.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.918 0.389 . . . . 0.0 111.13 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 36.8 m -57.22 137.43 55.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.874 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.1 t -47.93 124.31 7.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.039 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.747 ' HB2' HD12 ' A' ' 104' ' ' LEU . 14.4 ptmm? -82.26 21.63 0.9 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.387 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.0 t -68.85 -45.13 71.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.918 0.39 . . . . 0.0 111.057 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.546 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.2 m-85 -60.15 -31.33 69.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.304 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.747 HD12 ' HB2' ' A' ' 101' ' ' LYS . 71.6 mt -52.29 -40.9 62.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.369 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t -92.48 129.1 38.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.917 0.389 . . . . 0.0 110.816 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.779 HD13 ' HE2' ' A' ' 153' ' ' LYS . 20.4 tp -145.39 124.65 12.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.304 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.66 129.97 41.47 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 59.1 37.13 24.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.979 0.419 . . . . 0.0 110.439 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -163.81 147.52 13.1 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.78 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -112.8 139.57 48.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.375 -0.413 . . . . 0.0 110.517 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.7 t -111.21 134.65 52.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.291 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.544 ' O ' HG23 ' A' ' 126' ' ' VAL . 3.1 m-85 -108.59 130.21 55.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.883 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.442 ' N ' HD22 ' A' ' 113' ' ' LEU . 3.6 mm? -104.69 140.96 37.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.664 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.6 t -155.06 138.58 15.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.034 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.92 127.91 0.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.308 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 164.81 -139.68 5.97 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.183 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -177.63 -62.42 0.01 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.224 0.535 . . . . 0.0 111.008 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.863 ' N ' ' HA ' ' A' ' 119' ' ' PRO . 3.4 tm? -74.15 -42.69 5.75 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.918 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.863 ' HA ' ' N ' ' A' ' 118' ' ' LEU . 96.5 Cg_endo -90.11 126.25 6.61 Favored 'Cis proline' 0 N--CA 1.454 -0.799 0 C-N-CA 124.03 -1.238 . . . . 0.0 112.944 0.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.577 ' N ' ' HB3' ' A' ' 118' ' ' LEU . . . -74.41 -23.6 58.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.783 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.431 ' C ' ' H ' ' A' ' 123' ' ' GLY . 88.2 mt 70.24 29.48 3.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.311 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.9 35.87 0.13 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.96 0.41 . . . . 0.0 111.094 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 121' ' ' LEU . . . 140.36 29.29 0.19 Allowed Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.05 146.77 33.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.921 0.391 . . . . 0.0 111.514 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -108.31 138.74 44.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.662 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 112' ' ' PHE . 12.7 p -127.57 136.74 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.115 0.484 . . . . 0.0 112.0 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -105.04 128.08 53.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.076 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.546 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 15.2 m-85 -98.45 139.29 34.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.0 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' A' ' 129' ' ' ARG . 46.7 mtp85 -150.0 129.59 13.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.75 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 40.0 t -89.2 144.87 25.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.29 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.8 154.76 17.03 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.321 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.479 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 6.0 Cg_endo -47.93 159.98 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.077 2.518 . . . . 0.0 112.17 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.51 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 61.5 t0 76.86 -26.96 0.18 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.374 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.763 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 2.7 m-85 -122.04 132.77 54.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.932 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.473 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -109.38 137.98 46.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.09 0.471 . . . . 0.0 112.01 -179.352 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 137' ' ' VAL . 6.4 tt -74.02 128.96 36.9 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.56 ' N ' HD23 ' A' ' 136' ' ' LEU . 42.9 t -128.05 74.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 171.33 -127.6 1.46 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.687 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.827 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.4 t -70.84 61.25 0.25 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.13 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.4 t -58.12 -20.76 42.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.922 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.738 ' HD3' ' H ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -129.31 143.87 51.01 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.801 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.7 m -150.25 144.59 25.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.282 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.7 p -140.31 134.38 35.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.057 0.456 . . . . 0.0 111.594 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 54.0 t -116.63 147.57 41.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.204 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 49.1 m -154.66 41.5 0.47 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 145' ' ' SER . 41.8 tt0 176.17 -57.4 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.897 0.379 . . . . 0.0 111.21 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.06 37.31 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -173.37 137.9 0.68 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -84.23 133.91 34.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.228 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -50.23 -64.03 0.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.934 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 33.4 p -92.55 138.25 24.0 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.2 146.32 63.25 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.784 2.323 . . . . 0.0 111.795 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.779 ' HE2' HD13 ' A' ' 106' ' ' LEU . 83.9 tttt -48.06 129.3 12.18 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.629 0.252 . . . . 0.0 110.796 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.827 ' HB3' ' H ' ' A' ' 139' ' ' SER . 89.8 Cg_endo -81.41 -152.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.647 2.231 . . . . 0.0 113.334 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.69 148.31 26.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.024 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.763 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 13.0 t -98.49 139.2 34.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.056 0.455 . . . . 0.0 111.246 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.473 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 34.3 tp60 -103.05 146.13 28.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.696 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 158' ' ' VAL . 6.5 p -66.71 81.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.348 0.594 . . . . 0.0 111.271 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.51 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 35.7 t30 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.942 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 92' ' ' GLU . 5.3 tp10 . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.113 0.482 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -174.14 42.52 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.878 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -152.05 -43.45 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.67 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 64.08 135.57 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.048 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.482 HG23 HH11 ' A' ' 97' ' ' ARG . 10.8 p -169.86 135.88 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.523 ' HG2' ' HA3' ' A' ' 147' ' ' GLY . 0.4 OUTLIER -56.98 126.64 28.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.917 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.907 ' H ' HD13 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -96.27 142.78 13.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.364 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 80.8 m -51.79 141.74 16.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.12 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.1 m -47.94 130.71 15.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.393 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -78.72 -6.89 57.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.086 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.9 p -55.88 -42.4 75.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.106 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.641 ' O ' HG21 ' A' ' 111' ' ' VAL . 2.1 m-85 -59.17 -35.4 73.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.437 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.8 mt -54.97 -47.3 74.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.682 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.1 m -92.56 130.81 38.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.839 0.352 . . . . 0.0 111.405 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.715 HD13 ' HE2' ' A' ' 153' ' ' LYS . 28.7 tp -145.44 127.86 15.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.834 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -66.71 130.65 43.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.301 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 57.13 41.16 27.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.026 0.441 . . . . 0.0 110.401 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.28 153.68 22.45 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.596 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -121.25 143.67 49.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.816 0.341 . . . . 0.0 110.76 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 103' ' ' TYR . 61.9 t -110.63 140.23 30.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.221 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -105.86 153.58 21.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.332 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.66 HD23 ' N ' ' A' ' 114' ' ' THR . 6.7 tt -153.33 135.06 14.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.884 0.373 . . . . 0.0 110.521 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.66 ' N ' HD23 ' A' ' 113' ' ' LEU . 89.2 m -156.21 125.64 6.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.784 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.89 -125.67 1.38 Allowed Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.833 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.32 -125.44 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.047 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.732 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 12.2 p-10 -173.36 128.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.726 ' O ' HD12 ' A' ' 118' ' ' LEU . 4.4 pp -38.66 138.04 0.8 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.317 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -85.88 35.64 3.63 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.424 -1.49 . . . . 0.0 113.097 0.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.732 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -90.73 46.42 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.981 0.42 . . . . 0.0 110.623 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.455 ' HG ' ' HB ' ' A' ' 98' ' ' ILE . 3.7 mm? -54.75 -39.94 68.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.342 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.28 139.96 58.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 0.0 111.011 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.43 -36.38 3.65 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.314 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.3 142.09 52.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.95 0.405 . . . . 0.0 111.51 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.581 ' HD3' ' N ' ' A' ' 125' ' ' ARG . 1.0 OUTLIER -108.51 139.87 42.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.23 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 142' ' ' SER . 21.8 m -124.67 142.75 40.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 111.961 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.485 ' OE1' ' HG2' ' A' ' 141' ' ' ARG . 5.2 mm-40 -121.44 119.62 32.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.83 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.547 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 3.1 m-85 -85.1 152.57 23.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.422 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.3 ttt-85 -163.34 125.77 2.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.903 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 100.0 m -89.19 142.18 27.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.375 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -55.34 158.18 5.8 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.573 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.538 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 1.1 Cg_endo -43.14 155.03 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.095 2.53 . . . . 0.0 112.186 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.6 m-20 79.43 -35.81 0.16 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.656 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 157' ' ' GLN . 5.9 m-85 -108.8 129.28 55.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.574 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.522 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -102.87 145.34 29.95 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 111.85 -179.587 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 137' ' ' VAL . 2.4 tm? -75.56 132.88 40.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.969 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.682 ' N ' HD13 ' A' ' 136' ' ' LEU . 7.4 p -135.65 70.38 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.518 ' CA ' ' HB3' ' A' ' 154' ' ' PRO . . . 171.23 -123.6 1.05 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.756 -1.211 . . . . 0.0 113.363 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.877 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 27.5 t -71.68 55.07 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.705 0.288 . . . . 0.0 111.775 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.553 ' HB3' HD12 ' A' ' 136' ' ' LEU . 94.3 p -56.16 -21.93 25.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.436 0.636 . . . . 0.0 109.322 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.485 ' HG2' ' OE1' ' A' ' 127' ' ' GLU . 62.4 mtm-85 -140.59 126.43 19.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.489 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.558 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 47.2 t -142.98 134.48 26.32 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.94 0.4 . . . . 0.0 111.418 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.8 t -98.24 134.18 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.637 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 144' ' ' CYS . 41.9 t -79.17 48.02 0.83 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 111.29 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 83.4 p -65.14 126.96 29.73 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 55.21 -140.0 0.95 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.523 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -106.5 37.47 3.81 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.098 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -155.41 143.87 20.34 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 122.261 0.224 . . . . 0.0 110.513 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.584 ' CE2' ' HB3' ' A' ' 99' ' ' CYS . 45.1 m95 -84.14 137.91 33.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.704 0.288 . . . . 0.0 110.418 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.9 t -57.19 -61.26 2.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.302 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.1 p -94.13 133.87 26.76 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.746 0.307 . . . . 0.0 111.759 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 139' ' ' SER . 36.7 Cg_endo -65.21 140.08 63.21 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.758 2.305 . . . . 0.0 112.152 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.715 ' HE2' HD13 ' A' ' 106' ' ' LEU . 86.9 tttt -42.56 131.62 2.89 Favored Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.526 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.877 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 84.6 Cg_endo -81.58 -158.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.881 2.387 . . . . 0.0 112.872 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.572 ' O ' HG12 ' A' ' 137' ' ' VAL . 12.5 p-80 -153.64 150.64 28.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.642 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 72.3 m -96.18 139.36 32.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.97 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.522 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 17.5 tt0 -130.59 133.68 46.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.711 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.6 124.72 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.959 0.409 . . . . 0.0 110.407 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.999 -179.418 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.813 0.339 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.14 -140.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.812 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 56.24 -146.51 0.56 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.073 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 63.45 137.37 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.065 0.46 . . . . 0.0 111.321 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.7 m -58.5 142.38 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.996 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.522 ' NE ' ' HA ' ' A' ' 97' ' ' ARG . 4.0 mmp_? -54.58 136.2 45.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.851 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.447 ' HB ' HD22 ' A' ' 121' ' ' LEU . 26.2 pt -151.02 46.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 75.6 m 63.01 131.75 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.966 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 87.4 p -47.97 126.42 10.58 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.897 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -78.34 -11.39 59.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.142 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.0 t -54.54 -36.58 64.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.043 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.501 ' CE2' ' HA ' ' A' ' 152' ' ' PRO . 2.0 m-85 -77.35 47.27 0.56 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.487 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.8 mt -133.86 20.13 3.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.942 0.401 . . . . 0.0 110.436 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.459 ' O ' ' HE3' ' A' ' 153' ' ' LYS . 86.0 m -147.43 132.65 18.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.509 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.402 HD22 ' HD2' ' A' ' 128' ' ' PHE . 25.4 tp -145.4 133.76 21.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.967 0.413 . . . . 0.0 111.443 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.664 ' HG2' ' OD1' ' A' ' 108' ' ' ASN . 33.2 tt0 -78.0 141.75 38.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.879 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.664 ' OD1' ' HG2' ' A' ' 107' ' ' GLU . 5.6 m120 63.17 30.15 16.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.81 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 176.12 -160.81 28.93 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.915 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.528 ' HG3' ' HE1' ' A' ' 112' ' ' PHE . 14.9 ptmm? -142.04 153.62 44.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.656 0.265 . . . . 0.0 110.412 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.65 137.92 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.075 0.464 . . . . 0.0 111.763 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.64 ' HB2' ' HG3' ' A' ' 127' ' ' GLU . 6.1 m-85 -107.74 146.15 32.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.308 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.579 HD23 ' H ' ' A' ' 113' ' ' LEU . 1.9 pt? -146.17 139.44 25.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.004 0.43 . . . . 0.0 111.041 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.8 t -168.83 133.98 1.62 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.969 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 140.6 -40.51 1.36 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.35 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 121' ' ' LEU . . . -66.32 150.15 51.74 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.058 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -136.74 56.32 1.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.69 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 1.6 pt? -39.36 127.72 1.36 Allowed Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.345 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 94.2 Cg_endo -84.73 74.09 0.07 OUTLIER 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 123.683 -1.382 . . . . 0.0 113.059 -0.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.69 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -168.69 58.44 0.06 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.837 0.351 . . . . 0.0 111.167 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.575 ' HA ' ' HA2' ' A' ' 116' ' ' GLY . 5.3 mp -74.92 37.98 0.12 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.334 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 120' ' ' ALA . 1.5 m-20 -72.26 132.2 43.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.914 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.5 37.36 94.56 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.926 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.39 137.0 52.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.538 0.208 . . . . 0.0 110.587 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' A' ' 125' ' ' ARG . 49.3 ttp85 -130.52 139.22 50.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.41 . . . . 0.0 111.374 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' A' ' 113' ' ' LEU . 30.7 m -130.11 138.22 54.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.125 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.64 ' HG3' ' HB2' ' A' ' 112' ' ' PHE . 13.9 pt-20 -114.98 124.47 51.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.497 ' HE2' ' HG2' ' A' ' 153' ' ' LYS . 2.0 m-85 -90.36 146.85 23.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.213 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.434 HH11 ' HG3' ' A' ' 129' ' ' ARG . 7.5 ptm180 -168.62 126.95 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.127 0.489 . . . . 0.0 111.12 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.524 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 69.5 m -89.76 157.39 17.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.382 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 133' ' ' ASP . 34.9 m-20 -52.7 149.66 10.83 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.536 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -52.25 81.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.178 2.585 . . . . 0.0 112.789 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 36.5 t70 178.67 -20.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.186 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 31.7 m-85 -129.38 132.93 47.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.723 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -102.81 127.22 50.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.038 0.447 . . . . 0.0 111.078 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.631 HD21 ' HA ' ' A' ' 140' ' ' SER . 16.5 tp -71.92 131.06 42.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.034 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 36.0 t -136.01 66.73 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.739 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.53 -134.73 1.88 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.247 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.753 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 67.9 m -75.03 51.77 0.53 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.795 0.331 . . . . 0.0 111.099 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.631 ' HA ' HD21 ' A' ' 136' ' ' LEU . 46.7 t -51.08 -39.05 55.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.746 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -99.45 133.15 44.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.572 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.4 t -145.33 119.41 9.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 0.0 110.697 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.8 p -108.78 125.34 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.088 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 149' ' ' TRP . 47.4 t -71.9 145.29 48.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.389 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.6 p -161.37 122.85 2.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.953 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 64.3 tt0 57.06 43.05 24.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.188 0.518 . . . . 0.0 109.839 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.55 -49.87 3.71 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.754 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -77.34 137.83 38.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.704 0.287 . . . . 0.0 111.362 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 144' ' ' CYS . 68.2 m95 -84.23 143.89 29.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.513 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 65.3 m -53.91 -61.42 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.745 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 60.5 p -111.98 134.56 21.37 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.677 0.275 . . . . 0.0 111.503 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.501 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 44.4 Cg_endo -68.23 -163.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.382 2.055 . . . . 0.0 112.166 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.596 ' HB3' ' NZ ' ' A' ' 153' ' ' LYS . 9.3 mtpm? -83.35 125.43 74.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.219 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.753 ' HB3' ' H ' ' A' ' 139' ' ' SER . 62.4 Cg_endo -73.73 -144.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.705 2.27 . . . . 0.0 112.376 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.413 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 19.8 p-80 -153.66 139.9 18.51 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.801 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 86.2 m -98.67 133.97 42.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.027 0.442 . . . . 0.0 111.217 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 12.3 tp-100 -103.07 142.69 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.198 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 82.7 t -53.57 102.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.945 0.402 . . . . 0.0 110.496 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 38.9 t30 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.115 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.883 0.373 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.1 -48.02 59.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.187 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.77 -20.21 65.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.964 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.574 ' HB3' HD13 ' A' ' 98' ' ' ILE . 1.8 m-85 -76.65 44.79 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.812 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.1 m -65.67 131.38 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.979 0.419 . . . . 0.0 111.923 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 37.4 45.86 0.59 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.483 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.795 ' HA ' HD11 ' A' ' 121' ' ' LEU . 16.1 pt -65.03 133.42 30.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.749 0.309 . . . . 0.0 110.821 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.738 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 69.7 m -56.29 138.78 50.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.455 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.5 m -47.97 132.0 15.31 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.603 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -89.76 11.41 20.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.13 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.1 t -66.35 -35.78 81.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 110.945 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.568 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 0.9 OUTLIER -55.98 -33.24 64.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.909 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.4 mt -57.03 146.43 27.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.985 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.8 m 65.18 132.4 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.352 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.757 HD13 ' HE2' ' A' ' 153' ' ' LYS . 28.1 tp -145.41 135.41 23.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.124 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 59.7 mp0 -69.85 131.29 44.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.269 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.0 m-20 57.81 39.6 26.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.456 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.556 ' HA2' ' H ' ' A' ' 131' ' ' ASP . . . -174.78 155.41 20.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.7 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -113.12 146.29 39.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.863 0.363 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.0 t -108.17 139.01 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.061 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.534 ' C ' HD12 ' A' ' 113' ' ' LEU . 3.4 m-85 -106.52 140.49 39.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.807 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 112' ' ' PHE . 5.2 mp -133.51 137.32 45.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 110.484 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.1 m -159.98 143.56 14.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.157 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.7 132.24 7.23 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.61 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 52.28 -149.58 9.59 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.83 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.698 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 7.8 t70 178.41 117.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.926 HD12 ' HA ' ' A' ' 119' ' ' PRO . 29.9 tp -40.19 134.3 1.48 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.502 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.926 ' HA ' HD12 ' A' ' 118' ' ' LEU . 66.8 Cg_endo -94.02 44.58 2.52 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.713 -1.37 . . . . 0.0 113.109 0.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.698 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -71.95 -49.73 34.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.139 0.495 . . . . 0.0 110.845 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.795 HD11 ' HA ' ' A' ' 98' ' ' ILE . 65.7 mt 54.76 40.89 32.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.533 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.664 ' OD1' ' HB1' ' A' ' 120' ' ' ALA . 1.2 m-20 -75.89 48.04 0.46 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.033 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.86 39.95 95.28 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.294 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.38 138.26 58.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.772 0.32 . . . . 0.0 110.849 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -107.84 140.92 40.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.735 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 32.8 m -129.06 141.02 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.994 0.426 . . . . 0.0 111.671 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 95.4 mt-10 -113.24 123.79 51.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.629 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.466 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 8.0 m-85 -90.23 52.06 2.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.55 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -61.72 129.17 39.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.783 0.325 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 79.9 m -89.25 142.29 27.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.399 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.556 ' H ' ' HA2' ' A' ' 109' ' ' GLY . 54.9 m-20 -57.75 158.37 12.32 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.306 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 2.2 Cg_endo -44.71 156.04 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.305 2.67 . . . . 0.0 112.382 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 1.7 m-20 73.58 -12.32 0.84 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.422 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.452 ' CE2' HG22 ' A' ' 158' ' ' VAL . 7.5 m-85 -130.64 137.3 49.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.77 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.666 ' ND1' ' HB2' ' A' ' 159' ' ' ASN . 14.1 p-80 -121.1 137.05 54.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.064 0.459 . . . . 0.0 111.608 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.743 HD12 ' HB2' ' A' ' 140' ' ' SER . 2.2 tm? -68.29 130.38 42.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.029 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.697 ' N ' HD13 ' A' ' 136' ' ' LEU . 21.3 t -134.35 62.52 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.524 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.452 ' H ' ' CD1' ' A' ' 136' ' ' LEU . . . -176.01 -133.43 1.77 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.018 -1.087 . . . . 0.0 113.227 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.653 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 66.8 m -74.44 56.31 0.66 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.565 0.346 . . . . 0.0 111.397 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.743 ' HB2' HD12 ' A' ' 136' ' ' LEU . 34.4 t -54.56 -39.57 67.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.106 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -99.36 130.2 45.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.093 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.1 m -147.04 146.77 30.13 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.57 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.36 132.03 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.032 0.444 . . . . 0.0 111.377 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.685 ' SG ' HD22 ' A' ' 121' ' ' LEU . 39.0 t -72.13 132.46 44.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.088 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.9 m -166.41 130.82 2.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.82 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 55.82 44.38 26.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.37 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 57.45 45.28 93.17 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.967 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -177.12 142.01 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.635 0.255 . . . . 0.0 110.643 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.738 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 45.7 m95 -84.15 145.14 28.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.882 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.8 t -51.93 -49.63 62.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.022 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 60.4 p -127.85 140.42 38.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.058 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 35.3 Cg_exo -60.33 -165.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.564 2.176 . . . . 0.0 112.476 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.757 ' HE2' HD13 ' A' ' 106' ' ' LEU . 84.5 tttt -86.56 125.29 67.81 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.653 ' HB3' ' N ' ' A' ' 139' ' ' SER . 73.6 Cg_endo -75.35 -151.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.562 2.175 . . . . 0.0 112.677 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -153.8 146.22 23.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.06 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 75.3 m -97.95 132.4 43.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.598 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -103.05 142.9 33.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.168 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.452 HG22 ' CE2' ' A' ' 134' ' ' PHE . 53.0 t -67.25 80.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.868 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.666 ' HB2' ' ND1' ' A' ' 135' ' ' HIS . 34.1 t30 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.048 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.774 0.321 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' A' ' 96' ' ' VAL . . . -169.09 -136.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.974 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.434 ' HG3' ' CD1' ' A' ' 95' ' ' PHE . 40.1 tp10 65.92 128.59 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.887 0.375 . . . . 0.0 110.978 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.434 ' CD1' ' HG3' ' A' ' 94' ' ' GLU . 2.5 m-85 54.51 36.1 24.93 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.023 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.693 HG12 ' HG3' ' A' ' 97' ' ' ARG . 91.8 t -99.61 137.28 27.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.312 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.693 ' HG3' HG12 ' A' ' 96' ' ' VAL . 23.4 mtm105 60.45 56.53 3.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.571 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.537 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -53.16 145.84 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.7 m -53.36 135.43 39.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.241 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.8 t -47.93 123.33 6.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.521 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -81.24 113.1 19.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.606 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.0 m -171.15 -41.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.171 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.873 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 1.6 m-85 -62.51 -28.7 70.02 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.074 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.428 HD21 ' HH2' ' A' ' 149' ' ' TRP . 61.4 mt -72.14 28.21 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.332 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.444 ' O ' ' HE3' ' A' ' 153' ' ' LYS . 64.5 p -147.48 127.61 13.76 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.914 0.388 . . . . 0.0 111.666 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.416 HD13 ' HZ1' ' A' ' 153' ' ' LYS . 27.9 tp -145.44 121.98 11.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.297 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -92.28 40.22 1.04 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -163.65 36.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.719 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.34 -146.45 11.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.837 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -141.56 139.37 33.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.528 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.6 t -105.97 136.6 39.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.981 0.419 . . . . 0.0 111.007 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 1.6 m-85 -107.83 145.78 33.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.408 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.715 HD23 ' N ' ' A' ' 114' ' ' THR . 6.7 tt -152.55 138.97 18.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.928 0.394 . . . . 0.0 110.846 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.715 ' N ' HD23 ' A' ' 113' ' ' LEU . 84.9 m -153.53 123.16 6.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.683 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.27 -38.51 0.28 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.104 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -168.2 -130.08 1.14 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.138 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.694 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 8.2 t70 -172.3 125.47 0.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.643 ' H ' HD12 ' A' ' 118' ' ' LEU . 6.8 mp -41.84 138.48 1.78 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.208 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -86.73 41.37 1.88 Allowed 'Cis proline' 0 C--N 1.347 0.465 0 C-N-CA 123.574 -1.428 . . . . 0.0 113.478 0.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.728 ' C ' HD22 ' A' ' 121' ' ' LEU . . . -92.49 129.87 38.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.831 0.348 . . . . 0.0 111.065 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.728 HD22 ' C ' ' A' ' 120' ' ' ALA . 3.8 mm? -131.47 51.13 2.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.585 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.88 59.66 1.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.931 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.91 42.27 99.61 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.578 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.52 141.22 57.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.724 0.297 . . . . 0.0 111.18 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -106.95 130.43 54.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.194 0.521 . . . . 0.0 110.733 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.44 134.3 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.59 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -118.31 123.89 46.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.306 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.547 ' CE2' ' HG2' ' A' ' 153' ' ' LYS . 19.0 m-85 -82.78 151.08 26.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.2 0.524 . . . . 0.0 111.942 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.413 ' HG2' HH11 ' A' ' 129' ' ' ARG . 15.4 tpp85 -153.46 121.97 6.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.644 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 9.2 t -102.38 144.63 30.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.035 0.445 . . . . 0.0 111.748 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -56.28 157.76 8.64 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.338 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.493 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 71.4 Cg_exo -48.82 163.14 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.765 2.31 . . . . 0.0 112.275 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.523 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 55.7 m-20 76.56 -32.53 0.2 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.847 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.869 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 1.4 m-85 -108.5 133.78 52.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.391 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.462 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 20.4 p-80 -112.95 137.34 51.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.972 0.415 . . . . 0.0 111.284 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.671 HD21 ' HA ' ' A' ' 140' ' ' SER . 18.7 tp -68.35 135.91 52.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.308 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 155' ' ' HIS . 14.8 p -136.74 60.01 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.822 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . 171.97 -123.42 1.02 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 119.172 -1.489 . . . . 0.0 113.692 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.811 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 39.9 t -65.11 66.06 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.866 0.365 . . . . 0.0 111.553 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.671 ' HA ' HD21 ' A' ' 136' ' ' LEU . 98.9 p -66.39 -14.81 62.68 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.266 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.616 ' HD3' ' H ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -140.62 138.16 34.18 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.973 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.475 ' HA ' ' HB3' ' A' ' 150' ' ' SER . 86.1 p -141.62 140.51 33.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.771 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.776 HG12 ' HB2' ' A' ' 150' ' ' SER . 7.3 p -134.75 132.84 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.063 0.459 . . . . 0.0 111.981 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 121' ' ' LEU . 41.5 t -79.34 149.98 31.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.828 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.1 t -147.79 -130.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.715 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -58.44 -42.72 87.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.643 0.259 . . . . 0.0 111.202 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 176.15 47.5 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.657 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -173.71 142.24 0.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.735 0.302 . . . . 0.0 110.696 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.428 ' HH2' HD21 ' A' ' 104' ' ' LEU . 59.0 m95 -84.2 153.36 23.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.074 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.776 ' HB2' HG12 ' A' ' 143' ' ' VAL . 43.2 t -48.08 -57.65 5.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.87 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.669 HG23 ' OG ' ' A' ' 139' ' ' SER . 0.5 OUTLIER -147.42 143.73 18.46 Favored Pre-proline 0 C--N 1.332 -0.163 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.543 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.52 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 31.4 Cg_exo -57.82 140.81 94.97 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.483 2.789 . . . . 0.0 112.716 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.873 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 9.0 mtpm? -49.81 137.35 18.87 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.024 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.822 ' HB3' ' HA3' ' A' ' 138' ' ' GLY . 85.2 Cg_endo -83.05 -140.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.989 2.459 . . . . 0.0 112.142 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.598 ' O ' HG12 ' A' ' 137' ' ' VAL . 18.9 p-80 -153.72 152.16 30.46 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.763 0.316 . . . . 0.0 110.999 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.869 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 71.1 m -94.95 127.37 40.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.555 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.462 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 69.8 tp60 -105.56 136.76 44.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.818 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.4 t -76.3 122.95 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.164 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 133' ' ' ASP . 24.4 p30 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.953 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.795 0.331 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.23 -42.78 95.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.255 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.485 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -62.69 131.49 49.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.631 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -65.97 -43.2 88.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.94 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 98' ' ' ILE . 60.3 t 66.77 139.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.011 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -49.69 136.16 17.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.369 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 96' ' ' VAL . 33.9 pt -137.43 145.71 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.923 0.392 . . . . 0.0 111.473 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 38.7 m -51.49 140.17 18.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.058 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.4 t -47.91 130.26 14.95 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.308 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.586 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -83.14 -28.44 29.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.235 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.1 m -68.89 38.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.779 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 6.8 m-85 -127.28 -46.92 1.47 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.573 0.225 . . . . 0.0 111.305 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.784 HD12 ' H ' ' A' ' 105' ' ' THR . 0.4 OUTLIER -52.92 -32.08 43.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.462 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.784 ' H ' HD12 ' A' ' 104' ' ' LEU . 41.9 p -96.29 135.37 38.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.663 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 34.5 tp -145.43 131.19 19.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 111.135 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.01 131.73 45.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.66 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 54.1 41.8 31.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.401 . . . . 0.0 110.6 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.53 148.56 9.51 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.522 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -104.09 151.75 22.9 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.953 0.406 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 104' ' ' LEU . 96.4 t -128.2 141.39 46.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.987 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.8 m-85 -105.83 134.3 49.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.84 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.656 HD13 ' N ' ' A' ' 114' ' ' THR . 2.7 tm? -109.18 131.76 54.76 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.656 ' N ' HD13 ' A' ' 113' ' ' LEU . 72.3 m -157.51 125.09 5.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.91 0.386 . . . . 0.0 111.107 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 157.93 -133.52 3.53 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.293 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.85 -135.24 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.394 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -160.17 123.4 3.49 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.585 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -53.27 136.41 50.18 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.003 -179.293 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 65.1 Cg_endo -90.21 63.16 0.26 Allowed 'Cis proline' 0 C--N 1.346 0.445 0 C-N-CA 123.834 -1.319 . . . . 0.0 113.032 0.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.531 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -155.43 57.21 0.63 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.779 0.323 . . . . 0.0 111.549 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 121' ' ' LEU . 5.2 mp -77.28 45.87 0.48 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.855 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.65 131.27 49.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 111.215 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.83 35.52 39.53 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.749 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.57 136.94 32.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.673 0.273 . . . . 0.0 111.35 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.454 ' NH2' HH21 ' A' ' 141' ' ' ARG . 15.9 ptm180 -130.55 130.29 43.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 110.789 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.48 HG23 ' HE1' ' A' ' 128' ' ' PHE . 23.2 m -100.27 139.81 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.027 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 46.6 mp0 -102.93 123.88 47.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.245 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.48 ' HE1' HG23 ' A' ' 126' ' ' VAL . 7.0 m-85 -91.31 143.04 27.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.144 0.497 . . . . 0.0 112.036 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.453 ' HD3' ' CE1' ' A' ' 112' ' ' PHE . 47.9 mtp85 -152.59 125.1 8.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.723 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 26.2 t -89.29 163.8 15.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.943 0.402 . . . . 0.0 111.462 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -52.79 156.71 3.13 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.306 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.08 52.44 1.84 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.286 2.658 . . . . 0.0 112.868 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -155.88 -37.72 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.121 0.486 . . . . 0.0 109.989 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.452 ' CE2' ' HB ' ' A' ' 158' ' ' VAL . 0.9 OUTLIER -108.32 146.53 32.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.724 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -100.08 132.99 45.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.137 0.494 . . . . 0.0 111.152 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.786 HD21 ' HA ' ' A' ' 140' ' ' SER . 27.9 tp -73.46 128.47 35.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.279 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.6 t -134.98 64.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.225 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.53 -123.52 0.72 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.005 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.931 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.4 t -71.17 52.28 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.678 0.391 . . . . 0.0 111.686 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.786 ' HA ' HD21 ' A' ' 136' ' ' LEU . 44.9 t -56.02 -26.35 48.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.066 0.46 . . . . 0.0 110.15 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.454 HH21 ' NH2' ' A' ' 125' ' ' ARG . 24.0 mmm180 -132.87 129.14 38.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.853 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.465 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 47.1 t -141.77 148.56 39.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.237 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 125' ' ' ARG . 7.3 p -144.04 131.35 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.818 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 45.4 t -68.47 144.11 54.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.595 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.6 t -172.72 129.51 0.52 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.546 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 56.6 43.93 24.79 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.05 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 57.31 42.75 93.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.315 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -174.33 140.18 0.64 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 0.0 110.498 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.444 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 56.0 m95 -84.24 140.81 31.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.937 0.399 . . . . 0.0 110.965 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.8 m -54.2 -60.64 3.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.478 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -94.32 129.08 38.13 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.739 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 139' ' ' SER . 73.7 Cg_endo -75.91 148.86 32.39 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.848 2.366 . . . . 0.0 112.273 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.779 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 14.1 mmmm -40.86 127.27 1.96 Allowed Pre-proline 0 N--CA 1.464 0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 111.267 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.931 ' HB3' ' H ' ' A' ' 139' ' ' SER . 91.5 Cg_endo -83.77 -149.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.972 2.448 . . . . 0.0 113.571 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.405 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 17.8 p-80 -153.75 150.09 28.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.337 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 82.7 m -94.95 127.63 41.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.799 0.333 . . . . 0.0 110.933 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -103.48 137.09 42.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.52 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 134' ' ' PHE . 11.7 p -86.62 131.29 35.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.432 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.829 -179.598 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.798 0.332 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 59.54 48.05 10.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.482 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -174.08 47.41 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.188 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -172.36 146.08 1.76 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.178 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.1 p -176.39 136.07 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.258 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 97' ' ' ARG . 29.4 tpt180 52.21 54.74 10.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.074 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.663 ' HB ' ' HG ' ' A' ' 121' ' ' LEU . 35.7 pt -55.56 142.48 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.088 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.488 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 95.1 m -51.09 135.77 24.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.362 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.8 t -47.97 127.48 12.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.301 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.772 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -81.07 12.61 3.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 179.727 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.1 t -68.82 -41.55 78.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.793 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.634 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.9 m-85 -56.09 -34.94 66.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.21 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.601 HD12 ' HB2' ' A' ' 101' ' ' LYS . 87.1 mt -47.77 -46.02 29.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.961 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 60.1 p -92.61 137.95 31.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.516 HD13 ' HE2' ' A' ' 153' ' ' LYS . 30.4 tp -145.41 133.4 21.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 110.972 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.97 132.23 46.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.772 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 58.65 33.03 22.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.152 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.519 ' CA ' ' HA ' ' A' ' 130' ' ' CYS . . . -175.51 153.14 14.44 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.423 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -109.27 144.5 37.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.513 -0.344 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.634 HG21 ' O ' ' A' ' 103' ' ' TYR . 93.1 t -109.66 136.94 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.95 0.405 . . . . 0.0 111.058 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.448 ' CE1' ' HD3' ' A' ' 129' ' ' ARG . 2.8 m-85 -108.57 146.51 33.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.755 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.644 HD23 ' N ' ' A' ' 114' ' ' THR . 6.3 tt -144.26 131.45 20.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.546 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.644 ' N ' HD23 ' A' ' 113' ' ' LEU . 68.7 p -150.08 123.36 8.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.567 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.02 -36.01 0.27 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.242 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.4 -135.12 1.8 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.419 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.598 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 12.2 p-10 -175.67 129.5 0.25 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.722 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -41.28 138.82 1.44 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.279 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -86.69 40.32 2.2 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.503 -1.457 . . . . 0.0 113.117 0.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.598 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -96.62 47.11 1.06 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.783 0.325 . . . . 0.0 111.242 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.663 ' HG ' ' HB ' ' A' ' 98' ' ' ILE . 3.9 mm? -54.42 -40.59 68.44 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.789 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -61.21 136.93 58.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.505 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.87 54.4 7.24 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.458 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.485 ' O ' HG23 ' A' ' 143' ' ' VAL . . . -143.62 136.12 27.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.0 111.189 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 125' ' ' ARG . 48.6 mmt-85 -105.66 143.56 33.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.733 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 142' ' ' SER . 32.7 m -133.74 135.53 55.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.088 0.47 . . . . 0.0 111.489 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -112.9 118.34 34.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.514 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.468 ' HE1' ' HB3' ' A' ' 142' ' ' SER . 5.4 m-85 -82.42 140.53 33.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.024 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.448 ' HD3' ' CE1' ' A' ' 112' ' ' PHE . 16.6 ptm180 -166.66 127.46 1.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.77 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.519 ' HA ' ' CA ' ' A' ' 109' ' ' GLY . 61.5 m -92.89 160.6 14.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.149 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.435 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 31.9 m-20 -52.68 157.58 2.55 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.556 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 17.9 Cg_endo -58.78 76.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.142 2.561 . . . . 0.0 112.64 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.3 t70 -177.07 -38.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.675 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.77 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 2.9 m-85 -108.91 132.58 53.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.872 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.467 ' CE1' ' HB2' ' A' ' 157' ' ' GLN . 17.6 p-80 -102.8 127.79 49.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.993 0.425 . . . . 0.0 111.145 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' A' ' 154' ' ' PRO . 26.7 tp -72.11 129.51 38.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.648 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.1 t -135.33 67.89 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.749 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.12 -136.09 2.28 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.623 -1.275 . . . . 0.0 113.398 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.483 ' HB2' ' CB ' ' A' ' 151' ' ' THR . 71.1 p -74.82 58.26 0.82 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.022 0.439 . . . . 0.0 110.854 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.693 ' HA ' HD21 ' A' ' 136' ' ' LEU . 36.5 t -52.16 -31.39 31.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.743 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -99.44 136.26 39.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.779 0.323 . . . . 0.0 111.237 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.468 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 42.8 t -150.05 149.56 30.49 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.34 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 124' ' ' ALA . 7.3 p -144.36 135.69 21.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.993 0.425 . . . . 0.0 111.75 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 121' ' ' LEU . 43.1 t -66.72 151.2 47.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.005 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.1 t -151.54 -136.91 0.07 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.054 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -74.63 66.56 1.45 Allowed 'General case' 0 C--O 1.232 0.153 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.36 43.45 92.67 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.649 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -176.41 139.9 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.757 0.313 . . . . 0.0 110.505 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.488 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 33.8 m95 -84.26 141.65 30.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.653 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.5 t -49.54 -52.72 27.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.645 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.483 ' CB ' ' HB2' ' A' ' 139' ' ' SER . 48.8 p -124.95 133.88 25.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 0.0 111.803 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.87 147.5 85.21 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.773 2.316 . . . . 0.0 111.841 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.516 ' HE2' HD13 ' A' ' 106' ' ' LEU . 50.2 mtpt -46.66 131.37 8.33 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.325 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.698 ' HG2' HD11 ' A' ' 136' ' ' LEU . 3.9 Cg_exo -78.93 -141.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.073 2.515 . . . . 0.0 112.086 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.422 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.1 p-80 -153.75 134.75 13.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.772 0.32 . . . . 0.0 110.948 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.77 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 77.5 m -98.73 132.41 44.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.487 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.467 ' HB2' ' CE1' ' A' ' 135' ' ' HIS . 78.3 mt-30 -103.4 142.46 34.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.821 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -76.21 135.99 25.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.21 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.917 -179.523 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.804 0.335 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.43 42.98 0.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.427 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.433 ' HB3' ' H ' ' A' ' 95' ' ' PHE . 51.7 mp0 48.86 -137.47 0.95 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.626 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.433 ' H ' ' HB3' ' A' ' 94' ' ' GLU . 13.6 t80 -173.92 47.31 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.973 0.416 . . . . 0.0 110.969 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.4 t -65.09 138.82 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.054 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.436 ' HG2' HH11 ' A' ' 97' ' ' ARG . 22.4 ptt-85 -55.64 141.75 36.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.706 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.4 pt -142.31 144.79 24.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.315 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.571 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 73.7 m -51.51 139.46 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.54 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.3 t -47.99 127.52 12.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.021 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.547 ' NZ ' ' HB3' ' A' ' 101' ' ' LYS . 8.4 mtpm? -74.16 14.36 0.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.343 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.1 m -68.87 -46.19 69.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.936 0.398 . . . . 0.0 110.895 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -61.7 -41.12 97.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.116 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.9 mt -54.94 -41.79 71.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.501 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.6 p -92.54 136.89 32.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.865 0.364 . . . . 0.0 111.564 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.44 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 40.4 tp -145.44 130.81 18.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.572 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 10.3 pm0 -90.48 38.94 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.335 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.412 ' OD1' ' HG2' ' A' ' 107' ' ' GLU . 8.2 m120 -155.85 25.44 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 154.57 -144.36 11.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.88 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.413 ' HE2' ' CZ ' ' A' ' 112' ' ' PHE . 25.0 pttm -141.97 140.19 32.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.251 -0.474 . . . . 0.0 110.302 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.33 143.91 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.013 0.435 . . . . 0.0 111.354 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.413 ' CZ ' ' HE2' ' A' ' 110' ' ' LYS . 1.4 m-85 -105.36 151.76 23.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.146 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.573 HD21 HD22 ' A' ' 121' ' ' LEU . 56.5 tp -145.29 132.97 20.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.605 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.2 p -150.95 147.32 27.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.429 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.2 39.7 26.31 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.918 -0.583 . . . . 0.0 113.017 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.596 ' HA2' ' HB2' ' A' ' 124' ' ' ALA . . . -79.61 -140.88 2.24 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.158 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -176.1 49.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 118' ' ' LEU . 1.7 pt? -42.47 135.07 2.62 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.986 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -87.71 63.04 0.19 OUTLIER 'Cis proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.638 -1.401 . . . . 0.0 113.345 0.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.579 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -166.32 132.56 2.47 Favored 'General case' 0 C--O 1.228 -0.074 0 CA-C-O 120.929 0.395 . . . . 0.0 111.486 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.573 HD22 HD21 ' A' ' 113' ' ' LEU . 83.3 mt -80.9 43.09 0.67 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.84 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -65.01 126.24 27.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.236 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 50.12 31.42 18.76 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.007 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.596 ' HB2' ' HA2' ' A' ' 116' ' ' GLY . . . -84.25 140.25 31.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.579 0.228 . . . . 0.0 110.959 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -108.54 124.23 50.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.785 0.326 . . . . 0.0 110.438 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 142' ' ' SER . 7.5 p -103.59 140.26 22.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.537 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -125.25 111.97 15.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.166 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -75.23 146.59 41.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.57 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.402 ' NH1' ' O ' ' A' ' 130' ' ' CYS . 26.7 tpt85 -156.27 117.06 3.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.097 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.514 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 98.6 m -96.41 165.25 12.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.691 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.544 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 56.2 m-20 -52.66 162.32 0.97 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.017 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 56.7 Cg_endo -70.92 51.76 1.29 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.851 2.368 . . . . 0.0 112.727 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -146.53 -35.85 0.26 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.773 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.634 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 0.7 OUTLIER -108.82 135.93 49.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.034 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 157' ' ' GLN . 17.0 p-80 -102.74 129.86 49.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.948 0.404 . . . . 0.0 110.826 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.732 HD21 ' HA ' ' A' ' 140' ' ' SER . 50.7 tp -72.72 128.18 34.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.019 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.6 t -135.99 68.69 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.665 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.18 -131.36 1.74 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.442 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.764 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.2 t -69.84 63.8 0.2 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.958 0.408 . . . . 0.0 111.364 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.732 ' HA ' HD21 ' A' ' 136' ' ' LEU . 95.5 p -61.22 -15.12 31.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.729 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -139.04 137.96 36.74 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.721 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.7 ' O ' HG12 ' A' ' 126' ' ' VAL . 36.4 t -150.69 124.17 9.01 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.735 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.2 p -88.01 130.51 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.978 0.418 . . . . 0.0 111.084 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 26.4 t -75.84 78.13 2.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.56 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 51.5 m -65.59 -124.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.412 ' C ' ' H ' ' A' ' 148' ' ' GLN . 85.9 mt-30 -67.27 -140.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -77.29 29.32 1.67 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.445 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.412 ' H ' ' C ' ' A' ' 146' ' ' GLN . 87.9 mt-30 -157.76 150.24 22.63 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.725 0.297 . . . . 0.0 110.652 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.571 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 33.1 m95 -84.22 139.21 32.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.222 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 80.7 p -53.91 -63.07 1.27 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.517 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 40.2 p -92.6 132.31 31.9 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.706 0.288 . . . . 0.0 111.533 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.34 142.5 85.95 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.826 2.35 . . . . 0.0 112.356 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.44 ' NZ ' HD13 ' A' ' 106' ' ' LEU . 63.2 tttm -51.81 127.93 35.43 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.128 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.764 ' HB3' ' H ' ' A' ' 139' ' ' SER . 81.9 Cg_endo -78.15 -152.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.765 2.31 . . . . 0.0 112.805 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -153.83 138.96 17.39 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.073 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 99.7 m -98.72 131.55 44.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.891 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.42 ' HB2' ' CE1' ' A' ' 135' ' ' HIS . 85.2 mt-30 -103.0 140.16 37.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.793 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.505 ' O ' HG22 ' A' ' 158' ' ' VAL . 14.7 p -79.9 44.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.39 0.614 . . . . 0.0 110.583 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.174 179.989 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.816 0.341 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.72 127.84 0.4 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.076 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -74.84 133.74 41.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.003 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.42 40.39 0.65 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.37 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.6 p -175.07 129.19 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.907 0.384 . . . . 0.0 111.09 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -70.24 120.03 15.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.976 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.619 ' O ' HD12 ' A' ' 98' ' ' ILE . 2.5 pp -83.66 159.21 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.543 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.6 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 51.5 m -55.01 137.26 46.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.38 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.592 ' HB2' ' HE1' ' A' ' 149' ' ' TRP . 56.4 m -47.95 123.8 6.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.844 0.354 . . . . 0.0 111.226 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.737 ' HA ' HD13 ' A' ' 104' ' ' LEU . 58.9 tptt -75.47 -26.67 58.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.328 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.5 p -53.22 -41.8 65.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.488 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.678 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 3.7 m-85 -59.0 -42.63 90.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.651 0.262 . . . . 0.0 111.179 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.737 HD13 ' HA ' ' A' ' 101' ' ' LYS . 5.7 mp -55.74 -41.13 73.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.064 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.7 p -92.56 127.06 37.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.976 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.633 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 57.5 tp -145.36 128.36 16.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.092 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -69.15 138.06 53.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.971 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 m120 58.24 39.74 25.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.298 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.85 168.36 41.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.703 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -138.88 140.25 38.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.732 0.301 . . . . 0.0 110.743 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 74.9 t -109.18 141.45 24.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.206 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -105.53 136.1 45.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.644 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.551 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.6 mm? -101.05 144.2 30.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.575 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.9 m -151.76 126.62 9.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.713 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 65.01 149.98 0.06 OUTLIER Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.424 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.65 143.13 0.49 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.603 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -173.44 138.31 0.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.643 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -43.16 134.93 3.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.829 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 83.6 Cg_endo -87.9 54.01 0.52 Allowed 'Cis proline' 0 C--N 1.347 0.486 0 C-N-CA 123.721 -1.366 . . . . 0.0 113.401 0.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.454 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -135.11 135.55 41.27 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.7 0.286 . . . . 0.0 110.861 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.777 HD23 ' H ' ' A' ' 121' ' ' LEU . 2.1 pt? -124.42 -39.92 2.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.104 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -61.32 136.78 58.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.561 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.17 54.59 4.03 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.14 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.51 ' C ' ' HD2' ' A' ' 125' ' ' ARG . . . -147.7 132.17 17.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 0.0 111.068 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.51 ' HD2' ' C ' ' A' ' 124' ' ' ALA . 8.6 mpt_? -124.93 138.86 54.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.113 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.415 HG12 HD13 ' A' ' 113' ' ' LEU . 28.4 m -116.97 137.06 52.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.104 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -106.67 113.72 27.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.95 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -74.83 155.95 37.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.603 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.522 HH22 ' H ' ' A' ' 136' ' ' LEU . 2.4 tpm_? -161.11 128.45 4.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.525 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.47 ' H ' ' CZ ' ' A' ' 129' ' ' ARG . 87.6 m -89.22 140.77 29.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.067 0.46 . . . . 0.0 111.456 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -54.29 158.88 3.49 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.16 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.504 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 3.5 Cg_endo -45.92 153.14 0.95 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.002 2.468 . . . . 0.0 112.07 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 22.2 m-20 77.92 -32.07 0.17 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.664 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' A' ' 132' ' ' PRO . 3.2 m-85 -107.65 128.12 54.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.331 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -107.52 136.44 47.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.425 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.69 HD22 ' HB2' ' A' ' 140' ' ' SER . 6.2 tt -74.94 130.46 39.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.469 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.623 ' N ' HD23 ' A' ' 136' ' ' LEU . 40.8 t -135.04 67.43 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.461 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.5 -134.94 1.91 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.092 -1.052 . . . . 0.0 113.058 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.651 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 50.0 m -75.53 55.26 0.81 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.851 0.358 . . . . 0.0 110.964 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.69 ' HB2' HD22 ' A' ' 136' ' ' LEU . 33.6 t -49.77 -40.51 41.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.171 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.427 ' HG2' HH11 ' A' ' 141' ' ' ARG . 22.2 ptt-85 -99.31 134.53 42.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.98 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.2 m -146.29 133.87 20.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.77 0.319 . . . . 0.0 110.736 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.455 HG23 ' HG3' ' A' ' 125' ' ' ARG . 7.3 p -120.05 129.76 75.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.05 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 51.4 t -71.39 141.95 50.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.454 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.3 t -171.3 125.65 0.64 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.216 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.441 ' OE1' ' N ' ' A' ' 146' ' ' GLN . 0.6 OUTLIER 57.15 39.61 28.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 0.0 110.448 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.17 -51.65 3.26 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.774 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -76.92 143.7 39.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.678 0.275 . . . . 0.0 111.057 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.592 ' HE1' ' HB2' ' A' ' 100' ' ' SER . 70.0 m95 -84.2 146.82 27.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.828 0.347 . . . . 0.0 110.659 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.3 t -53.37 -61.17 2.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.524 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 139' ' ' SER . 82.4 p -107.79 135.78 19.77 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.774 0.321 . . . . 0.0 111.776 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 139' ' ' SER . 57.6 Cg_endo -70.78 145.67 51.9 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.785 2.323 . . . . 0.0 112.161 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.678 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 7.6 mtpm? -45.32 130.17 5.98 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.433 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.651 ' HB3' ' N ' ' A' ' 139' ' ' SER . 76.1 Cg_endo -77.51 -141.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.69 2.26 . . . . 0.0 112.547 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.482 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.4 p-80 -153.74 147.6 25.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.036 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 71.0 m -96.89 140.26 31.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.279 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -131.26 146.69 52.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.875 0.369 . . . . 0.0 111.48 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 79.6 t -76.61 125.18 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.174 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.067 -179.634 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.634 0.254 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 64.75 135.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.412 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -175.1 -43.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.237 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.422 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 4.4 m-85 -61.95 -43.99 97.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.344 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 92.6 t -62.2 128.73 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.89 0.376 . . . . 0.0 111.272 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.423 ' NH1' ' HA3' ' A' ' 147' ' ' GLY . 31.2 ptt85 -84.71 55.52 3.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.119 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.685 ' O ' HD12 ' A' ' 98' ' ' ILE . 2.3 pp -51.13 148.21 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.991 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.603 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 97.7 m -59.76 143.83 49.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.04 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.2 m -48.03 124.81 8.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.226 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -84.46 14.98 3.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.933 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.2 m -67.34 -35.63 79.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.678 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.739 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 3.4 m-85 -58.74 -25.69 63.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.417 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.4 mt -50.0 -38.41 37.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.737 0.303 . . . . 0.0 111.118 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.3 p -92.55 127.81 38.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.111 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.484 HD22 ' HA3' ' A' ' 109' ' ' GLY . 6.4 tt -145.37 124.02 12.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.182 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.457 ' N ' HD23 ' A' ' 106' ' ' LEU . 96.6 mt-10 -74.25 130.69 40.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.37 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 60.11 47.22 9.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.221 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.484 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -174.95 -171.83 39.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.075 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -142.09 146.29 35.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.659 0.266 . . . . 0.0 110.647 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 103' ' ' TYR . 60.3 t -108.05 127.4 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.631 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.627 ' C ' HG23 ' A' ' 126' ' ' VAL . 2.5 m-85 -112.01 70.88 0.72 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.149 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.702 ' HA ' ' HB ' ' A' ' 126' ' ' VAL . 2.3 tt -74.67 62.39 1.05 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.618 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.8 p -75.0 120.89 21.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.712 0.291 . . . . 0.0 111.118 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.14 -43.89 0.31 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.654 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -173.16 -128.26 1.05 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.531 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.86 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 11.6 p-10 -165.24 -136.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 118' ' ' LEU . 2.7 mm? -116.31 132.98 23.02 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.526 0.203 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 60.0 Cg_endo -93.09 42.06 3.15 Favored 'Cis proline' 0 C--N 1.348 0.537 0 C-N-CA 123.837 -1.318 . . . . 0.0 112.497 -0.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.86 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -74.07 140.89 45.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 0.0 111.742 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.541 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 2.1 pt? -167.39 36.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.803 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.93 60.57 1.39 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.917 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.22 40.84 32.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.225 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.526 ' O ' HG23 ' A' ' 143' ' ' VAL . . . -62.9 135.29 57.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 110.981 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.58 ' HD2' ' NH2' ' A' ' 141' ' ' ARG . 85.7 mtm180 -103.83 141.47 36.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.498 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.703 HG11 ' HZ3' ' A' ' 149' ' ' TRP . 6.5 p -143.23 135.66 24.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.257 0.551 . . . . 0.0 112.315 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -109.17 121.11 44.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.737 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.534 ' HE1' ' HB3' ' A' ' 142' ' ' SER . 3.2 m-85 -87.3 56.19 3.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.801 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 129' ' ' ARG . 63.5 mtt-85 -59.05 132.97 55.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.591 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 53.7 t -89.2 149.13 23.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.34 . . . . 0.0 111.13 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.482 ' OD1' ' HB2' ' A' ' 134' ' ' PHE . 52.5 p-10 -52.81 149.8 10.88 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.404 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 10.1 Cg_endo -51.59 152.74 12.0 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.751 2.301 . . . . 0.0 111.527 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.585 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 37.4 t70 76.44 -2.41 2.72 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.399 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.71 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 19.1 m-85 -134.28 130.61 37.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.951 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -104.16 128.19 51.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.923 0.392 . . . . 0.0 111.197 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.837 HD12 ' HB3' ' A' ' 140' ' ' SER . 2.8 tm? -71.44 132.15 44.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.795 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.625 ' N ' HD13 ' A' ' 136' ' ' LEU . 24.8 t -132.23 67.88 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.9 -135.13 2.11 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 119.901 -1.142 . . . . 0.0 113.276 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.652 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 39.2 p -74.99 56.05 0.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.929 0.395 . . . . 0.0 111.072 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.837 ' HB3' HD12 ' A' ' 136' ' ' LEU . 92.6 p -57.0 -38.95 73.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.801 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.58 ' NH2' ' HD2' ' A' ' 125' ' ' ARG . 29.4 tpt180 -99.32 133.97 42.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.703 0.287 . . . . 0.0 111.508 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.534 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 46.7 t -150.34 148.67 29.1 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.258 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 124' ' ' ALA . 7.4 p -146.23 130.27 10.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.146 0.498 . . . . 0.0 112.046 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 13.7 t -92.54 140.96 29.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.901 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.4 t -169.52 -60.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.042 0.449 . . . . 0.0 111.218 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -87.98 43.63 1.13 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.423 ' HA3' ' NH1' ' A' ' 97' ' ' ARG . . . 56.54 39.9 85.91 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.89 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -174.73 146.98 1.0 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.728 0.299 . . . . 0.0 110.402 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.703 ' HZ3' HG11 ' A' ' 126' ' ' VAL . 29.5 m95 -84.22 138.78 32.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.778 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.2 t -50.15 -46.31 53.95 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.965 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 70.9 p -135.65 138.84 29.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.891 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.499 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 28.0 Cg_exo -62.02 -162.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.561 2.174 . . . . 0.0 112.627 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.801 ' HZ2' ' HB3' ' A' ' 153' ' ' LYS . 3.9 mmmp? -80.75 127.3 75.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.783 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.652 ' HB3' ' N ' ' A' ' 139' ' ' SER . 84.0 Cg_endo -81.37 -151.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.635 2.223 . . . . 0.0 112.891 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.425 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 22.4 p-80 -153.65 136.52 15.38 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.936 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 7.8 t -98.72 136.83 38.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.979 0.418 . . . . 0.0 111.664 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -103.04 142.4 34.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.02 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 98.2 t -61.24 111.03 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.78 0.324 . . . . 0.0 110.327 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.585 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 38.6 t30 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.05 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.7 0.286 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 55.23 43.35 29.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.169 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -60.38 -44.71 95.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.792 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.417 ' HB2' ' H ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -175.34 -148.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.165 179.692 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.417 ' H ' ' HB2' ' A' ' 95' ' ' PHE . 61.0 t -73.47 134.45 29.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.868 0.366 . . . . 0.0 111.326 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -79.95 49.93 1.14 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.005 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.506 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -54.33 142.36 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 0.0 111.49 -179.547 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 82.1 m -56.42 154.47 8.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.757 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.7 m -45.67 127.51 7.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.492 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.572 ' HB2' HD12 ' A' ' 104' ' ' LEU . 7.8 ptpp? -76.19 -3.38 35.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.262 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.5 m -56.12 -41.15 74.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.87 0.367 . . . . 0.0 110.994 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.469 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 1.7 m-85 -59.98 -34.17 72.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.196 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.572 HD12 ' HB2' ' A' ' 101' ' ' LYS . 75.6 mt -52.11 -40.01 60.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.967 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.1 m -92.6 136.29 33.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.5 tp -145.42 131.35 19.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.86 0.362 . . . . 0.0 111.31 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -75.02 133.56 41.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.853 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 52.47 36.07 19.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 110.664 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.36 145.81 9.91 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.538 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.634 ' HB3' ' NZ ' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -101.93 140.87 35.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.972 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.03 135.93 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.79 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 126' ' ' VAL . 3.5 m-85 -110.35 136.16 49.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.779 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.48 HD11 HD22 ' A' ' 104' ' ' LEU . 94.8 mt -112.4 144.86 41.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.163 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.8 t -159.83 143.1 14.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.005 0.431 . . . . 0.0 111.81 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.09 126.07 0.13 Allowed Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.911 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 152.06 -140.36 7.7 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.312 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 120' ' ' ALA . 65.6 t0 -173.86 119.14 0.27 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.823 HD22 ' H ' ' A' ' 118' ' ' LEU . 3.1 mm? -29.49 126.16 0.26 Allowed Pre-proline 0 N--CA 1.465 0.301 0 O-C-N 123.591 0.557 . . . . 0.0 111.555 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 118' ' ' LEU . 25.5 Cg_exo -63.18 -22.1 4.86 Favored 'Cis proline' 0 C--N 1.351 0.682 0 C-N-CA 124.097 -1.209 . . . . 0.0 112.992 0.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 117' ' ' ASP . . . 69.26 129.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.413 0.625 . . . . 0.0 111.752 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.628 ' O ' HD13 ' A' ' 121' ' ' LEU . 2.2 tm? 175.33 -35.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.236 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -62.14 132.32 52.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.677 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.5 31.72 36.88 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.331 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -77.19 139.65 39.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.758 0.313 . . . . 0.0 111.193 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.403 HH11 ' HG3' ' A' ' 125' ' ' ARG . 41.1 ttt85 -103.98 63.25 0.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.126 0.489 . . . . 0.0 109.725 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 142' ' ' SER . 11.0 p -57.96 141.7 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.776 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -123.92 113.3 18.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.863 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -80.06 151.3 29.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.9 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.453 HH11 ' HG3' ' A' ' 129' ' ' ARG . 38.3 ttt85 -161.11 133.12 5.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.785 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 84.1 m -89.25 142.45 27.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.204 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 60.8 m-20 -56.27 160.81 4.54 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.022 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.53 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 78.2 Cg_exo -41.15 154.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.982 2.455 . . . . 0.0 112.652 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 8.1 t70 78.89 -33.77 0.16 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.717 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.411 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 1.7 m-85 -107.6 129.5 54.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.237 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -110.75 134.75 52.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.99 0.424 . . . . 0.0 111.08 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 137' ' ' VAL . 6.6 tt -75.21 132.42 41.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.597 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.602 ' N ' HD23 ' A' ' 136' ' ' LEU . 38.7 t -133.39 67.3 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.452 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.25 -126.33 1.07 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.15 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.604 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 42.7 t -70.2 64.46 0.25 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.986 0.422 . . . . 0.0 111.258 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.445 ' HB2' HD22 ' A' ' 136' ' ' LEU . 35.3 t -64.36 -18.0 64.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.172 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 56.5 mtt85 -140.7 140.86 34.97 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.056 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.608 ' O ' HG12 ' A' ' 126' ' ' VAL . 35.9 m -145.03 136.27 25.02 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 7.2 p -113.32 130.55 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.924 0.393 . . . . 0.0 111.357 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 45.6 t -75.05 139.46 42.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.96 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 m -163.12 134.58 4.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.844 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 12.8 tp-100 67.36 -66.68 0.19 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.462 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.0 37.44 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.526 -0.629 . . . . 0.0 111.526 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -176.32 152.36 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.105 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 27.9 m95 -84.19 140.93 31.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.741 0.305 . . . . 0.0 110.724 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.6 m -52.3 -59.89 3.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.013 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.2 p -100.91 134.26 20.56 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.05 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.461 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 38.3 Cg_endo -66.59 -157.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.398 2.066 . . . . 0.0 112.366 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.561 ' HB3' ' NZ ' ' A' ' 153' ' ' LYS . 9.5 mtpm? -92.98 129.93 37.98 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.037 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.604 ' HB3' ' N ' ' A' ' 139' ' ' SER . 66.5 Cg_endo -73.09 -144.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.673 2.249 . . . . 0.0 112.722 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.474 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.7 p-80 -153.67 149.26 27.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.415 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 73.9 m -97.86 129.33 44.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 0.0 111.189 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 33.6 tp60 -111.87 133.24 54.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.682 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.438 HG23 ' OD1' ' A' ' 133' ' ' ASP . 7.2 p -84.79 127.15 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.522 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.912 -179.767 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.894 0.378 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -170.07 -44.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.171 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -60.87 135.3 57.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.404 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 1.6 m-85 -65.85 -45.65 81.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.036 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.9 p -172.61 141.25 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.98 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.459 HH11 ' HG3' ' A' ' 97' ' ' ARG . 38.5 ttm-85 -56.4 127.14 29.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.166 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.476 HG22 HD23 ' A' ' 121' ' ' LEU . 31.7 pt -72.88 141.83 15.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.717 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 59.7 m -61.22 143.23 55.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.945 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.422 ' HB3' ' HE1' ' A' ' 149' ' ' TRP . 41.1 t -47.91 130.78 15.27 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.354 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -76.69 -19.93 57.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.429 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.3 p -53.06 -46.63 68.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.787 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.527 ' O ' HG21 ' A' ' 111' ' ' VAL . 3.5 m-85 -61.72 -36.72 81.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.587 0.232 . . . . 0.0 111.204 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.6 mt -54.43 -48.64 71.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.109 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.6 m -92.55 137.85 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.625 HD13 ' HE2' ' A' ' 153' ' ' LYS . 24.8 tp -145.4 130.77 18.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.037 0.446 . . . . 0.0 111.348 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -72.43 137.35 46.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.404 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.4 m120 61.06 37.21 18.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.147 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 178.98 -179.33 48.92 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.704 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -142.03 147.12 36.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.79 0.328 . . . . 0.0 110.791 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.527 HG21 ' O ' ' A' ' 103' ' ' TYR . 86.3 t -107.23 141.61 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.969 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.15 135.32 46.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.598 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.0 mm? -102.77 147.07 27.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.237 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.0 m -151.59 129.81 11.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.815 0.341 . . . . 0.0 111.256 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 56.19 43.56 89.0 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.62 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . -179.92 141.15 4.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.653 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -174.86 134.21 0.35 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.959 HD12 ' HA ' ' A' ' 119' ' ' PRO . 37.3 tp -43.82 131.62 4.07 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.939 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.959 ' HA ' HD12 ' A' ' 118' ' ' LEU . 84.6 Cg_endo -90.7 63.02 0.27 Allowed 'Cis proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.585 -1.423 . . . . 0.0 113.143 0.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.442 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -141.83 48.79 1.6 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.816 0.341 . . . . 0.0 111.26 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 121' ' ' LEU . 3.1 mm? -62.61 -45.08 94.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.636 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.455 ' OD1' ' HA ' ' A' ' 145' ' ' SER . 64.3 t0 -62.59 138.89 58.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.615 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.93 57.73 5.14 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.375 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.639 ' HB2' ' HA3' ' A' ' 116' ' ' GLY . . . -154.03 141.23 19.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 111.271 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.62 HH21 ' HD2' ' A' ' 141' ' ' ARG . 41.9 ttt85 -108.62 141.66 40.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.504 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.408 HG23 ' CE1' ' A' ' 128' ' ' PHE . 19.1 m -130.88 140.16 49.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.963 0.411 . . . . 0.0 111.679 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -103.5 125.26 49.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.094 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.408 ' CE1' HG23 ' A' ' 126' ' ' VAL . 9.7 m-85 -92.38 143.04 26.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.084 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.404 HH11 ' HG3' ' A' ' 129' ' ' ARG . 41.3 ttt85 -172.34 124.07 0.49 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.991 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.533 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 56.9 m -89.31 146.03 24.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.883 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.663 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 59.5 m-20 -55.88 167.14 0.89 Allowed Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.37 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 2.1 Cg_endo -45.01 159.81 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.268 2.645 . . . . 0.0 112.399 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.5 m-20 77.95 -37.67 0.24 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.258 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.488 ' CE2' HG22 ' A' ' 158' ' ' VAL . 6.6 m-85 -108.52 126.25 52.71 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -117.94 126.28 52.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.243 0.544 . . . . 0.0 111.335 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 137' ' ' VAL . 6.5 tt -72.58 130.16 39.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.029 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.539 ' N ' HD23 ' A' ' 136' ' ' LEU . 31.6 t -129.06 67.09 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.531 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.95 -131.99 1.48 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.496 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.534 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 80.1 p -73.86 64.51 0.98 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.979 0.418 . . . . 0.0 110.272 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.7 t -58.33 -2.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.436 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.62 ' HD2' HH21 ' A' ' 125' ' ' ARG . 53.8 mtm-85 -140.69 137.08 33.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.523 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.0 m -149.12 133.34 17.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.389 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 6.2 p -123.25 126.22 73.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.106 0.479 . . . . 0.0 111.289 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 52.6 t -98.99 140.04 33.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.755 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.455 ' HA ' ' OD1' ' A' ' 122' ' ' ASP . 43.7 t -170.05 38.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.128 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 52.0 tt0 177.68 47.18 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.502 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 54.36 35.27 55.51 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.949 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -177.39 144.86 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.422 ' HE1' ' HB3' ' A' ' 100' ' ' SER . 29.7 m95 -84.22 140.82 31.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.82 0.343 . . . . 0.0 110.689 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.4 t -52.72 -65.87 0.48 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.933 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 81.1 p -98.42 135.68 21.11 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.73 0.3 . . . . 0.0 111.8 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 27.1 Cg_exo -62.1 143.85 95.25 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.758 2.305 . . . . 0.0 111.616 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.625 ' HE2' HD13 ' A' ' 106' ' ' LEU . 83.3 tttt -47.92 130.71 11.81 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.839 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.534 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.3 Cg_endo -75.84 -148.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.814 2.343 . . . . 0.0 113.206 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.46 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 16.9 p-80 -153.75 130.99 11.17 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.181 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 93.5 m -99.07 135.38 40.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.064 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -103.02 141.51 35.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.224 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.488 HG22 ' CE2' ' A' ' 134' ' ' PHE . 49.3 t -69.52 79.53 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.055 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.472 -179.961 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.545 ' HG3' ' H ' ' A' ' 93' ' ' ALA . 5.1 tp10 . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 110.763 -0.088 . . . . 0.0 110.763 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.545 ' H ' ' HG3' ' A' ' 92' ' ' GLU . . . 58.61 -136.63 0.88 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.623 0.249 . . . . 0.0 111.061 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -148.77 -134.68 0.07 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.336 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.442 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 1.9 m-85 -61.29 -48.62 80.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.712 0.291 . . . . 0.0 110.639 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.8 p -179.89 138.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.916 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.459 ' O ' ' HA2' ' A' ' 147' ' ' GLY . 70.0 mtt-85 -56.93 136.99 55.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.534 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.536 ' HB ' ' HG ' ' A' ' 121' ' ' LEU . 29.4 pt -78.51 38.81 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.448 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.502 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 68.0 m 59.21 141.06 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.013 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.6 t -48.03 126.3 10.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.312 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.677 ' HA ' HD23 ' A' ' 104' ' ' LEU . 63.9 pttt -80.01 -12.97 59.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.881 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.6 m -57.07 -42.26 80.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.563 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.509 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.7 m-85 -52.94 -37.6 61.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.234 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.677 HD23 ' HA ' ' A' ' 101' ' ' LYS . 2.0 mm? -54.1 -41.59 68.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.336 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.5 m -92.54 136.07 33.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.043 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.848 HD13 ' HE2' ' A' ' 153' ' ' LYS . 15.5 tp -145.39 130.62 18.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.25 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.502 ' N ' HD12 ' A' ' 106' ' ' LEU . 42.6 tt0 -70.66 131.15 43.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.416 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.7 m120 54.81 42.42 31.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.993 0.425 . . . . 0.0 110.609 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.08 153.57 14.01 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.588 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -115.29 142.79 46.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.691 0.281 . . . . 0.0 110.758 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 103' ' ' TYR . 46.1 t -107.89 131.34 58.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.053 0.454 . . . . 0.0 110.977 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.428 ' O ' HG23 ' A' ' 126' ' ' VAL . 3.0 m-85 -109.82 150.78 27.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.784 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.663 ' O ' HD12 ' A' ' 113' ' ' LEU . 3.9 pp -158.13 149.78 21.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.916 0.388 . . . . 0.0 111.52 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.0 p -151.33 132.26 14.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.72 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 167.68 -129.78 1.97 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.433 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.75 -122.82 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.507 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.809 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 54.4 t0 -161.68 -127.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.478 0.18 . . . . 0.0 110.64 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 119' ' ' PRO . 31.9 tp -128.88 130.05 23.46 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.761 0.315 . . . . 0.0 111.172 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.868 ' HA ' HD12 ' A' ' 118' ' ' LEU . 89.7 Cg_endo -91.86 42.47 2.84 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.442 -1.483 . . . . 0.0 112.581 -0.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.809 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -80.96 46.96 0.94 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.523 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.536 ' HG ' ' HB ' ' A' ' 98' ' ' ILE . 3.5 mm? -61.89 -38.05 86.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.147 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -61.27 146.03 49.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.1 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.1 -34.54 3.02 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.61 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.08 141.88 38.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.904 0.383 . . . . 0.0 111.649 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.44 ' HD2' HG23 ' A' ' 143' ' ' VAL . 43.9 mmm-85 -104.26 136.96 42.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.087 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 112' ' ' PHE . 15.0 p -123.83 133.14 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.189 0.519 . . . . 0.0 111.986 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -112.81 120.58 41.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.697 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.407 ' HE1' ' HB3' ' A' ' 142' ' ' SER . 8.5 m-85 -88.75 149.81 23.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.256 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -164.64 134.81 3.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.051 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 70.5 m -89.23 155.44 19.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.772 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 133' ' ' ASP . 11.5 p-10 -52.69 149.11 11.7 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.987 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -58.14 74.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.08 2.52 . . . . 0.0 112.576 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.1 t70 -177.74 -40.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.736 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.474 ' CE2' ' HB ' ' A' ' 158' ' ' VAL . 1.4 m-85 -107.86 142.65 37.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.829 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -101.24 129.1 47.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 0.0 111.066 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 137' ' ' VAL . 6.9 tt -77.91 130.54 36.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.451 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.514 ' N ' HD23 ' A' ' 136' ' ' LEU . 38.5 t -131.87 66.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.415 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.04 -126.61 0.9 Allowed Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.079 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.713 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 34.9 t -72.3 58.52 0.39 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 111.201 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.5 t -56.58 -26.58 55.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.853 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.413 ' HG3' HH11 ' A' ' 141' ' ' ARG . 45.2 ttm-85 -129.84 137.76 50.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.407 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 39.4 t -149.25 175.83 11.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.023 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.44 HG23 ' HD2' ' A' ' 125' ' ' ARG . 8.6 p -160.6 137.34 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.08 0.467 . . . . 0.0 112.003 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 37.1 t -78.79 135.07 36.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.886 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.8 t -175.26 133.48 0.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.953 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 56.87 40.94 28.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 97' ' ' ARG . . . 56.15 43.2 88.8 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.522 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -175.13 138.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.69 0.281 . . . . 0.0 110.702 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.502 ' CE2' ' HB3' ' A' ' 99' ' ' CYS . 14.5 m95 -84.2 140.25 31.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.371 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.4 p -52.92 -60.83 2.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.741 0.305 . . . . 0.0 110.865 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 40.3 p -101.23 140.54 21.36 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.127 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 24.4 Cg_exo -63.62 -153.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.628 2.218 . . . . 0.0 112.365 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.848 ' HE2' HD13 ' A' ' 106' ' ' LEU . 83.7 tttt -102.39 127.9 29.47 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.486 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.713 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 60.3 Cg_endo -72.66 -153.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.538 2.159 . . . . 0.0 112.717 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -153.67 144.64 22.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.484 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 66.2 m -97.3 134.05 41.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.895 0.379 . . . . 0.0 110.775 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -117.9 138.75 51.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.136 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.474 ' HB ' ' CE2' ' A' ' 134' ' ' PHE . 8.6 p -85.95 129.45 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.436 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.2 p30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.968 -179.7 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.726 0.298 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -174.85 -133.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 60.32 49.73 6.79 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.72 0.295 . . . . 0.0 110.832 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 65.92 136.51 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.035 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 96' ' ' VAL . 15.0 p -167.52 46.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.365 0.603 . . . . 0.0 110.543 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 66.51 134.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.4 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.627 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -148.49 134.66 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.411 179.296 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 7.4 p -53.27 139.33 29.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.614 -179.332 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.4 m -47.91 128.1 12.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.482 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.687 ' HA ' HD13 ' A' ' 104' ' ' LEU . 9.0 ptpp? -84.56 3.75 35.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.019 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.4 t -63.29 -39.02 93.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.009 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.465 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.5 m-85 -54.94 -38.23 67.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.971 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.687 HD13 ' HA ' ' A' ' 101' ' ' LYS . 6.2 mp -54.56 -34.26 61.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.304 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.2 p -92.33 129.45 38.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 111.029 -179.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.844 HD13 ' HE2' ' A' ' 153' ' ' LYS . 22.3 tp -145.48 133.8 21.77 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.335 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 8.2 pm0 -74.73 132.19 41.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.331 179.124 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 55.89 39.22 30.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.609 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.31 151.2 14.02 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.821 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -112.48 142.1 45.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.351 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 103' ' ' TYR . 43.0 t -106.98 137.5 37.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.994 0.426 . . . . 0.0 111.287 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -104.72 142.09 35.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.293 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.651 ' HB3' HG23 ' A' ' 126' ' ' VAL . 4.1 pp -166.81 150.65 6.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.983 0.42 . . . . 0.0 111.697 -179.53 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.6 m -160.33 135.04 7.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.784 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 132.15 136.26 3.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.73 141.75 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.044 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 32.7 m-20 -130.53 -42.51 1.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.246 0.546 . . . . 0.0 109.64 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.715 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -130.27 123.01 20.36 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.407 179.559 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 87.4 Cg_endo -81.7 33.59 2.16 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 123.28 -1.55 . . . . 0.0 112.338 0.073 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 117' ' ' ASP . . . 66.65 146.82 0.04 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.874 0.369 . . . . 0.0 111.245 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.503 ' HB3' ' SG ' ' A' ' 99' ' ' CYS . 6.6 mp 62.43 35.1 15.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.01 -178.886 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.96 51.02 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.099 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.456 ' HA2' ' C ' ' A' ' 144' ' ' CYS . . . 71.44 42.32 56.41 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.567 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.35 -163.59 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 111.318 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -112.3 146.29 38.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.435 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.651 HG23 ' HB3' ' A' ' 113' ' ' LEU . 8.1 p -141.86 138.56 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.114 0.483 . . . . 0.0 111.4 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -132.59 111.68 11.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.375 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.471 ' HB2' HD11 ' A' ' 136' ' ' LEU . 3.1 m-85 -69.18 153.75 43.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.206 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.1 tpp85 -160.6 129.47 4.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.833 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 55.8 m -89.18 143.83 26.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.735 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 133' ' ' ASP . 61.4 m-20 -53.2 150.85 10.38 Favored Pre-proline 0 N--CA 1.462 0.155 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.123 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 52.7 Cg_exo -53.55 77.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.23 2.62 . . . . 0.0 113.105 -179.462 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 131' ' ' ASP . 39.0 t70 177.73 -38.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.761 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -108.33 142.37 38.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.797 179.201 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.479 ' CD2' ' HB3' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -100.8 132.71 46.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.126 0.489 . . . . 0.0 111.07 179.91 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 137' ' ' VAL . 4.9 tt -76.93 124.71 28.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.07 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.548 ' N ' HD23 ' A' ' 136' ' ' LEU . 21.2 t -134.78 61.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.598 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -166.11 -133.65 1.55 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 119.869 -1.158 . . . . 0.0 113.148 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.632 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 64.2 m -74.56 55.06 0.63 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.832 0.349 . . . . 0.0 110.991 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.528 ' HB2' HD22 ' A' ' 136' ' ' LEU . 36.6 t -51.39 -43.05 61.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.968 -179.746 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.434 HH11 ' HG3' ' A' ' 141' ' ' ARG . 40.1 ttt85 -99.47 131.16 45.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.829 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.437 ' O ' HG12 ' A' ' 126' ' ' VAL . 49.9 m -150.72 153.49 35.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.965 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.702 HG12 ' HB2' ' A' ' 150' ' ' SER . 15.0 p -138.27 134.24 43.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.172 0.51 . . . . 0.0 112.004 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.456 ' C ' ' HA2' ' A' ' 123' ' ' GLY . 27.5 t -74.14 152.51 39.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.481 179.202 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.9 p -155.9 -135.97 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.016 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -53.51 -38.88 64.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.882 0.373 . . . . 0.0 110.952 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . -174.11 -49.09 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.123 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -85.0 142.22 29.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.744 0.307 . . . . 0.0 110.355 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.411 ' NE1' ' HB2' ' A' ' 99' ' ' CYS . 35.9 m95 -84.11 151.18 25.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.484 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.702 ' HB2' HG12 ' A' ' 143' ' ' VAL . 48.3 t -44.97 -57.15 4.0 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.179 -179.31 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 72.4 p -121.23 145.13 41.4 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.947 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -57.61 -161.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.616 2.211 . . . . 0.0 112.765 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.844 ' HE2' HD13 ' A' ' 106' ' ' LEU . 83.0 tttt -94.12 126.13 49.93 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.833 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.632 ' HB3' ' N ' ' A' ' 139' ' ' SER . 57.1 Cg_endo -70.77 -155.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.481 2.12 . . . . 0.0 112.384 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -153.69 142.27 20.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 75.5 m -98.72 132.67 43.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.912 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.479 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 19.1 tt0 -116.33 141.05 48.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.808 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.03 132.42 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.287 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.7 p30 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.986 -179.422 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.811 0.339 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.44 -50.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.806 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -73.6 140.46 46.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.78 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -161.96 142.28 10.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.178 0.513 . . . . 0.0 111.152 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.8 t -61.67 138.8 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.214 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -77.5 49.78 0.75 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.357 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.1 pt -54.65 139.32 13.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.995 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.51 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 96.4 m -53.15 135.62 37.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.18 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.6 t -47.92 127.96 12.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.457 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.846 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -87.25 -6.53 58.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.935 179.666 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.1 p -54.09 -34.73 60.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.219 -179.596 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.581 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.9 m-85 -57.04 -35.55 69.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.56 -179.702 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 104' ' ' LEU . 4.1 mp -77.8 37.49 0.24 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.107 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.4 p -147.5 63.55 1.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.802 0.334 . . . . 0.0 110.803 179.125 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.744 HD13 ' HE2' ' A' ' 153' ' ' LYS . 29.6 tp -94.12 128.91 40.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.634 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -73.4 137.03 44.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.996 178.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.459 ' HB3' ' OD2' ' A' ' 131' ' ' ASP . 34.3 m-20 58.64 42.03 21.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.108 0.48 . . . . 0.0 110.126 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -171.27 164.58 37.57 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.647 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -125.14 141.84 51.86 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.411 HG21 ' HA ' ' A' ' 104' ' ' LEU . 4.7 t -109.38 137.04 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.885 0.374 . . . . 0.0 111.021 -179.501 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.636 ' O ' HG23 ' A' ' 126' ' ' VAL . 2.3 m-85 -107.69 141.77 38.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.684 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 114' ' ' THR . 7.1 tt -147.84 138.02 22.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.006 0.432 . . . . 0.0 111.015 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.589 ' N ' HD23 ' A' ' 113' ' ' LEU . 76.2 p -145.07 121.27 10.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.645 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.38 -43.37 0.77 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.163 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -179.7 -138.67 3.41 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.071 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -178.04 -60.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.004 0.43 . . . . 0.0 110.824 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.635 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -149.41 132.83 8.45 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.302 -179.468 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.07 19.72 6.56 Favored 'Cis proline' 0 C--N 1.347 0.464 0 C-N-CA 123.531 -1.446 . . . . 0.0 112.148 -0.018 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 50.73 -138.26 1.05 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.994 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 28.5 mt 58.72 63.2 1.72 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.831 0.348 . . . . 0.0 111.306 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -164.02 50.92 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.029 0.442 . . . . 0.0 110.702 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.93 41.39 97.4 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.971 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.32 134.3 39.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 111.058 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -112.72 144.61 41.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 112' ' ' PHE . 8.5 p -141.39 142.03 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.081 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -133.81 123.0 24.06 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.111 -179.443 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.581 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 2.8 m-85 -79.99 147.13 31.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.871 179.695 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -141.24 130.99 24.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 76.1 m -93.88 140.81 29.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.181 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.554 ' HB2' ' HD2' ' A' ' 132' ' ' PRO . 1.9 p30 -62.25 161.16 26.61 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.514 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 131' ' ' ASP . 1.5 Cg_endo -43.07 148.07 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.967 2.445 . . . . 0.0 112.067 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 21.8 m-20 78.96 -24.41 0.22 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.798 -179.039 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 157' ' ' GLN . 22.2 m-85 -108.61 134.86 50.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.7 0.286 . . . . 0.0 110.619 179.353 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -123.02 133.97 54.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.589 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.814 HD11 ' HG2' ' A' ' 154' ' ' PRO . 17.1 tp -75.35 130.14 38.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.722 -179.509 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.85 67.42 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.827 -179.199 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.87 -134.24 1.95 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.05 -1.072 . . . . 0.0 112.975 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.521 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 30.5 p -73.85 59.42 0.68 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.102 0.477 . . . . 0.0 110.712 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.443 ' HA ' HD21 ' A' ' 136' ' ' LEU . 94.2 p -54.97 -50.9 67.8 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.444 -178.881 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.68 ' HD2' ' O ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -99.38 141.79 31.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.144 0.497 . . . . 0.0 112.006 -179.259 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.636 ' HA ' ' OG ' ' A' ' 150' ' ' SER . 55.3 p -150.69 146.0 26.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.148 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.798 HG12 ' HB3' ' A' ' 150' ' ' SER . 10.0 p -126.92 134.76 65.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.053 0.454 . . . . 0.0 111.863 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.71 143.98 51.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.714 179.573 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.2 m -149.9 -134.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.41 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -52.85 -34.72 55.57 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.929 0.395 . . . . 0.0 110.476 179.735 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.5 -48.8 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.767 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -80.41 144.12 32.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.676 0.274 . . . . 0.0 110.724 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.569 ' HB3' ' HB2' ' A' ' 142' ' ' SER . 44.0 m95 -84.2 151.07 25.07 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.421 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.798 ' HB3' HG12 ' A' ' 143' ' ' VAL . 98.5 p -43.34 -42.85 4.75 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.78 0.324 . . . . 0.0 110.703 -179.477 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.8 p -141.39 145.8 39.59 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.469 179.387 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.8 -156.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.697 2.265 . . . . 0.0 112.769 -179.426 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.744 ' HE2' HD13 ' A' ' 106' ' ' LEU . 87.3 tttt -101.5 125.39 37.68 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.821 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.814 ' HG2' HD11 ' A' ' 136' ' ' LEU . 60.0 Cg_endo -74.87 -149.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.407 2.071 . . . . 0.0 112.565 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -153.7 147.75 25.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.251 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 73.0 m -98.54 129.2 45.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.687 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 134' ' ' PHE . 84.5 mt-30 -107.59 136.58 47.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.994 0.426 . . . . 0.0 111.764 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.51 ' O ' HG22 ' A' ' 158' ' ' VAL . 11.9 p -83.11 47.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.499 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 18.5 m120 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.954 -179.416 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.658 0.266 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.58 135.29 56.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.834 0.35 . . . . 0.0 111.421 -179.766 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -175.46 133.62 0.3 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.625 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -172.95 142.58 1.1 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.443 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.82 140.71 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.833 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -57.02 112.13 1.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.908 0.385 . . . . 0.0 110.756 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.648 ' H ' HD13 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -65.03 146.47 13.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.359 -179.644 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 35.1 m -52.21 143.23 14.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.464 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.631 ' HB2' ' HE1' ' A' ' 149' ' ' TRP . 53.3 m -47.98 125.7 9.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.998 0.427 . . . . 0.0 111.38 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.843 ' HD3' HD21 ' A' ' 104' ' ' LEU . 16.8 tppt? -82.18 84.82 6.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.081 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.0 t -171.07 -44.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.748 0.309 . . . . 0.0 111.582 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.567 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.5 m-85 -60.71 -42.61 97.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.736 -179.454 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.91 ' HA ' HG11 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -49.95 -29.52 8.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.622 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.796 HG23 HD13 ' A' ' 104' ' ' LEU . 74.6 p -98.45 127.4 44.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.713 0.292 . . . . 0.0 110.766 179.345 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.646 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 69.0 tp -145.42 121.55 10.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.013 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.51 ' OE1' HD12 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -72.44 136.01 45.9 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.224 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 58.71 39.3 24.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.136 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.75 155.87 23.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.313 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -111.67 140.05 46.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.975 0.417 . . . . 0.0 111.361 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.91 HG11 ' HA ' ' A' ' 104' ' ' LEU . 96.1 t -111.08 128.59 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.648 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.614 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.8 m-85 -112.38 65.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.482 -179.099 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.762 HD23 ' H ' ' A' ' 113' ' ' LEU . 2.2 pt? -75.84 45.06 0.32 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.686 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.8 p -73.89 134.78 43.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.787 0.327 . . . . 0.0 111.414 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 124' ' ' ALA . . . 160.33 -54.92 0.33 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.426 -0.893 . . . . 0.0 113.111 179.513 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.72 ' HA3' ' HA ' ' A' ' 121' ' ' LEU . . . -82.78 -147.36 6.81 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.333 -179.389 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.8 t0 179.3 67.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.749 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 88.2 mt -33.74 123.69 0.48 Allowed Pre-proline 0 N--CA 1.462 0.154 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.745 -178.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.64 92.61 0.12 OUTLIER 'Cis proline' 0 C--N 1.348 0.525 0 C-N-CA 123.471 -1.47 . . . . 0.0 112.559 -0.329 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.749 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -177.52 150.15 0.67 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.637 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.72 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 0.4 OUTLIER -170.15 39.18 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.657 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.94 124.52 26.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.745 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 53.45 40.07 61.03 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.595 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.574 ' O ' HG23 ' A' ' 143' ' ' VAL . . . -72.1 124.7 25.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.756 0.312 . . . . 0.0 111.236 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -113.08 144.48 42.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.186 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.636 ' HB ' ' HA ' ' A' ' 113' ' ' LEU . 5.8 p -133.05 130.44 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.365 0.603 . . . . 0.0 112.22 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -98.48 136.12 39.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.29 179.404 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.589 ' HB2' ' HB2' ' A' ' 140' ' ' SER . 20.4 m-85 -112.85 142.73 45.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 0.0 111.569 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -163.14 126.85 2.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.271 179.067 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 18.1 t -89.19 140.42 29.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.189 -179.369 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.504 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 59.2 m-20 -54.82 161.39 2.31 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.267 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 8.2 Cg_endo -49.54 165.09 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.011 2.474 . . . . 0.0 112.031 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 159' ' ' ASN . 28.3 m-20 75.43 -17.99 0.48 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.396 -179.233 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.888 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 11.4 m-85 -131.16 131.43 44.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.896 179.383 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.461 ' N ' ' CD2' ' A' ' 135' ' ' HIS . 7.1 m-70 -102.86 124.04 47.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.639 0.256 . . . . 0.0 111.156 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.812 HD22 ' HB3' ' A' ' 140' ' ' SER . 5.1 tt -79.54 118.91 21.83 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.489 ' N ' HD23 ' A' ' 136' ' ' LEU . 46.0 t -136.87 76.98 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.548 -179.28 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.627 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . -171.6 60.1 0.17 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.027 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.527 ' OG ' HG21 ' A' ' 151' ' ' THR . 37.7 t 53.1 67.23 1.03 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.088 0.471 . . . . 0.0 109.744 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.812 ' HB3' HD22 ' A' ' 136' ' ' LEU . 84.9 p -71.09 37.7 0.05 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.917 -178.666 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.459 HH11 ' HG3' ' A' ' 141' ' ' ARG . 38.5 ttt85 -140.62 132.6 27.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.314 179.328 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.462 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 52.7 m -150.7 147.69 27.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.821 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 124' ' ' ALA . 7.1 p -147.58 132.05 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.897 0.38 . . . . 0.0 111.236 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 55.6 m -64.6 148.48 50.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.147 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 42.8 m -149.54 -30.49 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.761 0.315 . . . . 0.0 111.353 -179.371 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -170.81 54.1 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.897 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.09 42.7 83.8 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.923 -179.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -172.5 136.88 0.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.631 ' HE1' ' HB2' ' A' ' 100' ' ' SER . 36.0 m95 -84.17 144.41 29.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.745 -179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 61.3 m -50.51 -49.77 54.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.697 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.527 HG21 ' OG ' ' A' ' 139' ' ' SER . 72.9 p -131.15 136.96 29.63 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.417 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 27.3 Cg_exo -62.61 159.38 37.01 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.089 2.526 . . . . 0.0 112.506 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.646 ' NZ ' HD13 ' A' ' 106' ' ' LEU . 3.9 mmmp? -53.61 134.76 54.46 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.331 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.627 ' HB3' ' HA3' ' A' ' 138' ' ' GLY . 5.7 Cg_exo -78.85 -146.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.328 2.686 . . . . 0.0 112.432 -179.765 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -153.71 149.43 27.49 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.602 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.888 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 74.4 m -95.24 133.88 38.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 110.848 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 134' ' ' PHE . 11.8 tp-100 -103.09 138.07 40.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.871 -179.713 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.412 HG12 ' OE1' ' A' ' 157' ' ' GLN . 9.1 p -60.18 133.15 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.497 ' HB2' ' O ' ' A' ' 133' ' ' ASP . 26.5 t-20 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.911 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.723 0.297 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.43 130.46 42.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.983 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -66.17 130.14 42.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.417 ' HB2' ' H ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -71.88 -146.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.475 -179.955 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.417 ' H ' ' HB2' ' A' ' 95' ' ' PHE . 7.6 p -175.37 134.7 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.687 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.456 HH11 ' HG3' ' A' ' 97' ' ' ARG . 19.4 mmt85 -67.17 118.97 11.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.068 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.9 pt -84.03 145.15 8.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.148 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.421 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 75.0 m -53.97 140.46 31.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.699 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.9 m -48.02 129.27 14.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.42 -179.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.57 ' HB2' HD12 ' A' ' 104' ' ' LEU . 17.6 ptpt -81.31 11.48 4.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.375 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.8 t -68.51 -39.75 81.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.036 0.446 . . . . 0.0 110.72 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.63 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.3 m-85 -61.73 -33.22 73.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.43 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.57 HD12 ' HB2' ' A' ' 101' ' ' LYS . 80.8 mt -45.63 -45.43 13.9 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.276 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t -92.52 138.53 31.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.501 179.339 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.811 HD22 ' HA3' ' A' ' 109' ' ' GLY . 6.6 tt -145.41 124.39 12.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.507 -179.268 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.473 ' O ' HD23 ' A' ' 106' ' ' LEU . 22.9 pt-20 -61.45 125.67 24.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.677 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 56.55 39.84 29.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.135 0.493 . . . . 0.0 110.09 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.811 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -161.72 174.94 38.29 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.121 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -142.01 137.55 31.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.792 0.33 . . . . 0.0 110.914 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.63 HG21 ' O ' ' A' ' 103' ' ' TYR . 94.0 t -109.73 132.43 57.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.009 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -111.76 133.13 54.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.624 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.71 ' HG ' HG12 ' A' ' 126' ' ' VAL . 6.1 mp -108.39 132.6 53.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.151 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.1 t -162.03 129.44 3.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.078 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 157.51 -39.43 0.54 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.373 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.31 -127.86 0.91 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.208 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -174.82 133.66 0.35 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.716 ' O ' HD12 ' A' ' 118' ' ' LEU . 4.3 pp -43.27 140.57 2.11 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -87.97 45.19 1.28 Allowed 'Cis proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.578 -1.426 . . . . 0.0 113.54 0.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.21 146.79 54.5 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.789 0.328 . . . . 0.0 110.778 179.544 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.446 HD13 ' C ' ' A' ' 121' ' ' LEU . 2.2 tm? -140.35 -52.0 0.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.154 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.98 44.99 0.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.759 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 169.42 61.1 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.134 -1.032 . . . . 0.0 113.022 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.66 125.62 4.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.955 0.407 . . . . 0.0 111.45 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.472 ' HG2' HG13 ' A' ' 143' ' ' VAL . 61.2 mtt85 -133.6 129.79 37.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.753 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.71 HG12 ' HG ' ' A' ' 113' ' ' LEU . 31.0 m -97.72 132.64 42.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 120.946 0.403 . . . . 0.0 111.501 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -98.16 124.98 42.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.764 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 126' ' ' VAL . 5.2 m-85 -93.18 143.93 25.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.965 0.412 . . . . 0.0 110.986 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -158.96 127.46 5.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.197 179.153 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 136' ' ' LEU . 49.8 t -89.27 144.93 25.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.263 -179.042 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.78 152.1 7.39 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.937 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.497 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 3.7 Cg_endo -46.66 156.66 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.961 2.441 . . . . 0.0 111.928 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 62.7 t0 78.64 -35.54 0.18 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.584 -179.217 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.712 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 0.6 OUTLIER -108.33 135.5 49.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.058 179.287 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -112.96 134.02 54.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.551 -179.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 137' ' ' VAL . 7.4 tt -79.02 132.89 36.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.203 179.508 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.521 ' N ' HD23 ' A' ' 136' ' ' LEU . 46.3 t -128.6 77.91 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.584 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . 173.88 -124.42 1.04 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.838 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.829 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 26.8 t -71.25 60.37 0.29 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.958 0.409 . . . . 0.0 111.263 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 128' ' ' PHE . 35.4 t -58.05 -23.74 55.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -140.64 139.78 34.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.705 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.577 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 63.3 m -144.53 130.3 19.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.9 0.381 . . . . 0.0 111.322 -179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.472 HG13 ' HG2' ' A' ' 125' ' ' ARG . 32.1 t -97.6 133.02 41.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.074 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 50.4 t -80.5 50.87 1.36 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.986 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 62.8 m -80.24 134.85 36.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.902 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 37.4 tt0 50.67 46.96 25.14 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.487 179.179 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 51.94 44.51 56.04 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.317 179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -165.48 142.79 5.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.738 0.304 . . . . 0.0 110.282 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 142' ' ' SER . 55.3 m95 -84.2 139.88 32.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.917 0.389 . . . . 0.0 111.046 -179.34 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -56.5 -51.66 67.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.375 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 29.0 p -118.85 134.28 23.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.804 0.335 . . . . 0.0 111.898 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.419 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 39.6 Cg_endo -66.52 145.36 76.34 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.985 2.456 . . . . 0.0 112.461 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.434 ' NZ ' ' HG ' ' A' ' 106' ' ' LEU . 60.8 tttm -46.76 127.35 8.44 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.949 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.829 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 68.4 Cg_endo -89.24 -141.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.096 2.531 . . . . 0.0 113.343 -179.311 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.486 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.2 p-80 -153.71 146.67 24.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.101 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.712 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 22.3 t -97.39 133.07 42.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 111.179 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -103.04 137.03 41.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.948 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.9 p -88.9 133.12 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 179.722 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.935 -179.837 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.637 0.256 . . . . 0.0 111.455 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.559 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -51.39 140.33 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.379 . . . . 0.0 111.28 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.627 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 87.2 m -55.28 157.79 3.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.061 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.7 p -47.69 128.54 13.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.328 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.577 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 10.1 mtmp? -80.44 -21.51 42.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.206 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.4 p -53.13 -40.97 64.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.573 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.68 ' HA ' ' HE3' ' A' ' 153' ' ' LYS . 2.6 m-85 -52.91 -31.29 39.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.551 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.449 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 96.6 mt -50.66 -42.89 57.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.816 0.341 . . . . 0.0 110.916 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.7 m -95.03 142.22 27.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.054 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.449 HD13 ' HD2' ' A' ' 153' ' ' LYS . 47.3 tp -145.31 127.7 15.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.833 0.349 . . . . 0.0 110.893 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -73.01 144.24 47.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.158 0.504 . . . . 0.0 111.276 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 57.91 32.85 22.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.241 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.426 ' CA ' ' HA ' ' A' ' 130' ' ' CYS . . . -176.98 -166.9 34.67 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.771 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -142.0 145.17 34.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.724 0.297 . . . . 0.0 110.786 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 103' ' ' TYR . 72.7 t -106.29 135.45 44.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.016 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.711 ' O ' HG23 ' A' ' 126' ' ' VAL . 2.7 m-85 -110.24 120.52 42.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.286 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.522 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.9 mm? -103.27 147.11 27.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.489 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.9 m -157.02 132.93 9.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.431 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 64.03 49.89 64.22 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.096 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.624 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . 178.08 136.47 2.53 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.996 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -174.93 124.38 0.26 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.568 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 7.2 tt -51.41 137.48 30.57 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.891 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.53 ' HA ' ' HG ' ' A' ' 118' ' ' LEU . 71.2 Cg_endo -89.19 60.42 0.31 Allowed 'Cis proline' 0 C--N 1.345 0.393 0 C-N-CA 123.558 -1.434 . . . . 0.0 113.02 0.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.568 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -155.61 162.1 40.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.597 0.237 . . . . 0.0 110.822 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.895 HD12 ' N ' ' A' ' 122' ' ' ASP . 1.7 pp -168.35 -34.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.744 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.895 ' N ' HD12 ' A' ' 121' ' ' LEU . 63.2 t0 36.38 51.13 0.82 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.925 0.393 . . . . 0.0 110.959 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.8 47.84 52.88 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.837 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.624 ' HB2' ' HA3' ' A' ' 116' ' ' GLY . . . -54.74 139.19 40.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.989 0.423 . . . . 0.0 111.697 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -107.27 151.51 25.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.379 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 112' ' ' PHE . 5.1 p -143.66 133.46 20.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.407 0.623 . . . . 0.0 112.232 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -105.04 131.58 52.37 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.543 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -102.8 143.52 32.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.004 0.43 . . . . 0.0 111.732 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -162.94 125.15 2.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.383 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.426 ' HA ' ' CA ' ' A' ' 109' ' ' GLY . 63.9 m -89.27 170.11 10.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.207 0.527 . . . . 0.0 112.222 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.7 157.01 2.85 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.636 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.87 69.37 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.025 2.483 . . . . 0.0 112.413 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -173.25 -31.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.861 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.804 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 3.7 m-85 -108.14 132.93 53.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.833 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.461 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 18.9 p-80 -102.13 125.98 48.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.012 0.434 . . . . 0.0 110.726 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.648 HD21 ' HA ' ' A' ' 140' ' ' SER . 20.5 tp -72.65 126.9 31.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.042 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 137' ' ' VAL . 22.0 t -135.39 60.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.584 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -170.59 -131.38 1.33 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 119.801 -1.19 . . . . 0.0 113.419 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.601 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 56.6 p -73.53 55.32 0.49 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 111.431 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.648 ' HA ' HD21 ' A' ' 136' ' ' LEU . 42.3 t -57.88 -42.11 83.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.136 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -99.37 132.24 44.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.068 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.0 p -149.84 145.02 26.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.302 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 124' ' ' ALA . 7.2 p -138.62 134.41 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.998 0.428 . . . . 0.0 111.698 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.652 ' SG ' HD22 ' A' ' 121' ' ' LEU . 37.9 t -67.46 134.87 52.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.023 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.1 m -165.63 130.03 2.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.072 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 50.9 tt0 53.62 45.25 28.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.966 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 56.91 43.51 92.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.603 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -173.12 140.56 0.89 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.352 . . . . 0.0 110.652 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.627 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 28.5 m95 -84.24 140.99 31.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.732 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 67.1 m -52.82 -56.51 15.24 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.015 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.42 ' HB ' ' HB2' ' A' ' 139' ' ' SER . 60.6 p -117.65 133.59 23.28 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.05 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.492 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 43.9 Cg_endo -67.8 -155.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.548 2.166 . . . . 0.0 112.758 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.68 ' HE3' ' HA ' ' A' ' 103' ' ' TYR . 27.8 mmtp -81.05 129.3 67.85 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.288 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.601 ' HB3' ' N ' ' A' ' 139' ' ' SER . 83.0 Cg_endo -81.61 -146.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.837 2.358 . . . . 0.0 112.242 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.442 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 24.3 p-80 -153.66 126.29 8.17 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.93 0.395 . . . . 0.0 111.328 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.804 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 76.2 m -99.13 130.34 45.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.156 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.461 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 4.3 tp-100 -103.92 140.14 38.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.005 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.456 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 9.7 p -75.35 136.09 25.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.388 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.484 HD22 ' N ' ' A' ' 159' ' ' ASN . 2.1 m120 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.18 -0.914 . . . . 0.0 110.94 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.431 ' O ' HG23 ' A' ' 98' ' ' ILE . 39.5 ptt180 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.744 0.307 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.456 ' HB ' HD13 ' A' ' 121' ' ' LEU . 20.9 pt -157.83 43.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.032 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.493 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 90.1 m 62.18 139.18 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.748 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.5 m -47.88 131.51 15.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.399 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -83.75 -28.64 28.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.079 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.2 p -53.18 -35.49 59.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.509 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.848 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.8 m-85 -50.86 -36.39 37.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.41 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.532 HD21 HG23 ' A' ' 114' ' ' THR . 88.4 mt -53.44 -44.45 68.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.955 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.1 m -92.55 133.99 35.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.25 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.2 tp -145.39 132.77 20.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.692 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.31 131.53 50.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.672 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m120 54.66 44.93 27.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.662 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.03 165.36 34.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.509 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -141.88 151.41 42.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.005 0.431 . . . . 0.0 110.942 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.504 HG11 ' HB ' ' A' ' 126' ' ' VAL . 95.1 t -111.18 141.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.253 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.402 ' CE1' ' HD2' ' A' ' 129' ' ' ARG . 3.7 m-85 -106.57 134.46 49.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.406 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.664 HD23 ' N ' ' A' ' 114' ' ' THR . 6.3 tt 69.79 129.96 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.374 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.664 ' N ' HD23 ' A' ' 113' ' ' LEU . 92.0 m -109.37 -45.99 3.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.929 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.61 ' HA3' ' HA ' ' A' ' 124' ' ' ALA . . . 79.92 53.44 4.24 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.26 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -142.19 150.67 22.29 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.462 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -159.67 65.81 0.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.967 0.413 . . . . 0.0 110.034 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.529 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 90.2 mt -38.39 137.77 0.78 Allowed Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.171 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -89.03 59.9 0.32 Allowed 'Cis proline' 0 CA--C 1.531 0.366 0 C-N-CA 123.762 -1.349 . . . . 0.0 113.265 0.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.529 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -164.13 126.3 2.38 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.927 0.394 . . . . 0.0 111.471 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.778 ' HG ' ' HB2' ' A' ' 124' ' ' ALA . 26.6 tp -78.87 -55.84 4.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.481 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.7 t70 38.37 109.13 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 55.46 54.6 33.42 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.728 -0.669 . . . . 0.0 114.224 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.778 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . . . -73.66 132.5 42.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.948 0.374 . . . . 0.0 110.894 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.548 ' HB2' HD22 ' A' ' 113' ' ' LEU . 62.2 mtt85 -137.97 153.63 49.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.583 HG22 ' CZ3' ' A' ' 149' ' ' TRP . 12.5 m -154.6 131.04 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.946 0.403 . . . . 0.0 111.322 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -107.59 117.78 34.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.32 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.472 ' HB2' ' CA ' ' A' ' 140' ' ' SER . 4.6 m-85 -86.56 141.38 29.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.121 0.486 . . . . 0.0 111.516 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.471 ' HG2' HH11 ' A' ' 129' ' ' ARG . 3.5 ptp85 -161.01 128.95 4.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.761 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 136' ' ' LEU . 20.7 t -89.2 147.41 24.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.744 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.655 ' OD1' ' HD2' ' A' ' 132' ' ' PRO . 36.4 t70 -52.72 145.75 20.56 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.906 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.655 ' HD2' ' OD1' ' A' ' 131' ' ' ASP . 3.2 Cg_exo -40.45 157.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.596 2.864 . . . . 0.0 112.545 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 55.6 m-20 80.93 -40.31 0.15 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.408 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -106.32 128.99 54.41 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.454 ' HE1' ' HA ' ' A' ' 159' ' ' ASN . 16.9 p-80 -102.76 128.32 49.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.973 0.416 . . . . 0.0 110.981 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.787 HD11 ' HG2' ' A' ' 154' ' ' PRO . 20.5 tp -74.55 127.33 32.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.497 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.6 t -131.13 72.2 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.79 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 154' ' ' PRO . . . -167.55 56.72 0.22 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.799 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.673 ' OG ' HG21 ' A' ' 151' ' ' THR . 41.1 t 51.46 65.05 1.61 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.472 ' CA ' ' HB2' ' A' ' 128' ' ' PHE . 96.0 p -70.43 38.81 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.53 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.409 ' H ' ' C ' ' A' ' 139' ' ' SER . 40.1 ttm180 -141.21 133.99 28.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.209 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.512 ' HB2' HG23 ' A' ' 126' ' ' VAL . 64.7 m -146.21 140.33 26.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.941 0.401 . . . . 0.0 111.319 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.513 ' HA ' ' HZ3' ' A' ' 149' ' ' TRP . 7.2 p -144.47 129.48 14.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.873 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 71.9 m -71.49 156.28 39.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.582 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.9 t -158.72 -29.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.471 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -149.29 48.08 0.97 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.719 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.82 35.49 89.72 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.493 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -159.19 146.81 17.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.706 0.288 . . . . 0.0 110.462 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.583 ' CZ3' HG22 ' A' ' 126' ' ' VAL . 68.3 m95 -84.19 142.22 30.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.864 0.364 . . . . 0.0 110.777 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 142' ' ' SER . 46.9 t -47.91 -45.52 30.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.141 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.673 HG21 ' OG ' ' A' ' 139' ' ' SER . 61.6 p -136.61 143.94 45.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.838 0.352 . . . . 0.0 111.797 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.496 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 24.0 Cg_exo -64.01 -159.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.856 2.371 . . . . 0.0 112.818 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.848 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 14.4 mmmm -86.12 127.14 62.94 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.263 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.787 ' HG2' HD11 ' A' ' 136' ' ' LEU . 92.4 Cg_endo -79.89 -149.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.741 2.294 . . . . 0.0 112.637 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.506 ' O ' HD12 ' A' ' 136' ' ' LEU . 17.9 p-80 -153.7 150.04 28.14 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.073 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 77.8 m -97.43 138.1 35.38 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.381 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -108.55 136.05 48.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.554 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.462 ' O ' HG22 ' A' ' 158' ' ' VAL . 11.4 p -82.47 52.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.498 0.666 . . . . 0.0 110.301 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.454 ' HA ' ' HE1' ' A' ' 135' ' ' HIS . 76.1 m-20 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.374 -0.822 . . . . 0.0 111.069 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.962 0.411 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.536 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -60.15 138.36 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.166 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.596 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 75.6 m -60.58 140.99 57.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.677 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.2 m -47.87 128.71 13.7 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.53 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.743 ' HA ' HD13 ' A' ' 104' ' ' LEU . 26.3 ttpp -82.76 11.01 6.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.6 t -68.31 -40.46 81.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.332 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.653 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.3 m-85 -59.59 -40.73 88.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.413 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.743 HD13 ' HA ' ' A' ' 101' ' ' LYS . 6.8 mp -49.28 -43.62 43.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.6 0.238 . . . . 0.0 111.295 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.4 t -92.56 126.06 37.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.861 0.362 . . . . 0.0 110.765 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.716 HD22 ' HZ2' ' A' ' 153' ' ' LYS . 14.0 tp -145.7 133.16 20.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.465 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.42 ' H ' HD12 ' A' ' 106' ' ' LEU . 44.7 tt0 -71.55 134.32 46.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.345 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 57.74 40.7 26.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.632 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -179.56 156.98 19.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.937 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -123.47 141.78 51.65 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.653 HG21 ' O ' ' A' ' 103' ' ' TYR . 90.5 t -109.94 142.36 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.253 0.549 . . . . 0.0 112.003 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.551 ' HB2' ' HG3' ' A' ' 127' ' ' GLU . 4.6 m-85 -103.42 139.87 38.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.738 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.629 ' HA ' HG22 ' A' ' 126' ' ' VAL . 1.5 pt? -139.21 57.69 1.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.029 0.442 . . . . 0.0 111.793 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.9 p -54.48 142.81 26.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.698 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.67 137.95 5.08 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.235 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 178.03 149.58 8.09 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.358 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -151.02 58.1 0.91 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.544 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 2.0 pt? -40.6 136.17 1.48 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.159 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -89.05 61.18 0.27 Allowed 'Cis proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.663 -1.39 . . . . 0.0 113.254 0.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.544 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -165.56 130.81 2.49 Favored 'General case' 0 C--O 1.23 0.064 0 CA-C-O 120.895 0.379 . . . . 0.0 111.335 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.879 HD23 ' H ' ' A' ' 121' ' ' LEU . 1.1 pt? -112.56 48.65 0.98 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.991 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -62.77 133.37 54.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.64 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.86 33.34 82.89 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.489 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 143' ' ' VAL . . . -78.11 135.07 37.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.691 0.281 . . . . 0.0 110.966 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -105.08 136.42 44.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.018 0.437 . . . . 0.0 110.422 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.629 HG22 ' HA ' ' A' ' 113' ' ' LEU . 2.6 t -132.08 137.1 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.957 -178.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.551 ' HG3' ' HB2' ' A' ' 112' ' ' PHE . 9.3 pt-20 -132.66 117.48 17.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.921 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.537 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 2.9 m-85 -77.4 147.53 35.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.211 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -145.8 117.75 8.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.663 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 16.9 t -89.22 147.67 24.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 111.254 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -52.71 152.1 7.26 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.312 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.495 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 1.1 Cg_endo -44.44 158.38 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.366 2.711 . . . . 0.0 112.738 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.495 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 38.5 t70 77.98 -31.89 0.16 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.959 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -108.89 127.18 53.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.679 0.276 . . . . 0.0 110.511 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -104.95 135.36 46.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 110.903 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.778 HD11 ' HG2' ' A' ' 154' ' ' PRO . 25.7 tp -71.58 133.35 45.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.466 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 137' ' ' VAL . 24.6 t -132.69 61.37 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.538 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -168.41 -135.58 1.91 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.914 -1.136 . . . . 0.0 113.091 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.588 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 93.4 p -74.26 61.82 0.9 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.808 0.337 . . . . 0.0 111.039 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 91.3 p -63.14 4.41 0.2 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.413 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.488 ' H ' ' C ' ' A' ' 139' ' ' SER . 16.8 ptm180 -140.53 133.9 29.84 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.955 0.407 . . . . 0.0 110.944 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 54.9 m -150.73 140.76 22.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.868 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 124' ' ' ALA . 14.2 p -126.93 131.86 70.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.996 0.427 . . . . 0.0 111.63 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 52.6 t -80.49 148.29 30.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.271 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 89.2 p -150.67 -137.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.936 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.504 ' H ' ' CD ' ' A' ' 146' ' ' GLN . 14.7 mp0 -55.88 -38.62 70.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.94 0.4 . . . . 0.0 110.55 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 148' ' ' GLN . . . 179.93 145.46 6.44 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.708 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.458 ' HB3' ' O ' ' A' ' 147' ' ' GLY . 69.0 tp60 69.67 147.74 0.07 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.915 0.388 . . . . 0.0 110.633 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.596 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 26.9 m95 -84.16 147.52 27.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.234 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.6 t -51.85 -55.02 22.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.106 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.559 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 74.8 p -123.39 134.58 25.3 Favored Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.66 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.82 143.19 95.67 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.825 2.35 . . . . 0.0 111.879 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.716 ' HZ2' HD22 ' A' ' 106' ' ' LEU . 21.9 ttmm -42.45 133.33 2.74 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 111.601 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.778 ' HG2' HD11 ' A' ' 136' ' ' LEU . 73.5 Cg_endo -75.26 -143.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.88 2.386 . . . . 0.0 112.678 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.476 ' O ' HD12 ' A' ' 136' ' ' LEU . 22.9 p-80 -153.68 154.43 34.11 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.292 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 89.6 m -95.7 140.37 30.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.065 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -132.96 144.41 50.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.262 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.2 p -75.11 133.52 31.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.457 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.9 p30 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.966 -179.617 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.974 0.416 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.789 ' HA ' HD12 ' A' ' 121' ' ' LEU . 38.6 pt -55.49 147.12 4.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 39.4 m -47.28 148.42 1.28 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.027 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.43 ' HB2' ' CD1' ' A' ' 149' ' ' TRP . 54.1 m -47.85 127.17 11.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.057 0.456 . . . . 0.0 111.252 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -85.25 -25.21 27.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.27 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.2 m -53.08 -41.15 64.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.552 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.479 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 1.4 m-85 -56.46 -41.57 76.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.887 0.375 . . . . 0.0 110.713 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.5 mt -59.9 -35.3 74.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.0 p -91.87 77.92 5.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.162 0.506 . . . . 0.0 110.569 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.721 HD22 ' HA3' ' A' ' 109' ' ' GLY . 7.2 tt -93.88 125.47 38.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.577 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.506 ' O ' HD23 ' A' ' 106' ' ' LEU . 24.6 pt-20 -68.1 127.61 33.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 62.94 48.47 3.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 0.0 110.583 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.721 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -158.56 -163.47 12.96 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.62 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.569 ' HB3' ' NZ ' ' A' ' 110' ' ' LYS . 8.2 mtpm? -144.02 -41.6 0.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.57 HG23 ' HA ' ' A' ' 128' ' ' PHE . 13.7 p 52.02 136.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 123.594 0.758 . . . . 0.0 112.581 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -108.11 142.74 37.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.586 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.442 HD12 ' H ' ' A' ' 114' ' ' THR . 24.9 tp -120.31 136.15 54.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.608 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.442 ' H ' HD12 ' A' ' 113' ' ' LEU . 68.5 p -145.0 139.1 27.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.211 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 66.36 44.1 91.25 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.457 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -179.49 130.6 1.53 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.974 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.831 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 54.3 m-20 -160.25 121.35 3.06 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.953 HD12 ' HA ' ' A' ' 119' ' ' PRO . 40.6 tp -38.58 133.51 1.01 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.279 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.953 ' HA ' HD12 ' A' ' 118' ' ' LEU . 77.1 Cg_endo -92.43 44.69 2.24 Favored 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.56 -1.433 . . . . 0.0 113.399 0.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.831 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -81.12 148.26 29.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.803 0.335 . . . . 0.0 111.209 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 98' ' ' ILE . 3.6 tt -162.45 79.27 0.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.309 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -167.07 122.07 1.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.595 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.7 31.16 29.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.718 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.594 ' O ' HG23 ' A' ' 143' ' ' VAL . . . -75.9 127.66 33.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.631 0.253 . . . . 0.0 110.804 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -125.46 143.4 51.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 111.021 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.24 135.7 56.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.133 0.492 . . . . 0.0 111.598 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.43 ' HG3' ' HE ' ' A' ' 141' ' ' ARG . 88.3 tt0 -109.36 88.83 2.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.312 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.57 ' HA ' HG23 ' A' ' 111' ' ' VAL . 67.0 m-85 -55.44 141.64 35.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 111.178 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.467 ' HG2' HH11 ' A' ' 129' ' ' ARG . 13.8 tpp85 -143.4 129.13 19.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.897 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 35.9 t -89.17 153.13 21.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.087 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -52.75 154.09 5.17 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.313 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 8.1 Cg_endo -49.64 155.47 3.71 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.802 2.334 . . . . 0.0 111.356 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 11.4 m-20 79.37 -29.74 0.14 Allowed 'General case' 0 N--CA 1.463 0.221 0 O-C-N 123.377 0.423 . . . . 0.0 110.098 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.775 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 1.6 m-85 -105.7 152.22 23.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.806 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -133.03 131.44 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.991 0.424 . . . . 0.0 111.442 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.505 HD21 ' HA ' ' A' ' 140' ' ' SER . 42.8 tp -69.37 133.81 48.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.428 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.0 t -131.33 70.93 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.905 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.27 -132.54 1.96 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.349 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.748 ' HB3' HG23 ' A' ' 151' ' ' THR . 49.4 m -73.15 58.82 0.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 122.712 0.405 . . . . 0.0 111.177 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.505 ' HA ' HD21 ' A' ' 136' ' ' LEU . 87.6 p -56.91 -28.13 61.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.688 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.435 HH11 ' HG3' ' A' ' 141' ' ' ARG . 20.1 mmt85 -109.95 139.21 45.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.991 0.424 . . . . 0.0 111.914 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.777 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 68.0 m -150.7 142.04 23.33 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.438 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.824 HG12 ' HB2' ' A' ' 150' ' ' SER . 7.7 p -145.49 137.34 20.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 111.648 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.494 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 41.3 m -60.36 159.03 10.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.73 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.8 t -162.8 -29.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.158 0.504 . . . . 0.0 110.67 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -166.68 57.07 0.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.975 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.6 37.84 89.76 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.541 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.423 ' HB3' ' H ' ' A' ' 149' ' ' TRP . 14.5 mm-40 -155.33 -149.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.045 0.45 . . . . 0.0 110.395 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.777 ' HB3' ' HB3' ' A' ' 142' ' ' SER . 86.6 m95 -146.54 155.6 42.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.329 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.824 ' HB2' HG12 ' A' ' 143' ' ' VAL . 47.5 t -41.93 -50.23 4.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.414 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.748 HG23 ' HB3' ' A' ' 139' ' ' SER . 1.5 t -147.44 145.89 23.15 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -47.15 156.99 0.7 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.431 2.754 . . . . 0.0 113.302 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.476 ' HE2' ' HG ' ' A' ' 106' ' ' LEU . 60.1 tttm -56.6 129.04 75.97 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.984 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.721 ' HB3' ' N ' ' A' ' 139' ' ' SER . 74.3 Cg_endo -75.02 -147.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.647 2.231 . . . . 0.0 112.568 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.423 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 23.2 p-80 -153.7 144.91 22.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.346 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.775 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 47.6 t -95.21 132.18 40.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.949 0.404 . . . . 0.0 110.575 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.411 ' NE2' ' HA ' ' A' ' 157' ' ' GLN . 3.0 tp-100 -116.69 138.54 51.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.952 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.32 131.71 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.167 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 25.0 p30 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.958 -179.565 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.578 ' NH1' ' HA3' ' A' ' 147' ' ' GLY . 33.2 ptt85 . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 121.066 0.46 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.5 pt -53.77 154.46 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.345 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.486 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 84.1 m -46.38 141.57 3.48 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.971 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.7 m -47.9 124.76 7.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.822 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -81.88 -13.18 57.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.28 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.2 p -53.12 -38.06 62.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.253 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.916 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 5.4 m-85 -48.48 -31.83 6.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.43 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.6 mt -77.23 39.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.583 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.6 p -147.36 58.58 1.15 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.886 0.374 . . . . 0.0 110.373 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.662 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 35.6 tp -93.83 130.52 39.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.584 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.548 ' HG2' ' ND2' ' A' ' 108' ' ' ASN . 89.3 tt0 -72.0 137.03 46.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.735 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.548 ' ND2' ' HG2' ' A' ' 107' ' ' GLU . 74.8 m-20 59.31 40.82 20.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.075 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.24 -166.44 13.14 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.375 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 111' ' ' VAL . 54.5 mtpt -142.14 -41.06 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.441 0.12 . . . . 0.0 111.102 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.598 HG23 ' HA ' ' A' ' 128' ' ' PHE . 9.0 p 51.0 133.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.735 0.814 . . . . 0.0 112.903 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -112.15 -167.05 1.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.448 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.611 HD23 ' N ' ' A' ' 114' ' ' THR . 8.1 tt -173.33 141.48 0.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.285 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.611 ' N ' HD23 ' A' ' 113' ' ' LEU . 89.8 m -154.07 145.97 23.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.159 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.29 43.94 19.02 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.147 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . 174.28 140.57 3.31 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.067 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -166.47 129.83 1.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.739 0.304 . . . . 0.0 110.241 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.568 ' H ' HD12 ' A' ' 118' ' ' LEU . 5.7 mp -52.07 135.2 39.27 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.812 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 59.2 Cg_endo -94.35 63.27 0.36 Allowed 'Cis proline' 0 N--CA 1.46 -0.453 0 C-N-CA 124.098 -1.209 . . . . 0.0 113.059 0.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -149.53 134.03 17.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.882 0.373 . . . . 0.0 111.689 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.476 HD13 ' SG ' ' A' ' 144' ' ' CYS . 88.1 mt -102.35 -45.07 5.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.801 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.428 ' OD1' ' HA2' ' A' ' 116' ' ' GLY . 10.2 p-10 36.4 47.97 0.55 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.512 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.94 45.86 94.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.302 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.436 ' HB2' ' HA3' ' A' ' 116' ' ' GLY . . . -58.25 136.9 57.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.776 0.322 . . . . 0.0 111.112 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.757 ' HD3' ' HD3' ' A' ' 141' ' ' ARG . 38.6 ttm180 -118.43 119.22 33.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 142' ' ' SER . 12.1 p -84.86 148.84 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.045 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -133.7 76.79 1.68 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.233 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.625 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 79.9 m-85 -53.85 151.9 6.05 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.886 0.374 . . . . 0.0 111.058 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -157.11 135.83 11.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.637 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 134' ' ' PHE . 59.6 m -89.23 146.9 24.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.785 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' ASP . 63.4 m-20 -52.69 154.7 4.53 Favored Pre-proline 0 N--CA 1.463 0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.491 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.12 73.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.483 2.789 . . . . 0.0 113.033 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 131' ' ' ASP . 39.0 t70 178.75 -38.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 130' ' ' CYS . 3.2 m-85 -108.14 139.22 43.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.529 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -102.52 132.24 48.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.041 0.448 . . . . 0.0 110.794 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.742 HD22 ' HB2' ' A' ' 140' ' ' SER . 6.0 tt -75.14 128.15 34.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.183 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.584 ' N ' HD23 ' A' ' 136' ' ' LEU . 21.8 t -131.96 65.05 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.488 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.86 -129.49 1.31 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.304 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.818 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.5 t -71.4 57.19 0.25 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.597 0.359 . . . . 0.0 111.874 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.742 ' HB2' HD22 ' A' ' 136' ' ' LEU . 32.6 t -60.9 -16.6 43.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.122 0.487 . . . . 0.0 110.037 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.757 ' HD3' ' HD3' ' A' ' 125' ' ' ARG . 39.1 ttm180 -140.09 140.29 36.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.901 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.656 ' O ' HG12 ' A' ' 126' ' ' VAL . 33.5 m -149.16 122.62 9.09 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.209 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.591 HG12 ' HB3' ' A' ' 150' ' ' SER . 11.8 p -83.78 132.55 31.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 111.749 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.476 ' SG ' HD13 ' A' ' 121' ' ' LEU . 16.3 t -83.97 130.35 34.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.592 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 25.4 t -114.34 -139.48 0.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.543 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -64.96 -40.82 95.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.807 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.578 ' HA3' ' NH1' ' A' ' 97' ' ' ARG . . . -175.88 46.58 0.12 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.169 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -170.07 134.76 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.734 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.521 ' HZ3' ' HB ' ' A' ' 126' ' ' VAL . 32.4 m95 -84.21 141.43 31.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.582 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.591 ' HB3' HG12 ' A' ' 143' ' ' VAL . 79.2 p -52.66 -60.35 3.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.577 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 27.4 p -114.38 134.18 22.33 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 0.0 111.897 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 16.5 Cg_exo -67.37 150.56 80.98 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.104 2.536 . . . . 0.0 112.179 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.916 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 8.7 mtpm? -42.8 132.27 3.02 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.556 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.818 ' HB3' ' H ' ' A' ' 139' ' ' SER . 98.9 Cg_endo -79.43 -140.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.819 2.346 . . . . 0.0 112.998 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.487 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.0 p-80 -153.64 144.44 22.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.43 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 81.9 m -97.89 133.11 42.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.833 0.349 . . . . 0.0 111.068 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -123.62 140.54 52.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.541 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.82 132.37 31.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.488 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.7 p30 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.008 -179.531 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.54 ' O ' HD21 ' A' ' 121' ' ' LEU . 68.1 mtt-85 . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.776 0.322 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.9 pt -54.22 140.79 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.36 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 72.8 m -56.3 127.0 28.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.7 t -48.01 128.36 13.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.37 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.894 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -90.23 25.83 2.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.807 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.0 p -68.82 -41.63 78.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.238 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.734 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 3.9 m-85 -56.95 -31.35 64.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.864 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.704 ' O ' HG22 ' A' ' 105' ' ' THR . 83.4 mt -53.99 146.72 13.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.761 -0.199 . . . . 0.0 111.098 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.704 HG22 ' O ' ' A' ' 104' ' ' LEU . 6.9 t 56.36 138.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.72 0.808 . . . . 0.0 112.367 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.7 tp -145.45 138.96 26.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.971 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.08 44.2 0.56 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.517 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -157.29 -30.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.858 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.661 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . -158.69 -141.36 3.12 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.947 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -139.47 152.26 46.86 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.912 0.386 . . . . 0.0 110.792 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.1 t -109.34 139.47 32.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.208 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.458 ' CE1' ' HD3' ' A' ' 129' ' ' ARG . 2.8 m-85 -108.34 137.56 46.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.05 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 125' ' ' ARG . 0.4 OUTLIER 71.85 133.97 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.697 -179.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.64 ' N ' HD13 ' A' ' 113' ' ' LEU . 66.1 p -126.69 -130.59 0.24 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.722 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.511 ' HA3' HD11 ' A' ' 118' ' ' LEU . . . -62.39 133.87 45.13 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.033 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.3 -48.87 75.35 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.835 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 118' ' ' LEU . 37.5 t70 -174.47 61.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.692 ' H ' HD12 ' A' ' 118' ' ' LEU . 7.2 mp -33.2 132.87 0.33 Allowed Pre-proline 0 N--CA 1.462 0.133 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.3 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -85.89 46.11 0.85 Allowed 'Cis proline' 0 C--N 1.346 0.413 0 C-N-CA 123.661 -1.391 . . . . 0.0 113.49 0.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.417 ' H ' ' CA ' ' A' ' 118' ' ' LEU . . . -85.53 127.64 34.5 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.616 0.246 . . . . 0.0 111.185 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.676 HD23 ' H ' ' A' ' 147' ' ' GLY . 5.7 mp -101.89 -42.63 6.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.034 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.33 61.18 0.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.954 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -177.39 -32.89 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.323 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.59 129.29 25.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.915 0.388 . . . . 0.0 111.162 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.731 ' O ' HD12 ' A' ' 113' ' ' LEU . 55.2 ttp85 -135.24 156.11 49.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.745 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.573 HG13 ' CH2' ' A' ' 149' ' ' TRP . 16.1 m -152.25 135.93 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.871 0.367 . . . . 0.0 111.085 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 54.5 mt-10 -121.1 104.26 9.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.132 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.65 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 4.5 m-85 -78.57 143.78 36.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.205 0.526 . . . . 0.0 111.977 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.458 ' HD3' ' CE1' ' A' ' 112' ' ' PHE . 8.0 ptm180 -166.53 124.28 1.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.659 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.661 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 96.3 m -89.22 149.43 23.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.323 0.582 . . . . 0.0 112.453 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.467 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 59.8 m-20 -52.71 159.68 1.67 Allowed Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.939 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 18.2 Cg_endo -59.22 76.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.111 2.54 . . . . 0.0 112.454 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.3 t70 -175.63 -42.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.706 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 5.3 m-85 -108.83 131.86 54.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.416 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.598 ' NE2' ' HB2' ' A' ' 157' ' ' GLN . 0.3 OUTLIER -101.23 121.6 42.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.245 0.545 . . . . 0.0 110.897 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.639 HD22 ' HB3' ' A' ' 140' ' ' SER . 5.5 tt -69.94 125.4 26.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.974 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.501 ' N ' HD23 ' A' ' 136' ' ' LEU . 15.0 t -134.32 63.13 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.578 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -169.98 -135.78 1.97 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.357 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.685 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 63.8 m -75.03 57.18 0.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.914 0.388 . . . . 0.0 111.037 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.639 ' HB3' HD22 ' A' ' 136' ' ' LEU . 99.1 p -51.65 -43.55 62.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.339 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -99.36 138.86 35.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.558 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 44.2 t -150.16 139.7 21.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.863 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.418 ' H ' ' HB3' ' A' ' 150' ' ' SER . 7.0 p -137.56 127.26 36.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.941 0.4 . . . . 0.0 111.222 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.427 ' HB2' ' CD2' ' A' ' 149' ' ' TRP . 45.8 t -87.71 149.31 24.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.591 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 38.4 t -167.13 30.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.207 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 52.8 tt0 175.7 43.32 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.85 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.676 ' H ' HD23 ' A' ' 121' ' ' LEU . . . 77.9 -51.07 3.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.975 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -88.42 149.37 23.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.573 ' CH2' HG13 ' A' ' 126' ' ' VAL . 81.7 m95 -84.15 146.27 27.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.911 0.386 . . . . 0.0 110.946 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 143' ' ' VAL . 48.3 t -45.0 -55.7 5.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.904 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 72.4 p -126.0 133.12 24.62 Favored Pre-proline 0 C--N 1.329 -0.308 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.775 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.438 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 23.7 Cg_exo -63.65 155.66 61.85 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.993 2.462 . . . . 0.0 112.326 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.734 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 55.1 mtpt -49.19 128.18 16.03 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.874 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.685 ' HB3' ' N ' ' A' ' 139' ' ' SER . 58.2 Cg_endo -71.4 -146.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.631 2.221 . . . . 0.0 112.582 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.423 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 22.5 p-80 -153.68 130.51 10.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.894 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.706 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 90.5 m -102.56 136.85 41.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.243 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.598 ' HB2' ' NE2' ' A' ' 135' ' ' HIS . 10.6 mm100 -104.21 147.85 26.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.106 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.3 p -72.73 129.02 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.363 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.522 HD22 ' N ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.101 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.995 0.426 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.54 ' O ' HD12 ' A' ' 98' ' ' ILE . 2.4 pp -61.27 145.92 12.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.679 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.576 ' HB2' HD23 ' A' ' 121' ' ' LEU . 43.8 m -56.93 135.61 56.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.05 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.0 t -47.9 126.97 11.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.129 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.497 ' HB2' HD12 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -83.06 16.77 2.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.98 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -68.92 -45.72 70.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.301 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.647 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 10.7 m-85 -58.37 -32.15 68.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.796 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' A' ' 101' ' ' LYS . 86.8 mt -49.77 140.33 11.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.553 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.9 m 67.13 139.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.965 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.618 HD12 ' HD2' ' A' ' 128' ' ' PHE . 7.3 tt -145.07 127.7 16.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.308 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.53 ' O ' HD23 ' A' ' 106' ' ' LEU . 23.5 pt-20 -64.98 128.43 35.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 111.213 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 63.68 40.3 7.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.725 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.416 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -170.83 -163.88 25.61 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.548 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -142.37 141.93 32.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.795 0.331 . . . . 0.0 110.891 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.5 t -110.25 129.84 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.99 0.424 . . . . 0.0 110.969 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.407 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 1.2 m-85 -110.7 152.92 25.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.184 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.477 HD13 ' CG1' ' A' ' 126' ' ' VAL . 47.9 tp -154.48 134.03 12.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.008 0.432 . . . . 0.0 111.706 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.5 p -154.05 132.81 12.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.606 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . 164.38 -44.69 0.31 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.688 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -169.67 -127.84 0.96 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.403 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.463 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 56.4 m-20 -149.17 -138.57 0.09 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.61 0.243 . . . . 0.0 110.609 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.846 HD12 ' HA ' ' A' ' 119' ' ' PRO . 35.0 tp -125.17 127.44 25.02 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.78 0.324 . . . . 0.0 111.099 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.846 ' HA ' HD12 ' A' ' 118' ' ' LEU . 78.2 Cg_endo -90.99 37.98 4.81 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.266 -1.556 . . . . 0.0 112.713 -0.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.463 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -88.15 37.59 0.82 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.852 0.358 . . . . 0.0 111.481 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.576 HD23 ' HB2' ' A' ' 99' ' ' CYS . 28.1 tp -77.67 0.38 23.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.811 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.59 141.81 58.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.18 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.61 -38.27 1.89 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.151 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.408 ' HB2' ' HA3' ' A' ' 115' ' ' GLY . . . -51.04 142.82 11.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 0.0 111.615 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' A' ' 125' ' ' ARG . 20.3 ptt-85 -127.44 134.63 49.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.924 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.503 HG23 ' CE1' ' A' ' 128' ' ' PHE . 29.1 m -97.37 139.45 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.218 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -110.39 128.2 55.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.247 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.618 ' HD2' HD12 ' A' ' 106' ' ' LEU . 6.4 m-85 -99.94 141.85 32.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.43 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -150.99 132.15 14.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.297 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 69.1 m -89.16 154.17 20.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.959 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.548 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 1.1 m-20 -52.62 163.45 0.78 Allowed Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.334 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 55.7 Cg_endo -70.0 50.2 0.85 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.075 2.517 . . . . 0.0 113.212 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -149.49 -43.01 0.14 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.416 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 0.8 OUTLIER -108.92 140.72 42.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.833 179.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -100.99 128.57 46.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.984 0.421 . . . . 0.0 110.954 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.687 HD22 ' HB2' ' A' ' 140' ' ' SER . 6.1 tt -68.87 130.12 41.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.625 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.558 ' N ' HD23 ' A' ' 136' ' ' LEU . 24.1 t -135.18 63.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.657 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -166.82 -134.04 1.63 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.205 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.678 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 67.2 m -74.95 53.59 0.61 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.74 0.305 . . . . 0.0 111.159 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.687 ' HB2' HD22 ' A' ' 136' ' ' LEU . 35.0 t -52.06 -43.71 63.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 58.9 mtm-85 -99.41 132.42 44.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.803 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.3 m -145.63 137.6 25.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.762 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.406 HG23 ' HB3' ' A' ' 125' ' ' ARG . 7.3 p -138.08 129.34 37.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.966 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 48.8 t -93.71 134.07 36.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 90.4 p -115.44 -35.12 4.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -144.99 -140.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.093 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.74 41.25 2.33 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.491 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -174.94 136.64 0.4 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.809 0.337 . . . . 0.0 110.922 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -84.19 149.39 26.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.839 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -55.9 -65.27 0.63 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.558 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 42.9 p -106.8 139.07 20.01 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.34 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.434 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 21.9 Cg_exo -65.17 -155.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.706 2.271 . . . . 0.0 112.558 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.647 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 12.9 mmmm -92.67 131.94 32.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.335 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.678 ' HB3' ' N ' ' A' ' 139' ' ' SER . 89.6 Cg_endo -84.55 -155.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.798 2.332 . . . . 0.0 112.786 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -153.7 148.86 26.88 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.764 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 84.0 m -97.41 131.38 44.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.817 0.342 . . . . 0.0 110.865 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -110.36 141.1 43.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.016 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.14 128.47 38.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.425 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.018 -179.714 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.508 ' N ' ' HD2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.724 0.297 . . . . 0.0 111.371 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 30.2 pt -56.4 139.38 15.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.918 0.389 . . . . 0.0 111.13 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 36.8 m -57.22 137.43 55.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.874 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.1 t -47.93 124.31 7.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.039 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.747 ' HB2' HD12 ' A' ' 104' ' ' LEU . 14.4 ptmm? -82.26 21.63 0.9 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.387 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.0 t -68.85 -45.13 71.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.918 0.39 . . . . 0.0 111.057 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.546 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.2 m-85 -60.15 -31.33 69.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.304 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.747 HD12 ' HB2' ' A' ' 101' ' ' LYS . 71.6 mt -52.29 -40.9 62.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.369 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t -92.48 129.1 38.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.917 0.389 . . . . 0.0 110.816 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.779 HD13 ' HE2' ' A' ' 153' ' ' LYS . 20.4 tp -145.39 124.65 12.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.304 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.66 129.97 41.47 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 59.1 37.13 24.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.979 0.419 . . . . 0.0 110.439 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -163.81 147.52 13.1 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.78 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -112.8 139.57 48.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.375 -0.413 . . . . 0.0 110.517 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.7 t -111.21 134.65 52.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.291 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.544 ' O ' HG23 ' A' ' 126' ' ' VAL . 3.1 m-85 -108.59 130.21 55.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.883 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.442 ' N ' HD22 ' A' ' 113' ' ' LEU . 3.6 mm? -104.69 140.96 37.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.664 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.6 t -155.06 138.58 15.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.034 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.92 127.91 0.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.308 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 164.81 -139.68 5.97 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.183 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -177.63 -62.42 0.01 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.224 0.535 . . . . 0.0 111.008 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.863 ' N ' ' HA ' ' A' ' 119' ' ' PRO . 3.4 tm? -74.15 -42.69 5.75 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.918 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.863 ' HA ' ' N ' ' A' ' 118' ' ' LEU . 96.5 Cg_endo -90.11 126.25 6.61 Favored 'Cis proline' 0 N--CA 1.454 -0.799 0 C-N-CA 124.03 -1.238 . . . . 0.0 112.944 0.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.577 ' N ' ' HB3' ' A' ' 118' ' ' LEU . . . -74.41 -23.6 58.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.783 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.431 ' C ' ' H ' ' A' ' 123' ' ' GLY . 88.2 mt 70.24 29.48 3.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.311 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.9 35.87 0.13 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.96 0.41 . . . . 0.0 111.094 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 121' ' ' LEU . . . 140.36 29.29 0.19 Allowed Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.05 146.77 33.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.921 0.391 . . . . 0.0 111.514 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -108.31 138.74 44.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.662 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 112' ' ' PHE . 12.7 p -127.57 136.74 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.115 0.484 . . . . 0.0 112.0 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -105.04 128.08 53.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.076 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.546 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 15.2 m-85 -98.45 139.29 34.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.0 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' A' ' 129' ' ' ARG . 46.7 mtp85 -150.0 129.59 13.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.75 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 40.0 t -89.2 144.87 25.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.29 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.8 154.76 17.03 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.321 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.479 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 6.0 Cg_endo -47.93 159.98 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.077 2.518 . . . . 0.0 112.17 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.51 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 61.5 t0 76.86 -26.96 0.18 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.374 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.763 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 2.7 m-85 -122.04 132.77 54.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.932 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.46 ' CG ' ' HB2' ' A' ' 159' ' ' ASN . 0.4 OUTLIER -109.38 137.98 46.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.09 0.471 . . . . 0.0 112.01 -179.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 137' ' ' VAL . 6.4 tt -74.02 128.96 36.9 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.56 ' N ' HD23 ' A' ' 136' ' ' LEU . 42.9 t -128.05 74.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 171.33 -127.6 1.46 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.687 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.827 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.4 t -70.84 61.25 0.25 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.13 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.4 t -58.12 -20.76 42.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.922 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.738 ' HD3' ' H ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -129.31 143.87 51.01 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.801 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.7 m -150.25 144.59 25.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.282 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.7 p -140.31 134.38 35.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.057 0.456 . . . . 0.0 111.594 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 54.0 t -116.63 147.57 41.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.204 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 49.1 m -154.66 41.5 0.47 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 145' ' ' SER . 41.8 tt0 176.17 -57.4 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.897 0.379 . . . . 0.0 111.21 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.06 37.31 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -173.37 137.9 0.68 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -84.23 133.91 34.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.228 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -50.23 -64.03 0.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.934 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 33.4 p -92.55 138.25 24.0 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.2 146.32 63.25 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.784 2.323 . . . . 0.0 111.795 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.779 ' HE2' HD13 ' A' ' 106' ' ' LEU . 83.9 tttt -48.06 129.3 12.18 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.629 0.252 . . . . 0.0 110.796 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.827 ' HB3' ' H ' ' A' ' 139' ' ' SER . 89.8 Cg_endo -81.41 -152.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.647 2.231 . . . . 0.0 113.334 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.69 148.31 26.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.024 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.763 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 13.0 t -98.49 139.2 34.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.056 0.455 . . . . 0.0 111.246 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -103.05 146.13 28.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.696 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 158' ' ' VAL . 6.5 p -66.71 81.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.348 0.594 . . . . 0.0 111.271 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.51 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 35.7 t30 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.942 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.523 ' HG2' ' HA3' ' A' ' 147' ' ' GLY . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.005 0.431 . . . . 0.0 110.917 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.907 ' H ' HD13 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -96.27 142.78 13.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.364 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 80.8 m -51.79 141.74 16.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.12 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.1 m -47.94 130.71 15.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.393 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -78.72 -6.89 57.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.086 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.9 p -55.88 -42.4 75.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.106 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.641 ' O ' HG21 ' A' ' 111' ' ' VAL . 2.1 m-85 -59.17 -35.4 73.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.437 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.8 mt -54.97 -47.3 74.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.682 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.1 m -92.56 130.81 38.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.839 0.352 . . . . 0.0 111.405 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.715 HD13 ' HE2' ' A' ' 153' ' ' LYS . 28.7 tp -145.44 127.86 15.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.834 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -66.71 130.65 43.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.301 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 57.13 41.16 27.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.026 0.441 . . . . 0.0 110.401 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.28 153.68 22.45 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.596 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -121.25 143.67 49.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.816 0.341 . . . . 0.0 110.76 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 103' ' ' TYR . 61.9 t -110.63 140.23 30.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.221 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -105.86 153.58 21.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.332 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.66 HD23 ' N ' ' A' ' 114' ' ' THR . 6.7 tt -153.33 135.06 14.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.884 0.373 . . . . 0.0 110.521 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.66 ' N ' HD23 ' A' ' 113' ' ' LEU . 89.2 m -156.21 125.64 6.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.784 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.89 -125.67 1.38 Allowed Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.833 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.32 -125.44 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.047 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.732 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 12.2 p-10 -173.36 128.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.726 ' O ' HD12 ' A' ' 118' ' ' LEU . 4.4 pp -38.66 138.04 0.8 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.317 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -85.88 35.64 3.63 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.424 -1.49 . . . . 0.0 113.097 0.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.732 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -90.73 46.42 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.981 0.42 . . . . 0.0 110.623 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.455 ' HG ' ' HB ' ' A' ' 98' ' ' ILE . 3.7 mm? -54.75 -39.94 68.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.342 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.28 139.96 58.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 0.0 111.011 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.43 -36.38 3.65 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.314 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.3 142.09 52.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.95 0.405 . . . . 0.0 111.51 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.581 ' HD3' ' N ' ' A' ' 125' ' ' ARG . 1.0 OUTLIER -108.51 139.87 42.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.23 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 142' ' ' SER . 21.8 m -124.67 142.75 40.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 111.961 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.485 ' OE1' ' HG2' ' A' ' 141' ' ' ARG . 5.2 mm-40 -121.44 119.62 32.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.83 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.547 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 3.1 m-85 -85.1 152.57 23.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.422 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.3 ttt-85 -163.34 125.77 2.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.903 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 100.0 m -89.19 142.18 27.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.375 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -55.34 158.18 5.8 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.573 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.538 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 1.1 Cg_endo -43.14 155.03 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.095 2.53 . . . . 0.0 112.186 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.6 m-20 79.43 -35.81 0.16 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.656 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 157' ' ' GLN . 5.9 m-85 -108.8 129.28 55.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.574 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.44 ' CD2' ' HB3' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -102.87 145.34 29.95 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 111.85 -179.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 137' ' ' VAL . 2.4 tm? -75.56 132.88 40.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.969 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.682 ' N ' HD13 ' A' ' 136' ' ' LEU . 7.4 p -135.65 70.38 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.518 ' CA ' ' HB3' ' A' ' 154' ' ' PRO . . . 171.23 -123.6 1.05 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.756 -1.211 . . . . 0.0 113.363 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.877 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 27.5 t -71.68 55.07 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.705 0.288 . . . . 0.0 111.775 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.553 ' HB3' HD12 ' A' ' 136' ' ' LEU . 94.3 p -56.16 -21.93 25.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.436 0.636 . . . . 0.0 109.322 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.485 ' HG2' ' OE1' ' A' ' 127' ' ' GLU . 62.4 mtm-85 -140.59 126.43 19.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.489 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.558 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 47.2 t -142.98 134.48 26.32 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.94 0.4 . . . . 0.0 111.418 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.8 t -98.24 134.18 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.637 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 144' ' ' CYS . 41.9 t -79.17 48.02 0.83 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 111.29 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 83.4 p -65.14 126.96 29.73 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 55.21 -140.0 0.95 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.523 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -106.5 37.47 3.81 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.098 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -155.41 143.87 20.34 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 122.261 0.224 . . . . 0.0 110.513 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.584 ' CE2' ' HB3' ' A' ' 99' ' ' CYS . 45.1 m95 -84.14 137.91 33.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.704 0.288 . . . . 0.0 110.418 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.9 t -57.19 -61.26 2.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.302 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.1 p -94.13 133.87 26.76 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.746 0.307 . . . . 0.0 111.759 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 139' ' ' SER . 36.7 Cg_endo -65.21 140.08 63.21 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.758 2.305 . . . . 0.0 112.152 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.715 ' HE2' HD13 ' A' ' 106' ' ' LEU . 86.9 tttt -42.56 131.62 2.89 Favored Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.526 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.877 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 84.6 Cg_endo -81.58 -158.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.881 2.387 . . . . 0.0 112.872 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.572 ' O ' HG12 ' A' ' 137' ' ' VAL . 12.5 p-80 -153.64 150.64 28.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.642 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 72.3 m -96.18 139.36 32.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.97 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 134' ' ' PHE . 40.4 tt0 -130.59 133.68 46.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.711 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.6 124.72 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.959 0.409 . . . . 0.0 110.407 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.999 -179.418 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.522 ' NE ' ' HA ' ' A' ' 97' ' ' ARG . 4.0 mmp_? . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.778 0.323 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.447 ' HB ' HD22 ' A' ' 121' ' ' LEU . 26.2 pt -151.02 46.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 75.6 m 63.01 131.75 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.966 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 87.4 p -47.97 126.42 10.58 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.897 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -78.34 -11.39 59.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.142 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.0 t -54.54 -36.58 64.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.043 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.501 ' CE2' ' HA ' ' A' ' 152' ' ' PRO . 2.0 m-85 -77.35 47.27 0.56 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.487 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.8 mt -133.86 20.13 3.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.942 0.401 . . . . 0.0 110.436 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.459 ' O ' ' HE3' ' A' ' 153' ' ' LYS . 86.0 m -147.43 132.65 18.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.509 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.402 HD22 ' HD2' ' A' ' 128' ' ' PHE . 25.4 tp -145.4 133.76 21.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.967 0.413 . . . . 0.0 111.443 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.664 ' HG2' ' OD1' ' A' ' 108' ' ' ASN . 33.2 tt0 -78.0 141.75 38.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.879 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.664 ' OD1' ' HG2' ' A' ' 107' ' ' GLU . 5.6 m120 63.17 30.15 16.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.81 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 176.12 -160.81 28.93 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.915 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.528 ' HG3' ' HE1' ' A' ' 112' ' ' PHE . 14.9 ptmm? -142.04 153.62 44.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.656 0.265 . . . . 0.0 110.412 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.65 137.92 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.075 0.464 . . . . 0.0 111.763 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.64 ' HB2' ' HG3' ' A' ' 127' ' ' GLU . 6.1 m-85 -107.74 146.15 32.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.308 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.579 HD23 ' H ' ' A' ' 113' ' ' LEU . 1.9 pt? -146.17 139.44 25.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.004 0.43 . . . . 0.0 111.041 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.8 t -168.83 133.98 1.62 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.969 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 140.6 -40.51 1.36 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.35 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 121' ' ' LEU . . . -66.32 150.15 51.74 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.058 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -136.74 56.32 1.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.69 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 1.6 pt? -39.36 127.72 1.36 Allowed Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.345 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 94.2 Cg_endo -84.73 74.09 0.07 OUTLIER 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 123.683 -1.382 . . . . 0.0 113.059 -0.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.69 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -168.69 58.44 0.06 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.837 0.351 . . . . 0.0 111.167 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.575 ' HA ' ' HA2' ' A' ' 116' ' ' GLY . 5.3 mp -74.92 37.98 0.12 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.334 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 120' ' ' ALA . 1.5 m-20 -72.26 132.2 43.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.914 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.5 37.36 94.56 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.926 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.39 137.0 52.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.538 0.208 . . . . 0.0 110.587 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' A' ' 125' ' ' ARG . 49.3 ttp85 -130.52 139.22 50.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.41 . . . . 0.0 111.374 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' A' ' 113' ' ' LEU . 30.7 m -130.11 138.22 54.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.125 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.64 ' HG3' ' HB2' ' A' ' 112' ' ' PHE . 13.9 pt-20 -114.98 124.47 51.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.497 ' HE2' ' HG2' ' A' ' 153' ' ' LYS . 2.0 m-85 -90.36 146.85 23.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.213 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.434 HH11 ' HG3' ' A' ' 129' ' ' ARG . 7.5 ptm180 -168.62 126.95 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.127 0.489 . . . . 0.0 111.12 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.524 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 69.5 m -89.76 157.39 17.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.382 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 133' ' ' ASP . 34.9 m-20 -52.7 149.66 10.83 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.536 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -52.25 81.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.178 2.585 . . . . 0.0 112.789 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 36.5 t70 178.67 -20.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.186 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 31.7 m-85 -129.38 132.93 47.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.723 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -102.81 127.22 50.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.038 0.447 . . . . 0.0 111.078 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.631 HD21 ' HA ' ' A' ' 140' ' ' SER . 16.5 tp -71.92 131.06 42.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.034 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 36.0 t -136.01 66.73 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.739 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.53 -134.73 1.88 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.247 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.753 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 67.9 m -75.03 51.77 0.53 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.795 0.331 . . . . 0.0 111.099 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.631 ' HA ' HD21 ' A' ' 136' ' ' LEU . 46.7 t -51.08 -39.05 55.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.746 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -99.45 133.15 44.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.572 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.4 t -145.33 119.41 9.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 0.0 110.697 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.8 p -108.78 125.34 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.088 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 149' ' ' TRP . 47.4 t -71.9 145.29 48.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.389 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.6 p -161.37 122.85 2.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.953 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 8.3 tt0 57.06 43.05 24.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.188 0.518 . . . . 0.0 109.839 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.55 -49.87 3.71 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.754 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -77.34 137.83 38.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.704 0.287 . . . . 0.0 111.362 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 144' ' ' CYS . 68.2 m95 -84.23 143.89 29.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.513 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 65.3 m -53.91 -61.42 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.745 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 60.5 p -111.98 134.56 21.37 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.677 0.275 . . . . 0.0 111.503 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.501 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 44.4 Cg_endo -68.23 -163.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.382 2.055 . . . . 0.0 112.166 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.596 ' HB3' ' NZ ' ' A' ' 153' ' ' LYS . 9.3 mtpm? -83.35 125.43 74.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.219 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.753 ' HB3' ' H ' ' A' ' 139' ' ' SER . 62.4 Cg_endo -73.73 -144.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.705 2.27 . . . . 0.0 112.376 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.413 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 19.8 p-80 -153.66 139.9 18.51 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.801 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 86.2 m -98.67 133.97 42.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.027 0.442 . . . . 0.0 111.217 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -103.07 142.69 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.198 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 82.7 t -53.57 102.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.945 0.402 . . . . 0.0 110.496 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 38.9 t30 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.115 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 . . . . . 0 N--CA 1.465 0.281 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.795 ' HA ' HD11 ' A' ' 121' ' ' LEU . 16.1 pt -65.03 133.42 30.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.749 0.309 . . . . 0.0 110.821 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.738 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 69.7 m -56.29 138.78 50.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.455 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.5 m -47.97 132.0 15.31 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.603 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -89.76 11.41 20.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.13 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.1 t -66.35 -35.78 81.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 110.945 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.568 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 0.9 OUTLIER -55.98 -33.24 64.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.909 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.4 mt -57.03 146.43 27.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.985 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.8 m 65.18 132.4 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.352 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.757 HD13 ' HE2' ' A' ' 153' ' ' LYS . 28.1 tp -145.41 135.41 23.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.124 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 59.7 mp0 -69.85 131.29 44.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.269 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.47 ' N ' HD22 ' A' ' 108' ' ' ASN . 2.3 m120 57.81 39.6 26.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.456 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.556 ' HA2' ' H ' ' A' ' 131' ' ' ASP . . . -174.78 155.41 20.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.7 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -113.12 146.29 39.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.863 0.363 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.0 t -108.17 139.01 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.061 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.534 ' C ' HD12 ' A' ' 113' ' ' LEU . 3.4 m-85 -106.52 140.49 39.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.807 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 112' ' ' PHE . 5.2 mp -133.51 137.32 45.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 110.484 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.1 m -159.98 143.56 14.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.157 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.7 132.24 7.23 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.61 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 52.28 -149.58 9.59 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.83 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.698 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 7.8 t70 178.41 117.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.926 HD12 ' HA ' ' A' ' 119' ' ' PRO . 29.9 tp -40.19 134.3 1.48 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.502 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.926 ' HA ' HD12 ' A' ' 118' ' ' LEU . 66.8 Cg_endo -94.02 44.58 2.52 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.713 -1.37 . . . . 0.0 113.109 0.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.698 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -71.95 -49.73 34.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.139 0.495 . . . . 0.0 110.845 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.795 HD11 ' HA ' ' A' ' 98' ' ' ILE . 65.7 mt 54.76 40.89 32.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.533 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.664 ' OD1' ' HB1' ' A' ' 120' ' ' ALA . 1.2 m-20 -75.89 48.04 0.46 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.033 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.86 39.95 95.28 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.294 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.38 138.26 58.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.772 0.32 . . . . 0.0 110.849 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -107.84 140.92 40.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.735 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 32.8 m -129.06 141.02 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.994 0.426 . . . . 0.0 111.671 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 95.4 mt-10 -113.24 123.79 51.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.629 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.466 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 8.0 m-85 -90.23 52.06 2.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.55 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -61.72 129.17 39.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.783 0.325 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 79.9 m -89.25 142.29 27.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.399 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.556 ' H ' ' HA2' ' A' ' 109' ' ' GLY . 54.9 m-20 -57.75 158.37 12.32 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.306 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 2.2 Cg_endo -44.71 156.04 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.305 2.67 . . . . 0.0 112.382 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 1.7 m-20 73.58 -12.32 0.84 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.422 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.452 ' CE2' HG22 ' A' ' 158' ' ' VAL . 7.5 m-85 -130.64 137.3 49.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.77 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.666 ' ND1' ' HB2' ' A' ' 159' ' ' ASN . 14.1 p-80 -121.1 137.05 54.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.064 0.459 . . . . 0.0 111.608 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.743 HD12 ' HB2' ' A' ' 140' ' ' SER . 2.2 tm? -68.29 130.38 42.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.029 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.697 ' N ' HD13 ' A' ' 136' ' ' LEU . 21.3 t -134.35 62.52 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.524 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.452 ' H ' ' CD1' ' A' ' 136' ' ' LEU . . . -176.01 -133.43 1.77 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.018 -1.087 . . . . 0.0 113.227 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.653 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 66.8 m -74.44 56.31 0.66 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.565 0.346 . . . . 0.0 111.397 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.743 ' HB2' HD12 ' A' ' 136' ' ' LEU . 34.4 t -54.56 -39.57 67.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.106 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -99.36 130.2 45.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.093 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.1 m -147.04 146.77 30.13 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.57 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.36 132.03 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.032 0.444 . . . . 0.0 111.377 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.685 ' SG ' HD22 ' A' ' 121' ' ' LEU . 39.0 t -72.13 132.46 44.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.088 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.9 m -166.41 130.82 2.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.82 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 55.82 44.38 26.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.37 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 57.45 45.28 93.17 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.967 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -177.12 142.01 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.635 0.255 . . . . 0.0 110.643 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.738 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 45.7 m95 -84.15 145.14 28.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.882 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.8 t -51.93 -49.63 62.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.022 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 60.4 p -127.85 140.42 38.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.058 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 35.3 Cg_exo -60.33 -165.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.564 2.176 . . . . 0.0 112.476 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.757 ' HE2' HD13 ' A' ' 106' ' ' LEU . 84.5 tttt -86.56 125.29 67.81 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.653 ' HB3' ' N ' ' A' ' 139' ' ' SER . 73.6 Cg_endo -75.35 -151.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.562 2.175 . . . . 0.0 112.677 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -153.8 146.22 23.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.06 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 75.3 m -97.95 132.4 43.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.598 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -103.05 142.9 33.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.168 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.452 HG22 ' CE2' ' A' ' 134' ' ' PHE . 53.0 t -67.25 80.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.868 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.666 ' HB2' ' ND1' ' A' ' 135' ' ' HIS . 34.1 t30 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.048 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.49 ' NH1' ' HB2' ' A' ' 97' ' ' ARG . 23.4 mtm105 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.795 0.331 . . . . 0.0 111.571 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.537 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -53.16 145.84 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.7 m -53.36 135.43 39.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.241 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.8 t -47.93 123.33 6.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.521 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -81.24 113.1 19.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.606 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.0 m -171.15 -41.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.171 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.873 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 1.6 m-85 -62.51 -28.7 70.02 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.074 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.428 HD21 ' HH2' ' A' ' 149' ' ' TRP . 61.4 mt -72.14 28.21 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.332 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.444 ' O ' ' HE3' ' A' ' 153' ' ' LYS . 64.5 p -147.48 127.61 13.76 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.914 0.388 . . . . 0.0 111.666 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.416 HD13 ' HZ1' ' A' ' 153' ' ' LYS . 27.9 tp -145.44 121.98 11.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.297 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -92.28 40.22 1.04 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -163.65 36.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.719 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.34 -146.45 11.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.837 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -141.56 139.37 33.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.528 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.6 t -105.97 136.6 39.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.981 0.419 . . . . 0.0 111.007 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 1.6 m-85 -107.83 145.78 33.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.408 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.715 HD23 ' N ' ' A' ' 114' ' ' THR . 6.7 tt -152.55 138.97 18.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.928 0.394 . . . . 0.0 110.846 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.715 ' N ' HD23 ' A' ' 113' ' ' LEU . 84.9 m -153.53 123.16 6.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.683 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.27 -38.51 0.28 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.104 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -168.2 -130.08 1.14 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.138 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.694 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 8.2 t70 -172.3 125.47 0.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.643 ' H ' HD12 ' A' ' 118' ' ' LEU . 6.8 mp -41.84 138.48 1.78 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.208 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -86.73 41.37 1.88 Allowed 'Cis proline' 0 C--N 1.347 0.465 0 C-N-CA 123.574 -1.428 . . . . 0.0 113.478 0.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.728 ' C ' HD22 ' A' ' 121' ' ' LEU . . . -92.49 129.87 38.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.831 0.348 . . . . 0.0 111.065 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.728 HD22 ' C ' ' A' ' 120' ' ' ALA . 3.8 mm? -131.47 51.13 2.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.585 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.88 59.66 1.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.931 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.91 42.27 99.61 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.578 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.52 141.22 57.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.724 0.297 . . . . 0.0 111.18 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -106.95 130.43 54.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.194 0.521 . . . . 0.0 110.733 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.44 134.3 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.59 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -118.31 123.89 46.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.306 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.547 ' CE2' ' HG2' ' A' ' 153' ' ' LYS . 19.0 m-85 -82.78 151.08 26.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.2 0.524 . . . . 0.0 111.942 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.413 ' HG2' HH11 ' A' ' 129' ' ' ARG . 15.4 tpp85 -153.46 121.97 6.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.644 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 9.2 t -102.38 144.63 30.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.035 0.445 . . . . 0.0 111.748 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -56.28 157.76 8.64 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.338 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.493 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 71.4 Cg_exo -48.82 163.14 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.765 2.31 . . . . 0.0 112.275 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.523 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 55.7 m-20 76.56 -32.53 0.2 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.847 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.869 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 1.4 m-85 -108.5 133.78 52.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.391 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.462 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 20.4 p-80 -112.95 137.34 51.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.972 0.415 . . . . 0.0 111.284 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.671 HD21 ' HA ' ' A' ' 140' ' ' SER . 18.7 tp -68.35 135.91 52.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.308 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 155' ' ' HIS . 14.8 p -136.74 60.01 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.822 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . 171.97 -123.42 1.02 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 119.172 -1.489 . . . . 0.0 113.692 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.811 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 39.9 t -65.11 66.06 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.866 0.365 . . . . 0.0 111.553 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.671 ' HA ' HD21 ' A' ' 136' ' ' LEU . 98.9 p -66.39 -14.81 62.68 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.266 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.616 ' HD3' ' H ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -140.62 138.16 34.18 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.973 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.475 ' HA ' ' HB3' ' A' ' 150' ' ' SER . 86.1 p -141.62 140.51 33.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.771 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.776 HG12 ' HB2' ' A' ' 150' ' ' SER . 7.3 p -134.75 132.84 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.063 0.459 . . . . 0.0 111.981 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 121' ' ' LEU . 41.5 t -79.34 149.98 31.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.828 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.1 t -147.79 -130.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.715 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -58.44 -42.72 87.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.643 0.259 . . . . 0.0 111.202 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 176.15 47.5 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.657 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -173.71 142.24 0.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.735 0.302 . . . . 0.0 110.696 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.428 ' HH2' HD21 ' A' ' 104' ' ' LEU . 59.0 m95 -84.2 153.36 23.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.074 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.776 ' HB2' HG12 ' A' ' 143' ' ' VAL . 43.2 t -48.08 -57.65 5.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.87 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.669 HG23 ' OG ' ' A' ' 139' ' ' SER . 0.5 OUTLIER -147.42 143.73 18.46 Favored Pre-proline 0 C--N 1.332 -0.163 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.52 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 31.4 Cg_exo -57.82 140.81 94.97 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.483 2.789 . . . . 0.0 112.716 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.873 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 9.0 mtpm? -49.81 137.35 18.87 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.024 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.822 ' HB3' ' HA3' ' A' ' 138' ' ' GLY . 85.2 Cg_endo -83.05 -140.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.989 2.459 . . . . 0.0 112.142 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.598 ' O ' HG12 ' A' ' 137' ' ' VAL . 18.9 p-80 -153.72 152.16 30.46 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.763 0.316 . . . . 0.0 110.999 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.869 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 71.1 m -94.95 127.37 40.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.555 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.462 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 69.8 tp60 -105.56 136.76 44.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.818 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.4 t -76.3 122.95 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.164 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 133' ' ' ASP . 24.4 p30 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.953 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.731 0.3 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.9 pt -137.43 145.71 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.923 0.392 . . . . 0.0 111.473 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 38.7 m -51.49 140.17 18.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.058 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.4 t -47.91 130.26 14.95 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.308 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.586 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -83.14 -28.44 29.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.235 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.1 m -68.89 38.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.779 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 6.8 m-85 -127.28 -46.92 1.47 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.573 0.225 . . . . 0.0 111.305 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.784 HD12 ' H ' ' A' ' 105' ' ' THR . 0.4 OUTLIER -52.92 -32.08 43.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.462 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.784 ' H ' HD12 ' A' ' 104' ' ' LEU . 41.9 p -96.29 135.37 38.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.663 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 34.5 tp -145.43 131.19 19.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 111.135 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.01 131.73 45.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.66 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 54.1 41.8 31.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.401 . . . . 0.0 110.6 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.53 148.56 9.51 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.522 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -104.09 151.75 22.9 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.953 0.406 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 104' ' ' LEU . 96.4 t -128.2 141.39 46.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.987 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.8 m-85 -105.83 134.3 49.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.84 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.656 HD13 ' N ' ' A' ' 114' ' ' THR . 2.7 tm? -109.18 131.76 54.76 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.656 ' N ' HD13 ' A' ' 113' ' ' LEU . 72.3 m -157.51 125.09 5.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.91 0.386 . . . . 0.0 111.107 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 157.93 -133.52 3.53 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.293 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.85 -135.24 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.394 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -160.17 123.4 3.49 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.585 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -53.27 136.41 50.18 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.003 -179.293 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 65.1 Cg_endo -90.21 63.16 0.26 Allowed 'Cis proline' 0 C--N 1.346 0.445 0 C-N-CA 123.834 -1.319 . . . . 0.0 113.032 0.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.531 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -155.43 57.21 0.63 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.779 0.323 . . . . 0.0 111.549 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 121' ' ' LEU . 5.2 mp -77.28 45.87 0.48 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.855 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.65 131.27 49.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 111.215 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.83 35.52 39.53 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.749 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.57 136.94 32.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.673 0.273 . . . . 0.0 111.35 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.454 ' NH2' HH21 ' A' ' 141' ' ' ARG . 15.9 ptm180 -130.55 130.29 43.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 110.789 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.48 HG23 ' HE1' ' A' ' 128' ' ' PHE . 23.2 m -100.27 139.81 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.027 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 46.6 mp0 -102.93 123.88 47.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.245 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.48 ' HE1' HG23 ' A' ' 126' ' ' VAL . 7.0 m-85 -91.31 143.04 27.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.144 0.497 . . . . 0.0 112.036 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.453 ' HD3' ' CE1' ' A' ' 112' ' ' PHE . 47.9 mtp85 -152.59 125.1 8.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.723 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 26.2 t -89.29 163.8 15.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.943 0.402 . . . . 0.0 111.462 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -52.79 156.71 3.13 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.306 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.08 52.44 1.84 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.286 2.658 . . . . 0.0 112.868 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -155.88 -37.72 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.121 0.486 . . . . 0.0 109.989 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.452 ' CE2' ' HB ' ' A' ' 158' ' ' VAL . 0.9 OUTLIER -108.32 146.53 32.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.724 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -100.08 132.99 45.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.137 0.494 . . . . 0.0 111.152 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.786 HD21 ' HA ' ' A' ' 140' ' ' SER . 27.9 tp -73.46 128.47 35.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.279 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.6 t -134.98 64.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.225 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.53 -123.52 0.72 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.005 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.931 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.4 t -71.17 52.28 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.678 0.391 . . . . 0.0 111.686 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.786 ' HA ' HD21 ' A' ' 136' ' ' LEU . 44.9 t -56.02 -26.35 48.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.066 0.46 . . . . 0.0 110.15 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.454 HH21 ' NH2' ' A' ' 125' ' ' ARG . 24.0 mmm180 -132.87 129.14 38.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.853 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.465 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 47.1 t -141.77 148.56 39.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.237 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 125' ' ' ARG . 7.3 p -144.04 131.35 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.818 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 45.4 t -68.47 144.11 54.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.595 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.6 t -172.72 129.51 0.52 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.546 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 56.6 43.93 24.79 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.05 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 57.31 42.75 93.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.315 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.401 ' HA ' ' NE2' ' A' ' 148' ' ' GLN . 3.0 tp-100 -174.33 140.18 0.64 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 0.0 110.498 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.444 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 56.0 m95 -84.24 140.81 31.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.937 0.399 . . . . 0.0 110.965 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.8 m -54.2 -60.64 3.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.478 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -94.32 129.08 38.13 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.739 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 139' ' ' SER . 73.7 Cg_endo -75.91 148.86 32.39 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.848 2.366 . . . . 0.0 112.273 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.779 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 14.1 mmmm -40.86 127.27 1.96 Allowed Pre-proline 0 N--CA 1.464 0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 111.267 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.931 ' HB3' ' H ' ' A' ' 139' ' ' SER . 91.5 Cg_endo -83.77 -149.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.972 2.448 . . . . 0.0 113.571 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.405 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 17.8 p-80 -153.75 150.09 28.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.337 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 82.7 m -94.95 127.63 41.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.799 0.333 . . . . 0.0 110.933 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -103.48 137.09 42.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.52 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 134' ' ' PHE . 11.7 p -86.62 131.29 35.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.432 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.829 -179.598 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 97' ' ' ARG . 29.4 tpt180 . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.925 0.393 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.663 ' HB ' ' HG ' ' A' ' 121' ' ' LEU . 35.7 pt -55.56 142.48 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.088 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.488 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 95.1 m -51.09 135.77 24.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.362 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.8 t -47.97 127.48 12.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.301 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.772 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -81.07 12.61 3.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 179.727 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.1 t -68.82 -41.55 78.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.793 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.634 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.9 m-85 -56.09 -34.94 66.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.21 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.601 HD12 ' HB2' ' A' ' 101' ' ' LYS . 87.1 mt -47.77 -46.02 29.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.961 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 60.1 p -92.61 137.95 31.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.516 HD13 ' HE2' ' A' ' 153' ' ' LYS . 30.4 tp -145.41 133.4 21.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 110.972 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.97 132.23 46.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.772 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.426 ' N ' HD22 ' A' ' 108' ' ' ASN . 2.5 m120 58.65 33.03 22.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.152 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.519 ' CA ' ' HA ' ' A' ' 130' ' ' CYS . . . -175.51 153.14 14.44 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.423 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -109.27 144.5 37.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.513 -0.344 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.634 HG21 ' O ' ' A' ' 103' ' ' TYR . 93.1 t -109.66 136.94 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.95 0.405 . . . . 0.0 111.058 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.448 ' CE1' ' HD3' ' A' ' 129' ' ' ARG . 2.8 m-85 -108.57 146.51 33.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.755 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.644 HD23 ' N ' ' A' ' 114' ' ' THR . 6.3 tt -144.26 131.45 20.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.546 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.644 ' N ' HD23 ' A' ' 113' ' ' LEU . 68.7 p -150.08 123.36 8.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.567 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.02 -36.01 0.27 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.242 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.4 -135.12 1.8 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.419 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.598 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 12.2 p-10 -175.67 129.5 0.25 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.722 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -41.28 138.82 1.44 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.279 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -86.69 40.32 2.2 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.503 -1.457 . . . . 0.0 113.117 0.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.598 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -96.62 47.11 1.06 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.783 0.325 . . . . 0.0 111.242 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.663 ' HG ' ' HB ' ' A' ' 98' ' ' ILE . 3.9 mm? -54.42 -40.59 68.44 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.789 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -61.21 136.93 58.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.505 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.87 54.4 7.24 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.458 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.485 ' O ' HG23 ' A' ' 143' ' ' VAL . . . -143.62 136.12 27.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.0 111.189 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 125' ' ' ARG . 48.6 mmt-85 -105.66 143.56 33.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.733 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 142' ' ' SER . 32.7 m -133.74 135.53 55.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.088 0.47 . . . . 0.0 111.489 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -112.9 118.34 34.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.514 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.468 ' HE1' ' HB3' ' A' ' 142' ' ' SER . 5.4 m-85 -82.42 140.53 33.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.024 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.448 ' HD3' ' CE1' ' A' ' 112' ' ' PHE . 16.6 ptm180 -166.66 127.46 1.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.77 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.519 ' HA ' ' CA ' ' A' ' 109' ' ' GLY . 61.5 m -92.89 160.6 14.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.149 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.435 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 31.9 m-20 -52.68 157.58 2.55 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.556 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 17.9 Cg_endo -58.78 76.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.142 2.561 . . . . 0.0 112.64 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.3 t70 -177.07 -38.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.675 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.77 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 2.9 m-85 -108.91 132.58 53.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.872 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.467 ' CE1' ' HB2' ' A' ' 157' ' ' GLN . 17.6 p-80 -102.8 127.79 49.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.993 0.425 . . . . 0.0 111.145 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' A' ' 154' ' ' PRO . 26.7 tp -72.11 129.51 38.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.648 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.1 t -135.33 67.89 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.749 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.12 -136.09 2.28 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.623 -1.275 . . . . 0.0 113.398 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.483 ' HB2' ' CB ' ' A' ' 151' ' ' THR . 71.1 p -74.82 58.26 0.82 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.022 0.439 . . . . 0.0 110.854 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.693 ' HA ' HD21 ' A' ' 136' ' ' LEU . 36.5 t -52.16 -31.39 31.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.743 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -99.44 136.26 39.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.779 0.323 . . . . 0.0 111.237 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.468 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 42.8 t -150.05 149.56 30.49 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.34 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 124' ' ' ALA . 7.3 p -144.36 135.69 21.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.993 0.425 . . . . 0.0 111.75 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 121' ' ' LEU . 43.1 t -66.72 151.2 47.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.005 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.1 t -151.54 -136.91 0.07 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.054 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -74.63 66.56 1.45 Allowed 'General case' 0 C--O 1.232 0.153 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.36 43.45 92.67 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.649 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -176.41 139.9 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.757 0.313 . . . . 0.0 110.505 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.488 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 33.8 m95 -84.26 141.65 30.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.653 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.5 t -49.54 -52.72 27.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.645 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.483 ' CB ' ' HB2' ' A' ' 139' ' ' SER . 48.8 p -124.95 133.88 25.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 0.0 111.803 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.87 147.5 85.21 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.773 2.316 . . . . 0.0 111.841 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.516 ' HE2' HD13 ' A' ' 106' ' ' LEU . 50.2 mtpt -46.66 131.37 8.33 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.325 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.698 ' HG2' HD11 ' A' ' 136' ' ' LEU . 3.9 Cg_exo -78.93 -141.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.073 2.515 . . . . 0.0 112.086 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.422 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.1 p-80 -153.75 134.75 13.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.772 0.32 . . . . 0.0 110.948 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.77 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 77.5 m -98.73 132.41 44.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.487 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.467 ' HB2' ' CE1' ' A' ' 135' ' ' HIS . 23.2 mt-30 -103.4 142.46 34.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.821 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -76.21 135.99 25.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.21 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.7 m120 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.917 -179.523 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.436 ' HG2' HH11 ' A' ' 97' ' ' ARG . 22.4 ptt-85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.749 0.309 . . . . 0.0 110.706 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.4 pt -142.31 144.79 24.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.315 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.571 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 73.7 m -51.51 139.46 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.54 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.3 t -47.99 127.52 12.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.021 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.547 ' NZ ' ' HB3' ' A' ' 101' ' ' LYS . 8.4 mtpm? -74.16 14.36 0.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.343 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.1 m -68.87 -46.19 69.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.936 0.398 . . . . 0.0 110.895 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -61.7 -41.12 97.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.116 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.9 mt -54.94 -41.79 71.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.501 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.6 p -92.54 136.89 32.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.865 0.364 . . . . 0.0 111.564 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.44 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 40.4 tp -145.44 130.81 18.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.572 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 10.3 pm0 -90.48 38.94 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.335 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.412 ' OD1' ' HG2' ' A' ' 107' ' ' GLU . 8.2 m120 -155.85 25.44 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 154.57 -144.36 11.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.88 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.413 ' HE2' ' CZ ' ' A' ' 112' ' ' PHE . 25.0 pttm -141.97 140.19 32.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.251 -0.474 . . . . 0.0 110.302 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.33 143.91 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.013 0.435 . . . . 0.0 111.354 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.413 ' CZ ' ' HE2' ' A' ' 110' ' ' LYS . 1.4 m-85 -105.36 151.76 23.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.146 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.573 HD21 HD22 ' A' ' 121' ' ' LEU . 56.5 tp -145.29 132.97 20.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.605 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.2 p -150.95 147.32 27.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.429 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.2 39.7 26.31 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.918 -0.583 . . . . 0.0 113.017 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.596 ' HA2' ' HB2' ' A' ' 124' ' ' ALA . . . -79.61 -140.88 2.24 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.158 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -176.1 49.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 118' ' ' LEU . 1.7 pt? -42.47 135.07 2.62 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.986 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -87.71 63.04 0.19 OUTLIER 'Cis proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.638 -1.401 . . . . 0.0 113.345 0.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.579 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -166.32 132.56 2.47 Favored 'General case' 0 C--O 1.228 -0.074 0 CA-C-O 120.929 0.395 . . . . 0.0 111.486 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.573 HD22 HD21 ' A' ' 113' ' ' LEU . 83.3 mt -80.9 43.09 0.67 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.84 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -65.01 126.24 27.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.236 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 50.12 31.42 18.76 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.007 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.596 ' HB2' ' HA2' ' A' ' 116' ' ' GLY . . . -84.25 140.25 31.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.579 0.228 . . . . 0.0 110.959 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -108.54 124.23 50.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.785 0.326 . . . . 0.0 110.438 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 142' ' ' SER . 7.5 p -103.59 140.26 22.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.537 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -125.25 111.97 15.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.166 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -75.23 146.59 41.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.57 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.402 ' NH1' ' O ' ' A' ' 130' ' ' CYS . 26.7 tpt85 -156.27 117.06 3.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.097 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.514 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 98.6 m -96.41 165.25 12.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.691 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.544 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 56.2 m-20 -52.66 162.32 0.97 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.017 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 56.7 Cg_endo -70.92 51.76 1.29 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.851 2.368 . . . . 0.0 112.727 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -146.53 -35.85 0.26 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.773 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.634 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 0.7 OUTLIER -108.82 135.93 49.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.034 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 157' ' ' GLN . 17.0 p-80 -102.74 129.86 49.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.948 0.404 . . . . 0.0 110.826 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.732 HD21 ' HA ' ' A' ' 140' ' ' SER . 50.7 tp -72.72 128.18 34.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.019 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.6 t -135.99 68.69 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.665 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.18 -131.36 1.74 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.442 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.764 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.2 t -69.84 63.8 0.2 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.958 0.408 . . . . 0.0 111.364 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.732 ' HA ' HD21 ' A' ' 136' ' ' LEU . 95.5 p -61.22 -15.12 31.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.729 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -139.04 137.96 36.74 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.721 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.7 ' O ' HG12 ' A' ' 126' ' ' VAL . 36.4 t -150.69 124.17 9.01 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.735 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.2 p -88.01 130.51 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.978 0.418 . . . . 0.0 111.084 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 26.4 t -75.84 78.13 2.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.56 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 51.5 m -65.59 -124.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.412 ' C ' ' H ' ' A' ' 148' ' ' GLN . 26.1 mt-30 -67.27 -140.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -77.29 29.32 1.67 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.445 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.412 ' H ' ' C ' ' A' ' 146' ' ' GLN . 87.9 mt-30 -157.76 150.24 22.63 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.725 0.297 . . . . 0.0 110.652 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.571 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 33.1 m95 -84.22 139.21 32.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.222 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 80.7 p -53.91 -63.07 1.27 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.517 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 40.2 p -92.6 132.31 31.9 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.706 0.288 . . . . 0.0 111.533 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.34 142.5 85.95 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.826 2.35 . . . . 0.0 112.356 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.44 ' NZ ' HD13 ' A' ' 106' ' ' LEU . 63.2 tttm -51.81 127.93 35.43 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.128 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.764 ' HB3' ' H ' ' A' ' 139' ' ' SER . 81.9 Cg_endo -78.15 -152.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.765 2.31 . . . . 0.0 112.805 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -153.83 138.96 17.39 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.073 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 99.7 m -98.72 131.55 44.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.891 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.42 ' HB2' ' CE1' ' A' ' 135' ' ' HIS . 25.9 mt-30 -103.0 140.16 37.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.793 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.505 ' O ' HG22 ' A' ' 158' ' ' VAL . 14.7 p -79.9 44.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.39 0.614 . . . . 0.0 110.583 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.174 179.989 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.872 0.368 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.619 ' O ' HD12 ' A' ' 98' ' ' ILE . 2.5 pp -83.66 159.21 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.543 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.6 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 51.5 m -55.01 137.26 46.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.38 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.592 ' HB2' ' HE1' ' A' ' 149' ' ' TRP . 56.4 m -47.95 123.8 6.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.844 0.354 . . . . 0.0 111.226 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.737 ' HA ' HD13 ' A' ' 104' ' ' LEU . 58.9 tptt -75.47 -26.67 58.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.328 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.5 p -53.22 -41.8 65.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.488 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.678 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 3.7 m-85 -59.0 -42.63 90.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.651 0.262 . . . . 0.0 111.179 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.737 HD13 ' HA ' ' A' ' 101' ' ' LYS . 5.7 mp -55.74 -41.13 73.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.064 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.7 p -92.56 127.06 37.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.976 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.633 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 57.5 tp -145.36 128.36 16.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.092 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -69.15 138.06 53.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.971 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 m120 58.24 39.74 25.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.298 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.85 168.36 41.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.703 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -138.88 140.25 38.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.732 0.301 . . . . 0.0 110.743 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 74.9 t -109.18 141.45 24.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.206 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -105.53 136.1 45.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.644 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.551 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.6 mm? -101.05 144.2 30.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.575 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.9 m -151.76 126.62 9.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.713 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 65.01 149.98 0.06 OUTLIER Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.424 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.65 143.13 0.49 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.603 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -173.44 138.31 0.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.643 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -43.16 134.93 3.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.829 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 83.6 Cg_endo -87.9 54.01 0.52 Allowed 'Cis proline' 0 C--N 1.347 0.486 0 C-N-CA 123.721 -1.366 . . . . 0.0 113.401 0.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.454 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -135.11 135.55 41.27 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.7 0.286 . . . . 0.0 110.861 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.777 HD23 ' H ' ' A' ' 121' ' ' LEU . 2.1 pt? -124.42 -39.92 2.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.104 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -61.32 136.78 58.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.561 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.17 54.59 4.03 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.14 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.51 ' C ' ' HD2' ' A' ' 125' ' ' ARG . . . -147.7 132.17 17.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 0.0 111.068 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.51 ' HD2' ' C ' ' A' ' 124' ' ' ALA . 8.6 mpt_? -124.93 138.86 54.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.113 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.415 HG12 HD13 ' A' ' 113' ' ' LEU . 28.4 m -116.97 137.06 52.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.104 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -106.67 113.72 27.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.95 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -74.83 155.95 37.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.603 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.522 HH22 ' H ' ' A' ' 136' ' ' LEU . 2.4 tpm_? -161.11 128.45 4.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.525 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.47 ' H ' ' CZ ' ' A' ' 129' ' ' ARG . 87.6 m -89.22 140.77 29.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.067 0.46 . . . . 0.0 111.456 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -54.29 158.88 3.49 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.16 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.504 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 3.5 Cg_endo -45.92 153.14 0.95 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.002 2.468 . . . . 0.0 112.07 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 22.2 m-20 77.92 -32.07 0.17 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.664 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' A' ' 132' ' ' PRO . 3.2 m-85 -107.65 128.12 54.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.331 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -107.52 136.44 47.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.425 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.69 HD22 ' HB2' ' A' ' 140' ' ' SER . 6.2 tt -74.94 130.46 39.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.469 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.623 ' N ' HD23 ' A' ' 136' ' ' LEU . 40.8 t -135.04 67.43 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.461 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.5 -134.94 1.91 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.092 -1.052 . . . . 0.0 113.058 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.651 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 50.0 m -75.53 55.26 0.81 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.851 0.358 . . . . 0.0 110.964 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.69 ' HB2' HD22 ' A' ' 136' ' ' LEU . 33.6 t -49.77 -40.51 41.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.171 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.427 ' HG2' HH11 ' A' ' 141' ' ' ARG . 22.2 ptt-85 -99.31 134.53 42.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.98 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.2 m -146.29 133.87 20.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.77 0.319 . . . . 0.0 110.736 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.455 HG23 ' HG3' ' A' ' 125' ' ' ARG . 7.3 p -120.05 129.76 75.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.05 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 51.4 t -71.39 141.95 50.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.454 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.3 t -171.3 125.65 0.64 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.216 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.441 ' OE1' ' N ' ' A' ' 146' ' ' GLN . 0.6 OUTLIER 57.15 39.61 28.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 0.0 110.448 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.17 -51.65 3.26 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.774 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -76.92 143.7 39.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.678 0.275 . . . . 0.0 111.057 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.592 ' HE1' ' HB2' ' A' ' 100' ' ' SER . 70.0 m95 -84.2 146.82 27.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.828 0.347 . . . . 0.0 110.659 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.3 t -53.37 -61.17 2.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.524 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 139' ' ' SER . 82.4 p -107.79 135.78 19.77 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.774 0.321 . . . . 0.0 111.776 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 139' ' ' SER . 57.6 Cg_endo -70.78 145.67 51.9 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.785 2.323 . . . . 0.0 112.161 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.678 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 7.6 mtpm? -45.32 130.17 5.98 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.433 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.651 ' HB3' ' N ' ' A' ' 139' ' ' SER . 76.1 Cg_endo -77.51 -141.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.69 2.26 . . . . 0.0 112.547 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.482 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.4 p-80 -153.74 147.6 25.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.036 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 71.0 m -96.89 140.26 31.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.279 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -131.26 146.69 52.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.875 0.369 . . . . 0.0 111.48 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 79.6 t -76.61 125.18 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.174 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.067 -179.634 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.423 ' NH1' ' HA3' ' A' ' 147' ' ' GLY . 31.2 ptt85 . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.92 0.39 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.685 ' O ' HD12 ' A' ' 98' ' ' ILE . 2.3 pp -51.13 148.21 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.991 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.603 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 97.7 m -59.76 143.83 49.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.04 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.2 m -48.03 124.81 8.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.226 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -84.46 14.98 3.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.933 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.2 m -67.34 -35.63 79.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.678 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.739 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 3.4 m-85 -58.74 -25.69 63.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.417 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.4 mt -50.0 -38.41 37.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.737 0.303 . . . . 0.0 111.118 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.3 p -92.55 127.81 38.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.111 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.484 HD22 ' HA3' ' A' ' 109' ' ' GLY . 6.4 tt -145.37 124.02 12.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.182 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.457 ' N ' HD23 ' A' ' 106' ' ' LEU . 96.6 mt-10 -74.25 130.69 40.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.37 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.504 ' N ' HD22 ' A' ' 108' ' ' ASN . 2.0 m120 60.11 47.22 9.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.221 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.484 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -174.95 -171.83 39.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.075 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -142.09 146.29 35.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.659 0.266 . . . . 0.0 110.647 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 103' ' ' TYR . 60.3 t -108.05 127.4 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.631 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.627 ' C ' HG23 ' A' ' 126' ' ' VAL . 2.5 m-85 -112.01 70.88 0.72 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.149 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.702 ' HA ' ' HB ' ' A' ' 126' ' ' VAL . 2.3 tt -74.67 62.39 1.05 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.618 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.8 p -75.0 120.89 21.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.712 0.291 . . . . 0.0 111.118 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.14 -43.89 0.31 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.654 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -173.16 -128.26 1.05 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.531 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.86 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 11.6 p-10 -165.24 -136.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 118' ' ' LEU . 2.7 mm? -116.31 132.98 23.02 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.526 0.203 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 60.0 Cg_endo -93.09 42.06 3.15 Favored 'Cis proline' 0 C--N 1.348 0.537 0 C-N-CA 123.837 -1.318 . . . . 0.0 112.497 -0.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.86 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -74.07 140.89 45.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 0.0 111.742 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.541 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 2.1 pt? -167.39 36.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.803 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.93 60.57 1.39 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.917 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.22 40.84 32.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.225 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.526 ' O ' HG23 ' A' ' 143' ' ' VAL . . . -62.9 135.29 57.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 110.981 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.58 ' HD2' ' NH2' ' A' ' 141' ' ' ARG . 85.7 mtm180 -103.83 141.47 36.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.498 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.703 HG11 ' HZ3' ' A' ' 149' ' ' TRP . 6.5 p -143.23 135.66 24.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.257 0.551 . . . . 0.0 112.315 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -109.17 121.11 44.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.737 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.534 ' HE1' ' HB3' ' A' ' 142' ' ' SER . 3.2 m-85 -87.3 56.19 3.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.801 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 129' ' ' ARG . 63.5 mtt-85 -59.05 132.97 55.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.591 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 53.7 t -89.2 149.13 23.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.34 . . . . 0.0 111.13 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.482 ' OD1' ' HB2' ' A' ' 134' ' ' PHE . 52.5 p-10 -52.81 149.8 10.88 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.404 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 10.1 Cg_endo -51.59 152.74 12.0 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.751 2.301 . . . . 0.0 111.527 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.585 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 37.4 t70 76.44 -2.41 2.72 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.399 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.71 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 19.1 m-85 -134.28 130.61 37.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.951 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -104.16 128.19 51.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.923 0.392 . . . . 0.0 111.197 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.837 HD12 ' HB3' ' A' ' 140' ' ' SER . 2.8 tm? -71.44 132.15 44.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.795 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.625 ' N ' HD13 ' A' ' 136' ' ' LEU . 24.8 t -132.23 67.88 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.9 -135.13 2.11 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 119.901 -1.142 . . . . 0.0 113.276 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.652 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 39.2 p -74.99 56.05 0.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.929 0.395 . . . . 0.0 111.072 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.837 ' HB3' HD12 ' A' ' 136' ' ' LEU . 92.6 p -57.0 -38.95 73.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.801 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.58 ' NH2' ' HD2' ' A' ' 125' ' ' ARG . 29.4 tpt180 -99.32 133.97 42.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.703 0.287 . . . . 0.0 111.508 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.534 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 46.7 t -150.34 148.67 29.1 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.258 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 124' ' ' ALA . 7.4 p -146.23 130.27 10.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.146 0.498 . . . . 0.0 112.046 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 13.7 t -92.54 140.96 29.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.901 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.4 t -169.52 -60.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.042 0.449 . . . . 0.0 111.218 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -87.98 43.63 1.13 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.423 ' HA3' ' NH1' ' A' ' 97' ' ' ARG . . . 56.54 39.9 85.91 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.89 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -174.73 146.98 1.0 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.728 0.299 . . . . 0.0 110.402 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.703 ' HZ3' HG11 ' A' ' 126' ' ' VAL . 29.5 m95 -84.22 138.78 32.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.778 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.2 t -50.15 -46.31 53.95 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.965 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 70.9 p -135.65 138.84 29.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.891 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.499 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 28.0 Cg_exo -62.02 -162.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.561 2.174 . . . . 0.0 112.627 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.801 ' HZ2' ' HB3' ' A' ' 153' ' ' LYS . 3.9 mmmp? -80.75 127.3 75.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.783 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.652 ' HB3' ' N ' ' A' ' 139' ' ' SER . 84.0 Cg_endo -81.37 -151.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.635 2.223 . . . . 0.0 112.891 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.425 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 22.4 p-80 -153.65 136.52 15.38 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.936 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 7.8 t -98.72 136.83 38.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.979 0.418 . . . . 0.0 111.664 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -103.04 142.4 34.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.02 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 98.2 t -61.24 111.03 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.78 0.324 . . . . 0.0 110.327 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.585 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 38.6 t30 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.05 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.744 0.307 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.506 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -54.33 142.36 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 0.0 111.49 -179.547 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 82.1 m -56.42 154.47 8.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.757 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.7 m -45.67 127.51 7.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.492 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.572 ' HB2' HD12 ' A' ' 104' ' ' LEU . 7.8 ptpp? -76.19 -3.38 35.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.262 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.5 m -56.12 -41.15 74.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.87 0.367 . . . . 0.0 110.994 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.469 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 1.7 m-85 -59.98 -34.17 72.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.196 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.572 HD12 ' HB2' ' A' ' 101' ' ' LYS . 75.6 mt -52.11 -40.01 60.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.967 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.1 m -92.6 136.29 33.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.5 tp -145.42 131.35 19.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.86 0.362 . . . . 0.0 111.31 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -75.02 133.56 41.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.853 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 52.47 36.07 19.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 110.664 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.36 145.81 9.91 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.538 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.634 ' HB3' ' NZ ' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -101.93 140.87 35.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.972 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.03 135.93 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.79 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 126' ' ' VAL . 3.5 m-85 -110.35 136.16 49.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.779 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.48 HD11 HD22 ' A' ' 104' ' ' LEU . 94.8 mt -112.4 144.86 41.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.163 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.8 t -159.83 143.1 14.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.005 0.431 . . . . 0.0 111.81 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.09 126.07 0.13 Allowed Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.911 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 152.06 -140.36 7.7 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.312 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 120' ' ' ALA . 65.6 t0 -173.86 119.14 0.27 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.823 HD22 ' H ' ' A' ' 118' ' ' LEU . 3.1 mm? -29.49 126.16 0.26 Allowed Pre-proline 0 N--CA 1.465 0.301 0 O-C-N 123.591 0.557 . . . . 0.0 111.555 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 118' ' ' LEU . 25.5 Cg_exo -63.18 -22.1 4.86 Favored 'Cis proline' 0 C--N 1.351 0.682 0 C-N-CA 124.097 -1.209 . . . . 0.0 112.992 0.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 117' ' ' ASP . . . 69.26 129.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.413 0.625 . . . . 0.0 111.752 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.628 ' O ' HD13 ' A' ' 121' ' ' LEU . 2.2 tm? 175.33 -35.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.236 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -62.14 132.32 52.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.677 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.5 31.72 36.88 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.331 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -77.19 139.65 39.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.758 0.313 . . . . 0.0 111.193 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.403 HH11 ' HG3' ' A' ' 125' ' ' ARG . 41.1 ttt85 -103.98 63.25 0.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.126 0.489 . . . . 0.0 109.725 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 142' ' ' SER . 11.0 p -57.96 141.7 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.776 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -123.92 113.3 18.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.863 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -80.06 151.3 29.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.9 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.453 HH11 ' HG3' ' A' ' 129' ' ' ARG . 38.3 ttt85 -161.11 133.12 5.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.785 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 84.1 m -89.25 142.45 27.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.204 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 60.8 m-20 -56.27 160.81 4.54 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.022 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.53 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 78.2 Cg_exo -41.15 154.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.982 2.455 . . . . 0.0 112.652 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 8.1 t70 78.89 -33.77 0.16 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.717 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.411 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 1.7 m-85 -107.6 129.5 54.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.237 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -110.75 134.75 52.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.99 0.424 . . . . 0.0 111.08 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 137' ' ' VAL . 6.6 tt -75.21 132.42 41.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.597 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.602 ' N ' HD23 ' A' ' 136' ' ' LEU . 38.7 t -133.39 67.3 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.452 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.25 -126.33 1.07 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.15 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.604 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 42.7 t -70.2 64.46 0.25 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.986 0.422 . . . . 0.0 111.258 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.445 ' HB2' HD22 ' A' ' 136' ' ' LEU . 35.3 t -64.36 -18.0 64.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.172 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 56.5 mtt85 -140.7 140.86 34.97 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.056 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.608 ' O ' HG12 ' A' ' 126' ' ' VAL . 35.9 m -145.03 136.27 25.02 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 7.2 p -113.32 130.55 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.924 0.393 . . . . 0.0 111.357 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 45.6 t -75.05 139.46 42.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.96 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 m -163.12 134.58 4.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.844 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 67.36 -66.68 0.19 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.462 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.0 37.44 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.526 -0.629 . . . . 0.0 111.526 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -176.32 152.36 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.105 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 27.9 m95 -84.19 140.93 31.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.741 0.305 . . . . 0.0 110.724 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.6 m -52.3 -59.89 3.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.013 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.2 p -100.91 134.26 20.56 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.05 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.461 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 38.3 Cg_endo -66.59 -157.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.398 2.066 . . . . 0.0 112.366 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.561 ' HB3' ' NZ ' ' A' ' 153' ' ' LYS . 9.5 mtpm? -92.98 129.93 37.98 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.037 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.604 ' HB3' ' N ' ' A' ' 139' ' ' SER . 66.5 Cg_endo -73.09 -144.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.673 2.249 . . . . 0.0 112.722 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.474 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.7 p-80 -153.67 149.26 27.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.415 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 73.9 m -97.86 129.33 44.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 0.0 111.189 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -111.87 133.24 54.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.682 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.438 HG23 ' OD1' ' A' ' 133' ' ' ASP . 7.2 p -84.79 127.15 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.522 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.912 -179.767 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.459 HH11 ' HG3' ' A' ' 97' ' ' ARG . 38.5 ttm-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.972 0.415 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.476 HG22 HD23 ' A' ' 121' ' ' LEU . 31.7 pt -72.88 141.83 15.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.717 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 59.7 m -61.22 143.23 55.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.945 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.422 ' HB3' ' HE1' ' A' ' 149' ' ' TRP . 41.1 t -47.91 130.78 15.27 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.354 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -76.69 -19.93 57.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.429 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.3 p -53.06 -46.63 68.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.787 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.527 ' O ' HG21 ' A' ' 111' ' ' VAL . 3.5 m-85 -61.72 -36.72 81.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.587 0.232 . . . . 0.0 111.204 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.6 mt -54.43 -48.64 71.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.109 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.6 m -92.55 137.85 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.625 HD13 ' HE2' ' A' ' 153' ' ' LYS . 24.8 tp -145.4 130.77 18.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.037 0.446 . . . . 0.0 111.348 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.474 ' HG2' ' ND2' ' A' ' 108' ' ' ASN . 44.4 tt0 -72.43 137.35 46.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.404 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.474 ' ND2' ' HG2' ' A' ' 107' ' ' GLU . 76.0 m-20 61.06 37.21 18.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.147 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 178.98 -179.33 48.92 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.704 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -142.03 147.12 36.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.79 0.328 . . . . 0.0 110.791 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.527 HG21 ' O ' ' A' ' 103' ' ' TYR . 86.3 t -107.23 141.61 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.969 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.15 135.32 46.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.598 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.0 mm? -102.77 147.07 27.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.237 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.0 m -151.59 129.81 11.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.815 0.341 . . . . 0.0 111.256 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 56.19 43.56 89.0 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.62 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . -179.92 141.15 4.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.653 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -174.86 134.21 0.35 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.959 HD12 ' HA ' ' A' ' 119' ' ' PRO . 37.3 tp -43.82 131.62 4.07 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.939 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.959 ' HA ' HD12 ' A' ' 118' ' ' LEU . 84.6 Cg_endo -90.7 63.02 0.27 Allowed 'Cis proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.585 -1.423 . . . . 0.0 113.143 0.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.442 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -141.83 48.79 1.6 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.816 0.341 . . . . 0.0 111.26 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 121' ' ' LEU . 3.1 mm? -62.61 -45.08 94.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.636 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.455 ' OD1' ' HA ' ' A' ' 145' ' ' SER . 64.3 t0 -62.59 138.89 58.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.615 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.93 57.73 5.14 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.375 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.639 ' HB2' ' HA3' ' A' ' 116' ' ' GLY . . . -154.03 141.23 19.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 111.271 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.62 HH21 ' HD2' ' A' ' 141' ' ' ARG . 41.9 ttt85 -108.62 141.66 40.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.504 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.408 HG23 ' CE1' ' A' ' 128' ' ' PHE . 19.1 m -130.88 140.16 49.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.963 0.411 . . . . 0.0 111.679 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -103.5 125.26 49.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.094 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.408 ' CE1' HG23 ' A' ' 126' ' ' VAL . 9.7 m-85 -92.38 143.04 26.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.084 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.404 HH11 ' HG3' ' A' ' 129' ' ' ARG . 41.3 ttt85 -172.34 124.07 0.49 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.991 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.533 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 56.9 m -89.31 146.03 24.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.883 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.663 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 59.5 m-20 -55.88 167.14 0.89 Allowed Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.37 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 2.1 Cg_endo -45.01 159.81 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.268 2.645 . . . . 0.0 112.399 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.5 m-20 77.95 -37.67 0.24 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.258 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.488 ' CE2' HG22 ' A' ' 158' ' ' VAL . 6.6 m-85 -108.52 126.25 52.71 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.46 ' H ' ' CD2' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -117.94 126.28 52.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.243 0.544 . . . . 0.0 111.335 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 137' ' ' VAL . 6.5 tt -72.58 130.16 39.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.029 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.539 ' N ' HD23 ' A' ' 136' ' ' LEU . 31.6 t -129.06 67.09 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.531 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.95 -131.99 1.48 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.496 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.534 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 80.1 p -73.86 64.51 0.98 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.979 0.418 . . . . 0.0 110.272 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.7 t -58.33 -2.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.436 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.62 ' HD2' HH21 ' A' ' 125' ' ' ARG . 53.8 mtm-85 -140.69 137.08 33.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.523 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.0 m -149.12 133.34 17.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.389 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 6.2 p -123.25 126.22 73.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.106 0.479 . . . . 0.0 111.289 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 52.6 t -98.99 140.04 33.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.755 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.455 ' HA ' ' OD1' ' A' ' 122' ' ' ASP . 43.7 t -170.05 38.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.128 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 52.0 tt0 177.68 47.18 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.502 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 54.36 35.27 55.51 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.949 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -177.39 144.86 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.422 ' HE1' ' HB3' ' A' ' 100' ' ' SER . 29.7 m95 -84.22 140.82 31.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.82 0.343 . . . . 0.0 110.689 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.4 t -52.72 -65.87 0.48 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.933 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 81.1 p -98.42 135.68 21.11 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.73 0.3 . . . . 0.0 111.8 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 27.1 Cg_exo -62.1 143.85 95.25 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.758 2.305 . . . . 0.0 111.616 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.625 ' HE2' HD13 ' A' ' 106' ' ' LEU . 83.3 tttt -47.92 130.71 11.81 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.839 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.534 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.3 Cg_endo -75.84 -148.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.814 2.343 . . . . 0.0 113.206 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.46 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 16.9 p-80 -153.75 130.99 11.17 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.181 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 93.5 m -99.07 135.38 40.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.064 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -103.02 141.51 35.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.224 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.488 HG22 ' CE2' ' A' ' 134' ' ' PHE . 49.3 t -69.52 79.53 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.055 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.472 -179.961 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.459 ' O ' ' HA2' ' A' ' 147' ' ' GLY . 70.0 mtt-85 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.588 0.233 . . . . 0.0 110.534 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.536 ' HB ' ' HG ' ' A' ' 121' ' ' LEU . 29.4 pt -78.51 38.81 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.448 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.502 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 68.0 m 59.21 141.06 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.013 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.6 t -48.03 126.3 10.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.312 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.677 ' HA ' HD23 ' A' ' 104' ' ' LEU . 63.9 pttt -80.01 -12.97 59.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.881 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.6 m -57.07 -42.26 80.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.563 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.509 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.7 m-85 -52.94 -37.6 61.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.234 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.677 HD23 ' HA ' ' A' ' 101' ' ' LYS . 2.0 mm? -54.1 -41.59 68.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.336 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.5 m -92.54 136.07 33.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.043 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.848 HD13 ' HE2' ' A' ' 153' ' ' LYS . 15.5 tp -145.39 130.62 18.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.25 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.502 ' N ' HD12 ' A' ' 106' ' ' LEU . 42.6 tt0 -70.66 131.15 43.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.416 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.436 ' ND2' ' HG2' ' A' ' 107' ' ' GLU . 76.5 m-20 54.81 42.42 31.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.993 0.425 . . . . 0.0 110.609 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.08 153.57 14.01 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.588 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -115.29 142.79 46.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.691 0.281 . . . . 0.0 110.758 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 103' ' ' TYR . 46.1 t -107.89 131.34 58.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.053 0.454 . . . . 0.0 110.977 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.428 ' O ' HG23 ' A' ' 126' ' ' VAL . 3.0 m-85 -109.82 150.78 27.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.784 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.663 ' O ' HD12 ' A' ' 113' ' ' LEU . 3.9 pp -158.13 149.78 21.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.916 0.388 . . . . 0.0 111.52 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.0 p -151.33 132.26 14.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.72 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 167.68 -129.78 1.97 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.433 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.75 -122.82 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.507 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.809 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 54.4 t0 -161.68 -127.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.478 0.18 . . . . 0.0 110.64 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 119' ' ' PRO . 31.9 tp -128.88 130.05 23.46 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.761 0.315 . . . . 0.0 111.172 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.868 ' HA ' HD12 ' A' ' 118' ' ' LEU . 89.7 Cg_endo -91.86 42.47 2.84 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.442 -1.483 . . . . 0.0 112.581 -0.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.809 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -80.96 46.96 0.94 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.523 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.536 ' HG ' ' HB ' ' A' ' 98' ' ' ILE . 3.5 mm? -61.89 -38.05 86.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.147 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -61.27 146.03 49.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.1 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.1 -34.54 3.02 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.61 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.08 141.88 38.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.904 0.383 . . . . 0.0 111.649 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.44 ' HD2' HG23 ' A' ' 143' ' ' VAL . 43.9 mmm-85 -104.26 136.96 42.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.087 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 112' ' ' PHE . 15.0 p -123.83 133.14 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.189 0.519 . . . . 0.0 111.986 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -112.81 120.58 41.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.697 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.407 ' HE1' ' HB3' ' A' ' 142' ' ' SER . 8.5 m-85 -88.75 149.81 23.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.256 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -164.64 134.81 3.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.051 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 70.5 m -89.23 155.44 19.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.772 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 133' ' ' ASP . 11.5 p-10 -52.69 149.11 11.7 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.987 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -58.14 74.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.08 2.52 . . . . 0.0 112.576 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.1 t70 -177.74 -40.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.736 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.474 ' CE2' ' HB ' ' A' ' 158' ' ' VAL . 1.4 m-85 -107.86 142.65 37.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.829 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -101.24 129.1 47.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 0.0 111.066 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 137' ' ' VAL . 6.9 tt -77.91 130.54 36.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.451 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.514 ' N ' HD23 ' A' ' 136' ' ' LEU . 38.5 t -131.87 66.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.415 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.04 -126.61 0.9 Allowed Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.079 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.713 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 34.9 t -72.3 58.52 0.39 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 111.201 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.5 t -56.58 -26.58 55.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.853 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.413 ' HG3' HH11 ' A' ' 141' ' ' ARG . 45.2 ttm-85 -129.84 137.76 50.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.407 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 39.4 t -149.25 175.83 11.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.023 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.44 HG23 ' HD2' ' A' ' 125' ' ' ARG . 8.6 p -160.6 137.34 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.08 0.467 . . . . 0.0 112.003 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 37.1 t -78.79 135.07 36.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.886 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.8 t -175.26 133.48 0.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.953 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 56.87 40.94 28.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 97' ' ' ARG . . . 56.15 43.2 88.8 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.522 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -175.13 138.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.69 0.281 . . . . 0.0 110.702 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.502 ' CE2' ' HB3' ' A' ' 99' ' ' CYS . 14.5 m95 -84.2 140.25 31.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.371 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.4 p -52.92 -60.83 2.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.741 0.305 . . . . 0.0 110.865 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 40.3 p -101.23 140.54 21.36 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.127 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 24.4 Cg_exo -63.62 -153.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.628 2.218 . . . . 0.0 112.365 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.848 ' HE2' HD13 ' A' ' 106' ' ' LEU . 83.7 tttt -102.39 127.9 29.47 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.486 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.713 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 60.3 Cg_endo -72.66 -153.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.538 2.159 . . . . 0.0 112.717 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -153.67 144.64 22.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.484 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 66.2 m -97.3 134.05 41.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.895 0.379 . . . . 0.0 110.775 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -117.9 138.75 51.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.136 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.474 ' HB ' ' CE2' ' A' ' 134' ' ' PHE . 8.6 p -85.95 129.45 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.436 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.2 p30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.968 -179.7 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.04 0.448 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.627 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -148.49 134.66 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.411 179.296 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 7.4 p -53.27 139.33 29.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.614 -179.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.4 m -47.91 128.1 12.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.482 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.687 ' HA ' HD13 ' A' ' 104' ' ' LEU . 9.0 ptpp? -84.56 3.75 35.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.019 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.4 t -63.29 -39.02 93.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.009 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.465 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.5 m-85 -54.94 -38.23 67.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.971 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.687 HD13 ' HA ' ' A' ' 101' ' ' LYS . 6.2 mp -54.56 -34.26 61.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.304 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.2 p -92.33 129.45 38.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 111.029 -179.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.844 HD13 ' HE2' ' A' ' 153' ' ' LYS . 22.3 tp -145.48 133.8 21.77 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.335 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 8.2 pm0 -74.73 132.19 41.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.331 179.124 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 55.89 39.22 30.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.609 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.31 151.2 14.02 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.821 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -112.48 142.1 45.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.351 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 103' ' ' TYR . 43.0 t -106.98 137.5 37.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.994 0.426 . . . . 0.0 111.287 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -104.72 142.09 35.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.293 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.651 ' HB3' HG23 ' A' ' 126' ' ' VAL . 4.1 pp -166.81 150.65 6.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.983 0.42 . . . . 0.0 111.697 -179.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.6 m -160.33 135.04 7.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.784 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 132.15 136.26 3.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.73 141.75 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.044 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 32.7 m-20 -130.53 -42.51 1.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.246 0.546 . . . . 0.0 109.64 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.715 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -130.27 123.01 20.36 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.407 179.559 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 87.4 Cg_endo -81.7 33.59 2.16 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 123.28 -1.55 . . . . 0.0 112.338 0.073 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 117' ' ' ASP . . . 66.65 146.82 0.04 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.874 0.369 . . . . 0.0 111.245 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.503 ' HB3' ' SG ' ' A' ' 99' ' ' CYS . 6.6 mp 62.43 35.1 15.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.01 -178.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.96 51.02 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.099 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.456 ' HA2' ' C ' ' A' ' 144' ' ' CYS . . . 71.44 42.32 56.41 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.567 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.35 -163.59 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 111.318 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -112.3 146.29 38.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.435 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.651 HG23 ' HB3' ' A' ' 113' ' ' LEU . 8.1 p -141.86 138.56 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.114 0.483 . . . . 0.0 111.4 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -132.59 111.68 11.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.375 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.471 ' HB2' HD11 ' A' ' 136' ' ' LEU . 3.1 m-85 -69.18 153.75 43.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.206 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.1 tpp85 -160.6 129.47 4.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.833 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 55.8 m -89.18 143.83 26.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.735 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 133' ' ' ASP . 61.4 m-20 -53.2 150.85 10.38 Favored Pre-proline 0 N--CA 1.462 0.155 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.123 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 52.7 Cg_exo -53.55 77.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.23 2.62 . . . . 0.0 113.105 -179.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 131' ' ' ASP . 39.0 t70 177.73 -38.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.761 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -108.33 142.37 38.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.797 179.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.479 ' CD2' ' HB3' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -100.8 132.71 46.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.126 0.489 . . . . 0.0 111.07 179.91 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 137' ' ' VAL . 4.9 tt -76.93 124.71 28.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.07 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.548 ' N ' HD23 ' A' ' 136' ' ' LEU . 21.2 t -134.78 61.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.598 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -166.11 -133.65 1.55 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 119.869 -1.158 . . . . 0.0 113.148 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.632 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 64.2 m -74.56 55.06 0.63 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.832 0.349 . . . . 0.0 110.991 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.528 ' HB2' HD22 ' A' ' 136' ' ' LEU . 36.6 t -51.39 -43.05 61.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.968 -179.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.434 HH11 ' HG3' ' A' ' 141' ' ' ARG . 40.1 ttt85 -99.47 131.16 45.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.829 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.437 ' O ' HG12 ' A' ' 126' ' ' VAL . 49.9 m -150.72 153.49 35.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.965 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.702 HG12 ' HB2' ' A' ' 150' ' ' SER . 15.0 p -138.27 134.24 43.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.172 0.51 . . . . 0.0 112.004 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.456 ' C ' ' HA2' ' A' ' 123' ' ' GLY . 27.5 t -74.14 152.51 39.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.481 179.202 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.9 p -155.9 -135.97 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.016 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -53.51 -38.88 64.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.882 0.373 . . . . 0.0 110.952 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . -174.11 -49.09 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.123 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -85.0 142.22 29.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.744 0.307 . . . . 0.0 110.355 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.411 ' NE1' ' HB2' ' A' ' 99' ' ' CYS . 35.9 m95 -84.11 151.18 25.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.484 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.702 ' HB2' HG12 ' A' ' 143' ' ' VAL . 48.3 t -44.97 -57.15 4.0 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.179 -179.31 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 72.4 p -121.23 145.13 41.4 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.947 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -57.61 -161.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.616 2.211 . . . . 0.0 112.765 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.844 ' HE2' HD13 ' A' ' 106' ' ' LEU . 83.0 tttt -94.12 126.13 49.93 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.833 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.632 ' HB3' ' N ' ' A' ' 139' ' ' SER . 57.1 Cg_endo -70.77 -155.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.481 2.12 . . . . 0.0 112.384 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -153.69 142.27 20.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 75.5 m -98.72 132.67 43.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.912 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.479 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 53.0 tt0 -116.33 141.05 48.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.808 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.03 132.42 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.287 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.7 p30 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.986 -179.422 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.701 0.286 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.1 pt -54.65 139.32 13.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.995 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.51 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 96.4 m -53.15 135.62 37.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.18 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.6 t -47.92 127.96 12.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.457 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.846 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -87.25 -6.53 58.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.935 179.666 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.1 p -54.09 -34.73 60.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.219 -179.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.581 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.9 m-85 -57.04 -35.55 69.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.56 -179.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 104' ' ' LEU . 4.1 mp -77.8 37.49 0.24 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.107 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.4 p -147.5 63.55 1.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.802 0.334 . . . . 0.0 110.803 179.125 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.744 HD13 ' HE2' ' A' ' 153' ' ' LYS . 29.6 tp -94.12 128.91 40.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.634 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -73.4 137.03 44.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.996 178.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.459 ' HB3' ' OD2' ' A' ' 131' ' ' ASP . 2.9 m120 58.64 42.03 21.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.108 0.48 . . . . 0.0 110.126 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -171.27 164.58 37.57 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.647 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -125.14 141.84 51.86 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.411 HG21 ' HA ' ' A' ' 104' ' ' LEU . 4.7 t -109.38 137.04 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.885 0.374 . . . . 0.0 111.021 -179.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.636 ' O ' HG23 ' A' ' 126' ' ' VAL . 2.3 m-85 -107.69 141.77 38.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.684 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 114' ' ' THR . 7.1 tt -147.84 138.02 22.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.006 0.432 . . . . 0.0 111.015 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.589 ' N ' HD23 ' A' ' 113' ' ' LEU . 76.2 p -145.07 121.27 10.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.645 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.38 -43.37 0.77 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.163 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -179.7 -138.67 3.41 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.071 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -178.04 -60.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.004 0.43 . . . . 0.0 110.824 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.635 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -149.41 132.83 8.45 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.302 -179.468 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.07 19.72 6.56 Favored 'Cis proline' 0 C--N 1.347 0.464 0 C-N-CA 123.531 -1.446 . . . . 0.0 112.148 -0.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 50.73 -138.26 1.05 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.994 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 28.5 mt 58.72 63.2 1.72 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.831 0.348 . . . . 0.0 111.306 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -164.02 50.92 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.029 0.442 . . . . 0.0 110.702 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.93 41.39 97.4 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.971 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.32 134.3 39.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 111.058 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -112.72 144.61 41.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 112' ' ' PHE . 8.5 p -141.39 142.03 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.081 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -133.81 123.0 24.06 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.111 -179.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.581 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 2.8 m-85 -79.99 147.13 31.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.871 179.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -141.24 130.99 24.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 76.1 m -93.88 140.81 29.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.181 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.554 ' HB2' ' HD2' ' A' ' 132' ' ' PRO . 1.9 p30 -62.25 161.16 26.61 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.514 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 131' ' ' ASP . 1.5 Cg_endo -43.07 148.07 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.967 2.445 . . . . 0.0 112.067 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 21.8 m-20 78.96 -24.41 0.22 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.798 -179.039 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 157' ' ' GLN . 22.2 m-85 -108.61 134.86 50.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.7 0.286 . . . . 0.0 110.619 179.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -123.02 133.97 54.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.589 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.814 HD11 ' HG2' ' A' ' 154' ' ' PRO . 17.1 tp -75.35 130.14 38.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.722 -179.509 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.85 67.42 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.827 -179.199 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.87 -134.24 1.95 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.05 -1.072 . . . . 0.0 112.975 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.521 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 30.5 p -73.85 59.42 0.68 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.102 0.477 . . . . 0.0 110.712 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.443 ' HA ' HD21 ' A' ' 136' ' ' LEU . 94.2 p -54.97 -50.9 67.8 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.444 -178.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.68 ' HD2' ' O ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -99.38 141.79 31.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.144 0.497 . . . . 0.0 112.006 -179.259 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.636 ' HA ' ' OG ' ' A' ' 150' ' ' SER . 55.3 p -150.69 146.0 26.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.148 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.798 HG12 ' HB3' ' A' ' 150' ' ' SER . 10.0 p -126.92 134.76 65.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.053 0.454 . . . . 0.0 111.863 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.71 143.98 51.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.714 179.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.2 m -149.9 -134.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.41 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -52.85 -34.72 55.57 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.929 0.395 . . . . 0.0 110.476 179.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.5 -48.8 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.767 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -80.41 144.12 32.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.676 0.274 . . . . 0.0 110.724 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.569 ' HB3' ' HB2' ' A' ' 142' ' ' SER . 44.0 m95 -84.2 151.07 25.07 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.421 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.798 ' HB3' HG12 ' A' ' 143' ' ' VAL . 98.5 p -43.34 -42.85 4.75 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.78 0.324 . . . . 0.0 110.703 -179.477 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.8 p -141.39 145.8 39.59 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.469 179.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.8 -156.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.697 2.265 . . . . 0.0 112.769 -179.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.744 ' HE2' HD13 ' A' ' 106' ' ' LEU . 87.3 tttt -101.5 125.39 37.68 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.821 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.814 ' HG2' HD11 ' A' ' 136' ' ' LEU . 60.0 Cg_endo -74.87 -149.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.407 2.071 . . . . 0.0 112.565 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -153.7 147.75 25.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.251 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 73.0 m -98.54 129.2 45.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.687 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 134' ' ' PHE . 84.5 mt-30 -107.59 136.58 47.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.994 0.426 . . . . 0.0 111.764 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.51 ' O ' HG22 ' A' ' 158' ' ' VAL . 11.9 p -83.11 47.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.499 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.954 -179.416 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.908 0.385 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.648 ' H ' HD13 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -65.03 146.47 13.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.359 -179.644 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 35.1 m -52.21 143.23 14.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.464 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.631 ' HB2' ' HE1' ' A' ' 149' ' ' TRP . 53.3 m -47.98 125.7 9.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.998 0.427 . . . . 0.0 111.38 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.843 ' HD3' HD21 ' A' ' 104' ' ' LEU . 16.8 tppt? -82.18 84.82 6.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.081 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.0 t -171.07 -44.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.748 0.309 . . . . 0.0 111.582 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.567 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.5 m-85 -60.71 -42.61 97.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.736 -179.454 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.91 ' HA ' HG11 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -49.95 -29.52 8.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.622 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.796 HG23 HD13 ' A' ' 104' ' ' LEU . 74.6 p -98.45 127.4 44.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.713 0.292 . . . . 0.0 110.766 179.345 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.646 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 69.0 tp -145.42 121.55 10.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.013 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.51 ' OE1' HD12 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -72.44 136.01 45.9 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.224 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 m120 58.71 39.3 24.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.136 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.75 155.87 23.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.313 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -111.67 140.05 46.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.975 0.417 . . . . 0.0 111.361 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.91 HG11 ' HA ' ' A' ' 104' ' ' LEU . 96.1 t -111.08 128.59 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.648 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.614 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.8 m-85 -112.38 65.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.482 -179.099 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.762 HD23 ' H ' ' A' ' 113' ' ' LEU . 2.2 pt? -75.84 45.06 0.32 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.686 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.8 p -73.89 134.78 43.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.787 0.327 . . . . 0.0 111.414 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 124' ' ' ALA . . . 160.33 -54.92 0.33 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.426 -0.893 . . . . 0.0 113.111 179.513 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.72 ' HA3' ' HA ' ' A' ' 121' ' ' LEU . . . -82.78 -147.36 6.81 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.333 -179.389 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.8 t0 179.3 67.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.749 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 88.2 mt -33.74 123.69 0.48 Allowed Pre-proline 0 N--CA 1.462 0.154 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.745 -178.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.64 92.61 0.12 OUTLIER 'Cis proline' 0 C--N 1.348 0.525 0 C-N-CA 123.471 -1.47 . . . . 0.0 112.559 -0.329 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.749 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -177.52 150.15 0.67 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.637 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.72 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 0.4 OUTLIER -170.15 39.18 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.657 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.94 124.52 26.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.745 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 53.45 40.07 61.03 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.595 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.574 ' O ' HG23 ' A' ' 143' ' ' VAL . . . -72.1 124.7 25.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.756 0.312 . . . . 0.0 111.236 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -113.08 144.48 42.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.186 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.636 ' HB ' ' HA ' ' A' ' 113' ' ' LEU . 5.8 p -133.05 130.44 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.365 0.603 . . . . 0.0 112.22 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -98.48 136.12 39.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.29 179.404 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.589 ' HB2' ' HB2' ' A' ' 140' ' ' SER . 20.4 m-85 -112.85 142.73 45.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 0.0 111.569 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -163.14 126.85 2.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.271 179.067 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 18.1 t -89.19 140.42 29.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.189 -179.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.504 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 59.2 m-20 -54.82 161.39 2.31 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.267 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 8.2 Cg_endo -49.54 165.09 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.011 2.474 . . . . 0.0 112.031 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 159' ' ' ASN . 28.3 m-20 75.43 -17.99 0.48 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.396 -179.233 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.888 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 11.4 m-85 -131.16 131.43 44.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.896 179.383 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.642 ' HE1' ' HA ' ' A' ' 159' ' ' ASN . 5.8 m80 -102.86 124.04 47.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.639 0.256 . . . . 0.0 111.156 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.812 HD22 ' HB3' ' A' ' 140' ' ' SER . 5.1 tt -79.54 118.91 21.83 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.489 ' N ' HD23 ' A' ' 136' ' ' LEU . 46.0 t -136.87 76.98 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.548 -179.28 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.627 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . -171.6 60.1 0.17 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.027 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.527 ' OG ' HG21 ' A' ' 151' ' ' THR . 37.7 t 53.1 67.23 1.03 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.088 0.471 . . . . 0.0 109.744 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.812 ' HB3' HD22 ' A' ' 136' ' ' LEU . 84.9 p -71.09 37.7 0.05 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.917 -178.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.459 HH11 ' HG3' ' A' ' 141' ' ' ARG . 38.5 ttt85 -140.62 132.6 27.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.314 179.328 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.462 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 52.7 m -150.7 147.69 27.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.821 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 124' ' ' ALA . 7.1 p -147.58 132.05 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.897 0.38 . . . . 0.0 111.236 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 55.6 m -64.6 148.48 50.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.147 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 42.8 m -149.54 -30.49 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.761 0.315 . . . . 0.0 111.353 -179.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -170.81 54.1 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.897 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.09 42.7 83.8 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.923 -179.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -172.5 136.88 0.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.631 ' HE1' ' HB2' ' A' ' 100' ' ' SER . 36.0 m95 -84.17 144.41 29.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.745 -179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 61.3 m -50.51 -49.77 54.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.697 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.527 HG21 ' OG ' ' A' ' 139' ' ' SER . 72.9 p -131.15 136.96 29.63 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.417 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 27.3 Cg_exo -62.61 159.38 37.01 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.089 2.526 . . . . 0.0 112.506 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.646 ' NZ ' HD13 ' A' ' 106' ' ' LEU . 3.9 mmmp? -53.61 134.76 54.46 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.331 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.627 ' HB3' ' HA3' ' A' ' 138' ' ' GLY . 5.7 Cg_exo -78.85 -146.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.328 2.686 . . . . 0.0 112.432 -179.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -153.71 149.43 27.49 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.602 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.888 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 74.4 m -95.24 133.88 38.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 110.848 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.676 HE21 HG12 ' A' ' 158' ' ' VAL . 71.0 tp60 -103.09 138.07 40.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.871 -179.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.676 HG12 HE21 ' A' ' 157' ' ' GLN . 9.1 p -60.18 133.15 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.642 ' HA ' ' HE1' ' A' ' 135' ' ' HIS . 26.5 t-20 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.911 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.456 HH11 ' HG3' ' A' ' 97' ' ' ARG . 19.4 mmt85 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.812 0.339 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.9 pt -84.03 145.15 8.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.148 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.421 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 75.0 m -53.97 140.46 31.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.699 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.9 m -48.02 129.27 14.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.42 -179.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.57 ' HB2' HD12 ' A' ' 104' ' ' LEU . 17.6 ptpt -81.31 11.48 4.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.375 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.8 t -68.51 -39.75 81.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.036 0.446 . . . . 0.0 110.72 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.63 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.3 m-85 -61.73 -33.22 73.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.43 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.57 HD12 ' HB2' ' A' ' 101' ' ' LYS . 80.8 mt -45.63 -45.43 13.9 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.276 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t -92.52 138.53 31.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.501 179.339 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.811 HD22 ' HA3' ' A' ' 109' ' ' GLY . 6.6 tt -145.41 124.39 12.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.507 -179.268 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.473 ' O ' HD23 ' A' ' 106' ' ' LEU . 22.9 pt-20 -61.45 125.67 24.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.677 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 56.55 39.84 29.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.135 0.493 . . . . 0.0 110.09 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.811 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -161.72 174.94 38.29 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.121 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -142.01 137.55 31.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.792 0.33 . . . . 0.0 110.914 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.63 HG21 ' O ' ' A' ' 103' ' ' TYR . 94.0 t -109.73 132.43 57.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.009 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -111.76 133.13 54.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.624 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.71 ' HG ' HG12 ' A' ' 126' ' ' VAL . 6.1 mp -108.39 132.6 53.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.151 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.1 t -162.03 129.44 3.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.078 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 157.51 -39.43 0.54 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.373 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.31 -127.86 0.91 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.208 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -174.82 133.66 0.35 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.716 ' O ' HD12 ' A' ' 118' ' ' LEU . 4.3 pp -43.27 140.57 2.11 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -87.97 45.19 1.28 Allowed 'Cis proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.578 -1.426 . . . . 0.0 113.54 0.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.21 146.79 54.5 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.789 0.328 . . . . 0.0 110.778 179.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.446 HD13 ' C ' ' A' ' 121' ' ' LEU . 2.2 tm? -140.35 -52.0 0.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.154 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.98 44.99 0.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.759 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 169.42 61.1 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.134 -1.032 . . . . 0.0 113.022 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.66 125.62 4.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.955 0.407 . . . . 0.0 111.45 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.472 ' HG2' HG13 ' A' ' 143' ' ' VAL . 61.2 mtt85 -133.6 129.79 37.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.753 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.71 HG12 ' HG ' ' A' ' 113' ' ' LEU . 31.0 m -97.72 132.64 42.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 120.946 0.403 . . . . 0.0 111.501 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -98.16 124.98 42.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.764 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 126' ' ' VAL . 5.2 m-85 -93.18 143.93 25.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.965 0.412 . . . . 0.0 110.986 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -158.96 127.46 5.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.197 179.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 136' ' ' LEU . 49.8 t -89.27 144.93 25.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.263 -179.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.78 152.1 7.39 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.937 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.497 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 3.7 Cg_endo -46.66 156.66 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.961 2.441 . . . . 0.0 111.928 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 62.7 t0 78.64 -35.54 0.18 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.584 -179.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.712 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 0.6 OUTLIER -108.33 135.5 49.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.058 179.287 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -112.96 134.02 54.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.551 -179.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 137' ' ' VAL . 7.4 tt -79.02 132.89 36.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.203 179.508 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.521 ' N ' HD23 ' A' ' 136' ' ' LEU . 46.3 t -128.6 77.91 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.584 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . 173.88 -124.42 1.04 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.838 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.829 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 26.8 t -71.25 60.37 0.29 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.958 0.409 . . . . 0.0 111.263 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 128' ' ' PHE . 35.4 t -58.05 -23.74 55.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -140.64 139.78 34.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.705 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.577 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 63.3 m -144.53 130.3 19.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.9 0.381 . . . . 0.0 111.322 -179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.472 HG13 ' HG2' ' A' ' 125' ' ' ARG . 32.1 t -97.6 133.02 41.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.074 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 50.4 t -80.5 50.87 1.36 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.986 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 62.8 m -80.24 134.85 36.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.902 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 37.4 tt0 50.67 46.96 25.14 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.487 179.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 51.94 44.51 56.04 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.317 179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -165.48 142.79 5.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.738 0.304 . . . . 0.0 110.282 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 142' ' ' SER . 55.3 m95 -84.2 139.88 32.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.917 0.389 . . . . 0.0 111.046 -179.34 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -56.5 -51.66 67.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.375 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 29.0 p -118.85 134.28 23.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.804 0.335 . . . . 0.0 111.898 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.419 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 39.6 Cg_endo -66.52 145.36 76.34 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.985 2.456 . . . . 0.0 112.461 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.434 ' NZ ' ' HG ' ' A' ' 106' ' ' LEU . 60.8 tttm -46.76 127.35 8.44 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.949 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.829 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 68.4 Cg_endo -89.24 -141.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.096 2.531 . . . . 0.0 113.343 -179.311 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.486 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.2 p-80 -153.71 146.67 24.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.101 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.712 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 22.3 t -97.39 133.07 42.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 111.179 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -103.04 137.03 41.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.948 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.9 p -88.9 133.12 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 179.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.935 -179.837 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.742 0.306 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -174.17 43.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.12 136.21 57.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.448 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 1.6 m-85 -62.39 134.65 56.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.802 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.748 HG23 HG23 ' A' ' 98' ' ' ILE . 20.4 m -58.73 134.41 23.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.241 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -78.9 57.53 2.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.455 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.748 HG23 HG23 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -51.39 140.33 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.379 . . . . 0.0 111.28 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.627 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 87.2 m -55.28 157.79 3.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.061 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.7 p -47.69 128.54 13.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.328 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.577 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 10.1 mtmp? -80.44 -21.51 42.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.206 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.4 p -53.13 -40.97 64.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.573 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.68 ' HA ' ' HE3' ' A' ' 153' ' ' LYS . 2.6 m-85 -52.91 -31.29 39.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.551 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.449 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 96.6 mt -50.66 -42.89 57.05 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.816 0.341 . . . . 0.0 110.916 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.7 m -95.03 142.22 27.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.054 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.449 HD13 ' HD2' ' A' ' 153' ' ' LYS . 47.3 tp -145.31 127.7 15.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.833 0.349 . . . . 0.0 110.893 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -73.01 144.24 47.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.158 0.504 . . . . 0.0 111.276 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 57.91 32.85 22.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.241 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.426 ' CA ' ' HA ' ' A' ' 130' ' ' CYS . . . -176.98 -166.9 34.67 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.771 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -142.0 145.17 34.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.724 0.297 . . . . 0.0 110.786 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 103' ' ' TYR . 72.7 t -106.29 135.45 44.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.016 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.711 ' O ' HG23 ' A' ' 126' ' ' VAL . 2.7 m-85 -110.24 120.52 42.72 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.286 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.522 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.9 mm? -103.27 147.11 27.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.489 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.9 m -157.02 132.93 9.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.431 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 64.03 49.89 64.22 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.096 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.624 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . 178.08 136.47 2.53 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.996 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -174.93 124.38 0.26 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.568 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 7.2 tt -51.41 137.48 30.57 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.891 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.53 ' HA ' ' HG ' ' A' ' 118' ' ' LEU . 71.2 Cg_endo -89.19 60.42 0.31 Allowed 'Cis proline' 0 C--N 1.345 0.393 0 C-N-CA 123.558 -1.434 . . . . 0.0 113.02 0.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.568 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -155.61 162.1 40.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.597 0.237 . . . . 0.0 110.822 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.895 HD12 ' N ' ' A' ' 122' ' ' ASP . 1.7 pp -168.35 -34.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.744 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.895 ' N ' HD12 ' A' ' 121' ' ' LEU . 63.2 t0 36.38 51.13 0.82 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.925 0.393 . . . . 0.0 110.959 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 68.8 47.84 52.88 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.837 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.624 ' HB2' ' HA3' ' A' ' 116' ' ' GLY . . . -54.74 139.19 40.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.989 0.423 . . . . 0.0 111.697 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -107.27 151.51 25.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.379 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 112' ' ' PHE . 5.1 p -143.66 133.46 20.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.407 0.623 . . . . 0.0 112.232 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -105.04 131.58 52.37 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.543 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -102.8 143.52 32.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.004 0.43 . . . . 0.0 111.732 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -162.94 125.15 2.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.383 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.426 ' HA ' ' CA ' ' A' ' 109' ' ' GLY . 63.9 m -89.27 170.11 10.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.207 0.527 . . . . 0.0 112.222 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.7 157.01 2.85 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.636 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.87 69.37 0.39 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.025 2.483 . . . . 0.0 112.413 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.9 p-10 -173.25 -31.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.861 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.804 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 3.7 m-85 -108.14 132.93 53.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.833 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.461 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 18.9 p-80 -102.13 125.98 48.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.012 0.434 . . . . 0.0 110.726 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.648 HD21 ' HA ' ' A' ' 140' ' ' SER . 20.5 tp -72.65 126.9 31.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.042 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 137' ' ' VAL . 22.0 t -135.39 60.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.584 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -170.59 -131.38 1.33 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 119.801 -1.19 . . . . 0.0 113.419 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.601 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 56.6 p -73.53 55.32 0.49 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 111.431 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.648 ' HA ' HD21 ' A' ' 136' ' ' LEU . 42.3 t -57.88 -42.11 83.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.136 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -99.37 132.24 44.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.068 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.0 p -149.84 145.02 26.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.302 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 124' ' ' ALA . 7.2 p -138.62 134.41 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.998 0.428 . . . . 0.0 111.698 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.652 ' SG ' HD22 ' A' ' 121' ' ' LEU . 37.9 t -67.46 134.87 52.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.023 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 67.1 m -165.63 130.03 2.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.072 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 50.9 tt0 53.62 45.25 28.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.966 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 56.91 43.51 92.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.603 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -173.12 140.56 0.89 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.352 . . . . 0.0 110.652 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.627 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 28.5 m95 -84.24 140.99 31.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.732 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 67.1 m -52.82 -56.51 15.24 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.015 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.42 ' HB ' ' HB2' ' A' ' 139' ' ' SER . 60.6 p -117.65 133.59 23.28 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.05 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.492 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 43.9 Cg_endo -67.8 -155.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.548 2.166 . . . . 0.0 112.758 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.68 ' HE3' ' HA ' ' A' ' 103' ' ' TYR . 27.8 mmtp -81.05 129.3 67.85 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.288 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.601 ' HB3' ' N ' ' A' ' 139' ' ' SER . 83.0 Cg_endo -81.61 -146.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.837 2.358 . . . . 0.0 112.242 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.442 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 24.3 p-80 -153.66 126.29 8.17 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-O 120.93 0.395 . . . . 0.0 111.328 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.804 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 76.2 m -99.13 130.34 45.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.156 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.461 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 4.3 tp-100 -103.92 140.14 38.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.005 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.456 ' HB ' ' CZ ' ' A' ' 134' ' ' PHE . 9.7 p -75.35 136.09 25.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.388 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.484 HD22 ' N ' ' A' ' 159' ' ' ASN . 2.1 m120 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.18 -0.914 . . . . 0.0 110.94 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.782 0.325 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.86 134.76 55.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.177 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.581 ' HG2' ' CD1' ' A' ' 95' ' ' PHE . 7.5 pm0 -72.23 -129.28 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.002 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.581 ' CD1' ' HG2' ' A' ' 94' ' ' GLU . 4.8 m-85 68.27 133.88 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.85 0.357 . . . . 0.0 111.091 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.6 m -149.24 135.81 12.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.861 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.431 ' O ' HG23 ' A' ' 98' ' ' ILE . 39.5 ptt180 -66.56 130.96 44.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.228 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.456 ' HB ' HD13 ' A' ' 121' ' ' LEU . 20.9 pt -157.83 43.59 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.032 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.493 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 90.1 m 62.18 139.18 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.748 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.5 m -47.88 131.51 15.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.399 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -83.75 -28.64 28.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.079 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.2 p -53.18 -35.49 59.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.509 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.848 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.8 m-85 -50.86 -36.39 37.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.41 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.532 HD21 HG23 ' A' ' 114' ' ' THR . 88.4 mt -53.44 -44.45 68.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.955 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.1 m -92.55 133.99 35.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.25 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.2 tp -145.39 132.77 20.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.692 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.31 131.53 50.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.672 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m120 54.66 44.93 27.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.662 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.03 165.36 34.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.509 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -141.88 151.41 42.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.005 0.431 . . . . 0.0 110.942 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.504 HG11 ' HB ' ' A' ' 126' ' ' VAL . 95.1 t -111.18 141.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.253 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.402 ' CE1' ' HD2' ' A' ' 129' ' ' ARG . 3.7 m-85 -106.57 134.46 49.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.406 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.664 HD23 ' N ' ' A' ' 114' ' ' THR . 6.3 tt 69.79 129.96 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.374 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.664 ' N ' HD23 ' A' ' 113' ' ' LEU . 92.0 m -109.37 -45.99 3.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.929 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.61 ' HA3' ' HA ' ' A' ' 124' ' ' ALA . . . 79.92 53.44 4.24 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.26 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -142.19 150.67 22.29 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.462 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -159.67 65.81 0.37 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.967 0.413 . . . . 0.0 110.034 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.529 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 90.2 mt -38.39 137.77 0.78 Allowed Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.171 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -89.03 59.9 0.32 Allowed 'Cis proline' 0 CA--C 1.531 0.366 0 C-N-CA 123.762 -1.349 . . . . 0.0 113.265 0.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.529 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -164.13 126.3 2.38 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.927 0.394 . . . . 0.0 111.471 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.778 ' HG ' ' HB2' ' A' ' 124' ' ' ALA . 26.6 tp -78.87 -55.84 4.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.481 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.7 t70 38.37 109.13 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 55.46 54.6 33.42 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 115.728 -0.669 . . . . 0.0 114.224 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.778 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . . . -73.66 132.5 42.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.948 0.374 . . . . 0.0 110.894 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.548 ' HB2' HD22 ' A' ' 113' ' ' LEU . 62.2 mtt85 -137.97 153.63 49.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.583 HG22 ' CZ3' ' A' ' 149' ' ' TRP . 12.5 m -154.6 131.04 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.946 0.403 . . . . 0.0 111.322 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -107.59 117.78 34.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.32 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.472 ' HB2' ' CA ' ' A' ' 140' ' ' SER . 4.6 m-85 -86.56 141.38 29.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.121 0.486 . . . . 0.0 111.516 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.471 ' HG2' HH11 ' A' ' 129' ' ' ARG . 3.5 ptp85 -161.01 128.95 4.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.761 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 136' ' ' LEU . 20.7 t -89.2 147.41 24.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.744 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.655 ' OD1' ' HD2' ' A' ' 132' ' ' PRO . 36.4 t70 -52.72 145.75 20.56 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.906 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.655 ' HD2' ' OD1' ' A' ' 131' ' ' ASP . 3.2 Cg_exo -40.45 157.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.596 2.864 . . . . 0.0 112.545 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 55.6 m-20 80.93 -40.31 0.15 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.408 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -106.32 128.99 54.41 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.454 ' HE1' ' HA ' ' A' ' 159' ' ' ASN . 16.9 p-80 -102.76 128.32 49.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.973 0.416 . . . . 0.0 110.981 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.787 HD11 ' HG2' ' A' ' 154' ' ' PRO . 20.5 tp -74.55 127.33 32.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.497 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.6 t -131.13 72.2 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.79 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 154' ' ' PRO . . . -167.55 56.72 0.22 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.799 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.673 ' OG ' HG21 ' A' ' 151' ' ' THR . 41.1 t 51.46 65.05 1.61 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.472 ' CA ' ' HB2' ' A' ' 128' ' ' PHE . 96.0 p -70.43 38.81 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.53 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.409 ' H ' ' C ' ' A' ' 139' ' ' SER . 40.1 ttm180 -141.21 133.99 28.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.209 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.512 ' HB2' HG23 ' A' ' 126' ' ' VAL . 64.7 m -146.21 140.33 26.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.941 0.401 . . . . 0.0 111.319 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.513 ' HA ' ' HZ3' ' A' ' 149' ' ' TRP . 7.2 p -144.47 129.48 14.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.873 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.627 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 71.9 m -71.49 156.28 39.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.582 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.9 t -158.72 -29.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.471 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -149.29 48.08 0.97 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.719 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.82 35.49 89.72 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.493 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -159.19 146.81 17.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.706 0.288 . . . . 0.0 110.462 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.583 ' CZ3' HG22 ' A' ' 126' ' ' VAL . 68.3 m95 -84.19 142.22 30.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.864 0.364 . . . . 0.0 110.777 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 142' ' ' SER . 46.9 t -47.91 -45.52 30.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.141 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.673 HG21 ' OG ' ' A' ' 139' ' ' SER . 61.6 p -136.61 143.94 45.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.838 0.352 . . . . 0.0 111.797 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.496 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 24.0 Cg_exo -64.01 -159.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.856 2.371 . . . . 0.0 112.818 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.848 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 14.4 mmmm -86.12 127.14 62.94 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.263 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.787 ' HG2' HD11 ' A' ' 136' ' ' LEU . 92.4 Cg_endo -79.89 -149.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.741 2.294 . . . . 0.0 112.637 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.506 ' O ' HD12 ' A' ' 136' ' ' LEU . 17.9 p-80 -153.7 150.04 28.14 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.073 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 77.8 m -97.43 138.1 35.38 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.381 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -108.55 136.05 48.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.554 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.462 ' O ' HG22 ' A' ' 158' ' ' VAL . 11.4 p -82.47 52.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.498 0.666 . . . . 0.0 110.301 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.454 ' HA ' ' HE1' ' A' ' 135' ' ' HIS . 76.1 m-20 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.374 -0.822 . . . . 0.0 111.069 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.4 ' HG3' ' N ' ' A' ' 93' ' ' ALA . 22.7 pt-20 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.671 0.272 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' A' ' 92' ' ' GLU . . . -177.21 136.89 0.21 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.066 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 64.9 135.56 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.428 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.8 t80 60.48 109.76 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.298 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.914 HG23 HD12 ' A' ' 98' ' ' ILE . 27.7 m -82.57 130.63 35.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.008 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -89.62 44.47 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.962 0.411 . . . . 0.0 111.039 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.914 HD12 HG23 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -60.15 138.36 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.166 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.596 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 75.6 m -60.58 140.99 57.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.677 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.2 m -47.87 128.71 13.7 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.53 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.743 ' HA ' HD13 ' A' ' 104' ' ' LEU . 26.3 ttpp -82.76 11.01 6.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.6 t -68.31 -40.46 81.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.332 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.653 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.3 m-85 -59.59 -40.73 88.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.413 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.743 HD13 ' HA ' ' A' ' 101' ' ' LYS . 6.8 mp -49.28 -43.62 43.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.6 0.238 . . . . 0.0 111.295 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.4 t -92.56 126.06 37.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.861 0.362 . . . . 0.0 110.765 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.716 HD22 ' HZ2' ' A' ' 153' ' ' LYS . 14.0 tp -145.7 133.16 20.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.465 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.42 ' H ' HD12 ' A' ' 106' ' ' LEU . 44.7 tt0 -71.55 134.32 46.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.345 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 57.74 40.7 26.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.632 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -179.56 156.98 19.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.937 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -123.47 141.78 51.65 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.653 HG21 ' O ' ' A' ' 103' ' ' TYR . 90.5 t -109.94 142.36 22.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.253 0.549 . . . . 0.0 112.003 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.551 ' HB2' ' HG3' ' A' ' 127' ' ' GLU . 4.6 m-85 -103.42 139.87 38.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.738 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.629 ' HA ' HG22 ' A' ' 126' ' ' VAL . 1.5 pt? -139.21 57.69 1.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.029 0.442 . . . . 0.0 111.793 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.9 p -54.48 142.81 26.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.698 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.67 137.95 5.08 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.235 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 178.03 149.58 8.09 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.358 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -151.02 58.1 0.91 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.544 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 2.0 pt? -40.6 136.17 1.48 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.159 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -89.05 61.18 0.27 Allowed 'Cis proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.663 -1.39 . . . . 0.0 113.254 0.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.544 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -165.56 130.81 2.49 Favored 'General case' 0 C--O 1.23 0.064 0 CA-C-O 120.895 0.379 . . . . 0.0 111.335 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.879 HD23 ' H ' ' A' ' 121' ' ' LEU . 1.1 pt? -112.56 48.65 0.98 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.991 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -62.77 133.37 54.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.64 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.86 33.34 82.89 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.489 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 143' ' ' VAL . . . -78.11 135.07 37.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.691 0.281 . . . . 0.0 110.966 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -105.08 136.42 44.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.018 0.437 . . . . 0.0 110.422 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.629 HG22 ' HA ' ' A' ' 113' ' ' LEU . 2.6 t -132.08 137.1 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.957 -178.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.551 ' HG3' ' HB2' ' A' ' 112' ' ' PHE . 9.3 pt-20 -132.66 117.48 17.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.921 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.537 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 2.9 m-85 -77.4 147.53 35.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.211 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -145.8 117.75 8.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.663 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 16.9 t -89.22 147.67 24.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 111.254 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -52.71 152.1 7.26 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.312 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.495 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 1.1 Cg_endo -44.44 158.38 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.366 2.711 . . . . 0.0 112.738 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.495 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 38.5 t70 77.98 -31.89 0.16 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.959 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -108.89 127.18 53.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.679 0.276 . . . . 0.0 110.511 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -104.95 135.36 46.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.896 0.379 . . . . 0.0 110.903 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.778 HD11 ' HG2' ' A' ' 154' ' ' PRO . 25.7 tp -71.58 133.35 45.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.466 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 137' ' ' VAL . 24.6 t -132.69 61.37 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.538 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -168.41 -135.58 1.91 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 119.914 -1.136 . . . . 0.0 113.091 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.588 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 93.4 p -74.26 61.82 0.9 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.808 0.337 . . . . 0.0 111.039 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 91.3 p -63.14 4.41 0.2 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.413 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.488 ' H ' ' C ' ' A' ' 139' ' ' SER . 16.8 ptm180 -140.53 133.9 29.84 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.955 0.407 . . . . 0.0 110.944 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 54.9 m -150.73 140.76 22.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.868 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 124' ' ' ALA . 14.2 p -126.93 131.86 70.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.996 0.427 . . . . 0.0 111.63 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 52.6 t -80.49 148.29 30.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.271 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 89.2 p -150.67 -137.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.936 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.504 ' H ' ' CD ' ' A' ' 146' ' ' GLN . 14.7 mp0 -55.88 -38.62 70.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.94 0.4 . . . . 0.0 110.55 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 148' ' ' GLN . . . 179.93 145.46 6.44 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.708 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.458 ' HB3' ' O ' ' A' ' 147' ' ' GLY . 69.0 tp60 69.67 147.74 0.07 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.915 0.388 . . . . 0.0 110.633 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.596 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 26.9 m95 -84.16 147.52 27.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.234 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.6 t -51.85 -55.02 22.52 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.106 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.559 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 74.8 p -123.39 134.58 25.3 Favored Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.66 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.82 143.19 95.67 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.825 2.35 . . . . 0.0 111.879 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.716 ' HZ2' HD22 ' A' ' 106' ' ' LEU . 21.9 ttmm -42.45 133.33 2.74 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 111.601 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.778 ' HG2' HD11 ' A' ' 136' ' ' LEU . 73.5 Cg_endo -75.26 -143.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.88 2.386 . . . . 0.0 112.678 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.476 ' O ' HD12 ' A' ' 136' ' ' LEU . 22.9 p-80 -153.68 154.43 34.11 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.292 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 89.6 m -95.7 140.37 30.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.065 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -132.96 144.41 50.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.262 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.2 p -75.11 133.52 31.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.457 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.9 p30 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.966 -179.617 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.589 0.233 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 57.96 46.38 16.65 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.809 0.337 . . . . 0.0 111.131 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 96' ' ' VAL . 57.6 mp0 -63.34 138.14 58.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.968 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.56 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -58.36 -41.03 83.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.445 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 94' ' ' GLU . 59.8 t 66.01 140.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.712 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 62.27 55.82 2.3 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.124 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.789 ' HA ' HD12 ' A' ' 121' ' ' LEU . 38.6 pt -55.49 147.12 4.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 39.4 m -47.28 148.42 1.28 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.027 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.43 ' HB2' ' CD1' ' A' ' 149' ' ' TRP . 54.1 m -47.85 127.17 11.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.057 0.456 . . . . 0.0 111.252 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -85.25 -25.21 27.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.27 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.2 m -53.08 -41.15 64.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.552 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.479 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 1.4 m-85 -56.46 -41.57 76.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.887 0.375 . . . . 0.0 110.713 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 95.5 mt -59.9 -35.3 74.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.0 p -91.87 77.92 5.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.162 0.506 . . . . 0.0 110.569 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.721 HD22 ' HA3' ' A' ' 109' ' ' GLY . 7.2 tt -93.88 125.47 38.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.577 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.506 ' O ' HD23 ' A' ' 106' ' ' LEU . 24.6 pt-20 -68.1 127.61 33.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.573 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 62.94 48.47 3.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 0.0 110.583 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.721 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -158.56 -163.47 12.96 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.62 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.569 ' HB3' ' NZ ' ' A' ' 110' ' ' LYS . 8.2 mtpm? -144.02 -41.6 0.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.57 HG23 ' HA ' ' A' ' 128' ' ' PHE . 13.7 p 52.02 136.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 123.594 0.758 . . . . 0.0 112.581 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -108.11 142.74 37.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.586 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.442 HD12 ' H ' ' A' ' 114' ' ' THR . 24.9 tp -120.31 136.15 54.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.608 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.442 ' H ' HD12 ' A' ' 113' ' ' LEU . 68.5 p -145.0 139.1 27.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.211 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 66.36 44.1 91.25 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.457 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -179.49 130.6 1.53 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.974 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.831 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 54.3 m-20 -160.25 121.35 3.06 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.953 HD12 ' HA ' ' A' ' 119' ' ' PRO . 40.6 tp -38.58 133.51 1.01 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.279 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.953 ' HA ' HD12 ' A' ' 118' ' ' LEU . 77.1 Cg_endo -92.43 44.69 2.24 Favored 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.56 -1.433 . . . . 0.0 113.399 0.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.831 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -81.12 148.26 29.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.803 0.335 . . . . 0.0 111.209 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 98' ' ' ILE . 3.6 tt -162.45 79.27 0.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.309 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -167.07 122.07 1.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.595 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.7 31.16 29.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.718 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.594 ' O ' HG23 ' A' ' 143' ' ' VAL . . . -75.9 127.66 33.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.631 0.253 . . . . 0.0 110.804 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -125.46 143.4 51.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 111.021 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.0 m -133.24 135.7 56.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.133 0.492 . . . . 0.0 111.598 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.43 ' HG3' ' HE ' ' A' ' 141' ' ' ARG . 88.3 tt0 -109.36 88.83 2.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.312 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.57 ' HA ' HG23 ' A' ' 111' ' ' VAL . 67.0 m-85 -55.44 141.64 35.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 111.178 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.467 ' HG2' HH11 ' A' ' 129' ' ' ARG . 13.8 tpp85 -143.4 129.13 19.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.897 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 35.9 t -89.17 153.13 21.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.087 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -52.75 154.09 5.17 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.313 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 8.1 Cg_endo -49.64 155.47 3.71 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.802 2.334 . . . . 0.0 111.356 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 11.4 m-20 79.37 -29.74 0.14 Allowed 'General case' 0 N--CA 1.463 0.221 0 O-C-N 123.377 0.423 . . . . 0.0 110.098 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.775 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 1.6 m-85 -105.7 152.22 23.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.806 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -133.03 131.44 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.991 0.424 . . . . 0.0 111.442 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.505 HD21 ' HA ' ' A' ' 140' ' ' SER . 42.8 tp -69.37 133.81 48.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.428 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.0 t -131.33 70.93 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.905 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.27 -132.54 1.96 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.876 -1.154 . . . . 0.0 113.349 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.748 ' HB3' HG23 ' A' ' 151' ' ' THR . 49.4 m -73.15 58.82 0.52 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 122.712 0.405 . . . . 0.0 111.177 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.505 ' HA ' HD21 ' A' ' 136' ' ' LEU . 87.6 p -56.91 -28.13 61.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.688 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.435 HH11 ' HG3' ' A' ' 141' ' ' ARG . 20.1 mmt85 -109.95 139.21 45.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.991 0.424 . . . . 0.0 111.914 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.777 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 68.0 m -150.7 142.04 23.33 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.438 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.824 HG12 ' HB2' ' A' ' 150' ' ' SER . 7.7 p -145.49 137.34 20.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 111.648 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.494 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 41.3 m -60.36 159.03 10.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.73 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.8 t -162.8 -29.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.158 0.504 . . . . 0.0 110.67 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -166.68 57.07 0.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.975 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 67.6 37.84 89.76 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.541 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.423 ' HB3' ' H ' ' A' ' 149' ' ' TRP . 14.5 mm-40 -155.33 -149.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.045 0.45 . . . . 0.0 110.395 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.777 ' HB3' ' HB3' ' A' ' 142' ' ' SER . 86.6 m95 -146.54 155.6 42.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.329 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.824 ' HB2' HG12 ' A' ' 143' ' ' VAL . 47.5 t -41.93 -50.23 4.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.414 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.748 HG23 ' HB3' ' A' ' 139' ' ' SER . 1.5 t -147.44 145.89 23.15 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -47.15 156.99 0.7 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.431 2.754 . . . . 0.0 113.302 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.476 ' HE2' ' HG ' ' A' ' 106' ' ' LEU . 60.1 tttm -56.6 129.04 75.97 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.984 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.721 ' HB3' ' N ' ' A' ' 139' ' ' SER . 74.3 Cg_endo -75.02 -147.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.647 2.231 . . . . 0.0 112.568 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.423 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 23.2 p-80 -153.7 144.91 22.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.346 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.775 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 47.6 t -95.21 132.18 40.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.949 0.404 . . . . 0.0 110.575 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.411 ' NE2' ' HA ' ' A' ' 157' ' ' GLN . 3.0 tp-100 -116.69 138.54 51.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.952 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.32 131.71 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.167 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 25.0 p30 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.958 -179.565 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.843 0.354 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.31 -140.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.188 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.501 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -174.29 135.07 0.43 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.919 0.39 . . . . 0.0 111.047 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -70.86 -130.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.018 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.2 m -51.55 145.83 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.481 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.578 ' NH1' ' HA3' ' A' ' 147' ' ' GLY . 33.2 ptt85 -69.88 70.55 0.34 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.409 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.5 pt -53.77 154.46 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.345 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.486 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 84.1 m -46.38 141.57 3.48 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.971 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.7 m -47.9 124.76 7.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.822 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -81.88 -13.18 57.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.28 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.2 p -53.12 -38.06 62.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.253 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.916 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 5.4 m-85 -48.48 -31.83 6.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.43 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.6 mt -77.23 39.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.583 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.6 p -147.36 58.58 1.15 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.886 0.374 . . . . 0.0 110.373 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.662 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 35.6 tp -93.83 130.52 39.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.584 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.548 ' HG2' ' ND2' ' A' ' 108' ' ' ASN . 89.3 tt0 -72.0 137.03 46.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.735 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.548 ' ND2' ' HG2' ' A' ' 107' ' ' GLU . 74.8 m-20 59.31 40.82 20.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.075 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -149.24 -166.44 13.14 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.375 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 111' ' ' VAL . 54.5 mtpt -142.14 -41.06 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.441 0.12 . . . . 0.0 111.102 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.598 HG23 ' HA ' ' A' ' 128' ' ' PHE . 9.0 p 51.0 133.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.735 0.814 . . . . 0.0 112.903 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -112.15 -167.05 1.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.448 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.611 HD23 ' N ' ' A' ' 114' ' ' THR . 8.1 tt -173.33 141.48 0.92 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.285 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.611 ' N ' HD23 ' A' ' 113' ' ' LEU . 89.8 m -154.07 145.97 23.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.159 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.29 43.94 19.02 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.147 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . 174.28 140.57 3.31 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.067 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -166.47 129.83 1.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.739 0.304 . . . . 0.0 110.241 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.568 ' H ' HD12 ' A' ' 118' ' ' LEU . 5.7 mp -52.07 135.2 39.27 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.812 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 59.2 Cg_endo -94.35 63.27 0.36 Allowed 'Cis proline' 0 N--CA 1.46 -0.453 0 C-N-CA 124.098 -1.209 . . . . 0.0 113.059 0.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -149.53 134.03 17.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.882 0.373 . . . . 0.0 111.689 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.476 HD13 ' SG ' ' A' ' 144' ' ' CYS . 88.1 mt -102.35 -45.07 5.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.801 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.428 ' OD1' ' HA2' ' A' ' 116' ' ' GLY . 10.2 p-10 36.4 47.97 0.55 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.512 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.94 45.86 94.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.302 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.436 ' HB2' ' HA3' ' A' ' 116' ' ' GLY . . . -58.25 136.9 57.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.776 0.322 . . . . 0.0 111.112 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.757 ' HD3' ' HD3' ' A' ' 141' ' ' ARG . 38.6 ttm180 -118.43 119.22 33.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 142' ' ' SER . 12.1 p -84.86 148.84 4.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.045 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -133.7 76.79 1.68 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.233 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.625 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 79.9 m-85 -53.85 151.9 6.05 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.886 0.374 . . . . 0.0 111.058 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.7 tpp85 -157.11 135.83 11.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.637 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 134' ' ' PHE . 59.6 m -89.23 146.9 24.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.785 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 133' ' ' ASP . 63.4 m-20 -52.69 154.7 4.53 Favored Pre-proline 0 N--CA 1.463 0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.491 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.12 73.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.483 2.789 . . . . 0.0 113.033 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 131' ' ' ASP . 39.0 t70 178.75 -38.09 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 130' ' ' CYS . 3.2 m-85 -108.14 139.22 43.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.529 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -102.52 132.24 48.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.041 0.448 . . . . 0.0 110.794 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.742 HD22 ' HB2' ' A' ' 140' ' ' SER . 6.0 tt -75.14 128.15 34.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.183 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.584 ' N ' HD23 ' A' ' 136' ' ' LEU . 21.8 t -131.96 65.05 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.488 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.86 -129.49 1.31 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.304 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.818 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.5 t -71.4 57.19 0.25 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 122.597 0.359 . . . . 0.0 111.874 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.742 ' HB2' HD22 ' A' ' 136' ' ' LEU . 32.6 t -60.9 -16.6 43.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.122 0.487 . . . . 0.0 110.037 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.757 ' HD3' ' HD3' ' A' ' 125' ' ' ARG . 39.1 ttm180 -140.09 140.29 36.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.901 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.656 ' O ' HG12 ' A' ' 126' ' ' VAL . 33.5 m -149.16 122.62 9.09 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.209 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.591 HG12 ' HB3' ' A' ' 150' ' ' SER . 11.8 p -83.78 132.55 31.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.026 0.441 . . . . 0.0 111.749 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.476 ' SG ' HD13 ' A' ' 121' ' ' LEU . 16.3 t -83.97 130.35 34.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.592 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 25.4 t -114.34 -139.48 0.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.543 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -64.96 -40.82 95.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.807 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.578 ' HA3' ' NH1' ' A' ' 97' ' ' ARG . . . -175.88 46.58 0.12 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.169 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -170.07 134.76 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.734 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.521 ' HZ3' ' HB ' ' A' ' 126' ' ' VAL . 32.4 m95 -84.21 141.43 31.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.582 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.591 ' HB3' HG12 ' A' ' 143' ' ' VAL . 79.2 p -52.66 -60.35 3.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.577 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 27.4 p -114.38 134.18 22.33 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 0.0 111.897 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 16.5 Cg_exo -67.37 150.56 80.98 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.104 2.536 . . . . 0.0 112.179 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.916 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 8.7 mtpm? -42.8 132.27 3.02 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.556 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.818 ' HB3' ' H ' ' A' ' 139' ' ' SER . 98.9 Cg_endo -79.43 -140.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.819 2.346 . . . . 0.0 112.998 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.487 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.0 p-80 -153.64 144.44 22.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.43 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 81.9 m -97.89 133.11 42.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.833 0.349 . . . . 0.0 111.068 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -123.62 140.54 52.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.541 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.82 132.37 31.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.488 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.7 p30 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.17 -0.919 . . . . 0.0 111.008 -179.531 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.573 0.225 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.1 -49.87 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.773 0.32 . . . . 0.0 111.13 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 41.4 tp10 55.49 49.19 17.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.113 0.483 . . . . 0.0 110.838 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -72.22 -133.73 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.393 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 119' ' ' PRO . 13.3 t -83.15 44.07 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-O 121.08 0.467 . . . . 0.0 110.917 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.54 ' O ' HD21 ' A' ' 121' ' ' LEU . 68.1 mtt-85 54.44 46.95 23.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.286 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.9 pt -54.22 140.79 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.36 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 72.8 m -56.3 127.0 28.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.7 t -48.01 128.36 13.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.37 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.894 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -90.23 25.83 2.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.807 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.0 p -68.82 -41.63 78.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.238 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.734 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 3.9 m-85 -56.95 -31.35 64.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.864 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.704 ' O ' HG22 ' A' ' 105' ' ' THR . 83.4 mt -53.99 146.72 13.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.761 -0.199 . . . . 0.0 111.098 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.704 HG22 ' O ' ' A' ' 104' ' ' LEU . 6.9 t 56.36 138.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.72 0.808 . . . . 0.0 112.367 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.7 tp -145.45 138.96 26.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.971 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.08 44.2 0.56 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.517 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -157.29 -30.33 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.858 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.661 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . -158.69 -141.36 3.12 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.947 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -139.47 152.26 46.86 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.912 0.386 . . . . 0.0 110.792 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.1 t -109.34 139.47 32.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.208 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.458 ' CE1' ' HD3' ' A' ' 129' ' ' ARG . 2.8 m-85 -108.34 137.56 46.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.05 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 125' ' ' ARG . 0.4 OUTLIER 71.85 133.97 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.697 -179.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.64 ' N ' HD13 ' A' ' 113' ' ' LEU . 66.1 p -126.69 -130.59 0.24 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.722 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.511 ' HA3' HD11 ' A' ' 118' ' ' LEU . . . -62.39 133.87 45.13 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.033 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.3 -48.87 75.35 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.835 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 118' ' ' LEU . 37.5 t70 -174.47 61.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.692 ' H ' HD12 ' A' ' 118' ' ' LEU . 7.2 mp -33.2 132.87 0.33 Allowed Pre-proline 0 N--CA 1.462 0.133 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.3 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.573 ' HB2' ' HB ' ' A' ' 96' ' ' VAL . 75.6 Cg_endo -85.89 46.11 0.85 Allowed 'Cis proline' 0 C--N 1.346 0.413 0 C-N-CA 123.661 -1.391 . . . . 0.0 113.49 0.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.417 ' H ' ' CA ' ' A' ' 118' ' ' LEU . . . -85.53 127.64 34.5 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.616 0.246 . . . . 0.0 111.185 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.676 HD23 ' H ' ' A' ' 147' ' ' GLY . 5.7 mp -101.89 -42.63 6.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.034 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.33 61.18 0.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.954 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -177.39 -32.89 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.323 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.59 129.29 25.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.915 0.388 . . . . 0.0 111.162 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.731 ' O ' HD12 ' A' ' 113' ' ' LEU . 55.2 ttp85 -135.24 156.11 49.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.745 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.573 HG13 ' CH2' ' A' ' 149' ' ' TRP . 16.1 m -152.25 135.93 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.871 0.367 . . . . 0.0 111.085 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 54.5 mt-10 -121.1 104.26 9.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.132 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.65 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 4.5 m-85 -78.57 143.78 36.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.205 0.526 . . . . 0.0 111.977 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.458 ' HD3' ' CE1' ' A' ' 112' ' ' PHE . 8.0 ptm180 -166.53 124.28 1.37 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.659 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.661 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 96.3 m -89.22 149.43 23.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.323 0.582 . . . . 0.0 112.453 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.467 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 59.8 m-20 -52.71 159.68 1.67 Allowed Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.939 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 18.2 Cg_endo -59.22 76.55 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.111 2.54 . . . . 0.0 112.454 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.3 t70 -175.63 -42.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.706 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 5.3 m-85 -108.83 131.86 54.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.416 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.598 ' NE2' ' HB2' ' A' ' 157' ' ' GLN . 0.3 OUTLIER -101.23 121.6 42.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.245 0.545 . . . . 0.0 110.897 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.639 HD22 ' HB3' ' A' ' 140' ' ' SER . 5.5 tt -69.94 125.4 26.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.974 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.501 ' N ' HD23 ' A' ' 136' ' ' LEU . 15.0 t -134.32 63.13 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.578 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -169.98 -135.78 1.97 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.357 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.685 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 63.8 m -75.03 57.18 0.8 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.914 0.388 . . . . 0.0 111.037 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.639 ' HB3' HD22 ' A' ' 136' ' ' LEU . 99.1 p -51.65 -43.55 62.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.339 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -99.36 138.86 35.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.86 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.558 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 44.2 t -150.16 139.7 21.55 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.863 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.418 ' H ' ' HB3' ' A' ' 150' ' ' SER . 7.0 p -137.56 127.26 36.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.941 0.4 . . . . 0.0 111.222 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.427 ' HB2' ' CD2' ' A' ' 149' ' ' TRP . 45.8 t -87.71 149.31 24.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.591 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 38.4 t -167.13 30.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.207 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 52.8 tt0 175.7 43.32 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.85 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.676 ' H ' HD23 ' A' ' 121' ' ' LEU . . . 77.9 -51.07 3.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.975 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -88.42 149.37 23.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.573 ' CH2' HG13 ' A' ' 126' ' ' VAL . 81.7 m95 -84.15 146.27 27.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.911 0.386 . . . . 0.0 110.946 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 143' ' ' VAL . 48.3 t -45.0 -55.7 5.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.904 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 72.4 p -126.0 133.12 24.62 Favored Pre-proline 0 C--N 1.329 -0.308 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.775 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.438 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 23.7 Cg_exo -63.65 155.66 61.85 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.993 2.462 . . . . 0.0 112.326 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.734 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 55.1 mtpt -49.19 128.18 16.03 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.874 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.685 ' HB3' ' N ' ' A' ' 139' ' ' SER . 58.2 Cg_endo -71.4 -146.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.631 2.221 . . . . 0.0 112.582 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.423 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 22.5 p-80 -153.68 130.51 10.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.894 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.706 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 90.5 m -102.56 136.85 41.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.243 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.598 ' HB2' ' NE2' ' A' ' 135' ' ' HIS . 10.6 mm100 -104.21 147.85 26.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.106 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.3 p -72.73 129.02 36.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.363 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.522 HD22 ' N ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.308 -0.853 . . . . 0.0 111.101 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.913 0.387 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -164.41 133.38 3.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.141 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.437 ' HB3' HG23 ' A' ' 96' ' ' VAL . 5.0 mm-40 -63.28 132.38 51.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.115 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -80.32 44.99 0.72 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.222 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 96' ' ' VAL . 21.8 t -80.05 49.98 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.032 0.444 . . . . 0.0 111.087 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -78.03 45.27 0.52 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.34 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.54 ' O ' HD12 ' A' ' 98' ' ' ILE . 2.4 pp -61.27 145.92 12.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.679 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.576 ' HB2' HD23 ' A' ' 121' ' ' LEU . 43.8 m -56.93 135.61 56.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.05 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.0 t -47.9 126.97 11.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.129 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.497 ' HB2' HD12 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -83.06 16.77 2.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.98 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 t -68.92 -45.72 70.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.301 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.647 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 10.7 m-85 -58.37 -32.15 68.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.796 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' A' ' 101' ' ' LYS . 86.8 mt -49.77 140.33 11.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.553 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.9 m 67.13 139.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.965 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.618 HD12 ' HD2' ' A' ' 128' ' ' PHE . 7.3 tt -145.07 127.7 16.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.308 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.53 ' O ' HD23 ' A' ' 106' ' ' LEU . 23.5 pt-20 -64.98 128.43 35.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 111.213 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 63.68 40.3 7.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.725 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.416 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -170.83 -163.88 25.61 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.548 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -142.37 141.93 32.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.795 0.331 . . . . 0.0 110.891 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.5 t -110.25 129.84 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.99 0.424 . . . . 0.0 110.969 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.407 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 1.2 m-85 -110.7 152.92 25.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.184 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.477 HD13 ' CG1' ' A' ' 126' ' ' VAL . 47.9 tp -154.48 134.03 12.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.008 0.432 . . . . 0.0 111.706 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.5 p -154.05 132.81 12.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.606 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . 164.38 -44.69 0.31 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.688 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -169.67 -127.84 0.96 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.403 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.463 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 56.4 m-20 -149.17 -138.57 0.09 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.61 0.243 . . . . 0.0 110.609 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.846 HD12 ' HA ' ' A' ' 119' ' ' PRO . 35.0 tp -125.17 127.44 25.02 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.78 0.324 . . . . 0.0 111.099 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.846 ' HA ' HD12 ' A' ' 118' ' ' LEU . 78.2 Cg_endo -90.99 37.98 4.81 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.266 -1.556 . . . . 0.0 112.713 -0.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.463 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -88.15 37.59 0.82 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.852 0.358 . . . . 0.0 111.481 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.576 HD23 ' HB2' ' A' ' 99' ' ' CYS . 28.1 tp -77.67 0.38 23.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.811 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.59 141.81 58.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.18 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.61 -38.27 1.89 Allowed Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.151 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.408 ' HB2' ' HA3' ' A' ' 115' ' ' GLY . . . -51.04 142.82 11.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 0.0 111.615 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' A' ' 125' ' ' ARG . 20.3 ptt-85 -127.44 134.63 49.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.924 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.503 HG23 ' CE1' ' A' ' 128' ' ' PHE . 29.1 m -97.37 139.45 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.218 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -110.39 128.2 55.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.247 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.618 ' HD2' HD12 ' A' ' 106' ' ' LEU . 6.4 m-85 -99.94 141.85 32.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.43 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -150.99 132.15 14.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.297 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 69.1 m -89.16 154.17 20.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.959 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.548 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 1.1 m-20 -52.62 163.45 0.78 Allowed Pre-proline 0 N--CA 1.464 0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.334 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 55.7 Cg_endo -70.0 50.2 0.85 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.075 2.517 . . . . 0.0 113.212 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -149.49 -43.01 0.14 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.416 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 0.8 OUTLIER -108.92 140.72 42.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.833 179.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -100.99 128.57 46.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.984 0.421 . . . . 0.0 110.954 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.687 HD22 ' HB2' ' A' ' 140' ' ' SER . 6.1 tt -68.87 130.12 41.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.625 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.558 ' N ' HD23 ' A' ' 136' ' ' LEU . 24.1 t -135.18 63.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.657 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -166.82 -134.04 1.63 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.205 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.678 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 67.2 m -74.95 53.59 0.61 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.74 0.305 . . . . 0.0 111.159 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.687 ' HB2' HD22 ' A' ' 136' ' ' LEU . 35.0 t -52.06 -43.71 63.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 58.9 mtm-85 -99.41 132.42 44.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.803 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.3 m -145.63 137.6 25.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.762 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.406 HG23 ' HB3' ' A' ' 125' ' ' ARG . 7.3 p -138.08 129.34 37.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.966 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 48.8 t -93.71 134.07 36.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.968 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 90.4 p -115.44 -35.12 4.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -144.99 -140.28 0.11 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.093 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.74 41.25 2.33 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.491 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -174.94 136.64 0.4 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.809 0.337 . . . . 0.0 110.922 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -84.19 149.39 26.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.839 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -55.9 -65.27 0.63 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.558 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 42.9 p -106.8 139.07 20.01 Favored Pre-proline 0 C--N 1.331 -0.211 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.34 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.434 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 21.9 Cg_exo -65.17 -155.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.706 2.271 . . . . 0.0 112.558 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.647 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 12.9 mmmm -92.67 131.94 32.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.335 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.678 ' HB3' ' N ' ' A' ' 139' ' ' SER . 89.6 Cg_endo -84.55 -155.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.798 2.332 . . . . 0.0 112.786 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -153.7 148.86 26.88 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.764 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 84.0 m -97.41 131.38 44.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.817 0.342 . . . . 0.0 110.865 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -110.36 141.1 43.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.016 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.14 128.47 38.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.425 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.018 -179.714 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.775 0.321 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.41 -135.92 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.197 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 57.83 42.31 23.47 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.964 0.411 . . . . 0.0 110.733 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -62.82 -41.74 99.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.972 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.408 ' CG2' HG23 ' A' ' 98' ' ' ILE . 23.1 m 42.67 -156.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.814 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.906 ' H ' ' HD2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -101.21 46.77 0.93 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.371 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.408 HG23 ' CG2' ' A' ' 96' ' ' VAL . 30.2 pt -56.4 139.38 15.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.918 0.389 . . . . 0.0 111.13 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 36.8 m -57.22 137.43 55.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.874 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.1 t -47.93 124.31 7.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.039 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.747 ' HB2' HD12 ' A' ' 104' ' ' LEU . 14.4 ptmm? -82.26 21.63 0.9 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.387 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.0 t -68.85 -45.13 71.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.918 0.39 . . . . 0.0 111.057 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.546 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.2 m-85 -60.15 -31.33 69.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.304 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.747 HD12 ' HB2' ' A' ' 101' ' ' LYS . 71.6 mt -52.29 -40.9 62.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.369 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t -92.48 129.1 38.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.917 0.389 . . . . 0.0 110.816 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.779 HD13 ' HE2' ' A' ' 153' ' ' LYS . 20.4 tp -145.39 124.65 12.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.304 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.66 129.97 41.47 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 59.1 37.13 24.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.979 0.419 . . . . 0.0 110.439 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -163.81 147.52 13.1 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.78 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -112.8 139.57 48.31 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.375 -0.413 . . . . 0.0 110.517 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.7 t -111.21 134.65 52.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.291 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.544 ' O ' HG23 ' A' ' 126' ' ' VAL . 3.1 m-85 -108.59 130.21 55.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.883 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.442 ' N ' HD22 ' A' ' 113' ' ' LEU . 3.6 mm? -104.69 140.96 37.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.664 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.6 t -155.06 138.58 15.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.034 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.92 127.91 0.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.308 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 164.81 -139.68 5.97 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.183 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -177.63 -62.42 0.01 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.224 0.535 . . . . 0.0 111.008 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.863 ' N ' ' HA ' ' A' ' 119' ' ' PRO . 3.4 tm? -74.15 -42.69 5.75 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.918 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.863 ' HA ' ' N ' ' A' ' 118' ' ' LEU . 96.5 Cg_endo -90.11 126.25 6.61 Favored 'Cis proline' 0 N--CA 1.454 -0.799 0 C-N-CA 124.03 -1.238 . . . . 0.0 112.944 0.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.577 ' N ' ' HB3' ' A' ' 118' ' ' LEU . . . -74.41 -23.6 58.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.783 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.431 ' C ' ' H ' ' A' ' 123' ' ' GLY . 88.2 mt 70.24 29.48 3.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.311 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -75.9 35.87 0.13 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.96 0.41 . . . . 0.0 111.094 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 121' ' ' LEU . . . 140.36 29.29 0.19 Allowed Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.05 146.77 33.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.921 0.391 . . . . 0.0 111.514 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -108.31 138.74 44.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.662 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 112' ' ' PHE . 12.7 p -127.57 136.74 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.115 0.484 . . . . 0.0 112.0 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -105.04 128.08 53.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.076 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.546 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 15.2 m-85 -98.45 139.29 34.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.0 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' A' ' 129' ' ' ARG . 46.7 mtp85 -150.0 129.59 13.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.75 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 40.0 t -89.2 144.87 25.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.29 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.8 154.76 17.03 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.321 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.479 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 6.0 Cg_endo -47.93 159.98 0.54 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.077 2.518 . . . . 0.0 112.17 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.51 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 61.5 t0 76.86 -26.96 0.18 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.374 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.763 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 2.7 m-85 -122.04 132.77 54.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.932 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.46 ' CG ' ' HB2' ' A' ' 159' ' ' ASN . 0.4 OUTLIER -109.38 137.98 46.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.09 0.471 . . . . 0.0 112.01 -179.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.56 HD23 ' N ' ' A' ' 137' ' ' VAL . 6.4 tt -74.02 128.96 36.9 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.56 ' N ' HD23 ' A' ' 136' ' ' LEU . 42.9 t -128.05 74.92 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 171.33 -127.6 1.46 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.687 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.827 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.4 t -70.84 61.25 0.25 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.13 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.4 t -58.12 -20.76 42.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.922 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.738 ' HD3' ' H ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -129.31 143.87 51.01 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.801 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.7 m -150.25 144.59 25.68 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.282 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.7 p -140.31 134.38 35.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.057 0.456 . . . . 0.0 111.594 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 54.0 t -116.63 147.57 41.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.204 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 146' ' ' GLN . 49.1 m -154.66 41.5 0.47 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 145' ' ' SER . 41.8 tt0 176.17 -57.4 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.897 0.379 . . . . 0.0 111.21 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.06 37.31 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -173.37 137.9 0.68 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -84.23 133.91 34.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.228 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -50.23 -64.03 0.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.934 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 33.4 p -92.55 138.25 24.0 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.2 146.32 63.25 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.784 2.323 . . . . 0.0 111.795 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.779 ' HE2' HD13 ' A' ' 106' ' ' LEU . 83.9 tttt -48.06 129.3 12.18 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.629 0.252 . . . . 0.0 110.796 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.827 ' HB3' ' H ' ' A' ' 139' ' ' SER . 89.8 Cg_endo -81.41 -152.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.647 2.231 . . . . 0.0 113.334 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.69 148.31 26.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.024 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.763 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 13.0 t -98.49 139.2 34.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.056 0.455 . . . . 0.0 111.246 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -103.05 146.13 28.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.696 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 158' ' ' VAL . 6.5 p -66.71 81.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.348 0.594 . . . . 0.0 111.271 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.51 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 35.7 t30 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.942 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 92' ' ' GLU . 5.3 tp10 . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 121.113 0.482 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -174.14 42.52 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.878 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -152.05 -43.45 0.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.67 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 64.08 135.57 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.048 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.482 HG23 HH11 ' A' ' 97' ' ' ARG . 10.8 p -169.86 135.88 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.081 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.523 ' HG2' ' HA3' ' A' ' 147' ' ' GLY . 0.4 OUTLIER -56.98 126.64 28.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.917 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.907 ' H ' HD13 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -96.27 142.78 13.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.364 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 80.8 m -51.79 141.74 16.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.12 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.1 m -47.94 130.71 15.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.393 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -78.72 -6.89 57.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.086 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.9 p -55.88 -42.4 75.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.106 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.641 ' O ' HG21 ' A' ' 111' ' ' VAL . 2.1 m-85 -59.17 -35.4 73.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.437 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.8 mt -54.97 -47.3 74.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.682 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 92.1 m -92.56 130.81 38.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.839 0.352 . . . . 0.0 111.405 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.715 HD13 ' HE2' ' A' ' 153' ' ' LYS . 28.7 tp -145.44 127.86 15.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.834 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -66.71 130.65 43.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.301 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 57.13 41.16 27.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.026 0.441 . . . . 0.0 110.401 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.28 153.68 22.45 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.596 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -121.25 143.67 49.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.816 0.341 . . . . 0.0 110.76 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 103' ' ' TYR . 61.9 t -110.63 140.23 30.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.221 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -105.86 153.58 21.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.332 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.66 HD23 ' N ' ' A' ' 114' ' ' THR . 6.7 tt -153.33 135.06 14.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.884 0.373 . . . . 0.0 110.521 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.66 ' N ' HD23 ' A' ' 113' ' ' LEU . 89.2 m -156.21 125.64 6.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.784 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.89 -125.67 1.38 Allowed Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.833 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.32 -125.44 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.047 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.732 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 12.2 p-10 -173.36 128.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.726 ' O ' HD12 ' A' ' 118' ' ' LEU . 4.4 pp -38.66 138.04 0.8 Allowed Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.317 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -85.88 35.64 3.63 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.424 -1.49 . . . . 0.0 113.097 0.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.732 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -90.73 46.42 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.981 0.42 . . . . 0.0 110.623 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.455 ' HG ' ' HB ' ' A' ' 98' ' ' ILE . 3.7 mm? -54.75 -39.94 68.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.342 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.28 139.96 58.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 0.0 111.011 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.43 -36.38 3.65 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.314 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.3 142.09 52.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.95 0.405 . . . . 0.0 111.51 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.581 ' HD3' ' N ' ' A' ' 125' ' ' ARG . 1.0 OUTLIER -108.51 139.87 42.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.23 179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 142' ' ' SER . 21.8 m -124.67 142.75 40.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 111.961 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.485 ' OE1' ' HG2' ' A' ' 141' ' ' ARG . 5.2 mm-40 -121.44 119.62 32.58 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.83 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.547 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 3.1 m-85 -85.1 152.57 23.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.422 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.3 ttt-85 -163.34 125.77 2.58 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.903 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 100.0 m -89.19 142.18 27.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.375 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -55.34 158.18 5.8 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.573 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.538 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 1.1 Cg_endo -43.14 155.03 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 123.095 2.53 . . . . 0.0 112.186 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.6 m-20 79.43 -35.81 0.16 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.656 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 157' ' ' GLN . 5.9 m-85 -108.8 129.28 55.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.574 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.44 ' CD2' ' HB3' ' A' ' 157' ' ' GLN . 0.5 OUTLIER -102.87 145.34 29.95 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 111.85 -179.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 137' ' ' VAL . 2.4 tm? -75.56 132.88 40.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.969 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.682 ' N ' HD13 ' A' ' 136' ' ' LEU . 7.4 p -135.65 70.38 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.518 ' CA ' ' HB3' ' A' ' 154' ' ' PRO . . . 171.23 -123.6 1.05 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.756 -1.211 . . . . 0.0 113.363 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.877 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 27.5 t -71.68 55.07 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.705 0.288 . . . . 0.0 111.775 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.553 ' HB3' HD12 ' A' ' 136' ' ' LEU . 94.3 p -56.16 -21.93 25.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.436 0.636 . . . . 0.0 109.322 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.485 ' HG2' ' OE1' ' A' ' 127' ' ' GLU . 62.4 mtm-85 -140.59 126.43 19.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.489 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.558 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 47.2 t -142.98 134.48 26.32 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.94 0.4 . . . . 0.0 111.418 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.8 t -98.24 134.18 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.637 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 144' ' ' CYS . 41.9 t -79.17 48.02 0.83 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 111.29 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 83.4 p -65.14 126.96 29.73 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 55.21 -140.0 0.95 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.523 ' HA3' ' HG2' ' A' ' 97' ' ' ARG . . . -106.5 37.47 3.81 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.098 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -155.41 143.87 20.34 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 122.261 0.224 . . . . 0.0 110.513 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.584 ' CE2' ' HB3' ' A' ' 99' ' ' CYS . 45.1 m95 -84.14 137.91 33.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.704 0.288 . . . . 0.0 110.418 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.9 t -57.19 -61.26 2.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.302 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.1 p -94.13 133.87 26.76 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.746 0.307 . . . . 0.0 111.759 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 139' ' ' SER . 36.7 Cg_endo -65.21 140.08 63.21 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.758 2.305 . . . . 0.0 112.152 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.715 ' HE2' HD13 ' A' ' 106' ' ' LEU . 86.9 tttt -42.56 131.62 2.89 Favored Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.526 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.877 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 84.6 Cg_endo -81.58 -158.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.881 2.387 . . . . 0.0 112.872 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.572 ' O ' HG12 ' A' ' 137' ' ' VAL . 12.5 p-80 -153.64 150.64 28.82 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.642 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 72.3 m -96.18 139.36 32.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.97 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 134' ' ' PHE . 40.4 tt0 -130.59 133.68 46.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.711 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.6 124.72 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.959 0.409 . . . . 0.0 110.407 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.999 -179.418 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.813 0.339 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.14 -140.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.812 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 56.24 -146.51 0.56 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.073 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 63.45 137.37 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.065 0.46 . . . . 0.0 111.321 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.7 m -58.5 142.38 14.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.996 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.522 ' NE ' ' HA ' ' A' ' 97' ' ' ARG . 4.0 mmp_? -54.58 136.2 45.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.851 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.447 ' HB ' HD22 ' A' ' 121' ' ' LEU . 26.2 pt -151.02 46.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.103 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 75.6 m 63.01 131.75 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.966 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 87.4 p -47.97 126.42 10.58 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.897 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -78.34 -11.39 59.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.142 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.0 t -54.54 -36.58 64.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.043 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.501 ' CE2' ' HA ' ' A' ' 152' ' ' PRO . 2.0 m-85 -77.35 47.27 0.56 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.487 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.8 mt -133.86 20.13 3.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.942 0.401 . . . . 0.0 110.436 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.459 ' O ' ' HE3' ' A' ' 153' ' ' LYS . 86.0 m -147.43 132.65 18.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.509 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.402 HD22 ' HD2' ' A' ' 128' ' ' PHE . 25.4 tp -145.4 133.76 21.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.967 0.413 . . . . 0.0 111.443 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.664 ' HG2' ' OD1' ' A' ' 108' ' ' ASN . 33.2 tt0 -78.0 141.75 38.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.879 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.664 ' OD1' ' HG2' ' A' ' 107' ' ' GLU . 5.6 m120 63.17 30.15 16.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.81 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 176.12 -160.81 28.93 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.915 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.528 ' HG3' ' HE1' ' A' ' 112' ' ' PHE . 14.9 ptmm? -142.04 153.62 44.36 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.656 0.265 . . . . 0.0 110.412 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.65 137.92 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.075 0.464 . . . . 0.0 111.763 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.64 ' HB2' ' HG3' ' A' ' 127' ' ' GLU . 6.1 m-85 -107.74 146.15 32.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.308 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.579 HD23 ' H ' ' A' ' 113' ' ' LEU . 1.9 pt? -146.17 139.44 25.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.004 0.43 . . . . 0.0 111.041 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.8 t -168.83 133.98 1.62 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.969 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 140.6 -40.51 1.36 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.35 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 121' ' ' LEU . . . -66.32 150.15 51.74 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.058 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -136.74 56.32 1.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.69 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 1.6 pt? -39.36 127.72 1.36 Allowed Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.345 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 94.2 Cg_endo -84.73 74.09 0.07 OUTLIER 'Cis proline' 0 C--N 1.349 0.57 0 C-N-CA 123.683 -1.382 . . . . 0.0 113.059 -0.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.69 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -168.69 58.44 0.06 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.837 0.351 . . . . 0.0 111.167 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.575 ' HA ' ' HA2' ' A' ' 116' ' ' GLY . 5.3 mp -74.92 37.98 0.12 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.334 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 120' ' ' ALA . 1.5 m-20 -72.26 132.2 43.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.914 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.5 37.36 94.56 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.926 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.39 137.0 52.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.538 0.208 . . . . 0.0 110.587 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' A' ' 125' ' ' ARG . 49.3 ttp85 -130.52 139.22 50.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.41 . . . . 0.0 111.374 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.45 HG12 ' CB ' ' A' ' 113' ' ' LEU . 30.7 m -130.11 138.22 54.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.125 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.64 ' HG3' ' HB2' ' A' ' 112' ' ' PHE . 13.9 pt-20 -114.98 124.47 51.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.497 ' HE2' ' HG2' ' A' ' 153' ' ' LYS . 2.0 m-85 -90.36 146.85 23.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.213 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.434 HH11 ' HG3' ' A' ' 129' ' ' ARG . 7.5 ptm180 -168.62 126.95 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.127 0.489 . . . . 0.0 111.12 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.524 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 69.5 m -89.76 157.39 17.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.382 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 133' ' ' ASP . 34.9 m-20 -52.7 149.66 10.83 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.536 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -52.25 81.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.178 2.585 . . . . 0.0 112.789 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 36.5 t70 178.67 -20.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.186 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 31.7 m-85 -129.38 132.93 47.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.723 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -102.81 127.22 50.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.038 0.447 . . . . 0.0 111.078 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.631 HD21 ' HA ' ' A' ' 140' ' ' SER . 16.5 tp -71.92 131.06 42.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.034 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 36.0 t -136.01 66.73 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.739 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.53 -134.73 1.88 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.247 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.753 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 67.9 m -75.03 51.77 0.53 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.795 0.331 . . . . 0.0 111.099 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.631 ' HA ' HD21 ' A' ' 136' ' ' LEU . 46.7 t -51.08 -39.05 55.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.746 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -99.45 133.15 44.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.572 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.4 t -145.33 119.41 9.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.877 0.37 . . . . 0.0 110.697 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.8 p -108.78 125.34 65.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.088 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 149' ' ' TRP . 47.4 t -71.9 145.29 48.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.389 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.6 p -161.37 122.85 2.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.953 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 8.3 tt0 57.06 43.05 24.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.188 0.518 . . . . 0.0 109.839 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 79.55 -49.87 3.71 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.754 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -77.34 137.83 38.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.704 0.287 . . . . 0.0 111.362 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 144' ' ' CYS . 68.2 m95 -84.23 143.89 29.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.513 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 65.3 m -53.91 -61.42 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.745 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 60.5 p -111.98 134.56 21.37 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.677 0.275 . . . . 0.0 111.503 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.501 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 44.4 Cg_endo -68.23 -163.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.382 2.055 . . . . 0.0 112.166 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.596 ' HB3' ' NZ ' ' A' ' 153' ' ' LYS . 9.3 mtpm? -83.35 125.43 74.22 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.219 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.753 ' HB3' ' H ' ' A' ' 139' ' ' SER . 62.4 Cg_endo -73.73 -144.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.705 2.27 . . . . 0.0 112.376 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.413 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 19.8 p-80 -153.66 139.9 18.51 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.801 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 86.2 m -98.67 133.97 42.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.027 0.442 . . . . 0.0 111.217 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -103.07 142.69 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.198 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 82.7 t -53.57 102.89 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.945 0.402 . . . . 0.0 110.496 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 38.9 t30 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.115 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.883 0.373 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.1 -48.02 59.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.187 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -63.77 -20.21 65.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.964 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.574 ' HB3' HD13 ' A' ' 98' ' ' ILE . 1.8 m-85 -76.65 44.79 0.38 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.812 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.1 m -65.67 131.38 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.979 0.419 . . . . 0.0 111.923 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 37.4 45.86 0.59 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.483 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.795 ' HA ' HD11 ' A' ' 121' ' ' LEU . 16.1 pt -65.03 133.42 30.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.749 0.309 . . . . 0.0 110.821 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.738 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 69.7 m -56.29 138.78 50.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.455 -179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.5 m -47.97 132.0 15.31 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.603 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -89.76 11.41 20.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.13 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.1 t -66.35 -35.78 81.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.87 0.367 . . . . 0.0 110.945 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.568 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 0.9 OUTLIER -55.98 -33.24 64.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.909 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.4 mt -57.03 146.43 27.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.985 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.8 m 65.18 132.4 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.352 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.757 HD13 ' HE2' ' A' ' 153' ' ' LYS . 28.1 tp -145.41 135.41 23.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.124 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 59.7 mp0 -69.85 131.29 44.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.269 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.47 ' N ' HD22 ' A' ' 108' ' ' ASN . 2.3 m120 57.81 39.6 26.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.456 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.556 ' HA2' ' H ' ' A' ' 131' ' ' ASP . . . -174.78 155.41 20.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.7 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -113.12 146.29 39.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.863 0.363 . . . . 0.0 110.92 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.0 t -108.17 139.01 32.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.061 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.534 ' C ' HD12 ' A' ' 113' ' ' LEU . 3.4 m-85 -106.52 140.49 39.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.807 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 112' ' ' PHE . 5.2 mp -133.51 137.32 45.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 110.484 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.1 m -159.98 143.56 14.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.157 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.7 132.24 7.23 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.61 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 52.28 -149.58 9.59 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.83 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.698 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 7.8 t70 178.41 117.31 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.926 HD12 ' HA ' ' A' ' 119' ' ' PRO . 29.9 tp -40.19 134.3 1.48 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.502 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.926 ' HA ' HD12 ' A' ' 118' ' ' LEU . 66.8 Cg_endo -94.02 44.58 2.52 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.713 -1.37 . . . . 0.0 113.109 0.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.698 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -71.95 -49.73 34.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.139 0.495 . . . . 0.0 110.845 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.795 HD11 ' HA ' ' A' ' 98' ' ' ILE . 65.7 mt 54.76 40.89 32.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.533 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.664 ' OD1' ' HB1' ' A' ' 120' ' ' ALA . 1.2 m-20 -75.89 48.04 0.46 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.033 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.86 39.95 95.28 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.294 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.38 138.26 58.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.772 0.32 . . . . 0.0 110.849 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -107.84 140.92 40.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.735 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 32.8 m -129.06 141.02 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.994 0.426 . . . . 0.0 111.671 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 95.4 mt-10 -113.24 123.79 51.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.629 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.466 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 8.0 m-85 -90.23 52.06 2.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.55 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -61.72 129.17 39.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.783 0.325 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 79.9 m -89.25 142.29 27.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.399 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.556 ' H ' ' HA2' ' A' ' 109' ' ' GLY . 54.9 m-20 -57.75 158.37 12.32 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.306 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 2.2 Cg_endo -44.71 156.04 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.305 2.67 . . . . 0.0 112.382 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 1.7 m-20 73.58 -12.32 0.84 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.422 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.452 ' CE2' HG22 ' A' ' 158' ' ' VAL . 7.5 m-85 -130.64 137.3 49.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.77 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.666 ' ND1' ' HB2' ' A' ' 159' ' ' ASN . 14.1 p-80 -121.1 137.05 54.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.064 0.459 . . . . 0.0 111.608 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.743 HD12 ' HB2' ' A' ' 140' ' ' SER . 2.2 tm? -68.29 130.38 42.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.029 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.697 ' N ' HD13 ' A' ' 136' ' ' LEU . 21.3 t -134.35 62.52 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.524 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.452 ' H ' ' CD1' ' A' ' 136' ' ' LEU . . . -176.01 -133.43 1.77 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.018 -1.087 . . . . 0.0 113.227 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.653 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 66.8 m -74.44 56.31 0.66 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.565 0.346 . . . . 0.0 111.397 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.743 ' HB2' HD12 ' A' ' 136' ' ' LEU . 34.4 t -54.56 -39.57 67.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.106 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -99.36 130.2 45.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.093 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.1 m -147.04 146.77 30.13 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.57 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.36 132.03 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.032 0.444 . . . . 0.0 111.377 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.685 ' SG ' HD22 ' A' ' 121' ' ' LEU . 39.0 t -72.13 132.46 44.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.088 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.9 m -166.41 130.82 2.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.82 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 55.82 44.38 26.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.37 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 57.45 45.28 93.17 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.967 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -177.12 142.01 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.635 0.255 . . . . 0.0 110.643 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.738 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 45.7 m95 -84.15 145.14 28.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.882 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.8 t -51.93 -49.63 62.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.022 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 60.4 p -127.85 140.42 38.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.058 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 35.3 Cg_exo -60.33 -165.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.564 2.176 . . . . 0.0 112.476 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.757 ' HE2' HD13 ' A' ' 106' ' ' LEU . 84.5 tttt -86.56 125.29 67.81 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.653 ' HB3' ' N ' ' A' ' 139' ' ' SER . 73.6 Cg_endo -75.35 -151.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.562 2.175 . . . . 0.0 112.677 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -153.8 146.22 23.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.06 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 75.3 m -97.95 132.4 43.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.598 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -103.05 142.9 33.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.168 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.452 HG22 ' CE2' ' A' ' 134' ' ' PHE . 53.0 t -67.25 80.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.868 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.666 ' HB2' ' ND1' ' A' ' 135' ' ' HIS . 34.1 t30 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.163 -0.922 . . . . 0.0 111.048 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.774 0.321 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' A' ' 96' ' ' VAL . . . -169.09 -136.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.974 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.434 ' HG3' ' CD1' ' A' ' 95' ' ' PHE . 40.1 tp10 65.92 128.59 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.887 0.375 . . . . 0.0 110.978 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.434 ' CD1' ' HG3' ' A' ' 94' ' ' GLU . 2.5 m-85 54.51 36.1 24.93 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.023 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.693 HG12 ' HG3' ' A' ' 97' ' ' ARG . 91.8 t -99.61 137.28 27.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.312 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.693 ' HG3' HG12 ' A' ' 96' ' ' VAL . 23.4 mtm105 60.45 56.53 3.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.571 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.537 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -53.16 145.84 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.7 m -53.36 135.43 39.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.241 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.8 t -47.93 123.33 6.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.521 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -81.24 113.1 19.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.606 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 58.0 m -171.15 -41.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.171 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.873 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 1.6 m-85 -62.51 -28.7 70.02 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.074 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.428 HD21 ' HH2' ' A' ' 149' ' ' TRP . 61.4 mt -72.14 28.21 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.332 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.444 ' O ' ' HE3' ' A' ' 153' ' ' LYS . 64.5 p -147.48 127.61 13.76 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.914 0.388 . . . . 0.0 111.666 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.416 HD13 ' HZ1' ' A' ' 153' ' ' LYS . 27.9 tp -145.44 121.98 11.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.297 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -92.28 40.22 1.04 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -163.65 36.13 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.719 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.34 -146.45 11.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.837 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -141.56 139.37 33.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.528 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.6 t -105.97 136.6 39.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.981 0.419 . . . . 0.0 111.007 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 1.6 m-85 -107.83 145.78 33.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.408 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.715 HD23 ' N ' ' A' ' 114' ' ' THR . 6.7 tt -152.55 138.97 18.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.928 0.394 . . . . 0.0 110.846 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.715 ' N ' HD23 ' A' ' 113' ' ' LEU . 84.9 m -153.53 123.16 6.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.683 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.27 -38.51 0.28 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.104 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -168.2 -130.08 1.14 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.138 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.694 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 8.2 t70 -172.3 125.47 0.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.643 ' H ' HD12 ' A' ' 118' ' ' LEU . 6.8 mp -41.84 138.48 1.78 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.208 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -86.73 41.37 1.88 Allowed 'Cis proline' 0 C--N 1.347 0.465 0 C-N-CA 123.574 -1.428 . . . . 0.0 113.478 0.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.728 ' C ' HD22 ' A' ' 121' ' ' LEU . . . -92.49 129.87 38.31 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.831 0.348 . . . . 0.0 111.065 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.728 HD22 ' C ' ' A' ' 120' ' ' ALA . 3.8 mm? -131.47 51.13 2.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.585 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -75.88 59.66 1.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.931 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.91 42.27 99.61 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.578 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.52 141.22 57.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.724 0.297 . . . . 0.0 111.18 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -106.95 130.43 54.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.194 0.521 . . . . 0.0 110.733 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.44 134.3 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.59 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -118.31 123.89 46.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.306 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.547 ' CE2' ' HG2' ' A' ' 153' ' ' LYS . 19.0 m-85 -82.78 151.08 26.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.2 0.524 . . . . 0.0 111.942 -179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.413 ' HG2' HH11 ' A' ' 129' ' ' ARG . 15.4 tpp85 -153.46 121.97 6.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.644 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 9.2 t -102.38 144.63 30.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.035 0.445 . . . . 0.0 111.748 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -56.28 157.76 8.64 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.338 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.493 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 71.4 Cg_exo -48.82 163.14 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.765 2.31 . . . . 0.0 112.275 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.523 ' HA ' ' ND2' ' A' ' 159' ' ' ASN . 55.7 m-20 76.56 -32.53 0.2 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.847 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.869 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 1.4 m-85 -108.5 133.78 52.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.391 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.462 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 20.4 p-80 -112.95 137.34 51.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.972 0.415 . . . . 0.0 111.284 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.671 HD21 ' HA ' ' A' ' 140' ' ' SER . 18.7 tp -68.35 135.91 52.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.308 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 155' ' ' HIS . 14.8 p -136.74 60.01 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.822 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . 171.97 -123.42 1.02 Allowed Glycine 0 C--N 1.332 0.348 0 C-N-CA 119.172 -1.489 . . . . 0.0 113.692 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.811 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 39.9 t -65.11 66.06 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.866 0.365 . . . . 0.0 111.553 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.671 ' HA ' HD21 ' A' ' 136' ' ' LEU . 98.9 p -66.39 -14.81 62.68 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.266 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.616 ' HD3' ' H ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -140.62 138.16 34.18 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.973 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.475 ' HA ' ' HB3' ' A' ' 150' ' ' SER . 86.1 p -141.62 140.51 33.33 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.771 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.776 HG12 ' HB2' ' A' ' 150' ' ' SER . 7.3 p -134.75 132.84 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.063 0.459 . . . . 0.0 111.981 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 121' ' ' LEU . 41.5 t -79.34 149.98 31.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.828 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.1 t -147.79 -130.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.715 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -58.44 -42.72 87.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.643 0.259 . . . . 0.0 111.202 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 176.15 47.5 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.657 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -173.71 142.24 0.9 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.735 0.302 . . . . 0.0 110.696 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.428 ' HH2' HD21 ' A' ' 104' ' ' LEU . 59.0 m95 -84.2 153.36 23.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.074 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.776 ' HB2' HG12 ' A' ' 143' ' ' VAL . 43.2 t -48.08 -57.65 5.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.87 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.669 HG23 ' OG ' ' A' ' 139' ' ' SER . 0.5 OUTLIER -147.42 143.73 18.46 Favored Pre-proline 0 C--N 1.332 -0.163 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -179.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.52 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 31.4 Cg_exo -57.82 140.81 94.97 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.483 2.789 . . . . 0.0 112.716 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.873 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 9.0 mtpm? -49.81 137.35 18.87 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.024 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.822 ' HB3' ' HA3' ' A' ' 138' ' ' GLY . 85.2 Cg_endo -83.05 -140.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.989 2.459 . . . . 0.0 112.142 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.598 ' O ' HG12 ' A' ' 137' ' ' VAL . 18.9 p-80 -153.72 152.16 30.46 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.763 0.316 . . . . 0.0 110.999 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.869 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 71.1 m -94.95 127.37 40.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.555 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.462 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 69.8 tp60 -105.56 136.76 44.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.818 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 86.4 t -76.3 122.95 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.164 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 133' ' ' ASP . 24.4 p30 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.953 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.795 0.331 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.23 -42.78 95.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.255 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.485 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 0.6 OUTLIER -62.69 131.49 49.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.631 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -65.97 -43.2 88.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.94 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 98' ' ' ILE . 60.3 t 66.77 139.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.011 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -49.69 136.16 17.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.369 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 96' ' ' VAL . 33.9 pt -137.43 145.71 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.923 0.392 . . . . 0.0 111.473 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 38.7 m -51.49 140.17 18.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.058 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.4 t -47.91 130.26 14.95 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.308 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.586 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -83.14 -28.44 29.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.235 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.1 m -68.89 38.6 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.779 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 6.8 m-85 -127.28 -46.92 1.47 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.573 0.225 . . . . 0.0 111.305 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.784 HD12 ' H ' ' A' ' 105' ' ' THR . 0.4 OUTLIER -52.92 -32.08 43.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.462 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.784 ' H ' HD12 ' A' ' 104' ' ' LEU . 41.9 p -96.29 135.37 38.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.663 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 34.5 tp -145.43 131.19 19.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.864 0.364 . . . . 0.0 111.135 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -69.01 131.73 45.53 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.66 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 54.1 41.8 31.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.401 . . . . 0.0 110.6 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.53 148.56 9.51 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.522 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -104.09 151.75 22.9 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.953 0.406 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 104' ' ' LEU . 96.4 t -128.2 141.39 46.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.987 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.8 m-85 -105.83 134.3 49.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.84 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.656 HD13 ' N ' ' A' ' 114' ' ' THR . 2.7 tm? -109.18 131.76 54.76 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.656 ' N ' HD13 ' A' ' 113' ' ' LEU . 72.3 m -157.51 125.09 5.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.91 0.386 . . . . 0.0 111.107 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 157.93 -133.52 3.53 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.293 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.85 -135.24 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.394 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -160.17 123.4 3.49 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.585 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -53.27 136.41 50.18 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.003 -179.293 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 65.1 Cg_endo -90.21 63.16 0.26 Allowed 'Cis proline' 0 C--N 1.346 0.445 0 C-N-CA 123.834 -1.319 . . . . 0.0 113.032 0.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.531 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -155.43 57.21 0.63 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.779 0.323 . . . . 0.0 111.549 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 121' ' ' LEU . 5.2 mp -77.28 45.87 0.48 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.855 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.65 131.27 49.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 111.215 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 51.83 35.52 39.53 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.749 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.57 136.94 32.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.673 0.273 . . . . 0.0 111.35 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.454 ' NH2' HH21 ' A' ' 141' ' ' ARG . 15.9 ptm180 -130.55 130.29 43.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 110.789 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.48 HG23 ' HE1' ' A' ' 128' ' ' PHE . 23.2 m -100.27 139.81 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.027 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 46.6 mp0 -102.93 123.88 47.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.245 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.48 ' HE1' HG23 ' A' ' 126' ' ' VAL . 7.0 m-85 -91.31 143.04 27.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.144 0.497 . . . . 0.0 112.036 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.453 ' HD3' ' CE1' ' A' ' 112' ' ' PHE . 47.9 mtp85 -152.59 125.1 8.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.723 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 26.2 t -89.29 163.8 15.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.943 0.402 . . . . 0.0 111.462 -179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -52.79 156.71 3.13 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.306 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.08 52.44 1.84 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.286 2.658 . . . . 0.0 112.868 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -155.88 -37.72 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.121 0.486 . . . . 0.0 109.989 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.452 ' CE2' ' HB ' ' A' ' 158' ' ' VAL . 0.9 OUTLIER -108.32 146.53 32.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.724 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -100.08 132.99 45.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.137 0.494 . . . . 0.0 111.152 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.786 HD21 ' HA ' ' A' ' 140' ' ' SER . 27.9 tp -73.46 128.47 35.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.279 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.6 t -134.98 64.08 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.225 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.53 -123.52 0.72 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.005 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.931 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.4 t -71.17 52.28 0.17 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.678 0.391 . . . . 0.0 111.686 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.786 ' HA ' HD21 ' A' ' 136' ' ' LEU . 44.9 t -56.02 -26.35 48.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.066 0.46 . . . . 0.0 110.15 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.454 HH21 ' NH2' ' A' ' 125' ' ' ARG . 24.0 mmm180 -132.87 129.14 38.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.853 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.465 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 47.1 t -141.77 148.56 39.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.237 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 125' ' ' ARG . 7.3 p -144.04 131.35 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.818 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 45.4 t -68.47 144.11 54.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.595 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.6 t -172.72 129.51 0.52 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.546 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 15.2 mp0 56.6 43.93 24.79 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.05 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 57.31 42.75 93.72 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.315 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.401 ' HA ' ' NE2' ' A' ' 148' ' ' GLN . 3.0 tp-100 -174.33 140.18 0.64 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 0.0 110.498 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.444 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 56.0 m95 -84.24 140.81 31.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.937 0.399 . . . . 0.0 110.965 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.8 m -54.2 -60.64 3.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.478 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 46.7 p -94.32 129.08 38.13 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.739 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 139' ' ' SER . 73.7 Cg_endo -75.91 148.86 32.39 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.848 2.366 . . . . 0.0 112.273 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.779 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 14.1 mmmm -40.86 127.27 1.96 Allowed Pre-proline 0 N--CA 1.464 0.271 0 CA-C-O 120.752 0.31 . . . . 0.0 111.267 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.931 ' HB3' ' H ' ' A' ' 139' ' ' SER . 91.5 Cg_endo -83.77 -149.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.972 2.448 . . . . 0.0 113.571 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.405 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 17.8 p-80 -153.75 150.09 28.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.337 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 82.7 m -94.95 127.63 41.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.799 0.333 . . . . 0.0 110.933 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -103.48 137.09 42.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.52 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 134' ' ' PHE . 11.7 p -86.62 131.29 35.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.432 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.829 -179.598 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.798 0.332 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 59.54 48.05 10.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.482 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -174.08 47.41 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.188 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -172.36 146.08 1.76 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.178 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.1 p -176.39 136.07 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.258 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 97' ' ' ARG . 29.4 tpt180 52.21 54.74 10.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.074 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.663 ' HB ' ' HG ' ' A' ' 121' ' ' LEU . 35.7 pt -55.56 142.48 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.088 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.488 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 95.1 m -51.09 135.77 24.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.362 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.8 t -47.97 127.48 12.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.301 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.772 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -81.07 12.61 3.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.897 179.727 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.1 t -68.82 -41.55 78.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.793 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.634 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.9 m-85 -56.09 -34.94 66.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.21 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.601 HD12 ' HB2' ' A' ' 101' ' ' LYS . 87.1 mt -47.77 -46.02 29.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.961 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 60.1 p -92.61 137.95 31.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.816 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.516 HD13 ' HE2' ' A' ' 153' ' ' LYS . 30.4 tp -145.41 133.4 21.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 110.972 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.97 132.23 46.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.772 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.426 ' N ' HD22 ' A' ' 108' ' ' ASN . 2.5 m120 58.65 33.03 22.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.152 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.519 ' CA ' ' HA ' ' A' ' 130' ' ' CYS . . . -175.51 153.14 14.44 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.423 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -109.27 144.5 37.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.513 -0.344 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.634 HG21 ' O ' ' A' ' 103' ' ' TYR . 93.1 t -109.66 136.94 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.95 0.405 . . . . 0.0 111.058 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.448 ' CE1' ' HD3' ' A' ' 129' ' ' ARG . 2.8 m-85 -108.57 146.51 33.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.755 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.644 HD23 ' N ' ' A' ' 114' ' ' THR . 6.3 tt -144.26 131.45 20.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.546 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.644 ' N ' HD23 ' A' ' 113' ' ' LEU . 68.7 p -150.08 123.36 8.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.567 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 165.02 -36.01 0.27 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.242 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -159.4 -135.12 1.8 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.419 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.598 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 12.2 p-10 -175.67 129.5 0.25 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.722 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -41.28 138.82 1.44 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.279 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -86.69 40.32 2.2 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.503 -1.457 . . . . 0.0 113.117 0.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.598 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -96.62 47.11 1.06 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.783 0.325 . . . . 0.0 111.242 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.663 ' HG ' ' HB ' ' A' ' 98' ' ' ILE . 3.9 mm? -54.42 -40.59 68.44 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.789 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -61.21 136.93 58.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.505 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.87 54.4 7.24 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.458 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.485 ' O ' HG23 ' A' ' 143' ' ' VAL . . . -143.62 136.12 27.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 0.0 111.189 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.415 ' HG2' HH11 ' A' ' 125' ' ' ARG . 48.6 mmt-85 -105.66 143.56 33.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.733 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 142' ' ' SER . 32.7 m -133.74 135.53 55.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.088 0.47 . . . . 0.0 111.489 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -112.9 118.34 34.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.514 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.468 ' HE1' ' HB3' ' A' ' 142' ' ' SER . 5.4 m-85 -82.42 140.53 33.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.024 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.448 ' HD3' ' CE1' ' A' ' 112' ' ' PHE . 16.6 ptm180 -166.66 127.46 1.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.77 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.519 ' HA ' ' CA ' ' A' ' 109' ' ' GLY . 61.5 m -92.89 160.6 14.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.149 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.435 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 31.9 m-20 -52.68 157.58 2.55 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.556 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 17.9 Cg_endo -58.78 76.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.142 2.561 . . . . 0.0 112.64 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.3 t70 -177.07 -38.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.675 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.77 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 2.9 m-85 -108.91 132.58 53.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.872 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.467 ' CE1' ' HB2' ' A' ' 157' ' ' GLN . 17.6 p-80 -102.8 127.79 49.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.993 0.425 . . . . 0.0 111.145 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' A' ' 154' ' ' PRO . 26.7 tp -72.11 129.51 38.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.648 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.1 t -135.33 67.89 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.749 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.12 -136.09 2.28 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.623 -1.275 . . . . 0.0 113.398 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.483 ' HB2' ' CB ' ' A' ' 151' ' ' THR . 71.1 p -74.82 58.26 0.82 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.022 0.439 . . . . 0.0 110.854 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.693 ' HA ' HD21 ' A' ' 136' ' ' LEU . 36.5 t -52.16 -31.39 31.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.743 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -99.44 136.26 39.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.779 0.323 . . . . 0.0 111.237 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.468 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 42.8 t -150.05 149.56 30.49 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.34 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 124' ' ' ALA . 7.3 p -144.36 135.69 21.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.993 0.425 . . . . 0.0 111.75 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 121' ' ' LEU . 43.1 t -66.72 151.2 47.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.005 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.1 t -151.54 -136.91 0.07 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.054 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -74.63 66.56 1.45 Allowed 'General case' 0 C--O 1.232 0.153 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.36 43.45 92.67 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.649 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -176.41 139.9 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.757 0.313 . . . . 0.0 110.505 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.488 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 33.8 m95 -84.26 141.65 30.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.653 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.5 t -49.54 -52.72 27.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.645 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.483 ' CB ' ' HB2' ' A' ' 139' ' ' SER . 48.8 p -124.95 133.88 25.21 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 0.0 111.803 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.87 147.5 85.21 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.773 2.316 . . . . 0.0 111.841 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.516 ' HE2' HD13 ' A' ' 106' ' ' LEU . 50.2 mtpt -46.66 131.37 8.33 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.325 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.698 ' HG2' HD11 ' A' ' 136' ' ' LEU . 3.9 Cg_exo -78.93 -141.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.073 2.515 . . . . 0.0 112.086 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.422 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.1 p-80 -153.75 134.75 13.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.772 0.32 . . . . 0.0 110.948 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.77 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 77.5 m -98.73 132.41 44.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.487 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.467 ' HB2' ' CE1' ' A' ' 135' ' ' HIS . 23.2 mt-30 -103.4 142.46 34.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.821 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -76.21 135.99 25.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.21 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.7 m120 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.917 -179.523 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.804 0.335 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.43 42.98 0.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.427 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.433 ' HB3' ' H ' ' A' ' 95' ' ' PHE . 51.7 mp0 48.86 -137.47 0.95 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.626 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.433 ' H ' ' HB3' ' A' ' 94' ' ' GLU . 13.6 t80 -173.92 47.31 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.973 0.416 . . . . 0.0 110.969 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.4 t -65.09 138.82 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.054 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.436 ' HG2' HH11 ' A' ' 97' ' ' ARG . 22.4 ptt-85 -55.64 141.75 36.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.706 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 31.4 pt -142.31 144.79 24.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.315 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.571 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 73.7 m -51.51 139.46 20.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.54 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.3 t -47.99 127.52 12.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.021 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.547 ' NZ ' ' HB3' ' A' ' 101' ' ' LYS . 8.4 mtpm? -74.16 14.36 0.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.343 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.1 m -68.87 -46.19 69.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.936 0.398 . . . . 0.0 110.895 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -61.7 -41.12 97.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.116 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.9 mt -54.94 -41.79 71.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.501 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.6 p -92.54 136.89 32.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.865 0.364 . . . . 0.0 111.564 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.44 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 40.4 tp -145.44 130.81 18.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.572 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 10.3 pm0 -90.48 38.94 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.335 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.412 ' OD1' ' HG2' ' A' ' 107' ' ' GLU . 8.2 m120 -155.85 25.44 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.566 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 154.57 -144.36 11.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.88 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.413 ' HE2' ' CZ ' ' A' ' 112' ' ' PHE . 25.0 pttm -141.97 140.19 32.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.251 -0.474 . . . . 0.0 110.302 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.33 143.91 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.013 0.435 . . . . 0.0 111.354 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.413 ' CZ ' ' HE2' ' A' ' 110' ' ' LYS . 1.4 m-85 -105.36 151.76 23.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.146 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.573 HD21 HD22 ' A' ' 121' ' ' LEU . 56.5 tp -145.29 132.97 20.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.605 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.2 p -150.95 147.32 27.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.429 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.2 39.7 26.31 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.918 -0.583 . . . . 0.0 113.017 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.596 ' HA2' ' HB2' ' A' ' 124' ' ' ALA . . . -79.61 -140.88 2.24 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.158 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -176.1 49.53 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 118' ' ' LEU . 1.7 pt? -42.47 135.07 2.62 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.986 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -87.71 63.04 0.19 OUTLIER 'Cis proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.638 -1.401 . . . . 0.0 113.345 0.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.579 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -166.32 132.56 2.47 Favored 'General case' 0 C--O 1.228 -0.074 0 CA-C-O 120.929 0.395 . . . . 0.0 111.486 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.573 HD22 HD21 ' A' ' 113' ' ' LEU . 83.3 mt -80.9 43.09 0.67 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.84 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -65.01 126.24 27.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.236 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 50.12 31.42 18.76 Favored Glycine 0 C--N 1.33 0.228 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.007 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.596 ' HB2' ' HA2' ' A' ' 116' ' ' GLY . . . -84.25 140.25 31.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.579 0.228 . . . . 0.0 110.959 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -108.54 124.23 50.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.785 0.326 . . . . 0.0 110.438 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 142' ' ' SER . 7.5 p -103.59 140.26 22.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.537 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -125.25 111.97 15.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.166 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -75.23 146.59 41.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.57 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.402 ' NH1' ' O ' ' A' ' 130' ' ' CYS . 26.7 tpt85 -156.27 117.06 3.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.097 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.514 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 98.6 m -96.41 165.25 12.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.691 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.544 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 56.2 m-20 -52.66 162.32 0.97 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.017 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 56.7 Cg_endo -70.92 51.76 1.29 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.851 2.368 . . . . 0.0 112.727 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -146.53 -35.85 0.26 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.773 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.634 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 0.7 OUTLIER -108.82 135.93 49.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.034 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 157' ' ' GLN . 17.0 p-80 -102.74 129.86 49.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.948 0.404 . . . . 0.0 110.826 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.732 HD21 ' HA ' ' A' ' 140' ' ' SER . 50.7 tp -72.72 128.18 34.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.019 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.6 t -135.99 68.69 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.665 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.18 -131.36 1.74 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.442 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.764 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 29.2 t -69.84 63.8 0.2 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.958 0.408 . . . . 0.0 111.364 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.732 ' HA ' HD21 ' A' ' 136' ' ' LEU . 95.5 p -61.22 -15.12 31.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.729 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -139.04 137.96 36.74 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.721 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.7 ' O ' HG12 ' A' ' 126' ' ' VAL . 36.4 t -150.69 124.17 9.01 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.735 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.2 p -88.01 130.51 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.978 0.418 . . . . 0.0 111.084 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 26.4 t -75.84 78.13 2.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.56 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 51.5 m -65.59 -124.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.412 ' C ' ' H ' ' A' ' 148' ' ' GLN . 26.1 mt-30 -67.27 -140.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -77.29 29.32 1.67 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.445 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.412 ' H ' ' C ' ' A' ' 146' ' ' GLN . 87.9 mt-30 -157.76 150.24 22.63 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.725 0.297 . . . . 0.0 110.652 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.571 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 33.1 m95 -84.22 139.21 32.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.222 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 80.7 p -53.91 -63.07 1.27 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.517 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 40.2 p -92.6 132.31 31.9 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.706 0.288 . . . . 0.0 111.533 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.34 142.5 85.95 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.826 2.35 . . . . 0.0 112.356 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.44 ' NZ ' HD13 ' A' ' 106' ' ' LEU . 63.2 tttm -51.81 127.93 35.43 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.128 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.764 ' HB3' ' H ' ' A' ' 139' ' ' SER . 81.9 Cg_endo -78.15 -152.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.765 2.31 . . . . 0.0 112.805 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -153.83 138.96 17.39 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.073 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 99.7 m -98.72 131.55 44.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.891 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.42 ' HB2' ' CE1' ' A' ' 135' ' ' HIS . 25.9 mt-30 -103.0 140.16 37.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.793 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.505 ' O ' HG22 ' A' ' 158' ' ' VAL . 14.7 p -79.9 44.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.39 0.614 . . . . 0.0 110.583 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.0 m-80 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.147 -0.93 . . . . 0.0 111.174 179.989 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.816 0.341 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.72 127.84 0.4 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.076 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -74.84 133.74 41.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.003 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -82.42 40.39 0.65 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.37 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.6 p -175.07 129.19 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.907 0.384 . . . . 0.0 111.09 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -70.24 120.03 15.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.976 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.619 ' O ' HD12 ' A' ' 98' ' ' ILE . 2.5 pp -83.66 159.21 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.543 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.6 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 51.5 m -55.01 137.26 46.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.38 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.592 ' HB2' ' HE1' ' A' ' 149' ' ' TRP . 56.4 m -47.95 123.8 6.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.844 0.354 . . . . 0.0 111.226 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.737 ' HA ' HD13 ' A' ' 104' ' ' LEU . 58.9 tptt -75.47 -26.67 58.41 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.328 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.5 p -53.22 -41.8 65.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.488 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.678 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 3.7 m-85 -59.0 -42.63 90.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.651 0.262 . . . . 0.0 111.179 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.737 HD13 ' HA ' ' A' ' 101' ' ' LYS . 5.7 mp -55.74 -41.13 73.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.064 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.7 p -92.56 127.06 37.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.976 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.633 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 57.5 tp -145.36 128.36 16.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.092 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -69.15 138.06 53.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.971 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 m120 58.24 39.74 25.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.298 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.85 168.36 41.18 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.703 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -138.88 140.25 38.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.732 0.301 . . . . 0.0 110.743 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 74.9 t -109.18 141.45 24.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.206 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -105.53 136.1 45.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.644 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.551 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.6 mm? -101.05 144.2 30.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.575 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.9 m -151.76 126.62 9.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.713 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 65.01 149.98 0.06 OUTLIER Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.424 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.65 143.13 0.49 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.603 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -173.44 138.31 0.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.643 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -43.16 134.93 3.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.829 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 83.6 Cg_endo -87.9 54.01 0.52 Allowed 'Cis proline' 0 C--N 1.347 0.486 0 C-N-CA 123.721 -1.366 . . . . 0.0 113.401 0.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.454 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -135.11 135.55 41.27 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.7 0.286 . . . . 0.0 110.861 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.777 HD23 ' H ' ' A' ' 121' ' ' LEU . 2.1 pt? -124.42 -39.92 2.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.104 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -61.32 136.78 58.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.561 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 79.17 54.59 4.03 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.14 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.51 ' C ' ' HD2' ' A' ' 125' ' ' ARG . . . -147.7 132.17 17.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.9 0.381 . . . . 0.0 111.068 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.51 ' HD2' ' C ' ' A' ' 124' ' ' ALA . 8.6 mpt_? -124.93 138.86 54.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.113 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.415 HG12 HD13 ' A' ' 113' ' ' LEU . 28.4 m -116.97 137.06 52.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.104 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -106.67 113.72 27.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.95 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -74.83 155.95 37.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.603 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.522 HH22 ' H ' ' A' ' 136' ' ' LEU . 2.4 tpm_? -161.11 128.45 4.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.525 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.47 ' H ' ' CZ ' ' A' ' 129' ' ' ARG . 87.6 m -89.22 140.77 29.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.067 0.46 . . . . 0.0 111.456 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -54.29 158.88 3.49 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.16 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.504 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 3.5 Cg_endo -45.92 153.14 0.95 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.002 2.468 . . . . 0.0 112.07 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 22.2 m-20 77.92 -32.07 0.17 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.664 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' A' ' 132' ' ' PRO . 3.2 m-85 -107.65 128.12 54.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.331 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -107.52 136.44 47.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.425 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.69 HD22 ' HB2' ' A' ' 140' ' ' SER . 6.2 tt -74.94 130.46 39.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.469 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.623 ' N ' HD23 ' A' ' 136' ' ' LEU . 40.8 t -135.04 67.43 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.461 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.5 -134.94 1.91 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.092 -1.052 . . . . 0.0 113.058 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.651 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 50.0 m -75.53 55.26 0.81 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.851 0.358 . . . . 0.0 110.964 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.69 ' HB2' HD22 ' A' ' 136' ' ' LEU . 33.6 t -49.77 -40.51 41.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.171 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.427 ' HG2' HH11 ' A' ' 141' ' ' ARG . 22.2 ptt-85 -99.31 134.53 42.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.98 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.2 m -146.29 133.87 20.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.77 0.319 . . . . 0.0 110.736 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.455 HG23 ' HG3' ' A' ' 125' ' ' ARG . 7.3 p -120.05 129.76 75.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.05 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 51.4 t -71.39 141.95 50.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.454 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.3 t -171.3 125.65 0.64 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.216 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.441 ' OE1' ' N ' ' A' ' 146' ' ' GLN . 0.6 OUTLIER 57.15 39.61 28.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 0.0 110.448 -179.311 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 77.17 -51.65 3.26 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.774 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -76.92 143.7 39.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.678 0.275 . . . . 0.0 111.057 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.592 ' HE1' ' HB2' ' A' ' 100' ' ' SER . 70.0 m95 -84.2 146.82 27.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.828 0.347 . . . . 0.0 110.659 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.3 t -53.37 -61.17 2.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.524 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 139' ' ' SER . 82.4 p -107.79 135.78 19.77 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 120.774 0.321 . . . . 0.0 111.776 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 139' ' ' SER . 57.6 Cg_endo -70.78 145.67 51.9 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.785 2.323 . . . . 0.0 112.161 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.678 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 7.6 mtpm? -45.32 130.17 5.98 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.433 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.651 ' HB3' ' N ' ' A' ' 139' ' ' SER . 76.1 Cg_endo -77.51 -141.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.69 2.26 . . . . 0.0 112.547 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.482 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.4 p-80 -153.74 147.6 25.42 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.036 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 71.0 m -96.89 140.26 31.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.279 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -131.26 146.69 52.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.875 0.369 . . . . 0.0 111.48 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 79.6 t -76.61 125.18 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.174 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.8 p30 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.224 -0.893 . . . . 0.0 111.067 -179.634 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.634 0.254 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 64.75 135.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.412 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -175.1 -43.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.237 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.422 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 4.4 m-85 -61.95 -43.99 97.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.344 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 92.6 t -62.2 128.73 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.89 0.376 . . . . 0.0 111.272 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.423 ' NH1' ' HA3' ' A' ' 147' ' ' GLY . 31.2 ptt85 -84.71 55.52 3.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.119 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.685 ' O ' HD12 ' A' ' 98' ' ' ILE . 2.3 pp -51.13 148.21 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.991 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.603 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 97.7 m -59.76 143.83 49.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.04 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.2 m -48.03 124.81 8.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.226 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -84.46 14.98 3.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.933 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.2 m -67.34 -35.63 79.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.678 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.739 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 3.4 m-85 -58.74 -25.69 63.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.417 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.4 mt -50.0 -38.41 37.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.737 0.303 . . . . 0.0 111.118 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.3 p -92.55 127.81 38.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.111 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.484 HD22 ' HA3' ' A' ' 109' ' ' GLY . 6.4 tt -145.37 124.02 12.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.182 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.457 ' N ' HD23 ' A' ' 106' ' ' LEU . 96.6 mt-10 -74.25 130.69 40.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.37 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.504 ' N ' HD22 ' A' ' 108' ' ' ASN . 2.0 m120 60.11 47.22 9.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.221 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.484 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -174.95 -171.83 39.38 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.075 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -142.09 146.29 35.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.659 0.266 . . . . 0.0 110.647 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 103' ' ' TYR . 60.3 t -108.05 127.4 64.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.631 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.627 ' C ' HG23 ' A' ' 126' ' ' VAL . 2.5 m-85 -112.01 70.88 0.72 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.149 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.702 ' HA ' ' HB ' ' A' ' 126' ' ' VAL . 2.3 tt -74.67 62.39 1.05 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.618 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.8 p -75.0 120.89 21.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.712 0.291 . . . . 0.0 111.118 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.14 -43.89 0.31 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.654 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -173.16 -128.26 1.05 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.531 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.86 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 11.6 p-10 -165.24 -136.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 118' ' ' LEU . 2.7 mm? -116.31 132.98 23.02 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.526 0.203 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 60.0 Cg_endo -93.09 42.06 3.15 Favored 'Cis proline' 0 C--N 1.348 0.537 0 C-N-CA 123.837 -1.318 . . . . 0.0 112.497 -0.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.86 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -74.07 140.89 45.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 0.0 111.742 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.541 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 2.1 pt? -167.39 36.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.803 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -75.93 60.57 1.39 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.917 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.22 40.84 32.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.225 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.526 ' O ' HG23 ' A' ' 143' ' ' VAL . . . -62.9 135.29 57.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.903 0.382 . . . . 0.0 110.981 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.58 ' HD2' ' NH2' ' A' ' 141' ' ' ARG . 85.7 mtm180 -103.83 141.47 36.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.498 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.703 HG11 ' HZ3' ' A' ' 149' ' ' TRP . 6.5 p -143.23 135.66 24.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.257 0.551 . . . . 0.0 112.315 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -109.17 121.11 44.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.737 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.534 ' HE1' ' HB3' ' A' ' 142' ' ' SER . 3.2 m-85 -87.3 56.19 3.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.801 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 129' ' ' ARG . 63.5 mtt-85 -59.05 132.97 55.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.591 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 53.7 t -89.2 149.13 23.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.813 0.34 . . . . 0.0 111.13 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.482 ' OD1' ' HB2' ' A' ' 134' ' ' PHE . 52.5 p-10 -52.81 149.8 10.88 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.404 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 10.1 Cg_endo -51.59 152.74 12.0 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.751 2.301 . . . . 0.0 111.527 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.585 ' O ' ' HB3' ' A' ' 159' ' ' ASN . 37.4 t70 76.44 -2.41 2.72 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.399 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.71 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 19.1 m-85 -134.28 130.61 37.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.951 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -104.16 128.19 51.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.923 0.392 . . . . 0.0 111.197 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.837 HD12 ' HB3' ' A' ' 140' ' ' SER . 2.8 tm? -71.44 132.15 44.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.795 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.625 ' N ' HD13 ' A' ' 136' ' ' LEU . 24.8 t -132.23 67.88 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.9 -135.13 2.11 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 119.901 -1.142 . . . . 0.0 113.276 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.652 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 39.2 p -74.99 56.05 0.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.929 0.395 . . . . 0.0 111.072 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.837 ' HB3' HD12 ' A' ' 136' ' ' LEU . 92.6 p -57.0 -38.95 73.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.801 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.58 ' NH2' ' HD2' ' A' ' 125' ' ' ARG . 29.4 tpt180 -99.32 133.97 42.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.703 0.287 . . . . 0.0 111.508 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.534 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 46.7 t -150.34 148.67 29.1 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.258 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 124' ' ' ALA . 7.4 p -146.23 130.27 10.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.146 0.498 . . . . 0.0 112.046 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 13.7 t -92.54 140.96 29.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.901 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.4 t -169.52 -60.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.042 0.449 . . . . 0.0 111.218 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -87.98 43.63 1.13 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.423 ' HA3' ' NH1' ' A' ' 97' ' ' ARG . . . 56.54 39.9 85.91 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.89 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -174.73 146.98 1.0 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.728 0.299 . . . . 0.0 110.402 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.703 ' HZ3' HG11 ' A' ' 126' ' ' VAL . 29.5 m95 -84.22 138.78 32.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.778 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.2 t -50.15 -46.31 53.95 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.965 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 70.9 p -135.65 138.84 29.26 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.891 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.499 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 28.0 Cg_exo -62.02 -162.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.561 2.174 . . . . 0.0 112.627 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.801 ' HZ2' ' HB3' ' A' ' 153' ' ' LYS . 3.9 mmmp? -80.75 127.3 75.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.783 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.652 ' HB3' ' N ' ' A' ' 139' ' ' SER . 84.0 Cg_endo -81.37 -151.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.635 2.223 . . . . 0.0 112.891 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.425 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 22.4 p-80 -153.65 136.52 15.38 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.936 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 7.8 t -98.72 136.83 38.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.979 0.418 . . . . 0.0 111.664 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -103.04 142.4 34.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.02 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 98.2 t -61.24 111.03 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.78 0.324 . . . . 0.0 110.327 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.585 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 38.6 t30 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.05 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.7 0.286 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 55.23 43.35 29.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.169 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -60.38 -44.71 95.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.792 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.417 ' HB2' ' H ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -175.34 -148.17 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.165 179.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.417 ' H ' ' HB2' ' A' ' 95' ' ' PHE . 61.0 t -73.47 134.45 29.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.868 0.366 . . . . 0.0 111.326 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -79.95 49.93 1.14 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.005 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.506 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -54.33 142.36 8.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.946 0.403 . . . . 0.0 111.49 -179.547 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 82.1 m -56.42 154.47 8.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.757 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.7 m -45.67 127.51 7.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.492 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.572 ' HB2' HD12 ' A' ' 104' ' ' LEU . 7.8 ptpp? -76.19 -3.38 35.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.262 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.5 m -56.12 -41.15 74.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.87 0.367 . . . . 0.0 110.994 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.469 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 1.7 m-85 -59.98 -34.17 72.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.196 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.572 HD12 ' HB2' ' A' ' 101' ' ' LYS . 75.6 mt -52.11 -40.01 60.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.967 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.1 m -92.6 136.29 33.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.816 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.5 tp -145.42 131.35 19.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.86 0.362 . . . . 0.0 111.31 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -75.02 133.56 41.62 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.853 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 52.47 36.07 19.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.06 0.457 . . . . 0.0 110.664 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.36 145.81 9.91 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.538 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.634 ' HB3' ' NZ ' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -101.93 140.87 35.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.342 -0.429 . . . . 0.0 110.972 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.6 t -108.03 135.93 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.79 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 126' ' ' VAL . 3.5 m-85 -110.35 136.16 49.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.779 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.48 HD11 HD22 ' A' ' 104' ' ' LEU . 94.8 mt -112.4 144.86 41.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.163 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.8 t -159.83 143.1 14.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.005 0.431 . . . . 0.0 111.81 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.09 126.07 0.13 Allowed Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.911 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 152.06 -140.36 7.7 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.312 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 120' ' ' ALA . 65.6 t0 -173.86 119.14 0.27 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.823 HD22 ' H ' ' A' ' 118' ' ' LEU . 3.1 mm? -29.49 126.16 0.26 Allowed Pre-proline 0 N--CA 1.465 0.301 0 O-C-N 123.591 0.557 . . . . 0.0 111.555 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 118' ' ' LEU . 25.5 Cg_exo -63.18 -22.1 4.86 Favored 'Cis proline' 0 C--N 1.351 0.682 0 C-N-CA 124.097 -1.209 . . . . 0.0 112.992 0.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 117' ' ' ASP . . . 69.26 129.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.413 0.625 . . . . 0.0 111.752 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.628 ' O ' HD13 ' A' ' 121' ' ' LEU . 2.2 tm? 175.33 -35.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.236 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -62.14 132.32 52.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.677 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 52.5 31.72 36.88 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.331 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -77.19 139.65 39.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.758 0.313 . . . . 0.0 111.193 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.403 HH11 ' HG3' ' A' ' 125' ' ' ARG . 41.1 ttt85 -103.98 63.25 0.76 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.126 0.489 . . . . 0.0 109.725 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 142' ' ' SER . 11.0 p -57.96 141.7 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.776 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -123.92 113.3 18.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.863 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -80.06 151.3 29.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.9 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.453 HH11 ' HG3' ' A' ' 129' ' ' ARG . 38.3 ttt85 -161.11 133.12 5.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.785 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 84.1 m -89.25 142.45 27.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.204 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 60.8 m-20 -56.27 160.81 4.54 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.022 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.53 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 78.2 Cg_exo -41.15 154.19 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.982 2.455 . . . . 0.0 112.652 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 8.1 t70 78.89 -33.77 0.16 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.717 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.411 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 1.7 m-85 -107.6 129.5 54.98 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.237 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -110.75 134.75 52.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.99 0.424 . . . . 0.0 111.08 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 137' ' ' VAL . 6.6 tt -75.21 132.42 41.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.597 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.602 ' N ' HD23 ' A' ' 136' ' ' LEU . 38.7 t -133.39 67.3 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.452 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.25 -126.33 1.07 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.15 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.604 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 42.7 t -70.2 64.46 0.25 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.986 0.422 . . . . 0.0 111.258 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.445 ' HB2' HD22 ' A' ' 136' ' ' LEU . 35.3 t -64.36 -18.0 64.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.172 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 56.5 mtt85 -140.7 140.86 34.97 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.056 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.608 ' O ' HG12 ' A' ' 126' ' ' VAL . 35.9 m -145.03 136.27 25.02 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 7.2 p -113.32 130.55 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.924 0.393 . . . . 0.0 111.357 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 45.6 t -75.05 139.46 42.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.96 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 m -163.12 134.58 4.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.844 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 67.36 -66.68 0.19 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.462 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.0 37.44 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.526 -0.629 . . . . 0.0 111.526 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -176.32 152.36 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.105 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 27.9 m95 -84.19 140.93 31.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.741 0.305 . . . . 0.0 110.724 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.6 m -52.3 -59.89 3.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.013 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.2 p -100.91 134.26 20.56 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.05 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.461 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 38.3 Cg_endo -66.59 -157.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.398 2.066 . . . . 0.0 112.366 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.561 ' HB3' ' NZ ' ' A' ' 153' ' ' LYS . 9.5 mtpm? -92.98 129.93 37.98 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.037 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.604 ' HB3' ' N ' ' A' ' 139' ' ' SER . 66.5 Cg_endo -73.09 -144.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.673 2.249 . . . . 0.0 112.722 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.474 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.7 p-80 -153.67 149.26 27.35 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.415 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 73.9 m -97.86 129.33 44.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.868 0.366 . . . . 0.0 111.189 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -111.87 133.24 54.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.682 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.438 HG23 ' OD1' ' A' ' 133' ' ' ASP . 7.2 p -84.79 127.15 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.522 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.912 -179.767 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.894 0.378 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -170.07 -44.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.171 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -60.87 135.3 57.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.404 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 1.6 m-85 -65.85 -45.65 81.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.036 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.9 p -172.61 141.25 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.98 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.459 HH11 ' HG3' ' A' ' 97' ' ' ARG . 38.5 ttm-85 -56.4 127.14 29.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.166 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.476 HG22 HD23 ' A' ' 121' ' ' LEU . 31.7 pt -72.88 141.83 15.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.717 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 59.7 m -61.22 143.23 55.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.945 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.422 ' HB3' ' HE1' ' A' ' 149' ' ' TRP . 41.1 t -47.91 130.78 15.27 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.354 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -76.69 -19.93 57.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.429 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 82.3 p -53.06 -46.63 68.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.787 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.527 ' O ' HG21 ' A' ' 111' ' ' VAL . 3.5 m-85 -61.72 -36.72 81.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.587 0.232 . . . . 0.0 111.204 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.6 mt -54.43 -48.64 71.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.109 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.6 m -92.55 137.85 32.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.927 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.625 HD13 ' HE2' ' A' ' 153' ' ' LYS . 24.8 tp -145.4 130.77 18.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.037 0.446 . . . . 0.0 111.348 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.474 ' HG2' ' ND2' ' A' ' 108' ' ' ASN . 44.4 tt0 -72.43 137.35 46.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.404 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.474 ' ND2' ' HG2' ' A' ' 107' ' ' GLU . 76.0 m-20 61.06 37.21 18.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.147 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 178.98 -179.33 48.92 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.704 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -142.03 147.12 36.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.79 0.328 . . . . 0.0 110.791 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.527 HG21 ' O ' ' A' ' 103' ' ' TYR . 86.3 t -107.23 141.61 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.969 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.15 135.32 46.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.598 ' N ' HD22 ' A' ' 113' ' ' LEU . 2.0 mm? -102.77 147.07 27.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.237 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.0 m -151.59 129.81 11.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.815 0.341 . . . . 0.0 111.256 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 56.19 43.56 89.0 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.62 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . -179.92 141.15 4.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.653 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -174.86 134.21 0.35 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.959 HD12 ' HA ' ' A' ' 119' ' ' PRO . 37.3 tp -43.82 131.62 4.07 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.939 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.959 ' HA ' HD12 ' A' ' 118' ' ' LEU . 84.6 Cg_endo -90.7 63.02 0.27 Allowed 'Cis proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.585 -1.423 . . . . 0.0 113.143 0.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.442 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -141.83 48.79 1.6 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.816 0.341 . . . . 0.0 111.26 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 121' ' ' LEU . 3.1 mm? -62.61 -45.08 94.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.636 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.455 ' OD1' ' HA ' ' A' ' 145' ' ' SER . 64.3 t0 -62.59 138.89 58.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.615 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.93 57.73 5.14 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.375 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.639 ' HB2' ' HA3' ' A' ' 116' ' ' GLY . . . -154.03 141.23 19.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.902 0.382 . . . . 0.0 111.271 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.62 HH21 ' HD2' ' A' ' 141' ' ' ARG . 41.9 ttt85 -108.62 141.66 40.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.504 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.408 HG23 ' CE1' ' A' ' 128' ' ' PHE . 19.1 m -130.88 140.16 49.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.963 0.411 . . . . 0.0 111.679 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -103.5 125.26 49.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.094 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.408 ' CE1' HG23 ' A' ' 126' ' ' VAL . 9.7 m-85 -92.38 143.04 26.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.084 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.404 HH11 ' HG3' ' A' ' 129' ' ' ARG . 41.3 ttt85 -172.34 124.07 0.49 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.991 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.533 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 56.9 m -89.31 146.03 24.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.883 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.663 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 59.5 m-20 -55.88 167.14 0.89 Allowed Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.37 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.663 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 2.1 Cg_endo -45.01 159.81 0.13 Allowed 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.268 2.645 . . . . 0.0 112.399 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.5 m-20 77.95 -37.67 0.24 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.258 -178.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.488 ' CE2' HG22 ' A' ' 158' ' ' VAL . 6.6 m-85 -108.52 126.25 52.71 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.46 ' H ' ' CD2' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -117.94 126.28 52.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.243 0.544 . . . . 0.0 111.335 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 137' ' ' VAL . 6.5 tt -72.58 130.16 39.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.029 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.539 ' N ' HD23 ' A' ' 136' ' ' LEU . 31.6 t -129.06 67.09 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.531 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -173.95 -131.99 1.48 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.496 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.534 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 80.1 p -73.86 64.51 0.98 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.979 0.418 . . . . 0.0 110.272 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.7 t -58.33 -2.2 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.436 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.62 ' HD2' HH21 ' A' ' 125' ' ' ARG . 53.8 mtm-85 -140.69 137.08 33.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.523 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.0 m -149.12 133.34 17.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.389 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 6.2 p -123.25 126.22 73.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.106 0.479 . . . . 0.0 111.289 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 52.6 t -98.99 140.04 33.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.755 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.455 ' HA ' ' OD1' ' A' ' 122' ' ' ASP . 43.7 t -170.05 38.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.128 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 52.0 tt0 177.68 47.18 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.502 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 54.36 35.27 55.51 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.949 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -177.39 144.86 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.422 ' HE1' ' HB3' ' A' ' 100' ' ' SER . 29.7 m95 -84.22 140.82 31.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.82 0.343 . . . . 0.0 110.689 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.4 t -52.72 -65.87 0.48 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.933 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 81.1 p -98.42 135.68 21.11 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.73 0.3 . . . . 0.0 111.8 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 27.1 Cg_exo -62.1 143.85 95.25 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.758 2.305 . . . . 0.0 111.616 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.625 ' HE2' HD13 ' A' ' 106' ' ' LEU . 83.3 tttt -47.92 130.71 11.81 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.839 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.534 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.3 Cg_endo -75.84 -148.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.814 2.343 . . . . 0.0 113.206 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.46 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 16.9 p-80 -153.75 130.99 11.17 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.181 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 93.5 m -99.07 135.38 40.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.064 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -103.02 141.51 35.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.224 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.488 HG22 ' CE2' ' A' ' 134' ' ' PHE . 49.3 t -69.52 79.53 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.055 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.43 -0.795 . . . . 0.0 111.472 -179.961 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.545 ' HG3' ' H ' ' A' ' 93' ' ' ALA . 5.1 tp10 . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 110.763 -0.088 . . . . 0.0 110.763 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.545 ' H ' ' HG3' ' A' ' 92' ' ' GLU . . . 58.61 -136.63 0.88 Allowed 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.623 0.249 . . . . 0.0 111.061 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -148.77 -134.68 0.07 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.336 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.442 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 1.9 m-85 -61.29 -48.62 80.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.712 0.291 . . . . 0.0 110.639 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.8 p -179.89 138.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.916 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.459 ' O ' ' HA2' ' A' ' 147' ' ' GLY . 70.0 mtt-85 -56.93 136.99 55.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.534 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.536 ' HB ' ' HG ' ' A' ' 121' ' ' LEU . 29.4 pt -78.51 38.81 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.448 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.502 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 68.0 m 59.21 141.06 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.013 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.6 t -48.03 126.3 10.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.312 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.677 ' HA ' HD23 ' A' ' 104' ' ' LEU . 63.9 pttt -80.01 -12.97 59.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.881 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.6 m -57.07 -42.26 80.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.563 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.509 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.7 m-85 -52.94 -37.6 61.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.234 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.677 HD23 ' HA ' ' A' ' 101' ' ' LYS . 2.0 mm? -54.1 -41.59 68.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.336 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.5 m -92.54 136.07 33.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.043 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.848 HD13 ' HE2' ' A' ' 153' ' ' LYS . 15.5 tp -145.39 130.62 18.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.25 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.502 ' N ' HD12 ' A' ' 106' ' ' LEU . 42.6 tt0 -70.66 131.15 43.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.416 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.436 ' ND2' ' HG2' ' A' ' 107' ' ' GLU . 76.5 m-20 54.81 42.42 31.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.993 0.425 . . . . 0.0 110.609 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.08 153.57 14.01 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.588 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -115.29 142.79 46.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.691 0.281 . . . . 0.0 110.758 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 103' ' ' TYR . 46.1 t -107.89 131.34 58.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.053 0.454 . . . . 0.0 110.977 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.428 ' O ' HG23 ' A' ' 126' ' ' VAL . 3.0 m-85 -109.82 150.78 27.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.784 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.663 ' O ' HD12 ' A' ' 113' ' ' LEU . 3.9 pp -158.13 149.78 21.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.916 0.388 . . . . 0.0 111.52 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.0 p -151.33 132.26 14.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.72 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 167.68 -129.78 1.97 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.433 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.75 -122.82 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.507 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.809 ' H ' ' HB3' ' A' ' 120' ' ' ALA . 54.4 t0 -161.68 -127.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.478 0.18 . . . . 0.0 110.64 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 119' ' ' PRO . 31.9 tp -128.88 130.05 23.46 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-O 120.761 0.315 . . . . 0.0 111.172 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.868 ' HA ' HD12 ' A' ' 118' ' ' LEU . 89.7 Cg_endo -91.86 42.47 2.84 Favored 'Cis proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.442 -1.483 . . . . 0.0 112.581 -0.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.809 ' HB3' ' H ' ' A' ' 117' ' ' ASP . . . -80.96 46.96 0.94 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.523 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.536 ' HG ' ' HB ' ' A' ' 98' ' ' ILE . 3.5 mm? -61.89 -38.05 86.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.147 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -61.27 146.03 49.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.1 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.1 -34.54 3.02 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.61 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.08 141.88 38.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.904 0.383 . . . . 0.0 111.649 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.44 ' HD2' HG23 ' A' ' 143' ' ' VAL . 43.9 mmm-85 -104.26 136.96 42.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.087 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 112' ' ' PHE . 15.0 p -123.83 133.14 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.189 0.519 . . . . 0.0 111.986 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -112.81 120.58 41.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.697 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.407 ' HE1' ' HB3' ' A' ' 142' ' ' SER . 8.5 m-85 -88.75 149.81 23.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.256 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -164.64 134.81 3.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.051 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 70.5 m -89.23 155.44 19.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.772 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 133' ' ' ASP . 11.5 p-10 -52.69 149.11 11.7 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.987 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -58.14 74.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.08 2.52 . . . . 0.0 112.576 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.1 t70 -177.74 -40.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.736 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.474 ' CE2' ' HB ' ' A' ' 158' ' ' VAL . 1.4 m-85 -107.86 142.65 37.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.829 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -101.24 129.1 47.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.068 0.461 . . . . 0.0 111.066 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 137' ' ' VAL . 6.9 tt -77.91 130.54 36.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.451 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.514 ' N ' HD23 ' A' ' 136' ' ' LEU . 38.5 t -131.87 66.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.415 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.04 -126.61 0.9 Allowed Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.079 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.713 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 34.9 t -72.3 58.52 0.39 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.947 0.403 . . . . 0.0 111.201 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.5 t -56.58 -26.58 55.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.853 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.413 ' HG3' HH11 ' A' ' 141' ' ' ARG . 45.2 ttm-85 -129.84 137.76 50.62 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.407 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 39.4 t -149.25 175.83 11.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.023 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.44 HG23 ' HD2' ' A' ' 125' ' ' ARG . 8.6 p -160.6 137.34 2.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.08 0.467 . . . . 0.0 112.003 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 37.1 t -78.79 135.07 36.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.886 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.8 t -175.26 133.48 0.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.953 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 56.87 40.94 28.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 97' ' ' ARG . . . 56.15 43.2 88.8 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.522 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -175.13 138.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.69 0.281 . . . . 0.0 110.702 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.502 ' CE2' ' HB3' ' A' ' 99' ' ' CYS . 14.5 m95 -84.2 140.25 31.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.371 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.4 p -52.92 -60.83 2.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.741 0.305 . . . . 0.0 110.865 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 40.3 p -101.23 140.54 21.36 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.127 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 24.4 Cg_exo -63.62 -153.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.628 2.218 . . . . 0.0 112.365 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.848 ' HE2' HD13 ' A' ' 106' ' ' LEU . 83.7 tttt -102.39 127.9 29.47 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.486 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.713 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 60.3 Cg_endo -72.66 -153.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.538 2.159 . . . . 0.0 112.717 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -153.67 144.64 22.78 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.484 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 66.2 m -97.3 134.05 41.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.895 0.379 . . . . 0.0 110.775 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -117.9 138.75 51.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.136 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.474 ' HB ' ' CE2' ' A' ' 134' ' ' PHE . 8.6 p -85.95 129.45 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.436 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.2 p30 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.968 -179.7 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.726 0.298 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -174.85 -133.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 60.32 49.73 6.79 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.72 0.295 . . . . 0.0 110.832 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 65.92 136.51 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.035 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 96' ' ' VAL . 15.0 p -167.52 46.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.365 0.603 . . . . 0.0 110.543 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 66.51 134.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.4 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.627 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -148.49 134.66 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.411 179.296 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 7.4 p -53.27 139.33 29.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.614 -179.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.4 m -47.91 128.1 12.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.482 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.687 ' HA ' HD13 ' A' ' 104' ' ' LEU . 9.0 ptpp? -84.56 3.75 35.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.019 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.4 t -63.29 -39.02 93.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.009 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.465 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.5 m-85 -54.94 -38.23 67.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.971 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.687 HD13 ' HA ' ' A' ' 101' ' ' LYS . 6.2 mp -54.56 -34.26 61.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.304 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.2 p -92.33 129.45 38.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 111.029 -179.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.844 HD13 ' HE2' ' A' ' 153' ' ' LYS . 22.3 tp -145.48 133.8 21.77 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.335 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 107' ' ' GLU . 8.2 pm0 -74.73 132.19 41.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.331 179.124 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 55.89 39.22 30.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.609 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.31 151.2 14.02 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.821 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -112.48 142.1 45.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.351 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 103' ' ' TYR . 43.0 t -106.98 137.5 37.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.994 0.426 . . . . 0.0 111.287 -179.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -104.72 142.09 35.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.293 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.651 ' HB3' HG23 ' A' ' 126' ' ' VAL . 4.1 pp -166.81 150.65 6.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.983 0.42 . . . . 0.0 111.697 -179.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.6 m -160.33 135.04 7.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.784 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 132.15 136.26 3.8 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 67.73 141.75 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.044 179.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 32.7 m-20 -130.53 -42.51 1.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.246 0.546 . . . . 0.0 109.64 179.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.715 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -130.27 123.01 20.36 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.407 179.559 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 118' ' ' LEU . 87.4 Cg_endo -81.7 33.59 2.16 Favored 'Cis proline' 0 C--N 1.347 0.461 0 C-N-CA 123.28 -1.55 . . . . 0.0 112.338 0.073 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 117' ' ' ASP . . . 66.65 146.82 0.04 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.874 0.369 . . . . 0.0 111.245 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.503 ' HB3' ' SG ' ' A' ' 99' ' ' CYS . 6.6 mp 62.43 35.1 15.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.01 -178.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -75.96 51.02 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.099 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.456 ' HA2' ' C ' ' A' ' 144' ' ' CYS . . . 71.44 42.32 56.41 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.567 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.35 -163.59 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.987 0.422 . . . . 0.0 111.318 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -112.3 146.29 38.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.435 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.651 HG23 ' HB3' ' A' ' 113' ' ' LEU . 8.1 p -141.86 138.56 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.114 0.483 . . . . 0.0 111.4 -179.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -132.59 111.68 11.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.375 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.471 ' HB2' HD11 ' A' ' 136' ' ' LEU . 3.1 m-85 -69.18 153.75 43.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.206 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.1 tpp85 -160.6 129.47 4.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.833 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 55.8 m -89.18 143.83 26.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.735 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' A' ' 133' ' ' ASP . 61.4 m-20 -53.2 150.85 10.38 Favored Pre-proline 0 N--CA 1.462 0.155 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.123 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 52.7 Cg_exo -53.55 77.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.23 2.62 . . . . 0.0 113.105 -179.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 131' ' ' ASP . 39.0 t70 177.73 -38.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.761 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -108.33 142.37 38.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.797 179.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.479 ' CD2' ' HB3' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -100.8 132.71 46.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.126 0.489 . . . . 0.0 111.07 179.91 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.548 HD23 ' N ' ' A' ' 137' ' ' VAL . 4.9 tt -76.93 124.71 28.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.07 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.548 ' N ' HD23 ' A' ' 136' ' ' LEU . 21.2 t -134.78 61.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.598 -179.259 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -166.11 -133.65 1.55 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 119.869 -1.158 . . . . 0.0 113.148 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.632 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 64.2 m -74.56 55.06 0.63 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.832 0.349 . . . . 0.0 110.991 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.528 ' HB2' HD22 ' A' ' 136' ' ' LEU . 36.6 t -51.39 -43.05 61.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.968 -179.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.434 HH11 ' HG3' ' A' ' 141' ' ' ARG . 40.1 ttt85 -99.47 131.16 45.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.829 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.437 ' O ' HG12 ' A' ' 126' ' ' VAL . 49.9 m -150.72 153.49 35.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.965 -179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.702 HG12 ' HB2' ' A' ' 150' ' ' SER . 15.0 p -138.27 134.24 43.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.172 0.51 . . . . 0.0 112.004 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.456 ' C ' ' HA2' ' A' ' 123' ' ' GLY . 27.5 t -74.14 152.51 39.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.481 179.202 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.9 p -155.9 -135.97 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.016 -179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -53.51 -38.88 64.16 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.882 0.373 . . . . 0.0 110.952 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . -174.11 -49.09 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.123 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -85.0 142.22 29.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.744 0.307 . . . . 0.0 110.355 179.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.411 ' NE1' ' HB2' ' A' ' 99' ' ' CYS . 35.9 m95 -84.11 151.18 25.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.484 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.702 ' HB2' HG12 ' A' ' 143' ' ' VAL . 48.3 t -44.97 -57.15 4.0 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.179 -179.31 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 72.4 p -121.23 145.13 41.4 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.947 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -57.61 -161.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.616 2.211 . . . . 0.0 112.765 -179.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.844 ' HE2' HD13 ' A' ' 106' ' ' LEU . 83.0 tttt -94.12 126.13 49.93 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.833 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.632 ' HB3' ' N ' ' A' ' 139' ' ' SER . 57.1 Cg_endo -70.77 -155.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.481 2.12 . . . . 0.0 112.384 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 24.9 p-80 -153.69 142.27 20.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 75.5 m -98.72 132.67 43.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.912 -179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.479 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 53.0 tt0 -116.33 141.05 48.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.808 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.03 132.42 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.287 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.7 p30 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.986 -179.422 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.811 0.339 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.44 -50.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.806 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -73.6 140.46 46.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.78 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -161.96 142.28 10.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.178 0.513 . . . . 0.0 111.152 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.8 t -61.67 138.8 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.214 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -77.5 49.78 0.75 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.357 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.1 pt -54.65 139.32 13.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.995 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.51 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 96.4 m -53.15 135.62 37.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.18 -179.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.6 t -47.92 127.96 12.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.457 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.846 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -87.25 -6.53 58.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.935 179.666 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.1 p -54.09 -34.73 60.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.219 -179.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.581 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.9 m-85 -57.04 -35.55 69.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.56 -179.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 104' ' ' LEU . 4.1 mp -77.8 37.49 0.24 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.107 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.4 p -147.5 63.55 1.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.802 0.334 . . . . 0.0 110.803 179.125 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.744 HD13 ' HE2' ' A' ' 153' ' ' LYS . 29.6 tp -94.12 128.91 40.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.634 -179.262 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -73.4 137.03 44.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.996 178.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.459 ' HB3' ' OD2' ' A' ' 131' ' ' ASP . 2.9 m120 58.64 42.03 21.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.108 0.48 . . . . 0.0 110.126 -179.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -171.27 164.58 37.57 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.647 -179.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -125.14 141.84 51.86 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.411 HG21 ' HA ' ' A' ' 104' ' ' LEU . 4.7 t -109.38 137.04 43.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.885 0.374 . . . . 0.0 111.021 -179.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.636 ' O ' HG23 ' A' ' 126' ' ' VAL . 2.3 m-85 -107.69 141.77 38.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.684 -179.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 114' ' ' THR . 7.1 tt -147.84 138.02 22.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.006 0.432 . . . . 0.0 111.015 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.589 ' N ' HD23 ' A' ' 113' ' ' LEU . 76.2 p -145.07 121.27 10.84 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.645 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.38 -43.37 0.77 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.163 -179.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -179.7 -138.67 3.41 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.071 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -178.04 -60.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.004 0.43 . . . . 0.0 110.824 179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.635 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -149.41 132.83 8.45 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.302 -179.468 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.07 19.72 6.56 Favored 'Cis proline' 0 C--N 1.347 0.464 0 C-N-CA 123.531 -1.446 . . . . 0.0 112.148 -0.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 50.73 -138.26 1.05 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.994 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 28.5 mt 58.72 63.2 1.72 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.831 0.348 . . . . 0.0 111.306 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -164.02 50.92 0.14 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.029 0.442 . . . . 0.0 110.702 -179.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.93 41.39 97.4 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.971 179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.32 134.3 39.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.768 0.318 . . . . 0.0 111.058 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -112.72 144.61 41.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 112' ' ' PHE . 8.5 p -141.39 142.03 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.081 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -133.81 123.0 24.06 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.111 -179.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.581 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 2.8 m-85 -79.99 147.13 31.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.871 179.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -141.24 130.99 24.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 76.1 m -93.88 140.81 29.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.181 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.554 ' HB2' ' HD2' ' A' ' 132' ' ' PRO . 1.9 p30 -62.25 161.16 26.61 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.514 179.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.554 ' HD2' ' HB2' ' A' ' 131' ' ' ASP . 1.5 Cg_endo -43.07 148.07 0.61 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.967 2.445 . . . . 0.0 112.067 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 21.8 m-20 78.96 -24.41 0.22 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.798 -179.039 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 157' ' ' GLN . 22.2 m-85 -108.61 134.86 50.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.7 0.286 . . . . 0.0 110.619 179.353 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -123.02 133.97 54.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.589 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.814 HD11 ' HG2' ' A' ' 154' ' ' PRO . 17.1 tp -75.35 130.14 38.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.722 -179.509 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.85 67.42 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.827 -179.199 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.87 -134.24 1.95 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.05 -1.072 . . . . 0.0 112.975 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.521 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 30.5 p -73.85 59.42 0.68 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.102 0.477 . . . . 0.0 110.712 179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.443 ' HA ' HD21 ' A' ' 136' ' ' LEU . 94.2 p -54.97 -50.9 67.8 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.444 -178.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.68 ' HD2' ' O ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -99.38 141.79 31.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.144 0.497 . . . . 0.0 112.006 -179.259 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.636 ' HA ' ' OG ' ' A' ' 150' ' ' SER . 55.3 p -150.69 146.0 26.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.148 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.798 HG12 ' HB3' ' A' ' 150' ' ' SER . 10.0 p -126.92 134.76 65.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.053 0.454 . . . . 0.0 111.863 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.71 143.98 51.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.714 179.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.2 m -149.9 -134.7 0.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.41 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -52.85 -34.72 55.57 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.929 0.395 . . . . 0.0 110.476 179.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.5 -48.8 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.767 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -80.41 144.12 32.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.676 0.274 . . . . 0.0 110.724 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.569 ' HB3' ' HB2' ' A' ' 142' ' ' SER . 44.0 m95 -84.2 151.07 25.07 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.421 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.798 ' HB3' HG12 ' A' ' 143' ' ' VAL . 98.5 p -43.34 -42.85 4.75 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.78 0.324 . . . . 0.0 110.703 -179.477 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.8 p -141.39 145.8 39.59 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.469 179.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.8 -156.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.697 2.265 . . . . 0.0 112.769 -179.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.744 ' HE2' HD13 ' A' ' 106' ' ' LEU . 87.3 tttt -101.5 125.39 37.68 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.821 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.814 ' HG2' HD11 ' A' ' 136' ' ' LEU . 60.0 Cg_endo -74.87 -149.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.407 2.071 . . . . 0.0 112.565 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -153.7 147.75 25.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.251 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 73.0 m -98.54 129.2 45.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.687 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 134' ' ' PHE . 84.5 mt-30 -107.59 136.58 47.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.994 0.426 . . . . 0.0 111.764 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.51 ' O ' HG22 ' A' ' 158' ' ' VAL . 11.9 p -83.11 47.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.499 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.954 -179.416 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.658 0.266 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.58 135.29 56.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.834 0.35 . . . . 0.0 111.421 -179.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -175.46 133.62 0.3 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.625 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -172.95 142.58 1.1 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.443 -179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.82 140.71 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.833 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -57.02 112.13 1.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.908 0.385 . . . . 0.0 110.756 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.648 ' H ' HD13 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -65.03 146.47 13.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.359 -179.644 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 35.1 m -52.21 143.23 14.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.464 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.631 ' HB2' ' HE1' ' A' ' 149' ' ' TRP . 53.3 m -47.98 125.7 9.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.998 0.427 . . . . 0.0 111.38 -179.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.843 ' HD3' HD21 ' A' ' 104' ' ' LEU . 16.8 tppt? -82.18 84.82 6.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.081 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.0 t -171.07 -44.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.748 0.309 . . . . 0.0 111.582 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.567 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.5 m-85 -60.71 -42.61 97.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.736 -179.454 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.91 ' HA ' HG11 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -49.95 -29.52 8.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.622 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.796 HG23 HD13 ' A' ' 104' ' ' LEU . 74.6 p -98.45 127.4 44.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.713 0.292 . . . . 0.0 110.766 179.345 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.646 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 69.0 tp -145.42 121.55 10.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.013 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.51 ' OE1' HD12 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -72.44 136.01 45.9 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.224 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 m120 58.71 39.3 24.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.136 -179.112 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.75 155.87 23.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.313 -179.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -111.67 140.05 46.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.975 0.417 . . . . 0.0 111.361 -179.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.91 HG11 ' HA ' ' A' ' 104' ' ' LEU . 96.1 t -111.08 128.59 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.648 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.614 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.8 m-85 -112.38 65.59 0.64 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.482 -179.099 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.762 HD23 ' H ' ' A' ' 113' ' ' LEU . 2.2 pt? -75.84 45.06 0.32 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.686 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 74.8 p -73.89 134.78 43.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.787 0.327 . . . . 0.0 111.414 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 124' ' ' ALA . . . 160.33 -54.92 0.33 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.426 -0.893 . . . . 0.0 113.111 179.513 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.72 ' HA3' ' HA ' ' A' ' 121' ' ' LEU . . . -82.78 -147.36 6.81 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.333 -179.389 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 65.8 t0 179.3 67.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.749 ' HA ' ' H ' ' A' ' 120' ' ' ALA . 88.2 mt -33.74 123.69 0.48 Allowed Pre-proline 0 N--CA 1.462 0.154 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.745 -178.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.64 92.61 0.12 OUTLIER 'Cis proline' 0 C--N 1.348 0.525 0 C-N-CA 123.471 -1.47 . . . . 0.0 112.559 -0.329 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.749 ' H ' ' HA ' ' A' ' 118' ' ' LEU . . . -177.52 150.15 0.67 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.637 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.72 ' HA ' ' HA3' ' A' ' 116' ' ' GLY . 0.4 OUTLIER -170.15 39.18 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.657 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.94 124.52 26.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.745 179.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 53.45 40.07 61.03 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.595 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.574 ' O ' HG23 ' A' ' 143' ' ' VAL . . . -72.1 124.7 25.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.756 0.312 . . . . 0.0 111.236 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -113.08 144.48 42.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.186 179.559 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.636 ' HB ' ' HA ' ' A' ' 113' ' ' LEU . 5.8 p -133.05 130.44 58.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.365 0.603 . . . . 0.0 112.22 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -98.48 136.12 39.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.29 179.404 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.589 ' HB2' ' HB2' ' A' ' 140' ' ' SER . 20.4 m-85 -112.85 142.73 45.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 0.0 111.569 -179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -163.14 126.85 2.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.271 179.067 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 18.1 t -89.19 140.42 29.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.189 -179.369 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.504 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 59.2 m-20 -54.82 161.39 2.31 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.267 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 8.2 Cg_endo -49.54 165.09 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.011 2.474 . . . . 0.0 112.031 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 159' ' ' ASN . 28.3 m-20 75.43 -17.99 0.48 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.396 -179.233 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.888 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 11.4 m-85 -131.16 131.43 44.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.896 179.383 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.642 ' HE1' ' HA ' ' A' ' 159' ' ' ASN . 5.8 m80 -102.86 124.04 47.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.639 0.256 . . . . 0.0 111.156 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.812 HD22 ' HB3' ' A' ' 140' ' ' SER . 5.1 tt -79.54 118.91 21.83 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.489 ' N ' HD23 ' A' ' 136' ' ' LEU . 46.0 t -136.87 76.98 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.548 -179.28 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.627 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . -171.6 60.1 0.17 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 119.807 -1.187 . . . . 0.0 113.027 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.527 ' OG ' HG21 ' A' ' 151' ' ' THR . 37.7 t 53.1 67.23 1.03 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.088 0.471 . . . . 0.0 109.744 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.812 ' HB3' HD22 ' A' ' 136' ' ' LEU . 84.9 p -71.09 37.7 0.05 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.917 -178.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.459 HH11 ' HG3' ' A' ' 141' ' ' ARG . 38.5 ttt85 -140.62 132.6 27.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.314 179.328 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.462 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 52.7 m -150.7 147.69 27.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.821 -179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 124' ' ' ALA . 7.1 p -147.58 132.05 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.897 0.38 . . . . 0.0 111.236 -179.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 55.6 m -64.6 148.48 50.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.147 179.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 42.8 m -149.54 -30.49 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.761 0.315 . . . . 0.0 111.353 -179.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -170.81 54.1 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.897 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.09 42.7 83.8 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.923 -179.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -172.5 136.88 0.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.631 ' HE1' ' HB2' ' A' ' 100' ' ' SER . 36.0 m95 -84.17 144.41 29.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.745 -179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 61.3 m -50.51 -49.77 54.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.697 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.527 HG21 ' OG ' ' A' ' 139' ' ' SER . 72.9 p -131.15 136.96 29.63 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.417 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 27.3 Cg_exo -62.61 159.38 37.01 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.089 2.526 . . . . 0.0 112.506 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.646 ' NZ ' HD13 ' A' ' 106' ' ' LEU . 3.9 mmmp? -53.61 134.76 54.46 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.331 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.627 ' HB3' ' HA3' ' A' ' 138' ' ' GLY . 5.7 Cg_exo -78.85 -146.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.328 2.686 . . . . 0.0 112.432 -179.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -153.71 149.43 27.49 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.602 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.888 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 74.4 m -95.24 133.88 38.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 110.848 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.676 HE21 HG12 ' A' ' 158' ' ' VAL . 71.0 tp60 -103.09 138.07 40.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.871 -179.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.676 HG12 HE21 ' A' ' 157' ' ' GLN . 9.1 p -60.18 133.15 25.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.642 ' HA ' ' HE1' ' A' ' 135' ' ' HIS . 26.5 t-20 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.911 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.723 0.297 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.43 130.46 42.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.983 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -66.17 130.14 42.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.417 ' HB2' ' H ' ' A' ' 96' ' ' VAL . 0.1 OUTLIER -71.88 -146.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.475 -179.955 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.417 ' H ' ' HB2' ' A' ' 95' ' ' PHE . 7.6 p -175.37 134.7 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.687 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.456 HH11 ' HG3' ' A' ' 97' ' ' ARG . 19.4 mmt85 -67.17 118.97 11.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.068 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.9 pt -84.03 145.15 8.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.148 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.421 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 75.0 m -53.97 140.46 31.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.699 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.9 m -48.02 129.27 14.66 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.42 -179.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.57 ' HB2' HD12 ' A' ' 104' ' ' LEU . 17.6 ptpt -81.31 11.48 4.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.375 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.8 t -68.51 -39.75 81.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.036 0.446 . . . . 0.0 110.72 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.63 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.3 m-85 -61.73 -33.22 73.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.43 -179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.57 HD12 ' HB2' ' A' ' 101' ' ' LYS . 80.8 mt -45.63 -45.43 13.9 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.276 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t -92.52 138.53 31.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.501 179.339 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.811 HD22 ' HA3' ' A' ' 109' ' ' GLY . 6.6 tt -145.41 124.39 12.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.507 -179.268 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.473 ' O ' HD23 ' A' ' 106' ' ' LEU . 22.9 pt-20 -61.45 125.67 24.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.677 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 56.55 39.84 29.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.135 0.493 . . . . 0.0 110.09 -179.268 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.811 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -161.72 174.94 38.29 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.121 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -142.01 137.55 31.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.792 0.33 . . . . 0.0 110.914 -179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.63 HG21 ' O ' ' A' ' 103' ' ' TYR . 94.0 t -109.73 132.43 57.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.009 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -111.76 133.13 54.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.624 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.71 ' HG ' HG12 ' A' ' 126' ' ' VAL . 6.1 mp -108.39 132.6 53.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.151 179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.1 t -162.03 129.44 3.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.078 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 157.51 -39.43 0.54 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.373 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.31 -127.86 0.91 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.208 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -174.82 133.66 0.35 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.716 ' O ' HD12 ' A' ' 118' ' ' LEU . 4.3 pp -43.27 140.57 2.11 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -87.97 45.19 1.28 Allowed 'Cis proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.578 -1.426 . . . . 0.0 113.54 0.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.21 146.79 54.5 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.789 0.328 . . . . 0.0 110.778 179.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.446 HD13 ' C ' ' A' ' 121' ' ' LEU . 2.2 tm? -140.35 -52.0 0.49 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.154 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.98 44.99 0.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.759 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 169.42 61.1 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.134 -1.032 . . . . 0.0 113.022 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -159.66 125.62 4.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.955 0.407 . . . . 0.0 111.45 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.472 ' HG2' HG13 ' A' ' 143' ' ' VAL . 61.2 mtt85 -133.6 129.79 37.45 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.753 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.71 HG12 ' HG ' ' A' ' 113' ' ' LEU . 31.0 m -97.72 132.64 42.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 120.946 0.403 . . . . 0.0 111.501 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -98.16 124.98 42.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.764 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 126' ' ' VAL . 5.2 m-85 -93.18 143.93 25.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.965 0.412 . . . . 0.0 110.986 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -158.96 127.46 5.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.197 179.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.448 ' HB2' ' HB2' ' A' ' 136' ' ' LEU . 49.8 t -89.27 144.93 25.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.263 -179.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.78 152.1 7.39 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.937 179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.497 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 3.7 Cg_endo -46.66 156.66 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.961 2.441 . . . . 0.0 111.928 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 62.7 t0 78.64 -35.54 0.18 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.584 -179.217 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.712 ' HB3' ' SG ' ' A' ' 156' ' ' CYS . 0.6 OUTLIER -108.33 135.5 49.53 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.058 179.287 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -112.96 134.02 54.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.551 -179.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 137' ' ' VAL . 7.4 tt -79.02 132.89 36.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.203 179.508 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.521 ' N ' HD23 ' A' ' 136' ' ' LEU . 46.3 t -128.6 77.91 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.584 -179.516 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . 173.88 -124.42 1.04 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.838 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.829 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 26.8 t -71.25 60.37 0.29 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.958 0.409 . . . . 0.0 111.263 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 128' ' ' PHE . 35.4 t -58.05 -23.74 55.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -140.64 139.78 34.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.705 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.577 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 63.3 m -144.53 130.3 19.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.9 0.381 . . . . 0.0 111.322 -179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.472 HG13 ' HG2' ' A' ' 125' ' ' ARG . 32.1 t -97.6 133.02 41.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.074 179.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 50.4 t -80.5 50.87 1.36 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.986 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 62.8 m -80.24 134.85 36.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.902 -179.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 37.4 tt0 50.67 46.96 25.14 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.487 179.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 51.94 44.51 56.04 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.317 179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -165.48 142.79 5.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.738 0.304 . . . . 0.0 110.282 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 142' ' ' SER . 55.3 m95 -84.2 139.88 32.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.917 0.389 . . . . 0.0 111.046 -179.34 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -56.5 -51.66 67.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.375 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 29.0 p -118.85 134.28 23.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.804 0.335 . . . . 0.0 111.898 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.419 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 39.6 Cg_endo -66.52 145.36 76.34 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.985 2.456 . . . . 0.0 112.461 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.434 ' NZ ' ' HG ' ' A' ' 106' ' ' LEU . 60.8 tttm -46.76 127.35 8.44 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.949 -179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.829 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 68.4 Cg_endo -89.24 -141.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.096 2.531 . . . . 0.0 113.343 -179.311 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.486 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.2 p-80 -153.71 146.67 24.48 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.101 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.712 ' SG ' ' HB3' ' A' ' 134' ' ' PHE . 22.3 t -97.39 133.07 42.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 111.179 -179.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -103.04 137.03 41.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.948 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.9 p -88.9 133.12 31.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 179.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.935 -179.837 . . . . . . . . 0 0 . 1 stop_ save_